FORM S-1
As filed with the Securities and Exchange Commission on
May 27, 2009
Registration
No. 333-
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form S-1
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
HCA Inc.
(Exact name of registrant issuer
as specified in its charter)
SEE TABLE OF ADDITIONAL REGISTRANTS
|
|
|
|
|
Delaware
|
|
8062
|
|
75-2497104
|
(State or other jurisdiction
of incorporation)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
One Park Plaza
Nashville, Tennessee 37203
(615) 344-9551
(Address, including zip code,
and telephone number, including area code, of registrants
principal executive offices)
John M. Franck II, Esq.
HCA Inc.
Vice President and Corporate Secretary
One Park Plaza
Nashville, Tennessee 37203
Telephone: (615) 344-9551
(Name, address, including zip
code, and telephone number, including area code, of agent for
service)
With a copy to:
Richard A. Fenyes, Esq.
John C. Ericson, Esq.
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, New York 10017-3954
Telephone: (212) 455-2000
Approximate date of commencement of proposed sale to
public: From time to time after this registration
statement becomes effective.
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933 check the
following
box: þ
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(d) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in Rule
12b-2 of the
Exchange Act. (Check one):
|
|
|
|
Large
accelerated
filer o
|
Accelerated
filer o
|
Non-accelerated
filer þ
|
Smaller
reporting
company o
|
(Do not check if a smaller reporting company)
CALCULATION
OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed Maximum
|
|
|
|
Proposed Maximum
|
|
|
|
Amount of
|
|
Title of Each Class of
|
|
|
Amount to
|
|
|
|
Offering
|
|
|
|
Aggregate
|
|
|
|
Registration
|
|
Securities to be Registered
|
|
|
be Registered
|
|
|
|
Price per Note
|
|
|
|
Offering Price
|
|
|
|
Fee
|
|
5.50% Senior Notes due 2009
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
8.75% Senior Notes due 2010
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
8.75% Senior Notes due 2010
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.875% Senior Notes due 2011
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
6.95% Senior Notes due 2012
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
6.30% Senior Notes due 2012
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
6.25% Senior Notes due 2013
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
6.75% Senior Notes due 2013
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
5.75% Senior Notes due 2014
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
6.375% Senior Notes due 2015
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
6.50% Senior Notes due 2016
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.69% Notes due 2025
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.50% Senior Notes due 2033
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.19% Debentures due 2015
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.50% Debentures due 2023
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
8.36% Debentures due 2024
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.05% Debentures due 2027
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.75% Debentures due 2036
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.50% Debentures due 2095
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
8.70% Medium-Term Notes due 2010
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
9.00% Medium-Term Notes due 2014
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
7.58% Medium-Term Notes due 2025
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
91/8% Senior
Secured Notes due 2014
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
91/4% Senior
Secured Notes due 2016
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
95/8/103/8% Senior
Secured Toggle Notes due 2016
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
97/8% Senior
Secured Notes due 2017
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
81/2% Senior
Secured Notes due 2019
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
Guarantees of
91/8% Senior
Secured Notes due 2014(2)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
Guarantees of
91/4% Senior
Secured Notes due 2016(2)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
Guarantees of
95/8/103/8% Senior
Secured Toggle Notes due 2016(2)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
Guarantees of
97/8% Senior
Secured Notes due 2017(2)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
Guarantees of
81/2% Senior
Secured Notes due 2019(2)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
An indeterminate amount of securities are being registered
hereby to be offered solely for market-making purposes by
affiliates of the registrant. Pursuant to Rule 457(q) under
the Securities Act of 1933, as amended, no filing fee is
required. |
|
(2) |
|
See inside facing page for additional registrant guarantors. |
The Registrants hereby amend this Registration Statement on
such date or dates as may be necessary to delay its effective
date until the Registrants shall file a further amendment which
specifically states that this Registration Statement shall
thereafter become effective in accordance with Section 8(a)
of the Securities Act of 1933, as amended, or until the
Registration Statement shall become effective on such date as
the Securities and Exchange Commission, acting pursuant to said
Section 8(a), may determine.
Table of
Additional Registrant Guarantors
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
American Medicorp Development Co.
|
|
Delaware
|
|
23-1696018
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Bay Hospital, Inc.
|
|
Florida
|
|
62-0976863
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Brigham City Community Hospital, Inc.
|
|
Utah
|
|
87-0318837
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Brookwood Medical Center of Gulfport, Inc.
|
|
Mississippi
|
|
63-0751470
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Capital Division, Inc.
|
|
Virginia
|
|
62-1668319
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Centerpoint Medical Center of Independence, LLC
|
|
Delaware
|
|
45-0503121
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Central Florida Regional Hospital, Inc.
|
|
Florida
|
|
59-1978725
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Central Shared Services, LLC
|
|
Virginia
|
|
76-0771216
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Central Tennessee Hospital Corporation
|
|
Tennessee
|
|
62-1620866
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
CHCA Bayshore, L.P.
|
|
Delaware
|
|
62-1801359
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
CHCA Conroe, L.P.
|
|
Delaware
|
|
62-1801361
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
CHCA Mainland, L.P.
|
|
Delaware
|
|
62-1801362
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
CHCA West Houston, L.P.
|
|
Delaware
|
|
62-1801363
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
CHCA Womans Hospital, L.P.
|
|
Delaware
|
|
62-1810381
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Chippenham & Johnston-Willis Hospitals, Inc.
|
|
Virginia
|
|
54-1779911
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
CMS GP, LLC
|
|
Delaware
|
|
62-1778113
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Colorado Health Systems, Inc.
|
|
Colorado
|
|
62-1593008
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia ASC Management, L.P.
|
|
California
|
|
33-0539838
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Jacksonville Healthcare System, Inc.
|
|
Florida
|
|
61-1272241
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia LaGrange Hospital, Inc.
|
|
Illinois
|
|
61-1276162
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Medical Center of Arlington Subsidiary, L.P.
|
|
Texas
|
|
62-1682201
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Medical Center of Denton Subsidiary, L.P.
|
|
Texas
|
|
62-1682213
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Medical Center of Las Colinas, Inc.
|
|
Texas
|
|
62-1650582
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Medical Center of Lewisville Subsidiary, L.P.
|
|
Texas
|
|
62-1682210
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Medical Center of McKinney Subsidiary, L.P.
|
|
Texas
|
|
62-1682207
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Medical Center of Plano Subsidiary, L.P.
|
|
Texas
|
|
62-1682203
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia North Hills Hospital Subsidiary, L.P.
|
|
Texas
|
|
62-1682205
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Ogden Medical Center, Inc.
|
|
Utah
|
|
62-1650578
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Parkersburg Healthcare System, LLC
|
|
West Virginia
|
|
62-1634494
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Plaza Medical Center of Fort Worth Subsidiary,
L.P.
|
|
Texas
|
|
62-1682202
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Polk General Hospital, Inc.
|
|
Georgia
|
|
62-1619423
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Rio Grande Healthcare, L.P.
|
|
Delaware
|
|
62-1656022
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Columbia Riverside, Inc.
|
|
California
|
|
62-1664328
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia Valley Healthcare System, L.P.
|
|
Delaware
|
|
62-1669572
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia/Alleghany Regional Hospital, Incorporated
|
|
Virginia
|
|
54-1761046
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbia/HCA John Randolph, Inc.
|
|
Virginia
|
|
61-1272888
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbine Psychiatric Center, Inc.
|
|
Colorado
|
|
84-1042212
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Columbus Cardiology, Inc.
|
|
Georgia
|
|
58-1941109
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Conroe Hospital Corporation
|
|
Texas
|
|
74-2467524
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Dallas/Ft. Worth Physician, LLC
|
|
Delaware
|
|
62-1769694
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Dauterive Hospital Corporation
|
|
Louisiana
|
|
58-1741846
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Dublin Community Hospital, LLC
|
|
Georgia
|
|
58-1431023
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Eastern Idaho Health Services, Inc.
|
|
Idaho
|
|
82-0436622
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Edmond Regional Medical Center, LLC
|
|
Delaware
|
|
62-1757655
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Edward White Hospital, Inc.
|
|
Florida
|
|
59-3089836
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
El Paso Surgicenter, Inc.
|
|
Texas
|
|
74-2361005
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Encino Hospital Corporation, Inc.
|
|
California
|
|
95-4113862
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
EP Health, LLC
|
|
Delaware
|
|
62-1769682
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Fairview Park GP, LLC
|
|
Delaware
|
|
62-1815913
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Fairview Park, Limited Partnership
|
|
Georgia
|
|
62-1817469
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Frankfort Hospital, Inc.
|
|
Kentucky
|
|
61-0859329
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Galen Property, LLC
|
|
Virginia
|
|
35-2260545
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
General Healthserv, LLC
|
|
Delaware
|
|
62-1769690
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Good Samaritan Hospital, L.P.
|
|
Delaware
|
|
62-1763090
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Goppert-Trinity Family Care, LLC
|
|
Delaware
|
|
76-0726651
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
GPCH-GP, Inc.
|
|
Delaware
|
|
64-0805500
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Grand Strand Regional Medical Center, LLC
|
|
Delaware
|
|
62-1768105
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Green Oaks Hospital Subsidiary, L.P.
|
|
Texas
|
|
62-1797829
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Greenview Hospital, Inc.
|
|
Kentucky
|
|
61-0724492
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Hamilton Medical Center, Inc.
|
|
Louisiana
|
|
58-1741727
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA IT&S Field Operations, Inc.
|
|
Delaware
|
|
06-1795732
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA IT&S Inventory Management, Inc.
|
|
Delaware
|
|
06-1796286
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA Central Group, Inc.
|
|
Tennessee
|
|
02-0762180
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA Health Services of Florida, Inc.
|
|
Florida
|
|
62-1113740
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
HCA Health Services of Louisiana, Inc.
|
|
Louisiana
|
|
62-1113736
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA Health Services of Oklahoma, Inc.
|
|
Oklahoma
|
|
62-1106156
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA Health Services of Tennessee, Inc.
|
|
Tennessee
|
|
62-1113737
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA Health Services of Virginia, Inc.
|
|
Virginia
|
|
62-1113733
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA Management Services, L.P.
|
|
Delaware
|
|
62-1778108
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HCA Realty, Inc.
|
|
Tennessee
|
|
06-1106160
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HD&S Corp. Successor, Inc.
|
|
Florida
|
|
62-1657694
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Health Midwest Office Facilities Corporation
|
|
Missouri
|
|
43-1175071
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Health Midwest Ventures Group, Inc.
|
|
Missouri
|
|
43-1315348
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Healthtrust MOB, LLC
|
|
Delaware
|
|
62-1824860
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Hendersonville Hospital Corporation
|
|
Tennessee
|
|
62-1321255
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Hospital Corporation of Tennessee
|
|
Tennessee
|
|
62-1124446
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Hospital Corporation of Utah
|
|
Utah
|
|
87-0322019
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Hospital Development Properties, Inc.
|
|
Delaware
|
|
62-1321246
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HSS Holdco, LLC
|
|
Delaware
|
|
62-1839825
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HSS Systems VA, LLC
|
|
Delaware
|
|
62-1804832
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
HSS Systems, LLC
|
|
Delaware
|
|
62-1804834
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HSS Virginia, L.P.
|
|
Virginia
|
|
62-1848294
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
HTI Memorial Hospital Corporation
|
|
Tennessee
|
|
62-1560757
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Integrated Regional Lab, LLC
|
|
Florida
|
|
36-4576441
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Integrated Regional Laboratories, LLP
|
|
Delaware
|
|
62-1687140
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
JFK Medical Center Limited Partnership
|
|
Delaware
|
|
62-1694180
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
KPH-Consolidation, Inc.
|
|
Texas
|
|
62-1619857
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Lakeland Medical Center, LLC
|
|
Delaware
|
|
62-1762603
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Lakeview Medical Center, LLC
|
|
Delaware
|
|
62-1762416
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Largo Medical Center, Inc.
|
|
Florida
|
|
62-1026428
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Las Vegas Surgicare, Inc.
|
|
Nevada
|
|
75-1890731
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Lawnwood Medical Center, Inc.
|
|
Florida
|
|
59-1764486
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Lewis-Gale Hospital, Incorporated
|
|
Virginia
|
|
54-0218835
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Lewis-Gale Medical Center, LLC
|
|
Delaware
|
|
62-1760148
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Lewis-Gale Physicians, LLC
|
|
Virginia
|
|
06-1755234
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Los Robles Regional Medical Center
|
|
California
|
|
95-2321136
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Management Services Holdings, Inc.
|
|
Delaware
|
|
62-1874287
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Marietta Surgical Center, Inc.
|
|
Georgia
|
|
58-1539547
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Marion Community Hospital, Inc.
|
|
Florida
|
|
59-1479652
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
MCA Investment Company
|
|
California
|
|
33-0539836
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Medical Centers of Oklahoma, LLC
|
|
Delaware
|
|
62-1771846
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Medical Office Buildings of Kansas, LLC
|
|
Delaware
|
|
62-1789791
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Memorial Healthcare Group, Inc.
|
|
Florida
|
|
59-3283127
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division ACH, LLC
|
|
Delaware
|
|
48-1301811
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division LRHC, LLC
|
|
Delaware
|
|
48-1301817
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division LSH, LLC
|
|
Delaware
|
|
45-0503141
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division MCI, LLC
|
|
Delaware
|
|
45-0503127
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division MMC, LLC
|
|
Delaware
|
|
48-1301826
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division OPRMC, LLC
|
|
Delaware
|
|
45-0503116
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division PFC, LLC
|
|
Delaware
|
|
48-1302330
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division RBH, LLC
|
|
Missouri
|
|
20-0851062
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Division RMC, LLC
|
|
Delaware
|
|
54-2092552
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Midwest Division RPC, LLC
|
|
Delaware
|
|
48-1301829
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Midwest Holdings, Inc.
|
|
Delaware
|
|
11-3676736
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Montgomery Regional Hospital, Inc.
|
|
Virginia
|
|
54-0889154
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Mountain View Hospital, Inc.
|
|
Utah
|
|
87-0333048
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Nashville Shared Services General Partnership
|
|
Delaware
|
|
62-1841237
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
National Patient Account Services, Inc.
|
|
Texas
|
|
62-1645596
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
New Port Richey Hospital, Inc.
|
|
Florida
|
|
59-2047041
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
New Rose Holding Company, Inc.
|
|
Colorado
|
|
62-1617432
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
North Florida Immediate Care Center, Inc.
|
|
Florida
|
|
58-2075775
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
North Florida Regional Medical Center, Inc.
|
|
Florida
|
|
61-1269294
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Northern Utah Healthcare Corporation
|
|
Utah
|
|
62-1650573
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Northern Virginia Community Hospital, LLC
|
|
Virginia
|
|
04-3665595
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Northlake Medical Center, LLC
|
|
Georgia
|
|
58-2433434
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Notami Hospitals of Louisiana, Inc.
|
|
Louisiana
|
|
95-4176923
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Notami Hospitals, LLC
|
|
Delaware
|
|
62-1761993
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Okaloosa Hospital, Inc.
|
|
Florida
|
|
59-1836808
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Okeechobee Hospital, Inc.
|
|
Florida
|
|
59-1833934
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Outpatient Cardiovascular Center of Central Florida, LLC
|
|
Delaware
|
|
52-2448149
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Palms West Hospital Limited Partnership
|
|
Delaware
|
|
62-1694178
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Palmyra Park Hospital, Inc.
|
|
Georgia
|
|
58-1091107
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Pasadena Bayshore Hospital, Inc.
|
|
Texas
|
|
74-1616679
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Plantation General Hospital, L.P.
|
|
Delaware
|
|
62-1372389
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Pulaski Community Hospital, Inc.
|
|
Virginia
|
|
54-0941129
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Redmond Park Hospital, LLC
|
|
Georgia
|
|
58-1123037
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Redmond Physician Practice Company
|
|
Georgia
|
|
62-1662134
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Reston Hospital Center, LLC
|
|
Delaware
|
|
62-1777534
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Retreat Hospital, LLC
|
|
Virginia
|
|
61-1272890
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Rio Grande Regional Hospital, Inc.
|
|
Texas
|
|
61-1276564
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Riverside Healthcare System, L.P.
|
|
California
|
|
33-0751869
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Riverside Hospital, Inc.
|
|
Delaware
|
|
74-2600687
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Samaritan, LLC
|
|
Delaware
|
|
62-1762605
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
San Jose Healthcare System, LP
|
|
Delaware
|
|
77-0498674
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
San Jose Hospital, L.P.
|
|
Delaware
|
|
62-1763091
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
San Jose Medical Center, LLC
|
|
Delaware
|
|
62-1762609
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
San Jose, LLC
|
|
Delaware
|
|
62-1756992
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Sarasota Doctors Hospital, Inc.
|
|
Florida
|
|
61-1258724
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
SJMC, LLC
|
|
Delaware
|
|
62-1762613
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Southern Hills Medical Center, LLC
|
|
Nevada
|
|
74-3048428
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Spotsylvania Medical Center, Inc
|
|
Virginia
|
|
06-1760818
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Spring Branch Medical Center, Inc.
|
|
Texas
|
|
61-1261492
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Spring Hill Hospital, Inc.
|
|
Tennessee
|
|
84-1706716
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
St. Marks Lone Peak Hospital, Inc.
|
|
Utah
|
|
25-1925376
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Sun City Hospital, Inc.
|
|
Florida
|
|
59-2822337
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Sunrise Mountainview Hospital, Inc.
|
|
Nevada
|
|
62-1600397
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Surgicare of Brandon, Inc.
|
|
Florida
|
|
58-1819994
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Surgicare of Florida, Inc.
|
|
Florida
|
|
95-3947578
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Surgicare of Houston Womens, Inc.
|
|
Texas
|
|
72-1563673
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Surgicare of Manatee, Inc.
|
|
Florida
|
|
75-2364410
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Surgicare of New Port Richey, Inc.
|
|
Florida
|
|
75-2243308
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Surgicare of Palms West, LLC
|
|
Florida
|
|
20-1008436
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Surgicare of Riverside, LLC
|
|
California
|
|
26-0047096
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Tallahassee Medical Center, Inc.
|
|
Florida
|
|
62-1091430
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
TCMC Madison-Portland, Inc.
|
|
Tennessee
|
|
76-0811731
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Terre Haute Hospital GP, Inc.
|
|
Delaware
|
|
62-1861156
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Terre Haute Hospital Holdings, Inc.
|
|
Delaware
|
|
62-1861158
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Terre Haute MOB, L.P.
|
|
Indiana
|
|
76-0775694
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Terre Haute Regional Hospital, L.P.
|
|
Delaware
|
|
35-1461805
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Timpanogos Regional Medical Services, Inc.
|
|
Utah
|
|
62-1831495
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Trident Medical Center, LLC
|
|
Delaware
|
|
62-1768106
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Utah Medco, LLC
|
|
Delaware
|
|
62-1769672
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
VH Holdco, Inc.
|
|
Nevada
|
|
62-1749073
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
VH Holdings, Inc.
|
|
Nevada
|
|
62-1720399
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Virginia Psychiatric Company, Inc.
|
|
Virginia
|
|
62-1410313
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
W & C Hospital, Inc.
|
|
Texas
|
|
61-1259838
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address, Including
|
|
|
|
|
|
|
Zip Code, and
|
|
|
|
|
|
|
Telephone Number,
|
|
|
|
|
|
|
Including Area
|
|
|
State or Other
|
|
|
|
Code, of Registrant
|
|
|
Jurisdiction of
|
|
I.R.S. Employer
|
|
Guarantors
|
Exact Name of Registrant Guarantor as Specified
|
|
Incorporation or
|
|
Identification
|
|
Principal Executive
|
in its Charter (or Other Organizational Document)
|
|
Organization
|
|
Number
|
|
Offices
|
|
Walterboro Community Hospital, Inc.
|
|
South Carolina
|
|
57-0712623
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Wesley Medical Center, LLC
|
|
Delaware
|
|
62-1762545
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
West Florida Regional Medical Center, Inc.
|
|
Florida
|
|
59-1525468
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
West Valley Medical Center, Inc.
|
|
Idaho
|
|
36-3525049
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Western Plains Capital, Inc.
|
|
Nevada
|
|
62-1727347
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
WHMC, Inc.
|
|
Texas
|
|
61-1261485
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Womans Hospital of Texas, Incorporated
|
|
Texas
|
|
74-1991424
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
Womens and Childrens Hospital, Inc.
|
|
Louisiana
|
|
58-1741726
|
|
One Park Plaza
Nashville, TN 37203
(615) 344-9551
|
The
information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these
securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not
permitted.
|
SUBJECT TO COMPLETION, DATED MAY
27, 2009
Preliminary Prospectus
HCA
Inc.
Debt
Securities
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of the notes
or passed upon the adequacy or accuracy of this prospectus. Any
representation to the contrary is a criminal offense.
This prospectus has been prepared for and may be used by Banc of
America Securities LLC, Merrill Lynch, Pierce,
Fenner & Smith Incorporated and their affiliates in
connection with offers and sales of the debt securities
referenced herein related to market-making transactions in such
debt securities effected from time to time. Such affiliates may
act as principal or agent in such transactions, including as
agent for the counterparty when acting as principal or as agent
for both counterparties, and may receive compensation in the
form of discounts and commissions, including from both
counterparties, when they act as agents for both. Such sales
will be made at prevailing market prices at the time of sale, at
prices related thereto or at negotiated prices. We will not
receive any proceeds from such sales.
You should rely only on the information contained in this
prospectus. We have not authorized anyone to provide you with
different information. The prospectus may be used only for the
purposes for which it has been published and no person has been
authorized to give any information not contained herein. If you
receive any other information, you should not rely on it. We are
not making an offer of these securities in any state where the
offer is not permitted.
Investing in the notes involves risks. See Risk
Factors beginning on page 6 for a discussion of
certain risks that you should consider before investing in the
securities.
We are offering to sell these securities only in places where
sales are permitted.
The date of this prospectus
is ,
2009.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
2
|
|
|
|
|
5
|
|
|
|
|
6
|
|
|
|
|
21
|
|
|
|
|
22
|
|
|
|
|
28
|
|
|
|
|
260
|
|
|
|
|
263
|
|
|
|
|
271
|
|
|
|
|
272
|
|
|
|
|
272
|
|
EX-3.3: AMERICAN MEDICORP DEVELOPMENT CO. ARTICLES OF INCORPORATION |
EX-3.4: AMERICAN MEDICORP DEVELOPMENT CO. BY-LAWS |
EX-3.60: COLUMBIA PARKERSBURG HEALTHCARE SYSTEM, LLC ARTICLES OF CONVERSION |
EX-3.124: HCA-IT&S FIELD OPERATIONS, INC. ARTICLES OF INCORPORATION |
EX-3.125: HCA-IT&S FIELD OPERATIONS, INC. BY-LAWS |
EX-3.126: HCA-IT&S INVENTORY MANAGEMENT, INC. ARTICLES OF INCORPORATION |
EX-3.127: HCA-IT&S INVENTORY MANAGEMENT, INC. BY-LAWS |
EX-3.142: HCA REALTY, INC. CHARTER |
EX-3.143: HCA REALTY, INC. BY-LAWS |
EX-3.267: PASADENA BAYSHORE HOSPITAL, INC. ARTICLES OF INCORPORATION |
EX-3.268: PASADENA BAYSHORE HOSPITAL INC. BY-LAWS |
EX-3.279: RETREAT HOSPITAL, LLC ARTICLES OF INCORPORATION |
EX-3.280: RETREAT HOSPITAL, LLC LIMITED LIABILITY COMPANY AGREEMENT |
EX-5.1: OPINION OF SIMPSON THACHER & BARTLETT LLP |
EX-5.2: OPINION OF ROBERT A. WATERMAN |
EX-12.1: STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES |
EX-21.1: SUBSIDIARIES |
EX-23.3: CONSENT OF ERNST & YOUNG LLP |
EX-25.1: FORM T-1 STATEMENT OF ELIGIBILITY |
EX-25.2: FORM T-1 STATEMENT OF ELIGIBILITY |
EX-25.3: FORM T-1 STATEMENT OF ELIGIBILITY |
EX-25.4: FORM T-1 STATEMENT OF ELIGIBILITY |
WHERE YOU
CAN FIND MORE INFORMATION ABOUT HCA INC.
We file certain reports with the Securities and Exchange
Commission (the SEC), including annual reports on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K.
The public may read and copy any materials we file with the SEC
at the SECs Public Reference Room at
100 F Street, N.E., Washington, DC 20549. The public
may obtain information on the operation of the Public Reference
Room by calling the SEC at
1-800-SEC-0330.
We are an electronic filer, and the SEC maintains an Internet
site at
http://www.sec.gov
that contains the reports and other information we file
electronically. Our website address is www.hcahealthcare.com.
Please note that our website address is provided as an inactive
textual reference only. The information provided on our website
is not part of this prospectus and is therefore not incorporated
by reference unless such information is specifically referenced
elsewhere in this prospectus. We make available free of charge,
through our website, our annual report on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K
and all amendments to those reports filed or furnished pursuant
to Section 15(d) of the Exchange Act, as soon as reasonably
practicable after such material is electronically filed with or
furnished to the SEC.
The SEC allows us to incorporate by reference into
this prospectus the information in documents we file with the
SEC, which means that we can disclose important information to
you by referring you to those documents. The information
incorporated by reference is considered to be a part of this
prospectus, and later information that we file with the SEC will
update and supersede this information. The information contained
in this prospectus supersedes any inconsistent information
contained in the documents incorporated by reference herein.
We incorporate by reference the documents listed below other
than, in each case, those documents or the portions of those
documents which are furnished and not filed:
|
|
|
|
|
HCA Inc.s annual report on
Form 10-K
for the year ended December 31, 2008;
|
|
|
|
HCA Inc.s quarterly report on
Form 10-Q
for the quarter ended March 31, 2009;
|
|
|
|
HCA Inc.s current reports on
Form 8-K
filed on February 11, 2009 (Item 5.02),
February 25, 2009, April 27, 2009, April 28,
2009, May 7, 2009 and May 27, 2009; and
|
|
|
|
the descriptions of the terms of the specified debt securities
contained under the captions indicated in the following
documents filed with the SEC:
|
|
|
|
|
|
the description of the 5.50% Senior Notes Due 2009 and the
6.375% Senior Notes Due 2015 set forth under the caption
Description of the Notes in the prospectus
supplement dated November 16, 2004, and under the caption
Description of the Debt Securities in the prospectus
dated October 16, 2003, each filed with the SEC on
November 17, 2004 (SEC File
No. 333-107536);
|
|
|
|
the description of the $750,000,000 in aggregate principal
amount of 8.75% Senior Notes Due 2010 set forth under the
caption Description of the Notes in the prospectus
supplement dated August 18, 2000, and under the caption
Description of the Debt Securities in the prospectus
dated August 5, 1999, each filed with the SEC on
August 21, 2000 (SEC File
No. 333-82219);
|
|
|
|
the description of the £150,000,000 in aggregate principal
amount of 8.75% Senior Notes Due 2010 set forth under the
caption Description of the Notes in the prospectus
supplement dated October 25, 2000, and under the caption
Description of the Debt Securities in the prospectus
dated August 5, 1999, each filed with the SEC on
October 27, 2000 (SEC File
No. 333-82219);
|
|
|
|
the description of the 7.875% Senior Notes Due 2011 set
forth under the caption Description of the Notes in
the prospectus supplement dated January 23, 2001, and under
the caption Description of the Debt Securities in
the prospectus dated December 19, 2000, each filed with the
SEC on January 24, 2001 (SEC File
No. 333-51540);
|
|
|
|
the description of the 6.95% Senior Notes Due 2012 set
forth under the caption Description of the Notes in
the prospectus supplement dated April 23, 2002, and under
the caption Description of the
|
2
|
|
|
|
|
Debt Securities in the prospectus dated December 19,
2000, each filed with the SEC on April 26, 2002 (SEC File
No. 333-51540);
|
|
|
|
|
|
the description of the 6.30% Senior Notes Due 2012 set
forth under the caption Description of the Notes in
the prospectus supplement dated September 18, 2002, and
under the caption Description of the Debt Securities
in the prospectus dated May 16, 2002, each filed with the
SEC on September 20, 2002 (SEC File
No. 333-87588);
|
|
|
|
the description of the 6.25% Senior Notes Due 2013 set
forth under the caption Description of the Notes in
the prospectus supplement dated February 5, 2003, and under
the caption Description of the Debt Securities in
the prospectus dated May 16, 2002, each filed with the SEC
on February 7, 2003 (SEC File
No. 333-87588);
|
|
|
|
the description of the 6.75% Senior Notes Due 2013 set
forth under the caption Description of the Notes in
the prospectus supplement dated July 23, 2003, and under
the caption Description of the Debt Securities in
the prospectus dated May 16, 2002, each filed with the SEC
on July 25, 2003 (SEC File
No. 333-87588);
|
|
|
|
the description of the 5.75% Senior Notes Due 2014 set
forth under the caption Description of the Notes in
the prospectus supplement dated March 3, 2004, and under
the caption Description of the Debt Securities in
the prospectus dated October 16, 2003, each filed with the
SEC on March 5, 2004 (SEC File
No. 333-107536);
|
|
|
|
the description of the 6.50% Senior Notes Due 2016 set
forth under the caption Description of the Notes in
the prospectus supplement dated February 3, 2006, and under
the caption Description of the Debt Securities in
the prospectus dated April 21, 2005, each filed with the
SEC on February 6, 2006 (SEC File
No. 333-121520);
|
|
|
|
the description of the 7.69% Notes Due 2025 set forth under
the caption Description of New Securities in the
prospectus and consent solicitation dated May 25, 1995,
filed with the SEC on May 26,1995 (SEC File
No. 33-58919);
|
|
|
|
the description of the 7.50% Senior Notes Due 2033 set
forth under the caption Description of the Notes in
the prospectus supplement dated October 31, 2003, and under
the caption Description of the Debt Securities in
the prospectus dated October 16, 2003, each filed with the
SEC on November 4, 2003 (SEC File
No. 333-107536);
|
|
|
|
the description of the 7.19% Debentures Due 2015 set forth
under the caption Description of the Notes in the
prospectus supplement dated November 20, 1995, and under
the caption Description of the Debt Securities in
the prospectus dated November 17, 1995, each filed with the
SEC on November 22, 1995 (SEC File
No. 33-64105);
|
|
|
|
the description of the 7.50% Debentures Due 2023 set forth
under the caption Description of the Securities in
the prospectus supplement dated December 9, 1993, and under
the caption Description of the Debt Securities in
the prospectus dated November 22, 1993, each filed with the
SEC on December 17, 1993 (SEC File
No. 33-50985);
|
|
|
|
the description of the 8.36% Debentures Due 2024 set forth
under the caption Description of the Debentures in
the prospectus supplement dated April 20, 1994, and under
the caption Description of the Debt Securities in
the prospectus dated November 22, 1993, each filed with the
SEC on April 21, 1994 (SEC File
No. 33-50985);
|
|
|
|
the description of the 7.05% Debentures Due 2027 set forth
under the caption Description of the Debentures in
the prospectus supplement dated December 5, 1995, and under
the caption Description of the Debt Securities in
the prospectus dated November 17, 1995, each filed with the
SEC on December 7, 1995 (SEC File
No. 33-64105);
|
|
|
|
the description of the 7.50% Debentures Due 2095 set forth
under the caption Description of the Debentures in
the prospectus supplement dated November 20, 1995, and
under the caption
|
3
|
|
|
|
|
Description of the Debt Securities in the prospectus
dated November 17, 1995, each filed with the SEC on
November 22, 1995 (SEC File
No. 33-64105);
|
|
|
|
|
|
the description of the 8.70% Medium-Term Notes Due 2010 set
forth in the Pricing Supplement, dated February 1, 1995,
filed with the SEC on February 2, 1995 (SEC File
No. 33-53409),
and under the caption Description of Notes in the
prospectus supplement dated July 11, 1994, and under the
caption Description of the Debt Securities in the
prospectus dated May 13, 1994, each filed with the SEC on
July 12, 1994 (SEC File
No. 33-53409);
|
|
|
|
the description of the 9.00% Medium-Term Notes Due 2014 set
forth in the Pricing Supplement, dated January 12, 1995,
filed with the SEC on January 13, 1995 (SEC File
No. 33-53409),
and under the caption Description of Notes in the
prospectus supplement dated July 11, 1994, and under the
caption Description of the Debt Securities in the
prospectus dated May 13, 1994, each filed with the SEC on
July 12, 1994 (SEC File
No. 33-53409); and
|
|
|
|
the description of the 7.58% Medium-Term Notes Due 2025 set
forth in the Pricing Supplement, dated September 11, 1995,
filed with the SEC on September 13, 1995 (SEC File
No. 33-53409),
and under the caption Description of Notes in the
prospectus supplement dated July 11, 1994, and under the
caption Description of the Debt Securities in the
prospectus dated May 13, 1994, each filed with the SEC on
July 12, 1994 (SEC File
No. 33-53409).
|
You may request a copy of these filings, at no cost, by writing
or calling us at the following address or telephone number:
Corporate
Secretary
HCA Inc.
One Park Plaza
Nashville, Tennessee 37203
(615) 344-9551
4
HCA
INC.
The terms Company, HCA,
we, our or us, as used
herein, refer to HCA Inc. and its affiliates unless otherwise
stated or indicated by context. The term affiliates
means direct and indirect subsidiaries of HCA Inc. and
partnerships and joint ventures in which such subsidiaries are
partners.
We are one of the leading health care services companies in the
United States. At March 31, 2009, we operated 163
hospitals, comprised of 157 general, acute care hospitals; five
psychiatric hospitals; and one rehabilitation hospital. The 163
hospital total includes eight hospitals (seven general, acute
care hospitals and one rehabilitation hospital) owned by joint
ventures in which an affiliate of HCA is a partner, and these
joint ventures are accounted for using the equity method. In
addition, we operated 105 freestanding surgery centers, eight of
which are owned by joint ventures in which an affiliate of HCA
is a partner, and these joint ventures are accounted for using
the equity method. Our facilities are located in 20 states
and England. For the year ended December 31, 2008, we
generated revenues of $28.374 billion and net income
attributable to HCA Inc. of $673 million, and for the three
months ended March 31, 2009, we generated revenues of
$7.431 billion and net income attributable to HCA Inc. of
$360 million.
Our primary objective is to provide a comprehensive array of
quality health care services in the most cost-effective manner
possible. Our general, acute care hospitals typically provide a
full range of services to accommodate such medical specialties
as internal medicine, general surgery, cardiology, oncology,
neurosurgery, orthopedics and obstetrics, as well as diagnostic
and emergency services. Outpatient and ancillary health care
services are provided by our general, acute care hospitals,
freestanding surgery centers, diagnostic centers and
rehabilitation facilities. Our psychiatric hospitals provide a
full range of mental health care services through inpatient,
partial hospitalization and outpatient settings.
We also provide a variety of management services to our health
care facilities, including patient safety programs; ethics and
compliance programs; national supply contracts; equipment
purchasing and leasing contracts; accounting, financial and
clinical systems; governmental reimbursement assistance;
construction planning and coordination; information technology
systems and solutions; legal counsel; human resources services;
and internal audit services.
HCA Inc. was incorporated in Nevada in January 1990 and
reincorporated in Delaware in September 1993. Our principal
executive offices are located at One Park Plaza, Nashville,
Tennessee 37203, and our telephone number is
(615) 344-9551.
5
RISK
FACTORS
You should carefully consider the risk factors set forth
below as well as the risk factors incorporated herein by
reference to our annual report on
Form 10-K
for the fiscal year ended December 31, 2008 (the 2008
10-K)
and our quarterly report on
Form 10-Q
for the quarter ended March 31, 2009 (the 2009 First
Quarter
10-Q)
and the other information contained in this prospectus before
purchasing the notes. This prospectus contains forward-looking
statements that involve risks and uncertainties. Any of the
following risks could materially and adversely affect our
business, financial condition or results of operations.
Additional risks and uncertainties not currently known to us or
those we currently view to be immaterial may also materially and
adversely affect our business, financial condition or results of
operations. In such a case, you may lose all or part of your
original investment.
As used herein, the senior secured credit
facilities refer to, collectively, our senior secured cash
flow credit facility, dated as of November 17, 2006, as
amended on February 16, 2007, and as amended on
March 2, 2009 (the cash flow credit facility),
and our senior secured asset-based revolving credit facility,
dated as of November 17, 2006, as amended and restated as
of June 20, 2007, and as amended on March 2, 2009 (the
asset-based revolving credit facility). We refer to
the senior notes as those notes, debentures and
medium-term notes issued under the indenture, dated as of
December 16, 1993, as amended or supplemented, to the
second lien notes as those notes issued under,
collectively, the indenture dated as of November 17, 2006
and the indenture dated as of February 19, 2009, each as
amended or supplemented, to the first lien notes as
those notes issued under the indenture, dated as of
April 22, 2009, as amended or supplemented, and to the
senior secured notes as, collectively, the second
lien notes and the first lien notes. We refer to the
notes as, collectively, the senior notes and the
senior secured notes. For a more detailed description of the
notes and the indentures and agreements governing such notes,
see Description of Notes.
Risks
Related to Our Indebtedness
Our
substantial leverage could adversely affect our ability to raise
additional capital to fund our operations, limit our ability to
react to changes in the economy or our industry, expose us to
interest rate risk to the extent of our variable rate debt and
prevent us from meeting our obligations.
Since completing our recapitalization in November 2006 we are
highly leveraged. As of March 31, 2009 our total
indebtedness was $26.567 billion. Our high degree of
leverage could have important consequences, including:
|
|
|
|
|
increasing our vulnerability to downturns or adverse changes in
general economic, industry or competitive conditions and adverse
changes in government regulations;
|
|
|
|
requiring a substantial portion of cash flow from operations to
be dedicated to the payment of principal and interest on our
indebtedness, therefore reducing our ability to use our cash
flow to fund our operations, capital expenditures and future
business opportunities;
|
|
|
|
exposing us to the risk of increased interest rates as certain
of our unhedged borrowings are at variable rates of interest;
|
|
|
|
limiting our ability to make strategic acquisitions or causing
us to make nonstrategic divestitures;
|
|
|
|
limiting our ability to obtain additional financing for working
capital, capital expenditures, product or service line
development, debt service requirements, acquisitions and general
corporate or other purposes; and
|
|
|
|
limiting our ability to adjust to changing market conditions and
placing us at a competitive disadvantage compared to our
competitors who are less highly leveraged.
|
We and our subsidiaries have the ability to incur additional
indebtedness in the future, subject to the restrictions
contained in our senior secured credit facilities and the
indentures governing our outstanding notes. If new indebtedness
is added to our current debt levels, the related risks that we
now face could intensify.
6
We may
not be able to generate sufficient cash to service all of our
indebtedness and may not be able to refinance our indebtedness
on favorable terms. If we are unable to do so, we may be forced
to take other actions to satisfy our obligations under our
indebtedness, which may not be successful.
Our ability to make scheduled payments on or to refinance our
debt obligations depends on our financial condition and
operating performance, which are subject to prevailing economic
and competitive conditions and to certain financial, business
and other factors beyond our control. We cannot assure you that
we will maintain a level of cash flows from operating activities
sufficient to permit us to pay the principal, premium, if any,
and interest on our indebtedness.
As of March 31, 2009, our substantial indebtedness included
$13.356 billion of indebtedness under our senior secured
credit facilities that matures in 2012 and 2013,
$6.000 billion of second lien notes maturing in 2014, 2016
and 2017 and $6.826 billion of unsecured senior notes and
debentures that mature on various dates from 2009 to 2095
(including $5.437 billion maturing through 2016). Because a
significant portion of our indebtedness matures in the next few
years, we may find it necessary or prudent to refinance that
indebtedness with longer-maturity debt at a higher interest
rate. In April 2009, for example, we issued $1.500 billion
of
81/2% Senior
Secured Notes due 2019. We used the net proceeds of that
offering to prepay term loans under our cash flow credit
facility, which currently bears interest at a lower floating
rate. Our ability to refinance our indebtedness on favorable
terms, or at all, is directly affected by the current global
economic and financial crisis. In addition, our ability to incur
secured indebtedness (which may enable us to achieve better
pricing than the incurrence of unsecured indebtedness) depends
in part on the value of our assets, which depends, in turn, on
the strength of our cash flows and results of operations, and on
economic and market conditions and other factors.
If our cash flows and capital resources are insufficient to fund
our debt service obligations or we are unable to refinance our
indebtedness, we may be forced to reduce or delay investments
and capital expenditures, or to sell assets, seek additional
capital or restructure our indebtedness. These alternative
measures may not be successful and may not permit us to meet our
scheduled debt service obligations. If our operating results and
available cash are insufficient to meet our debt service
obligations, we could face substantial liquidity problems and
might be required to dispose of material assets or operations to
meet our debt service and other obligations. We may not be able
to consummate those dispositions, or the proceeds from the
dispositions may not be adequate to meet any debt service
obligations then due.
Our
debt agreements contain restrictions that limit our flexibility
in operating our business.
Our senior secured credit facilities and the indentures
governing our outstanding notes contain various covenants that
limit our ability to engage in specified types of transactions.
These covenants limit our and certain of our subsidiaries
ability to, among other things:
|
|
|
|
|
incur additional indebtedness or issue certain preferred shares;
|
|
|
|
pay dividends on, repurchase or make distributions in respect of
our capital stock or make other restricted payments;
|
|
|
|
make certain investments;
|
|
|
|
sell or transfer assets;
|
|
|
|
create liens;
|
|
|
|
consolidate, merge, sell or otherwise dispose of all or
substantially all of our assets; and
|
|
|
|
enter into certain transactions with our affiliates.
|
Under our asset-based revolving credit facility, when (and for
as long as) the combined availability under our asset-based
revolving credit facility and our senior secured revolving
credit facility is less than a specified amount for a certain
period of time or, if a payment or bankruptcy event of default
has occurred and is continuing, funds deposited into any of our
depository accounts will be transferred on a daily basis into a
7
blocked account with the administrative agent and applied to
prepay loans under the asset-based revolving credit facility and
to cash collateralize letters of credit issued thereunder.
Under our senior secured credit facilities, we are required to
satisfy and maintain specified financial ratios. Our ability to
meet those financial ratios can be affected by events beyond our
control, and there can be no assurance that we will continue to
meet those ratios. A breach of any of these covenants could
result in a default under both our cash flow credit facility and
our asset-based revolving credit facility. Upon the occurrence
of an event of default under our senior secured credit
facilities, our lenders could elect to declare all amounts
outstanding under our senior secured credit facilities to be
immediately due and payable and terminate all commitments to
extend further credit. If we were unable to repay those amounts,
the lenders under our senior secured credit facilities could
proceed against the collateral granted to them to secure such
indebtedness. We have pledged a significant portion of our
assets as collateral under our senior secured credit facilities.
If any of the lenders under our senior secured credit facilities
accelerate the repayment of borrowings, we cannot assure you
that we will have sufficient assets to repay our senior secured
credit facilities and the notes.
Risks
Related to the Notes
Your
ability to transfer the notes may be limited by the absence of
an active trading market, and there is no assurance that any
active trading market for the notes exists or will
continue.
We do not intend to apply for a listing of the notes on a
securities exchange or automated dealer quotation system. We
cannot assure you as to the liquidity of markets that may
develop for the notes, your ability to sell the notes or the
price at which you would be able to sell the notes. No financial
institution is obligated to make a market in any of the notes,
and any financial institutions that do so may discontinue their
market-making activities at any time without notice. Therefore,
an active market for any of the notes, if developed, may not
continue. Because Banc of America Securities LLC, Merrill Lynch,
Pierce, Fenner & Smith Incorporated and their
respective affiliates (collectively, the market
makers) may be considered affiliates of ours, they are
required to deliver a current market-maker
prospectus in connection with any secondary market sale of the
notes, which may affect their ability to continue market-making
activities. Historically, the market for non investment-grade
debt has been subject to disruptions that have caused
substantial volatility in the prices of securities similar to
the notes. The market, if any, for any of the notes may not be
free from similar disruptions and any such disruptions may
adversely affect the prices at which you may sell your notes. In
addition, the notes may trade at a discount from your purchase
price, depending upon prevailing interest rates, the market for
similar notes, our performance and other factors.
If we
default on our obligations to pay our indebtedness, we may not
be able to make payments on the notes.
Any default under the agreements governing our indebtedness,
including a default under our senior secured credit facilities
that is not waived by the required lenders or a default under
any of the indentures governing the notes, and the remedies
sought by the holders of such indebtedness, could prevent us
from paying principal, premium, if any, and interest on the
notes and substantially decrease the market value of the notes.
If we are unable to generate sufficient cash flow and are
otherwise unable to obtain funds necessary to meet required
payments of principal, premium, if any, and interest on our
indebtedness, or if we otherwise fail to comply with the various
covenants, including financial and operating covenants, in the
instruments governing our indebtedness (including covenants in
our senior secured credit facilities and the indentures
governing the notes), we could be in default under the terms of
the agreements governing such indebtedness. In the event of such
default, the holders of such indebtedness could elect to declare
all the funds borrowed thereunder to be due and payable,
together with accrued and unpaid interest, the lenders under our
senior secured credit facilities could elect to terminate their
commitments thereunder, cease making further loans and institute
foreclosure proceedings against our assets, and we could be
forced into bankruptcy or liquidation. If our operating
performance declines, we may in the future need to obtain
waivers from the required lenders under our senior secured
credit facilities to avoid being in default. If we breach our
covenants under our senior secured credit facilities and seek a
waiver, we may not be able to obtain a waiver from the required
lenders. If
8
this occurs, we would be in default under the instruments
governing that indebtedness, the lenders could exercise their
rights, as described above, and we could be forced into
bankruptcy or liquidation.
Federal
and state fraudulent transfer laws may permit a court to void
the notes, and with respect to the senior secured notes, the
guarantees, and, if that occurs, you may not receive any
payments on the notes.
Federal and state fraudulent transfer and conveyance statutes
may apply to the issuance of the notes and, with respect to the
senior secured notes, the incurrence of the guarantees. Under
federal bankruptcy law and comparable provisions of state
fraudulent transfer or conveyance laws, which may vary from
state to state, the notes or guarantees could be voided as a
fraudulent transfer or conveyance if (1) we or any of the
guarantors, as applicable, issued the notes or incurred the
guarantees with the intent of hindering, delaying or defrauding
creditors or (2) we or any of the guarantors, as
applicable, received less than reasonably equivalent value or
fair consideration in return for either issuing the notes or
incurring the guarantees and, in the case of (2) only, one
of the following is also true at the time thereof:
|
|
|
|
|
we or any of the guarantors, as applicable, were insolvent or
rendered insolvent by reason of the issuance of the notes or the
incurrence of the guarantees;
|
|
|
|
the issuance of the notes or the incurrence of the guarantees
left us or any of the guarantors, as applicable, with an
unreasonably small amount of capital to carry on the business;
|
|
|
|
we or any of the guarantors intended to, or believed that we or
such guarantor would, incur debts beyond our or such
guarantors ability to pay as they mature; or
|
|
|
|
we were or any of the guarantors was a defendant in an action
for money damages, or had a judgment for money damages docketed
against us or such guarantor if, in either case, after final
judgment, the judgment was unsatisfied.
|
If a court were to find that the issuance of the notes or the
incurrence of any guarantee were a fraudulent transfer or
conveyance, the court could void the payment obligations under
the notes or such guarantee or further subordinate the notes or
such guarantee to presently existing and future indebtedness of
ours or of the related guarantor, or require the holders of the
notes to repay any amounts received with respect to such
guarantee. In the event of a finding that a fraudulent transfer
or conveyance occurred, you may not receive any repayment on the
notes. Further, the voidance of the notes could result in an
event of default with respect to our and our subsidiaries
other debt that could result in acceleration of such debt.
As a general matter, value is given for a transfer or an
obligation if, in exchange for the transfer or obligation,
property is transferred or an antecedent debt is secured or
satisfied. A debtor will generally not be considered to have
received value in connection with a debt offering if the debtor
uses the proceeds of that offering to make a dividend payment or
otherwise retire or redeem equity securities issued by the
debtor.
We cannot be certain as to the standards a court would use to
determine whether or not we or the guarantors were solvent at
the relevant time or, regardless of the standard that a court
uses, that the issuance of the guarantees would not be further
subordinated to our or any of our guarantors other debt.
Generally, however, an entity would be considered insolvent if,
at the time it incurred indebtedness:
|
|
|
|
|
the sum of its debts, including contingent liabilities, was
greater than the fair saleable value of all its assets;
|
|
|
|
the present fair saleable value of its assets was less than the
amount that would be required to pay its probable liability on
its existing debts, including contingent liabilities, as they
become absolute and mature; or
|
|
|
|
it could not pay its debts as they become due.
|
9
Risks
Related to the Senior Notes
The
senior notes are unsecured and effectively junior to our secured
indebtedness, including our senior secured credit facilities and
our senior secured notes, to the extent of the value of the
collateral securing such secured indebtedness.
Our obligations under our senior notes are unsecured and are
effectively junior to our secured indebtedness to the extent of
the value of the collateral securing such secured indebtedness.
Our senior secured credit facilities and our senior secured
notes are collateralized by, among other things, the capital
stock of any wholly owned first-tier subsidiary of our company
or of any U.S. subsidiary guarantor, substantially all of
our and the U.S. subsidiary guarantors other tangible
and intangible assets and accounts receivable of our company and
certain of our domestic subsidiaries, subject to exceptions. Our
senior secured credit facilities and the indentures governing
our senior secured notes also permit us to incur additional
secured indebtedness. The senior notes are effectively
subordinated to all such secured indebtedness to the extent of
the value of that collateral. If an event of default occurs
under the senior secured credit facilities or under the
indentures governing our senior secured notes, the holders of
such senior secured indebtedness will have a prior right to our
assets, to the exclusion of the holders of our senior notes,
even if we are in default with respect to such notes. In that
event, our assets would first be used to repay in full all
indebtedness and other obligations secured by them (including
all amounts outstanding under the senior secured credit
facilities and the senior secured notes), resulting in all or a
portion of our assets being unavailable to satisfy the claims of
the holders of the senior notes and other unsecured
indebtedness. Therefore, in the event of any distribution or
payment of our assets in any foreclosure, dissolution,
winding-up,
liquidation, reorganization, or other bankruptcy proceeding,
holders of the senior notes will participate in our remaining
assets ratably with each other and with all holders of our
unsecured indebtedness that is deemed to be of the same class as
such notes, and potentially with all of our other general
creditors, based upon the respective amounts owed to each holder
or creditor. In any of the foregoing events, we cannot assure
you that there will be sufficient assets to pay amounts due on
the senior notes. As a result, holders of such notes may receive
less, ratably, than holders of secured indebtedness.
As of March 31, 2009, on an as adjusted basis after giving
effect to our offering of $1.500 billion aggregate
principal amount of first lien notes in April 2009 and the use
of proceeds therefrom, we had outstanding an aggregate principal
amount of $19.855 billion of senior secured indebtedness.
This senior secured indebtedness includes that outstanding under
our senior secured credit facilities, including letters of
credit, the senior secured notes, capital leases and other
secured debt. We also had an additional $2.198 billion
available for borrowing under our senior secured revolving
credit facilities after giving effect to certain outstanding
letters of credit.
Claims
of holders of our senior notes will be structurally subordinate
to claims of creditors of all of our subsidiaries that do not
guarantee such notes.
The senior notes are not guaranteed by any of our subsidiaries.
Accordingly, claims of holders of the senior notes are
structurally subordinate to the claims of creditors of these
non-guarantor subsidiaries, including trade creditors. All
obligations of our subsidiaries that do not guarantee the senior
notes will have to be satisfied before any of the assets of such
subsidiaries would be available for distribution, upon a
liquidation or otherwise, to holders of the senior notes. In
addition, the indentures governing the notes permit, subject to
some limitations, these subsidiaries to incur additional
indebtedness and do not contain limitations on the amount of
certain other liabilities, such as trade payables, that may be
incurred by these subsidiaries.
Risks
Related to the Senior Secured Notes
The
value of the collateral securing the senior secured notes may
not be sufficient to satisfy our obligations under such
notes.
No appraisal of the value of the collateral was made in
connection with the offerings of each series of senior secured
notes, and the fair market value of the collateral is subject to
fluctuations based on factors that include, among others,
general economic conditions and similar factors. The amount to
be received upon a
10
sale of the collateral would be dependent on numerous factors,
including, but not limited to, the actual fair market value of
the collateral at such time, the timing and the manner of the
sale and the availability of buyers. By its nature, portions of
the collateral may be illiquid and may have no readily
ascertainable market value. In the event of a foreclosure,
liquidation, bankruptcy or similar proceeding, the collateral
may not be sold in a timely or orderly manner and the proceeds
from any sale or liquidation of this collateral may not be
sufficient to pay our obligations under the senior secured notes.
To the extent that liens securing obligations under the senior
secured credit facilities, pre-existing liens, liens permitted
under the indentures governing the senior secured notes and
other rights, including liens on excluded assets, such as those
securing purchase money obligations and capital lease
obligations granted to other parties (in addition to the holders
of any other obligations secured by higher-priority liens),
encumber any of the collateral securing the senior secured notes
and the guarantees, those parties have or may exercise rights
and remedies with respect to the collateral that could adversely
affect the value of the collateral and the ability of the
collateral agents, the trustees or the holders of the senior
secured notes to realize or foreclose on the collateral.
In addition, the senior secured notes and the related guarantees
are not secured by any of the European collateral described
under Description of Other Indebtedness Senior
Secured Credit Facilities Guarantee and
Security.
There may not be sufficient collateral to pay off all amounts we
may borrow under our senior secured credit facilities, the
existing senior secured notes and additional notes that we may
offer that would be secured on the same basis as the existing
senior secured notes. Consequently, liquidating the collateral
securing the senior secured notes may not result in proceeds in
an amount sufficient to pay any amounts due under such notes
after also satisfying the obligations to pay any creditors with
prior liens. In addition, we may be required to repay
obligations under our cash flow credit facility with proceeds
from a sale of assets before repaying the senior secured notes.
If the proceeds of any sale of collateral are not sufficient to
repay all amounts due on the senior secured notes, the holders
of such notes (to the extent not repaid from the proceeds of the
sale of the collateral) would have only a senior unsecured,
unsubordinated claim against our and the subsidiary
guarantors remaining assets.
Claims
of holders of our senior secured notes are structurally
subordinate to claims of creditors of all of our
non-U.S.
subsidiaries and some of our U.S. subsidiaries because they do
not guarantee such notes.
The senior secured notes are not guaranteed by any of our
non-U.S. subsidiaries,
our less than wholly-owned U.S. subsidiaries or certain
other U.S. subsidiaries. Accordingly, claims of holders of
the senior secured notes are structurally subordinate to the
claims of creditors of these non-guarantor subsidiaries,
including trade creditors. All obligations of our non-guarantor
subsidiaries will have to be satisfied before any of the assets
of such subsidiaries would be available for distribution, upon a
liquidation or otherwise, to us or a guarantor of the senior
secured notes.
On an as adjusted basis after giving effect to our offering of
$1.500 billion aggregate principal amount of first lien
notes in April 2009 and the use of proceeds therefrom, our
non-guarantor subsidiaries would have accounted for
approximately $11.867 billion, or 41.8%, of our total
revenues for the year ended December 31, 2008,
approximately $3.038 billion, or 40.9%, of our total
revenues for the three months ended March 31, 2009,
approximately $9.876 billion, or 40.7%, of our total
assets, and approximately $7.517 billion, or 22.5%, of our
total liabilities, in each case as of December 31, 2008,
and approximately $9.817 billion, or 40.4%, of our total
assets, and approximately $7.224 billion, or 21.9%, of our
total liabilities, in each case as of March 31, 2009.
There
are circumstances other than repayment or discharge of the
senior secured notes under which the collateral securing such
notes and guarantees will be released automatically, without
your consent or the consent of the applicable
trustee.
Under various circumstances, collateral securing the senior
secured notes will be released automatically, including:
|
|
|
|
|
a sale, transfer or other disposal of such collateral in a
transaction not prohibited under the indentures governing the
senior secured notes;
|
|
|
|
with respect to collateral held by a guarantor, upon the release
of such guarantor from its guarantee;
|
11
|
|
|
|
|
with respect to collateral that is capital stock, upon the
dissolution of the issuer of such capital stock in accordance
with the indentures governing the senior secured notes;
|
|
|
|
with respect to any collateral in which the second lien notes
have a second-priority or third-priority lien, upon any release
by the lenders under our senior secured credit facilities of
their first-priority or second-priority security interest in
such collateral unless such release occurs in connection with a
discharge in full in cash of first lien obligations, which
discharge is not in connection with a foreclosure of, or other
exercise of remedies with respect to, non-receivables collateral
by the first lien secured parties (such discharge not in
connection with any such foreclosure or exercise of remedies, a
Payment Discharge); provided that, in the case of a
Payment Discharge, the lien on any non-receivables collateral
disposed of in satisfaction in whole or in part of first lien
obligations shall be automatically released but any proceeds
thereof not used for purposes of the discharge of first lien
obligations in full in cash or otherwise in accordance with the
indentures governing the second lien notes shall be subject to a
lien in favor of the collateral agent for the second lien
noteholders;
|
|
|
|
with respect to any receivables collateral in which the first
lien notes have a second-priority lien, upon any release by the
lenders under our asset-based revolving credit facility of their
first-priority security interest in such collateral; provided
that, if the release occurs in connection with a foreclosure or
exercise of remedies by the collateral agent for the lenders
under our asset-based revolving credit facility, the lien on
that collateral will be automatically released but any proceeds
thereof not used to repay the obligations under our asset-based
revolving credit facility will be subject to lien in favor of
the collateral agent for the first lien noteholders and our cash
flow credit facility; and
|
|
|
|
with respect to the collateral upon which the first notes have a
first-priority lien, upon any release in connection with a
foreclosure or exercise of remedies with respect to that
collateral directed by the authorized representative of the
lenders under our cash flow credit facility during any period
that such authorized representative controls actions with
respect to the collateral pursuant to the first lien
intercreditor agreement. Even though the holders of the notes
share ratably with the lenders under our cash flow credit
facility, the authorized representative of the lenders under our
cash flow credit facility will initially control actions with
respect to the collateral, whether or not the holders of the
first lien notes agree or disagree with those actions. See
Risks Related to the First Lien Senior Secured
Notes Even though the holders of the first lien
notes have the benefit of a first-priority lien on the
collateral that secures our cash flow credit facility, the
representative of the lenders under the cash flow credit
facility will initially control most actions with respect to
that collateral.
|
In addition, the guarantee of a subsidiary guarantor will be
automatically released to the extent it is released under the
senior secured credit facilities or in connection with a sale of
such subsidiary guarantor in a transaction not prohibited by the
indentures.
The indentures governing the senior secured notes also permit us
to designate one or more of our restricted subsidiaries that is
a guarantor of the senior secured notes as an unrestricted
subsidiary. If we designate a subsidiary guarantor as an
unrestricted subsidiary for purposes of the indentures governing
the senior secured notes, all of the liens on any collateral
owned by such subsidiary or any of its subsidiaries and any
guarantees of the notes by such subsidiary or any of its
subsidiaries will be released under the indentures but not
necessarily under our senior secured credit facilities.
Designation of an unrestricted subsidiary will reduce the
aggregate value of the collateral securing the notes to the
extent that liens on the assets of the unrestricted subsidiary
and its subsidiaries are released. In addition, the creditors of
the unrestricted subsidiary and its subsidiaries will have a
senior claim on the assets of such unrestricted subsidiary and
its subsidiaries. See Description of Notes.
We
will in most cases have control over the collateral, and the
sale of particular assets by us could reduce the pool of assets
securing the senior secured notes and the
guarantees.
The collateral documents allow us to remain in possession of,
retain exclusive control over, freely operate, and collect,
invest and dispose of any income from, the collateral securing
the senior secured notes and the
12
guarantees, except, under certain circumstances, cash
transferred to accounts controlled by the administrative agent
under our asset-based revolving credit facility.
In addition, we are not required to comply with all or any
portion of Section 314(d) of the Trust Indenture Act
of 1939 (the Trust Indenture Act) if we
determine, in good faith based on advice of counsel, that, under
the terms of that Section
and/or any
interpretation or guidance as to the meaning thereof of the SEC
and its staff, including no action letters or
exemptive orders, all or such portion of Section 314(d) of
the Trust Indenture Act is inapplicable to the released
collateral. For example, so long as no default or event of
default under the indentures governing the senior secured notes
would result therefrom and such transaction would not violate
the Trust Indenture Act, we may, among other things,
without any release or consent by the applicable trustees,
conduct ordinary course activities with respect to collateral,
such as selling, factoring, abandoning or otherwise disposing of
collateral and making ordinary course cash payments (including
repayments of indebtedness). See Description of
Notes.
The
imposition of certain permitted liens will cause the assets on
which such liens are imposed to be excluded from the collateral
securing the senior secured notes and the guarantees. There are
also certain other categories of property that are also excluded
from the collateral.
The indentures governing the senior secured notes permit liens
in favor of third parties to secure additional debt, including
purchase money indebtedness and capital lease obligations, and
any assets subject to such liens will be automatically excluded
from the collateral securing the senior secured notes and the
guarantees. Our ability to incur purchase money indebtedness and
capital lease obligations is subject to the limitations as
described in Description of Notes. In addition,
certain categories of assets are excluded from the collateral
securing the senior secured notes and the guarantees. Excluded
assets include the assets of our non-guarantor subsidiaries and
equity investees, certain capital stock and other securities of
our subsidiaries and equity investees, certain properties that
do not secure our senior secured credit facilities, deposit
accounts, other bank or securities accounts, cash, leaseholds
and motor vehicles, and the proceeds from any of the foregoing.
The assets excluded from the collateral for the second lien
secured notes include the properties defined as principal
properties under our indenture dated as of
December 16, 1993, so long as that indenture remains in
effect. Although the first lien secured notes share a lien on
such principal properties, that lien is limited to
securing a portion of the indebtedness under the senior secured
notes and our cash flow credit facility that, in the aggregate,
does not exceed 10% of our consolidated net tangible assets. See
Description of Notes. If an event of default occurs
and the senior secured notes are accelerated, such notes and the
guarantees will rank equally with the holders of other
unsubordinated and unsecured indebtedness of the relevant entity
with respect to such excluded property.
On an as adjusted basis after giving effect to our offering of
$1.500 billion aggregate principal amount of first lien
notes in April 2009 and the use of proceeds therefrom, our
non-guarantor subsidiaries would have accounted for
approximately $9.817 billion, or 40.4%, of our total assets
as of March 31, 2009.
The
pledge of the capital stock, other securities and similar items
of our subsidiaries that secure the senior secured notes will
automatically be released from the lien on them and no longer
constitute collateral for so long as the pledge of such capital
stock or such other securities would require the filing of
separate financial statements with the SEC for that
subsidiary.
The senior secured notes and the guarantees are secured by a
pledge of the stock of some of our subsidiaries. Under the SEC
regulations in effect as of the issue date of the senior secured
notes, if the par value, book value as carried by us or market
value (whichever is greatest) of the capital stock, other
securities or similar items of a subsidiary pledged as part of
the collateral is greater than or equal to 20% of the aggregate
principal amount of the senior secured notes then outstanding,
such a subsidiary would be required to provide separate
financial statements to the SEC. Therefore, the indentures
governing the senior secured notes and the collateral documents
provide that any capital stock and other securities of any of
our subsidiaries will be excluded from the collateral for so
long as the pledge of such capital stock or other securities to
secure the senior secured notes would cause such subsidiary to
be required to file separate financial statements with the SEC
pursuant to
Rule 3-16
of
Regulation S-X
(as in effect from time to time).
13
As a result, holders of the senior secured notes could lose a
portion or all of their security interest in the capital stock
or other securities of those subsidiaries during such period. It
may be more difficult, costly and time-consuming for holders of
the senior secured notes to foreclose on the assets of a
subsidiary than to foreclose on its capital stock or other
securities, so the proceeds realized upon any such foreclosure
could be significantly less than those that would have been
received upon any sale of the capital stock or other securities
of such subsidiary. See Description of Notes.
Your
rights in the collateral may be adversely affected by the
failure to perfect security interests in certain collateral in
the future.
Applicable law requires that certain property and rights
acquired after the grant of a general security interest, such as
real property, equipment subject to a certificate and certain
proceeds, can only be perfected at the time such property and
rights are acquired and identified. The trustees or the
collateral agents for the senior secured notes may not monitor,
or we may not inform the trustees or the collateral agents for
the senior secured notes of, the future acquisition of property
and rights that constitute collateral, and necessary action may
not be taken to properly perfect the security interest in such
after-acquired collateral. The collateral agents for the senior
secured notes have no obligation to monitor the acquisition of
additional property or rights that constitute collateral or the
perfection of any security interest in favor of the senior
secured notes against third parties. Such failure may result in
the loss of the security interest therein or the priority of the
security interest in favor of the senior secured notes against
third parties.
The
collateral is subject to casualty risks.
We intend to maintain insurance or otherwise insure against
hazards in a manner appropriate and customary for our business.
There are, however, certain losses that may be either
uninsurable or not economically insurable, in whole or in part.
Insurance proceeds may not compensate us fully for our losses.
If there is a complete or partial loss of any of the pledged
collateral, the insurance proceeds may not be sufficient to
satisfy all of the secured obligations, including the senior
secured notes and the guarantees.
We may
not be able to repurchase the senior secured notes upon a change
of control.
Upon the occurrence of specific kinds of change of control
events, we will be required to offer to repurchase all
outstanding senior secured notes at 101% of their principal
amount plus accrued and unpaid interest. The source of funds for
any such purchase of such notes will be our available cash or
cash generated from our subsidiaries operations or other
sources, including borrowings, sales of assets or sales of
equity. We may not be able to repurchase the senior secured
notes upon a change of control because we may not have
sufficient financial resources to purchase all of the senior
secured notes that are tendered upon a change of control.
Further, we are contractually restricted under the terms of our
senior secured credit facilities from repurchasing all of the
notes tendered by holders upon a change of control. Accordingly,
we may not be able to satisfy our obligations to purchase the
senior secured notes unless we are able to refinance or obtain
waivers under the instruments governing that indebtedness. Our
failure to repurchase the senior secured notes upon a change of
control would cause a default under the indentures governing the
senior secured notes and a cross-default under the instruments
governing our senior secured credit facilities. The instruments
governing our senior secured credit facilities also provide that
a change of control will be a default that permits lenders to
accelerate the maturity of borrowings thereunder. Any of our
future debt agreements may contain similar provisions.
In the
event of our bankruptcy, the ability of the holders of the
senior secured notes to realize upon the collateral will be
subject to certain bankruptcy law limitations.
The ability of holders of the senior secured notes to realize
upon the collateral will be subject to certain bankruptcy law
limitations in the event of our bankruptcy. Under applicable
U.S. federal bankruptcy laws, secured creditors are
prohibited from repossessing their security from a debtor in a
bankruptcy case without bankruptcy court approval and may be
prohibited from disposing of security repossessed from such a
debtor without bankruptcy court approval. Moreover, applicable
federal bankruptcy laws generally permit the debtor
14
to continue to retain collateral, including cash collateral,
even though the debtor is in default under the applicable debt
instruments, provided that the secured creditor is given
adequate protection.
The meaning of the term adequate protection may vary
according to the circumstances, but is intended generally to
protect the value of the secured creditors interest in the
collateral at the commencement of the bankruptcy case and may
include cash payments or the granting of additional security if
and at such times as the court, in its discretion, determines
that a diminution in the value of the collateral occurs as a
result of the stay of repossession or the disposition of the
collateral during the pendency of the bankruptcy case. In view
of the lack of a precise definition of the term adequate
protection and the broad discretionary powers of a
U.S. bankruptcy court, we cannot predict whether or when
the collateral agents
and/or the
trustees under the indentures which govern senior secured notes
could foreclose upon or sell the collateral or whether or to
what extent holders of senior secured notes would be compensated
for any delay in payment or loss of value of the collateral
through the requirement of adequate protection.
Moreover, the collateral agents for the senior secured notes may
need to evaluate the impact of the potential liabilities before
determining to foreclose on collateral consisting of real
property, if any, because secured creditors that hold a security
interest in real property may be held liable under environmental
laws for the costs of remediating or preventing the release or
threatened releases of hazardous substances at such real
property. Consequently, the collateral agents for the senior
secured notes may decline to foreclose on such collateral or
exercise remedies available in respect thereof if they do not
receive indemnification to their satisfaction from the holders
of the senior secured notes.
Certain
series of senior secured notes were issued with original issue
discount for U.S. federal income tax purposes.
The
95/8%/103/8% senior
secured toggle notes due 2016, the
97/8% senior
secured notes due 2017 and the
81/2% senior
secured notes due 2019 (collectively, the OID Notes)
were issued with original issue discount (OID) for
U.S. federal income tax purposes. Thus, in addition to
stated interest on the OID Notes, U.S. holders (as defined
in Certain U.S. Federal Tax Consequences) will
be required to include amounts representing the OID in gross
income on a constant yield to maturity basis in advance of the
receipt of cash payment thereof, regardless of a
U.S. holders method of accounting for
U.S. federal income tax purposes. With respect to the
95/8%/103/8% senior
secured toggle notes due 2016, U.S. holders will be
required to include such OID in gross income even if we do not
pay cash interest. For more information about the
U.S. federal income tax consequences of owning the OID
Notes, see Certain U.S. Federal Tax
Consequences.
If a
bankruptcy petition were filed by or against us, holders of the
OID Notes may receive a lesser amount for their claim than they
would have been entitled to receive under the indenture
governing such notes.
If a bankruptcy petition were filed by or against us under the
U.S. Bankruptcy Code after the issuance of the OID Notes,
the claim by any holder of the notes for the principal amount of
the notes may be limited to an amount equal to the sum of:
|
|
|
|
|
the original issue price for such notes; and
|
|
|
|
that portion of the original issue discount that does not
constitute unmatured interest for purposes of the
U.S. Bankruptcy Code.
|
Any original issue discount that was not amortized as of the
date of the bankruptcy filing would constitute unmatured
interest. Accordingly, holders of the OID Notes under these
circumstances may receive a lesser amount than they would be
entitled to receive under the terms of the indenture governing
such notes, even if sufficient funds are available.
15
Risks
Related to the Second Lien Senior Secured Notes
Other
secured indebtedness, including our senior secured credit
facilities and first lien notes, is effectively senior to the
second lien notes to the extent of the value of the collateral
securing such indebtedness on a higher priority
basis.
Our cash flow credit facility and our first lien notes are
collateralized by a first-priority lien, subject to permitted
liens, in, among other things, the capital stock of any wholly
owned first-tier subsidiary of our company or of any
U.S. subsidiary guarantor and substantially all of our and
the U.S. subsidiary guarantors other tangible and
intangible assets, subject to exceptions. In addition, our
asset-based revolving credit facility has a first-priority lien
in the accounts receivable of our company and certain of our
subsidiaries, and our first lien notes and our cash flow credit
facility, other than the European term loan facility, have a
second-priority lien in those receivables (except for those of
certain special purpose subsidiaries that only guarantee and
pledge their assets under our asset-based revolving credit
facility). Our senior secured credit facilities and the
indentures governing our senior secured notes also permit us to
incur additional indebtedness secured on a first-priority basis
by such assets in the future. The first- and second-priority
liens in the collateral securing indebtedness under our senior
secured credit facilities and our first lien notes, as the case
may be, and any such future indebtedness is higher in priority
as to such collateral than the security interests securing the
second lien notes and the guarantees of such notes. The second
lien notes and the related guarantees are secured, subject to
permitted liens, by a second-priority lien or a third-priority
lien, as the case may be, in the assets that secure our cash
flow credit facility and first lien notes on a first-priority or
second-priority basis, as the case may be. Holders of the
indebtedness under our senior secured credit facilities, the
first lien notes and any other indebtedness collateralized by a
higher-priority lien in such collateral will be entitled to
receive proceeds from the realization of value of such
collateral to repay such indebtedness in full before the holders
of the second lien notes will be entitled to any recovery from
such collateral. As a result, holders of the second lien notes
will only be entitled to receive proceeds from the realization
of value of assets securing our senior secured credit facilities
and first lien notes on a higher-priority basis after all
indebtedness and other obligations under our senior secured
credit facilities, first lien notes and any other obligations
secured by higher-priority liens on such assets are repaid in
full. The second lien notes are effectively junior in right of
payment to indebtedness under our senior secured credit
facilities, the first lien notes and any other indebtedness
collateralized by a higher-priority lien in our assets, to the
extent of the realizable value of such collateral. In addition,
the indentures governing the second lien notes permit us to
incur additional indebtedness secured by a lien that ranks
equally with the second lien notes. Any such indebtedness may
further limit the recovery from the realization of the value of
such collateral available to satisfy holders of the second lien
notes.
As of March 31, 2009, on an as adjusted basis after giving
effect to our offering of $1.500 billion aggregate
principal amount of first lien notes in April 2009 and the use
of proceeds therefrom, we had outstanding an aggregate principal
amount of $13.855 billion of senior secured indebtedness
secured by liens ranking senior to those securing the second
lien notes. This indebtedness includes that outstanding under
our senior secured credit facilities, including letters of
credit, the first lien notes, capital leases and other debt
secured on a first priority basis. We also had an additional
$2.198 billion available for borrowing under our senior
secured revolving credit facilities after giving effect to
certain outstanding letters of credit.
The
lien ranking provisions of the indentures and other agreements
relating to the collateral securing the second lien notes limit
the rights of holders of such notes with respect to that
collateral, even during an event of default.
The rights of the holders of the second lien notes with respect
to the collateral that secures the notes on a second-priority or
third-priority basis, as the case may be, are substantially
limited by the terms of the lien ranking agreements set forth in
the indentures and the intercreditor agreements, even during an
event of default. Under the indentures and the intercreditor
agreements, at any time that obligations that have the benefit
of the higher-priority liens are outstanding, any actions that
may be taken with respect to such collateral, including the
ability to cause the commencement of enforcement proceedings
against such collateral and to control the conduct of such
proceedings, and the approval of amendments to, releases of such
collateral from the lien of, and waivers of past defaults under,
such documents relating to such collateral, will be at the
16
direction of the holders of the obligations secured by the
first-priority and second-priority liens, as applicable, and the
holders of the notes secured by lower-priority liens may be
adversely affected.
In addition, the indentures and the intercreditor agreements
contain certain provisions benefiting holders of indebtedness
under our senior secured credit facilities, including provisions
requiring the second lien trustees and the second lien
collateral agent not to object following the filing of a
bankruptcy petition to a number of important matters regarding
the collateral. After such filing, the value of this collateral
could materially deteriorate, and holders of the second lien
notes would be unable to raise an objection. In addition, the
right of holders of obligations secured by first-priority and
second-priority liens, as applicable, to foreclose upon and sell
such collateral upon the occurrence of an event of default also
would be subject to limitations under applicable bankruptcy laws
if we or any of our subsidiaries become subject to a bankruptcy
proceeding.
The collateral that secures the second lien notes and guarantees
on a lower-priority basis will also be subject to any and all
exceptions, defects, encumbrances, liens and other imperfections
as may be accepted by the lenders under our senior secured
credit facilities, the holders of our first lien notes and other
creditors that have the benefit of higher-priority liens on such
collateral from time to time, whether on or after the date the
second lien notes and guarantees are issued. The existence of
any such exceptions, defects, encumbrances, liens and other
imperfections could adversely affect the value of the collateral
securing the second lien notes as well as the ability of the
second lien collateral agent to realize or foreclose on such
collateral.
The
lenders under our senior secured credit facilities will have the
discretion to release the guarantors under the instruments
governing that indebtedness in a variety of circumstances, which
will cause those guarantors to be released from their guarantees
of the second lien notes.
While any obligations under our senior secured credit facilities
remain outstanding, any guarantee of the second lien notes may
be released without action by, or consent of, any holder of the
second lien notes or the trustees under the indentures governing
the second lien notes, at the discretion of lenders under our
senior secured credit facilities, if the related guarantor is no
longer a guarantor of obligations under that indebtedness or any
other indebtedness. See Description of Notes. The
lenders under our senior secured credit facilities will have the
discretion to release the guarantees under the senior secured
credit facilities in a variety of circumstances. You will not
have a claim as a creditor against any subsidiary that is no
longer a guarantor of the second lien notes, and the
indebtedness and other liabilities, including trade payables,
whether secured or unsecured, of those subsidiaries will
effectively be senior to claims of holders of such notes.
Risks
Related to the First Lien Senior Secured Notes
The
secured indebtedness under our senior secured asset-based
revolving credit facility is effectively senior to the first
lien notes to the extent of the value of the receivables
collateral securing such facility on a first-priority
basis.
Our asset-based revolving credit facility has a first-priority
lien in the accounts receivable of our company and our domestic
subsidiaries, with certain exceptions. Our other senior secured
credit facilities have, and our first lien notes have, a
second-priority lien in those receivables (except for those of
certain special purpose subsidiaries that only guarantee and
pledge their assets under our asset-based revolving credit
facility). The indentures governing both the second lien notes
and the first lien notes permit us to incur additional
indebtedness secured on a first-priority basis by such assets in
the future. The first-priority liens in the collateral securing
indebtedness under our asset-based revolving credit facility and
any such future indebtedness is higher in priority as to such
collateral than the security interests securing the first lien
notes and the guarantees. Holders of the indebtedness under our
asset-based revolving credit facility and any other indebtedness
secured by higher priority liens on such collateral will be
entitled to receive proceeds from the realization of value of
such collateral to repay such indebtedness in full before the
holders of the first lien notes will be entitled to any recovery
from such collateral. As a result, holders of the first lien
notes will only be entitled to receive proceeds from the
realization of value of assets securing our asset-based
revolving credit facility on a higher priority basis after all
indebtedness and other obligations under our asset-based
revolving credit facility and any other obligations secured by
higher priority liens on such assets are repaid in full. The
17
first lien notes are effectively junior in right of payment to
indebtedness under our asset-based revolving credit facility and
any other indebtedness secured by higher priority liens on such
collateral to the extent of the realizable value of such
collateral. Even if there were receivables collateral or
proceeds left over to pay the first lien notes and the cash flow
credit facility after a foreclosure on that collateral and
payment of the outstanding amounts under the asset-based
revolving credit facility, that collateral would be subject to
the first lien intercreditor agreement, and the representative
of the lenders under the cash flow credit facility would
initially control actions with respect to that collateral. See
Even though the holders of the first lien
notes have the benefit of a first-priority lien on the
collateral that secures our cash flow credit facility, the
representative of the lenders under the cash flow credit
facility will initially control actions with respect to that
collateral.
As of March 31, 2009, the first lien notes would have been
effectively junior to $1.715 billion of indebtedness
outstanding under our asset-based revolving credit facility to
the extent of the value of collateral securing such indebtedness.
The
lien ranking provisions of the indenture and other agreements
relating to the collateral securing the first lien notes limit
the rights of holders of the first lien notes with respect to
that collateral, even during an event of default.
The rights of the holders of the first lien notes with respect
to the receivables collateral that secures the asset-based
revolving credit facility on a first-priority basis and that
secures our cash flow credit facility and the first lien notes
on a second-priority basis are substantially limited by the
terms of the lien ranking agreements set forth in the indenture
governing the first lien notes and the applicable receivables
intercreditor agreement, even during an event of default. Under
the indenture governing the first lien notes and the applicable
receivables intercreditor agreement, at any time that
obligations that have the benefit of the higher priority liens
are outstanding, any actions that may be taken with respect to
such collateral, including the ability to cause the commencement
of enforcement proceedings against such collateral, to control
the conduct of such proceedings and to approve amendments to
releases of such collateral from the lien of, and waive past
defaults under, such documents relating to such collateral, will
be at the direction of the holders of the obligations secured by
the first-priority liens, and the holders of the first lien
notes secured by lower-priority liens may be adversely affected.
In addition, the indenture governing the first lien notes and
the applicable receivables intercreditor agreement contain
certain provisions benefiting holders of indebtedness under our
asset-based revolving credit facility, including provisions
requiring the trustee and the collateral agent for the first
lien notes not to object following the filing of a bankruptcy
petition to certain important matters regarding the receivables
collateral. After such filing, the value of this collateral
could materially deteriorate, and holders of the first lien
notes would be unable to raise an objection.
The receivables collateral that secures the first lien notes and
guarantees on a lower-priority basis will also be subject to any
and all exceptions, defects, encumbrances, liens and other
imperfections as may be accepted by the lenders under our
asset-based revolving credit facility, whether on or after the
date the first lien notes and guarantees were issued. The
existence of any such exceptions, defects, encumbrances, liens
and other imperfections could adversely affect the value of the
collateral securing the first lien notes, as well as the ability
of the collateral agent to realize or foreclose on such
collateral.
Even
though the holders of the first lien notes have the benefit of a
first-priority lien on the collateral that secures our cash flow
credit facility, the representative of the lenders under the
cash flow credit facility will initially control actions with
respect to that collateral.
The rights of the holders of the first lien notes with respect
to the collateral that secures such notes on a first-priority
basis are subject to a first lien intercreditor agreement among
all holders of obligations secured by that collateral on a
first-priority basis, including the obligations under our cash
flow credit facility. Under that intercreditor agreement, any
actions that may be taken with respect to such collateral,
including the ability to cause the commencement of enforcement
proceedings against such collateral, to control such proceedings
18
and to approve amendments to releases of such collateral from
the lien of, and waive past defaults under, such documents
relating to such collateral, will be at the direction of the
authorized representative of the lenders under the cash flow
credit facility until (1) our obligations under the cash
flow credit facility are discharged (which discharge does not
include certain refinancings of the cash flow credit facility)
or (2) 90 days after the occurrence of an event of
default under the indenture governing the first lien notes, if
the authorized representative of the holders of the first lien
notes represents the largest outstanding principal amount of
indebtedness secured by a first-priority lien on the collateral
(other than the cash flow credit facility) and has complied with
the applicable notice provisions.
However, even if the authorized representative of the first lien
notes gains the right to direct the collateral agent in the
circumstances described in clause (2) above, the authorized
representative must stop doing so (and those powers with respect
to the collateral would revert to the authorized representative
of the lenders under the cash flow credit facility) if the
lenders authorized representative has commenced and is
diligently pursuing enforcement action with respect to the
collateral or the grantor of the security interest in that
collateral (whether our company or the applicable subsidiary
guarantor) is then a debtor under or with respect to (or
otherwise subject to) an insolvency or liquidation proceeding.
In addition, the senior secured credit facilities and the
indenture governing the first lien notes permit us to issue
additional series of notes that also have a first-priority lien
on the same collateral. At any time that the representative of
the lenders under the cash flow credit facility does not have
the right to take actions with respect to the collateral
pursuant to the first lien intercreditor agreement, that right
passes to the authorized representative of the holders of the
next largest outstanding principal amount of indebtedness
secured by a first-priority lien on the collateral. If we issue
additional first lien notes in the future in a greater principal
amount than the existing first lien notes, then the authorized
representative for those additional notes would be next in line
to exercise rights under the first lien intercreditor agreement,
rather than the authorized representative for the existing first
lien notes.
Under the first lien intercreditor agreement, the authorized
representative of the holders of the first lien notes may not
object following the filing of a bankruptcy petition to any
debtor-in-possession
financing or to the use of the shared collateral to secure that
financing, subject to conditions and limited exceptions. After
such a filing, the value of this collateral could materially
deteriorate, and holders of the first lien notes would be unable
to raise an objection.
The collateral that secures the first lien notes and guarantees
on a first-priority basis will also be subject to any and all
exceptions, defects, encumbrances, liens and other imperfections
as may be accepted by the authorized representative of the
lenders under our cash flow credit facility during any period
that such authorized representative controls actions with
respect to the collateral pursuant to the first lien
intercreditor agreement. The existence of any such exceptions,
defects, encumbrances, liens and other imperfections could
adversely affect the value of the collateral securing the first
lien notes as well as the ability of the collateral agent to
realize or foreclose on such collateral for the benefit of the
holders of the first lien notes.
FORWARD-LOOKING
STATEMENTS
This prospectus and the documents incorporated herein by
reference contain forward-looking statements within
the meaning of the federal securities laws, which involve risks
and uncertainties. Forward-looking statements include all
statements that do not relate solely to historical or current
facts, and you can identify forward-looking statements because
they contain words such as believes,
expects, may, will,
should, seeks,
approximately, intends,
plans, estimates, projects,
continue, initiative or
anticipates or similar expressions that concern our
prospects, objectives, strategies, plans or intentions. All
statements made relating to our estimated and projected
earnings, margins, costs, expenditures, cash flows, growth rates
and financial results or to the impact of existing or proposed
laws or regulations described, or incorporated by reference, in
this prospectus are forward-looking statements. These
forward-looking statements are subject to risks and
uncertainties that may change at any time, and, therefore, our
actual results may differ materially from those expected. We
derive many of our forward-looking statements from our operating
budgets and forecasts, which are based upon many detailed
assumptions. While we believe that our assumptions are
19
reasonable, it is very difficult to predict the impact of known
factors, and, of course, it is impossible to anticipate all
factors that could affect our actual results.
Some of the important factors that could cause actual results to
differ materially from our expectations are disclosed under
Risk Factors and elsewhere in this prospectus as
well as in our 2008
10-K and
2009 First Quarter
10-Q
incorporated herein by reference. All subsequent written and
oral forward-looking statements attributable to us, or persons
acting on our behalf, are expressly qualified in their entirety
by these cautionary statements.
We do not undertake any obligation to publicly update or revise
any forward-looking statement as a result of new information,
future events or otherwise, except as otherwise required by law.
20
USE OF
PROCEEDS
This prospectus is delivered in connection with the sale of
notes by Banc of America Securities LLC, Merrill Lynch, Pierce,
Fenner & Smith Incorporated and their affiliates in
market-making transactions. We will not receive any of the
proceeds from such transactions.
21
DESCRIPTION
OF OTHER INDEBTEDNESS
Senior
Secured Credit Facilities
On November 17, 2006 in connection with our
recapitalization, we entered into the senior secured credit
facilities with Banc of America Securities LLC, J.P. Morgan
Securities Inc., Citigroup Global Markets Inc. and Merrill
Lynch, Pierce, Fenner & Smith Incorporated, as joint
lead arrangers and bookrunners, Bank of America, N.A., as
administrative agent, JPMorgan Chase Bank, N.A. and Citicorp
North America, Inc., as co-syndication agents and Merrill Lynch
Capital Corporation, as documentation agent.
The senior secured credit facilities provide senior secured
financing of $16.800 billion, consisting of:
|
|
|
|
|
$12.800 billion-equivalent in term loan facilities,
comprised of a $2.750 billion senior secured term loan A
facility with a term of six years, a $8.800 billion senior
secured term loan B facility with a term of seven years and a
1.000 billion ($1.250 billion) senior secured
European term loan facility with a term of seven years; and
|
|
|
|
$4.000 billion in revolving credit facilities, comprised of
a $2.000 billion senior secured asset-based revolving
credit facility available in dollars with a term of six years
and a $2.000 billion senior secured revolving credit
facility available in dollars, euros and pounds sterling with a
term of six years. Availability under the asset-based revolving
credit facility is subject to a borrowing base of 85% of
eligible accounts receivable less customary reserves.
|
We refer to these senior secured credit facilities, excluding
the asset-based revolving credit facility, as the cash
flow credit facility and, collectively with the
asset-based revolving credit facility, the senior secured
credit facilities.
HCA Inc. is the primary borrower under the senior secured credit
facilities, except that a U.K. subsidiary is the borrower under
the European term loan facility. The revolving credit facilities
include capacity available for the issuance of letters of credit
and for borrowings on
same-day
notice, referred to as the swingline loans. A portion of the
letter of credit availability under the cash-flow revolving
credit facility is available in euros, dollars and pounds
sterling. Lenders under the cash flow credit facility are
subject to a loss sharing agreement pursuant to which, upon the
occurrence of certain events, including a bankruptcy event of
default under the cash flow credit facility, each such lender
will automatically be deemed to have exchanged its interest in a
particular tranche of the cash flow credit facility for a pro
rata percentage in all of the tranches of the cash flow credit
facility.
The asset-based revolving credit facility is documented in a
separate loan agreement from the other senior secured credit
facilities.
On February 16, 2007, we amended our cash flow credit
facility to reduce the applicable margins with respect to the
term borrowings thereunder. On June 20, 2007, we amended
our asset-based revolving credit facility to reduce the
applicable margin with respect to borrowings thereunder.
On March 2, 2009, we amended our cash flow credit facility
to allow for one or more future issuances of additional secured
notes, which may include notes that are secured on a pari passu
basis or on a junior basis with the obligations under the cash
flow credit facility, so long as (1) such notes do not
require, subject to certain exceptions, scheduled repayments,
payment of principal or redemption prior to the scheduled term
loan B maturity date as currently in effect, (2) the terms
of such notes, taken as a whole, are not more restrictive than
those in the cash flow credit facility and (3) the proceeds
from any such issuance are used within three business days of
receipt to permanently prepay term loans under the cash flow
credit facility in accordance with the terms of the cash flow
credit facility. The U.S. security documents related to the
cash flow credit facility were also amended and restated or, in
the case of the U.S. mortgages, will be amended and
restated, in connection with the amendment in order to give
effect to the security interests to be granted to holders of
such additional secured notes.
On March 2, 2009, we also amended our asset-based revolving
credit facility to allow for one or more future issuances of
additional secured notes or loans, which may include notes or
loans that are secured on a
22
pari passu basis or on a junior basis with the obligations under
the cash flow credit facility, so long as (1) such notes or
loans do not require, subject to certain exceptions, scheduled
repayments, payment of principal or redemption prior to the
scheduled term loan B final maturity date as currently in
effect, (2) the terms of such notes or loans, as
applicable, taken as a whole, are not more restrictive than
those in the cash flow credit facility and (3) the proceeds
from any such issuance are used within three business days of
receipt to permanently prepay term loans under the cash flow
credit facility in accordance with the terms of the cash flow
credit facility. The amendment to the asset-based revolving
credit facility also altered the excess facility availability
requirement to include a separate minimum facility availability
requirement applicable to the asset-based revolving credit
facility and increased the applicable LIBOR and asset-based
revolving margins for all borrowings under the asset-based
revolving credit facility by 0.25% each.
See also our 2008
10-K under
Item 13. Certain Relationships and Related
Transactions for a description of certain relationships
between our company and Bank of America, N.A., the
administrative agent under the cash flow credit facility and the
asset-based revolving credit facility.
Interest
Rate and Fees
Borrowings under the senior secured credit facilities bear
interest at a rate equal to, at our option, either
(a) LIBOR for deposits in the applicable currency plus an
applicable margin or (b) the higher of (1) the prime
rate of Bank of America, N.A. and (2) the federal funds
effective rate plus 0.50%, plus an applicable margin. The
applicable margins currently in effect for borrowings are
(w) under the asset-based revolving credit facility, 0.50%
with respect to base rate borrowings and 1.50% with respect to
LIBOR borrowings, (x) under the senior secured revolving
credit facility and the term loan B facility, 1.25% with respect
to base rate borrowings and 2.25% with respect to LIBOR
borrowings, (y) under the term loan A facility, 1.00% with
respect to base rate borrowings and 2.00% with respect to LIBOR
borrowings and (z) under the European term loan facility,
2.00% with respect to LIBOR borrowings. The applicable margins
may be reduced or increased depending on our leverage ratios.
In addition to paying interest on outstanding principal under
the senior secured credit facilities, we are required to pay a
commitment fee to the lenders under the revolving credit
facilities in respect of the unutilized commitments thereunder.
The initial commitment fee rate is 0.50% per annum for the
revolving credit facility and 0.375% for the asset-based
revolving credit facility. Each of these commitment fee rates
may be reduced subject to our reducing our leverage to specified
ratios. We must also pay customary letter of credit fees.
Prepayments
The cash flow credit facility requires us to prepay outstanding
term loans, subject to certain exceptions, with:
|
|
|
|
|
50% (which percentage will be reduced to 25% if our total
leverage ratio is 5.50x or less and to 0% if our total leverage
ratio is 5.00x or less) of our annual excess cash flow;
|
|
|
|
100% of the net cash proceeds of all nonordinary course asset
sales or other dispositions of property, other than the
Receivables Collateral, as defined below, if we do not
(1) reinvest or commit to reinvest those proceeds in assets
to be used in our business or to make certain other permitted
investments within 15 months as long as, in the case of any
such commitment to reinvest or make certain other permitted
investments, such investment is completed within such
15-month
period or, if later, within 180 days after such commitment
is made or (2) apply such proceeds within 15 months to
repay debt of HCA Inc. that was outstanding on the effective
date of the Merger scheduled to mature prior to the earliest
final maturity of the senior secured credit facilities then
outstanding; and
|
|
|
|
100% of the net cash proceeds of any incurrence of debt, other
than proceeds from the receivables facilities and other debt
permitted under the senior secured credit facilities.
|
The foregoing mandatory prepayments are applied among the term
loan facilities (1) during the first three years after the
effective date of the Merger, pro rata to such facilities based
on the respective aggregate
23
amounts of unpaid principal installments thereof due during such
period, with amounts allocated to each facility being applied to
the remaining installments thereof in direct order of maturity
and (2) thereafter, pro rata to such facilities, with
amounts allocated to each facility being applied, in the case of
the term loan A facility, pro rata to the remaining installments
thereof and, in the case of the term loan B facility or the
European term loan facility, to the next eight unpaid scheduled
installments of principal of such facility and then pro rata to
the remaining amortization payments under such facility.
Notwithstanding the foregoing, (i) proceeds of asset sales
by foreign subsidiaries are applied solely to prepay European
term loans until such term loans have been repaid in full and
(ii) we are not required to prepay loans under the term
loan A facility or the term loan B facility with net cash
proceeds of asset sales or with excess cash flow, in each case
attributable to foreign subsidiaries, to the extent that the
repatriation of such amounts is prohibited or delayed by
applicable local law or would result in material adverse tax
consequences.
The asset-based revolving credit facility requires us to prepay
outstanding loans if borrowings exceed the borrowing base.
We may voluntarily repay outstanding loans under the senior
secured credit facilities at any time without premium or
penalty, other than customary breakage costs with
respect to LIBOR loans.
Amortization
We are required to repay the loans under the term loan
facilities as follows:
|
|
|
|
|
the term loan A facility amortizes in quarterly installments
such that the aggregate amount of the original funded principal
amount of such facility repaid pursuant to such amortization
payments in each year, commencing with the year ending
December 31, 2007, is equal to $112.5 million in years
1 and 2, $225 million in years 3 and 4, $450 million
in year 5 and $1.625 billion in year 6; and
|
|
|
|
each of the term loan B facility and the European term loan
facility amortizes in equal quarterly installments that
commenced on March 31, 2007 in aggregate annual amounts
equal to 1% of the original funded principal amount of such
facility, with the balance being payable on the final maturity
date of such term loans.
|
Principal amounts outstanding under the revolving credit
facilities are due and payable in full at maturity, six years
from the date of the closing of the senior secured credit
facilities.
Guarantee
and Security
All obligations under the senior secured credit facilities are
unconditionally guaranteed by substantially all existing and
future, direct and indirect, wholly-owned material domestic
subsidiaries that are Unrestricted Subsidiaries
under the 1993 Indenture (except for certain special purpose
subsidiaries that only guarantee and pledge their assets under
the asset-based revolving credit facility), and the obligations
under the European term loan facility are also unconditionally
guaranteed by HCA Inc. and each of our existing and future
wholly owned material subsidiaries formed under the laws of
England and Wales, subject, in each of the foregoing cases, to
any applicable legal, regulatory or contractual constraints and
to the requirement that such guarantee does not cause adverse
tax consequences.
All obligations under the asset-based revolving credit facility,
and the guarantees of those obligations, are secured, subject to
permitted liens and other exceptions, by a first-priority lien
on substantially all of the receivables of the borrowers and
each guarantor under such asset-based revolving credit facility
(the Receivables Collateral).
All obligations under the cash flow credit facility and the
guarantees of such obligations, are secured, subject to
permitted liens and other exceptions, by:
|
|
|
|
|
a first-priority lien on the capital stock owned by HCA Inc. or
by any U.S. guarantor in each of their respective
first-tier subsidiaries (limited, in the case of foreign
subsidiaries, to 65% of the voting stock of such subsidiaries);
|
24
|
|
|
|
|
a first-priority lien on substantially all present and future
assets of HCA Inc. and of each U.S. guarantor other than
(i) Principal Properties (as defined in the
1993 Indenture), except for certain Principal
Properties the aggregate amount of indebtedness secured
thereby in respect of the cash flow credit facility and the
notes offered hereby and any future First Lien Obligations,
taken as a whole, do not exceed 10% of Consolidated Net
Tangible Assets (as defined under the 1993 Indenture),
(ii) certain other real properties and (iii) deposit
accounts, other bank or securities accounts, cash, leaseholds,
motor-vehicles and certain other exceptions (such collateral
under this and the preceding bullet, the Non-Receivables
Collateral); and
|
|
|
|
a second-priority lien on certain of the Receivables Collateral
(such portion of the Receivables Collateral, the Shared
Receivables Collateral; the Receivables Collateral that
does not secure such cash flow credit facility on a
second-priority basis is referred to as the Separate
Receivables Collateral).
|
The obligations of the borrowers and the guarantors under the
European term loan facility are also secured by substantially
all present and future assets of the European subsidiary
borrower and each European guarantor (the European
Collateral), subject to permitted liens and other
exceptions (including, without limitation, exceptions for
deposit accounts, other bank or securities accounts, cash,
leaseholds, motor-vehicles and certain other exceptions) and
subject to such security interests otherwise being permitted by
applicable law and contract and not resulting in adverse tax
consequences. The notes offered hereby will not be secured by
any of the European Collateral.
Certain
Covenants and Events of Default
The senior secured credit facilities contain a number of
covenants that, among other things, restrict, subject to certain
exceptions, our ability to:
|
|
|
|
|
incur additional indebtedness;
|
|
|
|
create liens;
|
|
|
|
enter into sale and leaseback transactions;
|
|
|
|
engage in mergers or consolidations;
|
|
|
|
sell or transfer assets;
|
|
|
|
pay dividends and distributions or repurchase our capital stock;
|
|
|
|
make investments, loans or advances;
|
|
|
|
prepay certain subordinated indebtedness (including the notes
and certain other indebtedness existing on the effective date of
the Merger (Retained Indebtedness)), subject to
exceptions for repayments of Retained Indebtedness maturing
prior to the senior secured credit facilities and, in certain
cases, to satisfaction of a maximum first-lien leverage
condition;
|
|
|
|
make certain acquisitions;
|
|
|
|
engage in certain transactions with affiliates;
|
|
|
|
amend material agreements governing certain subordinated
indebtedness (including the senior secured second-lien notes
offered hereby); and
|
|
|
|
change our lines of business.
|
In addition, the senior secured credit facilities require us to
maintain the following financial covenants:
|
|
|
|
|
in the case of the asset-based revolving credit facility, a
minimum interest coverage ratio (applicable only when
availability under such facility is less than 10% of the
borrowing base thereunder); and
|
|
|
|
in the case of the other senior secured credit facilities, a
maximum total leverage ratio.
|
25
The senior secured credit facilities also contain certain
customary affirmative covenants and events of default, including
a change of control.
Existing
Indebtedness
Existing
Senior Notes, Debentures and Medium-Term Notes
As of March 31, 2009, we had outstanding an aggregate
principal amount of $6.296 billion and
£122 million of senior notes and debentures,
consisting of the following series:
|
|
|
|
|
$3,488,000 aggregate principal amount of 5.50% Senior Notes
due 2009;
|
|
|
|
$440,020,000 aggregate principal amount of 8.75% Senior
Notes due 2010;
|
|
|
|
£122, 259,000 aggregate principal amount of
8.75% Senior Notes due 2010;
|
|
|
|
$273,321,000 aggregate principal amount of 7.875% Senior
Notes due 2011;
|
|
|
|
$402,499,000 aggregate principal amount of 6.95% Senior
Notes due 2012;
|
|
|
|
$500,000,000 aggregate principal amount of 6.30% Senior
Notes due 2012;
|
|
|
|
$500,000,000 aggregate principal amount of 6.25% Senior
Notes due 2013;
|
|
|
|
$500,000,000 aggregate principal amount of 6.75% Senior
Notes due 2013;
|
|
|
|
$500,000,000 aggregate principal amount of 5.75% Senior
Notes due 2014;
|
|
|
|
$750,000,000 aggregate principal amount of 6.375% Senior
Notes due 2015;
|
|
|
|
$1,000,000,000 aggregate principal amount of 6.50% Senior
Notes due 2016;
|
|
|
|
$291,436,000 aggregate principal amount of 7.69% Notes due
2025;
|
|
|
|
$250,000,000 aggregate principal amount of 7.50% Senior
Notes due 2033;
|
|
|
|
$150,000,000 aggregate principal amount of 7.19% Debentures
due 2015;
|
|
|
|
$135,645,000 aggregate principal amount of 7.50% Debentures
due 2023;
|
|
|
|
$150,000,000 aggregate principal amount of 8.36% Debentures
due 2024;
|
|
|
|
$150,000,000 aggregate principal amount of 7.05% Debentures
due 2027;
|
|
|
|
$100,000,000 aggregate principal amount of 7.75% Debentures
due 2036; and
|
|
|
|
$200,000,000 aggregate principal amount of 7.50% Debentures
due 2095.
|
As of March 31, 2009, we also had outstanding $121,180,000
aggregate principal amount of our 8.70% Medium-Term Notes due
2010; $121,110,000 aggregate principal amount of our 9.00%
Medium-Term Notes due 2014; and $125,000,000 aggregate principal
amount of our 7.58% Medium-Term Notes due 2025.
All of our outstanding series of senior notes, debentures and
medium-term notes were issued under the 1993 Indenture. The
terms of the 1993 Indenture governing the existing senior notes,
debentures and medium-term notes provide that in addition to
customary events of default and a customary covenant limiting
mergers and consolidations of HCA, the aggregate amount of all
other indebtedness of HCA secured by mortgages on
Principal Properties (as such term is defined in the
indenture) together with the aggregate principal amount of all
indebtedness of restricted subsidiaries (as such term is defined
in the indenture) and the attributable debt in respect of
sale-leasebacks of Principal Properties, may not exceed 15% of
the consolidated net tangible assets of HCA and its consolidated
subsidiaries, subject to exceptions for certain permitted
mortgages and debt. See Description of Notes
Senior Notes, Debentures and Medium-Term Notes Issued Under the
1993 Indenture.
26
Existing
Senior Secured Notes
Also in connection with the Recapitalization, we issued
$4.200 billion of senior secured notes (comprised of
$1.000 billion of
91/8% notes
due 2014 and $3.200 billion of
91/4% notes
due 2016) and $1.500 billion of
95/8/103/8% senior
secured toggle notes (which allow us, at our option, to pay
interest in kind during the first five years at the higher
interest rate of
103/8%)
due 2016. See Description of Notes Senior
Secured Notes Issued Under the 2006 Indenture.
As of March 31, 2009, we had outstanding an aggregate
principal amount of $5.700 billion of senior secured notes
consisting of the following series:
|
|
|
|
|
$1,000,000,000 aggregate principal amount of
91/8% Senior
Secured Notes due 2014;
|
|
|
|
$3,200,000,000 aggregate principal amount of
91/4% Senior
Secured Notes due 2016; and
|
|
|
|
$1,500,000,000 aggregate principal amount of
95/8/103/8% Senior
Secured Toggle Notes due 2016.
|
In November 2008, we elected to make an interest payment on the
senior secured toggle notes for the interest period ending in
May 2009 by paying in kind (PIK) at the PIK interest
rate of
103/8%
instead of paying interest in cash. On May 15, 2009, the
aggregate principal amount of the senior secured toggle notes
increased by $77,813,000 as a result of the PIK interest payment.
On February 19, 2009, we issued $310 million aggregate
principal amount of
97/8% senior
secured notes due 2017 at a price of 96.673% of their face
value, resulting in approximately $300 million of gross
proceeds. These notes and the related guarantees are secured by
second-priority liens, subject to permitted liens, on our and
our subsidiary guarantors assets, subject to certain
exceptions, that secure our cash flow credit facility on a
first-priority basis and are secured by third-priority liens,
subject to permitted liens, on our and our subsidiary
guarantors assets that secure our asset-based revolving
credit facility on a first priority basis and our other cash
flow credit facility on a second-priority basis. See
Description of Notes Senior Secured Notes
Issued Under the 2009 Second Lien Indenture.
On April 22, 2009 we issued $1.500 billion aggregate
principal amount of
81/2% senior
secured notes due 2019 at a price of 96.755% of their face
value, resulting in approximately $1.451 billion of gross
proceeds. These notes and the related guarantees are secured by
first-priority liens, subject to permitted liens, on our and our
subsidiary guarantors assets, subject to certain
exceptions, that secure our cash flow credit facility on a
first-priority basis and are secured by second priority liens,
subject to permitted liens, on our and our subsidiary
guarantors assets that secure our asset-based revolving
credit facility on a first priority basis and our other cash
flow credit facility on a second-priority basis. See
Description of Notes Senior Secured Notes
Issued Under the 2009 First Lien Indenture.
Other
Existing Secured Indebtedness
We had outstanding approximately $385 million of capital
leases and other secured debt as of March 31, 2009.
Under our lease with HRT of Roanoke, Inc., effective
December 20, 2005, we make annual payments for rent and
additional expenses for the use of premises in Roanoke and
Salem, Virginia. The rent payments will increase each year
beginning January 1, 2007 by the lesser of 3% or the change
in the Consumer Price Index. The lease is for a fixed-term of
12 years with the option to extend the lease for another
ten years.
Under our lease with Medical City Dallas Limited, effective
March 18, 2004, we make annual payments for rent for the
use of premises that are a part of a complex known as
Medical City Dallas located in Dallas, Texas. The
rent payment is adjusted yearly based on the fair market value
of the premises and a capitalization rate. The initial term is
240 months with the option to extend for two more terms of
240 months each.
27
DESCRIPTION
OF NOTES
We have issued senior debt securities, debentures and
medium-term notes, each as described below under
Senior Notes, Debentures and Medium-Term Notes
Issued Under the 1993 Indenture and senior secured notes
as described under Senior Secured Notes Issued
Under the 2006 Indenture, Senior Secured
Notes Issued Under the 2009 Second Lien Indenture and
Senior Secured Notes Issued Under the 2009
First Lien Indenture. The terms used in each respective
section apply only to that section, and the summaries contained
therein are qualified in their entirety by the actual text of
the applicable agreements and indentures, each of which are
filed as an exhibit to the registration statement, of which this
prospectus is a part or which may be requested by contacting us
at the address set forth under Where You Can Find More
Information about HCA Inc.
Senior
Notes, Debentures and Medium-Term Notes Issued Under the 1993
Indenture
General
The below description of the debt securities begins with a
summary of certain of the terms of the Indenture. Following that
summary, specific securities and relevant terms are listed,
divided into two categories of debt securities issued:
(a) notes and debentures and (b) medium-term notes.
Each series of these debt securities has been issued under the
Indenture, dated as of December 16, 1993, between Columbia
Healthcare Corporation and The First National Bank of Chicago,
as Trustee, as supplemented or amended by the First Supplemental
Indenture, dated as of May 25, 2000, between the Issuer and
Bank One Trust Company, N.A., as Trustee, the Second
Supplemental Indenture, dated as of July 1, 2001, between
the Issuer and Bank One Trust Company, N.A., as Trustee,
the Third Supplemental Indenture, dated as of December 5,
2001, between the Issuer and The Bank of New York, and the
Fourth Supplemental Indenture, dated as of November 14,
2006, between the Company and The Bank of New York, as Trustee
(Trustee) (as may be further amended or
supplemented, the Indenture).
Ranking
The debt securities are our senior unsecured obligations and
rank equally in right of payment to any of our existing and
future senior indebtedness, are senior in right of payment to
all of our existing and future subordinated indebtedness, are
effectively subordinated in right of payment to our secured
obligations to the extent of the value of the collateral
securing such obligations and are structurally subordinated in
right of payment to all existing and future indebtedness of our
subsidiaries that do not guarantee the debt securities. In a
liquidation or reorganization of any of our subsidiaries, the
right of holders of the debt securities to participate in any
distribution is subject to the prior claims of creditors of that
subsidiary, except to the extent that we are a creditor.
Limitations
on Us and Our Subsidiaries
Limitation
on Mortgages
The Indenture provides that neither we nor any of our
subsidiaries will issue, assume or guarantee any indebtedness or
obligation secured by mortgages, liens, pledges or other
encumbrances (referred to collectively as mortgages)
upon any principal property (as defined below under
Certain Definitions), unless the debt
securities shall be secured equally and ratably with (or prior
to) such debt. This restriction will not apply to:
|
|
|
|
|
mortgages securing the purchase price or cost of construction of
property or additions, substantial repairs, alterations or
improvements, if the debt and the mortgages are incurred within
18 months of the acquisition or completion of construction
and full operation or additions, repairs, alterations or
improvements;
|
|
|
|
mortgages existing on property at the time of its acquisition by
us or our subsidiary or on the property of a corporation at the
time of the acquisition of such corporation by us or our
subsidiary;
|
|
|
|
mortgages to secure debt on which the interest payments are
exempt from federal income tax under Section 103 of the
Internal Revenue Code;
|
|
|
|
mortgages in favor of us or a consolidated subsidiary;
|
28
|
|
|
|
|
mortgages existing on the date of the Indenture;
|
|
|
|
certain mortgages to governmental entities;
|
|
|
|
mortgages incurred in connection with the borrowing of funds
used to repay debt within 120 days in the same principal
amount secured by other mortgages on principal property with at
least the same appraised fair market value;
|
|
|
|
mortgages incurred within 90 days (or any longer period,
not in excess of one year, as permitted by law) after
acquisition of the related property or equipment arising solely
in connection with the transfer of tax benefits in accordance
with Section 168(f)(8) of the Internal Revenue Code; and
|
|
|
|
any extension, renewal or replacement of any mortgage referred
to above, provided the amount secured is not increased and it
relates to the same property.
|
Limitation
on Sale and Lease-Back Transactions
The Indenture provides that neither we nor any subsidiary will
enter into any sale and lease-back transaction with respect to
any principal property involving a lease of more than three
years with another person (other than our company or a
subsidiary) unless either:
|
|
|
|
|
we or our subsidiary could incur indebtedness secured by a
mortgage on the property to be leased; or
|
|
|
|
within 120 days, we apply the greater of the net proceeds
of the sale of the leased property or the fair value of the
leased property, as determined by our chief financial officer
(less the principal amount of any debt securities delivered
within 120 days for retirement or cancellation or other
funded debt voluntarily retired within 120 days) to the
voluntary retirement of our long-term funded debt or the
acquisition or construction of a principal property.
|
Limitation
on Subsidiary Debt and Preferred Stock
The Indenture provides that none of our restricted subsidiaries
may, directly or indirectly, create, incur, issue, assume or
otherwise become liable with respect to, extend the maturity of,
or become responsible for the payment of, any debt or preferred
stock except:
|
|
|
|
|
debt outstanding on the date of the Indenture; or
|
|
|
|
debt representing the assumption by one restricted subsidiary of
debt of another;
|
|
|
|
debt or preferred stock of any corporation or partnership
existing when it becomes a subsidiary;
|
|
|
|
debt of a restricted subsidiary arising from agreements
providing for indemnification, adjustment of purchase price or
similar obligations or from guarantees, letters of credit,
surety bonds or performance bonds securing any of our
obligations or those of our subsidiaries incurred or assumed in
connection with the disposition of any business, property or
subsidiary, except for the purpose of financing an acquisition,
provided that the maximum aggregate liability does not exceed
the gross proceeds from the disposition;
|
|
|
|
debt of a restricted subsidiary in respect of performance,
surety and other similar bonds, bankers acceptances and letters
of credit provided in the ordinary course of business;
|
|
|
|
debt secured by a mortgage incurred to finance the purchase
price or cost of construction of property or additions,
substantial repairs, alterations or improvements, if the
mortgage and debt are incurred within 18 months of the
later of the acquisition or completion of construction and full
operation or additions, repairs, alterations or improvements and
the mortgage does not relate to any other property;
|
|
|
|
permitted subsidiary refinancing debt (as defined below under
Certain Definitions);
|
|
|
|
debt, including guarantees, of a restricted subsidiary to us or
another subsidiary as long as we hold it; or
|
|
|
|
any obligation pursuant to a permitted sale and lease-back
transaction.
|
29
Exempted
Transactions
Even if otherwise prohibited by these limitations, if the
aggregate outstanding principal amount of all our other debt and
that of our subsidiaries subject to these limitations does not
exceed 15% of our consolidated net tangible assets, then:
|
|
|
|
|
we or any of our subsidiaries may issue, assume or guarantee
debt secured by mortgages;
|
|
|
|
we or any of our subsidiaries may enter into any sale and
lease-back transaction; and
|
|
|
|
any restricted subsidiary may issue, assume or become liable for
any debt or preferred stock.
|
Events of
Default
Under the Indenture, an event of default applicable to the debt
securities of any series means:
|
|
|
|
|
failure to pay the principal or any premium on any debt
securities of that series when due;
|
|
|
|
failure to pay any interest on any debt securities of that
series when due, continued for 30 days;
|
|
|
|
failure to deposit any sinking fund payment in respect of any
debt securities of that series when due;
|
|
|
|
failure to perform, or the breach of, any of our other
applicable covenants or warranties in the Indenture, continued
for 60 days after written notice;
|
|
|
|
events in bankruptcy, insolvency or reorganization; and
|
|
|
|
any other event of default provided with respect to debt
securities of that series.
|
If any event of default with respect to debt securities of any
series occurs and is continuing, either the Trustee or the
holders of at least 25% in aggregate principal amount of the
outstanding debt securities of that series may declare the
principal amount, or in the case of discount securities, the
applicable portion of the principal amount, of all the debt
securities of that series to be due and payable immediately. The
holders may, under certain circumstances, rescind and annul this
acceleration prior to obtaining a judgment or decree.
Other than the duties of the Trustee during a default to act
with the required standard of care, the Trustee is not obligated
to exercise any of its rights or powers under the Indenture at
the request or direction of any of the holders unless the
holders shall have offered to the Trustee reasonable indemnity.
Subject to these indemnification provisions and certain other
conditions described in the Indenture, the holders of a majority
in aggregate principal amount of the outstanding debt securities
of any series may direct the time, method and place of
conducting any proceeding for any remedy available to the
Trustee, or exercising any trust or power conferred on the
Trustee, with respect to the debt securities of that series.
We will furnish the Trustee annually with a statement as to our
performance of our obligations under the Indenture and as to any
default in our performance.
Modification
and Waiver
We and the Trustee may modify and amend the Indenture with the
consent of the holders of a majority in aggregate principal
amount of the outstanding debt securities of each series
affected voting separately. We must have the consent of the
holder of each outstanding debt security affected to:
|
|
|
|
|
change the stated maturity of the principal of, or any
installment of interest on, any debt security;
|
|
|
|
reduce the principal, premium or interest on any debt security;
|
|
|
|
reduce the amount of principal of discount securities payable
upon acceleration of the maturity;
|
|
|
|
change the currency of payment of principal, premium or interest
on any debt security;
|
|
|
|
impair the right to institute suit for the enforcement of any
payment on or with respect to any debt securities; or
|
30
|
|
|
|
|
reduce the percentage of holders of any series whose consent is
required for modification or amendment of the Indenture or for
waiver of compliance with certain provisions of the Indenture or
certain defaults.
|
The holders of a majority in aggregate principal amount of the
outstanding debt securities of each series may, on behalf of all
holders of that series, waive any past default under the
Indenture with respect to debt securities of that series.
However, such holders may not waive a past default in the
payment of principal, premium or interest, or any sinking fund
installment with respect to the debt securities, or waive a
covenant or provision that cannot be modified or amended without
the consent of the holders of each outstanding debt security
affected.
We and the Trustee may modify and amend the Indenture without
the consent of the holders of the debt securities to, among
other things:
|
|
|
|
|
evidence the succession of another corporation to our company;
|
|
|
|
add to the covenants for the benefit of the holders or surrender
any right or power conferred upon our company;
|
|
|
|
add additional events of default;
|
|
|
|
secure the debt securities;
|
|
|
|
supplement the Indenture to the extent necessary to permit or
facilitate defeasance and discharge of any series of debt
securities; provided that this action does not adversely
affect the holders of debt securities in any material respect;
|
|
|
|
establish the form and terms of debt securities of any new
series;
|
|
|
|
provide for a successor trustee or for co-trustees;
|
|
|
|
cure any ambiguity, correct or supplement any provision of the
Indenture that may be defective or inconsistent with any other
provision, or make any other provisions that are not
inconsistent with any provision of the Indenture; provided
that those other provisions do not adversely affect the
interests of the holders of outstanding debt securities of any
series in any material respect; or
|
|
|
|
change any place where principal, premium (if any) and interest
is payable, where debt securities may be surrendered for
registration, transfer or exchange or where notices or demands
on our company may be served.
|
Consolidation,
Merger, Sale or Lease of Assets
We may consolidate with or merge into, or transfer or lease our
assets substantially as an entirety to any corporation without
the consent of the holders of any of the outstanding debt
securities under the Indenture if:
|
|
|
|
|
the successor corporation is a corporation organized under the
laws of the United States, any state there of or the
District of Columbia and expressly assumes our obligations on
the debt securities and under the Indenture;
|
|
|
|
after giving effect to the transaction, no event of default, and
no event which, after notice or lapse of time or both, would
become an event of default, shall have occurred and be
continuing;
|
|
|
|
if, as a result of the transaction, our company would become
subject to a mortgage, pledge, lien, security interest or other
encumbrance that would not be permitted by the Indenture, we or
the successor corporation will secure the debt securities
equally and ratably with (or prior to) all indebtedness secured
thereby; and
|
|
|
|
we have delivered to the Trustee an officers certificate
and an opinion of counsel stating that the transaction complies
with the Indenture and that all conditions precedent have been
complied with.
|
Defeasance
If so specified in the terms of any series of debt securities,
we may be discharged from all obligations under the debt
securities of any series, and we will not be subject to the
limitations in the Indenture discussed in the above sections
(known as legal defeasance) or we may cease to be under any
obligation to comply with
31
specified covenants in the Indenture (known as covenant
defeasance), if (1) we deposit with the Trustee trust money or
U.S. government obligations that are sufficient to pay all
principal, premium and interest on the debt securities of the
series and certain other conditions are met. We would deliver to
the Trustee an opinion of counsel to the effect that the deposit
and related defeasance would not (1) cause the holders of
the debt securities of the series to recognize income, gain or
loss for United States income tax purposes or (2) result in
the delisting of the debt securities from any national
securities exchange (if so listed).
Optional
Redemption
If the terms of any series of debt securities (other than the
£150,000,000 in aggregate principal amount of
8.75% Senior Notes Due 2010, which are discussed below
under the heading Provisions that Apply Only
to the £150,000,000 8.75% Senior Notes Due 2010)
indicate that they are redeemable at the option of our company,
the debt securities of that series will be redeemable, at our
option, at any time in whole, or in part from time to time, at a
redemption price equal to the greater of (1) 100% of the
principal amount of the notes to be redeemed or (2) the sum
of the present values of the remaining scheduled payments of
principal and interest on the notes to be redeemed (exclusive of
interest accrued to the date of redemption) discounted to the
date of redemption on a semiannual basis (assuming a
360-day year
consisting of twelve
30-day
months) at the then current Treasury Rate (as defined below),
plus the number of basis points specified in the terms of the
debt securities. In each case, we will pay accrued and unpaid
interest on the principal amount being redeemed to the date of
redemption.
We will mail notice of any redemption between 30 and
60 days preceding the redemption date to each holder of the
debt securities to be redeemed.
The notice of the redemption for such debt securities will
state, among other things, the principal amount of the debt
securities to be redeemed, the redemption price and the place or
places that payment will be made upon presentation and surrender
of the debt securities to be redeemed.
Unless we default in payment of the redemption price, on and
after the redemption date, interest will cease to accrue on the
debt securities or portions called for redemption.
Method
for Determining the Treasury Rate for any Optional Redemption of
the 5.50% Senior Notes due 2009, the 6.30% Senior
Notes due 2012, the 6.25% Senior Notes due 2013, the
6.75% Senior Notes due 2013, the 5.75% Senior Notes
due 2014, the 6.375% Senior Notes due 2015, the
6.50% Senior Notes due 2016 and the 7.50% Senior Notes
due 2033
With respect to each of the series of redeemable debt securities
listed above, for the purposes of determining the applicable
redemption price, Treasury Rate and the other
defined terms listed below have the respective meanings assigned
to them in this subsection.
Treasury Rate means, with respect to any
redemption date, the rate per year equal to: (1) the yield
under the heading which represents the average for the
immediately preceding week, appearing in the most recently
published statistical release designated H.15(519)
or any successor publication which is published weekly by the
Board of Governors of the Federal Reserve System and which
establishes yields on actively traded United States Treasury
securities adjusted to constant maturity under the caption
Treasury Constant Maturities, for the maturity
corresponding to the Comparable Treasury Issue; provided
that, if no maturity is within three months before or after
the Remaining Life of the notes to be redeemed, yields for the
two published maturities most closely corresponding to the
Comparable Treasury Issue shall be determined and the Treasury
Rate shall be interpolated or extrapolated from those yields on
a straight line basis, rounding to the nearest month; or
(2) if such release (or any successor release) is not
published during the week preceding the calculation date or does
not contain such yields, the rate per year equal to the
semiannual equivalent yield to maturity of the Comparable
Treasury Issue, calculated using a price for the Comparable
Treasury Issue (expressed as a percentage of its principal
amount) equal to the Comparable Treasury Price for such
redemption date. The Treasury Rate shall be calculated on the
third business day preceding the redemption date.
Comparable Treasury Issue means the United
States Treasury security selected by an Independent Investment
Banker and having a maturity comparable to the remaining term of
the debt securities to be
32
redeemed that would be utilized, at the time of selection and in
accordance with customary financial practice, in pricing new
issues of corporate debt securities of comparable maturity to
the remaining term of such debt securities.
Remaining Life means the maturity of a United
States Treasury security selected by an Independent Investment
Banker that is comparable to the remaining term of such debt
securities.
Independent Investment Banker means one of
the Reference Treasury Dealers appointed by the Trustee after
consultation with us.
Comparable Treasury Price means, with respect
to any redemption date, (a) the average of the Reference
Treasury Dealer Quotations for the redemption date, after
excluding the highest and lowest Reference Treasury Dealer
Quotations, or (b) if the Trustee obtains fewer than four
Reference Treasury Dealer Quotations, the average of all the
quotations.
Reference Treasury Dealer Quotations means,
with respect to each Reference Treasury Dealer and any
redemption date, the average, as determined by the Trustee, of
the bid and asked prices for the Comparable Treasury Issue
(expressed in each case as a percentage of its principal amount)
quoted in writing to the Trustee by the Reference Treasury
Dealer at 5:00 p.m. on the third business day preceding the
redemption date.
Reference Treasury Dealer means each of the
financial institutions specified in the terms of the securities
and their respective successors; provided however, that
if any of the foregoing shall cease to be a primary
U.S. government securities dealer in New York City (a
Primary Treasury Dealer), we shall substitute
another Primary Treasury Dealer.
Method
for Determining the Treasury Rate for any Optional Redemption of
the 8.75% Senior Notes due 2010, the 7.875% Senior
Notes due 2011, the 6.95% Senior Notes due 2012 and the
7.19% Debentures due 2015
With respect to each of the series of redeemable debt securities
listed above, for the purposes of determining the applicable
redemption price, Treasury Rate and the other
defined terms listed below have the respective meanings assigned
to them in this subsection.
Treasury Rate means, with respect to any
redemption date, the rate per annum equal to the semiannual
equivalent yield to maturity of the Comparable Treasury Issue,
assuming a price for the Comparable Treasury Issue (expressed as
a percentage of its principal amount) equal to the Comparable
Treasury Price for the redemption date.
Comparable Treasury Issue means the United
States Treasury security selected by an Independent Investment
Banker and having a maturity comparable to the remaining term of
the debt securities to be redeemed that would be utilized, at
the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of
comparable maturity to the remaining term of such debt
securities.
Independent Investment Banker means one of
the Reference Treasury Dealers appointed by the Trustee after
consultation with us, except that with respect to the
7.19% Debentures due 2015, such term means Morgan
Stanley & Co. Incorporated or, if such firm is
unwilling or unable to select the Comparable Treasury Issue, an
independent banking institution of national standing appointed
by the Trustee.
Comparable Treasury Price means, with respect
to any redemption date, (1) the average of the bid and
asked prices for the Comparable Treasury Issue (expressed in
each case as a percentage of its principal amount) on the third
business day preceding the redemption date, as set forth in the
daily statistical release (or any successor release) published
by the Federal Reserve Bank of New York and designated
Composite 3:30 p.m. Quotations for
U.S. Government Securities or (2) if the release
(or any successor release) is not published or does not contain
the prices on that business day, (a) the average of the
Reference Treasury Dealer Quotations for the redemption date,
after excluding the highest and lowest Reference Treasury Dealer
Quotations, or (b) if the Trustee obtains fewer than four
Reference Treasury Dealer Quotations, the average of all the
quotations.
33
Reference Treasury Dealer Quotations means,
with respect to each Reference Treasury Dealer and any
redemption date, the average, as determined by the Trustee, of
the bid and asked prices for the Comparable Treasury Issue
(expressed in each case as a percentage of its principal amount)
quoted in writing to the Trustee by the Reference Treasury
Dealer at 5:00 p.m. on the third business day preceding the
redemption date.
Reference Treasury Dealer means each of the
financial institutions specified in the terms of the securities
and their respective successors; provided however, that
if any of the foregoing shall cease to be a primary
U.S. Government securities dealer in New York City (a
Primary Treasury Dealer), we shall substitute
another Primary Treasury Dealer.
Provisions
that Apply Only to the £150,000,000 8.75% Senior Notes
Due 2010
Optional
Redemption of the £150,000,000 8.75% Senior Notes Due
2010
The £150,000,000 in aggregate principal amount of
8.75% Senior Notes Due 2010 (the 2010 Pounds
Sterling Notes) will be redeemable as a whole or in
part, at our option, at any time after November 1, 2003, at
a redemption price equal to the greater of (1) 100% of the
principal amount of such notes and (2) as determined by the
Calculation Agent, the price at which the Gross
Redemption Yield on the outstanding principal amount of the
notes on the Reference Date is equal to the Gross
Redemption Yield (determined by reference to the
middle-market price) at 3:00 p.m. (London time) on that
date on the Benchmark Gilt, plus 50 basis points, in either
case, plus accrued and unpaid interest on the notes up to, but
excluding, the date specified as the redemption date (the
Redemption Price).
Gross Redemption Yield means a yield
calculated on the basis indicated by the Joint Index and
Classification Committee of the Institute and Faculty of
Actuaries as reported in the Journal of the Institute of
Actuaries, Vol. 105, Part 1, 1978, page 18 or on such
other basis as the Trustee may approve.
Reference Date means the date which is the
first dealing day in London prior to the publication of the
notice of redemption referred to below.
Benchmark Gilt means the 5.75% Treasury Stock
due December 7, 2009 or such other United Kingdom
government stock as the Calculation Agent may, with the advice
of three brokers
and/or
United Kingdom gilt-edged market makers or such other three
persons operating in the United Kingdom gilt-edged market as the
Calculation Agent may determine from time to time to be the most
appropriate benchmark United Kingdom government stock for the
notes.
Calculation Agent means Deutsche Bank AG
London or any successor entity.
We will give notice of any redemption between 30 and
60 days preceding the redemption date to each holder of the
notes to be redeemed.
In the case of any partial redemption, selection of the notes
for redemption will be made by the Trustee in compliance with
the requirements of the principal securities exchange, if any,
on which the notes are listed or, if the notes are not so listed
or such exchange prescribes no method of selection, on a pro
rata basis, by lot or by such other method as the Trustee in its
sole discretion shall deem to be fair and appropriate, although
no note of £1,000 in original principal amount or less
shall be redeemed in part. If any note is to be redeemed in part
only, the notice of redemption relating to the note shall state
the portion of the principal amount thereof to be redeemed. A
new note in principal amount equal to the unredeemed portion
thereof will be issued and delivered to the Trustee, or its
nominee, or, in the case of notes in definitive form, issued in
the name of the holder thereof, in each case upon cancellation
of the original note.
Unless we default in payment of the Redemption Price, on
and after the redemption date, interest will cease to accrue on
the notes or portions called for redemption.
Tax
Redemption of the £150,000,000 8.75% Senior Notes Due
2010
The 2010 Pounds Sterling Notes may be redeemed at our option, in
whole but not in part, at a redemption price equal to 100% of
the principal amount of the notes to be redeemed, together with
interest accrued and
34
unpaid to the date fixed for redemption, at any time, on giving
not less than 30 nor more than 60 days notice, which
notice shall be irrevocable, if:
|
|
|
|
|
we have or will become obliged to pay Additional Amounts (as
defined under Additional Amounts below)
as a result of any change in or amendment to the laws,
regulations or rulings of the United States or any political
subdivision or any taxing authority of or in the United States
affecting taxation, or any change in or amendment to an official
application, interpretation, administration or enforcement of
such laws, regulations or rulings, which change or amendment is
announced or becomes effective on or after November 1,
2000; or
|
|
|
|
any action shall have been taken by a taxing authority, or any
action has been brought in a court of competent jurisdiction, in
the United States or any political subdivision or taxing
authority of or in the United States, including any of those
actions specified in the first bullet point above, whether or
not such action was taken or brought with respect to our
company, or any change, clarification, amendment, application or
interpretation of such laws, regulations or rulings shall be
officially proposed, in any such case, on or after
October 25, 2000, which results in a substantial likelihood
that we will be required to pay Additional Amounts on the next
interest payment date.
|
However, no such notice of redemption shall be given earlier
than 90 days prior to the earliest date on which we would
be, in the case of a redemption for the reasons specified in the
first bullet point above, or there would be a substantial
likelihood that we would be, in the case of a redemption for the
reasons specified in the second bullet point above, obligated to
pay such Additional Amounts if a payment in respect of the notes
were then due.
Prior to the publication of any notice of redemption pursuant to
this subsection, we will deliver to the Trustee:
|
|
|
|
|
a certificate signed by one of our duly authorized officers
stating that we are entitled to effect such redemption and
setting forth a statement of facts showing that the conditions
precedent to our right so to redeem have occurred; and
|
|
|
|
a written opinion of independent legal counsel of recognized
standing to the effect that we have or will become obligated to
pay such Additional Amounts as a result of such change or
amendment or that there is a substantial likelihood that we will
be required to pay such Additional Amounts as a result of such
action or proposed change, clarification, amendment, application
or interpretation, as the case may be.
|
Such notice, once delivered by us to the Trustee, will be
irrevocable.
Additional
Amounts
All payments of principal and interest in respect of the 2010
Pounds Sterling Notes will be made without deduction or
withholding for or on account of any present or future taxes,
duties, assessments or other governmental charges of whatsoever
nature imposed, levied, collected, withheld or assessed by the
United States or any political subdivision or taxing authority
of or in the United States, unless such withholding or deduction
is required by law.
In the event such withholding or deduction is required by law,
subject to the limitations described below, we will pay as
additional interest on the notes to the holder or beneficial
owner of any note who is a
non-U.S. holder
(as defined below), such additional amounts (Additional
Amounts) as may be necessary in order that every net
payment by us or any paying agent of principal of or interest on
the notes (including upon redemption), after deduction or
withholding for or on account of any present or future tax,
duty, assessment or other governmental charge imposed upon or as
a result of such payment by the United States or any political
subdivision or taxing authority of or in the United States, will
not be less than the amount provided for in such note to be then
due and payable before any such tax, duty, assessment or other
governmental charge.
35
However, our obligation to pay Additional Amounts shall not
apply to:
(a) any tax, duty, assessment or other governmental charge
which would not have been so imposed but for:
(1) the existence of any present or former connection
between such holder or beneficial owner (or between a fiduciary,
settlor, beneficiary, member or shareholder or other equity
owner of, or a person having a power over, such holder or
beneficial owner, if such holder or beneficial owner is an
estate, a trust, a limited liability company, a partnership, a
corporation or other entity) and the United States, including,
without limitation, such holder or beneficial owner (or such
fiduciary, settlor, beneficiary, member, shareholder or other
equity owner or person having such a power) being or having been
a citizen or resident or treated as a resident of the United
States or being or having been engaged in a trade or business in
the United States or being or having been present in the United
States or having had a permanent establishment in the United
States;
(2) the failure of such holder or beneficial owner to
comply with any requirement under United States tax laws and
regulations to establish entitlement to a partial or complete
exemption from such tax, duty, assessment or other governmental
charge (including, but not limited to, the requirement to
provide Internal Revenue Service
Forms W-8BEN,
Forms W-8ECI,
or any subsequent versions thereof or successor thereto); or
(3) such holders or beneficial owners present
or former status as a personal holding company or a foreign
personal holding company with respect to the United States, as a
controlled foreign corporation with respect to the United
States, as a passive foreign investment company with respect to
the United States, as a private foundation or other tax exempt
organization with respect to the United States or as a
corporation which accumulates earnings to avoid United States
federal income tax;
(b) any tax, duty, assessment or other governmental charge
imposed by reason of the holder or beneficial owner:
(1) owning or having owned, directly or indirectly,
actually or constructively, 10% or more of the total combined
voting power of all classes of HCA Inc.s stock;
(2) being a bank receiving interest described in
section 881(c)(3)(A) of the Internal Revenue Code; or
(3) being a controlled foreign corporation with respect to
the United States that is related to HCA Inc. by stock ownership;
(c) any tax, duty, assessment or other governmental charge
which would not have been so imposed but for the presentation by
the holder or beneficial owner of such note for payment on a
date more than 30 days after the date on which such payment
became due and payable or the date on which payment of the note
is duly provided for and notice is given to holders, whichever
occurs later, except to the extent that the holder or beneficial
owner would have been entitled to such additional amounts on
presenting such note on any date during such
30-day
period;
(d) any estate, inheritance, gift, sales, transfer,
personal property, wealth, interest equalization or similar tax,
assessment or other governmental charge;
(e) any tax, duty, assessment or other governmental charge
which is payable otherwise than by withholding from payment of
principal of or interest on such note;
(f) any tax, duty, assessment or other governmental charge
which is payable by a holder that is not the beneficial owner of
the note, or a portion of the note, or that is a fiduciary,
partnership, limited liability company or other similar entity,
but only to the extent that a beneficial owner, a beneficiary or
settlor with respect to such fiduciary or member of such
partnership, limited liability company or similar entity would
not have been entitled to the payment of an additional amount
had such beneficial owner, settlor, beneficiary or member
received directly its beneficial or distributive share of the
payment;
36
(g) any tax, duty, assessment or other governmental charge
required to be withheld by any paying agent from any payment of
principal of or interest on any note, if such payment can be
made without such withholding by any other paying agent; or
(h) any combination of items (a), (b), (c), (d), (e),
(f) and (g).
For purposes of this subsection, the holding of or the receipt
of any payment with respect to a note will not constitute a
connection (1) between the holder or beneficial owner and
the United States or (2) between a fiduciary, settlor,
beneficiary, member or shareholder or other equity owner of, or
a person having a power over, such holder or beneficial owner,
if such holder or beneficial owner is an estate, a trust, a
limited liability company, a partnership, a corporation or other
entity, and the United States or any political subdivision or
taxing authority thereof or therein.
Any reference in this prospectus, in the Indenture or in the
notes to principal or interest with respect to the 2010 Pounds
Sterling Notes shall be deemed to refer also to Additional
Amounts which may be payable under the provisions of this
subsection.
We will pay all stamp and other duties, if any, which may be
imposed by the United States or any political subdivision
thereof or taxing authority therein with respect to the issuance
of the notes.
Except as specifically provided in the notes, we will not be
required to make any payment with respect to any tax, duty,
assessment or other governmental charge imposed by any
government or any political subdivision or taxing authority of
or in the United States.
Unless previously redeemed or repurchased and cancelled, the
notes will be payable at par, including Additional Amounts, if
any, on November 1, 2010 or such earlier date on which the
applicable notes shall be due and payable in accordance with the
terms and conditions of the applicable notes. However, if the
maturity date of the applicable notes is not a Business Day, the
notes will be payable on the next succeeding business day and no
interest shall accrue for the period from the maturity date to
such payment date.
For purposes of the 2010 Pounds Sterling Notes, a
non-U.S. holder
is a beneficial owner of the notes that is not a
U.S. holder. A U.S. holder is a
beneficial owner of the notes that is for United States federal
income tax purposes:
|
|
|
|
|
a United States citizen or resident alien individual;
|
|
|
|
a corporation or partnership created or organized in or under
the laws of the United States or any State thereof (including
the District of Columbia);
|
|
|
|
an estate if its income is subject to United States federal
income taxation regardless of its source; or
|
|
|
|
a trust (1) that validly elects to be treated as a United
States person for United States federal income tax purposes or
(2)(a) the administration over which a U.S. court can
exercise primary supervision and (b) all of the substantial
decisions of which one or more United States persons has the
authority to control.
|
Issuance
of Additional Debt Securities
If the terms of any series of debt securities so indicate, we
may, without the consent of the holders of that series of debt
securities, increase the principal amount of the debt securities
of that series by issuing additional debt securities in the
future on the same terms and conditions, except for any
differences in the issue price and interest accrued prior to the
issue date of the additional debt securities, and with the same
CUSIP number as existing debt securities of that series. The
existing debt securities of that series and any additional debt
securities of that series would rank equally and ratably for all
purposes under the Indenture.
Governing
Law
We will construe the Indenture and the debt securities in
accordance with the laws of the State of New York.
Certain
Definitions
Set forth below are certain defined terms used in the Indenture.
37
joint venture subsidiary means a subsidiary
as of the date of the Indenture of which we, directly or
indirectly, own less than 100% of the voting securities
entitling the holders thereof to elect a majority of the
directors (or, in the case of a partnership, of which we,
directly or indirectly, own less than 100% of the general
partnership interests therein).
permitted subsidiary refinancing debt means
debt of any subsidiary, the proceeds of which are used to renew,
extend, refinance or refund outstanding debt of that subsidiary;
provided that the debt is scheduled to mature no earlier
than the debt being renewed, extended, refinanced or refunded;
provided, further, that the debt will be permitted
subsidiary refinancing debt only to the extent that the
aggregate principal amount of that debt (or, if that debt is
issued at a price less than the principal amount thereof, the
aggregate amount of gross proceeds therefrom) does not exceed
the aggregate principal amount then outstanding under the debt
being renewed, extended, refinanced or refunded (or if the debt
being renewed, extended, refinanced or refunded was issued at a
price less than the principal amount thereof, then not in excess
of the amount of liability in respect thereof determined in
accordance with generally accepted accounting principles.)
principal property means each acute care
hospital providing general medical and surgical services
(excluding equipment, personal property and hospitals that
primarily provide specialty medical services, such as
psychiatric and obstetrical and gynecological services) owned
solely by our company
and/or one
or more of our subsidiaries and located in the United States of
America.
restricted subsidiary means (1) any
subsidiary other than an unrestricted subsidiary and
(2) any subsidiary that was an unrestricted subsidiary but
which, subsequent to the date hereof, is designated by our
company (by board resolution) to be a restricted subsidiary;
provided, that we may not designate any such subsidiary
to be a restricted subsidiary if we would thereby breach any
covenant or agreement contained in the Indenture (on the
assumption that any transaction to which that subsidiary was a
party at the time of such designation and which would have given
rise to debt or preferred stock or constituted a sale and
lease-back transaction at the time it was entered into had that
subsidiary then been a restricted subsidiary was entered into at
the time of that designation).
subsidiary means (1) any corporation of
which at least a majority of the outstanding stock having
ordinary voting power to elect a majority of the directors of
that corporation, whether or not at the time stock of any other
class or classes of that corporation have or might have voting
power by reason of the happening of any contingency, is at the
time, directly or indirectly, owned or controlled by our company
or by one or more of our subsidiaries, or by our company and one
or more of our subsidiaries or (2) any partnership or joint
venture of which at least a majority of the equity ownership,
whether in the form of membership, general, special or limited
partnership interests or otherwise, is directly or indirectly
owned or controlled by our company or by one or more of our
subsidiaries, or by our company and one or more of our
subsidiaries; provided, that the term
subsidiary does not include any corporation or
partnership controlled by our company (referred to in this
definition as an affiliated entity) that:
|
|
|
|
|
does not transact any substantial portion of its business or
regularly maintain any substantial portion of its operating
assets within the continental limits of the United States of
America;
|
|
|
|
is principally engaged in the business of financing (including,
without limitation, the purchase, holding, sale or discounting
of or lending upon any notes, contracts, leases or other forms
of obligations) the sale or lease of merchandise, equipment or
services (1) by our company, (2) by a subsidiary
(whether such sales or leases have been made before or after the
date when the corporation or partnership became a subsidiary),
(3) by another affiliated entity or (4) by any
corporation or partnership prior to the time when substantially
all its assets have been or are acquired by our company;
|
|
|
|
is principally engaged in the business of owning, leasing,
dealing in or developing real property;
|
|
|
|
is principally engaged in the holding of stock in,
and/or the
financing of operations of, an affiliated entity; or
|
|
|
|
is principally engaged in the business of (1) offering
health benefit products or (2) insuring against
professional and general liability risks of our company.
|
unrestricted subsidiary means (1) any
subsidiary acquired or organized after the date hereof;
provided, that the subsidiary is not a successor,
directly or indirectly, to, and does not directly or indirectly
own any equity interest in, any restricted subsidiary;
(2) any subsidiary the principal business of which consists
of
38
obtaining financing in capital markets outside the United States
of America or financing the acquisition or disposition of
machinery, equipment, inventory, accounts receivable and other
real, personal and intangible property by persons including our
company or a subsidiary; (3) any subsidiary the principal
business of which is owning, leasing, dealing in or developing
real property for residential or office building purposes or
land, buildings or related real property owned by our company or
any subsidiary as of the date of the Indenture; (4) any
joint venture subsidiary; or (5) stock or other securities
of an unrestricted subsidiary of the character described in
clauses (1) through (4) of this definition, unless and
until, in each of the cases specified in this paragraph, any
such subsidiary has been designated a restricted subsidiary
pursuant to clause (2) of the definition of
restricted subsidiary.
Senior
Notes and Debentures
The principal terms of the debt securities issued and
outstanding as of the date of this prospectus are set forth
below. Interest on the below series of debt securities accrues
at the annual rate indicated in the title of the series and is
payable on the indicated interest payment dates to the
registered holders on the preceding record date. The debt
securities of the series listed below are not subject to a
sinking fund.
5.50% Senior
Notes Due 2009
|
|
|
|
|
Principal amount of the series: $500,000,000
|
|
|
|
Maturity date: December 1, 2009
|
|
|
|
Interest payment dates: June 1 and December 1
|
|
|
|
Record dates: May 15 and November 15
|
|
|
|
Issuance date: November 19, 2004
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 30 basis points)
|
8.75% Senior
Notes Due 2010
|
|
|
|
|
Principal amount of the series: $750,000,000
|
|
|
|
Maturity date: September 1, 2010
|
|
|
|
Interest payment dates: March 1 and September 1
|
|
|
|
Record dates: February 15 and August 15
|
|
|
|
Issuance date: August 23, 2000
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 50 basis points)
|
8.75% Senior
Notes Due 2010
|
|
|
|
|
Principal amount of the series: £150,000,000
|
|
|
|
Maturity date: November 1, 2010
|
|
|
|
Interest payment dates: May 1 and November 1
|
|
|
|
Record dates: April 15 and October 15
|
|
|
|
Issuance date: November 1, 2000
|
|
|
|
Redemption prior to maturity: Redeemable after November 1,
2003 at an applicable premium and redeemable at any time upon
certain events related to U.S. taxation, in each case as
described above under Provisions that Apply Only to
the 2010 Pounds Sterling Note
|
7.875% Senior
Notes Due 2011
|
|
|
|
|
Principal amount of the series: $500,000,000
|
|
|
|
Maturity date: February 1, 2011
|
39
|
|
|
|
|
Interest payment dates: February 1 and August 1
|
|
|
|
Record dates: January 15 and July 15
|
|
|
|
Issuance date: January 26, 2001
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 50 basis points)
|
6.95% Senior
Notes Due 2012
|
|
|
|
|
Principal amount of the series: $500,000,000
|
|
|
|
Maturity date: May 1, 2012
|
|
|
|
Interest payment dates: May 1 and November 1
|
|
|
|
Record dates: April 15 and October 15
|
|
|
|
Issuance date: April 26, 2002
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 25 basis points)
|
6.30% Senior
Notes Due 2012
|
|
|
|
|
Principal amount of the series: $500,000,000
|
|
|
|
Maturity date: October 1, 2012
|
|
|
|
Interest payment dates: April 1 and October 1
|
|
|
|
Record dates: March 15 and September 15
|
|
|
|
Issuance date: September 23, 2002
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 37.5 basis points)
|
6.25% Senior
Notes Due 2013
|
|
|
|
|
Principal amount of the series: $500,000,000
|
|
|
|
Maturity date: February 15, 2013
|
|
|
|
Interest payment dates: August 15 and February 15
|
|
|
|
Record dates: August 1 and February 1
|
|
|
|
Issuance date: February 10, 2003
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 35 basis points)
|
6.75% Senior
Notes Due 2013
|
|
|
|
|
Principal amount of the series: $500,000,000
|
|
|
|
Maturity date: July 15, 2013
|
|
|
|
Interest payment dates: January 15 and July 15
|
|
|
|
Record dates: January 1 and July 1
|
|
|
|
Issuance date: July 28, 2003
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 35 basis points)
|
5.75% Senior
Notes Due 2014
|
|
|
|
|
Principal amount of the series: $500,000,000
|
|
|
|
Maturity date: March 15, 2014
|
40
|
|
|
|
|
Interest payment dates: March 15 and September 15
|
|
|
|
Record dates: March 1 and September 1
|
|
|
|
Issuance date: March 8, 2004
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 30 basis points)
|
6.375% Senior
Notes Due 2015
|
|
|
|
|
Principal amount of the series: $750,000,000
|
|
|
|
Maturity date: January 15, 2015
|
|
|
|
Interest payment dates: January 15 and July 15
|
|
|
|
Record dates: January 1 and July 1
|
|
|
|
Issuance date: November 19, 2004
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 35 basis points)
|
6.50% Senior
Notes due 2016
|
|
|
|
|
Principal amount of the series: $1,000,000,000
|
|
|
|
Maturity date: February 15, 2016
|
|
|
|
Interest payment dates: February 15 and August 15
|
|
|
|
Record dates: February 1 and August 1
|
|
|
|
Issuance date: February 8, 2006
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 30 basis points)
|
7.69% Notes
Due 2025
|
|
|
|
|
Principal amount of the series: $300,000,000
|
|
|
|
Maturity date: June 15, 2025
|
|
|
|
Interest payment dates: June 15 and December 15
|
|
|
|
Record dates: June 1 and December 1
|
|
|
|
Issuance date: June 30, 1995
|
|
|
|
Redemption prior to maturity: Not redeemable prior to maturity
|
7.50% Senior
Notes Due 2033
|
|
|
|
|
Principal amount of the series: $250,000,000
|
|
|
|
Maturity date: November 6, 2033
|
|
|
|
Interest payment dates: May 6 and November 6
|
|
|
|
Record dates: April 21, and October 21
|
|
|
|
Issuance date: November 6, 2003
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 37.5 basis points)
|
7.19% Debentures
Due 2015
|
|
|
|
|
Principal amount of the series: $150,000,000
|
|
|
|
Maturity date: November 15, 2015
|
|
|
|
Interest payment dates: May 15 and November 15
|
41
|
|
|
|
|
Record dates: May 1 and November 1
|
|
|
|
Issuance date: November 27, 1995
|
|
|
|
Redemption prior to maturity: Redeemable at any time at our
option, in whole or in part, subject to an applicable premium
(based on the Treasury Rate plus 20 basis points)
|
7.50% Debentures
Due 2023
|
|
|
|
|
Principal amount of the series: $150,000,000
|
|
|
|
Maturity date: December 15, 2023
|
|
|
|
Interest payment dates: June 15 and December 15
|
|
|
|
Record dates: June 1 and December 1
|
|
|
|
Issuance date: December 16, 1993
|
|
|
|
Redemption prior to maturity: Not redeemable prior to maturity
|
8.36% Debentures
Due 2024
|
|
|
|
|
Principal amount of the series: $150,000,000
|
|
|
|
Maturity date: April 15, 2024
|
|
|
|
Interest payment dates: April 15 and October 15
|
|
|
|
Record dates: April 1 and October 1
|
|
|
|
Issuance date: April 27, 1994
|
|
|
|
Redemption prior to maturity: Not redeemable prior to maturity
|
7.05% Debentures
Due 2027
|
|
|
|
|
Principal amount of the series: $150,000,000
|
|
|
|
Maturity date: December 1, 2027
|
|
|
|
Interest payment dates: June 1 and December 1
|
|
|
|
Record dates: May 15 and November 15
|
|
|
|
Issuance date: December 8, 1995
|
|
|
|
Redemption prior to maturity: Not redeemable prior to maturity
|
7.75% Debentures
Due 2036
|
|
|
|
|
Principal amount of the series: $100,000,000
|
|
|
|
Maturity date: July 15, 2036
|
|
|
|
Interest payment dates: July 15 and January 15
|
|
|
|
Record dates: July 1 and January 1
|
|
|
|
Issuance date: July 8, 1996
|
|
|
|
Redemption prior to maturity: Not redeemable prior to maturity
|
7.50% Debentures
Due 2095
|
|
|
|
|
Principal amount of the series: $200,000,000
|
|
|
|
Maturity date: November 15, 2095
|
|
|
|
Interest payment dates: May 15 and November 15
|
|
|
|
Record dates: May 1 and November 1
|
|
|
|
Issuance date: November 27, 1995
|
|
|
|
Redemption prior to maturity: Not redeemable prior to maturity
|
42
Medium-Term
Notes
In the table below, we specify the following terms of the
Medium-Term Notes (the Medium-Term Notes): issuance
date; principal amount; maturity date; interest rate; and
redemption terms, if any.
The Medium-Term Notes are not subject to a sinking fund and are
not redeemable prior to maturity unless indicated below.
|
|
|
|
|
|
|
|
|
Issuance Date
|
|
Principal Amount
|
|
|
Maturity Date
|
|
Interest Rate/Redemption Terms
|
|
February 8, 1995
|
|
$
|
150,000,000
|
|
|
February 10, 2010
|
|
8.70%
|
|
|
|
|
|
|
|
|
Not redeemable prior to maturity
|
January 20, 1995
|
|
$
|
150,000,000
|
|
|
December 15, 2014
|
|
9.00%
|
|
|
|
|
|
|
|
|
Not redeemable prior to maturity
|
September 14, 1995
|
|
$
|
125,000,000
|
|
|
September 15, 2025
|
|
7.58%
|
|
|
|
|
|
|
|
|
Not redeemable prior to maturity
|
Senior
Secured Notes Issued Under the 2006 Indenture
We have issued senior secured notes as described below under an
indenture, dated as of November 17, 2006, among the
Company, the guarantors named therein and The Bank of New York,
as trustee. Terms used in this Senior Secured
Notes Issued Under the 2006 Indenture apply only to the
Notes described herein.
General
Certain terms used in this description are defined under the
subheading Certain Definitions. In this description,
the terms we, our,
us and the Company each
refer to HCA Inc. (the Issuer) and its
consolidated Subsidiaries.
The Issuer issued $1,000,000,000 aggregate principal amount of
91/8% senior
secured notes due 2014 (the 2014 Cash Pay
Notes), $3,200,000,000 aggregate principal amount of
91/4% senior
secured notes due 2016 (the 2016 Cash Pay
Notes and, together with the 2014 Cash Pay Notes, the
Cash Pay Notes) and $1,500,000,000 aggregate
principal amount of
95/8%/103/8%
optional PIK interest senior secured notes due 2016 (the
Toggle Notes and, together with the Cash Pay
Notes, the Notes) under the indenture dated
November 17, 2006 (the Indenture) among
the Issuer, the Guarantors and The Bank of New York, as trustee
(the Trustee). The Notes were issued in a
private transaction that was not subject to the registration
requirements of the Securities Act. Except as set forth herein,
the terms of the Notes are substantially identical and include
those stated in the Indenture and those made part of the
Indenture by reference to the Trust Indenture Act.
The following description is only a summary of the material
provisions of the Indenture, does not purport to be complete and
is qualified in its entirety by reference to the provisions of
that agreement, including the definitions therein of certain
terms used below. We urge you to read the Indenture because it,
and not this description, will define your rights as Holders of
the Notes.
Brief
Description of Notes
The Notes are:
|
|
|
|
|
general senior obligations of the Issuer;
|
|
|
|
secured on a second-priority basis, equally and ratably with all
existing and future obligations of the Issuer and the Guarantors
under any future Junior Lien Obligations, by all of the assets
of the Issuer and the Guarantors which are not Principal
Properties and which secure the General Credit Facility (other
than the European Collateral), subject to the Liens securing the
Issuers and the Guarantors obligations under the
General Credit Facility and any other Priority Lien Obligations
and other Permitted Liens;
|
43
|
|
|
|
|
secured on a third-priority basis, equally and ratably with all
existing and future obligations of the Issuer and the Guarantors
under any future Junior Lien Obligations, by all of the assets
of the Issuer and the Guarantors securing the ABL Facility which
also secure the General Credit Facility, subject to the Liens
securing the Issuers and the Guarantors obligations
under the Senior Credit Facilities and any other Priority Lien
Obligations and other Permitted Liens;
|
|
|
|
effectively subordinated, to the extent of the value of the
assets securing such Indebtedness (which, in any event, exclude
the European Collateral, which does not secure the Notes), to
the Issuers and the Guarantors obligations under the
General Credit Facility and any future Priority Lien
Obligations, that will be secured (A) on a first-priority
basis by the same assets of the Issuer and the Guarantors that
secure the Notes and by certain other assets of the Issuer and
the Guarantors, including the Principal Properties, that do not
secure the Notes and (B) on a second-priority basis by the
Shared Receivables Collateral;
|
|
|
|
effectively subordinated to the Issuers and the
Guarantors obligations under the ABL Facility, to the
extent of the value of the Shared Receivables Collateral;
|
|
|
|
effectively subordinated to any obligations secured by Permitted
Liens, to the extent of the value of the assets of the Issuer
and the Guarantors subject to those Permitted Liens;
|
|
|
|
structurally subordinated to any existing and future
indebtedness and liabilities of non-guarantor Subsidiaries,
including the ABL Financing Entities and the Issuers
Foreign Subsidiaries and any Unrestricted Subsidiaries;
|
|
|
|
ranked equally in right of payment with all existing and future
senior Indebtedness of the Issuer and the Guarantors but, to the
extent of the value of the Collateral, are effectively senior to
all of the Issuers and the Guarantors unsecured
senior Indebtedness (including the Existing Notes);
|
|
|
|
senior in right of payment to any future Subordinated
Indebtedness (as defined with respect to the Notes) of the
Issuer; and
|
|
|
|
initially unconditionally guaranteed on a joint and several and
senior basis by each Restricted Subsidiary that guarantees the
General Credit Facility (other than any Foreign Subsidiary).
|
Guarantees
The Guarantors, as primary obligors and not merely as sureties,
jointly and severally fully and unconditionally guaranteed, on a
senior basis, the performance and full and punctual payment when
due, whether at maturity, by acceleration or otherwise, of all
obligations of the Issuer under the Indenture and the Notes,
whether for payment of principal of, premium, if any, or
interest or Additional Interest in respect of the Notes,
expenses, indemnification or otherwise, on the terms set forth
in the Indenture by executing the Indenture.
The Restricted Subsidiaries which guarantee the General Credit
Facility guarantee the Notes. Each of the Guarantees of the
Notes is a general senior obligation of each Guarantor and is
secured by a second-priority lien on all of the assets of each
Guarantor which secure the General Credit Facility and which are
not Principal Properties and by a third-priority lien on all of
the assets of each Guarantor which secure the ABL Facility. The
Guarantees rank equally in right of payment with all existing
and future senior Indebtedness of the Guarantor but, to the
extent of the value of the Collateral, are effectively senior to
all of the Guarantors unsecured senior Indebtedness and,
to the extent of the Collateral, are effectively subordinated to
the Guarantors Obligations under the Senior Credit
Facilities and any future Priority Lien Obligations. The
Guarantees are senior in right of payment to all existing and
future Subordinated Indebtedness of each Guarantor. The Notes
are structurally subordinated to Indebtedness and other
liabilities of Subsidiaries of the Issuer that do not Guarantee
the Notes.
Not all of the Issuers Subsidiaries Guarantee the Notes.
In the event of a bankruptcy, liquidation or reorganization of
any of these non-guarantor Subsidiaries, the non-guarantor
Subsidiaries will pay the holders of their debt and their trade
creditors before they will be able to distribute any of their
assets to the Issuer.
44
None of our Subsidiaries which are Restricted
Subsidiaries for purposes of the Existing Notes Indenture,
Foreign Subsidiaries, ABL Financing Entities, non-Wholly Owned
Subsidiaries or any Receivables Subsidiaries guarantee the
Notes. The obligations of each Guarantor under its Guarantee are
limited as necessary to prevent the Guarantee from constituting
a fraudulent conveyance under applicable law.
On an as adjusted basis after giving effect to our offering of
$1.500 billion aggregate principal amount of first lien
notes in April 2009 and the use of proceeds therefrom, our
non-guarantor subsidiaries would have accounted for
approximately $11.867 billion, or 41.8%, of our total
revenues for the year ended December 31, 2008,
approximately $3.038 billion, or 40.9%, of our total
revenues for the three months ended March 31, 2009,
approximately $9.876 billion, or 40.7%, of our total
assets, and approximately $7.517 billion, or 22.5%, of our
total liabilities, in each case, as of December 31, 2008,
and approximately $9.817 billion, or 40.4%, of our total
assets, and approximately $7.224 billion, or 21.9%, of our
total liabilities, in each case, as of March 31, 2009.
Any entity that makes a payment under its Guarantee is entitled
upon payment in full of all guaranteed obligations under the
Indenture to a contribution from each other Guarantor in an
amount equal to such other Guarantors pro rata portion of
such payment based on the respective net assets of all the
Guarantors at the time of such payment determined in accordance
with GAAP.
If a Guarantee were rendered voidable, it could be subordinated
by a court to all other indebtedness (including guarantees and
other contingent liabilities) of the Guarantor, and, depending
on the amount of such indebtedness, a Guarantors liability
on its Guarantee could be reduced to zero. See Risk
Factors Risks Related to the Notes
Federal and state fraudulent transfer laws may permit a court to
void the notes, and with respect to the senior secured notes,
the guarantees, and, if that occurs, you may not receive any
payment on the notes.
Each Guarantee by a Guarantor provides by its terms that it will
be automatically and unconditionally released and discharged
upon:
(1) (a) any sale, exchange or transfer (by merger or
otherwise) of the Capital Stock of such Guarantor (including any
sale, exchange or transfer), after which the applicable
Guarantor is no longer a Restricted Subsidiary or all or
substantially all the assets of such Guarantor, which sale,
exchange or transfer is made in compliance with the applicable
provisions of the Indenture;
(b) the release or discharge of the guarantee by such
Guarantor of the Senior Credit Facilities or such other
guarantee that resulted in the creation of such Guarantee,
except a discharge or release by or as a result of payment under
such guarantee;
(c) the designation of any Restricted Subsidiary that is a
Guarantor as an Unrestricted Subsidiary in compliance with the
applicable provisions of the Indenture; or
(d) the exercise by the Issuer of its legal defeasance
option or covenant defeasance option as described under
Legal Defeasance and Covenant Defeasance or the
discharge of the Issuers obligations under the Indenture
in accordance with the terms of the Indenture; and
(2) such Guarantor delivering to the Trustee an
Officers Certificate and an Opinion of Counsel, each
stating that all conditions precedent provided for in the
Indenture relating to such transaction have been complied with.
Holding
Company Structure
The Issuer is a holding company for its Subsidiaries, with no
material operations of its own and only limited assets.
Accordingly, the Issuer is dependent upon the distribution of
the earnings of its Subsidiaries, whether in the form of
dividends, advances or payments on account of intercompany
obligations, to service its debt obligations.
45
Security
General
The Notes and the Guarantees are secured by perfected
second-priority security interests in the Non-Receivables
Collateral (second in priority to the Liens on the
Non-Receivables Collateral securing the First Lien Obligations)
and by perfected third-priority security interests in the Shared
Receivables Collateral (third in priority to the first-priority
and second-priority Liens on the Shared Receivables Collateral
securing the ABL Obligations and the First Lien Obligations,
respectively), in each case, subject to Permitted Liens;
provided, that with respect to the portion of the
Collateral comprised of real property, the Issuer and the
Guarantors have such time as is reasonably necessary from the
Issue Date to complete the actions required to perfect the
second-priority Lien on such Collateral. The Cash Pay Notes and
the Toggle Notes share in the benefit of such security interests
pro rata based on the respective amounts of the
Obligations thereunder. Notwithstanding the foregoing, neither
the Notes nor the Guarantees are or will be secured by the
European Collateral or the Separate Receivables Collateral and,
until after the Discharge of the First Lien Obligations, the
Notes and the Guarantees will not be secured by any Principal
Properties. Upon the Discharge of First Lien Obligations and so
long as no First Lien Obligations are outstanding, the Principal
Properties that constituted Collateral under the
First Lien Security Documents Facility will become Collateral
with respect to the Notes, subject to the same limitation on the
amount of Obligations secured thereby as contained in the First
Lien Security Documents. See also Certain
Limitations on the Collateral below. Priority Lien Secured
Parties have rights and remedies with respect to the Collateral
that, if exercised, could adversely affect the value of the
Collateral or the ability of the respective agents under the
Intercreditor Agreements to realize or foreclose on the
Collateral on behalf of holders of the Notes. For a description
of the Shared Receivables Collateral and the Non-Receivables
Collateral, see Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
The Issuer and the Guarantors are and will be able to incur
additional Indebtedness in the future which could share in the
Collateral, including additional First Lien Obligations,
additional ABL Obligations, additional Junior Lien Obligations
and Obligations secured by Permitted Liens. The amount of such
additional Obligations are and will be limited by the covenant
described under Certain Covenants Liens
and the covenant described under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock.
Under certain circumstances, the amount of any such additional
Obligations could be significant.
After-Acquired
Collateral
From and after the Issue Date and subject to certain limitations
and exceptions, (a) if the Issuer or any Guarantor creates
any additional security interest upon any property or asset that
would constitute Collateral to secure any First Lien Obligations
(other than Principal Properties prior to the Discharge of First
Lien Obligations and so long as no First Lien Obligations are
outstanding and other than European Collateral and Separate
Receivables Collateral), it must concurrently grant a
second-priority perfected security interest (subject to
Permitted Liens) upon such property as security for the Notes
and (b) if the Issuer or any Guarantor creates any
additional security interest upon any property or asset that
would constitute Shared Receivables Collateral to secure any
Priority Lien Obligations, it must concurrently grant a
third-priority perfected security interest (subject to Permitted
Liens) upon such property as security for the Notes.
Liens
with Respect to the Collateral
Security
Documents and Intercreditor Agreements
The Issuer, the Guarantors and the Junior Lien Collateral Agent
entered into the Security Documents with respect to the
Collateral defining the terms of the security interests that
secure the Notes and the Guarantees with respect to such
Collateral. These security interests secure the payment and
performance when due of all of the Obligations of the Issuer and
the Guarantors under the Notes, the Indenture, the Guarantees
and the Security Documents, as provided in the Security
Documents.
46
The Junior Lien Collateral Agent and the First Lien Collateral
Agent entered into the General Intercreditor Agreement (as the
same may be amended from time to time, the General
Intercreditor Agreement) with respect to the
Collateral. The First Lien Collateral Agent is initially the
Collateral Agent under the General Credit Facility. The Junior
Lien Collateral Agent is initially the Trustee. Pursuant to the
terms of the General Intercreditor Agreement, prior to the
Discharge of First Lien Obligations, the First Lien Collateral
Agent, acting on behalf of the First Lien Secured Parties, will
determine the time and method by which the security interests in
the Collateral will be enforced and will have the sole and
exclusive right to manage, perform and enforce the terms of the
Security Documents relating to the Collateral and to exercise
and enforce all privileges, rights and remedies thereunder
according to its direction, including to take or retake control
or possession of such Collateral and to hold, prepare for sale,
marshall, process, sell, lease, dispose of or liquidate such
Collateral, including, without limitation, following the
occurrence of a Default or Event of Default under the Indenture.
The Junior Lien Collateral Agent will not be permitted to
enforce the security interests even if any Event of Default
under the Indenture has occurred and the Notes have been
accelerated except (a) in any insolvency or liquidation
proceeding, solely as necessary to file a proof of claim or
statement of interest with respect to the Junior Lien
Obligations or (b) as necessary to take any action in order
to prove, preserve, perfect or protect (but not enforce) its
security interest and rights in, and the perfection and priority
of its Lien on, the Collateral. See Risk
Factors Risks Related to the Notes The
lien ranking provisions of the Indenture and other agreements
relating to the collateral securing the notes will limit the
rights of holders of the notes with respect to that collateral,
even during an event of default. After the Discharge of
First Lien Obligations, the Junior Lien Collateral Agent in
accordance with the provisions of the Junior Lien Documents will
distribute all cash proceeds (after payment of the costs of
enforcement and collateral administration and any other amounts
owed to the Junior Lien Collateral Agent) of the Collateral
received by it under the Security Documents for the ratable
benefit of the holders of Junior Lien Obligations. The proceeds
from the sale of the Collateral remaining after the satisfaction
of all First Lien Obligations may not be sufficient to satisfy
the Junior Lien Obligations. By its nature some or all of the
Collateral is and will be illiquid and may have no readily
ascertainable market value. Accordingly, the Collateral may not
be able to be sold in a short period of time, if salable. See
Risk Factors Risks Related to the
Notes The value of the collateral securing the notes
may not be sufficient to satisfy our obligations under the
notes.
The Junior Lien Collateral Agent, for itself and on behalf of
each Junior Lien Secured Party, has agreed in the General
Intercreditor Agreement that (a) it will not (and thereby
waives any right to) take any action to challenge, contest or
support any other Person in contesting or challenging, directly
or indirectly, in any proceeding (including any insolvency or
liquidation proceeding), the validity, perfection, priority or
enforceability of a Lien securing any First Lien Obligations
held (or purported to be held) by or on behalf of the First Lien
Collateral Agent or any of the First Lien Secured Parties or any
agent or trustee therefor in any Collateral or other First Lien
Collateral and (b) it will not oppose or otherwise contest
(or support any other Person contesting) any request for
judicial relief made in any court by the First Lien Collateral
Agent or any First Lien Secured Parties relating to the lawful
enforcement of any First Priority Lien on Collateral or other
First Lien Collateral.
In addition, the Security Documents provide that, prior to the
Discharge of First Lien Obligations, (1) the First Lien
Collateral Agent may take actions with respect to the Collateral
(including the release of Collateral and the manner of
realization (subject to the provisions described under
Release of Collateral)) without the
consent of the Junior Lien Collateral Agent or other Junior Lien
Secured Parties and (2) the Issuer and the Guarantors may
require the Junior Lien Collateral Agent to agree to modify the
Security Documents, or the General Intercreditor Agreement,
without the consent of the Junior Lien Collateral Agent or other
Junior Lien Secured Parties, to secure additional extensions of
credit and add additional First Lien Secured Parties or Junior
Lien Secured Parties so long as such modifications do not
expressly violate the provisions of the General Credit Facility
or the Indenture. In addition, the General Intercreditor
Agreement provides that with respect to Collateral in the event
that the First Lien Collateral Agent or the First Lien Secured
Parties enter into any amendment, waiver or consent in respect
of or replace any of the First Lien Security Documents for the
purpose of adding to, or deleting from, or waiving or consenting
to any departures from any provisions of, any First Lien
Security Document or changing in any manner the rights of the
First Lien Collateral Agent, the First Lien Secured Parties, the
Issuer or any Guarantor thereunder (including the release of any
Liens in
47
Collateral in accordance with the provisions described under
Release of Collateral), then such
amendment, waiver or consent shall apply automatically to any
comparable provision of each comparable Security Document in
favor of the Junior Lien Obligations without the consent of the
Junior Lien Collateral Agent, any Junior Lien Representative or
any Junior Lien Secured Party and without any action by the
Junior Lien Collateral Agent, any Junior Lien Representative,
the Issuer or any Guarantor; provided that such
amendment, waiver or consent does not materially adversely
affect the rights of the Junior Lien Secured Parties or the
interests of the Junior Lien Secured Parties in the Collateral
in a manner materially different from that affecting the rights
of the First Lien Secured Parties thereunder or therein. Any
provider of additional extensions of credit shall be entitled to
rely on the determination of an Officer that such modifications
do not expressly violate the provisions of the General Credit
Facility or the Indenture if such determination is set forth in
an Officers Certificate delivered to such provider.
So long as the Discharge of First Lien Obligations has not
occurred, the Collateral or proceeds thereof received in
connection with the sale or other disposition of, or collection
on, such Non-Receivables Collateral upon the exercise of
remedies will be applied by the First Lien Collateral Agent to
the First Lien Obligations in such order as specified in the
relevant First Lien Documents until the Discharge of First Lien
Obligations has occurred. Upon the Discharge of First Lien
Obligations, the First Lien Collateral Agent shall deliver to
the Junior Lien Collateral Agent (for the benefit of all Junior
Lien Secured Parties) any remaining proceeds of Collateral held
by it in the same form as received, with any necessary
endorsements or as a court of competent jurisdiction may
otherwise direct to be applied by the Junior Lien Collateral
Agent to the Junior Lien Obligations in such order as specified
in the Junior Lien Documents.
In addition, so long as the Discharge of First Lien Obligations
has not occurred, neither the Junior Lien Collateral Agent nor
any Junior Lien Representative shall acquire or hold any Lien on
any assets of the Issuer or any Subsidiary (and neither the
Issuer nor any Subsidiary shall grant such Lien) securing any
Junior Lien Obligations that are not also subject to the First
Priority Lien in respect of the First Lien Obligations under the
First Lien Documents. If the Junior Lien Collateral Agent or any
Junior Lien Representative shall acquire or hold any Lien on any
assets of the Issuer or any Subsidiary that is not also subject
to the First Priority Lien in respect of the First Lien
Obligations under the First Lien Documents, then such Junior
Lien Collateral Agent or other Junior Lien Representative shall,
without the need for any further consent of any party and
notwithstanding anything to the contrary in any other document,
be deemed to also hold and have held such Lien for the benefit
of the First Lien Collateral Agent as security for the First
Lien Obligations (subject to the lien priority and other terms
hereof).
The Junior Lien Collateral Agent and each other Junior Lien
Secured Party have agreed that any Lien purported to be granted
on any Collateral as security for First Lien Obligations shall
be deemed to be and shall be deemed to remain senior in all
respects and prior to all Liens on the Collateral securing any
Junior Lien Obligations for all purposes regardless of whether
the Lien purported to be granted is found to be improperly
granted, improperly perfected, preferential, a fraudulent
conveyance or legally or otherwise deficient or invalid, in
whole or in part, in any manner.
Any Collateral or proceeds thereof received by any Junior Lien
Secured Party at a time when such receipt is not expressly
permitted by the terms of the General Intercreditor Agreement or
prior to the Discharge of First Lien Obligations shall be
segregated and held in trust for the benefit of and forthwith
paid over to the First Lien Collateral Agent (and/or its
designees) for the benefit of the First Lien Secured Parties in
the same form as received, with any necessary endorsements or as
a court of competent jurisdiction may otherwise direct.
If any First Lien Secured Party is required in any insolvency or
liquidation proceeding or otherwise to turn over or otherwise
pay to the estate of the Issuer or any other Guarantor (or any
trustee, receiver or similar person therefor), because the
payment of such amount was declared to be fraudulent or
preferential in any respect or for any other reason, any amount
(a Recovery), whether received as proceeds of
security, enforcement of any right of setoff or otherwise, then
as among the parties hereto, the First Lien Obligations shall be
deemed to be reinstated to the extent of such Recovery and to be
outstanding as if such payment had not occurred and such First
Lien Secured Party shall be entitled to a reinstatement of First
Lien Obligations
48
with respect to all such recovered amounts and shall have all
rights hereunder. If the General Intercreditor Agreement shall
have been terminated prior to such Recovery, the General
Intercreditor Agreement shall be reinstated in full force and
effect, and such prior termination shall not diminish, release,
discharge, impair or otherwise affect the obligations of the
parties thereto. Any Collateral or other First Lien Collateral
or proceeds thereof received by any Junior Lien Secured Party
prior to the time of such Recovery shall be deemed to have been
received prior to the Discharge of First Lien Obligations and
subject to the provisions of the immediately preceding paragraph.
In addition, if at any time in connection with or after the
Discharge of First Lien Obligations the Issuer either in
connection therewith or thereafter enters into any Refinancing
of any First Lien Document evidencing a First Lien Obligation,
then such Discharge of First Lien Obligations shall
automatically be deemed not to have occurred for all purposes of
the General Intercreditor Agreement, the First Lien Documents
and the Junior Lien Documents, and the obligations under such
Refinancing shall automatically be treated as First Lien
Obligations for all purposes of the General Intercreditor
Agreement, including for purposes of the Lien priorities and
rights in respect of Collateral set forth therein, the related
documents shall be treated as First Lien Documents for all
purposes of the General Intercreditor Agreement and the first
lien collateral agent under such Refinanced First Lien Documents
shall be First Lien Collateral Agent for all purposes of the
General Intercreditor Agreement.
The General Intercreditor Agreement provides that, prior to the
Discharge of First Lien Obligations, neither the Junior Lien
Collateral Agent nor any other Junior Lien Secured Parties may
assert or enforce any right of marshalling accorded to a junior
lienholder, as against the First Lien Collateral Agent or any
First Lien Secured Party (in their capacity as priority
lienholders). Following the Discharge of First Lien Obligations,
the Junior Lien Secured Parties may assert their right under the
Uniform Commercial Code or otherwise to any proceeds remaining
following a sale or other disposition of Collateral by, or on
behalf of, the First Lien Collateral Agent or the First Lien
Secured Parties. This waiver of all rights of marshalling prior
to the Discharge of First Lien Obligations may result in
proceeds from the sale of Collateral (in which the Junior Lien
Secured Parties have second-priority Liens) being applied to
repay First Lien Obligations prior to the application of the
proceeds of Shared Receivables Collateral (in which the Junior
Lien Secured Parties have third-priority Liens), the Principal
Properties (in which the Junior Lien Secured Parties will not
have a security interest prior to the Discharge of First Lien
Obligations and during any time that any First Lien Obligations
are outstanding) or the European Collateral or the Separate
Receivables Collateral (in which the Junior Lien Secured Parties
do not have a security interest). In that scenario, Junior Lien
Secured Parties may recover less than they would have if such
proceeds were applied in the order most favorable to the Junior
Lien Secured Parties.
So long as the Discharge of First Lien Obligations has not
occurred, whether or not any insolvency or liquidation
proceeding has been commenced by or against the Issuer or any
Guarantor, (i) neither the Junior Lien Collateral Agent,
any Junior Lien Representative nor any Junior Lien Secured Party
will (x) exercise or seek to exercise any rights or
remedies (including setoff or the right to credit bid debt
(except as set forth in the next paragraph below)) with respect
to any Collateral in respect of any applicable Junior Lien
Obligations, or institute any action or proceeding with respect
to such rights or remedies (including any action of
foreclosure), (y) contest, protest or otherwise object to
any foreclosure or enforcement proceeding or action brought with
respect to the Collateral or any other collateral by the First
Lien Collateral Agent or any First Lien Secured Party in respect
of the First Lien Obligations, the exercise of any right by the
First Lien Collateral Agent or any First Lien Secured Party (or
any agent or
sub-agent on
their behalf) in respect of the First Lien Obligations under any
control agreement, lockbox agreement, landlord waiver or
bailees letter or similar agreement or arrangement to
which the Junior Lien Collateral Agent, any Junior Lien
Representative or any Junior Lien Secured Party either is a
party or may have rights as a third-party beneficiary, or any
other exercise by any such party of any rights and remedies as a
secured party relating to the Collateral or any other collateral
under the First Lien Documents or otherwise in respect of First
Lien Obligations, or (z) object to any waiver or
forbearance by the First Lien Secured Parties from or in respect
of bringing or pursuing any foreclosure proceeding or action or
any other exercise of any rights or remedies relating to the
Collateral or any other collateral in respect of First Lien
Obligations and (ii) except as otherwise provided in the
General
49
Intercreditor Agreement, the First Lien Collateral Agent and the
First Lien Secured Parties shall have the sole and exclusive
right to enforce rights, exercise remedies (including setoff and
the right to credit bid their debt), marshal, process and make
determinations regarding the release, disposition or
restrictions, or waiver or forbearance of rights or remedies
with respect to the Collateral without any consultation with or
the consent of the Junior Lien Collateral Agent, any Junior Lien
Representative or any Junior Lien Secured Party.
Notwithstanding the foregoing, the General Intercreditor
Agreement shall not be construed to in any way limit or impair
the right of any Junior Lien Secured Party from exercising a
credit bid with respect to the Junior Lien Obligations in a sale
or other disposition of Collateral under Section 363 of the
Bankruptcy Code; provided that in connection with and
immediately after giving effect to such sale and credit bid
there occurs a Discharge of First Lien Obligations.
In addition, the Junior Lien Collateral Agent, each Junior Lien
Representative and each other Junior Lien Secured Party have
agreed that if the Issuer or any Guarantor is subject to any
insolvency or liquidation proceeding:
(1) if the First Lien Collateral Agent acting on behalf of
First Lien Secured Parties desires to permit the use of cash
collateral or to permit the Issuer or any Guarantor to obtain
financing under Section 363 or Section 364 of the
Bankruptcy Code or any similar provision in any Bankruptcy Law
(DIP Financing), including if such DIP
Financing is secured by Liens senior in priority to the Liens
securing the Notes or other Junior Lien Obligations, then the
Junior Lien Collateral Agent and each Junior Lien
Representative, on behalf of itself and each applicable Junior
Lien Secured Party, agrees not to object to such use of cash
collateral or DIP Financing and will not request adequate
protection or any other relief in connection therewith (except
to the extent permitted by the General Intercreditor Agreement,
as set forth below) and, to the extent the Liens securing the
First Lien Obligations are subordinated or pari passu
with such DIP Financing, will subordinate its Liens in the
Collateral and any other collateral to such DIP Financing (and
all Obligations relating thereto) on the same basis as they are
subordinated to the First Lien Obligations;
(2) none of them will object to, or otherwise contest (or
support any other Person contesting), any motion for relief from
the automatic stay or from any injunction against foreclosure or
enforcement in respect of the First Lien Obligations made by the
First Lien Collateral Agent or any First Lien Secured Party;
(3) none of them will object to, or otherwise contest (or
support any other Person contesting), any order relating to a
sale of assets of any Issuer or Guarantor for which the First
Lien Collateral Agent has consented that provides, to the extent
that sale is to be free and clear of Liens, that the Liens
securing the First Lien Obligations and the Junior Lien
Obligations will attach to the proceeds of the sale on the same
basis of priority as the existing Liens in accordance with the
General Intercreditor Agreement;
(4) none of them will seek relief from the automatic stay
or any other stay in any insolvency or liquidation proceeding in
respect of the Collateral or any other First Lien Collateral,
without the prior written consent of the First Lien Collateral
Agent;
(5) none of them will object to, or otherwise contest (or
support any other Person contesting), (a) any request by
the First Lien Collateral Agent or any First Lien Secured Party
for adequate protection or (b) any objection by the First
Lien Collateral Agent or any First Lien Secured Party to any
motion, relief, action or proceeding based on the First Lien
Collateral Agents or such First Lien Secured Partys
claiming a lack of adequate protection;
(6) none of them will assert or enforce (or support any
Person asserting or enforcing) any claim under
Section 506(c) of the Bankruptcy Code senior to or on a
parity with the Liens securing the First Lien Obligations for
costs or expenses of preserving or disposing of any Collateral
or First Lien Collateral;
50
(7) none of them will oppose or otherwise contest (or
support any other Person contesting) any lawful exercise by the
First Lien Collateral Agent or any First Lien Secured Party of
the right to credit bid First Lien Obligations at any sale of
Collateral or First Lien Collateral; and
(8) none of them will challenge (or support any other
person challenging) the validity, enforceability, perfection or
priority of the First Priority Liens on Collateral or First Lien
Collateral (and the General Intercreditor Agreement will provide
that the First Lien Secured Parties agree that none of them will
challenge the validity, enforceability, perfection or priority
of the Liens in favor of the Trustee and each other Junior Lien
Secured Party on the Collateral).
In addition, neither the Junior Lien Collateral Agent, any
Junior Lien Representative nor any other Junior Lien Secured
Party will file or prosecute in any insolvency or liquidation
proceeding any motion for adequate protection (or any comparable
request for relief) based upon their respective security
interests in the Collateral, except that:
(1) any of them may freely seek and obtain relief granting
a junior Lien co-extensive in all respects with, but
subordinated to, all Liens granted in the insolvency or
liquidation proceeding to, or for the benefit of, the First Lien
Secured Parties (and the General Intercreditor Agreement will
provide that the First Lien Secured Parties will not object to
the granting of such a junior Lien); and
(2) any of them may freely seek and obtain any relief upon
a motion for adequate protection (or any comparable relief),
without any condition or restriction whatsoever, at any time
after the Discharge of First Lien Obligations.
Without limiting the generality of any provisions of the General
Intercreditor Agreement, any vote to accept, and any other act
to support the confirmation or approval of, any Non-Conforming
Plan of Reorganization shall be inconsistent with and,
accordingly, a violation of the terms of the General
Intercreditor Agreement, and the First Lien Collateral Agent
shall be entitled to have any such vote to accept a
Non-Conforming Plan of Reorganization dismissed and any such
support of any Non-Conforming Plan of Reorganization withdrawn.
Subject to the terms of the Security Documents, the Issuer and
the Guarantors have the right to remain in possession and retain
exclusive control of the Collateral securing the Notes and the
Junior Lien Obligations (other than securities, instruments and
chattel paper constituting part of the Collateral and deposited
with the First Lien Collateral Agent in accordance with the
provisions of the First Lien Security Documents and any Shared
Receivables Collateral subject to a control agreement under the
circumstances described in the First Lien Security Documents),
to freely operate the Collateral and to collect, invest and
dispose of any income therefrom.
The Junior Lien Collateral Agent and each Junior Lien
Representative, on behalf of the Junior Lien Secured Parties,
have acknowledged and agreed in the General Intercreditor
Agreement that (a) the Junior Lien Secured Parties
claims against the Issuer
and/or any
Guarantor in respect of the Collateral constitute junior claims
separate and apart (and of a different class) from the senior
claims of the First Lien Secured Parties against the Issuer and
the Guarantor in respect of the Collateral, (b) the First
Lien Obligations include all interest that accrues after the
commencement of any insolvency or liquidation proceeding of the
Issuer or any Guarantor at the rate provided for in the
applicable First Lien Documents governing the same, whether or
not a claim for post-petition interest is allowed or allowable
in any such insolvency or liquidation proceeding and
(c) the Intercreditor Agreement constitutes a
subordination agreement under Section 510 of
the Bankruptcy Code.
51
Release
of Collateral
The Issuer and the Guarantors are entitled to the release of
property and other assets constituting Collateral from the Liens
securing the Notes and the Junior Lien Obligations under any one
or more of the following circumstances:
(1) to enable us to consummate the sale, transfer or other
disposition of such property or assets to the extent not
prohibited under the covenant described under
Repurchase at the Option of
Holders Asset Sales;
(2) the release of Excess Proceeds or Collateral Excess
Proceeds that remain unexpended after the conclusion of an Asset
Sale Offer or a Collateral Asset Sale Offer conducted in
accordance with the Indenture;
(3) in the case of a Guarantor that is released from its
Guarantee with respect to the Notes pursuant to the terms of the
Indenture, the release of the property and assets of such
Guarantor;
(4) with the consent of the holders of at least 75% of the
aggregate principal amount of the Notes then outstanding and
affected thereby and a majority of all Junior Lien Obligations
(including the Notes) then outstanding and affected thereby
(including, without limitation, consents obtained in connection
with a tender offer or exchange offer for, or purchase of,
Junior Lien Obligations); or
(5) as described under Amendment,
Supplement and Waiver below.
The Junior Liens on any Collateral securing the Junior Lien
Obligations will also terminate and be released automatically if
the First Priority Liens on such Collateral securing First Lien
Obligations are released by the First Lien Collateral Agent on
behalf of the First Lien Secured Parties, unless such release
occurs in connection with, and after giving effect to, a
Discharge of First Lien Obligations, which discharge is not in
connection with a foreclosure of, or other exercise of remedies
with respect to, Collateral by the First Lien Secured Parties
(such discharge not in connection with any such foreclosure or
exercise of remedies, a Payment Discharge)
(provided that, in the case of a Payment Discharge, the
Liens on any Collateral disposed of in connection with the
satisfaction in whole or in part of First Lien Obligations shall
be automatically released but any proceeds thereof not used for
purposes of the Discharge of First Lien Obligations or otherwise
in accordance with the Indenture shall be subject to Liens in
favor of the Junior Lien Secured Parties). In the event of a
Payment Discharge, the Junior Liens on Collateral shall become
first-priority security interests, subject to Permitted Liens,
any intercreditor agreements or arrangements among Junior Lien
Secured Parties permitted under the General Intercreditor
Agreement and, with respect to Shared Receivables Collateral,
subject to the Shared Receivables Intercreditor Agreement;
provided that if the Issuer or the Guarantors incur at
any time thereafter any new or replacement First Lien
Obligations permitted under the Indenture, then such Payment
Discharge shall automatically be deemed not to have occurred for
all purposes of the General Intercreditor Agreement, the First
Lien Documents and the Junior Lien Documents, and such new
Obligations shall automatically be treated as First Lien
Obligations for all purposes of the General Intercreditor
Agreement, including for purposes of the Lien priorities and
rights in respect of Collateral set forth therein, and the
related documents shall be treated as First Lien Documents.
To the extent necessary and for so long as required for such
Subsidiary not to be subject to any requirement pursuant to
Rule 3-16
of
Regulation S-X
under the Securities Act to file separate financial statements
with the SEC (or any other governmental agency), the Capital
Stock of any Subsidiary of the Company shall not be included in
the Collateral with respect to the respective Notes so affected
(as described under Certain Limitations on the
Collateral) and shall not be subject to the Liens securing
such Notes and the Junior Lien Obligations.
The Junior Liens on the Collateral securing the Notes and the
Guarantees also will be released upon (i) payment in full
of the principal of, together with accrued and unpaid interest
(including Additional Interest, if any) on, the Notes and all
other Obligations under the Indenture, the Guarantees and the
Security Documents that are due and payable at or prior to the
time such principal, together with accrued and unpaid interest
(including Additional Interest, if any), are paid or (ii) a
legal defeasance or covenant defeasance under
52
the Indenture as described below under Legal Defeasance
and Covenant Defeasance or a discharge of the Indenture as
described under Satisfaction and Discharge.
Any certificate or opinion required by Section 314(d) of
the Trust Indenture Act may be made by an Officer of the
Company, except in cases where Section 314(d) requires that
such certificate or opinion be made by an independent engineer,
appraiser or other expert.
Notwithstanding anything to the contrary herein, the Issuer and
its Subsidiaries will not be required to comply with all or any
portion of Section 314(d) of the Trust Indenture Act
if they determine, in good faith based on advice of counsel,
that under the terms of that section
and/or any
interpretation or guidance as to the meaning thereof of the SEC
and its staff, including no action letters or
exemptive orders, all or any portion of Section 314(d) of
the Trust Indenture Act is inapplicable to the released
Collateral.
Without limiting the generality of the foregoing, certain no
action letters issued by the SEC have permitted an indenture
qualified under the Trust Indenture Act to contain
provisions permitting the release of collateral from Liens under
such indenture in the ordinary course of the issuers
business without requiring the issuer to provide certificates
and other documents under Section 314(d) of the
Trust Indenture Act. The Issuer and the Guarantors may,
subject to the provisions of the Indenture, among other things,
without any release or consent by the Junior Lien Collateral
Agent, conduct ordinary course activities with respect to the
Collateral, including, without limitation:
|
|
|
|
|
selling or otherwise disposing of, in any transaction or series
of related transactions, any property subject to the Lien of the
Security Documents that has become worn out, defective, obsolete
or not used or useful in the business;
|
|
|
|
abandoning, terminating, canceling, releasing or making
alterations in or substitutions of any leases or contracts
subject to the Lien of the Indenture or any of the Security
Documents;
|
|
|
|
surrendering or modifying any franchise, license or permit
subject to the Lien of the Security Documents that it may own or
under which it may be operating;
|
|
|
|
altering, repairing, replacing, changing the location or
position of and adding to its structures, machinery, systems,
equipment, fixtures and appurtenances;
|
|
|
|
granting a license of any intellectual property;
|
|
|
|
selling, transferring or otherwise disposing of inventory in the
ordinary course of business;
|
|
|
|
collecting accounts receivable in the ordinary course of
business as permitted by the covenant described under
Repurchase at the Option of Holders Asset
Sales;
|
|
|
|
making cash payments (including for the repayment of
Indebtedness or interest) from cash that is at any time part of
the Collateral in the ordinary course of business that are not
otherwise prohibited by the Indenture and the Security
Documents; and
|
|
|
|
abandoning any intellectual property that is no longer used or
useful in the Issuers business.
|
The Issuer must deliver an Officers Certificate to the
Junior Lien Collateral Agent within 30 calendar days following
the end of each six-month period beginning on May 15 and
November 15 of each year, to the effect that all such releases
and withdrawals during the preceding six-month period (or since
the Issue Date, in the case of the first such certificate) in
the ordinary course of the Issuers or the Guarantors
business, as described in the preceding paragraph, were not
prohibited by the Indenture.
Shared
Receivables Intercreditor Agreement
In addition, the Junior Lien Collateral Agent, the First Lien
Collateral Agent and the collateral agent with respect to the
ABL Facility (the ABL Collateral Agent)
entered into a Shared Receivables Intercreditor Agreement (as
the same may be amended from time to time, the Shared
Receivables Intercreditor Agreement) with respect to
the Shared Receivables Collateral. The Shared Receivables
Intercreditor Agreement contains provisions with respect to the
Shared Receivables Collateral and the relative rights,
53
privileges and obligations relating thereto as between
(a) the Junior Lien Collateral Agent, the other Junior Lien
Secured Parties, the First Lien Collateral Agent and the First
Lien Secured Parties and (b) the ABL Collateral Agent and
the ABL Secured Parties. The Shared Receivables Intercreditor
Agreement provides for first-priority Liens in the Shared
Receivables Collateral in favor of the ABL Secured Parties,
second-priority Liens in the Shared Receivables Collateral in
favor of the First Lien Secured Parties and third-priority
security interests in the Shared Receivables Collateral in favor
of the Junior Lien Secured Parties, in each case, subject to
Permitted Liens. The relative rights, privileges and obligations
with respect to the Shared Receivables Collateral of the ABL
Secured Parties, on the one hand, and the Junior Lien Collateral
Agent, the other Junior Lien Secured Parties, the First Lien
Collateral Agent and the First Lien Secured Parties, on the
other, are substantially identical to the relative rights,
privileges and obligations with respect to the Non-Receivables
Collateral of the First Lien Secured Parties, on the one hand,
and the Junior Lien Secured Parties, on the other, respectively,
except that the Liens of the Junior Lien Secured Parties in the
Shared Receivables Collateral are third-priority Liens and
except to the extent customary or necessary with respect to
collateral of the type that constitutes Shared Receivables
Collateral.
Certain
Limitations on the Collateral
The Collateral securing the Notes does not and will not include
any of the following assets:
(1) the property or assets owned by any Subsidiary of the
Issuer that is not a Guarantor, including each ABL Financing
Entity;
(2) any rights or interests of the Issuer or any Guarantor
in, to or under any agreement, contract, license, instrument,
document or other general intangible (referred to solely for
purposes of this clause (2) as a
Contract), any intellectual property or any
security or other investment property (i) to the extent the
security interest in such Collateral is prohibited by any
applicable contract, agreement or other instrument without the
consent of any other party thereto (other than a party to the
General Credit Facility or the Indenture or, in the case of
investment property, a Wholly-Owned Subsidiary), (ii) to
the extent the security interest in such Contract would give any
other party (other than a party to the General Credit Facility
or the Indenture or, in the case of investment property, a
Wholly-Owned Subsidiary) to such Collateral the right to
terminate its obligations thereunder or (iii) to the extent
all necessary consents to such grant of a security interest have
not been obtained from the other parties thereto (other than to
the extent that any such prohibition referred to in clauses (i),
(ii) and (iii) would be rendered ineffective pursuant
to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
successor provision or provisions) of any relevant jurisdiction
or any other applicable law)); provided that this
limitation shall not affect, limit, restrict or impair the grant
by the Issuer or such Guarantor of a security interest in any
account receivable or any money or other amounts due or to
become due under any Contract;
(3) any equipment of the Issuer or any Guarantor that is
subject to, or secured by, a Capitalized Lease Obligation or
Purchase Money Obligations and any equipment that constitutes an
asset of an entity acquired in a transaction permitted by the
Indenture to the extent that such equipment subject to a Lien
permitted by the Indenture and the terms of the Indebtedness
secured by such Lien prohibit assignment of, or granting of a
security interest in, the Issuers or such Guarantors
rights and interests therein (other than to the extent that any
such prohibition would be rendered ineffective pursuant to
Sections 9-406,
9-407, 9-408
or 9-409 of the Uniform Commercial Code (or any successor
provision or provisions) of any relevant jurisdiction or any
other applicable law); provided that immediately upon the
repayment of all Indebtedness secured by such Lien, the Issuer
or the Guarantor, as the case may be, shall be deemed to have
granted a security interest in all the rights and interests with
respect to such equipment;
(4) any Voting Stock that is issued by any Foreign
Subsidiary, if and to the extent that the inclusion of such
Voting Stock in the Collateral would cause the Collateral
pledged by the Issuer or the applicable Guarantor, as the case
may be, to include in the aggregate more than 65% of the total
combined voting power of all classes of Voting Stock of such
Foreign Subsidiary;
54
(5) any Capital Stock that is issued by a Subsidiary that
is not owned directly by the Issuer or a Guarantor;
(6) prior to the Discharge of First Lien Obligations and so
long as any First Lien Obligations are outstanding, any
Principal Properties;
(7) any Capital Stock and other securities of a Subsidiary
(excluding Healthtrust, Inc. The Hospital Company, a
Delaware corporation and its successors and assigns) to the
extent that the pledge of such Capital Stock and other
securities results in the Companys being required to file
separate financial statements of such Subsidiary with the SEC,
but only to the extent necessary to not be subject to such
requirement and only for so long as such requirement is in
existence and only with respect to the relevant Notes affected;
provided that neither the Issuer nor any Subsidiary shall
take any action in the form of a reorganization, merger or other
restructuring a principal purpose of which is to provide for the
release of the Lien on any Capital Stock pursuant to this clause
(7). In addition, in the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
the SEC to require (or is replaced with another rule or
regulation, or any other law, rule or regulation is adopted,
which would require) the filing with the SEC (or any other
governmental agency) of separate financial statements of any
Subsidiary of the Company due to the fact that such
Subsidiarys Capital Stock secures the Notes affected
thereby, then the Capital Stock of such Subsidiary will
automatically be deemed not to be part of the Collateral
securing the relevant Notes affected thereby but only to the
extent necessary to not be subject to such requirement and only
for so long as required to not be subject to such requirement.
In such event, the Security Documents may be amended or
modified, without the consent of any holder of such Notes, to
the extent necessary to release the security interests in favor
of the applicable collateral agents on the shares of Capital
Stock that are so deemed to no longer constitute part of the
Collateral for the relevant Notes. In the event that Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
the SEC to permit (or is replaced with another rule or
regulation, or any other law, rule or regulation is adopted,
which would permit) such Subsidiarys Capital Stock to
secure the Notes in excess of the amount then pledged without
the filing with the SEC (or any other governmental agency) of
separate financial statements of such Subsidiary, then the
Capital Stock of such Subsidiary will automatically be deemed to
be a part of the Collateral for the relevant Notes but only to
the extent necessary to not be subject to any such financial
statement requirement;
(8) certain non-Principal Properties that do not constitute
Non-Receivables Collateral;
(9) any deposit accounts, other bank or securities accounts
or cash of the Issuer or any Guarantor;
(10) any leaseholds and motor vehicles of the Issuer or any
Guarantor;
(11) any Capital Stock or securities convertible into or
exchangeable for Capital Stock (i) if, in the reasonable
judgment of the Issuer, the cost or other consequences of
pledging such Collateral shall be excessive in view of the
benefits to be obtained by the Junior Lien Secured Parties
therefrom or (ii) the pledge of such Collateral would
result in adverse tax consequences to the Issuer or any of its
Subsidiaries as reasonably determined by the Issuer and
identified in writing to the Junior Lien Collateral Agent;
(12) any collateral to the extent the grant of the security
interest therein would violate any requirement of law; and
(13) proceeds and products from any and all of the
foregoing excluded collateral described in clauses (1)
through (12), unless such proceeds or products would otherwise
constitute Collateral securing the Notes.
Sufficiency
of Collateral
The fair market value of the Collateral is subject to
fluctuations based on factors that include, among others, the
condition of the healthcare industry, the ability to sell the
Collateral in an orderly sale, general economic conditions, the
availability of buyers and similar factors. The amount to be
received upon a sale of the Collateral would also be dependent
on numerous factors, including, but not limited to, the actual
fair
55
market value of the Collateral at such time and the timing and
the manner of the sale. By their nature, portions of the
Collateral may be illiquid and may have no readily ascertainable
market value. Accordingly, there can be no assurance that the
Collateral can be sold in a short period of time or in an
orderly manner. In addition, in the event of a bankruptcy, the
ability of the holders to realize upon any of the Collateral may
be subject to certain bankruptcy law limitations as described
below.
Certain
Bankruptcy Limitations
The right of the Trustee to repossess and dispose of the
Collateral upon the occurrence of an Event of Default would be
significantly impaired by any Bankruptcy Law in the event that a
bankruptcy case were to be commenced by or against the Company
or any Guarantor prior to the Trustees having repossessed
and disposed of the Collateral. Upon the commencement of a case
for relief under the Bankruptcy Code, a secured creditor such as
the Trustee is prohibited from repossessing its security from a
debtor in a bankruptcy case, or from disposing of security
without bankruptcy court approval.
In view of the broad equitable powers of a U.S. bankruptcy
court, it is impossible to predict how long payments under the
Notes could be delayed following commencement of a bankruptcy
case, whether or when the Trustee could repossess or dispose of
the Collateral, the value of the Collateral at any time during a
bankruptcy case or whether or to what extent holders of the
Notes would be compensated for any delay in payment or loss of
value of the Collateral. The Bankruptcy Code permits only the
payment
and/or
accrual of post-petition interest, costs and attorneys
fees to a secured creditor during a debtors bankruptcy
case to the extent the value of such creditors interest in
the Collateral is determined by the bankruptcy court to exceed
the aggregate outstanding principal amount of the obligations
secured by the Collateral.
Furthermore, in the event a domestic or foreign bankruptcy court
determines that the value of the Collateral is not sufficient to
repay all amounts due on the Notes, the holders of the Notes
would hold secured claims only to the extent of the value of the
Collateral to which the holders of the Notes are entitled, and
unsecured claims with respect to such shortfall.
Paying
Agent and Registrar for the Notes
The Issuer must maintain one or more paying agents for the Notes
in the Borough of Manhattan, City of New York. The initial
paying agent for the Notes is the Trustee.
The Issuer must also maintain a registrar with offices in the
Borough of Manhattan, City of New York. The initial registrar is
the Trustee. The registrar maintains a register reflecting
ownership of the Notes outstanding from time to time and makes
payments on and facilitates transfer of Notes on behalf of the
Issuer.
The Issuer may change the paying agents or the registrars
without prior notice to the Holders. The Issuer or any of its
Subsidiaries may act as a paying agent or registrar.
Transfer
and Exchange
A Holder may transfer or exchange Notes in accordance with the
Indenture. The registrar and the Trustee may require a Holder to
furnish appropriate endorsements and transfer documents in
connection with a transfer of Notes. Holders will be required to
pay all taxes due on transfer. The Issuer will not be required
to transfer or exchange any Note selected for redemption. Also,
the Issuer will not be required to transfer or exchange any Note
for a period of 15 days before a selection of Notes to be
redeemed.
Principal,
Maturity and Interest
The Issuer issued $5,700,000,000 in aggregate principal amount
of Notes in a private transaction that was not subject to the
registration requirements of the Securities Act, of which
$1,000,000,000 in aggregate principal amount are 2014 Cash Pay
Notes, $3,200,000,000 in aggregate principal amount are 2016
Cash Pay Notes and $1,500,000,000 in aggregate principal amount
are Toggle Notes. The 2014 Cash Pay Notes will mature on
November 15, 2014, the 2016 Cash Pay Notes will mature on
November 15, 2016 and the Toggle Notes will mature on
November 15, 2016. Subject to compliance with the covenant
described below under the
56
caption Certain Covenants Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock, the Issuer may issue additional 2014
Cash Pay Notes, 2016 Cash Pay Notes
and/or
Toggle Notes from time to time after this offering under the
Indenture (any such 2014 Cash Pay Notes, 2016 Cash Pay Notes or
Toggle Notes, Additional Notes). In addition,
in connection with the payment of PIK Interest or Partial PIK
Interest in respect of the Toggle Notes, the Issuer is entitled
to, without the consent of the Holders, increase the outstanding
principal amount of the Toggle Notes or issue additional Toggle
Notes (the PIK Notes) under the Indenture on
the same terms and conditions as the Toggle Notes (in each case,
the PIK Payment). The Cash Pay Notes and the
Toggle Notes are each separate series of Notes but are treated
as a single class of securities under the Indenture, except as
otherwise stated herein. As a result, Holders of each series of
Notes do not have separate rights to, among other things, give
notice of Defaults or to direct the Trustee to exercise remedies
during Event of Default or otherwise. Except as described under
Amendment, Supplement and Waiver, the Notes offered
by the Issuer, the PIK Notes and any Additional Notes
subsequently issued under the Indenture will be treated as a
single class for all purposes under the Indenture, including
waivers, amendments, redemptions and offers to purchase. Unless
the context requires otherwise, references to Notes
for all purposes of the Indenture and this Description of
Notes include any PIK Notes and Additional Notes that are
actually issued, and references to principal amount
of the Notes includes any increase in the principal amount of
the outstanding Notes as a result of a PIK Payment.
Cash
Pay Notes
2014 Cash
Pay Notes
Interest on the 2014 Cash Pay Notes accrues at the rate of
91/8%
per annum and is payable semi-annually in arrears on May 15 and
November 15, commencing on May 15, 2007, to the
Holders of 2014 Cash Pay Notes of record on the immediately
preceding May 1 and November 1. Interest on the 2014 Cash
Pay Notes accrues from the most recent date to which interest
has been paid or, if no interest has been paid, from and
including the Issue Date. Interest on the 2014 Cash Pay Notes is
computed on the basis of a
360-day year
comprised of twelve
30-day
months.
2016 Cash
Pay Notes
Interest on the 2016 Cash Pay Notes accrues at the rate of
91/4%
per annum and is payable semi-annually in arrears on May 15 and
November 15, commencing on May 15, 2007, to the
Holders of 2016 Cash Pay Notes of record on the immediately
preceding May 1 and November 1. Interest on the 2016 Cash
Pay Notes accrues from the most recent date to which interest
has been paid or, if no interest has been paid, from and
including the Issue Date. Interest on the 2016 Cash Pay Notes is
computed on the basis of a
360-day year
comprised of twelve
30-day
months.
Toggle
Notes
Interest on the Toggle Notes is payable semi-annually in arrears
on May 15 and November 15, commencing on May 15, 2007,
to the Holders of Toggle Notes of record on the immediately
preceding May 1 and November 1. Interest on the Toggle
Notes accrues from the most recent date to which interest has
been paid or, if no interest has been paid, from and including
the Issue Date. Interest on the Toggle Notes is computed on the
basis of a
360-day year
comprised of twelve
30-day
months.
For any interest payment period after the initial interest
payment period and prior to November 15, 2011, the Issuer
may, at its option, elect to pay interest on the Toggle Notes:
|
|
|
|
|
entirely in cash (Cash Interest);
|
|
|
|
entirely by increasing the principal amount of the outstanding
Toggle Notes or by issuing PIK Notes (PIK
Interest); or
|
|
|
|
on 50% of the outstanding principal amount of the Toggle Notes
in cash and on 50% of the principal amount by increasing the
principal amount of the outstanding Toggle Notes or by issuing
PIK Notes (Partial PIK Interest).
|
57
The Issuer must elect the form of interest payment with respect
to each interest period by delivering a notice to the Trustee
prior to the beginning of each interest period. The Trustee
shall promptly deliver a corresponding notice to the Holders. In
the absence of such an election for any interest period,
interest on the Toggle Notes shall be payable according to the
election for the previous interest period. Interest for the
first interest period commencing on the Issue Date shall be
payable entirely in cash. After November 15, 2011, the
Issuer will make all interest payments on the Toggle Notes
entirely in cash. Notwithstanding anything to the contrary, the
payment of accrued interest in connection with any redemption of
Toggle Notes as described under Optional
Redemption Toggle Notes or Repurchase at
the Option of Holders shall be made solely in cash.
Cash Interest on the Toggle Notes accrues at a rate of
95/8%
per annum and is payable in cash. PIK Interest on the Toggle
Notes accrues at a rate of
103/8%
per annum and is payable (x) with respect to Toggle Notes
represented by one or more global notes registered in the name
of, or held by, The Depository Trust Company
(DTC) or its nominee on the relevant record
date, by increasing the principal amount of the outstanding
global Toggle Note by an amount equal to the amount of PIK
Interest for the applicable interest period (rounded up to the
nearest $1,000) and (y) with respect to Toggle Notes
represented by certificated notes, by issuing PIK Notes in
certificated form in an aggregate principal amount equal to the
amount of PIK Interest for the applicable period (rounded up to
the nearest whole dollar), and the Trustee will, at the request
of the Issuer, authenticate and deliver such PIK Notes in
certificated form for original issuance to the Holders on the
relevant record date, as shown by the records of the register of
Holders. In the event that the Issuer elects to pay Partial PIK
Interest for any interest period, each Holder will be entitled
to receive Cash Interest in respect of 50% of the principal
amount of the Toggle Notes held by such Holder on the relevant
record date and PIK Interest in respect of 50% of the principal
amount of the Toggle Notes held by such Holder on the relevant
record date. Following an increase in the principal amount of
the outstanding global Toggle Notes as a result of a PIK
Payment, the global Toggle Notes will bear interest on such
increased principal amount from and after the date of such PIK
Payment. Any PIK Notes issued in certificated form will be dated
as of the applicable interest payment date and will bear
interest from and after such date. All Toggle Notes issued
pursuant to a PIK Payment will mature on November 15, 2016
and will be governed by, and subject to the terms, provisions
and conditions of, the Indenture and shall have the same rights
and benefits as the Toggle Notes issued on the Issue Date. Any
certificated PIK Notes will be issued with the description PIK
on the face of such PIK Note.
If the toggle notes would otherwise constitute applicable
high yield discount obligations within the meaning of
Section 163(i)(1) of the Code, at the end of the first
accrual period ending after the fifth anniversary of the toggle
notes issuance (the AHYDO redemption
date), the Issuer will be required to redeem for cash
a portion of each toggle note then outstanding equal to the
Mandatory Principal Redemption Amount (such
redemption, a Mandatory Principal
Redemption). The redemption price for the portion of
each toggle note redeemed pursuant to a Mandatory Principal
Redemption will be 100% of the principal amount of such portion
plus any accrued interest thereon on the date of redemption. The
Mandatory Principal Redemption Amount
means the portion of a toggle note required to be redeemed to
prevent such toggle note from being treated as an
applicable high yield discount obligation within the
meaning of Section 163(i)(1) of the Code. No partial
redemption or repurchase of the toggle notes prior to the AHYDO
redemption date pursuant to any other provision of the indenture
will alter the Issuers obligation to make the Mandatory
Principal Redemption with respect to any toggle notes that
remain outstanding on the AHYDO redemption date.
Additional
Interest
Additional Interest may accrue on the Notes in certain
circumstances pursuant to the Registration Rights Agreement. Any
Additional Interest on the Notes will be payable in the same
form elected by the Issuer for payment of interest for the
applicable interest payment period. All references in the
Indenture, in any context, to any interest or other amount
payable on or with respect to the Notes shall be deemed to
include any Additional Interest pursuant to the Registration
Rights Agreement.
58
Principal of, premium, if any, and interest on the Notes will be
payable at the office or agency of the Issuer maintained for
such purpose within the City and State of New York or, at the
option of the Issuer, payment of interest may be made by check
mailed to the Holders of the Notes at their respective addresses
set forth in the register of Holders; provided that all
payments of principal, premium, if any, and interest with
respect to the Notes represented by one or more global notes
registered in the name of or held by DTC or its nominee will be
made by wire transfer of immediately available funds to the
accounts specified by the Holder or Holders thereof. Until
otherwise designated by the Issuer, the Issuers office or
agency in New York will be the office of the Trustee maintained
for such purpose.
Mandatory
Redemption; Offers to Purchase; Open Market Purchases
Except as set forth in the last paragraph under Principal,
Maturity and Interest Toggle Notes the Issuer
is not required to make any mandatory redemption or sinking fund
payments with respect to the Notes. However, under certain
circumstances, the Issuer may be required to offer to purchase
Notes as described under the caption Repurchase at the
Option of Holders. The Issuer may at any time and from
time to time purchase Notes in the open market or otherwise.
Optional
Redemption
2014
Cash Pay Notes
Except as set forth below, the Issuer is not entitled to redeem
2014 Cash Pay Notes at its option prior to November 15,
2010.
At any time prior to November 15, 2010, the Issuer may
redeem all or a part of the 2014 Cash Pay Notes, upon not less
than 30 nor more than 60 days prior notice mailed by
first-class mail to the registered address of each Holder of
2014 Cash Pay Notes or otherwise in accordance with the
procedures of DTC, at a redemption price equal to 100% of the
principal amount of the 2014 Cash Pay Notes redeemed plus the
Applicable Premium as of, and accrued and unpaid interest and
Additional Interest, if any, to the date of redemption (the
Redemption Date), subject to the rights
of Holders of 2014 Cash Pay Notes on the relevant record date to
receive interest due on the relevant interest payment date.
On and after November 15, 2010, the Issuer may redeem the
2014 Cash Pay Notes, in whole or in part, upon not less than 30
nor more than 60 days prior notice mailed by
first-class mail to the registered address of each Holder of
2014 Cash Pay Notes or otherwise in accordance with the
procedures of DTC, at the redemption prices (expressed as
percentages of principal amount of the 2014 Cash Pay Notes to be
redeemed) set forth below, plus accrued and unpaid interest
thereon and Additional Interest, if any, to the applicable
Redemption Date, subject to the right of Holders of 2014
Cash Pay Notes of record on the relevant record date to receive
interest due on the relevant interest payment date, if redeemed
during the twelve-month period beginning on November 15 of each
of the years indicated below:
|
|
|
|
|
Year
|
|
Percentage
|
|
|
2010
|
|
|
104.563
|
%
|
2011
|
|
|
102.281
|
%
|
2012 and thereafter
|
|
|
100.000
|
%
|
In addition, until November 15, 2009, the Issuer may, at
its option, on one or more occasions redeem up to 35% of the
aggregate principal amount of 2014 Cash Pay Notes at a
redemption price equal to 109.125% of the aggregate principal
amount thereof, plus accrued and unpaid interest thereon and
Additional Interest, if any, to the applicable
Redemption Date, subject to the right of Holders of 2014
Cash Pay Notes of record on the relevant record date to receive
interest due on the relevant interest payment date, with the net
cash proceeds of one or more Equity Offerings; provided
that at least 50% of the sum of the original aggregate
principal amount of 2014 Cash Pay Notes issued under the
Indenture and the original principal amount of any Additional
Notes that are 2014 Cash Pay Notes issued under the Indenture
after the Issue Date remains outstanding immediately after the
occurrence of each such redemption; provided further that
each such redemption occurs within 90 days of the date of
closing of each such Equity Offering.
59
Any notice of any redemption may be given prior to the
redemption thereof, and any such redemption or notice may, at
the Issuers discretion, be subject to one or more
conditions precedent, including, but not limited to, completion
of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding 2014 Cash
Pay Notes, the Trustee shall select the 2014 Cash Pay Notes to
be redeemed in the manner described under Repurchase at
the Option of Holders Selection and Notice.
2016
Cash Pay Notes
Except as set forth below, the Issuer is not entitled to redeem
2016 Cash Pay Notes at its option prior to November 15,
2011.
At any time prior to November 15, 2011, the Issuer may
redeem all or a part of the 2016 Cash Pay Notes, upon not less
than 30 nor more than 60 days prior notice mailed by
first-class mail to the registered address of each Holder of
2016 Cash Pay Notes or otherwise in accordance with the
procedures of DTC, at a redemption price equal to 100% of the
principal amount of the 2016 Cash Pay Notes redeemed plus the
Applicable Premium as of, and accrued and unpaid interest and
Additional Interest, if any, to the Redemption Date,
subject to the rights of Holders of 2016 Cash Pay Notes on the
relevant record date to receive interest due on the relevant
interest payment date.
On and after November 15, 2011, the Issuer may redeem the
2016 Cash Pay Notes, in whole or in part, upon not less than 30
nor more than 60 days prior notice mailed by
first-class mail to the registered address of each Holder of
2016 Cash Pay Notes or otherwise in accordance with the
procedures of DTC, at the redemption prices (expressed as
percentages of principal amount of the 2016 Cash Pay Notes to be
redeemed) set forth below, plus accrued and unpaid interest
thereon and Additional Interest, if any, to the applicable
Redemption Date, subject to the right of Holders of 2016
Cash Pay Notes of record on the relevant record date to receive
interest due on the relevant interest payment date, if redeemed
during the twelve-month period beginning on November 15 of each
of the years indicated below:
|
|
|
|
|
Year
|
|
Percentage
|
|
|
2011
|
|
|
104.625
|
|
2012
|
|
|
103.083
|
|
2013
|
|
|
101.542
|
|
2014 and thereafter
|
|
|
100.000
|
|
In addition, until November 15, 2009, the Issuer may, at
its option, on one or more occasions redeem up to 35% of the
aggregate principal amount of 2016 Cash Pay Notes at a
redemption price equal to 109.250% of the aggregate principal
amount thereof, plus accrued and unpaid interest thereon and
Additional Interest, if any, to the applicable
Redemption Date, subject to the right of Holders of 2016
Cash Pay Notes of record on the relevant record date to receive
interest due on the relevant interest payment date, with the net
cash proceeds of one or more Equity Offerings; provided
that at least 50% of the sum of the original aggregate
principal amount of 2016 Cash Pay Notes issued under the
Indenture and the original principal amount of any Additional
Notes that are 2016 Cash Pay Notes issued under the Indenture
after the Issue Date remains outstanding immediately after the
occurrence of each such redemption; provided further that
each such redemption occurs within 90 days of the date of
closing of each such Equity Offering.
Any notice of any redemption may be given prior to the
redemption thereof, and any such redemption or notice may, at
the Issuers discretion, be subject to one or more
conditions precedent, including, but not limited to, completion
of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding 2016 Cash
Pay Notes, the Trustee shall select the 2016 Cash Pay Notes to
be redeemed in the manner described under Repurchase at
the Option of Holders Selection and Notice.
60
Toggle
Notes
Except as set forth below, the Issuer is not entitled to redeem
Toggle Notes at its option prior to November 15, 2011.
At any time prior to November 15, 2011, the Issuer may
redeem all or a part of the Toggle Notes, upon not less than 30
nor more than 60 days prior notice mailed by
first-class mail to the registered address of each Holder of
Toggle Notes or otherwise in accordance with the procedures of
DTC, at a redemption price equal to 100% of the principal amount
of the Toggle Notes redeemed plus the Applicable Premium as of,
and accrued and unpaid interest and Additional Interest, if any,
to the Redemption Date, subject to the rights of Holders of
Toggle Notes on the relevant record date to receive interest due
on the relevant interest payment date.
On and after November 15, 2011, the Issuer may redeem the
Toggle Notes, in whole or in part, upon not less than 30 nor
more than 60 days prior notice mailed by first-class
mail to the registered address of each Holder of Toggle Notes or
otherwise in accordance with the procedures of DTC, at the
redemption prices (expressed as percentages of principal amount
of the Toggle Notes to be redeemed) set forth below, plus
accrued and unpaid interest thereon and Additional Interest, if
any, to the applicable Redemption Date, subject to the
right of Holders of Toggle Notes of record on the relevant
record date to receive interest due on the relevant interest
payment date, if redeemed during the twelve-month period
beginning on November 15 of each of the years indicated below:
|
|
|
|
|
Year
|
|
Percentage
|
|
|
2011
|
|
|
104.813
|
|
2012
|
|
|
103.208
|
|
2013
|
|
|
101.604
|
|
2014 and thereafter
|
|
|
100.000
|
|
In addition, until November 15, 2009, the Issuer may, at
its option, on one or more occasions redeem up to 35% of the
aggregate principal amount of Toggle Notes at a redemption price
equal to 109.625% of the aggregate principal amount thereof,
plus accrued and unpaid interest thereon and Additional
Interest, if any, to the applicable Redemption Date,
subject to the right of Holders of Toggle Notes of record on the
relevant record date to receive interest due on the relevant
interest payment date, with the net cash proceeds of one or more
Equity Offerings; provided that at least 50% of the sum
of the original aggregate principal amount of Toggle Notes
issued under the Indenture and the original principal amount of
any Additional Notes that are Toggle Notes issued under the
Indenture after the Issue Date remains outstanding immediately
after the occurrence of each such redemption; provided
further that each such redemption occurs within 90 days
of the date of closing of each such Equity Offering.
Any notice of any redemption may be given prior to the
redemption thereof, and any such redemption or notice may, at
the Issuers discretion, be subject to one or more
conditions precedent, including, but not limited to, completion
of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding Toggle
Notes, the Trustee shall select the Toggle Notes to be redeemed
in the manner described under Repurchase at the Option of
Holders Selection and Notice.
Repurchase
at the Option of Holders
Change
of Control
The Notes provide that if a Change of Control occurs, unless the
Issuer has previously or concurrently mailed a redemption notice
with respect to all the outstanding Notes as described under
Optional Redemption, the Issuer will make an offer
to purchase all of the Notes pursuant to the offer described
below (the Change of Control Offer) at a price in
cash (the Change of Control Payment) equal to 101%
of the aggregate principal amount thereof plus accrued and
unpaid interest and Additional Interest, if any, to the date of
purchase, subject to the right of Holders of the Notes of record
on the relevant record date to receive
61
interest due on the relevant interest payment date. Within
30 days following any Change of Control, the Issuer will
send notice of such Change of Control Offer by first-class mail,
with a copy to the Trustee, to each Holder of Notes to the
address of such Holder appearing in the security register with a
copy to the Trustee or otherwise in accordance with the
procedures of DTC, with the following information:
(1) that a Change of Control Offer is being made pursuant
to the covenant entitled Change of Control and that
all Notes properly tendered pursuant to such Change of Control
Offer will be accepted for payment by the Issuer;
(2) the purchase price and the purchase date, which will be
no earlier than 30 days nor later than 60 days from
the date such notice is mailed (the Change of Control
Payment Date);
(3) that any Note not properly tendered will remain
outstanding and continue to accrue interest;
(4) that unless the Issuer defaults in the payment of the
Change of Control Payment, all Notes accepted for payment
pursuant to the Change of Control Offer will cease to accrue
interest on the Change of Control Payment Date;
(5) that Holders electing to have any Notes purchased
pursuant to a Change of Control Offer will be required to
surrender such Notes, with the form entitled Option of
Holder to Elect Purchase on the reverse of such Notes
completed, to the paying agent specified in the notice at the
address specified in the notice prior to the close of business
on the third Business Day preceding the Change of Control
Payment Date;
(6) that Holders will be entitled to withdraw their
tendered Notes and their election to require the Issuer to
purchase such Notes; provided that the paying agent
receives, not later than the close of business on the
30th day following the date of the Change of Control
notice, a telegram, facsimile transmission or letter setting
forth the name of the Holder of the Notes, the principal amount
of Notes tendered for purchase, and a statement that such Holder
is withdrawing its tendered Notes and its election to have such
Notes purchased;
(7) that if the Issuer is redeeming less than all of the
Notes, the Holders of the remaining Notes will be issued new
Notes and such new Notes will be equal in principal amount to
the unpurchased portion of the Notes surrendered. The
unpurchased portion of the Notes must be equal to $2,000 or an
integral multiple of $1,000 in excess thereof; and
(8) the other instructions, as determined by us, consistent
with the covenant described hereunder, that a Holder must follow.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder to the extent such laws or regulations
are applicable in connection with the repurchase of Notes
pursuant to a Change of Control Offer. To the extent that the
provisions of any securities laws or regulations conflict with
the provisions of the Indenture, the Issuer will comply with the
applicable securities laws and regulations and shall not be
deemed to have breached its obligations described in the
Indenture by virtue thereof.
On the Change of Control Payment Date, the Issuer will, to the
extent permitted by law,
(1) accept for payment all Notes issued by it or portions
thereof properly tendered pursuant to the Change of Control
Offer;
(2) deposit with the paying agent an amount equal to the
aggregate Change of Control Payment in respect of all Notes or
portions thereof so tendered; and
(3) deliver, or cause to be delivered, to the Trustee for
cancellation the Notes so accepted together with an
Officers Certificate to the Trustee stating that such
Notes or portions thereof have been tendered to and purchased by
the Issuer.
The Senior Credit Facilities, and future credit agreements or
other agreements relating to Senior Indebtedness to which the
Issuer becomes a party may, provide that certain change of
control events with
62
respect to the Issuer would constitute a default thereunder
(including a Change of Control under the Indenture). If we
experience a change of control that triggers a default under our
Senior Credit Facilities, we could seek a waiver of such default
or seek to refinance our Senior Credit Facilities. In the event
we do not obtain such a waiver or refinance the Senior Credit
Facilities, such default could result in amounts outstanding
under our Senior Credit Facilities being declared due and
payable and could cause a Receivables Facility to be wound down.
Our ability to pay cash to the Holders of Notes following the
occurrence of a Change of Control may be limited by our
then-existing financial resources. Therefore, sufficient funds
may not be available when necessary to make any required
repurchases.
The Change of Control purchase feature of the Notes may in
certain circumstances make more difficult or discourage a sale
or takeover of us and, thus, the removal of incumbent
management. The Change of Control purchase feature is a result
of negotiations between the Initial Purchasers and us. We have
no present intention to engage in a transaction involving a
Change of Control, although it is possible that we could decide
to do so in the future. Subject to the limitations discussed
below, we could, in the future, enter into certain transactions,
including acquisitions, refinancings or other recapitalizations,
that would not constitute a Change of Control under the
Indenture, but that could increase the amount of indebtedness
outstanding at such time or otherwise affect our capital
structure or credit ratings. Restrictions on our ability to
incur additional Indebtedness are contained in the covenants
described under Certain Covenants Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock and Certain
Covenants Liens. Such restrictions in the
Indenture can be waived only with the consent of the Holders of
a majority in principal amount of the Notes then outstanding.
Except for the limitations contained in such covenants, however,
the Indenture does not contain any covenants or provisions that
may afford Holders of the Notes protection in the event of a
highly leveraged transaction.
The Issuer is not required to make a Change of Control Offer
following a Change of Control if a third party makes the Change
of Control Offer in the manner, at the times and otherwise in
compliance with the requirements set forth in the Indenture
applicable to a Change of Control Offer made by us and purchases
all Notes validly tendered and not withdrawn under such Change
of Control Offer. Notwithstanding anything to the contrary
herein, a Change of Control Offer may be made in advance of a
Change of Control, conditional upon such Change of Control, if a
definitive agreement is in place for the Change of Control at
the time of making of the Change of Control Offer.
The definition of Change of Control includes a
disposition of all or substantially all of the assets of the
Issuer to any Person. Although there is a limited body of case
law interpreting the phrase substantially all, there
is no precise established definition of the phrase under
applicable law. Accordingly, in certain circumstances there may
be a degree of uncertainty as to whether a particular
transaction would involve a disposition of all or
substantially all of the assets of the Issuer. As a
result, it may be unclear as to whether a Change of Control has
occurred and whether a Holder of Notes may require the Issuer to
make an offer to repurchase the Notes as described above.
The provisions under the Indenture relating to the Issuers
obligation to make an offer to repurchase the Notes as a result
of a Change of Control may be waived or modified with the
written consent of the Holders of a majority in principal amount
of the Notes.
Asset
Sales
The Indenture provides that the Issuer will not, and will not
permit any of its Restricted Subsidiaries to consummate,
directly or indirectly, an Asset Sale, unless:
(1) the Issuer or such Restricted Subsidiary, as the case
may be, receives consideration at the time of such Asset Sale at
least equal to the fair market value (as determined in good
faith by the Issuer) of the assets sold or otherwise disposed
of; and
63
(2) except in the case of a Permitted Asset Swap, at least
75% of the consideration therefor received by the Issuer or such
Restricted Subsidiary, as the case may be, is in the form of
cash or Cash Equivalents; provided that the amount of:
(a) any liabilities (as shown on the Issuers or such
Restricted Subsidiarys most recent balance sheet or in the
footnotes thereto) of the Issuer or such Restricted Subsidiary,
other than liabilities that are by their terms subordinated to
the Notes, that are assumed by the transferee of any such assets
and for which the Issuer and all of its Restricted Subsidiaries
have been validly released by all creditors in writing,
(b) any securities received by the Issuer or such
Restricted Subsidiary from such transferee that are converted by
the Issuer or such Restricted Subsidiary into cash (to the
extent of the cash received) within 180 days following the
closing of such Asset Sale, and
(c) any Designated Non-cash Consideration received by the
Issuer or such Restricted Subsidiary in such Asset Sale having
an aggregate fair market value, taken together with all other
Designated Non-cash Consideration received pursuant to this
clause (c) that is at that time outstanding, not to exceed
5% of Total Assets at the time of the receipt of such Designated
Non-cash Consideration, with the fair market value of each item
of Designated Non-cash Consideration being measured at the time
received and without giving effect to subsequent changes in
value, shall be deemed to be cash for purposes of this provision
and for no other purpose.
Within 450 days after the receipt of any Net Proceeds of
any Asset Sale, the Issuer or such Restricted Subsidiary, at its
option, may apply the Net Proceeds from such Asset Sale,
(1) to permanently reduce:
(a) Obligations under Priority Lien Obligations and to
correspondingly reduce commitments with respect thereto;
(b) Obligations under Senior Indebtedness (other than any
Junior Lien Obligation) that is secured by a Lien permitted
under the Indenture (which Lien is senior to the Lien of the
Notes with respect to the Collateral), and to correspondingly
reduce commitments with respect thereto;
(c) Obligations under Junior Lien Obligations (and to
correspondingly reduce commitments with respect thereto) through
open-market purchases (to the extent such purchases are at or
above 100% of the principal amount thereof) or by making an
Asset Sale Offer or a Collateral Asset Sale Offer in accordance
with the procedures set forth below; provided that the
Issuer shall equally and ratably reduce Obligations under the
Notes as provided under Optional Redemption, through
open-market purchases or otherwise by making an offer (in
accordance with the procedures set forth below for an Asset Sale
Offer or a Collateral Asset Sale Offer) to all Holders to
purchase their Notes at 100% of the principal amount thereof,
plus the amount of accrued but unpaid interest, if any, on the
amount of the Notes that would otherwise be prepaid;
(d) Obligations under the Existing Notes which have a final
maturity date (as in effect on the Issue Date) on or prior to
November 15, 2016; provided that, at the time of,
and after giving effect to, such repurchase, redemption or
defeasance, the aggregate amount of Net Proceeds used to
repurchase, redeem or defease Existing Notes pursuant to this
subclause (d) following the Issue Date shall not exceed 5%
of the consolidated total assets of the Issuer and its
subsidiaries at such time; or
(e) Indebtedness of a Restricted Subsidiary that is not a
Guarantor, other than Indebtedness owed to the Issuer or another
Restricted Subsidiary (or any affiliate thereof);
(2) to make (a) an Investment in any one or more
businesses, provided that such Investment in any business
is in the form of the acquisition of Capital Stock and results
in the Issuer or another of its Restricted Subsidiaries, as the
case may be, owning an amount of the Capital Stock of such
business such that it constitutes a Restricted Subsidiary,
(b) capital expenditures or (c) acquisitions of other
assets, in each of (a), (b) and (c), used or useful in a
Similar Business; or
64
(3) to make an investment in (a) any one or more
businesses, provided that such Investment in any business
is in the form of the acquisition of Capital Stock and results
in the Issuer or another of its Restricted Subsidiaries, as the
case may be, owning an amount of the Capital Stock of such
business such that it constitutes a Restricted Subsidiary,
(b) properties or (c) acquisitions of other assets
that, in each of (a), (b) and (c), replace the businesses,
properties
and/or
assets that are the subject of such Asset Sale;
provided that, in the case of clauses (2) and
(3) above, a binding commitment shall be treated as a
permitted application of the Net Proceeds from the date of such
commitment so long as the Issuer, or such other Restricted
Subsidiary enters into such commitment with the good faith
expectation that such Net Proceeds will be applied to satisfy
such commitment within 180 days of such commitment (an
Acceptable Commitment) and, in the event any
Acceptable Commitment is later cancelled or terminated for any
reason before the Net Proceeds are applied in connection
therewith, the Issuer or such Restricted Subsidiary enters into
another Acceptable Commitment (a Second
Commitment) within 180 days of such cancellation
or termination; provided, further, that if any
Second Commitment is later cancelled or terminated for any
reason before such Net Proceeds are applied, then such Net
Proceeds shall constitute Excess Proceeds.
Any Net Proceeds from Asset Sales of Collateral that are not
invested or applied as set forth in the first sentence of the
preceding paragraph will be deemed to constitute
Collateral Excess Proceeds. When the
aggregate amount of Collateral Excess Proceeds exceeds
$200.0 million, the Issuer shall make an offer to all
Holders of the Notes and, if required by the terms of any Junior
Lien Obligations which are not subordinated to the Notes or
Obligations secured by a Lien permitted under the Indenture
(which Lien is not subordinate to the Lien of the Notes with
respect to the Collateral), to the holders of such Junior Lien
Obligations or such other Obligations (a Collateral
Asset Sale Offer), to purchase the maximum aggregate
principal amount of the Notes and such Junior Lien Obligations
or such other Obligations that is a minimum of $2,000 or an
integral multiple of $1,000 in excess thereof that may be
purchased out of the Collateral Excess Proceeds at an offer
price in cash in an amount equal to 100% of the principal amount
thereof, plus accrued and unpaid interest and Additional
Interest, if any, to the date fixed for the closing of such
offer, in accordance with the procedures set forth in the
Indenture. The Issuer will commence a Collateral Asset Sale
Offer with respect to Collateral Excess Proceeds within ten
Business Days after the date that Collateral Excess Proceeds
exceed $200.0 million by mailing the notice required
pursuant to the terms of the Indenture, with a copy to the
Trustee.
Any Net Proceeds from Asset Sales of non-Collateral that are not
invested or applied as provided and within the time period set
forth in the first sentence of the second preceding paragraph
will be deemed to constitute Excess Proceeds.
When the aggregate amount of Excess Proceeds exceeds
$200.0 million, the Issuer shall make an offer to all
Holders of the Notes and, if required or permitted by the terms
of any Senior Indebtedness, to the holders of such Senior
Indebtedness (an Asset Sale Offer), to
purchase the maximum aggregate principal amount of the Notes and
such Senior Indebtedness that is a minimum of $2,000 or an
integral multiple of $1,000 in excess thereof that may be
purchased out of the Excess Proceeds at an offer price in cash
in an amount equal to 100% of the principal amount thereof, plus
accrued and unpaid interest and Additional Interest, if any, to
the date fixed for the closing of such offer, in accordance with
the procedures set forth in the Indenture. The Issuer will
commence an Asset Sale Offer with respect to Excess Proceeds
within ten Business Days after the date that Excess Proceeds
exceed $200.0 million by mailing the notice required
pursuant to the terms of the Indenture, with a copy to the
Trustee.
To the extent that the aggregate amount of Notes and such Junior
Lien Obligations or Obligations secured by a Lien permitted by
the Indenture (which Lien is not subordinate to the Lien of the
Notes with respect to the Collateral) tendered pursuant to a
Collateral Asset Sale Offer is less than the Collateral Excess
Proceeds, the Issuer may use any remaining Collateral Excess
Proceeds for general corporate purposes, subject to other
covenants contained in the Indenture. To the extent that the
aggregate amount of Notes and such Senior Indebtedness tendered
pursuant to an Asset Sale Offer is less than the Excess
Proceeds, the Issuer may use any remaining Excess Proceeds for
general corporate purposes, subject to other covenants contained
in the Indenture. If the aggregate principal amount of Notes or
Junior Lien Obligations or such other Obligations surrendered by
such holders thereof exceeds the amount of Collateral Excess
Proceeds, the Trustee shall select the Notes and such Junior
Lien Obligations or such other Obligations to be purchased on a
pro rata basis
65
based on the accreted value or principal amount of the Notes or
such Junior Lien Obligations or such other Obligations tendered.
If the aggregate principal amount of Notes or the Senior
Indebtedness surrendered by such holders thereof exceeds the
amount of Excess Proceeds, the Trustee shall select the Notes
and such Senior Indebtedness to be purchased on a pro rata basis
based on the accreted value or principal amount of the Notes or
such Senior Indebtedness tendered. Upon completion of any such
Collateral Asset Sale Offer or Asset Sale Offer, the amount of
Collateral Excess Proceeds or Excess Proceeds, as the case may
be, shall be reset at zero. Additionally, the Issuer may, at its
option, make a Collateral Asset Sale Offer or an Asset Sale
Offer using proceeds from any Asset Sale at any time after
consummation of such Asset Sale; provided that such
Collateral Asset Sale Offer or Asset Sale Offer shall be in an
aggregate amount of not less than $50.0 million. Upon
consummation of such Collateral Asset Sale Offer or Asset Sale
Offer, any Net Proceeds not required to be used to purchase
Notes shall not be deemed Excess Proceeds.
Pending the final application of any Net Proceeds pursuant to
this covenant, the holder of such Net Proceeds may apply such
Net Proceeds temporarily to reduce Indebtedness outstanding
under a revolving credit facility or otherwise invest such Net
Proceeds in any manner not prohibited by the Indenture.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder to the extent such laws or regulations
are applicable in connection with the repurchase of the Notes
pursuant to a Collateral Asset Sale Offer or an Asset Sale
Offer. To the extent that the provisions of any securities laws
or regulations conflict with the provisions of the Indenture,
the Issuer will comply with the applicable securities laws and
regulations and shall not be deemed to have breached its
obligations described in the Indenture by virtue thereof.
Selection
and Notice
If the Issuer is redeeming less than all of the Notes issued by
it at any time, the Trustee will select the Notes to be redeemed
(a) if the Notes are listed on any national securities
exchange, in compliance with the requirements of the principal
national securities exchange on which the Notes are listed,
(b) on a pro rata basis to the extent practicable or
(c) by lot or such other similar method in accordance with
the procedures of DTC.
Notices of purchase or redemption shall be mailed by first-class
mail, postage prepaid, at least 30 but not more than
60 days before the purchase or Redemption Date to each
Holder of Notes at such Holders registered address or
otherwise in accordance with the procedures of DTC, except that
redemption notices may be mailed more than 60 days prior to
a Redemption Date if the notice is issued in connection
with a defeasance of the Notes or a satisfaction and discharge
of the Indenture. If any Note is to be purchased or redeemed in
part only, any notice of purchase or redemption that relates to
such Note shall state the portion of the principal amount
thereof that has been or is to be purchased or redeemed.
The Issuer will issue a new Note in a principal amount equal to
the unredeemed portion of the original Note in the name of the
Holder upon cancellation of the original Note. Notes called for
redemption become due on the date fixed for redemption. On and
after the Redemption Date, interest ceases to accrue on
Notes or portions thereof called for redemption.
Certain
Covenants
Set forth below are summaries of certain covenants contained in
the Indenture. If on any date following the Issue Date
(i) the Notes have Investment Grade Ratings from both
Rating Agencies, and (ii) no Default has occurred and is
continuing under the Indenture (the occurrence of the events
described in the foregoing clauses (i) and (ii) being
collectively referred to as a Covenant Suspension
Event), the Issuer and the Restricted Subsidiaries
will not be subject to the following covenants (collectively,
the Suspended Covenants):
(1) Repurchase at the Option of Holders;
(2) Limitation on Restricted Payments;
66
(3) Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
(4) clause (4) of the first paragraph of
Merger, Consolidation or Sale of All or
Substantially All Assets;
(5) Transactions with
Affiliates; and
(6) Dividend and Other Payment Restrictions
Affecting Restricted Subsidiaries.
In the event that the Issuer and the Restricted Subsidiaries are
not subject to the Suspended Covenants under the Indenture for
any period of time as a result of the foregoing, and on any
subsequent date (the Reversion Date) one or
both of the Rating Agencies (a) withdraw their Investment
Grade Rating or downgrade the rating assigned to the Notes below
an Investment Grade Rating
and/or
(b) the Issuer or any of its Affiliates enter into an
agreement to effect a transaction that would result in a Change
of Control and one or more of the Rating Agencies indicate that
if consummated, such transaction (alone or together with any
related recapitalization or refinancing transactions) would
cause such Rating Agency to withdraw its Investment Grade Rating
or downgrade the ratings assigned to the Notes below an
Investment Grade Rating, then the Issuer and the Restricted
Subsidiaries will thereafter again be subject to the Suspended
Covenants under the Indenture with respect to future events,
including, without limitation, a proposed transaction described
in clause (b) above.
The period of time between the Suspension Date and the Reversion
Date is referred to in this description as the
Suspension Period. Additionally, upon the
occurrence of a Covenant Suspension Event, the amount of Excess
Proceeds from Net Proceeds shall be reset at zero. In the event
of any such reinstatement, no action taken or omitted to be
taken by the Issuer or any of its Restricted Subsidiaries prior
to such reinstatement will give rise to a Default or Event of
Default under the Indentures with respect to Notes; provided
that (1) with respect to Restricted Payments made after any
such reinstatement, the amount of Restricted Payments made will
be calculated as though the covenant described under the caption
Limitation on Restricted Payments had
been in effect prior to, but not during the Suspension Period,
provided that any Subsidiaries designated as Unrestricted
Subsidiaries during the Suspension Period shall automatically
become Restricted Subsidiaries on the Reversion Date (subject to
the Issuers right to subsequently designate them as
Unrestricted Subsidiaries in compliance with the covenants set
out below) and (2) all Indebtedness incurred, or
Disqualified Stock or Preferred Stock issued, during the
Suspension Period will be classified to have been incurred or
issued pursuant to clause (3) of the second paragraph of
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock.
There can be no assurance that the Notes will ever achieve or
maintain Investment Grade Ratings.
Limitation
on Restricted Payments
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly:
(I) declare or pay any dividend or make any payment or
distribution on account of the Issuers, or any of its
Restricted Subsidiaries Equity Interests, including any
dividend or distribution payable in connection with any merger
or consolidation other than:
(a) dividends or distributions by the Issuer payable solely
in Equity Interests (other than Disqualified Stock) of the
Issuer; or
(b) dividends or distributions by a Restricted Subsidiary
so long as, in the case of any dividend or distribution payable
on or in respect of any class or series of securities issued by
a Restricted Subsidiary other than a Wholly-Owned Subsidiary,
the Issuer or a Restricted Subsidiary receives at least its pro
rata share of such dividend or distribution in accordance with
its Equity Interests in such class or series of securities;
67
(II) purchase, redeem, defease or otherwise acquire or
retire for value any Equity Interests of the Issuer or any
direct or indirect parent of the Issuer, including in connection
with any merger or consolidation;
(III) make any principal payment on, or redeem, repurchase,
defease or otherwise acquire or retire for value in each case,
prior to any scheduled repayment, sinking fund payment or
maturity, any Subordinated Indebtedness, other than:
(a) Indebtedness permitted under clauses (7) and
(8) of the covenant described under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock; or
(b) the purchase, repurchase or other acquisition of
Subordinated Indebtedness purchased in anticipation of
satisfying a sinking fund obligation, principal installment or
final maturity, in each case due within one year of the date of
purchase, repurchase or acquisition; or
(IV) make any Restricted Investment
(all such payments and other actions set forth in
clauses (I) through (IV) above (other than any
exception thereto) being collectively referred to as
Restricted Payments), unless, at the time of
such Restricted Payment:
(1) no Default shall have occurred and be continuing or
would occur as a consequence thereof;
(2) immediately after giving effect to such transaction on
a pro forma basis, the Issuer could incur $1.00 of
additional Indebtedness under the provisions of the first
paragraph of the covenant described under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred
Stock; and
(3) such Restricted Payment, together with the aggregate
amount of all other Restricted Payments made by the Issuer and
its Restricted Subsidiaries after the Issue Date (including
Restricted Payments permitted by clauses (1), (2) (with respect
to the payment of dividends on Refunding Capital Stock (as
defined below) pursuant to clause (b) thereof only),
(6)(c), (9) and (14) of the next succeeding paragraph,
but excluding all other Restricted Payments permitted by the
next succeeding paragraph), is less than the sum of (without
duplication):
(a) 50% of the Consolidated Net Income of the Issuer for
the period (taken as one accounting period) beginning
October 1, 2006, to the end of the Issuers most
recently ended fiscal quarter for which internal financial
statements are available at the time of such Restricted Payment,
or, in the case such Consolidated Net Income for such period is
a deficit, minus 100% of such deficit; plus
(b) 100% of the aggregate net cash proceeds and the fair
market value, as determined in good faith by the Issuer, of
marketable securities or other property received by the Issuer
since immediately after the Issue Date (other than net cash
proceeds to the extent such net cash proceeds have been used to
incur Indebtedness, Disqualified Stock or Preferred Stock
pursuant to clause (12)(a) of the second paragraph of
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock) from
the issue or sale of:
(i) (A) Equity Interests of the Issuer, including
Treasury Capital Stock (as defined below), but excluding cash
proceeds and the fair market value, as determined in good faith
by the Issuer, of marketable securities or other property
received from the sale of:
(x) Equity Interests to members of management, directors or
consultants of the Issuer, any direct or indirect parent company
of the Issuer and the Issuers Subsidiaries after the Issue
Date to the extent such amounts have been applied to Restricted
Payments made in accordance with clause (4) of the next
succeeding paragraph; and
(y) Designated Preferred Stock; and
68
(B) to the extent such net cash proceeds are actually
contributed to the Issuer, Equity Interests of the Issuers
direct or indirect parent companies (excluding contributions of
the proceeds from the sale of Designated Preferred Stock of such
companies or contributions to the extent such amounts have been
applied to Restricted Payments made in accordance with
clause (4) of the next succeeding paragraph); or
(ii) debt securities of the Issuer that have been converted
into or exchanged for such Equity Interests of the Issuer;
provided, however, that this clause (b) shall not
include the proceeds from (V) Refunding Capital Stock (as
defined below), (W) Equity Interests or convertible debt
securities of the Issuer sold to a Restricted Subsidiary, as the
case may be, (X) Disqualified Stock or debt securities that
have been converted into Disqualified Stock, (Y) Excluded
Contributions or (Z) the Delayed Equity Amount; plus
(c) 100% of the aggregate amount of cash and the fair
market value, as determined in good faith by the Issuer, of
marketable securities or other property contributed to the
capital of the Issuer following the Issue Date (other than net
cash proceeds to the extent such net cash proceeds (i) have
been used to incur Indebtedness, Disqualified Stock or Preferred
Stock pursuant to clause (12)(a) of the second paragraph of
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock,
(ii) are contributed by a Restricted Subsidiary,
(iii) constitute Excluded Contributions or
(iv) constitute the Delayed Equity Amount); plus
(d) 100% of the aggregate amount received in cash and the
fair market value, as determined in good faith by the Issuer, of
marketable securities or other property received by means of:
(i) the sale or other disposition (other than to the Issuer
or a Restricted Subsidiary) of Restricted Investments made by
the Issuer or its Restricted Subsidiaries and repurchases and
redemptions of such Restricted Investments from the Issuer or
its Restricted Subsidiaries and repayments of loans or advances,
and releases of guarantees, which constitute Restricted
Investments by the Issuer or its Restricted Subsidiaries, in
each case after the Issue Date; or
(ii) the sale (other than to the Issuer or a Restricted
Subsidiary) of the stock of an Unrestricted Subsidiary or a
distribution from an Unrestricted Subsidiary (other than in each
case to the extent the Investment in such Unrestricted
Subsidiary was made by the Issuer or a Restricted Subsidiary
pursuant to clause (7) of the next succeeding paragraph or
to the extent such Investment constituted a Permitted
Investment) or a dividend from an Unrestricted Subsidiary after
the Issue Date; plus
(e) in the case of the redesignation of an Unrestricted
Subsidiary as a Restricted Subsidiary after the Issue Date, the
fair market value of the Investment in such Unrestricted
Subsidiary, as determined by the Issuer in good faith (or if
such fair market value exceeds $250.0 million, in writing
by an Independent Financial Advisor), at the time of the
redesignation of such Unrestricted Subsidiary as a Restricted
Subsidiary other than to the extent the Investment in such
Unrestricted Subsidiary was made by the Issuer or a Restricted
Subsidiary pursuant to clause (7) of the next succeeding
paragraph or to the extent such Investment constituted a
Permitted Investment.
The foregoing provisions will not prohibit:
(1) the payment of any dividend within 60 days after
the date of declaration thereof, if at the date of declaration
such payment would have complied with the provisions of the
Indenture;
(2) (a) the redemption, repurchase, retirement or
other acquisition of any Equity Interests (Treasury
Capital Stock) or Subordinated Indebtedness of the
Issuer or any Equity Interests of any direct or indirect parent
company of the Issuer, in exchange for, or out of the proceeds
of the substantially concurrent sale (other than to a Restricted
Subsidiary) of, Equity Interests of the Issuer or any direct or
indirect parent company of the Issuer to the extent contributed
to the Issuer (in each case, other than any Disqualified Stock)
(Refunding Capital Stock) and (b) if
immediately prior to the retirement of
69
Treasury Capital Stock, the declaration and payment of dividends
thereon was permitted under clause (6) of this paragraph,
the declaration and payment of dividends on the Refunding
Capital Stock (other than Refunding Capital Stock the proceeds
of which were used to redeem, repurchase, retire or otherwise
acquire any Equity Interests of any direct or indirect parent
company of the Issuer) in an aggregate amount per year no
greater than the aggregate amount of dividends per annum that
were declarable and payable on such Treasury Capital Stock
immediately prior to such retirement;
(3) the redemption, repurchase or other acquisition or
retirement of Subordinated Indebtedness of the Issuer or a
Guarantor made in exchange for, or out of the proceeds of the
substantially concurrent sale of, new Indebtedness of the Issuer
or a Guarantor, as the case may be, which is incurred in
compliance with Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock so long as:
(a) the principal amount (or accreted value) of such new
Indebtedness does not exceed the principal amount of (or
accreted value, if applicable), plus any accrued and unpaid
interest on, the Subordinated Indebtedness being so redeemed,
repurchased, acquired or retired for value, plus the amount of
any reasonable premium (including reasonable tender premiums),
defeasance costs and any reasonable fees and expenses incurred
in connection with the issuance of such new Indebtedness;
(b) such new Indebtedness is subordinated to the Notes or
the applicable Guarantee at least to the same extent as such
Subordinated Indebtedness so purchased, exchanged, redeemed,
repurchased, acquired or retired for value;
(c) such new Indebtedness has a final scheduled maturity
date equal to or later than the final scheduled maturity date of
the Subordinated Indebtedness being so redeemed, repurchased,
acquired or retired; and
(d) such new Indebtedness has a Weighted Average Life to
Maturity equal to or greater than the remaining Weighted Average
Life to Maturity of the Subordinated Indebtedness being so
redeemed, repurchased, acquired or retired;
(4) a Restricted Payment to pay for the repurchase,
retirement or other acquisition or retirement for value of
Equity Interests (other than Disqualified Stock) of the Issuer
or any of its direct or indirect parent companies held by any
future, present or former employee, director or consultant of
the Issuer, any of its Subsidiaries or any of its direct or
indirect parent companies pursuant to any management equity plan
or stock option plan or any other management or employee benefit
plan or agreement, including any Equity Interests rolled over by
management of the Company or any of its direct or indirect
parent companies in connection with the Transaction;
provided, however, that the aggregate Restricted
Payments made under this clause (4) do not exceed in any
calendar year $75.0 million (which shall increase to
$150.0 million subsequent to the consummation of an
underwritten public Equity Offering by the Issuer or any direct
or indirect parent entity of the Issuer) (with unused amounts in
any calendar year being carried over to succeeding calendar
years subject to a maximum (without giving effect to the
following proviso) of $225.0 million in any calendar year
(which shall increase to $450.0 million subsequent to the
consummation of an underwritten public Equity Offering by the
Issuer or any direct or indirect parent corporation of the
Issuer)); provided further that such amount in any
calendar year may be increased by an amount not to exceed:
(a) the cash proceeds from the sale of Equity Interests
(other than Disqualified Stock) of the Issuer and, to the extent
contributed to the Issuer, Equity Interests of any of the
Issuers direct or indirect parent companies, in each case
to members of management, directors or consultants of the
Issuer, any of its Subsidiaries or any of its direct or indirect
parent companies that occurs after the Issue Date, to the extent
the cash proceeds from the sale of such Equity Interests have
not otherwise been applied to the payment of Restricted Payments
by virtue of clause (3) of the preceding paragraph;
plus
70
(b) the cash proceeds of key man life insurance policies
received by the Issuer or its Restricted Subsidiaries after the
Issue Date; less
(c) the amount of any Restricted Payments previously made
with the cash proceeds described in clauses (a) and
(b) of this clause (4);
and provided, further, that cancellation of
Indebtedness owing to the Issuer or any Restricted Subsidiary
from members of management of the Issuer, any of the
Issuers direct or indirect parent companies or any of the
Issuers Restricted Subsidiaries in connection with a
repurchase of Equity Interests of the Issuer or any of its
direct or indirect parent companies will not be deemed to
constitute a Restricted Payment for purposes of this covenant or
any other provision of the Indenture;
(5) the declaration and payment of dividends to holders of
any class or series of Disqualified Stock of the Issuer or any
of its Restricted Subsidiaries or any class or series of
Preferred Stock of any Restricted Subsidiary issued in
accordance with the covenant described under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock to the
extent such dividends are included in the definition of
Fixed Charges;
(6) (a) the declaration and payment of dividends to
holders of any class or series of Designated Preferred Stock
(other than Disqualified Stock) issued by the Issuer after the
Issue Date;
(b) the declaration and payment of dividends to a direct or
indirect parent company of the Issuer, the proceeds of which
will be used to fund the payment of dividends to holders of any
class or series of Designated Preferred Stock (other than
Disqualified Stock) of such parent corporation issued after the
Issue Date; provided that the amount of dividends paid
pursuant to this clause (b) shall not exceed the aggregate
amount of cash actually contributed to the Issuer from the sale
of such Designated Preferred Stock; or
(c) the declaration and payment of dividends on Refunding
Capital Stock that is Preferred Stock in excess of the dividends
declarable and payable thereon pursuant to clause (2) of
this paragraph;
provided, however, in the case of each of
(a) and (c) of this clause (6), that for the most
recently ended four full fiscal quarters for which internal
financial statements are available immediately preceding the
date of issuance of such Designated Preferred Stock or the
declaration of such dividends on Refunding Capital Stock that is
Preferred Stock, after giving effect to such issuance or
declaration on a pro forma basis, the Issuer and its
Restricted Subsidiaries on a consolidated basis would have had a
Fixed Charge Coverage Ratio of at least 2.00 to 1.00;
(7) Investments in Unrestricted Subsidiaries having an
aggregate fair market value, taken together with all other
Investments made pursuant to this clause (7) that are at
the time outstanding, without giving effect to the sale of an
Unrestricted Subsidiary to the extent the proceeds of such sale
do not consist of cash or marketable securities, not to exceed
2.5% of Total Assets at the time of such Investment (with the
fair market value of each Investment being measured at the time
made and without giving effect to subsequent changes in value);
(8) repurchases of Equity Interests deemed to occur upon
exercise of stock options or warrants if such Equity Interests
represent a portion of the exercise price of such options or
warrants;
(9) the declaration and payment of dividends on the
Issuers common stock (or the payment of dividends to any
direct or indirect parent entity to fund a payment of dividends
on such entitys common stock), following consummation of
the first public offering of the Issuers common stock or
the common stock of any of its direct or indirect parent
companies after the Issue Date, of up to 6% per annum of the net
cash proceeds received by or contributed to the Issuer in or
from any such public offering, other than public offerings with
respect to the Issuers common stock registered on
Form S-8
and other than any public sale constituting an Excluded
Contribution;
(10) Restricted Payments that are made with Excluded
Contributions;
71
(11) other Restricted Payments in an aggregate amount taken
together with all other Restricted Payments made pursuant to
this clause (11) not to exceed 3.0% of Total Assets at the
time made;
(12) distributions or payments of Receivables Fees;
(13) any Restricted Payment made as part of the Transaction
and the fees and expenses related thereto or used to fund
amounts owed to Affiliates (including dividends to any direct or
indirect parent of the Issuer to permit payment by such parent
of such amount), in each case to the extent permitted by the
covenant described under Transactions with
Affiliates;
(14) the repurchase, redemption or other acquisition or
retirement for value of any Subordinated Indebtedness in
accordance with the provisions similar to those described under
the captions Repurchase at the Option of
Holders Change of Control and Repurchase
at the Option of Holders Asset Sales;
provided that all Notes tendered by Holders in connection
with a Change of Control Offer, Collateral Asset Sale Offer or
Asset Sale Offer, as applicable, have been repurchased, redeemed
or acquired for value;
(15) the declaration and payment of dividends by the Issuer
to, or the making of loans to, any direct or indirect parent in
amounts required for any direct or indirect parent companies to
pay, in each case without duplication,
(a) franchise and excise taxes and other fees, taxes and
expenses required to maintain their corporate existence;
(b) foreign, federal, state and local income taxes, to the
extent such income taxes are attributable to the income of the
Issuer and its Restricted Subsidiaries and, to the extent of the
amount actually received from its Unrestricted Subsidiaries, in
amounts required to pay such taxes to the extent attributable to
the income of such Unrestricted Subsidiaries; provided
that in each case the amount of such payments in any fiscal
year does not exceed the amount that the Issuer and its
Restricted Subsidiaries would be required to pay in respect of
foreign, federal, state and local taxes for such fiscal year
were the Issuer, its Restricted Subsidiaries and its
Unrestricted Subsidiaries (to the extent described above) to pay
such taxes separately from any such parent entity;
(c) for as long as Hercules Holding II, LLC is a parent of
the Issuer, distributions equal to any taxable income of
Hercules Holding II, LLC resulting from the Hedging Arrangements
multiplied by 45%;
(d) customary salary, bonus and other benefits payable to
officers and employees of any direct or indirect parent company
of the Issuer to the extent such salaries, bonuses and other
benefits are attributable to the ownership or operation of the
Issuer and its Restricted Subsidiaries;
(e) general corporate operating and overhead costs and
expenses of any direct or indirect parent company of the Issuer
to the extent such costs and expenses are attributable to the
ownership or operation of the Issuer and its Restricted
Subsidiaries; and
(f) fees and expenses other than to Affiliates of the
Issuer related to any unsuccessful equity or debt offering of
such parent entity; and
(16) the distribution, by dividend or otherwise, of shares
of Capital Stock of, or Indebtedness owed to the Issuer or a
Restricted Subsidiary by, Unrestricted Subsidiaries (other than
Unrestricted Subsidiaries, the primary assets of which are cash
and/or Cash
Equivalents);
provided, however, that at the time of, and after
giving effect to, any Restricted Payment permitted under
clauses (11) and (16), no Default shall have occurred and
be continuing or would occur as a consequence thereof.
As of the Issue Date, all of the Issuers Subsidiaries were
Restricted Subsidiaries. The Issuer will not permit any
Unrestricted Subsidiary to become a Restricted Subsidiary except
pursuant to the last sentence of the definition of
Unrestricted Subsidiary. For purposes of designating
any Restricted Subsidiary as an
72
Unrestricted Subsidiary, all outstanding Investments by the
Issuer and its Restricted Subsidiaries (except to the extent
repaid) in the Subsidiary so designated will be deemed to be
Restricted Payments in an amount determined as set forth in the
last sentence of the definition of Investment. Such
designation will be permitted only if a Restricted Payment in
such amount would be permitted at such time, whether pursuant to
the first paragraph of this covenant or under clause (7),
(10) or (11) of the second paragraph of this covenant,
or pursuant to the definition of Permitted
Investments, and if such Subsidiary otherwise meets the
definition of an Unrestricted Subsidiary. Unrestricted
Subsidiaries are not subject to any of the restrictive covenants
set forth in the Indenture.
Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly, create, incur, issue,
assume, guarantee or otherwise become directly or indirectly
liable, contingently or otherwise (collectively,
incur and collectively, an
incurrence) with respect to any Indebtedness
(including Acquired Indebtedness), and the Issuer will not issue
any shares of Disqualified Stock and will not permit any
Restricted Subsidiary to issue any shares of Disqualified Stock
or Preferred Stock; provided, however, that the
Issuer may incur Indebtedness (including Acquired Indebtedness)
or issue shares of Disqualified Stock, and any of its Restricted
Subsidiaries may incur Indebtedness (including Acquired
Indebtedness), issue shares of Disqualified Stock and issue
shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
a consolidated basis for the Issuer and its Restricted
Subsidiaries most recently ended four fiscal quarters for
which internal financial statements are available immediately
preceding the date on which such additional Indebtedness is
incurred or such Disqualified Stock or Preferred Stock is issued
would have been at least 2.00 to 1.00, determined on a pro
forma basis (including a pro forma application of the
net proceeds therefrom), as if the additional Indebtedness had
been incurred, or the Disqualified Stock or Preferred Stock had
been issued, as the case may be, and the application of proceeds
therefrom had occurred at the beginning of such four-quarter
period; provided, further, that Restricted Subsidiaries
that are not Guarantors may not incur Indebtedness or
Disqualified Stock or Preferred Stock if, after giving pro
forma effect to such incurrence or issuance (including a
pro forma application of the net proceeds therefrom),
more than an aggregate of $2,000.0 million of Indebtedness
or Disqualified Stock or Preferred Stock of Restricted
Subsidiaries that are not Guarantors would be outstanding
pursuant to this paragraph and clauses (12), (14) and
(19) below at such time.
The foregoing limitations will not apply to:
(1) the incurrence of Indebtedness under (x) Credit
Facilities (other than the ABL Facility) by the Issuer or any of
its Restricted Subsidiaries and the issuance and creation of
letters of credit and bankers acceptances thereunder (with
letters of credit and bankers acceptances being deemed to
have a principal amount equal to the face amount thereof), up to
an aggregate principal amount of $16,500.0 million
outstanding at any one time and (y) the ABL Facility by the
Issuer or any of its Restricted Subsidiaries and the issuance
and creation of letters of credit and bankers acceptances
thereunder (with letters of credit and bankers acceptances
being deemed to have a principal amount equal to the face amount
thereof), up to an aggregate principal amount equal to the ABL
Facility Cap;
(2) the incurrence by the Issuer and any Guarantor of
Indebtedness represented by the Notes (including any PIK Notes
and any Guarantee) (other than any Additional Notes (including
Guarantees thereof));
(3) Indebtedness of the Issuer and its Restricted
Subsidiaries in existence on the Issue Date (other than
Indebtedness described in clauses (1) and (2)), including
the Existing Notes;
(4) Indebtedness consisting of Capitalized Lease
Obligations and Purchase Money Obligations; so long as such
Indebtedness exists at the date of such purchase, lease or
improvement, or is created within 270 days thereafter;
(5) Indebtedness incurred by the Issuer or any of its
Restricted Subsidiaries constituting reimbursement obligations
with respect to letters of credit issued in the ordinary course
of business, including letters of credit in respect of
workers compensation, medical malpractice or employee
health claims, or
73
other Indebtedness with respect to reimbursement-type
obligations regarding workers compensation, medical
malpractice or employee health claims; provided,
however, that upon the drawing of such letters of credit
or the incurrence of such Indebtedness, such obligations are
reimbursed within 30 days following such drawing or
incurrence;
(6) Indebtedness arising from agreements of the Issuer or
its Restricted Subsidiaries providing for indemnification,
adjustment of purchase price or similar obligations, in each
case, incurred or assumed in connection with the disposition of
any business, assets or a Subsidiary, other than guarantees of
Indebtedness incurred by any Person acquiring all or any portion
of such business, assets or a Subsidiary for the purpose of
financing such acquisition; provided, however,
that such Indebtedness is not reflected on the balance sheet of
the Issuer, or any of its Restricted Subsidiaries (contingent
obligations referred to in a footnote to financial statements
and not otherwise reflected on the balance sheet will not be
deemed to be reflected on such balance sheet for purposes of
this clause (6));
(7) Indebtedness of the Issuer to a Restricted Subsidiary;
provided that any such Indebtedness owing to a Restricted
Subsidiary that is not a Guarantor is expressly subordinated in
right of payment to the Notes; provided, further,
that any subsequent issuance or transfer of any Capital Stock or
any other event which results in any Restricted Subsidiary
ceasing to be a Restricted Subsidiary or any other subsequent
transfer of any such Indebtedness (except to the Issuer or
another Restricted Subsidiary) shall be deemed, in each case, to
be an incurrence of such Indebtedness;
(8) Indebtedness of a Restricted Subsidiary to the Issuer
or another Restricted Subsidiary; provided that if a
Guarantor incurs such Indebtedness to a Restricted Subsidiary
that is not a Guarantor, such Indebtedness is expressly
subordinated in right of payment to the Guarantee of the Notes
of such Guarantor; provided, further, that any
subsequent transfer of any such Indebtedness (except to the
Issuer or another Restricted Subsidiary) shall be deemed, in
each case, to be an incurrence of such Indebtedness not
permitted by this clause;
(9) shares of Preferred Stock of a Restricted Subsidiary
issued to the Issuer or another Restricted Subsidiary;
provided that any subsequent issuance or transfer of any
Capital Stock or any other event which results in any such
Restricted Subsidiary ceasing to be a Restricted Subsidiary or
any other subsequent transfer of any such shares of Preferred
Stock (except to the Issuer or another of its Restricted
Subsidiaries) shall be deemed in each case to be an issuance of
such shares of Preferred Stock not permitted by this clause;
(10) Hedging Obligations (excluding Hedging Obligations
entered into for speculative purposes) for the purpose of
limiting interest rate risk with respect to any Indebtedness
permitted to be incurred pursuant to
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock,
exchange rate risk or commodity pricing risk;
(11) obligations in respect of performance, bid, appeal and
surety bonds and completion guarantees provided by the Issuer or
any of its Restricted Subsidiaries in the ordinary course of
business;
(12) (a) Indebtedness or Disqualified Stock of the
Issuer and Indebtedness, Disqualified Stock or Preferred Stock
of the Issuer or any Restricted Subsidiary equal to 200.0% of
the net cash proceeds received by the Issuer since immediately
after the Issue Date from the issue or sale of Equity Interests
of the Issuer or cash contributed to the capital of the Issuer
(in each case, other than Excluded Contributions or proceeds of
Disqualified Stock or sales of Equity Interests to the Issuer or
any of its Subsidiaries) as determined in accordance with
clauses (3)(b) and (3)(c) of the first paragraph of
Limitation on Restricted Payments to the
extent such net cash proceeds or cash have not been applied
pursuant to such clauses to make Restricted Payments or to make
other Investments, payments or exchanges pursuant to the second
paragraph of Limitation on Restricted
Payments or to make Permitted Investments (other than
Permitted Investments specified in clauses (1) and
(3) of the definition thereof) and (b) Indebtedness or
Disqualified Stock of Issuer and Indebtedness, Disqualified
Stock or Preferred Stock of the Issuer or any Restricted
Subsidiary not otherwise permitted hereunder in an aggregate
principal amount or liquidation preference, which when
aggregated with the principal amount and liquidation preference
of all
74
other Indebtedness, Disqualified Stock and Preferred Stock then
outstanding and incurred pursuant to this clause (12)(b), does
not at any one time outstanding exceed $1,500.0 million;
provided, however that on a pro forma basis,
together with any amounts incurred and outstanding by Restricted
Subsidiaries that are not Guarantors pursuant to the second
proviso to the first paragraph of this covenant and
clauses (14) and (19), no more than $2,000.0 million
of Indebtedness, Disqualified Stock or Preferred Stock at any
one time outstanding and incurred pursuant to this clause
(12)(b) shall be incurred by Restricted Subsidiaries that are
not Guarantors (it being understood that any Indebtedness,
Disqualified Stock or Preferred Stock incurred pursuant to this
clause (12)(b) shall cease to be deemed incurred or outstanding
for purposes of this clause (12)(b) but shall be deemed incurred
for the purposes of the first paragraph of this covenant from
and after the first date on which the Issuer or such Restricted
Subsidiary could have incurred such Indebtedness, Disqualified
Stock or Preferred Stock under the first paragraph of this
covenant without reliance on this clause (12)(b));
(13) the incurrence or issuance by the Issuer or any
Restricted Subsidiary of Indebtedness, Disqualified Stock or
Preferred Stock which serves to refund or refinance any
Indebtedness, Disqualified Stock or Preferred Stock of the
Issuer or any Restricted Subsidiary incurred as permitted under
the first paragraph of this covenant and clauses (2), (3),
(4) and (12)(a) above, this clause (13) and
clause (14) below or any Indebtedness, Disqualified Stock
or Preferred Stock of the Issuer or any Restricted Subsidiary
issued to so refund or refinance such Indebtedness, Disqualified
Stock or Preferred Stock of the Issuer or any Restricted
Subsidiary including additional Indebtedness, Disqualified Stock
or Preferred Stock incurred to pay premiums (including
reasonable tender premiums), defeasance costs and fees in
connection therewith (the Refinancing
Indebtedness) prior to its respective maturity;
provided, however, that such Refinancing
Indebtedness:
(a) has a Weighted Average Life to Maturity at the time
such Refinancing Indebtedness is incurred which is not less than
the remaining Weighted Average Life to Maturity of the
Indebtedness, Disqualified Stock or Preferred Stock being
refunded or refinanced,
(b) to the extent such Refinancing Indebtedness refinances
(i) Indebtedness subordinated or pari passu to the
Notes or any Guarantee thereof, such Refinancing Indebtedness is
subordinated or pari passu to the Notes or the Guarantee
at least to the same extent as the Indebtedness being refinanced
or refunded or (ii) Disqualified Stock or Preferred Stock,
such Refinancing Indebtedness must be Disqualified Stock or
Preferred Stock, respectively, and
(c) shall not include Indebtedness, Disqualified Stock or
Preferred Stock of a Subsidiary of the Issuer that is not a
Guarantor that refinances Indebtedness, Disqualified Stock or
Preferred Stock of the Issuer or a Guarantor;
and, provided further, that subclause (a) of this
clause (13) will not apply to any refunding or refinancing
of any Priority Lien Obligations and Obligations secured by
Permitted Liens;
(14) Indebtedness, Disqualified Stock or Preferred Stock of
(x) the Issuer or a Restricted Subsidiary incurred to
finance an acquisition or (y) Persons that are acquired by
the Issuer or any Restricted Subsidiary or merged into the
Issuer or a Restricted Subsidiary in accordance with the terms
of the Indenture; provided that after giving effect to
such acquisition or merger, either
(a) the Issuer would be permitted to incur at least $1.00
of additional Indebtedness pursuant to the Fixed Charge Coverage
Ratio test set forth in the first sentence of this
covenant, or
(b) the Fixed Charge Coverage Ratio of the Issuer and the
Restricted Subsidiaries is greater than immediately prior to
such acquisition or merger;
provided, however that on a pro forma basis,
together with amounts incurred and outstanding pursuant to the
second proviso to the first paragraph of this covenant and
clauses (12) and (19), no more than $2,000.0 million
of Indebtedness, Disqualified Stock or Preferred Stock at any
one time outstanding and incurred by Restricted Subsidiaries
that are not Guarantors pursuant to this clause (14) shall
be incurred and outstanding;
75
(15) Indebtedness arising from the honoring by a bank or
other financial institution of a check, draft or similar
instrument drawn against insufficient funds in the ordinary
course of business; provided that such Indebtedness is
extinguished within two Business Days of its incurrence;
(16) Indebtedness of the Issuer or any of its Restricted
Subsidiaries supported by a letter of credit issued pursuant to
any Credit Facilities, in a principal amount not in excess of
the stated amount of such letter of credit;
(17) (a) any guarantee by the Issuer or a Restricted
Subsidiary of Indebtedness or other obligations of any
Restricted Subsidiary, so long as the incurrence of such
Indebtedness incurred by such Restricted Subsidiary is permitted
under the terms of the Indenture, or (b) any guarantee by a
Restricted Subsidiary of Indebtedness of the Issuer; provided
that such guarantee is incurred in accordance with the
covenant described below under Limitation on
Guarantees of Indebtedness by Restricted Subsidiaries;
(18) Indebtedness of Foreign Subsidiaries of the Issuer in
an amount not to exceed at any one time outstanding and together
with any other Indebtedness incurred under this clause (18)
7.5% of the Total Assets of the Foreign Subsidiaries (it being
understood that any Indebtedness incurred pursuant to this
clause (18) shall cease to be deemed incurred or
outstanding for purposes of this clause (18) but shall be
deemed incurred for the purposes of the first paragraph of this
covenant from and after the first date on which the Issuer or
such Restricted Subsidiaries could have incurred such
Indebtedness under the first paragraph of this covenant without
reliance on this clause (18));
(19) Indebtedness, Disqualified Stock or Preferred Stock of
a Restricted Subsidiary incurred to finance or assumed in
connection with an acquisition in a principal amount not to
exceed $200.0 million in the aggregate at any one time
outstanding together with all other Indebtedness, Disqualified
Stock and/or
Preferred Stock issued under this clause (19) (it being
understood that any Indebtedness, Disqualified Stock or
Preferred Stock incurred pursuant to this clause (19) shall
cease to be deemed incurred or outstanding for purposes of this
clause (19) but shall be deemed incurred for the purposes
of the first paragraph of this covenant from and after the first
date on which such Restricted Subsidiary could have incurred
such Indebtedness, Disqualified Stock or Preferred Stock under
the first paragraph of this covenant without reliance on this
clause (19)); provided, however, that, on a pro forma
basis, together with amounts incurred and outstanding by
Restricted Subsidiaries that are not Guarantors pursuant to the
second proviso to the first paragraph of this covenant and
clauses (12) and (14), no more than $2,000.0 million
of Indebtedness would be incurred and outstanding by Restricted
Subsidiaries that are not Guarantors;
(20) Indebtedness of the Issuer or any of its Restricted
Subsidiaries consisting of (i) the financing of insurance
premiums or
(ii) take-or-pay
obligations contained in supply arrangements, in each case,
incurred in the ordinary course of business;
(21) Indebtedness consisting of Indebtedness issued by the
Issuer or any of its Restricted Subsidiaries to current or
former officers, directors and employees thereof, their
respective estates, spouses or former spouses, in each case to
finance the purchase or redemption of Equity Interests of the
Issuer or any direct or indirect parent company of the Issuer to
the extent described in clause (4) of the second paragraph
under the caption Limitation on Restricted
Payments;
(22) Physician Support Obligations incurred by the Issuer
or any Restricted Subsidiary; and
(23) Indebtedness of the Issuer or any of its Restricted
Subsidiaries undertaken in connection with cash management and
related activities with respect to any Subsidiary or joint
venture operating one or more healthcare facilities, including,
without limitation, hospitals, ambulatory surgery centers,
outpatient diagnostic centers or imaging centers, in each case,
in the ordinary course of business.
For purposes of determining compliance with this covenant:
(1) in the event that an item of Indebtedness, Disqualified
Stock or Preferred Stock (or any portion thereof) meets the
criteria of more than one of the categories of permitted
Indebtedness, Disqualified Stock or Preferred Stock described in
clauses (1) through (23) above or is entitled to be
incurred pursuant
76
to the first paragraph of this covenant, the Issuer, in its sole
discretion, will classify or reclassify such item of
Indebtedness, Disqualified Stock or Preferred Stock (or any
portion thereof) and will only be required to include the amount
and type of such Indebtedness, Disqualified Stock or Preferred
Stock in one of the above clauses; provided that all
Indebtedness outstanding under the Credit Facilities on the
Issue Date will be treated as incurred on the Issue Date under
clause (1) of the preceding paragraph; and
(2) at the time of incurrence, the Issuer will be entitled
to divide and classify an item of Indebtedness in more than one
of the types of Indebtedness described in the first and second
paragraphs above.
Accrual of interest, the accretion of accreted value and the
payment of interest in the form of additional Indebtedness,
Disqualified Stock or Preferred Stock will not be deemed to be
an incurrence of Indebtedness, Disqualified Stock or Preferred
Stock for purposes of this covenant.
For purposes of determining compliance with any
U.S. dollar-denominated restriction on the incurrence of
Indebtedness, the U.S. dollar-equivalent principal amount
of Indebtedness denominated in a foreign currency shall be
calculated based on the relevant currency exchange rate in
effect on the date such Indebtedness was incurred, in the case
of term debt, or first committed, in the case of revolving
credit debt; provided that if such Indebtedness is
incurred to refinance other Indebtedness denominated in a
foreign currency, and such refinancing would cause the
applicable U.S. dollar-denominated restriction to be
exceeded if calculated at the relevant currency exchange rate in
effect on the date of such refinancing, such
U.S. dollar-denominated restriction shall be deemed not to
have been exceeded so long as the principal amount of such
refinancing Indebtedness does not exceed the principal amount of
such Indebtedness being refinanced.
The principal amount of any Indebtedness incurred to refinance
other Indebtedness, if incurred in a different currency from the
Indebtedness being refinanced, shall be calculated based on the
currency exchange rate applicable to the currencies in which
such respective Indebtedness is denominated that is in effect on
the date of such refinancing.
The Indenture provides that the Issuer will not, and will not
permit any Guarantor to, directly or indirectly, incur any
Indebtedness (including Acquired Indebtedness) that is
subordinated or junior in right of payment to any Indebtedness
of the Issuer or such Guarantor, as the case may be, unless such
Indebtedness is expressly subordinated in right of payment to
the Notes or such Guarantors Guarantee to the extent and
in the same manner as such Indebtedness is subordinated to other
Indebtedness of the Issuer or such Guarantor, as the case may be.
The Indenture does not treat (1) unsecured Indebtedness as
subordinated or junior to Secured Indebtedness merely because it
is unsecured or (2) Senior Indebtedness as subordinated or
junior to any other Senior Indebtedness merely because it has a
junior priority with respect to the same collateral.
Limitation
on Prepayment or Modification of Existing Notes
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly purchase, redeem,
defease or otherwise acquire or retire for value any of the
Existing Notes prior to the final maturity date thereof (as in
effect on the Issue Date); provided that the Issuer may:
(1) purchase, redeem, defease or otherwise acquire or
retire for value any of the Existing Notes which have a final
maturity date (as in effect on the Issue Date) on or prior to
December 31, 2011; and
(2) purchase, redeem, defease or otherwise acquire or
retire for value any other Existing Notes which have a final
maturity date (as in effect on the Issue Date) on or prior to
November 15, 2016; provided that, in the case of any
such prepayment funded with the proceeds of the issuance of
Secured Indebtedness, at the time of incurrence and after giving
pro forma effect thereto and to the application of the
proceeds thereof, (x) the Consolidated Secured Debt Ratio
would be no greater than 5.25 to 1.0 and (y) the
Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, amend the Existing Notes Indenture, or any
supplemental indenture in respect thereof, in any way to advance
the final maturity date or
77
shorten the Weighted Average Life to Maturity of any series of
the Existing Notes such that any Existing Notes with a maturity
date following the maturity of the Notes would have a maturity
date on or prior to the date one year following the maturity
date of the 2016 Cash Pay Notes or which would prohibit the
making of the Guarantees or the creation of Liens in favor of
the Notes and the Guarantees on the Collateral.
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, designate any additional subsidiaries as
Restricted Subsidiaries (as defined in the Existing
Notes Indenture) for purposes of the Existing Notes Indenture.
Liens
The Issuer will not, and will not permit any Guarantor to,
directly or indirectly, create, incur, assume or suffer to exist
any Lien (except Permitted Liens) that secures obligations under
any Indebtedness or any related Guarantee, on any asset or
property of the Issuer or any Guarantor, or any income or
profits therefrom, or assign or convey any right to receive
income therefrom, unless:
(1) in the case of Liens securing Subordinated
Indebtedness, the Notes and related Guarantees are secured by a
Lien on such property, assets or proceeds that is senior in
priority to such Liens; or
(2) in all other cases, the Notes or the Guarantees are
equally and ratably secured or are secured by a Lien on such
property, assets or proceeds that is senior in priority to such
Liens;
except that the foregoing shall not apply to (a) Liens
securing the Notes and the related Guarantees, (b) Liens
securing Indebtedness permitted to be incurred under Credit
Facilities, including any letter of credit relating thereto,
that was permitted by the terms of the Indenture to be incurred
pursuant to clause (1) of the second paragraph under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock;
provided that, with respect to Liens securing Obligations
permitted under this subclause (b), the Notes and the related
Guarantees are secured by Liens on the assets subject to such
Liens (except any European Collateral) to the extent, with the
priority and subject to intercreditor arrangements, in each case
no less favorable to the holders of the Notes than those
described under Security above and (c) Liens
which are senior in priority to the Liens securing the Notes and
related Guarantees and are incurred to secure Obligations in
respect of any Indebtedness permitted to be incurred pursuant to
the covenant described above under Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock; provided that, with respect to
Liens securing Obligations permitted under this subclause (c),
(i) at the time of incurrence and after giving pro forma
effect thereto, the ratio of (1) the aggregate amount of
Indebtedness subject to a Lien incurred pursuant to
subclause (b) above, this subclause (c) and
clause (6) of the definition of Permitted Liens
(other than Liens securing Indebtedness incurred pursuant to
clauses (4) and (18) of the covenant described above
under Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock) to
(2) the Issuers EBITDA for the most recently ended
four full fiscal quarters for which internal financial
statements are available immediately preceding the date on which
such event for which such calculation is being made shall occur,
in each case with such pro forma adjustments to
Indebtedness and EBITDA as are appropriate and consistent with
the pro forma adjustment provisions set forth in the
definition of Fixed Charge Coverage Ratio would be no greater
than 4.25 to 1.0 and (ii) the Notes and the Guarantees are
secured by Liens with the priority and subject to intercreditor
arrangements no less favorable to the holders of the Notes than
those described under Security above.
Merger,
Consolidation or Sale of All or Substantially All
Assets
The Issuer may not consolidate or merge with or into or wind up
into (whether or not the Issuer is the surviving corporation),
or sell, assign, transfer, lease, convey or otherwise dispose of
all or substantially all of its properties or assets, in one or
more related transactions, to any Person unless:
(1) the Issuer is the surviving corporation or the Person
formed by or surviving any such consolidation or merger (if
other than the Issuer) or to which such sale, assignment,
transfer, lease, conveyance or other disposition will have been
made is a corporation organized or existing under the
78
laws of the jurisdiction of organization of the Issuer or the
laws of the United States, any state thereof, the District of
Columbia, or any territory thereof (such Person, as the case may
be, being herein called the Successor
Company);
(2) the Successor Company, if other than the Issuer,
expressly assumes all the obligations of the Issuer under the
Notes and the Security Documents pursuant to supplemental
indentures or other documents or instruments in form reasonably
satisfactory to the Trustee;
(3) immediately after such transaction, no Default exists;
(4) immediately after giving pro forma effect to
such transaction and any related financing transactions, as if
such transactions had occurred at the beginning of the
applicable four-quarter period,
(a) the Successor Company would be permitted to incur at
least $1.00 of additional Indebtedness pursuant to the Fixed
Charge Coverage Ratio test set forth in the first sentence of
the covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock, or
(b) the Fixed Charge Coverage Ratio for the Successor
Company, the Issuer and its Restricted Subsidiaries would be
greater than such ratio for the Issuer and its Restricted
Subsidiaries immediately prior to such transaction;
(5) each Guarantor, unless it is the other party to the
transactions described above, in which case clause (b) of
the second succeeding paragraph shall apply, shall have by
supplemental indenture confirmed that its Guarantee shall apply
to such Persons obligations under the Indenture, the Notes
and the Registration Rights Agreement;
(6) the Collateral owned by the Successor Company will
(a) continue to constitute Collateral under the Indenture
and the Security Documents, (b) be subject to a Lien in
favor of the Junior Lien Collateral Agent for the benefit of the
Trustee and the Holders of the Notes and (c) not be subject
to any other Lien, other than Permitted Liens;
(7) to the extent any assets of the Person which is merged
or consolidated with or into the Successor Company are assets of
the type which would constitute Collateral under the Security
Documents, the Successor Company will take such action as may be
reasonably necessary to cause such property and assets to be
made subject to the Lien of the Security Documents in the manner
and to the extent required in the Indenture or any of the
Security Documents and shall take all reasonably necessary
action so that such Lien is perfected to the extent required by
the Security Documents; and
(8) the Issuer shall have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel, each
stating that such consolidation, merger or transfer and such
supplemental indentures, if any, comply with the Indenture and,
if a supplemental indenture or any supplement to any Security
Document is required in connection with such transaction, such
supplement shall comply with the applicable provisions of the
Indenture.
The Successor Company will succeed to, and be substituted for
the Issuer, as the case may be, under the Indenture, the
Guarantees and the Notes, as applicable. Notwithstanding the
foregoing clauses (3) and (4),
(1) any Restricted Subsidiary may consolidate with or merge
into or transfer all or part of its properties and assets to the
Issuer, and
(2) the Issuer may merge with an Affiliate of the Issuer,
as the case may be, solely for the purpose of reincorporating
the Issuer in a State of the United States or any state thereof,
the District of Columbia or any territory thereof so long as the
amount of Indebtedness of the Issuer and its Restricted
Subsidiaries is not increased thereby.
Subject to certain limitations described in the Indenture
governing release of a Guarantee upon the sale, disposition or
transfer of a Guarantor, no Guarantor will, and the Issuer will
not permit any Guarantor to, consolidate or merge with or into
or wind up into (whether or not the Issuer or Guarantor is the
surviving
79
corporation), or sell, assign, transfer, lease, convey or
otherwise dispose of all or substantially all of its properties
or assets, in one or more related transactions, to any Person
unless:
(1) (a) such Guarantor is the surviving corporation or
the Person formed by or surviving any such consolidation or
merger (if other than such Guarantor) or to which such sale,
assignment, transfer, lease, conveyance or other disposition
will have been made is a corporation, partnership, limited
partnership, limited liability corporation or trust organized or
existing under the laws of the jurisdiction of organization of
such Guarantor, as the case may be, or the laws of the United
States, any state thereof, the District of Columbia, or any
territory thereof (such Guarantor or such Person, as the case
may be, being herein called the Successor
Person);
(b) the Successor Person, if other than such Guarantor,
expressly assumes all the obligations of such Guarantor under
the Indenture and such Guarantors related Guarantee
pursuant to supplemental indentures or other documents or
instruments in form reasonably satisfactory to the Trustee;
(c) immediately after such transaction, no Default
exists; and
(d) the Issuer shall have delivered to the Trustee an
Officers Certificate, each stating that such
consolidation, merger or transfer and such supplemental
indentures, if any, comply with the Indenture; or
(2) the transaction is made in compliance with the covenant
described under Repurchase at the Option of
Holders Asset Sales.
Subject to certain limitations described in the Indenture, the
Successor Person will succeed to, and be substituted for, such
Guarantor under the Indenture and such Guarantors
Guarantee. Notwithstanding the foregoing, any Guarantor may
(i) merge into or transfer all or part of its properties
and assets to another Guarantor or the Issuer, (ii) merge
with an Affiliate of the Company solely for the purpose of
reincorporating the Guarantor in the United States, any state
thereof, the District of Columbia or any territory thereof or
(iii) convert into a corporation, partnership, limited
partnership, limited liability corporation or trust organized or
existing under the laws of the jurisdiction of organization of
such Guarantor.
Transactions
with Affiliates
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, make any payment to, or sell, lease, transfer
or otherwise dispose of any of its properties or assets to, or
purchase any property or assets from, or enter into or make or
amend any transaction, contract, agreement, understanding, loan,
advance or guarantee with, or for the benefit of, any Affiliate
of the Issuer (each of the foregoing, an Affiliate
Transaction) involving aggregate payments or
consideration in excess of $40.0 million, unless:
(1) such Affiliate Transaction is on terms that are not
materially less favorable to the Issuer or its relevant
Restricted Subsidiary than those that would have been obtained
in a comparable transaction by the Issuer or such Restricted
Subsidiary with an unrelated Person on an arms-length
basis; and
(2) the Issuer delivers to the Trustee with respect to any
Affiliate Transaction or series of related Affiliate
Transactions involving aggregate payments or consideration in
excess of $80.0 million, a resolution adopted by the
majority of the board of directors of the Issuer approving such
Affiliate Transaction and set forth in an Officers
Certificate certifying that such Affiliate Transaction complies
with clause (1) above.
The foregoing provisions will not apply to the following:
(1) transactions between or among the Issuer or any of its
Restricted Subsidiaries;
(2) Restricted Payments permitted by the provisions of the
Indenture described above under the covenant
Limitation on Restricted Payments and
the definition of Permitted Investments;
(3) the payment of management, consulting, monitoring and
advisory fees and related expenses to the Investors and the
Frist Entities pursuant to the Sponsor Management Agreement
(plus any unpaid management, consulting, monitoring and advisory
fees and related expenses accrued in any prior year)
80
and the termination fees pursuant to the Sponsor Management
Agreement, in each case as in effect on the Issue Date, or any
amendment thereto (so long as any such amendment is not
disadvantageous in the good faith judgment of the board of
directors of the Issuer to the Holders when taken as a whole as
compared to the Sponsor Management Agreement in effect on the
Issue Date);
(4) the payment of reasonable and customary fees paid to,
and indemnities provided for the benefit of, officers,
directors, employees or consultants of Issuer, any of its direct
or indirect parent companies or any of its Restricted
Subsidiaries;
(5) transactions in which the Issuer or any of its
Restricted Subsidiaries, as the case may be, delivers to the
Trustee a letter from an Independent Financial Advisor stating
that such transaction is fair to the Issuer or such Restricted
Subsidiary from a financial point of view or stating that the
terms are not materially less favorable to the Issuer or its
relevant Restricted Subsidiary than those that would have been
obtained in a comparable transaction by the Issuer or such
Restricted Subsidiary with an unrelated Person on an
arms-length basis;
(6) any agreement as in effect as of the Issue Date, or any
amendment thereto (so long as any such amendment is not
disadvantageous to the Holders when taken as a whole as compared
to the applicable agreement as in effect on the Issue Date);
(7) the existence of, or the performance by the Issuer or
any of its Restricted Subsidiaries of its obligations under the
terms of, any stockholders agreement (including any registration
rights agreement or purchase agreement related thereto) to which
it is a party as of the Issue Date and any similar agreements
which it may enter into thereafter; provided,
however, that the existence of, or the performance by the
Issuer or any of its Restricted Subsidiaries of obligations
under any future amendment to any such existing agreement or
under any similar agreement entered into after the Issue Date
shall only be permitted by this clause (7) to the extent
that the terms of any such amendment or new agreement are not
otherwise disadvantageous to the Holders when taken as a whole;
(8) the Transaction and the payment of all fees and
expenses related to the Transaction, in each case as disclosed
in the Offering Memorandum;
(9) transactions with customers, clients, suppliers, or
purchasers or sellers of goods or services, in each case in the
ordinary course of business and otherwise in compliance with the
terms of the Indenture which are fair to the Issuer and its
Restricted Subsidiaries, in the reasonable determination of the
board of directors of the Issuer or the senior management
thereof, or are on terms at least as favorable as might
reasonably have been obtained at such time from an unaffiliated
party;
(10) the issuance of Equity Interests (other than
Disqualified Stock) of the Issuer to any Permitted Holder or to
any director, officer, employee or consultant;
(11) sales of accounts receivable, or participations
therein, in connection with the ABL Facility and any Receivables
Facility;
(12) payments by the Issuer or any of its Restricted
Subsidiaries to any of the Investors made for any financial
advisory, financing, underwriting or placement services or in
respect of other investment banking activities, including,
without limitation, in connection with acquisitions or
divestitures, which payments are approved by a majority of the
board of directors of the Issuer in good faith;
(13) payments or loans (or cancellation of loans) to
employees or consultants of the Issuer, any of its direct or
indirect parent companies or any of its Restricted Subsidiaries
and employment agreements, stock option plans and other similar
arrangements with such employees or consultants which, in each
case, are approved by the Issuer in good faith;
(14) investments by the Investors or the Frist Entities in
securities of the Issuer or any of its Restricted Subsidiaries
so long as (i) the investment is being offered generally to
other investors on the same or more favorable terms and
(ii) the investment constitutes less than 5% of the
proposed or outstanding issue amount of such class of securities;
81
(15) payments to or from, and transactions with, any joint
venture owning or operating one or more healthcare facilities,
including, without limitation, hospitals, ambulatory surgery
centers, outpatient diagnostic centers or imaging centers, in
each case in the ordinary course of business (including, without
limitation, any cash management activities related
thereto); and
(16) payments by the Issuer (and any direct or indirect
parent thereof) and its Subsidiaries pursuant to tax sharing
agreements among the Issuer (and any such parent) and its
Subsidiaries on customary terms to the extent attributable to
the ownership or operation of the Issuer and its Subsidiaries;
provided that in each case the amount of such payments in
any fiscal year does not exceed the amount that the Issuer, its
Restricted Subsidiaries and its Unrestricted Subsidiaries (to
the extent of amounts received from Unrestricted Subsidiaries)
would be required to pay in respect of foreign, federal, state
and local taxes for such fiscal year were the Issuer and its
Restricted Subsidiaries (to the extent described above) to pay
such taxes separately from any such parent entity.
Dividend
and Other Payment Restrictions Affecting Restricted
Subsidiaries
The Issuer will not, and will not permit any of its Restricted
Subsidiaries that are not Guarantors to, directly or indirectly,
create or otherwise cause or suffer to exist or become effective
any consensual encumbrance or consensual restriction on the
ability of any such Restricted Subsidiary to:
(1) (a) pay dividends or make any other distributions
to the Issuer or any of its Restricted Subsidiaries on its
Capital Stock or with respect to any other interest or
participation in, or measured by, its profits, or
(b) pay any Indebtedness owed to the Issuer or any of its
Restricted Subsidiaries;
(2) make loans or advances to the Issuer or any of its
Restricted Subsidiaries; or
(3) sell, lease or transfer any of its properties or assets
to the Issuer or any of its Restricted Subsidiaries,
except (in each case) for such encumbrances or restrictions
existing under or by reason of:
(a) contractual encumbrances or restrictions in effect on
the Issue Date, including pursuant to the Senior Credit
Facilities and the related documentation and the Existing Notes
Indenture and the related documentation;
(b) the Indenture and the Notes;
(c) purchase money obligations for property acquired in the
ordinary course of business that impose restrictions of the
nature discussed in clause (3) above on the property so
acquired;
(d) applicable law or any applicable rule, regulation or
order;
(e) any agreement or other instrument of a Person acquired
by the Issuer or any Restricted Subsidiary in existence at the
time of such acquisition (but not created in contemplation
thereof), which encumbrance or restriction is not applicable to
any Person, or the properties or assets of any Person, other
than the Person and its Subsidiaries, or the property or assets
of the Person and its Subsidiaries, so acquired;
(f) contracts for the sale of assets, including customary
restrictions with respect to a Subsidiary of the Issuer pursuant
to an agreement that has been entered into for the sale or
disposition of all or substantially all of the Capital Stock or
assets of such Subsidiary;
(g) Secured Indebtedness that limits the right of the
debtor to dispose of the assets securing such Indebtedness that
is otherwise permitted to be incurred pursuant to the covenants
described under Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock and Liens;
82
(h) restrictions on cash or other deposits or net worth
imposed by customers under contracts entered into in the
ordinary course of business;
(i) other Indebtedness, Disqualified Stock or Preferred
Stock of Foreign Subsidiaries permitted to be incurred
subsequent to the Issue Date pursuant to the provisions of the
covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock;
(j) customary provisions in joint venture agreements and
other agreements or arrangements relating solely to such joint
venture;
(k) customary provisions contained in leases or licenses of
intellectual property and other agreements, in each case entered
into in the ordinary course of business;
(l) any encumbrances or restrictions of the type referred
to in clauses (1), (2) and (3) above imposed by any
amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings of the
contracts, instruments or obligations referred to in
clauses (a) through (k) above; provided that
such amendments, modifications, restatements, renewals,
increases, supplements, refundings, replacements or refinancings
are, in the good faith judgment of the Issuer, no more
restrictive with respect to such encumbrance and other
restrictions taken as a whole than those prior to such
amendment, modification, restatement, renewal, increase,
supplement, refunding, replacement or refinancing; and
(m) restrictions created in connection with any Receivables
Facility that, in the good faith determination of the Issuer,
are necessary or advisable to effect the transactions
contemplated under such Receivables Facility.
Limitation
on Guarantees of Indebtedness by Restricted
Subsidiaries
The Issuer will not permit any of its Wholly-Owned Subsidiaries
that are Restricted Subsidiaries (and non-Wholly-Owned
Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
other capital markets debt securities of the Issuer or any
Guarantor), other than a Guarantor, a Foreign Subsidiary or a
Receivables Subsidiary, to guarantee the payment of any
Indebtedness of the Issuer or any other Guarantor unless:
(1) such Restricted Subsidiary within 30 days executes
and delivers a supplemental indenture to the Indenture providing
for a Guarantee by such Restricted Subsidiary, except that with
respect to a guarantee of Indebtedness of the Issuer or any
Guarantor:
(a) if the Notes or such Guarantors Guarantee are
subordinated in right of payment to such Indebtedness, the
Guarantee under the supplemental indenture shall be subordinated
to such Restricted Subsidiarys guarantee with respect to
such Indebtedness substantially to the same extent as the Notes
are subordinated to such Indebtedness; and
(b) if such Indebtedness is by its express terms
subordinated in right of payment to the Notes or such
Guarantors Guarantee, any such guarantee by such
Restricted Subsidiary with respect to such Indebtedness shall be
subordinated in right of payment to such Guarantee substantially
to the same extent as such Indebtedness is subordinated to the
Notes; and
(2) such Restricted Subsidiary waives, and will not in any
manner whatsoever claim or take the benefit or advantage of, any
rights of reimbursement, indemnity or subrogation or any other
rights against the Issuer or any other Restricted Subsidiary as
a result of any payment by such Restricted Subsidiary under its
Guarantee;
provided that this covenant shall not be applicable to
(i) any guarantee of any Restricted Subsidiary that existed
at the time such Person became a Restricted Subsidiary and was
not incurred in connection with, or in contemplation of, such
Person becoming a Restricted Subsidiary and (ii) guarantees
of the ABL Facility by the ABL Financing Entities or of any
Receivables Facility by any Receivables Subsidiary.
83
Reports
and Other Information
Notwithstanding that the Issuer may not be subject to the
reporting requirements of Section 13 or 15(d) of the
Exchange Act or otherwise report on an annual and quarterly
basis on forms provided for such annual and quarterly reporting
pursuant to rules and regulations promulgated by the SEC, the
Indenture requires the Issuer to file with the SEC (and make
available to the Trustee and Holders of the Notes (without
exhibits), without cost to any Holder, within 15 days after
it files them with the SEC) from and after the Issue Date,
(1) within 90 days (or any other time period then in
effect under the rules and regulations of the Exchange Act with
respect to the filing of a
Form 10-K
by a non-accelerated filer) after the end of each fiscal year,
annual reports on
Form 10-K,
or any successor or comparable form, containing the information
required to be contained therein, or required in such successor
or comparable form;
(2) within 45 days after the end of each of the first
three fiscal quarters of each fiscal year, reports on
Form 10-Q
containing all quarterly information that would be required to
be contained in
Form 10-Q,
or any successor or comparable form;
(3) promptly from time to time after the occurrence of an
event required to be therein reported, such other reports on
Form 8-K,
or any successor or comparable form; and
(4) any other information, documents and other reports
which the Issuer would be required to file with the SEC if it
were subject to Section 13 or 15(d) of the Exchange Act;
in each case in a manner that complies in all material respects
with the requirements specified in such form; provided
that the Issuer shall not be so obligated to file such
reports with the SEC if the SEC does not permit such filing, in
which event the Issuer will make available such information to
prospective purchasers of Notes, in addition to providing such
information to the Trustee and the Holders of the Notes, in each
case within 15 days after the time the Issuer would be
required to file such information with the SEC if it were
subject to Section 13 or 15(d) of the Exchange Act. In
addition, to the extent not satisfied by the foregoing, the
Issuer has agreed that, for so long as any Notes are
outstanding, it will furnish to Holders and to securities
analysts and prospective investors, upon their request, the
information required to be delivered pursuant to
Rule 144A(d)(4) under the Securities Act.
In the event that any direct or indirect parent company of the
Issuer becomes a Guarantor of the Notes, the Indenture permits
the Issuer to satisfy its obligations in this covenant with
respect to financial information relating to the Issuer by
furnishing financial information relating to such parent;
provided that the same is accompanied by consolidating
information that explains in reasonable detail the differences
between the information relating to such parent, on the one
hand, and the information relating to the Issuer and its
Restricted Subsidiaries on a standalone basis, on the other hand.
Notwithstanding the foregoing, such requirements shall be deemed
satisfied prior to the commencement of the exchange offers or
the effectiveness of the shelf registration statement described
in the Registration Rights Agreement (1) by the filing with
the SEC of the exchange offer registration statement or shelf
registration statement (or any other similar registration
statement), and any amendments thereto, with such financial
information that satisfies
Regulation S-X,
subject to exceptions consistent with the presentation of
financial information in the Offering Memorandum, to the extent
filed within the times specified above, or (2) by posting
reports that would be required to be filed substantially in the
form required by the SEC on the Companys website (or that
of any of its parent companies) or providing such reports to the
Trustee within 15 days after the time the Issuer would be
required to file such information with the SEC if it were
subject to Section 13 or 15(d) of the Exchange Act, the
financial information (including a Managements
Discussion and Analysis of Financial Condition and Results of
Operations section) that would be required to be included
in such reports, subject to exceptions consistent with the
presentation of financial information in the Offering
Memorandum, to the extent filed within the times specified above.
84
Events of
Default and Remedies
The Indenture provides that each of the following is an
Event of Default:
(1) default in payment when due and payable, upon
redemption, acceleration or otherwise, of principal of, or
premium, if any, on the Notes;
(2) default for 30 days or more in the payment when
due of interest or Additional Interest on or with respect to the
Notes;
(3) failure by the Issuer or any Guarantor for 60 days
after receipt of written notice given by the Trustee or the
Holders of not less 30% in principal amount of the Notes to
comply with any of its obligations, covenants or agreements
(other than a default referred to in clauses (1) and
(2) above) contained in the Indenture or the Notes;
(4) default under any mortgage, indenture or instrument
under which there is issued or by which there is secured or
evidenced any Indebtedness for money borrowed by the Issuer or
any of its Restricted Subsidiaries or the payment of which is
guaranteed by the Issuer or any of its Restricted Subsidiaries,
other than Indebtedness owed to the Issuer or a Restricted
Subsidiary, whether such Indebtedness or guarantee now exists or
is created after the issuance of the Notes, if both:
(a) such default either results from the failure to pay any
principal of such Indebtedness at its stated final maturity
(after giving effect to any applicable grace periods) or relates
to an obligation other than the obligation to pay principal of
any such Indebtedness at its stated final maturity and results
in the holder or holders of such Indebtedness causing such
Indebtedness to become due prior to its stated maturity; and
(b) the principal amount of such Indebtedness, together
with the principal amount of any other such Indebtedness in
default for failure to pay principal at stated final maturity
(after giving effect to any applicable grace periods), or the
maturity of which has been so accelerated, aggregate
$200.0 million or more at any one time outstanding;
(5) failure by the Issuer or any Significant Subsidiary to
pay final judgments aggregating in excess of
$200.0 million, which final judgments remain unpaid,
undischarged and unstayed for a period of more than 60 days
after such judgment becomes final, and in the event such
judgment is covered by insurance, an enforcement proceeding has
been commenced by any creditor upon such judgment or decree
which is not promptly stayed;
(6) certain events of bankruptcy or insolvency with respect
to the Issuer or any Significant Subsidiary;
(7) the Guarantee of any Significant Subsidiary shall for
any reason cease to be in full force and effect or be declared
null and void or any responsible officer of any Guarantor that
is a Significant Subsidiary, as the case may be, denies that it
has any further liability under its Guarantee or gives notice to
such effect, other than by reason of the termination of the
Indenture or the release of any such Guarantee in accordance
with the Indenture; or
(8) with respect to any Collateral having a fair market
value in excess of $200 million, individually or in the
aggregate, (a) the security interest under the Security
Documents, at any time, ceases to be in full force and effect
for any reason other than in accordance with the terms of the
Indenture, the Security Documents and the Intercreditor
Agreements, (b) any security interest created thereunder or
under the Indenture is declared invalid or unenforceable by a
court of competent jurisdiction or (c) the Issuer or any
Guarantor asserts, in any pleading in any court of competent
jurisdiction, that any such security interest is invalid or
unenforceable.
If any Event of Default (other than of a type specified in
clause (6) above) occurs and is continuing under the
Indenture, the Trustee or the Holders of at least 30% in
principal amount of the then total outstanding Notes may declare
the principal, premium, if any, interest and any other monetary
obligations on all the then outstanding Notes to be due and
payable immediately.
85
Upon the effectiveness of such declaration, such principal and
interest will be due and payable immediately. Notwithstanding
the foregoing, in the case of an Event of Default arising under
clause (6) of the first paragraph of this section, all
outstanding Notes will become due and payable without further
action or notice. The Indenture provides that the Trustee may
withhold from the Holders notice of any continuing Default,
except a Default relating to the payment of principal, premium,
if any, or interest, if it determines that withholding notice is
in their interest. In addition, the Trustee shall have no
obligation to accelerate the Notes if in the best judgment of
the Trustee acceleration is not in the best interest of the
Holders of the Notes.
The Indenture provides that the Holders of a majority in
aggregate principal amount of the then outstanding Notes by
notice to the Trustee may on behalf of the Holders of all of the
Notes waive any existing Default and its consequences under the
Indenture except a continuing Default in the payment of interest
on, premium, if any, or the principal of any Note held by a
non-consenting Holder. In the event of any Event of Default
specified in clause (4) above, such Event of Default and
all consequences thereof (excluding any resulting payment
default, other than as a result of acceleration of the Notes)
shall be annulled, waived and rescinded, automatically and
without any action by the Trustee or the Holders, if within
20 days after such Event of Default arose:
(1) the Indebtedness or guarantee that is the basis for
such Event of Default has been discharged; or
(2) holders thereof have rescinded or waived the
acceleration, notice or action (as the case may be) giving rise
to such Event of Default; or
(3) the default that is the basis for such Event of Default
has been cured.
Subject to the provisions of the Indenture relating to the
duties of the Trustee thereunder, in case an Event of Default
occurs and is continuing, the Trustee is under no obligation to
exercise any of the rights or powers under the Indenture at the
request or direction of any of the Holders of the Notes unless
the Holders have offered to the Trustee reasonable indemnity or
security against any loss, liability or expense. Except to
enforce the right to receive payment of principal, premium, if
any, or interest when due, no Holder of a Note may pursue any
remedy with respect to the Indenture or the Notes unless:
(1) such Holder has previously given the Trustee notice
that an Event of Default is continuing;
(2) Holders of at least 30% in principal amount of the
total outstanding Notes have requested the Trustee to pursue the
remedy;
(3) Holders of the Notes have offered the Trustee
reasonable security or indemnity against any loss, liability or
expense;
(4) the Trustee has not complied with such request within
60 days after the receipt thereof and the offer of security
or indemnity; and
(5) Holders of a majority in principal amount of the total
outstanding Notes have not given the Trustee a direction
inconsistent with such request within such
60-day
period.
Subject to certain restrictions, under the Indenture the Holders
of a majority in principal amount of the total outstanding Notes
are given the right to direct the time, method and place of
conducting any proceeding for any remedy available to the
Trustee or of exercising any trust or power conferred on the
Trustee. The Trustee, however, may refuse to follow any
direction that conflicts with law or the Indenture or that the
Trustee determines is unduly prejudicial to the rights of any
other Holder of a Note or that would involve the Trustee in
personal liability.
The Indenture provides that the Issuer is required to deliver to
the Trustee annually a statement regarding compliance with the
Indenture, and the Issuer is required, within five Business
Days, upon becoming aware of any Default, to deliver to the
Trustee a statement specifying such Default.
86
No
Personal Liability of Directors, Officers, Employees and
Stockholders
No director, officer, employee, incorporator or stockholder of
the Issuer or any Guarantor or any of their parent companies
(other than the Issuer and the Guarantors) shall have any
liability for any obligations of the Issuer or the Guarantors
under the Notes, the Guarantees or the Indenture or for any
claim based on, in respect of, or by reason of such obligations
or their creation. Each Holder by accepting the Notes waives and
releases all such liability. The waiver and release are part of
the consideration for issuance of the Notes. Such waiver may not
be effective to waive liabilities under the federal securities
laws, and it is the view of the SEC that such a waiver is
against public policy.
Legal
Defeasance and Covenant Defeasance
The obligations of the Issuer and the Guarantors under the
Indenture will terminate (other than certain obligations) and
will be released upon payment in full of all of the Notes. The
Issuer may, at its option and at any time, elect to have all of
its obligations discharged with respect to the Notes and have
the Issuers and each Guarantors obligation
discharged with respect to its Guarantee (Legal
Defeasance) and cure all then existing Events of
Default except for:
(1) the rights of Holders of Notes to receive payments in
respect of the principal of, premium, if any, and interest on
the Notes when such payments are due solely out of the trust
created pursuant to the Indenture;
(2) the Issuers obligations with respect to Notes
concerning issuing temporary Notes, registration of such Notes,
mutilated, destroyed, lost or stolen Notes and the maintenance
of an office or agency for payment and money for security
payments held in trust;
(3) the rights, powers, trusts, duties and immunities of
the Trustee, and the Issuers obligations in connection
therewith; and
(4) the Legal Defeasance provisions of the Indenture.
In addition, the Issuer may, at its option and at any time,
elect to have its obligations and those of each Guarantor
released with respect to certain covenants that are described in
the Indenture (Covenant Defeasance) and
thereafter any omission to comply with such obligations shall
not constitute a Default with respect to the Notes. In the event
Covenant Defeasance occurs, certain events (not including
bankruptcy, receivership, rehabilitation and insolvency events
pertaining to the Issuer) described under Events of
Default and Remedies will no longer constitute an Event of
Default with respect to the Notes.
In order to exercise either Legal Defeasance or Covenant
Defeasance with respect to the Notes:
(1) the Issuer must irrevocably deposit with the Trustee,
in trust, for the benefit of the Holders of the Notes, cash in
U.S. dollars, Government Securities, or a combination
thereof, in such amounts as will be sufficient, in the opinion
of a nationally recognized firm of independent public
accountants, to pay the principal of, premium, if any, and
interest due on the Notes on the stated maturity date or on the
redemption date, as the case may be, of such principal, premium,
if any, or interest on such Notes, and the Issuer must specify
whether such Notes are being defeased to maturity or to a
particular redemption date;
(2) in the case of Legal Defeasance, the Issuer shall have
delivered to the Trustee an Opinion of Counsel reasonably
acceptable to the Trustee confirming that, subject to customary
assumptions and exclusions,
(a) the Issuer has received from, or there has been
published by, the United States Internal Revenue Service a
ruling, or
(b) since the issuance of the Notes, there has been a
change in the applicable U.S. federal income tax law,
87
in either case to the effect that, and based thereon such
Opinion of Counsel shall confirm that, subject to customary
assumptions and exclusions, the Holders of the Notes will not
recognize income, gain or loss for U.S. federal income tax
purposes, as applicable, as a result of such Legal Defeasance
and will be subject to U.S. federal income tax on the same
amounts, in the same manner and at the same times as would have
been the case if such Legal Defeasance had not occurred;
(3) in the case of Covenant Defeasance, the Issuer shall
have delivered to the Trustee an Opinion of Counsel reasonably
acceptable to the Trustee confirming that, subject to customary
assumptions and exclusions, the Holders of the Notes will not
recognize income, gain or loss for U.S. federal income tax
purposes as a result of such Covenant Defeasance and will be
subject to such tax on the same amounts, in the same manner and
at the same times as would have been the case if such Covenant
Defeasance had not occurred;
(4) no Default (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith) shall have
occurred and be continuing on the date of such deposit;
(5) such Legal Defeasance or Covenant Defeasance shall not
result in a breach or violation of, or constitute a default
under the Senior Credit Facilities or any other material
agreement or instrument (other than the Indenture) to which the
Issuer or any Guarantor is a party or by which the Issuer or any
Guarantor is bound (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith);
(6) the Issuer shall have delivered to the Trustee an
Opinion of Counsel to the effect that, as of the date of such
opinion and subject to customary assumptions and exclusions
following the deposit, the trust funds will not be subject to
the effect of Section 547 of Title 11 of the United
States Code;
(7) the Issuer shall have delivered to the Trustee an
Officers Certificate stating that the deposit was not made
by the Issuer with the intent of defeating, hindering, delaying
or defrauding any creditors of the Issuer or any Guarantor or
others; and
(8) the Issuer shall have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel (which
Opinion of Counsel may be subject to customary assumptions and
exclusions) each stating that all conditions precedent provided
for or relating to the Legal Defeasance or the Covenant
Defeasance, as the case may be, have been complied with.
Satisfaction
and Discharge
The Indenture will be discharged and will cease to be of further
effect as to all Notes, when either:
(1) all Notes theretofore authenticated and delivered,
except lost, stolen or destroyed Notes which have been replaced
or paid and Notes for whose payment money has theretofore been
deposited in trust, have been delivered to the Trustee for
cancellation; or
(2) (a) all Notes not theretofore delivered to the
Trustee for cancellation have become due and payable by reason
of the making of a notice of redemption or otherwise, will
become due and payable within one year or may be called for
redemption within one year under arrangements satisfactory to
the Trustee for the giving of notice of redemption by the
Trustee in the name, and at the expense, of the Issuer, and the
Issuer or any Guarantor has irrevocably deposited or caused to
be deposited with the Trustee as trust funds in trust solely for
the benefit of the Holders of the Notes, cash in
U.S. dollars, Government Securities, or a combination
thereof, in such amounts as will be sufficient without
consideration of any reinvestment of interest to pay and
discharge the entire indebtedness on the Notes not theretofore
delivered to the Trustee for cancellation for principal,
premium, if any, and accrued interest to the date of maturity or
redemption;
(b) no Default (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of
88
Liens in connection therewith) with respect to the Indenture or
the Notes shall have occurred and be continuing on the date of
such deposit or shall occur as a result of such deposit, and
such deposit will not result in a breach or violation of, or
constitute a default under, the Senior Credit Facilities or any
other material agreement or instrument (other than the
Indenture) to which the Issuer or any Guarantor is a party or by
which the Issuer or any Guarantor is bound (other than that
resulting from borrowing funds to be applied to make such
deposit and any similar and simultaneous deposit relating to
other Indebtedness and, in each case, the granting of Liens in
connection therewith);
(c) the Issuer has paid or caused to be paid all sums
payable by it under the Indenture; and
(d) the Issuer has delivered irrevocable instructions to
the Trustee to apply the deposited money toward the payment of
the Notes at maturity or the redemption date, as the case may be.
In addition, the Issuer must deliver an Officers
Certificate and an Opinion of Counsel to the Trustee stating
that all conditions precedent to satisfaction and discharge have
been satisfied.
Amendment,
Supplement and Waiver
Except as provided in the next two succeeding paragraphs, the
Indenture, any Guarantee, any Security Document and the Notes
may be amended or supplemented with the consent of the Holders
of at least a majority in principal amount of the Notes then
outstanding, including consents obtained in connection with a
purchase of, or tender offer or exchange offer for, Notes, and
any existing Default or compliance with any provision of the
Indenture, the Notes issued thereunder, any Guarantee or the
Security Documents may be waived with the consent of the Holders
of a majority in principal amount of the then outstanding Notes,
other than Notes beneficially owned by the Issuer or its
Affiliates (including consents obtained in connection with a
purchase of or tender offer or exchange offer for the Notes);
provided, however, that that if any amendment,
waiver or other modification will affect only the Cash Pay Notes
or Toggle Notes, only the consent of the Holders of at least a
majority in principal amount of the then outstanding Cash Pay
Notes or Toggle Notes (and not the consent of at least a
majority of all Notes), as the case may be, shall be required.
The Indenture provides that, without the consent of each
affected Holder of Notes, an amendment or waiver may not, with
respect to any Notes held by a non-consenting Holder:
(1) reduce the principal amount of such Notes whose Holders
must consent to an amendment, supplement or waiver;
(2) reduce the principal of or change the fixed final
maturity of any such Note or alter or waive the provisions with
respect to the redemption of such Notes (other than provisions
relating to the covenants described above under the caption
Repurchase at the Option of Holders);
(3) reduce the rate of or change the time for payment of
interest on any Note;
(4) waive a Default in the payment of principal of or
premium, if any, or interest on the Notes, except a rescission
of acceleration of the Notes by the Holders of at least a
majority in aggregate principal amount of the Notes and a waiver
of the payment default that resulted from such acceleration, or
in respect of a covenant or provision contained in the Indenture
or any Guarantee which cannot be amended or modified without the
consent of all Holders;
(5) make any Note payable in money other than that stated
therein;
(6) make any change in the provisions of the Indenture
relating to waivers of past Defaults or the rights of Holders to
receive payments of principal of or premium, if any, or interest
on the Notes;
(7) make any change in these amendment and waiver
provisions;
(8) impair the right of any Holder to receive payment of
principal of, or interest on such Holders Notes on or
after the due dates therefor or to institute suit for the
enforcement of any payment on or with respect to such
Holders Notes;
89
(9) make any change to or modify the ranking of the Notes
or the subordination of the Liens with respect to the Notes that
would adversely affect the Holders; or
(10) except as expressly permitted by the Indenture, modify
the Guarantees of any Significant Subsidiary in any manner
adverse to the Holders of the Notes.
In addition, without the consent of at least 75% in aggregate
principal amount of Notes then outstanding, an amendment,
supplement or waiver may not:
(1) modify any Security Document or the provisions of the
Indenture dealing with the Security Documents or application of
trust moneys, or otherwise release any Collateral, in any manner
materially adverse to the Holders other than in accordance with
the Indenture, the Security Documents and the Intercreditor
Agreements; or
(2) modify any Intercreditor Agreement in any manner
materially adverse to the Holders other than in accordance with
the Indenture, the Security Documents and the Intercreditor
Agreements.
Notwithstanding the foregoing, the Issuer, any Guarantor (with
respect to a Guarantee or the Indenture to which it is a party)
and the Trustee may amend or supplement the Indenture, any
Security Document and any Guarantee or Notes without the consent
of any Holder;
(1) to cure any ambiguity, omission, mistake, defect or
inconsistency;
(2) to provide for uncertificated Notes of such series in
addition to or in place of certificated Notes;
(3) to comply with the covenant relating to mergers,
consolidations and sales of assets;
(4) to provide for the assumption of the Issuers or
any Guarantors obligations to the Holders;
(5) to make any change that would provide any additional
rights or benefits to the Holders or that does not adversely
affect the legal rights under the Indenture of any such Holder;
(6) to add covenants for the benefit of the Holders or to
surrender any right or power conferred upon the Issuer or any
Guarantor;
(7) to comply with requirements of the SEC in order to
effect or maintain the qualification of the Indenture under the
Trust Indenture Act;
(8) to evidence and provide for the acceptance and
appointment under the Indenture of a successor Trustee
thereunder pursuant to the requirements thereof;
(9) to provide for the issuance of Exchange Notes or
private exchange notes, which are identical to Exchange Notes
except that they are not freely transferable;
(10) to add a Guarantor under the Indenture;
(11) to conform the text of the Indenture, Security
Documents, Guarantees or the Notes to any provision of this
Description of Notes to the extent that such
provision in this Description of Notes was intended
to be a verbatim recitation of a provision of the Indenture,
Security Documents, Guarantee or Notes;
(12) to make any amendment to the provisions of the
Indenture relating to the transfer and legending of Notes as
permitted by the Indenture, including, without limitation to
facilitate the issuance and administration of the Notes;
provided, however, that (i) compliance with
the Indenture as so amended would not result in Notes being
transferred in violation of the Securities Act or any applicable
securities law and (ii) such amendment does not materially
and adversely affect the rights of Holders to transfer Notes;
(13) to mortgage, pledge, hypothecate or grant any other
Lien in favor of the Trustee for the benefit of the Holders of
the Notes, as additional security for the payment and
performance of all or any portion of the Obligations, in any
property or assets, including any which are required to be
mortgaged, pledged
90
or hypothecated, or in which a Lien is required to be granted to
or for the benefit of the Trustee or the Collateral Agent
pursuant to the Indenture, any of the Security Documents or
otherwise; or
(14) to release Collateral from the Lien of the Indenture
and the Security Documents when permitted or required by the
Security Documents or the Indenture.
The consent of the Holders is not necessary under the Indenture
to approve the particular form of any proposed amendment. It is
sufficient if such consent approves the substance of the
proposed amendment.
Notices
Notices given by publication will be deemed given on the first
date on which publication is made and notices given by
first-class mail, postage prepaid, will be deemed given five
calendar days after mailing.
Concerning
the Trustee
The Indenture contains certain limitations on the rights of the
Trustee thereunder, should it become a creditor of the Issuer,
to obtain payment of claims in certain cases, or to realize on
certain property received in respect of any such claim as
security or otherwise. The Trustee is permitted to engage in
other transactions; however, if it acquires any conflicting
interest it must eliminate such conflict within 90 days,
apply to the SEC for permission to continue or resign.
The Indenture provides that the Holders of a majority in
principal amount of the outstanding Notes have the right to
direct the time, method and place of conducting any proceeding
for exercising any remedy available to the Trustee, subject to
certain exceptions. The Indenture provides that in case an Event
of Default shall occur (which shall not be cured), the Trustee
will be required, in the exercise of its power, to use the
degree of care of a prudent person in the conduct of his own
affairs. Subject to such provisions, the Trustee is under no
obligation to exercise any of its rights or powers under the
Indenture at the request of any Holder of the Notes, unless such
Holder shall have offered to the Trustee security and indemnity
satisfactory to it against any loss, liability or expense.
Governing
Law
The Indenture, the Notes and any Guarantee are governed by and
construed in accordance with the laws of the State of New York.
Certain
Definitions
Set forth below are certain defined terms used in the Indenture.
For purposes of the Indenture, unless otherwise specifically
indicated, the term consolidated with respect to any
Person refers to such Person on a consolidated basis in
accordance with GAAP, but excluding from such consolidation any
Unrestricted Subsidiary as if such Unrestricted Subsidiary were
not an Affiliate of such Person.
ABL Facility means the Asset-Based Revolving
Credit Agreement entered into as of the Issue Date by and among
the Issuer, the lenders party thereto in their capacities as
lenders thereunder and Bank of America, N.A., as Administrative
Agent, including any guarantees, collateral documents,
instruments and agreements executed in connection therewith, and
any amendments, supplements, modifications, extensions,
renewals, restatements, refundings or refinancings thereof and
any indentures or credit facilities or commercial paper
facilities with banks or other institutional lenders or
investors that replace, refund or refinance any part of the
loans, notes, other credit facilities or commitments thereunder,
including any such replacement, refunding or refinancing
facility or indenture that increases the amount borrowable
thereunder or alters the maturity thereof (provided that
such increase in borrowings is permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock
above).
ABL Facility Cap means an amount equal to the
greater of (x) $2,000.0 million and (y) 75% of
the consolidated accounts receivable of the Issuer and its
subsidiaries determined in accordance with GAAP.
91
ABL Financing Entity means the Issuer and
certain of its subsidiaries from time to time named as borrowers
or guarantors under the ABL Facility.
ABL Obligations means Obligations under the
ABL Facility.
ABL Secured Parties means each of
(i) the ABL Collateral Agent on behalf of itself and the
lenders under the ABL Facility and lenders or their affiliates
counterparty to related Hedging Obligations and (ii) each
other holder of ABL Obligations.
Acquired Indebtedness means, with respect to
any specified Person,
(1) Indebtedness of any other Person existing at the time
such other Person is merged with or into or became a Restricted
Subsidiary of such specified Person, including Indebtedness
incurred in connection with, or in contemplation of, such other
Person merging with or into or becoming a Restricted Subsidiary
of such specified Person, and
(2) Indebtedness secured by a Lien encumbering any asset
acquired by such specified Person.
Additional Interest means all additional
interest then owing pursuant to the Registration Rights
Agreement.
Affiliate of any specified Person means any
other Person directly or indirectly controlling or controlled by
or under direct or indirect common control with such specified
Person. For purposes of this definition, control
(including, with correlative meanings, the terms
controlling, controlled by and
under common control with), as used with respect to
any Person, shall mean the possession, directly or indirectly,
of the power to direct or cause the direction of the management
or policies of such Person, whether through the ownership of
voting securities, by agreement or otherwise.
Applicable Premium means, with respect to any
Note on any Redemption Date, the greater of:
(1) 1.0% of the principal amount of such Note; and
(2) (A) with respect to the 2016 Cash Pay Notes and
the Toggle Notes, the excess, if any, of (a) the present
value at such Redemption Date of (i) the redemption
price of such Note at November 15, 2011 (such redemption
price being set forth in the tables appearing above under the
captions Optional Redemption 2016 Cash Pay
Notes and Optional Redemption Toggle
Notes), plus (ii) all required interest payments (in
the case of the Toggle Notes, calculated based on the cash
interest rate payable on the Toggle Notes) due on such Note
through November 15, 2011 (excluding accrued but unpaid
interest to the Redemption Date), computed using a discount
rate equal to the Treasury Rate as of such Redemption Date
plus 50 basis points; over (b) the principal amount of
such Note, or
(B) with respect to the 2014 Cash Pay Notes, the excess, if
any, of (a) the present value at such Redemption Date
of (i) the redemption price of such 2014 Cash Pay Note at
November 15, 2010 (such redemption price being set forth in
the tables appearing above under the caption Optional
Redemption 2014 Cash Pay Notes), plus
(ii) all required interest payments due on such 2014
Cash Pay Note through November 15, 2010 (excluding accrued
but unpaid interest to the Redemption Date), computed using
a discount rate equal to the Treasury Rate as of such
Redemption Date plus 50 basis points; over
(b) the principal amount of such 2014 Cash Pay Note.
Asset Sale means:
(1) the sale, conveyance, transfer or other disposition,
whether in a single transaction or a series of related
transactions, of property or assets (including by way of a Sale
and Lease-Back Transaction) of the Issuer or any of its
Restricted Subsidiaries (each referred to in this definition as
a disposition); or
(2) the issuance or sale of Equity Interests of any
Restricted Subsidiary, whether in a single transaction or a
series of related transactions (other than Preferred Stock of
Restricted Subsidiaries issued in compliance with the covenant
described under Certain Covenants Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock);
92
in each case, other than:
(a) any disposition of Cash Equivalents or Investment Grade
Securities or obsolete or worn out equipment in the ordinary
course of business or any disposition of inventory or goods (or
other assets) held for sale in the ordinary course of business;
(b) the disposition of all or substantially all of the
assets of the Issuer in a manner permitted pursuant to the
provisions described above under Certain
Covenants Merger, Consolidation or Sale of All or
Substantially All Assets or any disposition that
constitutes a Change of Control pursuant to the Indenture;
(c) the making of any Restricted Payment or Permitted
Investment that is permitted to be made, and is made, under the
covenant described above under Certain
Covenants Limitation on Restricted Payments;
(d) any disposition of assets or issuance or sale of Equity
Interests of any Restricted Subsidiary in any transaction or
series of related transactions with an aggregate fair market
value of less than $100.0 million;
(e) any disposition of property or assets or issuance of
securities by a Restricted Subsidiary of the Issuer to the
Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
to another Restricted Subsidiary of the Issuer;
(f) to the extent allowable under Section 1031 of the
Code or any comparable or successor provision, any exchange of
like property (excluding any boot thereon) for use in a Similar
Business;
(g) the lease, assignment or
sub-lease of
any real or personal property in the ordinary course of business;
(h) any issuance or sale of Equity Interests in, or
Indebtedness or other securities of, an Unrestricted Subsidiary;
(i) foreclosures on assets;
(j) sales of accounts receivable, or participations
therein, in connection with the ABL Facility or any Receivables
Facility;
(k) any financing transaction with respect to property
built or acquired by the Issuer or any Restricted Subsidiary
after the Issue Date, including Sale and Lease-Back Transactions
and asset securitizations permitted by the Indenture;
(l) dispositions in the ordinary course of business by any
Restricted Subsidiary (including, without limitation, HCI)
engaged in the insurance business in order to provide insurance
to the Issuer and its Subsidiaries;
(m) sales, transfers and other dispositions of Investments
in joint ventures to the extent required by, or made pursuant
to, customary buy/sell arrangements between the joint venture
parties set forth in joint venture arrangements and similar
binding arrangements;
(n) any issuance or sale of Equity Interests or
dispositions in connection with ordinary course syndications of
Subsidiaries or joint ventures owning or operating one or more
healthcare facilities, including, without limitation, hospitals,
ambulatory surgery centers, outpatient diagnostic centers or
imaging centers in any transaction or series of related
transactions with an aggregate fair market value of less than
$100.0 million; and
(o) any issuance or sale of Equity Interests of any
Restricted Subsidiary (including, without limitation,
HealthTrust Purchasing Group, L.P.) to any Person operating in a
Similar Business for which such Restricted Subsidiary provides
shared purchasing, billing, collection or similar services in
the ordinary course of business.
93
Asset Sale Offer has the meaning set forth in
the fourth paragraph under Repurchase at the Option of
Holders Asset Sales.
Bankruptcy Code means Title 11 of the
United States Code, as amended.
Bankruptcy Law means the Bankruptcy Code and
any similar federal, state or foreign law for the relief of
debtors.
Business Day means each day which is not a
Legal Holiday.
Capital Stock means:
(1) in the case of a corporation, corporate stock;
(2) in the case of an association or business entity, any
and all shares, interests, participations, rights or other
equivalents (however designated) of corporate stock;
(3) in the case of a partnership or limited liability
company, partnership or membership interests (whether general or
limited); and
(4) any other interest or participation that confers on a
Person the right to receive a share of the profits and losses
of, or distributions of assets of, the issuing Person.
Capitalized Lease Obligation means, at the
time any determination thereof is to be made, the amount of the
liability in respect of a capital lease that would at such time
be required to be capitalized and reflected as a liability on a
balance sheet (excluding the footnotes thereto) in accordance
with GAAP.
Capitalized Software Expenditures means, for
any period, the aggregate of all expenditures (whether paid in
cash or accrued as liabilities) by a Person and its Restricted
Subsidiaries during such period in respect of purchased software
or internally developed software and software enhancements that,
in conformity with GAAP, are or are required to be reflected as
capitalized costs on the consolidated balance sheet of a Person
and its Restricted Subsidiaries.
Cash Equivalents means:
(1) United States dollars;
(2) euro or any national currency of any participating
member state of the EMU or such local currencies held by the
Company and its Restricted Subsidiaries from time to time in the
ordinary course of business;
(3) securities issued or directly and fully and
unconditionally guaranteed or insured by the
U.S. government (or any agency or instrumentality thereof
the securities of which are unconditionally guaranteed as a full
faith and credit obligation of the U.S. government) with
maturities of 24 months or less from the date of
acquisition;
(4) certificates of deposit, time deposits and eurodollar
time deposits with maturities of one year or less from the date
of acquisition, bankers acceptances with maturities not
exceeding one year and overnight bank deposits, in each case
with any commercial bank having capital and surplus of not less
than $500.0 million in the case of U.S. banks and
$100.0 million (or the U.S. dollar equivalent as of
the date of determination) in the case of
non-U.S. banks;
(5) repurchase obligations for underlying securities of the
types described in clauses (3) and (4) entered into
with any financial institution meeting the qualifications
specified in clause (4) above;
(6) commercial paper rated at least
P-1 by
Moodys or at least
A-1 by
S&P and in each case maturing within 24 months after
the date of creation thereof;
(7) marketable short-term money market and similar
securities having a rating of at least
P-2 or
A-2 from
either Moodys or S&P, respectively (or, if at any
time neither Moodys nor S&P shall be rating such
obligations, an equivalent rating from another Rating Agency)
and in each case maturing within 24 months after the date
of creation thereof;
94
(8) investment funds investing 95% of their assets in
securities of the types described in clauses (1) through
(7) above;
(9) readily marketable direct obligations issued by any
state, commonwealth or territory of the United States or any
political subdivision or taxing authority thereof having an
Investment Grade Rating from either Moodys or S&P
with maturities of 24 months or less from the date of
acquisition;
(10) Indebtedness or Preferred Stock issued by Persons with
a rating of A or higher from S&P or
A2 or higher from Moodys with maturities of
24 months or less from the date of acquisition; and
(11) Investments with average maturities of 24 months
or less from the date of acquisition in money market funds rated
AAA- (or the equivalent thereof) or better by S&P or Aaa3
(or the equivalent thereof) or better by Moodys.
Notwithstanding the foregoing, Cash Equivalents shall include
amounts denominated in currencies other than those set forth in
clauses (1) and (2) above; provided that such
amounts are converted into any currency listed in
clauses (1) and (2) as promptly as practicable and in
any event within ten Business Days following the receipt of such
amounts.
Cash Interest has the meaning set forth under
Principal, Maturity and Interest Toggle
Notes.
Change of Control means the occurrence of any
of the following:
(1) the sale, lease or transfer, in one or a series of
related transactions, of all or substantially all of the assets
of the Issuer and its Subsidiaries, taken as a whole, to any
Person other than a Permitted Holder; or
(2) the Issuer becomes aware (by way of a report or any
other filing pursuant to Section 13(d) of the Exchange Act,
proxy, vote, written notice or otherwise) of the acquisition by
any Person or group (within the meaning of Section 13(d)(3)
or Section 14(d)(2) of the Exchange Act, or any successor
provision), including any group acting for the purpose of
acquiring, holding or disposing of securities (within the
meaning of
Rule 13d-5(b)(1)
under the Exchange Act), other than the Permitted Holders, in a
single transaction or in a related series of transactions, by
way of merger, consolidation or other business combination or
purchase of beneficial ownership (within the meaning of
Rule 13d-3
under the Exchange Act, or any successor provision) of 50% or
more of the total voting power of the Voting Stock of the Issuer
or any of its direct or indirect parent companies holding
directly or indirectly 100% of the total voting power of the
Voting Stock of the Issuer.
Code means the Internal Revenue Code of 1986,
as amended, or any successor thereto.
Collateral means, collectively, the Shared
Receivables Collateral and Non-Receivables Collateral.
Collateral Asset Sale Offer has the meaning
set forth in the third paragraph under Repurchase at the
Option of Holders Asset Sales.
Collateral Excess Proceeds has the meaning
set forth in the third paragraph under Repurchase at the
Option of Holders Asset Sales.
Consolidated Depreciation and Amortization
Expense means with respect to any Person for any
period, the total amount of depreciation and amortization
expense, including the amortization of deferred financing fees,
debt issuance costs, commissions, fees and expenses and
Capitalized Software Expenditures, of such Person and its
Restricted Subsidiaries for such period on a consolidated basis
and otherwise determined in accordance with GAAP.
Consolidated Interest Expense means, with
respect to any Person for any period, without duplication, the
sum of:
(1) consolidated interest expense of such Person and its
Restricted Subsidiaries for such period, to the extent such
expense was deducted (and not added back) in computing
Consolidated Net Income (including (a) amortization of
original issue discount resulting from the issuance of
Indebtedness at less
95
than par, (b) all commissions, discounts and other fees and
charges owed with respect to letters of credit or bankers
acceptances, (c) non-cash interest payments (but excluding
any non-cash interest expense attributable to the movement in
the mark to market valuation of Hedging Obligations or other
derivative instruments pursuant to GAAP), (d) the interest
component of Capitalized Lease Obligations, and (e) net
payments, if any, pursuant to interest rate Hedging Obligations
with respect to Indebtedness, and excluding (u) accretion
or accrual of discounted liabilities not constituting
Indebtedness, (v) any expense resulting from the
discounting of the Existing Notes or other Indebtedness in
connection with the application of recapitalization accounting
or, if applicable, purchase accounting, (w) any Additional
Interest and any comparable additional interest with
respect to other securities, (x) amortization of deferred
financing fees, debt issuance costs, commissions, fees and
expenses, (y) any expensing of bridge, commitment and other
financing fees and (z) commissions, discounts, yield and
other fees and charges (including any interest expense) related
to any Receivables Facility); plus
(2) consolidated capitalized interest of such Person and
its Restricted Subsidiaries for such period, whether paid or
accrued; less
(3) interest income for such period.
For purposes of this definition, interest on a Capitalized Lease
Obligation shall be deemed to accrue at an interest rate
reasonably determined by such Person to be the rate of interest
implicit in such Capitalized Lease Obligation in accordance with
GAAP.
Consolidated Leverage Ratio, with respect to
any Person as of any date of determination, means the ratio of
(x) Consolidated Total Indebtedness of such Person as of
the end of the most recent fiscal quarter for which internal
financial statements are available immediately preceding the
date on which such event for which such calculation is being
made shall occur to (y) the aggregate amount of EBITDA of
such Person for the period of the most recently ended four full
consecutive fiscal quarters for which internal financial
statements are available immediately preceding the date on which
such event for which such calculation is being made shall occur,
in each case with such pro forma adjustments to
Consolidated Total Indebtedness and EBITDA as are appropriate
and consistent with the pro forma adjustment provisions
set forth in the definition of Fixed Charge Coverage
Ratio.
Consolidated Net Income means, with respect
to any Person for any period, the aggregate of the Net Income of
such Person for such period, on a consolidated basis, and
otherwise determined in accordance with GAAP; provided,
however, that, without duplication,
(1) any after-tax effect of extraordinary, non-recurring or
unusual gains or losses (less all fees and expenses relating
thereto) or expenses (including relating to the Transaction to
the extent incurred on or prior to December 31, 2007),
severance, relocation costs, consolidation and closing costs,
integration and facilities opening costs, business optimization
costs, transition costs, restructuring costs, signing, retention
or completion bonuses, and curtailments or modifications to
pension and post-retirement employee benefit plans shall be
excluded,
(2) the cumulative effect of a change in accounting
principles during such period shall be excluded,
(3) any after-tax effect of income (loss) from disposed,
abandoned or discontinued operations and any net after-tax gains
or losses on disposal of disposed, abandoned, transferred,
closed or discontinued operations shall be excluded,
(4) any after-tax effect of gains or losses (less all fees
and expenses relating thereto) attributable to asset
dispositions or abandonments other than in the ordinary course
of business, as determined in good faith by the Issuer, shall be
excluded,
(5) the Net Income for such period of any Person that is an
Unrestricted Subsidiary shall be excluded, and, solely for the
purpose of determining the amount available for Restricted
Payments under clause 3(a) of the first paragraph of
Certain Covenants Limitation on Restricted
Payments, the Net Income for such period of any Person
that is not a Subsidiary or that is accounted for by the equity
method of accounting shall be excluded; provided that
Consolidated Net Income of the Issuer shall be increased by the
amount of
96
dividends or distributions or other payments that are actually
paid in cash (or to the extent converted into cash) to the
referent Person or a Restricted Subsidiary thereof in respect of
such period,
(6) solely for the purpose of determining the amount
available for Restricted Payments under clause (3)(a) of the
first paragraph of Certain Covenants
Limitation on Restricted Payments, the Net Income for such
period of any Restricted Subsidiary (other than any Guarantor)
shall be excluded to the extent that the declaration or payment
of dividends or similar distributions by that Restricted
Subsidiary of its Net Income is not at the date of determination
wholly permitted without any prior governmental approval (which
has not been obtained) or, directly or indirectly, by the
operation of the terms of its charter or any agreement,
instrument, judgment, decree, order, statute, rule, or
governmental regulation applicable to that Restricted Subsidiary
or its stockholders, unless such restriction with respect to the
payment of dividends or similar distributions has been legally
waived; provided that Consolidated Net Income of the
Issuer will be increased by the amount of dividends or other
distributions or other payments actually paid in cash (or to the
extent converted into cash) or Cash Equivalents to the Issuer or
a Restricted Subsidiary thereof in respect of such period, to
the extent not already included therein,
(7) effects of adjustments (including the effects of such
adjustments pushed down to the Issuer and its Restricted
Subsidiaries) in the property, equipment, inventory, software
and other intangible assets, deferred revenue and debt line
items in such Persons consolidated financial statements
pursuant to GAAP resulting from the application of
recapitalization accounting or, if applicable, purchase
accounting in relation to the Transaction or any consummated
acquisition or the amortization or write-off of any amounts
thereof, net of taxes, shall be excluded,
(8) any after-tax effect of income (loss) from the early
extinguishment of Indebtedness or Hedging Obligations or other
derivative instruments shall be excluded,
(9) any impairment charge or asset write-off, including,
without limitation, impairment charges or asset write-offs
related to intangible assets, long-lived assets or investments
in debt and equity securities, in each case, pursuant to GAAP
and the amortization of intangibles arising pursuant to GAAP
shall be excluded,
(10) any non-cash compensation expense recorded from grants
of stock appreciation or similar rights, stock options,
restricted stock or other rights, and any cash charges
associated with the rollover, acceleration or payout of Equity
Interests by management of the Company or any of its direct or
indirect parent companies in connection with the Transaction,
shall be excluded,
(11) any fees and expenses incurred during such period, or
any amortization thereof for such period, in connection with any
acquisition, Investment, Asset Sale, issuance or repayment of
Indebtedness, issuance of Equity Interests, refinancing
transaction or amendment or modification of any debt instrument
(in each case, including any such transaction consummated prior
to the Issue Date and any such transaction undertaken but not
completed) and any charges or non-recurring merger costs
incurred during such period as a result of any such transaction
shall be excluded,
(12) accruals and reserves that are established or adjusted
within twelve months after the Issue Date that are so required
to be established as a result of the Transaction in accordance
with GAAP, or changes as a result of adoption or modification of
accounting policies, shall be excluded, and
(13) to the extent covered by insurance and actually
reimbursed, or, so long as the Issuer has made a determination
that there exists reasonable evidence that such amount will in
fact be reimbursed by the insurer and only to the extent that
such amount is (a) not denied by the applicable carrier in
writing within 180 days and (b) in fact reimbursed
within 365 days of the date of such evidence (with a
deduction for any amount so added back to the extent not so
reimbursed within 365 days), expenses with respect to
liability or casualty events or business interruption shall be
excluded.
Notwithstanding the foregoing, for the purpose of the covenant
described under Certain Covenants Limitation
on Restricted Payments only (other than clause (3)(d)
thereof), there shall be excluded from Consolidated Net Income
any income arising from any sale or other disposition of
Restricted Investments made by the Issuer and its Restricted
Subsidiaries, any repurchases and redemptions of Restricted
Investments
97
from the Issuer and its Restricted Subsidiaries, any repayments
of loans and advances which constitute Restricted Investments by
the Issuer or any of its Restricted Subsidiaries, any sale of
the stock of an Unrestricted Subsidiary or any distribution or
dividend from an Unrestricted Subsidiary, in each case only to
the extent such amounts increase the amount of Restricted
Payments permitted under such covenant pursuant to clause (3)(d)
thereof.
Consolidated Secured Debt Ratio as of any
date of determination, means the ratio of (1) Consolidated
Total Indebtedness of the Issuer and its Restricted Subsidiaries
that is secured by Liens as of the end of the most recent fiscal
period for which internal financial statements are available
immediately preceding the date on which such event for which
such calculation is being made shall occur to (2) the
Issuers EBITDA for the most recently ended four full
fiscal quarters for which internal financial statements are
available immediately preceding the date on which such event for
which such calculation is being made shall occur, in each case
with such pro forma adjustments to Consolidated Total
Indebtedness and EBITDA as are appropriate and consistent with
the pro forma adjustment provisions set forth in the
definition of Fixed Charge Coverage Ratio.
Consolidated Total Indebtedness means, as at
any date of determination, an amount equal to the sum of
(1) the aggregate amount of all outstanding Indebtedness of
the Issuer and its Restricted Subsidiaries on a consolidated
basis consisting of Indebtedness for borrowed money, Obligations
in respect of Capitalized Lease Obligations and debt obligations
evidenced by promissory notes and similar instruments (and
excluding, for the avoidance of doubt, all obligations relating
to Receivables Facilities) and (2) the aggregate amount of
all outstanding Disqualified Stock of the Issuer and all
Preferred Stock of its Restricted Subsidiaries on a consolidated
basis, with the amount of such Disqualified Stock and Preferred
Stock equal to the greater of their respective voluntary or
involuntary liquidation preferences and maximum fixed repurchase
prices, in each case determined on a consolidated basis in
accordance with GAAP. For purposes hereof, the maximum
fixed repurchase price of any Disqualified Stock or
Preferred Stock that does not have a fixed repurchase price
shall be calculated in accordance with the terms of such
Disqualified Stock or Preferred Stock as if such Disqualified
Stock or Preferred Stock were purchased on any date on which
Consolidated Total Indebtedness shall be required to be
determined pursuant to the Indenture, and if such price is based
upon, or measured by, the fair market value of such Disqualified
Stock or Preferred Stock, such fair market value shall be
determined reasonably and in good faith by the Issuer.
Contingent Obligations means, with respect to
any Person, any obligation of such Person guaranteeing any
leases, dividends or other obligations that do not constitute
Indebtedness (primary obligations) of any
other Person (the primary obligor) in any
manner, whether directly or indirectly, including, without
limitation, any obligation of such Person, whether or not
contingent,
(1) to purchase any such primary obligation or any property
constituting direct or indirect security therefor,
(2) to advance or supply funds
(a) for the purchase or payment of any such primary
obligation, or
(b) to maintain working capital or equity capital of the
primary obligor or otherwise to maintain the net worth or
solvency of the primary obligor, or
(3) to purchase property, securities or services primarily
for the purpose of assuring the owner of any such primary
obligation of the ability of the primary obligor to make payment
of such primary obligation against loss in respect thereof.
Credit Facilities means, with respect to the
Issuer or any of its Restricted Subsidiaries, one or more debt
facilities, including the Senior Credit Facilities, or other
financing arrangements (including, without limitation,
commercial paper facilities or indentures) providing for
revolving credit loans, term loans, letters of credit or other
long-term indebtedness, including any notes, mortgages,
guarantees, collateral documents, instruments and agreements
executed in connection therewith, and any amendments,
supplements, modifications, extensions, renewals, restatements
or refundings thereof and any indentures or credit facilities or
commercial paper facilities that replace, refund or refinance
any part of the loans, notes, other credit facilities
98
or commitments thereunder, including any such replacement,
refunding or refinancing facility or indenture that increases
the amount permitted to be borrowed thereunder or alters the
maturity thereof (provided that such increase in
borrowings is permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock) or
adds Restricted Subsidiaries as additional borrowers or
guarantors thereunder and whether by the same or any other
agent, lender or group of lenders.
Default means any event that is, or with the
passage of time or the giving of notice or both would be, an
Event of Default.
Delayed Equity Amount means any equity
contribution of the Investors, the Frist Entities or certain
other management investors described in the Offering Memorandum
on or before March 31, 2007, the proceeds of which were
used to repay borrowings under the senior secured revolving
credit facility included in the General Credit Facility or the
ABL Facility in the manner described in the Offering Memorandum.
Designated Non-cash Consideration means the
fair market value of non-cash consideration received by the
Issuer or a Restricted Subsidiary in connection with an Asset
Sale that is so designated as Designated Non-cash Consideration
pursuant to an Officers Certificate, setting forth the
basis of such valuation, executed by the principal financial
officer of the Issuer, less the amount of cash or Cash
Equivalents received in connection with a subsequent sale of or
collection on such Designated Non-cash Consideration.
Designated Preferred Stock means Preferred
Stock of the Issuer or any parent corporation thereof (in each
case other than Disqualified Stock) that is issued for cash
(other than to a Restricted Subsidiary or an employee stock
ownership plan or trust established by the Issuer or any of its
Subsidiaries) and is so designated as Designated Preferred
Stock, pursuant to an Officers Certificate executed by the
principal financial officer of the Issuer or the applicable
parent corporation thereof, as the case may be, on the issuance
date thereof, the cash proceeds of which are excluded from the
calculation set forth in clause (3) of the first paragraph
under Certain Covenants Limitation on
Restricted Payments.
Discharge of First Lien Obligations shall
mean the satisfaction and discharge of all of the First Lien
Obligations in full in cash, pursuant to the First Lien
Documents and the General Intercreditor Agreement.
Disqualified Stock means, with respect to any
Person, any Capital Stock of such Person which, by its terms, or
by the terms of any security into which it is convertible or for
which it is putable or exchangeable, or upon the happening of
any event, matures or is mandatorily redeemable (other than
solely as a result of a change of control or asset sale)
pursuant to a sinking fund obligation or otherwise, or is
redeemable at the option of the holder thereof (other than
solely as a result of a change of control or asset sale), in
whole or in part, in each case prior to the date 91 days
after the earlier of the maturity date of the Notes or the date
the Notes are no longer outstanding; provided,
however, that if such Capital Stock is issued to any plan
for the benefit of employees of the Issuer or its Subsidiaries
or by any such plan to such employees, such Capital Stock shall
not constitute Disqualified Stock solely because it may be
required to be repurchased by the Issuer or its Subsidiaries in
order to satisfy applicable statutory or regulatory obligations.
EBITDA means, with respect to any Person for
any period, the Consolidated Net Income of such Person for such
period
(1) increased (without duplication) by:
(a) provision for taxes based on income or profits or
capital gains, including, without limitation, foreign, federal,
state, franchise and similar taxes (such as the Pennsylvania
capital tax) and foreign withholding taxes (including penalties
and interest related to such taxes or arising from tax
examinations) of such Person paid or accrued during such period
deducted (and not added back) in computing Consolidated Net
Income; plus
(b) Fixed Charges of such Person for such period (including
(x) net losses on Hedging Obligations or other derivative
instruments entered into for the purpose of hedging interest
rate risk and (y) costs of surety bonds in connection with
financing activities, in each case, to the extent included in
Fixed Charges), together with items excluded from the definition
of Consolidated Interest Expense pursuant
99
to clauses (1)(u), (v), (w), (x), (y) and (z) of the
definition thereof, and, in each such case, to the extent the
same were deducted (and not added back) in calculating such
Consolidated Net Income; plus
(c) Consolidated Depreciation and Amortization Expense of
such Person for such period to the extent the same was deducted
(and not added back) in computing Consolidated Net Income;
plus
(d) any expenses or charges (other than depreciation or
amortization expense) related to any Equity Offering, Permitted
Investment, acquisition, disposition, recapitalization or the
incurrence of Indebtedness permitted to be incurred by the
Indenture (including a refinancing thereof) (whether or not
successful), including (i) such fees, expenses or charges
related to the offering of the Notes and any Credit Facilities
and (ii) any amendment or other modification of the Notes,
and, in each case, deducted (and not added back) in computing
Consolidated Net Income; plus
(e) the amount of any restructuring charge or reserve
deducted (and not added back) in such period in computing
Consolidated Net Income, including any one-time costs incurred
in connection with acquisitions after the Issue Date and costs
related to the closure
and/or
consolidation of facilities; plus
(f) any other non-cash charges, including any write-offs or
write-downs, reducing Consolidated Net Income for such period
(provided that if any such non-cash charges represent an
accrual or reserve for potential cash items in any future
period, the cash payment in respect thereof in such future
period shall be subtracted from EBITDA to such extent, and
excluding amortization of a prepaid cash item that was paid in a
prior period); plus
(g) the amount of any minority interest expense consisting
of income attributable to minority equity interests of third
parties deducted (and not added back) in such period in
calculating Consolidated Net Income; plus
(h) the amount of management, monitoring, consulting and
advisory fees and related expenses paid in such period to the
Investors and the Frist Entities to the extent otherwise
permitted under Certain Covenants Transactions
with Affiliates; plus
(i) the amount of net cost savings projected by the Issuer
in good faith to be realized as a result of specified actions
taken or to be taken (calculated on a pro forma basis as
though such cost savings had been realized on the first day of
such period), net of the amount of actual benefits realized
during such period from such actions; provided that
(w) such cost savings are reasonably identifiable and
factually supportable, (x) such actions have been taken or
are to be taken within 15 months after the date of
determination to take such action, (y) no cost savings
shall be added pursuant to this clause (i) to the extent
duplicative of any expenses or charges relating to such cost
savings that are included in clause (e) above with respect
to such period and (z) the aggregate amount of cost savings
added pursuant to this clause (i) shall not exceed
$150.0 million for any four consecutive quarter period
(which adjustments may be incremental to pro forma
adjustments made pursuant to the second paragraph of the
definition of Fixed Charge Coverage Ratio);
plus
(j) the amount of loss on sales of receivables and related
assets to the Receivables Subsidiary in connection with a
Receivables Facility; plus
(k) any costs or expense incurred by the Issuer or a
Restricted Subsidiary pursuant to any management equity plan or
stock option plan or any other management or employee benefit
plan or agreement or any stock subscription or shareholder
agreement, to the extent that such cost or expenses are funded
with cash proceeds contributed to the capital of the Issuer or
net cash proceeds of an issuance of Equity Interests of the
Issuer (other than Disqualified Stock) solely to the extent that
such net cash proceeds are excluded from the calculation set
forth in clause (3) of the first paragraph under
Certain Covenants Limitation on Restricted
Payments;
(2) decreased by (without duplication) non-cash gains
increasing Consolidated Net Income of such Person for such
period, excluding any non-cash gains to the extent they
represent the reversal of an accrual or reserve for a potential
cash item that reduced EBITDA in any prior period; and
100
(3) increased or decreased by (without duplication):
(a) any net gain or loss resulting in such period from
Hedging Obligations and the application of Statement of
Financial Accounting Standards No. 133; plus or
minus, as applicable,
(b) any net gain or loss resulting in such period from
currency translation gains or losses related to currency
remeasurements of Indebtedness (including any net loss or gain
resulting from Hedging Obligations for currency exchange risk).
EMU means the economic and monetary union as
contemplated in the Treaty on European Union.
Equity Interests means Capital Stock and all
warrants, options or other rights to acquire Capital Stock, but
excluding any debt security that is convertible into, or
exchangeable for, Capital Stock.
Equity Offering means any public or private
sale of common stock or Preferred Stock of the Issuer or any of
its direct or indirect parent companies (excluding Disqualified
Stock), other than:
(1) public offerings with respect to the Issuers or
any direct or indirect parent companys common stock
registered on
Form S-8;
(2) issuances to any Subsidiary of the Issuer; and
(3) any such public or private sale that constitutes an
Excluded Contribution.
euro means the single currency of
participating member states of the EMU.
European Collateral has the meaning set forth
under Description of Other Indebtedness Senior
Secured Credit Facilities Guarantee and
Security.
Event of Default has the meaning set forth
under Events of Default and Remedies.
Excess Proceeds has the meaning set forth in
the fourth paragraph under Repurchase at the Option of
Holders Asset Sales.
Exchange Act means the Securities Exchange
Act of 1934, as amended, and the rules and regulations of the
SEC promulgated thereunder.
Exchange Notes means any notes issued in
exchange for the Notes pursuant to the Registration Rights
Agreement or similar agreement.
Excluded Contribution means net cash
proceeds, marketable securities or Qualified Proceeds received
by the Issuer after the Issue Date from
(1) contributions to its common equity capital, and
(2) the sale (other than to a Subsidiary of the Issuer or
to any management equity plan or stock option plan or any other
management or employee benefit plan or agreement of the Issuer)
of Capital Stock (other than Disqualified Stock and Designated
Preferred Stock) of the Issuer,
in each case designated as Excluded Contributions pursuant to an
Officers Certificate executed by the principal financial
officer of the Issuer on the date such capital contributions are
made or the date such Equity Interests are sold, as the case may
be, which are excluded from the calculation set forth in
clause (3) of the first paragraph under Certain
Covenants Limitation on Restricted Payments.
Existing Notes means the $121.2 million
aggregate principal amount of 8.700% medium-term notes due 2010,
$691.2 million aggregate principal amount of
8.750% notes due 2010, £150.0 million aggregate
principal amount of 8.750% notes due 2010,
$475.8 million aggregate principal amount of
7.875% notes due 2011, $500.0 million aggregate
principal amount of 6.950% notes due 2012,
$500.0 million aggregate principal amount of
6.300% notes due 2012, $500.0 million aggregate
principal amount of 6.250% notes due 2013,
$500.0 million aggregate principal amount of
6.750% notes due 2013, $500.0 million aggregate
principal amount of 5.750% notes due 2014,
$121.1 million aggregate principal amount of 9.000%
medium-term notes due 2014, $750.0 million aggregate
principal amount of 6.375% notes due 2015,
$150.0 million aggregate
101
principal amount of 7.190% debentures due 2015,
$1,000.0 million aggregate principal amount of
6.500% notes due 2016, $135.6 million aggregate
principal amount of 7.500% debentures due 2023,
$150.0 million aggregate principal amount of
8.360% debentures due 2024, $291.4 million aggregate
principal amount of 7.690% notes due 2025,
$125.0 million aggregate principal amount of 7.580%
medium-term notes due 2025, $150.0 million aggregate
principal amount of 7.050% debentures due 2027,
$250.0 million aggregate principal amount of
7.500% notes due 2033, $100.0 million aggregate
principal amount of 7.750% debentures due 2036 and
$200.0 million aggregate principal amount of
7.500% debentures due 2095, each issued by the Issuer and
outstanding on the Issue Date.
Existing Notes Indenture means that certain
Indenture, dated as of December 16, 1993, between Columbia
Healthcare Corporation and The First National Bank of Chicago,
as Trustee, as amended by the First Supplemental Indenture,
dated as of May 25, 2000, between the Issuer and Bank One
Trust Company, N.A., as Trustee, the Second Supplemental
Indenture, dated as of July 1, 2001, between the Issuer and
Bank One Trust Company, N.A., as Trustee, and the Third
Supplemental Indenture, dated as of December 5, 2001,
between the Issuer and The Bank of New York, as Trustee.
First Lien Collateral means all of the assets
of the Issuer or any Guarantor, whether real, personal or mixed,
with respect to which a Lien has been granted as security for
any First Lien Obligations pursuant to a First Lien Document.
First Lien Collateral Agent shall mean Bank
of America, N.A., in its capacity as administrative agent and
collateral agent for the lenders and other secured parties under
the General Credit Facility and the other First Lien Documents,
together with its successors and permitted assigns under the
General Credit Facility exercising substantially the same rights
and powers; and in each case provided that if such First Lien
Collateral Agent is not Bank of America, N.A., such First Lien
Collateral Agent shall have become a party to the Intercreditor
Agreements and the other applicable First Lien Security
Documents.
First Lien Documents means the credit,
guarantee and security documents governing the First Lien
Obligations, including, without limitation, the General Credit
Facility and the First Lien Security Documents.
First Lien Obligations shall mean
(a) all General Credit Facility Obligations and
(b) all other Obligations of the Issuer and its
Subsidiaries under any refinancings of the General Credit
Facility Obligations (and any related Hedging Obligations). For
the avoidance of doubt, Obligations with respect to the ABL
Facility shall not constitute First Lien Obligations.
First Lien Secured Parties means, at any
relevant time, the holders of First Lien Obligations at such
time, including, without limitation, the lenders and agents
under the General Credit Facility and the First Lien Collateral
Agent.
First Lien Security Documents means the
Security Documents (as defined in the General Credit Facility)
and any other agreement, document or instrument pursuant to
which a Lien is granted or purported to be granted securing
First Lien Obligations or under which rights or remedies with
respect to such Liens are governed.
First Priority Liens means the first priority
Liens securing the First Lien Obligations.
Fixed Charge Coverage Ratio means, with
respect to any Person for any period, the ratio of EBITDA of
such Person for such period to the Fixed Charges of such Person
for such period. In the event that the Issuer or any Restricted
Subsidiary incurs, assumes, guarantees, redeems, retires or
extinguishes any Indebtedness (other than Indebtedness incurred
under any revolving credit facility unless such Indebtedness has
been permanently repaid and has not been replaced) or issues or
redeems Disqualified Stock or Preferred Stock subsequent to the
commencement of the period for which the Fixed Charge Coverage
Ratio is being calculated but prior to or simultaneously with
the event for which the calculation of the Fixed Charge Coverage
Ratio is made (the Fixed Charge Coverage Ratio
Calculation Date), then the Fixed Charge Coverage
Ratio shall be calculated giving pro forma effect to such
incurrence, assumption, guarantee, redemption, retirement or
extinguishment of Indebtedness, or such issuance or redemption
of Disqualified Stock or Preferred Stock, as if the same had
occurred at the beginning of the applicable four-quarter period.
102
For purposes of making the computation referred to above,
Investments, acquisitions, dispositions, mergers, consolidations
and disposed operations (as determined in accordance with GAAP)
that have been made by the Issuer or any of its Restricted
Subsidiaries during the four-quarter reference period or
subsequent to such reference period and on or prior to or
simultaneously with the Fixed Charge Coverage Ratio Calculation
Date shall be calculated on a pro forma basis assuming
that all such Investments, acquisitions, dispositions, mergers,
consolidations and disposed operations (and the change in any
associated fixed charge obligations and the change in EBITDA
resulting therefrom) had occurred on the first day of the
four-quarter reference period. If, since the beginning of such
period, any Person that subsequently became a Restricted
Subsidiary or was merged with or into the Issuer or any of its
Restricted Subsidiaries since the beginning of such period shall
have made any Investment, acquisition, disposition, merger,
consolidation or disposed operation that would have required
adjustment pursuant to this definition, then the Fixed Charge
Coverage Ratio shall be calculated giving pro forma
effect thereto for such period as if such Investment,
acquisition, disposition, merger, consolidation or disposed
operation had occurred at the beginning of the applicable
four-quarter period.
For purposes of this definition, whenever pro forma
effect is to be given to a transaction, the pro forma
calculations shall be made in good faith by a responsible
financial or accounting officer of the Issuer. If any
Indebtedness bears a floating rate of interest and is being
given pro forma effect, the interest on such Indebtedness
shall be calculated as if the rate in effect on the Fixed Charge
Coverage Ratio Calculation Date had been the applicable rate for
the entire period (taking into account any Hedging Obligations
applicable to such Indebtedness). Interest on a Capitalized
Lease Obligation shall be deemed to accrue at an interest rate
reasonably determined by a responsible financial or accounting
officer of the Issuer to be the rate of interest implicit in
such Capitalized Lease Obligation in accordance with GAAP. For
purposes of making the computation referred to above, interest
on any Indebtedness under a revolving credit facility computed
on a pro forma basis shall be computed based upon the
average daily balance of such Indebtedness during the applicable
period except as set forth in the first paragraph of this
definition. Interest on Indebtedness that may optionally be
determined at an interest rate based upon a factor of a prime or
similar rate, a eurocurrency interbank offered rate or other
rate shall be deemed to have been based upon the rate actually
chosen, or, if none, then based upon such optional rate chosen
as the Issuer may designate.
Fixed Charges means, with respect to any
Person for any period, the sum of:
(1) Consolidated Interest Expense of such Person for such
period;
(2) all cash dividends or other distributions paid
(excluding items eliminated in consolidation) on any series of
Preferred Stock during such period; and
(3) all cash dividends or other distributions paid
(excluding items eliminated in consolidation) on any series of
Disqualified Stock during such period.
Foreign Subsidiary means, with respect to any
Person, any Restricted Subsidiary of such Person that is not
organized or existing under the laws of the United States, any
state thereof or the District of Columbia and any Restricted
Subsidiary of such Foreign Subsidiary.
Frist Entities means Dr. Thomas F.
Frist, Jr., any Person controlled by Dr. Frist and any
charitable organization selected by Dr. Frist that holds
Equity Interests of the Issuer on the Issue Date.
GAAP means generally accepted accounting
principles in the United States which are in effect on the Issue
Date.
General Credit Facility means the credit
agreement entered into as of the Issue Date by and among the
Issuer, the European subsidiary borrowers party thereto, the
lenders party thereto in their capacities as lenders thereunder
and Bank of America, N.A., as U.S. Administrative Agent and
as European Administrative Agent, including any guarantees,
collateral documents, instruments and agreements executed in
connection therewith, and any amendments, supplements,
modifications, extensions, renewals, restatements, refundings or
refinancings thereof and any indentures or credit facilities or
commercial paper facilities with banks or other institutional
lenders or investors that replace, refund or refinance any part
of the loans, notes, other credit
103
facilities or commitments thereunder, including any such
replacement, refunding or refinancing facility or indenture that
increases the amount borrowable thereunder or alters the
maturity thereof (provided that such increase in
borrowings is permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock
above).
General Credit Facility Obligations means
Obligations as defined in the General Credit
Facility.
General Intercreditor Agreement has the
meaning set forth under Security Liens with
Respect to the Collateral.
Government Securities means securities that
are:
(1) direct obligations of the United States of America for
the timely payment of which its full faith and credit is
pledged; or
(2) obligations of a Person controlled or supervised by and
acting as an agency or instrumentality of the United States of
America the timely payment of which is unconditionally
guaranteed as a full faith and credit obligation by the United
States of America,
which, in either case, are not callable or redeemable at the
option of the issuers thereof, and shall also include a
depository receipt issued by a bank (as defined in
Section 3(a)(2) of the Securities Act), as custodian with
respect to any such Government Securities or a specific payment
of principal of or interest on any such Government Securities
held by such custodian for the account of the holder of such
depository receipt; provided that (except as required by
law) such custodian is not authorized to make any deduction from
the amount payable to the holder of such depository receipt from
any amount received by the custodian in respect of the
Government Securities or the specific payment of principal of or
interest on the Government Securities evidenced by such
depository receipt.
guarantee means a guarantee (other than by
endorsement of negotiable instruments for collection in the
ordinary course of business), direct or indirect, in any manner
(including letters of credit and reimbursement agreements in
respect thereof), of all or any part of any Indebtedness or
other obligations.
Guarantee means the guarantee by any
Guarantor of the Issuers Obligations under the Indenture.
Guarantor means each Restricted Subsidiary
that Guarantees the Notes in accordance with the terms of the
Indenture.
HCI means Health Care Indemnity, Inc., an
insurance company formed under the laws of the State of Colorado
and a Wholly-Owned Subsidiary of the Issuer.
Hedging Arrangements means the fixed-pay
interest rate swap agreements, entered into by Hercules Holding
on or about September 13, 2006 and with respect to which
the Issuer will be the counterparty in connection with the
Recapitalization, relating to $8,000 million of the
outstanding principal amount under the First Lien Obligations
and the ABL Obligations.
Hedging Obligations means, with respect to
any Person, the obligations of such Person under any interest
rate swap agreement, interest rate cap agreement, interest rate
collar agreement, commodity swap agreement, commodity cap
agreement, commodity collar agreement, foreign exchange
contract, currency swap agreement or similar agreement providing
for the transfer or mitigation of interest rate or currency
risks either generally or under specific contingencies.
Holder means the Person in whose name a Note
is registered on the registrars books.
Indebtedness means, with respect to any
Person, without duplication:
(1) any indebtedness (including principal and premium) of
such Person, whether or not contingent:
(a) in respect of borrowed money;
(b) evidenced by bonds, notes, debentures or similar
instruments or letters of credit or bankers acceptances
(or, without duplication, reimbursement agreements in respect
thereof);
104
(c) representing the balance deferred and unpaid of the
purchase price of any property (including Capitalized Lease
Obligations), except (i) any such balance that constitutes
a trade payable or similar obligation to a trade creditor, in
each case accrued in the ordinary course of business and
(ii) any earn-out obligations until such obligation becomes
a liability on the balance sheet of such Person in accordance
with GAAP; or
(d) representing any Hedging Obligations;
if and to the extent that any of the foregoing Indebtedness
(other than letters of credit and Hedging Obligations) would
appear as a liability upon a balance sheet (excluding the
footnotes thereto) of such Person prepared in accordance with
GAAP;
(2) to the extent not otherwise included, any obligation by
such Person to be liable for, or to pay, as obligor, guarantor
or otherwise on, the obligations of the type referred to in
clause (1) of a third Person (whether or not such items
would appear upon the balance sheet of the such obligor or
guarantor), other than by endorsement of negotiable instruments
for collection in the ordinary course of business; and
(3) to the extent not otherwise included, the obligations
of the type referred to in clause (1) of a third Person
secured by a Lien on any asset owned by such first Person,
whether or not such Indebtedness is assumed by such first Person;
provided, however, that notwithstanding the
foregoing, Indebtedness shall be deemed not to include
(a) Contingent Obligations incurred in the ordinary course
of business or (b) obligations under or in respect of
Receivables Facilities.
Independent Financial Advisor means an
accounting, appraisal, investment banking firm or consultant to
Persons engaged in Similar Businesses of nationally recognized
standing that is, in the good faith judgment of the Issuer,
qualified to perform the task for which it has been engaged.
Initial Purchasers means Citigroup Global
Markets Inc., Banc of America Securities LLC, J.P. Morgan
Securities Inc., Merrill Lynch, Pierce, Fenner & Smith
Incorporated, Deutsche Bank Securities Inc. and Wachovia Capital
Markets, LLC.
insolvency or liquidation proceeding means:
(1) any case commenced by or against the Issuer or any
Guarantor under any Bankruptcy Law for the relief of debtors,
any other proceeding for the reorganization, recapitalization or
adjustment or marshalling of the assets or liabilities of the
Issuer or any Guarantor, any receivership or assignment for the
benefit of creditors relating to the Issuer or any Guarantor or
any similar case or proceeding relative to the Issuer or any
Guarantor or its creditors, as such, in each case whether or not
voluntary;
(2) any liquidation, dissolution, marshalling of assets or
liabilities or other winding up of or relating to the Issuer or
any Guarantor, in each case whether or not voluntary and whether
or not involving bankruptcy or insolvency; or
(3) any other proceeding of any type or nature in which
substantially all claims of creditors of the Issuer or any
Guarantor are determined and any payment or distribution is or
may be made on account of such claims.
Intercreditor Agreements means, collectively,
the Shared Receivables Intercreditor Agreement and the General
Intercreditor Agreement.
Investment Grade Rating means a rating equal
to or higher than Baa3 (or the equivalent) by Moodys and
BBB- (or the equivalent) by S&P, or an equivalent rating by
any other Rating Agency.
Investment Grade Securities means:
(1) securities issued or directly and fully guaranteed or
insured by the United States government or any agency or
instrumentality thereof (other than Cash Equivalents);
105
(2) debt securities or debt instruments with an Investment
Grade Rating, but excluding any debt securities or instruments
constituting loans or advances among the Issuer and its
Subsidiaries;
(3) investments in any fund that invests exclusively in
investments of the type described in clauses (1) and
(2) which fund may also hold immaterial amounts of cash
pending investment or distribution; and
(4) corresponding instruments in countries other than the
United States customarily utilized for high quality investments.
Investments means, with respect to any
Person, all investments by such Person in other Persons
(including Affiliates) in the form of loans (including
guarantees), advances or capital contributions (excluding
accounts receivable, trade credit, advances to customers,
commissions, travel and similar advances to officers and
employees, in each case made in the ordinary course of
business), purchases or other acquisitions for consideration of
Indebtedness, Equity Interests or other securities issued by any
other Person and investments that are required by GAAP to be
classified on the balance sheet (excluding the footnotes) of the
Issuer in the same manner as the other investments included in
this definition to the extent such transactions involve the
transfer of cash or other property. For purposes of the
definition of Unrestricted Subsidiary and the
covenant described under Certain Covenants
Limitation on Restricted Payments:
(1) Investments shall include the
portion (proportionate to the Issuers equity interest in
such Subsidiary) of the fair market value of the net assets of a
Subsidiary of the Issuer at the time that such Subsidiary is
designated an Unrestricted Subsidiary; provided,
however, that upon a redesignation of such Subsidiary as
a Restricted Subsidiary, the Issuer shall be deemed to continue
to have a permanent Investment in an Unrestricted
Subsidiary in an amount (if positive) equal to:
(a) the Issuers Investment in such
Subsidiary at the time of such redesignation; less
(b) the portion (proportionate to the Issuer equity
interest in such Subsidiary) of the fair market value of the net
assets of such Subsidiary at the time of such
redesignation; and
(2) any property transferred to or from an Unrestricted
Subsidiary shall be valued at its fair market value at the time
of such transfer, in each case as determined in good faith by
the Issuer.
Investors means Bain Capital Partners, LLC,
Kohlberg Kravis Roberts & Co. L.P., Merrill Lynch
Global Partners, Inc. and each of their respective Affiliates
but not including, however, any portfolio companies of any of
the foregoing.
Issue Date means November 17, 2006.
Issuer has the meaning set forth in the first
paragraph under General; provided that when
used in the context of determining the fair market value of an
asset or liability under the Indenture, Issuer shall
be deemed to mean the board of directors of the Issuer when the
fair market value is equal to or in excess of
$500.0 million (unless otherwise expressly stated).
Junior Lien Collateral Agent shall mean
(i) so long as the Notes are outstanding, the Trustee, in
its capacity as Trustee and collateral agent for the Holders and
other secured parties under the Indenture and the Security
Documents, and (ii) at any time thereafter, such agent or
trustee as is designated Junior Lien Collateral
Agent by Junior Lien Secured Parties holding a majority in
principal amount of the Junior Lien Obligations then outstanding
or pursuant to such other arrangements as agreed to among the
holders of the Junior Lien Obligations, it being understood that
as of the Issue Date, the Trustee shall be so designated Junior
Lien Collateral Agent.
Junior Lien Documents means the credit and
security documents governing the Junior Lien Obligations,
including, without limitation, the Indenture, the related
Security Documents and Intercreditor Agreements.
Junior Lien Obligations means the Notes and
Obligations with respect to other Indebtedness permitted to be
incurred under the Indenture and the General Credit Facility
which is by its terms intended to be secured equally and ratably
with the Notes or on a basis junior to the Liens securing the
Notes; provided such Lien is
106
permitted to be incurred under the Indenture and the General
Credit Facility; provided, further, that the holders of
such Indebtedness or their Junior Lien Representative is a party
to the Security Documents in accordance with the terms thereof
and has appointed the Junior Lien Collateral Agent as collateral
agent for such holders of Junior Lien Obligations with respect
to all or a portion of the Collateral.
Junior Lien Representative means any duly
authorized representative of any holders of Junior Lien
Obligations, which representative is party to the Security
Documents.
Junior Lien Secured Parties means
(i) Holders (including the Holders of any Additional Notes
subsequently issued under and in compliance with the terms of
the Indenture), (ii) the Junior Lien Collateral Agent and
(iii) the holders from time to time of any other Junior
Lien Obligations and each Junior Lien Representative.
Junior Liens means the Liens securing the
Junior Lien Obligations.
Legal Holiday means a Saturday, a Sunday or a
day on which commercial banking institutions are not required to
be open in the State of New York.
Lien means, with respect to any asset, any
mortgage, lien (statutory or otherwise), pledge, hypothecation,
charge, security interest, preference, priority or encumbrance
of any kind in respect of such asset, whether or not filed,
recorded or otherwise perfected under applicable law, including
any conditional sale or other title retention agreement, any
lease in the nature thereof, any option or other agreement to
sell or give a security interest in and any filing of or
agreement to give any financing statement under the Uniform
Commercial Code (or equivalent statutes) of any jurisdiction;
provided that in no event shall an operating lease be
deemed to constitute a Lien.
Moodys means Moodys Investors
Service, Inc. and any successor to its rating agency business.
Net Income means, with respect to any Person,
the net income (loss) of such Person, determined in accordance
with GAAP and before any reduction in respect of Preferred Stock
dividends.
Net Proceeds means the aggregate cash
proceeds received by the Issuer or any of its Restricted
Subsidiaries in respect of any Asset Sale, including any cash
received upon the sale or other disposition of any Designated
Non-cash Consideration received in any Asset Sale, net of the
direct costs relating to such Asset Sale and the sale or
disposition of such Designated Non-cash Consideration, including
legal, accounting and investment banking fees, and brokerage and
sales commissions, any relocation expenses incurred as a result
thereof, taxes paid or payable as a result thereof (after taking
into account any available tax credits or deductions and any tax
sharing arrangements), amounts required to be applied to the
repayment of principal, premium, if any, and interest on Senior
Indebtedness required (other than required by clause (1) of
the second paragraph of Repurchase at the Option of
Holders Asset Sales) to be paid as a result of
such transaction and any deduction of appropriate amounts to be
provided by the Issuer or any of its Restricted Subsidiaries as
a reserve in accordance with GAAP against any liabilities
associated with the asset disposed of in such transaction and
retained by the Issuer or any of its Restricted Subsidiaries
after such sale or other disposition thereof, including pension
and other post-employment benefit liabilities and liabilities
related to environmental matters or against any indemnification
obligations associated with such transaction.
Non-Conforming Plan of Reorganization means
any Plan of Reorganization that grants the Junior Lien
Collateral Agent or any Junior Lien Secured Party any right or
benefit, directly or indirectly, which right or benefit is
prohibited at such time by the provisions of the General
Intercreditor Agreement.
Non-Receivables Collateral has the meaning
set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security, subject to
the provisions of the third and fourth sentences of the first
paragraph under Security
General.
Obligations means any principal, interest
(including any interest accruing subsequent to the filing of a
petition in bankruptcy, reorganization or similar proceeding at
the rate provided for in the documentation with respect thereto,
whether or not such interest is an allowed claim under
applicable state, federal or foreign law), premium, penalties,
fees, indemnifications, reimbursements (including reimbursement
obligations with respect
107
to letters of credit and bankers acceptances), damages and
other liabilities, and guarantees of payment of such principal,
interest, penalties, fees, indemnifications, reimbursements,
damages and other liabilities, payable under the documentation
governing any Indebtedness.
Offering Memorandum means the offering
memorandum, dated November 9, 2006, relating to the initial
private offering of the Notes.
Officer means the Chairman of the Board, the
Chief Executive Officer, the President, any Executive Vice
President, Senior Vice President or Vice President, the
Treasurer or the Secretary of the Issuer.
Officers Certificate means a
certificate signed on behalf of the Issuer by an Officer of the
Issuer, who must be the principal executive officer, the
principal financial officer, the treasurer or the principal
accounting officer of the Issuer, that meets the requirements
set forth in the Indenture.
Opinion of Counsel means a written opinion
from legal counsel who is acceptable to the Trustee. The counsel
may be an employee of or counsel to the Issuer or the Trustee.
Partial PIK Interest has the meaning set
forth under Principal, Maturity and Interest
Toggle Notes.
Permitted Asset Swap means the concurrent
purchase and sale or exchange of Related Business Assets or a
combination of Related Business Assets and cash or Cash
Equivalents between the Issuer or any of its Restricted
Subsidiaries and another Person; provided, that any cash
or Cash Equivalents received must be applied in accordance with
the covenant described under Repurchase at the Option of
Holders Asset Sales.
Permitted Holders means each of the
Investors, the Frist Entities, the Management Participants (as
defined in the Offering Memorandum), Citigroup Inc. and Banc of
America Securities LLC (which institutions are assignees of
certain equity commitments of the Investors as of the Issue
Date) who are holders of Equity Interests of the Issuer (or any
of its direct or indirect parent companies) and any group
(within the meaning of Section 13(d)(3) or
Section 14(d)(2) of the Exchange Act or any successor
provision) of which any of the foregoing are members;
provided that, in the case of such group and without
giving effect to the existence of such group or any other group,
such Investors, Frist Entities, members of management and
assignees of the equity commitments of the Investors,
collectively, have beneficial ownership of more than 50% of the
total voting power of the Voting Stock of the Issuer or any of
its direct or indirect parent companies.
Permitted Investments means:
(1) any Investment in the Issuer or any of its Restricted
Subsidiaries;
(2) any Investment in cash and Cash Equivalents or
Investment Grade Securities;
(3) any Investment by the Issuer or any of its Restricted
Subsidiaries in a Person that is engaged in a Similar Business
if as a result of such Investment:
(a) such Person becomes a Restricted Subsidiary; or
(b) such Person, in one transaction or a series of related
transactions, is merged or consolidated with or into, or
transfers or conveys substantially all of its assets to, or is
liquidated into, the Issuer or a Restricted Subsidiary, and, in
each case, any Investment held by such Person; provided,
that such Investment was not acquired by such Person in
contemplation of such acquisition, merger, consolidation or
transfer;
(4) any Investment in securities or other assets not
constituting cash, Cash Equivalents or Investment Grade
Securities and received in connection with an Asset Sale made
pursuant to the provisions described under Repurchase at
the Option of Holders Asset Sales or any other
disposition of assets not constituting an Asset Sale;
(5) any Investment existing on the Issue Date;
108
(6) any Investment acquired by the Issuer or any of its
Restricted Subsidiaries:
(a) in exchange for any other Investment or accounts
receivable held by the Issuer or any such Restricted Subsidiary
in connection with or as a result of a bankruptcy, workout,
reorganization or recapitalization of the issuer of such other
Investment or accounts receivable; or
(b) as a result of a foreclosure by the Issuer or any of
its Restricted Subsidiaries with respect to any secured
Investment or other transfer of title with respect to any
secured Investment in default;
(7) Hedging Obligations permitted under clause (10) of
the second paragraph of the covenant described in Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
(8) any Investment in a Similar Business having an
aggregate fair market value, taken together with all other
Investments made pursuant to this clause (8) that are at
that time outstanding, not to exceed 5% of Total Assets at the
time of such Investment (with the fair market value of each
Investment being measured at the time made and without giving
effect to subsequent changes in value);
(9) Investments the payment for which consists of Equity
Interests (exclusive of Disqualified Stock) of the Issuer or any
of its direct or indirect parent companies; provided,
however, that such Equity Interests will not increase the
amount available for Restricted Payments under clause (3)
of the first paragraph under the covenant described in
Certain Covenants Limitations on Restricted
Payments;
(10) guarantees of Indebtedness permitted under the
covenant described in Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock;
(11) any transaction to the extent it constitutes an
Investment that is permitted and made in accordance with the
provisions of the second paragraph of the covenant described
under Certain Covenants Transactions with
Affiliates (except transactions described in clauses (2),
(5) and (9) of such paragraph);
(12) Investments consisting of purchases and acquisitions
of inventory, supplies, material or equipment;
(13) additional Investments having an aggregate fair market
value, taken together with all other Investments made pursuant
to this clause (13) that are at that time outstanding
(without giving effect to the sale of an Unrestricted Subsidiary
to the extent the proceeds of such sale do not consist of cash
or marketable securities), not to exceed 5% of Total Assets at
the time of such Investment (with the fair market value of each
Investment being measured at the time made and without giving
effect to subsequent changes in value);
(14) Investments relating to an ABL Financing Entity or a
Receivables Subsidiary that, in the good faith determination of
the Issuer, are necessary or advisable to effect the ABL
Facility or any Receivables Facility, as the case may be;
(15) advances to, or guarantees of Indebtedness of,
employees not in excess of $50.0 million outstanding at any
one time, in the aggregate;
(16) loans and advances to officers, directors and
employees for business-related travel expenses, moving expenses
and other similar expenses, in each case incurred in the
ordinary course of business or consistent with past practices or
to fund such Persons purchase of Equity Interests of the
Issuer or any direct or indirect parent company thereof;
(17) Physician Support Obligations made by the Issuer or
any Restricted Subsidiary;
(18) any Investment in any joint venture existing on the
Issue Date that owns or operates one or more healthcare
facilities, including, without limitation, hospitals, ambulatory
surgery centers, outpatient diagnostic centers or imaging
centers to the extent contemplated by the organizational
documents of such joint venture as in existence on the Issue
Date;
109
(19) any Investment in the ordinary course of business or
as may be required by applicable law by any Restricted
Subsidiary (including, without limitation, HCI) engaged in the
insurance business in order to provide insurance to the Issuer
and its Subsidiaries;
(20) any Investment pursuant to any customary buy/sell
arrangement in favor of investors or joint venture parties in
connection with syndications of healthcare facilities,
including, without limitation, hospitals, ambulatory surgery
centers, outpatient diagnostic centers or imaging
centers; and
(21) any Investment in any Subsidiary or any joint venture
in connection with intercompany cash management arrangements or
related activities arising in the ordinary course of business.
Permitted Liens means, with respect to any
Person:
(1) pledges or deposits by such Person under workmens
compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids,
tenders, contracts (other than for the payment of Indebtedness)
or leases to which such Person is a party, or deposits to secure
public or statutory obligations of such Person or deposits of
cash or U.S. government bonds to secure surety or appeal
bonds to which such Person is a party, or deposits as security
for contested taxes or import duties or for the payment of rent,
in each case incurred in the ordinary course of business;
(2) Liens imposed by law, such as carriers,
warehousemens and mechanics Liens, in each case for
sums not yet overdue for a period of more than 30 days or
being contested in good faith by appropriate proceedings or
other Liens arising out of judgments or awards against such
Person with respect to which such Person shall then be
proceeding with an appeal or other proceedings for review if
adequate reserves with respect thereto are maintained on the
books of such Person in accordance with GAAP;
(3) Liens for taxes, assessments or other governmental
charges not yet overdue for a period of more than 30 days
or payable or subject to penalties for nonpayment or which are
being contested in good faith by appropriate proceedings
diligently conducted, if adequate reserves with respect thereto
are maintained on the books of such Person in accordance with
GAAP;
(4) Liens in favor of issuers of performance and surety
bonds or bid bonds or with respect to other regulatory
requirements or letters of credit issued pursuant to the request
of and for the account of such Person in the ordinary course of
its business;
(5) minor survey exceptions, minor encumbrances, easements
or reservations of, or rights of others for, licenses,
rights-of-way,
sewers, electric lines, telegraph and telephone lines and other
similar purposes, or zoning or other restrictions as to the use
of real properties or Liens incidental to the conduct of the
business of such Person or to the ownership of its properties
which were not incurred in connection with Indebtedness and
which do not in the aggregate materially adversely affect the
value of said properties or materially impair their use in the
operation of the business of such Person;
(6) Liens securing Indebtedness permitted to be incurred
pursuant to clause (4), (12), (13), (18) or (19) of
the second paragraph under Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock; provided
that (a) Liens securing Indebtedness, Disqualified
Stock or Preferred Stock permitted to be incurred pursuant to
clause (13) relate only to Refinancing Indebtedness that
serves to refund or refinance Indebtedness, Disqualified Stock
or Preferred Stock incurred under clause (4) or
(12) of the second paragraph under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock,
(b) Liens securing Indebtedness permitted to be incurred
pursuant to clause (18) extend only to the assets of
Foreign Subsidiaries, (c) Liens securing Indebtedness
permitted to be incurred pursuant to clause (19) are solely
on acquired property or the assets of the acquired entity, as
the case may be and (d) Liens securing Indebtedness,
Disqualified Stock or Preferred Stock permitted to be incurred
pursuant to clause (4) of the second paragraph under
Certain Covenants Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock extend only to the assets so financed, purchased,
constructed or improved;
110
(7) Liens existing on the Issue Date (other than Liens in
favor of the lenders under the Senior Credit Facilities);
(8) Liens on property or shares of stock of a Person at the
time such Person becomes a Subsidiary; provided,
however, such Liens are not created or incurred in
connection with, or in contemplation of, such other Person
becoming such a Subsidiary; provided, further,
however, that such Liens may not extend to any other
property owned by the Issuer or any of its Restricted
Subsidiaries;
(9) Liens on property at the time the Issuer or a
Restricted Subsidiary acquired the property, including any
acquisition by means of a merger or consolidation with or into
the Issuer or any of its Restricted Subsidiaries;
provided, however, that such Liens are not created
or incurred in connection with, or in contemplation of, such
acquisition; provided, further, however,
that the Liens may not extend to any other property owned by the
Issuer or any of its Restricted Subsidiaries;
(10) Liens securing Indebtedness or other obligations of a
Restricted Subsidiary owing to the Issuer or another Restricted
Subsidiary permitted to be incurred in accordance with the
covenant described under Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock;
(11) Liens securing Hedging Obligations so long as the
related Indebtedness is, and is permitted to be under the
Indenture, secured by a Lien on the same property securing such
Hedging Obligations;
(12) Liens on specific items of inventory or other goods
and proceeds of any Person securing such Persons
obligations in respect of bankers acceptances issued or
created for the account of such Person to facilitate the
purchase, shipment or storage of such inventory or other goods;
(13) leases, subleases, licenses or sublicenses granted to
others in the ordinary course of business which do not
materially interfere with the ordinary conduct of the business
of the Issuer or any of its Restricted Subsidiaries and do not
secure any Indebtedness;
(14) Liens arising from Uniform Commercial Code financing
statement filings regarding operating leases entered into by the
Issuer and its Restricted Subsidiaries in the ordinary course of
business;
(15) Liens in favor of the Issuer or any Guarantor;
(16) Liens on equipment of the Issuer or any of its
Restricted Subsidiaries granted in the ordinary course of
business;
(17) Liens on accounts receivable and related assets
incurred in connection with a Receivables Facility;
(18) Liens to secure any refinancing, refunding, extension,
renewal or replacement (or successive refinancing, refunding,
extensions, renewals or replacements) as a whole, or in part, of
any Indebtedness secured by any Lien referred to in the
foregoing clauses (6), (7), (8) and (9); provided,
however, that (a) such new Lien shall be limited to
all or part of the same property that secured the original Lien
(plus improvements on such property), and (b) the
Indebtedness secured by such Lien at such time is not increased
to any amount greater than the sum of (i) the outstanding
principal amount or, if greater, committed amount of the
Indebtedness described under clauses (6), (7), (8) and
(9) at the time the original Lien became a Permitted Lien
under the Indenture, and (ii) an amount necessary to pay
any fees and expenses, including premiums, related to such
refinancing, refunding, extension, renewal or replacement;
(19) deposits made in the ordinary course of business to
secure liability to insurance carriers;
(20) other Liens securing obligations incurred in the
ordinary course of business which obligations do not exceed
$100.0 million at any one time outstanding;
(21) Liens securing judgments for the payment of money not
constituting an Event of Default under clause (5) under the
caption Events of Default and Remedies so long as
such Liens are adequately bonded and any appropriate legal
proceedings that may have been duly initiated for the review of
such
111
judgment have not been finally terminated or the period within
which such proceedings may be initiated has not expired;
(22) Liens in favor of customs and revenue authorities
arising as a matter of law to secure payment of customs duties
in connection with the importation of goods in the ordinary
course of business;
(23) Liens (i) of a collection bank arising under
Section 4-210
of the Uniform Commercial Code, or any comparable or successor
provision, on items in the course of collection,
(ii) attaching to commodity trading accounts or other
commodity brokerage accounts incurred in the ordinary course of
business, and (iii) in favor of banking institutions
arising as a matter of law encumbering deposits (including the
right of set-off) and which are within the general parameters
customary in the banking industry;
(24) Liens deemed to exist in connection with Investments
in repurchase agreements permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
provided that such Liens do not extend to any assets
other than those that are the subject of such repurchase
agreements;
(25) Liens encumbering reasonable customary initial
deposits and margin deposits and similar Liens attaching to
commodity trading accounts or other brokerage accounts incurred
in the ordinary course of business and not for speculative
purposes;
(26) Liens that are contractual rights of set-off
(i) relating to the establishment of depository relations
with banks not given in connection with the issuance of
Indebtedness, (ii) relating to pooled deposit or sweep
accounts of the Issuer or any of its Restricted Subsidiaries to
permit satisfaction of overdraft or similar obligations incurred
in the ordinary course of business of the Issuer and its
Restricted Subsidiaries or (iii) relating to purchase
orders and other agreements entered into with customers of the
Issuer or any of its Restricted Subsidiaries in the ordinary
course of business; and
(27) Liens arising out of conditional sale, title
retention, consignment or similar arrangements for the sale or
purchase of goods entered into by the Issuer or any Restricted
Subsidiary in the ordinary course of business.
For purposes of this definition, the term
Indebtedness shall be deemed to include interest on
such Indebtedness.
Person means any individual, corporation,
limited liability company, partnership, joint venture,
association, joint stock company, trust, unincorporated
organization, government or any agency or political subdivision
thereof or any other entity.
Physician Support Obligation means (1) a
loan to or on behalf of, or a guarantee of Indebtedness or
income of, a physician or healthcare professional providing
service to patients in the service area of a healthcare facility
operated by the Issuer, any of its Restricted Subsidiaries or
any affiliated joint venture otherwise permitted by the
Indenture made or given by the Issuer or any Restricted
Subsidiary of the Issuer in the ordinary course of business and
pursuant to a written agreement having a period not to exceed
five years or (2) guarantees by the Issuer or any
Restricted Subsidiary of the Issuer of leases and loans to
acquire property (real or personal) for or on behalf of a
physician or healthcare professional providing service to
patients in the service area of a healthcare facility operated
by the Issuer, any of its Restricted Subsidiaries or any
affiliated joint venture otherwise permitted by the Indenture.
PIK Interest has the meaning set forth under
Principal, Maturity and Interest Toggle
Notes.
PIK Notes has the meaning set forth under
Principal, Maturity and Interest.
PIK Payment has the meaning set forth under
Principal, Maturity and Interest.
Plan of Reorganization means any plan of
reorganization, plan of liquidation, agreement for composition,
or other type of plan of arrangement proposed in or in
connection with any insolvency or liquidation proceeding.
112
Preferred Stock means any Equity Interest
with preferential rights of payment of dividends or upon
liquidation, dissolution or winding up.
Principal Property means each acute care
hospital providing general medical and surgical services
(excluding equipment, personal property and hospitals that
primarily provide specialty medical services, such as
psychiatric and obstetrical and gynecological services) owned
solely by the Issuer
and/or one
or more of its Subsidiaries (used in this definition as defined
in the Existing Notes Indenture) and located in the
United States of America.
Priority Lien Obligations means,
collectively, ABL Obligations and First Lien Obligations.
Priority Lien Secured Parties means,
collectively, the ABL Secured Parties and the First Lien Secured
Parties.
Purchase Money Obligations means any
Indebtedness incurred to finance or refinance the acquisition,
leasing, construction or improvement of property (real or
personal) or assets (other than Capital Stock), and whether
acquired through the direct acquisition of such property or
assets, or otherwise.
Qualified Proceeds means assets that are used
or useful in, or Capital Stock of any Person engaged in, a
Similar Business; provided that the fair market value of
any such assets or Capital Stock shall be determined by the
Issuer in good faith.
Rating Agencies means Moodys and
S&P or if Moodys or S&P or both shall not make a
rating on the Notes publicly available, a nationally recognized
statistical rating agency or agencies, as the case may be,
selected by the Issuer which shall be substituted for
Moodys or S&P or both, as the case may be.
Receivables Facility means any of one or more
receivables financing facilities as amended, supplemented,
modified, extended, renewed, restated or refunded from time to
time, the Obligations of which are non-recourse (except for
customary representations, warranties, covenants and indemnities
made in connection with such facilities) to the Issuer or any of
its Restricted Subsidiaries (other than a Receivables
Subsidiary) pursuant to which the Issuer or any of its
Restricted Subsidiaries purports to sell its accounts receivable
to either (a) a Person that is not a Restricted Subsidiary
or (b) a Receivables Subsidiary that in turn funds such
purchase by purporting to sell its accounts receivable to a
Person that is not a Restricted Subsidiary or by borrowing from
such a Person or from another Receivables Subsidiary that in
turn funds itself by borrowing from such a Person.
Receivables Fees means distributions or
payments made directly or by means of discounts with respect to
any accounts receivable or participation interest therein issued
or sold in connection with, and other fees paid to a Person that
is not a Restricted Subsidiary in connection with any
Receivables Facility.
Receivables Subsidiary means any Subsidiary
formed for the purpose of facilitating or entering into one or
more Receivables Facilities, and in each case engages only in
activities reasonably related or incidental thereto.
Redemption Date has the meaning set
forth under Optional Redemption Cash Pay
Notes.
Registration Rights Agreement means the
Registration Rights Agreement related to the Notes, dated as of
the Issue Date, among the Issuer, the Guarantors and the Initial
Purchasers.
Related Business Assets means assets (other
than cash or Cash Equivalents) used or useful in a Similar
Business; provided that any assets received by the Issuer
or a Restricted Subsidiary in exchange for assets transferred by
the Issuer or a Restricted Subsidiary will not be deemed to be
Related Business Assets if they consist of securities of a
Person, unless upon receipt of the securities of such Person,
such Person would become a Restricted Subsidiary.
Restricted Investment means an Investment
other than a Permitted Investment.
Restricted Subsidiary means, at any time, any
direct or indirect Subsidiary of the Issuer (including any
Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
provided, however, that upon an Unrestricted
113
Subsidiarys ceasing to be an Unrestricted Subsidiary, such
Subsidiary shall be included in the definition of
Restricted Subsidiary.
S&P means Standard &
Poors, a division of The McGraw-Hill Companies, Inc., and
any successor to its rating agency business.
Sale and Lease-Back Transaction means any
arrangement providing for the leasing by the Issuer or any of
its Restricted Subsidiaries of any real or tangible personal
property, which property has been or is to be sold or
transferred by the Issuer or such Restricted Subsidiary to a
third Person in contemplation of such leasing.
SEC means the U.S. Securities and
Exchange Commission.
Secured Indebtedness means any Indebtedness
of the Issuer or any of its Restricted Subsidiaries secured by a
Lien.
Securities Act means the Securities Act of
1933, as amended, and the rules and regulations of the SEC
promulgated thereunder.
Security Documents means, collectively, the
Intercreditor Agreements, the security agreements relating to
the Collateral and the mortgages and instruments filed and
recorded in appropriate jurisdictions to preserve and protect
the Liens on the Collateral (including, without limitation,
financing statements under the Uniform Commercial Code of the
relevant states) applicable to the Collateral, each as in effect
on the Issue Date and as amended, amended and restated,
modified, renewed or replaced from time to time.
Senior Credit Facilities means the ABL
Facility and the General Credit Facility.
Senior Indebtedness means:
(1) all Indebtedness of the Issuer or any Guarantor
outstanding under the Senior Credit Facilities or Notes and
related Guarantees (including interest accruing on or after the
filing of any petition in bankruptcy or similar proceeding or
for reorganization of the Issuer or any Guarantor (at the rate
provided for in the documentation with respect thereto,
regardless of whether or not a claim for post-filing interest is
allowed in such proceedings)), and any and all other fees,
expense reimbursement obligations, indemnification amounts,
penalties, and other amounts (whether existing on the Issue Date
or thereafter created or incurred) and all obligations of the
Issuer or any Guarantor to reimburse any bank or other Person in
respect of amounts paid under letters of credit, acceptances or
other similar instruments;
(2) all Hedging Obligations (and guarantees thereof) owing
to a Lender (as defined in the Senior Credit Facilities) or any
Affiliate of such Lender (or any Person that was a Lender or an
Affiliate of such Lender at the time the applicable agreement
giving rise to such Hedging Obligation was entered into);
provided that such Hedging Obligations are permitted to
be incurred under the terms of the Indenture;
(3) any other Indebtedness of the Issuer or any Guarantor
permitted to be incurred under the terms of the Indenture,
unless the instrument under which such Indebtedness is incurred
expressly provides that it is subordinated in right of payment
to the Notes or any related Guarantee; and
(4) all Obligations with respect to the items listed in the
preceding clauses (1), (2) and (3);
provided, however, that Senior Indebtedness shall
not include:
(a) any obligation of such Person to the Issuer or any of
its Subsidiaries;
(b) any liability for federal, state, local or other taxes
owed or owing by such Person;
(c) any accounts payable or other liability to trade
creditors arising in the ordinary course of business;
(d) any Indebtedness or other Obligation of such Person
which is subordinate or junior in any respect to any other
Indebtedness or other Obligation of such Person; or
114
(e) that portion of any Indebtedness which at the time of
incurrence is incurred in violation of the Indenture.
Separate Receivables Collateral has the
meaning set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
Shared Receivables Collateral has the meaning
set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
Shared Receivables Intercreditor Agreement
has the meaning set forth under Security Liens
with Respect to Shared Receivables Collateral.
Significant Subsidiary means any Restricted
Subsidiary that would be a significant subsidiary as
defined in Article 1,
Rule 1-02
of
Regulation S-X,
promulgated pursuant to the Securities Act, as such regulation
is in effect on the Issue Date.
Similar Business means any business conducted
or proposed to be conducted by the Issuer and its Restricted
Subsidiaries on the Issue Date or any business that is similar,
reasonably related, incidental or ancillary thereto.
Sponsor Management Agreement means the
management agreement between certain of the management companies
associated with the Investors, the Frist Entities and the Issuer.
Subordinated Indebtedness means, with respect
to the Notes,
(1) any Indebtedness of the Issuer which is by its terms
subordinated in right of payment to the Notes, and
(2) any Indebtedness of any Guarantor which is by its terms
subordinated in right of payment to the Guarantee of such entity
of the Notes.
Subsidiary means, with respect to any Person:
(1) any corporation, association, or other business entity
(other than a partnership, joint venture, limited liability
company or similar entity) of which more than 50% of the total
voting power of shares of Capital Stock entitled (without regard
to the occurrence of any contingency) to vote in the election of
directors, managers or trustees thereof is at the time of
determination owned or controlled, directly or indirectly, by
such Person or one or more of the other Subsidiaries of that
Person or a combination thereof or is consolidated under GAAP
with such Person at such time; and
(2) any partnership, joint venture, limited liability
company or similar entity of which
(x) more than 50% of the capital accounts, distribution
rights, total equity and voting interests or general or limited
partnership interests, as applicable, are owned or controlled,
directly or indirectly, by such Person or one or more of the
other Subsidiaries of that Person or a combination thereof
whether in the form of membership, general, special or limited
partnership or otherwise, and
(y) such Person or any Restricted Subsidiary of such Person
is a controlling general partner or otherwise controls such
entity.
Total Assets means the total assets of the
Issuer and its Restricted Subsidiaries on a consolidated basis,
as shown on the most recent consolidated balance sheet of the
Issuer or such other Person as may be expressly stated.
Transaction means the transactions
contemplated by the Transaction Agreement, the issuance of the
Notes and borrowings under the Senior Credit Facilities as in
effect on the Issue Date.
Transaction Agreement means the Agreement and
Plan of Merger, dated as of July 24, 2006, between Hercules
Holding II, LLC, Hercules Acquisition Corporation and the
Issuer, as amended prior to the Issue Date.
115
Treasury Rate means, as of any
Redemption Date, the yield to maturity as of such
Redemption Date of United States Treasury securities with a
constant maturity (as compiled and published in the most recent
Federal Reserve Statistical Release H.15 (519) that has
become publicly available at least two Business Days prior to
the Redemption Date (or, if such Statistical Release is no
longer published, any publicly available source of similar
market data)) most nearly equal to the period from the
Redemption Date to November 15, 2010 with respect to
the 2014 Cash Pay Notes and November 15, 2011 with respect
to the 2016 Cash Pay Notes and the Toggle Notes;
provided, however, that if the period from the
Redemption Date to November 15, 2010 with respect to
the 2014 Cash Pay Notes and November 15, 2011 with respect
to the 2016 Cash Pay Notes and the Toggle Notes is less than one
year, the weekly average yield on actually traded United States
Treasury securities adjusted to a constant maturity of one year
will be used.
Trust Indenture Act means the
Trust Indenture Act of 1939, as amended (15 U.S.C.
§§ 77aaa-777bbbb).
Unrestricted Subsidiary means:
(1) any Subsidiary of the Issuer which at the time of
determination is an Unrestricted Subsidiary (as designated by
the Issuer, as provided below); and
(2) any Subsidiary of an Unrestricted Subsidiary.
The Issuer may designate any Subsidiary of the Issuer (including
any existing Subsidiary and any newly acquired or newly formed
Subsidiary) to be an Unrestricted Subsidiary unless such
Subsidiary or any of its Subsidiaries owns any Equity Interests
or Indebtedness of, or owns or holds any Lien on, any property
of, the Issuer or any Subsidiary of the Issuer (other than
solely any Subsidiary of the Subsidiary to be so designated);
provided that
(1) any Unrestricted Subsidiary must be an entity of which
the Equity Interests entitled to cast at least a majority of the
votes that may be cast by all Equity Interests having ordinary
voting power for the election of directors or Persons performing
a similar function are owned, directly or indirectly, by the
Issuer;
(2) such designation complies with the covenants described
under Certain Covenants Limitation on
Restricted Payments; and
(3) each of:
(a) the Subsidiary to be so designated; and
(b) its Subsidiaries has not at the time of designation,
and does not thereafter, create, incur, issue, assume, guarantee
or otherwise become directly or indirectly liable with respect
to any Indebtedness pursuant to which the lender has recourse to
any of the assets of the Issuer or any Restricted Subsidiary.
The Issuer may designate any Unrestricted Subsidiary to be a
Restricted Subsidiary; provided that, immediately after
giving effect to such designation, no Default shall have
occurred and be continuing and either:
(1) the Issuer could incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio test
described in the first paragraph under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred
Stock; or
(2) the Fixed Charge Coverage Ratio for the Issuer and its
Restricted Subsidiaries would be greater than such ratio for the
Issuer and its Restricted Subsidiaries immediately prior to such
designation, in each case on a pro forma basis taking
into account such designation.
Any such designation by the Issuer shall be notified by the
Issuer to the Trustee by promptly filing with the Trustee a copy
of the resolution of the board of directors of the Issuer or any
committee thereof giving effect to such designation and an
Officers Certificate certifying that such designation
complied with the foregoing provisions.
Voting Stock of any Person as of any date
means the Capital Stock of such Person that is at the time
entitled to vote in the election of the board of directors of
such Person.
116
Weighted Average Life to Maturity means, when
applied to any Indebtedness, Disqualified Stock or Preferred
Stock, as the case may be, at any date, the quotient obtained by
dividing:
(1) the sum of the products of the number of years from the
date of determination to the date of each successive scheduled
principal payment of such Indebtedness or redemption or similar
payment with respect to such Disqualified Stock or Preferred
Stock multiplied by the amount of such payment; by
(2) the sum of all such payments.
Wholly-Owned Subsidiary of any Person means a
Subsidiary of such Person, 100% of the outstanding Equity
Interests of which (other than directors qualifying
shares) shall at the time be owned by such Person or by one or
more Wholly-Owned Subsidiaries of such Person.
Senior
Secured Notes Issued Under the 2009 Second Lien
Indenture
HCA Inc. has issued senior secured notes as described below
under an indenture, dated as of February 19, 2009, among
the Issuer, the Guarantors, The Bank of New York Mellon as
collateral agent and The Bank of New York Mellon
Trust Company, N.A., as trustee. Terms used in this
Senior Secured Notes Issued Under the 2009
Second Lien Indenture apply only to the Notes described
herein.
General
Certain terms used in this description are defined under the
subheading Certain Definitions. In this description,
the terms we, our,
us and the Company each
refer to HCA Inc. (the Issuer) and its
consolidated Subsidiaries.
The Issuer issued $310.0 million aggregate principal amount
of
97/8% senior
secured notes due 2017 (the Notes) under an
indenture dated as of February 19, 2009 (the
Indenture) among the Issuer, the Guarantors
and The Bank of New York Mellon Trust Company, N.A., as
trustee (the Trustee). The Notes were issued
in a private transaction that was not subject to the
registration requirements of the Securities Act. Except as set
forth herein, the terms of the Notes are substantially identical
and include those stated in the Indenture and those made part of
the Indenture by reference to the Trust Indenture Act.
The following description is only a summary of the material
provisions of the Indenture, does not purport to be complete and
is qualified in its entirety by reference to the provisions of
those agreements, including the definitions therein of certain
terms used below. We urge you to read the Indenture because it,
and not this description, will define your rights as Holders of
the Notes.
Brief
Description of Notes
The Notes:
|
|
|
|
|
are general senior obligations of the Issuer;
|
|
|
|
are secured on a second-priority basis, equally and ratably with
the 2006 Notes and all future obligations of the Issuer and the
Guarantors under any future Junior Lien Obligations, by all of
the assets of the Issuer and the Guarantors which are not
Principal Properties and which secure the General Credit
Facility (other than the European Collateral), subject to the
Liens securing the Issuers and the Guarantors
obligations under the General Credit Facility and any other
Priority Lien Obligations and other Permitted Liens;
|
|
|
|
are secured on a third-priority basis, equally and ratably with
the 2006 Notes and all future obligations of the Issuer and the
Guarantors under any future Junior Lien Obligations, by all of
the assets of the Issuer and the Guarantors securing the ABL
Facility which also secure the General Credit Facility, subject
to the Liens securing the Issuers and the Guarantors
obligations under the Senior Credit Facilities and any other
Priority Lien Obligations and other Permitted Liens;
|
|
|
|
are effectively subordinated, to the extent of the value of the
assets securing such Indebtedness (which, in any event, exclude
the European Collateral, which does not secure the Notes), to
the Issuers and the
|
117
|
|
|
|
|
Guarantors obligations under the General Credit Facility
and any future Priority Lien Obligations, that will be secured
(A) on a first-priority basis by the same assets of the
Issuers and the Guarantors that secure the Notes and by certain
other assets of the Issuer and the Guarantors, including the
Principal Properties, that do not secure the Notes and
(B) on a second-priority basis by the Shared Receivables
Collateral;
|
|
|
|
|
|
are effectively subordinated to the Issuers and the
Guarantors obligations under the ABL Facility, to the
extent of the value of the Shared Receivables Collateral;
|
|
|
|
are effectively subordinated to any obligations secured by
Permitted Liens, to the extent of the value of the assets of the
Issuer and the Guarantors subject to those Permitted Liens;
|
|
|
|
are structurally subordinated to any existing and future
indebtedness and liabilities of non-guarantor Subsidiaries,
including the ABL Financing Entities and the Issuers
Foreign Subsidiaries and any Unrestricted Subsidiaries;
|
|
|
|
rank equally in right of payment with all existing and future
senior Indebtedness of the Issuer and the Guarantors but, to the
extent of the value of the Collateral, will be effectively
senior to all of the Issuers and the Guarantors
unsecured senior Indebtedness (including the Existing Notes);
|
|
|
|
are senior in right of payment to any future Subordinated
Indebtedness (as defined with respect to the Notes) of the
Issuer;
|
|
|
|
are initially unconditionally guaranteed on a joint and several
and senior basis by each Restricted Subsidiary that guarantees
the General Credit Facility (other than any Foreign
Subsidiary); and
|
|
|
|
are subject to registration with the SEC pursuant to the
Registration Rights Agreement.
|
Guarantees
The Guarantors, as primary obligors and not merely as sureties,
jointly and severally fully and unconditionally guaranteed, on a
senior basis, the performance and full and punctual payment when
due, whether at maturity, by acceleration or otherwise, of all
obligations of the Issuer under the Indenture and the Notes,
whether for payment of principal of, premium, if any, or
interest or Additional Interest in respect of the Notes,
expenses, indemnification or otherwise, on the terms set forth
in the Indenture by executing the Indenture.
The Restricted Subsidiaries which guarantee the General Credit
Facility guarantee the Notes. Each of the Guarantees of the
Notes is a general senior obligation of each Guarantor and is
secured by a second-priority lien on all of the assets of each
Guarantor which secure the General Credit Facility and which are
not Principal Properties and by a third-priority lien on all of
the assets of each Guarantor which secure the ABL Facility. The
Guarantees rank equally in right of payment with all existing
and future senior Indebtedness of the Guarantor but, to the
extent of the value of the Collateral, are effectively senior to
all of the Guarantors unsecured senior Indebtedness and,
to the extent of the Collateral, are effectively subordinated to
the Guarantors Obligations under the Senior Credit
Facilities and any future Priority Lien Obligations. The
Guarantees are senior in right of payment to all existing and
future Subordinated Indebtedness of each Guarantor. The Notes
are structurally subordinated to Indebtedness and other
liabilities of Subsidiaries of the Issuer that do not Guarantee
the Notes.
Not all of the Issuers Subsidiaries Guarantee the Notes.
In the event of a bankruptcy, liquidation or reorganization of
any of these non-guarantor Subsidiaries, the non-guarantor
Subsidiaries will pay the holders of their debt and their trade
creditors before they will be able to distribute any of their
assets to the Issuer. None of our Subsidiaries which are
Restricted Subsidiaries for purposes of the Existing
Notes Indenture, Foreign Subsidiaries, ABL Financing Entities,
non-Wholly Owned Subsidiaries or any Receivables Subsidiaries
will guarantee the Notes.
On an as adjusted basis after giving effect to our offering of
$1.500 billion aggregate principal amount of first lien
notes in April 2009 and the use of proceeds therefrom, our
non-guarantor subsidiaries would have
118
accounted for approximately $11.867 billion, or 41.8%, of
our total revenues for the year ended December 31, 2008,
approximately $3.038 billion, or 40.9%, of our total
revenues for the three months ended March 31, 2009,
approximately $9.876 billion, or 40.7%, of our total
assets, and approximately $7.517 billion, or 22.5%, of our
total liabilities, in each case, as of December 31, 2008,
and approximately $9.817 billion, or 40.4%, of our total
assets, and approximately $7.224 billion, or 21.9%, of our
total liabilities, in each case, as of March 31, 2009.
The obligations of each Guarantor under its Guarantee are
limited as necessary to prevent the Guarantee from constituting
a fraudulent conveyance under applicable law.
Any entity that makes a payment under its Guarantee is entitled
upon payment in full of all guaranteed obligations under the
Indenture to a contribution from each other Guarantor in an
amount equal to such other Guarantors pro rata portion of
such payment based on the respective net assets of all the
Guarantors at the time of such payment determined in accordance
with GAAP.
If a Guarantee were rendered voidable, it could be subordinated
by a court to all other indebtedness (including guarantees and
other contingent liabilities) of the Guarantor, and, depending
on the amount of such indebtedness, a Guarantors liability
on its Guarantee could be reduced to zero. See Risk
Factors Risks Related to the Notes
Federal and state fraudulent transfer laws may permit a court to
void the notes, and with respect to the senior secured notes,
the guarantees, and, if that occurs, you may not receive any
payment on the notes.
Each Guarantee by a Guarantor provides by its terms that it will
be automatically and unconditionally released and discharged
upon:
(1) (a) any sale, exchange or transfer (by merger or
otherwise) of the Capital Stock of such Guarantor (including any
sale, exchange or transfer), after which the applicable
Guarantor is no longer a Restricted Subsidiary or all or
substantially all the assets of such Guarantor, which sale,
exchange or transfer is made in compliance with the applicable
provisions of the Indenture;
(b) the release or discharge of the guarantee by such
Guarantor of the Senior Credit Facilities or such other
guarantee that resulted in the creation of such Guarantee,
except a discharge or release by or as a result of payment under
such guarantee;
(c) the designation of any Restricted Subsidiary that is a
Guarantor as an Unrestricted Subsidiary in compliance with the
applicable provisions of the Indenture; or
(d) the exercise by the Issuer of its legal defeasance
option or covenant defeasance option as described under
Legal Defeasance and Covenant Defeasance or the
discharge of the Issuers obligations under the Indenture
in accordance with the terms of the Indenture; and
(2) such Guarantor delivering to the Trustee an
Officers Certificate and an Opinion of Counsel, each
stating that all conditions precedent provided for in the
Indenture relating to such transaction have been complied with.
Holding
Company Structure
The Issuer is a holding company for its Subsidiaries, with no
material operations of its own and only limited assets.
Accordingly, the Issuer is dependent upon the distribution of
the earnings of its Subsidiaries, whether in the form of
dividends, advances or payments on account of intercompany
obligations, to service its debt obligations.
Security
General
The Notes and the Guarantees are secured by perfected
second-priority security interests in the Non-Receivables
Collateral (second in priority to the Liens on the
Non-Receivables Collateral securing the First Lien Obligations)
and by perfected third-priority security interests in the Shared
Receivables Collateral (third
119
in priority to the first-priority and second-priority Liens on
the Shared Receivables Collateral securing the ABL Obligations
and the First Lien Obligations, respectively), in each case,
equally and ratably with the 2006 Notes and subject to Permitted
Liens. Notwithstanding the foregoing, neither the Notes nor the
Guarantees are secured by the European Collateral or the
Separate Receivables Collateral and, until after the Discharge
of the First Lien Obligations, the Notes and the Guarantees will
not be secured by any Principal Properties. Upon the Discharge
of First Lien Obligations and so long as no First Lien
Obligations are outstanding, the Principal Properties that
constituted Collateral under the First Lien Security
Documents Facility will become Collateral with respect to the
Notes, subject to the same limitation on the amount of
Obligations secured thereby as contained in the First Lien
Security Documents. See also Certain
Limitations on the Collateral below. Priority Lien Secured
Parties have rights and remedies with respect to the Collateral
that, if exercised, could adversely affect the value of the
Collateral or the ability of the respective agents under the
Intercreditor Agreements to realize or foreclose on the
Collateral on behalf of holders of the Notes. For a description
of the Shared Receivables Collateral and the Non-Receivables
Collateral, see Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
The Issuer and the Guarantors are and will be able to incur
additional Indebtedness in the future which could share in the
Collateral, including additional First Lien Obligations,
additional ABL Obligations, additional Junior Lien Obligations
and Obligations secured by Permitted Liens. The amount of such
additional Obligations is and will be limited by the covenant
described under Certain Covenants Liens
and the covenant described under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock.
Under certain circumstances, the amount of any such additional
Obligations could be significant.
After-Acquired
Collateral
From and after the Issue Date and subject to certain limitations
and exceptions, (a) if the Issuer or any Guarantor creates
any additional security interest upon any property or asset that
would constitute Collateral to secure any First Lien Obligations
(other than Principal Properties prior to the Discharge of First
Lien Obligations and so long as no First Lien Obligations are
outstanding and other than European Collateral and Separate
Receivables Collateral), it must concurrently grant a
second-priority perfected security interest (subject to
Permitted Liens) upon such property as security for the Notes
and (b) if the Issuer or any Guarantor creates any
additional security interest upon any property or asset that
would constitute Shared Receivables Collateral to secure any
Priority Lien Obligations, it must concurrently grant a
third-priority perfected security interest (subject to Permitted
Liens) upon such property as security for the Notes.
Liens
with Respect to the Collateral
Security
Documents and Intercreditor Agreements
The Issuer, the Guarantors and the Junior Lien Collateral Agent
entered into Security Documents in connection with the 2006
Notes with respect to the Collateral defining the terms of the
security interests that secure the 2006 Notes and the Guarantees
with respect to such Collateral and that will define the terms
of the security interests that secure the Notes and the
Guarantees with respect to such collateral. These security
interests will secure the payment and performance when due of
all of the Obligations of the Issuers and the Guarantors under
the Notes, the Indenture, the Guarantees and the Security
Documents, as provided in the Security Documents.
The Junior Lien Collateral Agent and the First Lien Collateral
Agent entered into a joinder to the General Intercreditor
Agreement dated as of November 17, 2006 by and among the
trustee under the 2006 Notes and the administrative agent under
the General Credit Facility (as the same may be amended from
time to time, the General Intercreditor
Agreement) with respect to the Collateral. The First
Lien Collateral Agent is initially the Collateral Agent under
the General Credit Facility. The Junior Lien Collateral Agent is
initially the trustee under the 2006 Notes. Pursuant to the
terms of the General Intercreditor Agreement, prior to the
Discharge of First Lien Obligations, the First Lien Collateral
Agent, acting on behalf of the First Lien Secured Parties, will
determine the time and method by which the security interests in
the Collateral will be enforced
120
and will have the sole and exclusive right to manage, perform
and enforce the terms of the Security Documents relating to the
Collateral and to exercise and enforce all privileges, rights
and remedies thereunder according to its direction, including to
take or retake control or possession of such Collateral and to
hold, prepare for sale, marshall, process, sell, lease, dispose
of or liquidate such Collateral, including, without limitation,
following the occurrence of a Default or Event of Default under
the Indenture. The Junior Lien Collateral Agent will not be
permitted to enforce the security interests even if any Event of
Default under the Indenture has occurred and the Notes have been
accelerated except (a) in any insolvency or liquidation
proceeding, solely as necessary to file a proof of claim or
statement of interest with respect to the Junior Lien
Obligations or (b) as necessary to take any action in order
to prove, preserve, perfect or protect (but not enforce) its
security interest and rights in, and the perfection and priority
of its Lien on, the Collateral. See Risk
Factors Risks Related to the Notes The
lien ranking provisions of the Indenture and other agreements
relating to the collateral securing the notes will limit the
rights of holders of the notes with respect to that collateral,
even during an event of default. After the Discharge of
First Lien Obligations, the Junior Lien Collateral Agent in
accordance with the provisions of the Junior Lien Documents will
distribute all cash proceeds (after payment of the costs of
enforcement and collateral administration and any other amounts
owed to the Junior Lien Collateral Agent) of the Collateral
received by it under the Security Documents for the ratable
benefit of the holders of Junior Lien Obligations. The proceeds
from the sale of the Collateral remaining after the satisfaction
of all First Lien Obligations may not be sufficient to satisfy
the Junior Lien Obligations. By its nature some or all of the
Collateral is and will be illiquid and may have no readily
ascertainable market value. Accordingly, the Collateral may not
be able to be sold in a short period of time, if salable. See
Risk Factors Risks Related to the
Notes The value of the collateral securing the notes
may not be sufficient to satisfy our obligations under the
notes.
The Junior Lien Collateral Agent, for itself and on behalf of
each Junior Lien Secured Party, has agreed pursuant to the
General Intercreditor Agreement that (a) it will not (and
thereby waives any right to) take any action to challenge,
contest or support any other Person in contesting or
challenging, directly or indirectly, in any proceeding
(including any insolvency or liquidation proceeding), the
validity, perfection, priority or enforceability of a Lien
securing any First Lien Obligations held (or purported to be
held) by or on behalf of the First Lien Collateral Agent or any
of the First Lien Secured Parties or any agent or trustee
therefor in any Collateral or other First Lien Collateral and
(b) it will not oppose or otherwise contest (or support any
other Person contesting) any request for judicial relief made in
any court by the First Lien Collateral Agent or any First Lien
Secured Parties relating to the lawful enforcement of any First
Priority Lien on Collateral or other First Lien Collateral.
In addition, the Security Documents provide that, prior to the
Discharge of First Lien Obligations, (1) the First Lien
Collateral Agent may take actions with respect to the Collateral
(including the release of Collateral and the manner of
realization (subject to the provisions described under
Release of Collateral)) without the
consent of the Junior Lien Collateral Agent or other Junior Lien
Secured Parties and (2) the Issuer and the Guarantors may
require the Junior Lien Collateral Agent to agree to modify the
Security Documents, or the General Intercreditor Agreement,
without the consent of the Junior Lien Collateral Agent or other
Junior Lien Secured Parties, to secure additional extensions of
credit and add additional First Lien Secured Parties or Junior
Lien Secured Parties so long as such modifications do not
expressly violate the provisions of the General Credit Facility
or the Indenture. In addition, the General Intercreditor
Agreement provides that with respect to Collateral in the event
that the First Lien Collateral Agent or the First Lien Secured
Parties enter into any amendment, waiver or consent in respect
of or replace any of the First Lien Security Documents for the
purpose of adding to, or deleting from, or waiving or consenting
to any departures from any provisions of, any First Lien
Security Document or changing in any manner the rights of the
First Lien Collateral Agent, the First Lien Secured Parties, the
Issuer or any Guarantor thereunder (including the release of any
Liens in Collateral in accordance with the provisions described
under Release of Collateral), then such
amendment, waiver or consent shall apply automatically to any
comparable provision of each comparable Security Document in
favor of the Junior Lien Obligations without the consent of the
Junior Lien Collateral Agent, any Junior Lien Representative or
any Junior Lien Secured Party and without any action by the
Junior Lien Collateral Agent, any Junior Lien Representative,
the Issuer or any Guarantor; provided that such
amendment, waiver or consent does not materially adversely
affect the rights of the Junior Lien Secured Parties or the
121
interests of the Junior Lien Secured Parties in the Collateral
in a manner materially different from that affecting the rights
of the First Lien Secured Parties thereunder or therein. Any
provider of additional extensions of credit shall be entitled to
rely on the determination of an Officer that such modifications
do not expressly violate the provisions of the General Credit
Facility or the Indenture if such determination is set forth in
an Officers Certificate delivered to such provider.
So long as the Discharge of First Lien Obligations has not
occurred, the Collateral or proceeds thereof received in
connection with the sale or other disposition of, or collection
on, such Non-Receivables Collateral upon the exercise of
remedies will be applied by the First Lien Collateral Agent to
the First Lien Obligations in such order as specified in the
relevant First Lien Documents until the Discharge of First Lien
Obligations has occurred. Upon the Discharge of First Lien
Obligations, the First Lien Collateral Agent shall deliver to
the Junior Lien Collateral Agent (for the benefit of all Junior
Lien Secured Parties) any remaining proceeds of Collateral held
by it in the same form as received, with any necessary
endorsements or as a court of competent jurisdiction may
otherwise direct to be applied by the Junior Lien Collateral
Agent to the Junior Lien Obligations in such order as specified
in the Junior Lien Documents.
In addition, so long as the Discharge of First Lien Obligations
has not occurred, neither the Junior Lien Collateral Agent nor
any Junior Lien Representative shall acquire or hold any Lien on
any assets of the Issuer or any Subsidiary (and neither the
Issuer nor any Subsidiary shall grant such Lien) securing any
Junior Lien Obligations that are not also subject to the First
Priority Lien in respect of the First Lien Obligations under the
First Lien Documents. If the Junior Lien Collateral Agent or any
Junior Lien Representative shall acquire or hold any Lien on any
assets of the Issuer or any Subsidiary that is not also subject
to the First Priority Lien in respect of the First Lien
Obligations under the First Lien Documents, then such Junior
Lien Collateral Agent or other Junior Lien Representative shall,
without the need for any further consent of any party and
notwithstanding anything to the contrary in any other document,
be deemed to also hold and have held such Lien for the benefit
of the First Lien Collateral Agent as security for the First
Lien Obligations (subject to the lien priority and other terms
hereof).
The Junior Lien Collateral Agent and each other Junior Lien
Secured Party have agreed that any Lien purported to be granted
on any Collateral as security for First Lien Obligations shall
be deemed to be and shall be deemed to remain senior in all
respects and prior to all Liens on the Collateral securing any
Junior Lien Obligations for all purposes regardless of whether
the Lien purported to be granted is found to be improperly
granted, improperly perfected, preferential, a fraudulent
conveyance or legally or otherwise deficient or invalid, in
whole or in part, in any manner.
Any Collateral or proceeds thereof received by any Junior Lien
Secured Party at a time when such receipt is not expressly
permitted by the terms of the General Intercreditor Agreement or
prior to the Discharge of First Lien Obligations shall be
segregated and held in trust for the benefit of and forthwith
paid over to the First Lien Collateral Agent (and/or its
designees) for the benefit of the First Lien Secured Parties in
the same form as received, with any necessary endorsements or as
a court of competent jurisdiction may otherwise direct.
If any First Lien Secured Party is required in any insolvency or
liquidation proceeding or otherwise to turn over or otherwise
pay to the estate of the Issuer or any other Guarantor (or any
trustee, receiver or similar person therefor), because the
payment of such amount was declared to be fraudulent or
preferential in any respect or for any other reason, any amount
(a Recovery), whether received as proceeds of
security, enforcement of any right of setoff or otherwise, then
as among the parties hereto, the First Lien Obligations shall be
deemed to be reinstated to the extent of such Recovery and to be
outstanding as if such payment had not occurred and such First
Lien Secured Party shall be entitled to a reinstatement of First
Lien Obligations with respect to all such recovered amounts and
shall have all rights hereunder. If the General Intercreditor
Agreement shall have been terminated prior to such Recovery, the
General Intercreditor Agreement shall be reinstated in full
force and effect, and such prior termination shall not diminish,
release, discharge, impair or otherwise affect the obligations
of the parties thereto. Any Collateral or other First Lien
Collateral or proceeds thereof received by any Junior Lien
Secured Party prior to the time of such Recovery shall be deemed
to have
122
been received prior to the Discharge of First Lien Obligations
and subject to the provisions of the immediately preceding
paragraph.
In addition, if at any time in connection with or after the
Discharge of First Lien Obligations the Issuer either in
connection therewith or thereafter enters into any Refinancing
of any First Lien Document evidencing a First Lien Obligation,
then such Discharge of First Lien Obligations shall
automatically be deemed not to have occurred for all purposes of
the General Intercreditor Agreement, the First Lien Documents
and the Junior Lien Documents, and the obligations under such
Refinancing shall automatically be treated as First Lien
Obligations for all purposes of the General Intercreditor
Agreement, including for purposes of the Lien priorities and
rights in respect of Collateral set forth therein, the related
documents shall be treated as First Lien Documents for all
purposes of the General Intercreditor Agreement and the first
lien collateral agent under such Refinanced First Lien Documents
shall be First Lien Collateral Agent for all purposes of the
General Intercreditor Agreement.
The General Intercreditor Agreement provides that, prior to the
Discharge of First Lien Obligations, neither the Junior Lien
Collateral Agent nor any other Junior Lien Secured Parties may
assert or enforce any right of marshalling accorded to a junior
lienholder, as against the First Lien Collateral Agent or any
First Lien Secured Party (in their capacity as priority
lienholders). Following the Discharge of First Lien Obligations,
the Junior Lien Secured Parties may assert their right under the
Uniform Commercial Code or otherwise to any proceeds remaining
following a sale or other disposition of Collateral by, or on
behalf of, the First Lien Collateral Agent or the First Lien
Secured Parties. This waiver of all rights of marshalling prior
to the Discharge of First Lien Obligations may result in
proceeds from the sale of Collateral (in which the Junior Lien
Secured Parties have second-priority Liens) being applied to
repay First Lien Obligations prior to the application of the
proceeds of Shared Receivables Collateral (in which the Junior
Lien Secured Parties have third-priority Liens), the Principal
Properties (in which the Junior Lien Secured Parties will not
have a security interest prior to the Discharge of First Lien
Obligations and during any time that any First Lien Obligations
are outstanding) or the European Collateral or the Separate
Receivables Collateral (in which the Junior Lien Secured Parties
do not have a security interest). In that scenario, Junior Lien
Secured Parties may recover less than they would have if such
proceeds were applied in the order most favorable to the Junior
Lien Secured Parties.
So long as the Discharge of First Lien Obligations has not
occurred, whether or not any insolvency or liquidation
proceeding has been commenced by or against the Issuer or any
Guarantor, (i) neither the Junior Lien Collateral Agent,
any Junior Lien Representative nor any Junior Lien Secured Party
will (x) exercise or seek to exercise any rights or
remedies (including setoff or the right to credit bid debt
(except as set forth in the next paragraph below)) with respect
to any Collateral in respect of any applicable Junior Lien
Obligations, or institute any action or proceeding with respect
to such rights or remedies (including any action of
foreclosure), (y) contest, protest or otherwise object to
any foreclosure or enforcement proceeding or action brought with
respect to the Collateral or any other collateral by the First
Lien Collateral Agent or any First Lien Secured Party in respect
of the First Lien Obligations, the exercise of any right by the
First Lien Collateral Agent or any First Lien Secured Party (or
any agent or
sub-agent on
their behalf) in respect of the First Lien Obligations under any
control agreement, lockbox agreement, landlord waiver or
bailees letter or similar agreement or arrangement to
which the Junior Lien Collateral Agent, any Junior Lien
Representative or any Junior Lien Secured Party either is a
party or may have rights as a third-party beneficiary, or any
other exercise by any such party of any rights and remedies as a
secured party relating to the Collateral or any other collateral
under the First Lien Documents or otherwise in respect of First
Lien Obligations, or (z) object to any waiver or
forbearance by the First Lien Secured Parties from or in respect
of bringing or pursuing any foreclosure proceeding or action or
any other exercise of any rights or remedies relating to the
Collateral or any other collateral in respect of First Lien
Obligations and (ii) except as otherwise provided in the
General Intercreditor Agreement, the First Lien Collateral Agent
and the First Lien Secured Parties shall have the sole and
exclusive right to enforce rights, exercise remedies (including
setoff and the right to credit bid their debt), marshal, process
and make determinations regarding the release, disposition or
restrictions, or waiver or forbearance of rights or remedies
with respect to the Collateral without any consultation with or
the consent of the Junior Lien Collateral Agent, any Junior Lien
Representative or any Junior Lien Secured Party.
123
Notwithstanding the foregoing, the General Intercreditor
Agreement shall not be construed to in any way limit or impair
the right of any Junior Lien Secured Party from exercising a
credit bid with respect to the Junior Lien Obligations in a sale
or other disposition of Collateral under Section 363 of the
Bankruptcy Code; provided that in connection with and
immediately after giving effect to such sale and credit bid
there occurs a Discharge of First Lien Obligations.
In addition, the Junior Lien Collateral Agent, each Junior Lien
Representative and each other Junior Lien Secured Party have
agreed that if the Issuer or any Guarantor is subject to any
insolvency or liquidation proceeding:
(1) if the First Lien Collateral Agent acting on behalf of
First Lien Secured Parties desires to permit the use of cash
collateral or to permit the Issuer or any Guarantor to obtain
financing under Section 363 or Section 364 of the
Bankruptcy Code or any similar provision in any Bankruptcy Law
(DIP Financing), including if such DIP
Financing is secured by Liens senior in priority to the Liens
securing the Notes or other Junior Lien Obligations, then the
Junior Lien Collateral Agent and each Junior Lien
Representative, on behalf of itself and each applicable Junior
Lien Secured Party, agrees not to object to such use of cash
collateral or DIP Financing and will not request adequate
protection or any other relief in connection therewith (except
to the extent permitted by the General Intercreditor Agreement,
as set forth below) and, to the extent the Liens securing the
First Lien Obligations are subordinated or pari passu
with such DIP Financing, will subordinate its Liens in the
Collateral and any other collateral to such DIP Financing (and
all Obligations relating thereto) on the same basis as they are
subordinated to the First Lien Obligations;
(2) none of them will object to, or otherwise contest (or
support any other Person contesting), any motion for relief from
the automatic stay or from any injunction against foreclosure or
enforcement in respect of the First Lien Obligations made by the
First Lien Collateral Agent or any First Lien Secured Party;
(3) none of them will object to, or otherwise contest (or
support any other Person contesting), any order relating to a
sale of assets of any Issuer or Guarantor for which the First
Lien Collateral Agent has consented that provides, to the extent
that sale is to be free and clear of Liens, that the Liens
securing the First Lien Obligations and the Junior Lien
Obligations will attach to the proceeds of the sale on the same
basis of priority as the existing Liens in accordance with the
General Intercreditor Agreement;
(4) none of them will seek relief from the automatic stay
or any other stay in any insolvency or liquidation proceeding in
respect of the Collateral or any other First Lien Collateral,
without the prior written consent of the First Lien Collateral
Agent;
(5) none of them will object to, or otherwise contest (or
support any other Person contesting), (a) any request by
the First Lien Collateral Agent or any First Lien Secured Party
for adequate protection or (b) any objection by the First
Lien Collateral Agent or any First Lien Secured Party to any
motion, relief, action or proceeding based on the First Lien
Collateral Agents or such First Lien Secured Partys
claiming a lack of adequate protection;
(6) none of them will assert or enforce (or support any
Person asserting or enforcing) any claim under
Section 506(c) of the Bankruptcy Code senior to or on a
parity with the Liens securing the First Lien Obligations for
costs or expenses of preserving or disposing of any Collateral
or First Lien Collateral;
(7) none of them will oppose or otherwise contest (or
support any other Person contesting) any lawful exercise by the
First Lien Collateral Agent or any First Lien Secured Party of
the right to credit bid First Lien Obligations at any sale of
Collateral or First Lien Collateral; and
(8) none of them will challenge (or support any other
person challenging) the validity, enforceability, perfection or
priority of the First Priority Liens on Collateral or First Lien
Collateral (and the General Intercreditor Agreement will provide
that the First Lien Secured Parties agree that none of them will
124
challenge the validity, enforceability, perfection or priority
of the Liens in favor of the Trustee and each other Junior Lien
Secured Party on the Collateral).
In addition, neither the Junior Lien Collateral Agent, any
Junior Lien Representative nor any other Junior Lien Secured
Party will file or prosecute in any insolvency or liquidation
proceeding any motion for adequate protection (or any comparable
request for relief) based upon their respective security
interests in the Collateral, except that:
(1) any of them may freely seek and obtain relief granting
a junior Lien co-extensive in all respects with, but
subordinated to, all Liens granted in the insolvency or
liquidation proceeding to, or for the benefit of, the First Lien
Secured Parties (and the General Intercreditor Agreement will
provide that the First Lien Secured Parties will not object to
the granting of such a junior Lien); and
(2) any of them may freely seek and obtain any relief upon
a motion for adequate protection (or any comparable relief),
without any condition or restriction whatsoever, at any time
after the Discharge of First Lien Obligations.
Without limiting the generality of any provisions of the General
Intercreditor Agreement, any vote to accept, and any other act
to support the confirmation or approval of, any Non-Conforming
Plan of Reorganization shall be inconsistent with and,
accordingly, a violation of the terms of the General
Intercreditor Agreement, and the First Lien Collateral Agent
shall be entitled to have any such vote to accept a
Non-Conforming Plan of Reorganization dismissed and any such
support of any Non-Conforming Plan of Reorganization withdrawn.
Subject to the terms of the Security Documents, the Issuer and
the Guarantors have the right to remain in possession and retain
exclusive control of the Collateral securing the Notes and the
Junior Lien Obligations (other than securities, instruments and
chattel paper constituting part of the Collateral and deposited
with the First Lien Collateral Agent in accordance with the
provisions of the First Lien Security Documents and any Shared
Receivables Collateral subject to a control agreement under the
circumstances described in the First Lien Security Documents),
to freely operate the Collateral and to collect, invest and
dispose of any income therefrom.
The Junior Lien Collateral Agent and each Junior Lien
Representative, on behalf of the Junior Lien Secured Parties,
have acknowledged and agreed in the General Intercreditor
Agreement that (a) the Junior Lien Secured Parties
claims against the Issuer
and/or any
Guarantor in respect of the Collateral constitute junior claims
separate and apart (and of a different class) from the senior
claims of the First Lien Secured Parties against the Issuer and
the Guarantor in respect of the Collateral, (b) the First
Lien Obligations include all interest that accrues after the
commencement of any insolvency or liquidation proceeding of the
Issuer or any Guarantor at the rate provided for in the
applicable First Lien Documents governing the same, whether or
not a claim for post-petition interest is allowed or allowable
in any such insolvency or liquidation proceeding and
(c) the Intercreditor Agreement constitutes a
subordination agreement under Section 510 of
the Bankruptcy Code.
Release
of Collateral
The Issuer and the Guarantors are entitled to the release of
property and other assets constituting Collateral from the Liens
securing the Notes and the Junior Lien Obligations under any one
or more of the following circumstances:
(1) to enable us to consummate the sale, transfer or other
disposition of such property or assets to the extent not
prohibited under the covenant described under
Repurchase at the Option of
Holders Asset Sales;
(2) the release of Excess Proceeds or Collateral Excess
Proceeds that remain unexpended after the conclusion of an Asset
Sale Offer or a Collateral Asset Sale Offer conducted in
accordance with the Indenture;
125
(3) in the case of a Guarantor that is released from its
Guarantee with respect to the Notes pursuant to the terms of the
Indenture, the release of the property and assets of such
Guarantor;
(4) with the consent of the holders of at least 75% of the
aggregate principal amount of the Notes then outstanding and
affected thereby and a majority of all Junior Lien Obligations
(including the Notes) then outstanding and affected thereby
(including, without limitation, consents obtained in connection
with a tender offer or exchange offer for, or purchase of,
Junior Lien Obligations); or
(5) as described under Amendment,
Supplement and Waiver below.
The Junior Liens on any Collateral securing the Junior Lien
Obligations will also terminate and be released automatically if
the First Priority Liens on such Collateral securing First Lien
Obligations are released by the First Lien Collateral Agent on
behalf of the First Lien Secured Parties, unless such release
occurs in connection with, and after giving effect to, a
Discharge of First Lien Obligations, which discharge is not in
connection with a foreclosure of, or other exercise of remedies
with respect to, Collateral by the First Lien Secured Parties
(such discharge not in connection with any such foreclosure or
exercise of remedies, a Payment Discharge)
(provided that, in the case of a Payment Discharge, the
Liens on any Collateral disposed of in connection with the
satisfaction in whole or in part of First Lien Obligations shall
be automatically released but any proceeds thereof not used for
purposes of the Discharge of First Lien Obligations or otherwise
in accordance with the Indenture shall be subject to Liens in
favor of the Junior Lien Secured Parties). In the event of a
Payment Discharge, the Junior Liens on Collateral shall become
first-priority security interests, subject to Permitted Liens,
any intercreditor agreements or arrangements among Junior Lien
Secured Parties permitted under the General Intercreditor
Agreement and, with respect to Shared Receivables Collateral,
subject to the Shared Receivables Intercreditor Agreement;
provided that if the Issuer or the Guarantors incur at
any time thereafter any new or replacement First Lien
Obligations permitted under the Indenture, then such Payment
Discharge shall automatically be deemed not to have occurred for
all purposes of the General Intercreditor Agreement, the First
Lien Documents and the Junior Lien Documents, and such new
Obligations shall automatically be treated as First Lien
Obligations for all purposes of the General Intercreditor
Agreement, including for purposes of the Lien priorities and
rights in respect of Collateral set forth therein, and the
related documents shall be treated as First Lien Documents.
To the extent necessary and for so long as required for such
Subsidiary not to be subject to any requirement pursuant to
Rule 3-16
of
Regulation S-X
under the Securities Act to file separate financial statements
with the SEC (or any other governmental agency), the Capital
Stock of any Subsidiary of the Company (excluding Healthtrust,
Inc. The Hospital Company, a Delaware corporation
and its successors and assigns) shall not be included in the
Collateral with respect to the respective Notes so affected (as
described under Certain Limitations on the
Collateral) and shall not be subject to the Liens securing
such Notes and the Junior Lien Obligations.
The Junior Liens on the Collateral securing the Notes and the
Guarantees also will be released upon (i) payment in full
of the principal of, together with accrued and unpaid interest
(including Additional Interest, if any) on, the Notes and all
other Obligations under the Indenture, the Guarantees and the
Security Documents (including the 2006 Notes) that are due and
payable at or prior to the time such principal, together with
accrued and unpaid interest (including Additional Interest, if
any), are paid or (ii) a legal defeasance or covenant
defeasance under the Indenture as described below under
Legal Defeasance and Covenant Defeasance or a
discharge of the Indenture as described under Satisfaction
and Discharge.
Any certificate or opinion required by Section 314(d) of
the Trust Indenture Act may be made by an Officer of the
Company, except in cases where Section 314(d) requires that
such certificate or opinion be made by an independent engineer,
appraiser or other expert.
Notwithstanding anything to the contrary herein, the Issuer and
its Subsidiaries will not be required to comply with all or any
portion of Section 314(d) of the Trust Indenture Act
if they determine, in good faith based on advice of counsel,
that under the terms of that section
and/or any
interpretation or guidance as to the meaning thereof of the SEC
and its staff, including no action letters or
exemptive orders, all or any portion of Section 314(d) of
the Trust Indenture Act is inapplicable to the released
Collateral.
126
Without limiting the generality of the foregoing, certain no
action letters issued by the SEC have permitted an indenture
qualified under the Trust Indenture Act to contain
provisions permitting the release of collateral from Liens under
such indenture in the ordinary course of the issuers
business without requiring the issuer to provide certificates
and other documents under Section 314(d) of the
Trust Indenture Act. The Issuer and the Guarantors may,
subject to the provisions of the Indenture, among other things,
without any release or consent by the Junior Lien Collateral
Agent, conduct ordinary course activities with respect to the
Collateral, including, without limitation:
|
|
|
|
|
selling or otherwise disposing of, in any transaction or series
of related transactions, any property subject to the Lien of the
Security Documents that has become worn out, defective, obsolete
or not used or useful in the business;
|
|
|
|
abandoning, terminating, canceling, releasing or making
alterations in or substitutions of any leases or contracts
subject to the Lien of the Indenture or any of the Security
Documents;
|
|
|
|
surrendering or modifying any franchise, license or permit
subject to the Lien of the Security Documents that it may own or
under which it may be operating;
|
|
|
|
altering, repairing, replacing, changing the location or
position of and adding to its structures, machinery, systems,
equipment, fixtures and appurtenances;
|
|
|
|
granting a license of any intellectual property;
|
|
|
|
selling, transferring or otherwise disposing of inventory in the
ordinary course of business;
|
|
|
|
collecting accounts receivable in the ordinary course of
business as permitted by the covenant described under
Repurchase at the Option of Holders Asset
Sales;
|
|
|
|
making cash payments (including for the repayment of
Indebtedness or interest) from cash that is at any time part of
the Collateral in the ordinary course of business that are not
otherwise prohibited by the Indenture and the Security
Documents; and
|
|
|
|
abandoning any intellectual property that is no longer used or
useful in the Issuers business.
|
The Issuer must deliver an Officers Certificate to the
Junior Lien Collateral Agent within 30 calendar days following
the end of each six-month period beginning on May 15 and
November 15 of each year, to the effect that all such releases
and withdrawals during the preceding six-month period in the
ordinary course of the Issuers or the Guarantors
business, as described in the preceding paragraph, were not
prohibited by the Indenture.
Shared
Receivables Intercreditor Agreement
In addition, the Junior Lien Collateral Agent, have entered into
a joinder to the Shared Receivables Intercreditor Agreement
dated as of November 17, 2006 by and among the trustee
under the 2006 Notes, the administrative agent under the General
Credit Facility and the administrative agent under the ABL
Facility (as the same may be amended from time to time, the
Shared Receivables Intercreditor Agreement)
with respect to the Shared Receivables Collateral. The Shared
Receivables Intercreditor Agreement contains provisions with
respect to the Shared Receivables Collateral and the relative
rights, privileges and obligations relating thereto as between
(a) the Junior Lien Collateral Agent, the other Junior Lien
Secured Parties, the First Lien Collateral Agent and the First
Lien Secured Parties and (b) the collateral agent with
respect to the ABL Facility (the ABL Collateral
Agent) and the ABL Secured Parties. The Shared Receivables
Intercreditor Agreement provides for first-priority Liens in the
Shared Receivables Collateral in favor of the ABL Secured
Parties, second-priority Liens in the Shared Receivables
Collateral in favor of the First Lien Secured Parties and
third-priority security interests in the Shared Receivables
Collateral in favor of the Junior Lien Secured Parties, in each
case, subject to Permitted Liens. The relative rights,
privileges and obligations with respect to the Shared
Receivables Collateral of the ABL Secured Parties, on the one
hand, and the Junior Lien Collateral Agent, the other Junior
Lien Secured Parties, the First Lien Collateral Agent and the
First Lien Secured Parties, on the other, are substantially
identical to the relative rights, privileges and obligations
with respect to the Non-
127
Receivables Collateral of the First Lien Secured Parties, on the
one hand, and the Junior Lien Secured Parties, on the other,
respectively, except that the Liens of the Junior Lien Secured
Parties in the Shared Receivables Collateral are third-priority
Liens and except to the extent customary or necessary with
respect to collateral of the type that constitutes Shared
Receivables Collateral.
Certain
Limitations on the Collateral
The Collateral securing the Notes does not include any of the
following assets:
(1) the property or assets owned by any Subsidiary of the
Issuer that is not a Guarantor, including each ABL Financing
Entity;
(2) any rights or interests of the Issuer or any Guarantor
in, to or under any agreement, contract, license, instrument,
document or other general intangible (referred to solely for
purposes of this clause (2) as a
Contract), any intellectual property or any
security or other investment property (i) to the extent the
security interest in such Collateral is prohibited by any
applicable contract, agreement or other instrument without the
consent of any other party thereto (other than a party to the
General Credit Facility or the Indenture or, in the case of
investment property, a Wholly-Owned Subsidiary), (ii) to
the extent the security interest in such Contract would give any
other party (other than a party to the General Credit Facility
or the Indenture or, in the case of investment property, a
Wholly-Owned Subsidiary) to such Collateral the right to
terminate its obligations thereunder or (iii) to the extent
all necessary consents to such grant of a security interest have
not been obtained from the other parties thereto (other than to
the extent that any such prohibition referred to in clauses (i),
(ii) and (iii) would be rendered ineffective pursuant
to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
successor provision or provisions) of any relevant jurisdiction
or any other applicable law); provided that this
limitation shall not affect, limit, restrict or impair the grant
by the Issuer or such Guarantor of a security interest in any
account receivable or any money or other amounts due or to
become due under any Contract;
(3) any equipment of the Issuer or any Guarantor that is
subject to, or secured by, a Capitalized Lease Obligation or
Purchase Money Obligations and any equipment that constitutes an
asset of an entity acquired in a transaction permitted by the
Indenture to the extent that such equipment subject to a Lien
permitted by the Indenture and the terms of the Indebtedness
secured by such Lien prohibit assignment of, or granting of a
security interest in, the Issuers or such Guarantors
rights and interests therein (other than to the extent that any
such prohibition would be rendered ineffective pursuant to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
successor provision or provisions) of any relevant jurisdiction
or any other applicable law); provided that immediately
upon the repayment of all Indebtedness secured by such Lien, the
Issuer or the Guarantor, as the case may be, shall be deemed to
have granted a security interest in all the rights and interests
with respect to such equipment;
(4) any Voting Stock that is issued by any Foreign
Subsidiary, if and to the extent that the inclusion of such
Voting Stock in the Collateral would cause the Collateral
pledged by the Issuer or the applicable Guarantor, as the case
may be, to include in the aggregate more than 65% of the total
combined voting power of all classes of Voting Stock of such
Foreign Subsidiary;
(5) any Capital Stock that is issued by a Subsidiary that
is not owned directly by the Issuer or a Guarantor;
(6) prior to the Discharge of First Lien Obligations and so
long as any First Lien Obligations are outstanding, any
Principal Properties;
(7) any Capital Stock and other securities of a Subsidiary
(excluding Healthtrust, Inc. The Hospital Company, a
Delaware corporation and its successors and assigns) to the
extent that the pledge of such Capital Stock and other
securities results in the Companys being required to file
separate financial statements of such Subsidiary with the SEC,
but only to the extent necessary to not be subject to such
requirement and only for so long as such requirement is in
existence and only with respect to the relevant Notes affected;
provided that neither the Issuer nor any Subsidiary shall
take any action in the form of a
128
reorganization, merger or other restructuring a principal
purpose of which is to provide for the release of the Lien on
any Capital Stock pursuant to this clause (7). In addition, in
the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
the SEC to require (or is replaced with another rule or
regulation, or any other law, rule or regulation is adopted,
which would require) the filing with the SEC (or any other
governmental agency) of separate financial statements of any
Subsidiary of the Company (excluding Healthtrust,
Inc. The Hospital Company, a Delaware corporation
and its successors and assigns) due to the fact that such
Subsidiarys Capital Stock secures the Notes affected
thereby, then the Capital Stock of such Subsidiary will
automatically be deemed not to be part of the Collateral
securing the relevant Notes affected thereby but only to the
extent necessary to not be subject to such requirement and only
for so long as required to not be subject to such requirement.
In such event, the Security Documents may be amended or
modified, without the consent of any holder of such Notes, to
the extent necessary to release the security interests in favor
of the applicable collateral agents on the shares of Capital
Stock that are so deemed to no longer constitute part of the
Collateral for the relevant Notes. In the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
the SEC to permit (or is replaced with another rule or
regulation, or any other law, rule or regulation is adopted,
which would permit) such Subsidiarys Capital Stock to
secure the Notes in excess of the amount then pledged without
the filing with the SEC (or any other governmental agency) of
separate financial statements of such Subsidiary, then the
Capital Stock of such Subsidiary will automatically be deemed to
be a part of the Collateral for the relevant Notes but only to
the extent necessary to not be subject to any such financial
statement requirement;
(8) certain non-Principal Properties that do not constitute
Non-Receivables Collateral;
(9) any deposit accounts, other bank or securities accounts
or cash of the Issuer or any Guarantor;
(10) any leaseholds and motor vehicles of the Issuer or any
Guarantor;
(11) any Capital Stock or securities convertible into or
exchangeable for Capital Stock (i) if, in the reasonable
judgment of the Issuer, the cost or other consequences of
pledging such Collateral shall be excessive in view of the
benefits to be obtained by the Junior Lien Secured Parties
therefrom or (ii) the pledge of such Collateral would
result in adverse tax consequences to the Issuer or any of its
Subsidiaries as reasonably determined by the Issuer and
identified in writing to the Junior Lien Collateral Agent;
(12) any collateral to the extent the grant of the security
interest therein would violate any requirement of law; and
(13) proceeds and products from any and all of the
foregoing excluded collateral described in clauses (1)
through (12), unless such proceeds or products would otherwise
constitute Collateral securing the Notes.
Sufficiency
of Collateral
The fair market value of the Collateral is subject to
fluctuations based on factors that include, among others, the
condition of the healthcare industry, the ability to sell the
Collateral in an orderly sale, general economic conditions, the
availability of buyers and similar factors. The amount to be
received upon a sale of the Collateral would also be dependent
on numerous factors, including, but not limited to, the actual
fair market value of the Collateral at such time and the timing
and the manner of the sale. By their nature, portions of the
Collateral may be illiquid and may have no readily ascertainable
market value. Accordingly, there can be no assurance that the
Collateral can be sold in a short period of time or in an
orderly manner. In addition, in the event of a bankruptcy, the
ability of the holders to realize upon any of the Collateral may
be subject to certain bankruptcy law limitations as described
below.
Certain
Bankruptcy Limitations
The right of the Trustee to repossess and dispose of the
Collateral upon the occurrence of an Event of Default would be
significantly impaired by any Bankruptcy Law in the event that a
bankruptcy case were to be commenced by or against the Company
or any Guarantor prior to the Trustees having repossessed
and
129
disposed of the Collateral. Upon the commencement of a case for
relief under the Bankruptcy Code, a secured creditor such as the
Trustee is prohibited from repossessing its security from a
debtor in a bankruptcy case, or from disposing of security
without bankruptcy court approval.
In view of the broad equitable powers of a U.S. bankruptcy
court, it is impossible to predict how long payments under the
Notes could be delayed following commencement of a bankruptcy
case, whether or when the Trustee could repossess or dispose of
the Collateral, the value of the Collateral at any time during a
bankruptcy case or whether or to what extent holders of the
Notes would be compensated for any delay in payment or loss of
value of the Collateral. The Bankruptcy Code permits only the
payment
and/or
accrual of post-petition interest, costs and attorneys
fees to a secured creditor during a debtors bankruptcy
case to the extent the value of such creditors interest in
the Collateral is determined by the bankruptcy court to exceed
the aggregate outstanding principal amount of the obligations
secured by the Collateral.
Furthermore, in the event a domestic or foreign bankruptcy court
determines that the value of the Collateral is not sufficient to
repay all amounts due on the Notes, the holders of the Notes
would hold secured claims only to the extent of the value of the
Collateral to which the holders of the Notes are entitled, and
unsecured claims with respect to such shortfall.
Paying
Agent and Registrar for the Notes
The Issuer must maintain one or more paying agents for the Notes
in the Borough of Manhattan, City of New York or Atlanta,
Georgia. The initial paying agent for the Notes is the Trustee.
The Issuer must also maintain a registrar with offices in the
Borough of Manhattan, City of New York or Atlanta, Georgia. The
initial registrar is the Trustee. The registrar maintains a
register reflecting ownership of the Notes outstanding from time
to time and makes payments on and facilitates transfer of Notes
on behalf of the Issuer.
The Issuer may change the paying agents or the registrars
without prior notice to the Holders. The Issuer or any of its
Subsidiaries may act as a paying agent or registrar.
Transfer
and Exchange
A Holder may transfer or exchange Notes in accordance with the
Indenture. The registrar and the Trustee may require a Holder to
furnish appropriate endorsements and transfer documents in
connection with a transfer of Notes. Holders will be required to
pay all taxes due on transfer. The Issuer will not be required
to transfer or exchange any Note selected for redemption. Also,
the Issuer will not be required to transfer or exchange any Note
for a period of 15 days before a selection of Notes to be
redeemed.
Principal,
Maturity and Interest
The Issuer issued $310.0 million in aggregate principal
amount of Notes in this offering. The Notes will mature on
February 15, 2017. Subject to compliance with the covenant
described below under the caption Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock,
the Issuer may issue additional Notes, from time to time after
this offering under the Indenture (any such Notes,
Additional Notes). Except as described under
Amendment, Supplement and Waiver, the Notes offered
by the Issuer and any Additional Notes subsequently issued under
the Indenture will be treated as a single class for all purposes
under the Indenture, including waivers, amendments, redemptions
and offers to purchase. Unless the context requires otherwise,
references to Notes for all purposes of the
Indenture and this Description of Notes include any
Additional Notes that are actually issued.
Interest on the Notes will accrue at the rate of
97/8%
per annum and is payable semi-annually in arrears on February 15
and August 15 commencing August 15, 2009, to the Holders of
record on the immediately preceding February 1 and
August 1. Interest on the Notes will accrue from the most
recent date to which interest has been paid or, if no interest
has been paid, from and including the Issue Date. Interest on
the Notes will be computed on the basis of a
360-day year
comprised of twelve
30-day
months.
130
Additional
Interest
Additional Interest may accrue on the Notes in certain
circumstances pursuant to the Registration Rights Agreement. All
references in the Indenture, in any context, to any interest or
other amount payable on or with respect to the Notes shall be
deemed to include any Additional Interest pursuant to the
Registration Rights Agreement. Principal of, premium, if any,
and interest on the Notes will be payable at the office or
agency of the Issuer maintained for such purpose within the City
and State of New York or, at the option of the Issuer, payment
of interest may be made by check mailed to the Holders of the
Notes at their respective addresses set forth in the register of
Holders; provided that all payments of principal,
premium, if any, and interest with respect to the Notes
represented by one or more global notes registered in the name
of or held by DTC or its nominee will be made by wire transfer
of immediately available funds to the accounts specified by the
Holder or Holders thereof. Until otherwise designated by the
Issuer, the Issuers office or agency in New York will be
the office of the Trustee maintained for such purpose.
Mandatory
Redemption; Offers to Purchase; Open Market Purchases
The Issuer will not be required to make any mandatory redemption
or sinking fund payments with respect to the Notes. However,
under certain circumstances, the Issuer may be required to offer
to purchase Notes as described under the caption
Repurchase at the Option of Holders. The Issuer may
at any time and from time to time purchase Notes in the open
market or otherwise.
Optional
Redemption
Except as set forth below, the Issuer is not entitled to redeem
Notes at its option prior to February 15, 2013.
At any time prior to February 15, 2013, the Issuer may
redeem all or a part of the Notes, upon not less than 30 nor
more than 60 days prior notice mailed by first-class
mail to the registered address of each Holder or otherwise in
accordance with the procedures of DTC, at a redemption price
equal to 100% of the principal amount of the Notes redeemed plus
the Applicable Premium as of, and accrued and unpaid interest
and Additional Interest, if any, to the date of redemption (the
Redemption Date), subject to the rights
of Holders of Notes on the relevant record date to receive
interest due on the relevant interest payment date.
On and after February 15, 2013, the Issuer may redeem the
Notes, in whole or in part, upon not less than 30 nor more than
60 days prior notice mailed by first-class mail to
the registered address of each Holder or otherwise in accordance
with the procedures of DTC, at the redemption prices (expressed
as percentages of principal amount of the Notes to be redeemed)
set forth below, plus accrued and unpaid interest thereon and
Additional Interest, if any, to the applicable
Redemption Date, subject to the right of Holders of record
on the relevant record date to receive interest due on the
relevant interest payment date, if redeemed during the
twelve-month period beginning on February 15 of each of the
years indicated below:
|
|
|
|
|
Year
|
|
Percentage
|
|
|
2013
|
|
|
104.938
|
%
|
2014
|
|
|
102.469
|
%
|
2015 and thereafter
|
|
|
100.000
|
%
|
In addition, until February 15, 2012, the Issuer may, at
its option, on one or more occasions redeem up to 35% of the
aggregate principal amount of Notes at a redemption price equal
to 109.875% of the aggregate principal amount thereof, plus
accrued and unpaid interest thereon and Additional Interest, if
any, to the applicable Redemption Date, subject to the
right of Holders of record on the relevant record date to
receive interest due on the relevant interest payment date, with
the net cash proceeds of one or more Equity Offerings;
provided that at least 50% of the sum of the original
aggregate principal amount of Notes issued under the Indenture
and the original principal amount of any Additional Notes that
are Notes issued under the Indenture after the Issue Date
remains outstanding immediately after the occurrence of each
such redemption; provided further that each such
redemption occurs within 90 days of the date of closing of
each such Equity Offering.
131
Any notice of any redemption may be given prior to the
redemption thereof, and any such redemption or notice may, at
the Issuers discretion, be subject to one or more
conditions precedent, including, but not limited to, completion
of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding Notes,
the Trustee shall select the Notes to be redeemed in the manner
described under Repurchase at the Option of
Holders Selection and Notice.
Repurchase
at the Option of Holders
Change
of Control
The Notes provide that if a Change of Control occurs, unless the
Issuer has previously or concurrently mailed a redemption notice
with respect to all the outstanding Notes as described under
Optional Redemption, the Issuer will make an offer
to purchase all of the Notes pursuant to the offer described
below (the Change of Control Offer) at a
price in cash (the Change of Control Payment)
equal to 101% of the aggregate principal amount thereof plus
accrued and unpaid interest and Additional Interest, if any, to
the date of purchase, subject to the right of Holders of the
Notes of record on the relevant record date to receive interest
due on the relevant interest payment date. Within 30 days
following any Change of Control, the Issuer will send notice of
such Change of Control Offer by first-class mail, with a copy to
the Trustee, to each Holder of Notes to the address of such
Holder appearing in the security register with a copy to the
Trustee or otherwise in accordance with the procedures of DTC,
with the following information:
(1) that a Change of Control Offer is being made pursuant
to the covenant entitled Change of Control and that
all Notes properly tendered pursuant to such Change of Control
Offer will be accepted for payment by the Issuer;
(2) the purchase price and the purchase date, which will be
no earlier than 30 days nor later than 60 days from
the date such notice is mailed (the Change of Control
Payment Date);
(3) that any Note not properly tendered will remain
outstanding and continue to accrue interest;
(4) that unless the Issuer defaults in the payment of the
Change of Control Payment, all Notes accepted for payment
pursuant to the Change of Control Offer will cease to accrue
interest on the Change of Control Payment Date;
(5) that Holders electing to have any Notes purchased
pursuant to a Change of Control Offer will be required to
surrender such Notes, with the form entitled Option of
Holder to Elect Purchase on the reverse of such Notes
completed, to the paying agent specified in the notice at the
address specified in the notice prior to the close of business
on the third Business Day preceding the Change of Control
Payment Date;
(6) that Holders will be entitled to withdraw their
tendered Notes and their election to require the Issuer to
purchase such Notes; provided that the paying agent receives,
not later than the close of business on the 30th day
following the date of the Change of Control notice, a telegram,
facsimile transmission or letter setting forth the name of the
Holder of the Notes, the principal amount of Notes tendered for
purchase, and a statement that such Holder is withdrawing its
tendered Notes and its election to have such Notes purchased;
(7) that if the Issuer is redeeming less than all of the
Notes, the Holders of the remaining Notes will be issued new
Notes and such new Notes will be equal in principal amount to
the unpurchased portion of the Notes surrendered. The
unpurchased portion of the Notes must be equal to $2,000 or an
integral multiple of $1,000 in excess thereof; and
(8) the other instructions, as determined by us, consistent
with the covenant described hereunder, that a Holder must follow.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder to the extent such laws or regulations
are applicable in connection with the repurchase of Notes
pursuant to a Change of Control Offer. To the extent that the
provisions of any
132
securities laws or regulations conflict with the provisions of
the Indenture, the Issuer will comply with the applicable
securities laws and regulations and shall not be deemed to have
breached its obligations described in the Indenture by virtue
thereof.
On the Change of Control Payment Date, the Issuer will, to the
extent permitted by law,
(1) accept for payment all Notes issued by it or portions
thereof properly tendered pursuant to the Change of Control
Offer;
(2) deposit with the paying agent an amount equal to the
aggregate Change of Control Payment in respect of all Notes or
portions thereof so tendered; and
(3) deliver, or cause to be delivered, to the Trustee for
cancellation the Notes so accepted together with an
Officers Certificate to the Trustee stating that such
Notes or portions thereof have been tendered to and purchased by
the Issuer.
The Senior Credit Facilities provide, and future credit
agreements or other agreements relating to Senior Indebtedness
to which the Issuer becomes a party may, provide that certain
change of control events with respect to the Issuer would
constitute a default thereunder (including a Change of Control
under the Indenture). If we experience a change of control that
triggers a default under our Senior Credit Facilities, we could
seek a waiver of such default or seek to refinance our Senior
Credit Facilities. In the event we do not obtain such a waiver
or refinance the Senior Credit Facilities, such default could
result in amounts outstanding under our Senior Credit Facilities
being declared due and payable and could cause a Receivables
Facility to be wound down.
Our ability to pay cash to the Holders of Notes following the
occurrence of a Change of Control may be limited by our
then-existing financial resources. Therefore, sufficient funds
may not be available when necessary to make any required
repurchases.
The Change of Control purchase feature of the Notes may in
certain circumstances make more difficult or discourage a sale
or takeover of us and, thus, the removal of incumbent
management. The Change of Control purchase feature is a result
of negotiations between the Initial Purchasers and us. We have
no present intention to engage in a transaction involving a
Change of Control, although it is possible that we could decide
to do so in the future. Subject to the limitations discussed
below, we could, in the future, enter into certain transactions,
including acquisitions, refinancings or other recapitalizations,
that would not constitute a Change of Control under the
Indenture, but that could increase the amount of indebtedness
outstanding at such time or otherwise affect our capital
structure or credit ratings. Restrictions on our ability to
incur additional Indebtedness are contained in the covenants
described under Certain Covenants Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock and Certain
Covenants Liens. Such restrictions in the
Indenture can be waived only with the consent of the Holders of
a majority in principal amount of the Notes then outstanding.
Except for the limitations contained in such covenants, however,
the Indenture does not contain any covenants or provisions that
may afford Holders of the Notes protection in the event of a
highly leveraged transaction.
The Issuer is not required to make a Change of Control Offer
following a Change of Control if a third party makes the Change
of Control Offer in the manner, at the times and otherwise in
compliance with the requirements set forth in the Indenture
applicable to a Change of Control Offer made by us and purchases
all Notes validly tendered and not withdrawn under such Change
of Control Offer. Notwithstanding anything to the contrary
herein, a Change of Control Offer may be made in advance of a
Change of Control, conditional upon such Change of Control, if a
definitive agreement is in place for the Change of Control at
the time of making of the Change of Control Offer.
The definition of Change of Control includes a
disposition of all or substantially all of the assets of the
Issuer to any Person. Although there is a limited body of case
law interpreting the phrase substantially all, there
is no precise established definition of the phrase under
applicable law. Accordingly, in certain circumstances there may
be a degree of uncertainty as to whether a particular
transaction would involve a disposition of all or
substantially all of the assets of the Issuer. As a
result, it may be unclear as to whether
133
a Change of Control has occurred and whether a Holder of Notes
may require the Issuer to make an offer to repurchase the Notes
as described above.
The provisions under the Indenture relating to the Issuers
obligation to make an offer to repurchase the Notes as a result
of a Change of Control may be waived or modified with the
written consent of the Holders of a majority in principal amount
of the Notes.
Asset
Sales
The Indenture provides that the Issuer will not, and will not
permit any of its Restricted Subsidiaries to consummate,
directly or indirectly, an Asset Sale, unless:
(1) the Issuer or such Restricted Subsidiary, as the case
may be, receives consideration at the time of such Asset Sale at
least equal to the fair market value (as determined in good
faith by the Issuer) of the assets sold or otherwise disposed
of; and
(2) except in the case of a Permitted Asset Swap, at least
75% of the consideration therefor received by the Issuer or such
Restricted Subsidiary, as the case may be, is in the form of
cash or Cash Equivalents; provided that the amount of:
(a) any liabilities (as shown on the Issuers or such
Restricted Subsidiarys most recent balance sheet or in the
footnotes thereto) of the Issuer or such Restricted Subsidiary,
other than liabilities that are by their terms subordinated to
the Notes, that are assumed by the transferee of any such assets
and for which the Issuer and all of its Restricted Subsidiaries
have been validly released by all creditors in writing,
(b) any securities received by the Issuer or such
Restricted Subsidiary from such transferee that are converted by
the Issuer or such Restricted Subsidiary into cash (to the
extent of the cash received) within 180 days following the
closing of such Asset Sale, and
(c) any Designated Non-cash Consideration received by the
Issuer or such Restricted Subsidiary in such Asset Sale having
an aggregate fair market value, taken together with all other
Designated Non-cash Consideration received pursuant to this
clause (c) that is at that time outstanding, not to exceed
5% of Total Assets at the time of the receipt of such Designated
Non-cash Consideration, with the fair market value of each item
of Designated Non-cash Consideration being measured at the time
received and without giving effect to subsequent changes in
value, shall be deemed to be cash for purposes of this provision
and for no other purpose.
Within 450 days after the receipt of any Net Proceeds of
any Asset Sale, the Issuer or such Restricted Subsidiary, at its
option, may apply the Net Proceeds from such Asset Sale,
(1) to permanently reduce:
(a) Obligations under Priority Lien Obligations and to
correspondingly reduce commitments with respect thereto;
(b) Obligations under Senior Indebtedness (other than any
Junior Lien Obligation) that is secured by a Lien permitted
under the Indenture (which Lien is senior to the Lien of the
Notes with respect to the Collateral), and to correspondingly
reduce commitments with respect thereto;
(c) Obligations under Junior Lien Obligations (and to
correspondingly reduce commitments with respect thereto) through
open-market purchases (to the extent such purchases are at or
above 100% of the principal amount thereof) or by making an
Asset Sale Offer or a Collateral Asset Sale Offer in accordance
with the procedures set forth below; provided that the
Issuer shall equally and ratably reduce Obligations under the
Notes as provided under Optional Redemption, through
open-market purchases or otherwise by making an offer (in
accordance with the procedures set forth below for an Asset Sale
Offer or a Collateral Asset Sale Offer) to all Holders to
purchase their Notes at 100% of the principal amount thereof,
plus the amount of accrued but unpaid interest, if any, on the
amount of the Notes that would otherwise be prepaid;
134
(d) Obligations under the Existing Notes which have a final
maturity date (as in effect on the Issue Date) on or prior to
November 15, 2016; provided that, at the time of,
and after giving effect to, such repurchase, redemption or
defeasance, the aggregate amount of Net Proceeds used to
repurchase, redeem or defease Existing Notes pursuant to this
subclause (d) following the Issue Date shall not exceed 5%
of the consolidated total assets of the Issuer and its
subsidiaries at such time; or
(e) Indebtedness of a Restricted Subsidiary that is not a
Guarantor, other than Indebtedness owed to the Issuer or another
Restricted Subsidiary (or any affiliate thereof);
(2) to make (a) an Investment in any one or more
businesses, provided that such Investment in any business
is in the form of the acquisition of Capital Stock and results
in the Issuer or another of its Restricted Subsidiaries, as the
case may be, owning an amount of the Capital Stock of such
business such that it constitutes a Restricted Subsidiary,
(b) capital expenditures or (c) acquisitions of other
assets, in each of (a), (b) and (c), used or useful in a
Similar Business; or
(3) to make an investment in (a) any one or more
businesses, provided that such Investment in any business
is in the form of the acquisition of Capital Stock and results
in the Issuer or another of its Restricted Subsidiaries, as the
case may be, owning an amount of the Capital Stock of such
business such that it constitutes a Restricted Subsidiary,
(b) properties or (c) acquisitions of other assets
that, in each of (a), (b) and (c), replace the businesses,
properties
and/or
assets that are the subject of such Asset Sale;
provided that, in the case of clauses (2) and
(3) above, a binding commitment shall be treated as a
permitted application of the Net Proceeds from the date of such
commitment so long as the Issuer, or such other Restricted
Subsidiary enters into such commitment with the good faith
expectation that such Net Proceeds will be applied to satisfy
such commitment within 180 days of such commitment (an
Acceptable Commitment) and, in the event any
Acceptable Commitment is later cancelled or terminated for any
reason before the Net Proceeds are applied in connection
therewith, the Issuer or such Restricted Subsidiary enters into
another Acceptable Commitment (a Second
Commitment) within 180 days of such cancellation
or termination; provided, further, that if any
Second Commitment is later cancelled or terminated for any
reason before such Net Proceeds are applied, then such Net
Proceeds shall constitute Excess Proceeds.
Any Net Proceeds from Asset Sales of Collateral that are not
invested or applied as set forth in the first sentence of the
preceding paragraph will be deemed to constitute
Collateral Excess Proceeds. When the
aggregate amount of Collateral Excess Proceeds exceeds
$200.0 million, the Issuer shall make an offer to all
Holders of the Notes and, if required by the terms of any Junior
Lien Obligations, including the 2006 Notes, which are not
subordinated to the Notes or Obligations secured by a Lien
permitted under the Indenture (which Lien is not subordinate to
the Lien of the Notes with respect to the Collateral), to the
holders of such Junior Lien Obligations or such other
Obligations (a Collateral Asset Sale Offer),
to purchase the maximum aggregate principal amount of the Notes
and such Junior Lien Obligations or such other Obligations that
is a minimum of $2,000 or an integral multiple of $1,000 in
excess thereof that may be purchased out of the Collateral
Excess Proceeds at an offer price in cash in an amount equal to
100% of the principal amount thereof, plus accrued and unpaid
interest and Additional Interest, if any, to the date fixed for
the closing of such offer, in accordance with the procedures set
forth in the Indenture. The Issuer will commence a Collateral
Asset Sale Offer with respect to Collateral Excess Proceeds
within ten Business Days after the date that Collateral Excess
Proceeds exceed $200.0 million by mailing the notice
required pursuant to the terms of the Indenture, with a copy to
the Trustee.
Any Net Proceeds from Asset Sales of non-Collateral that are not
invested or applied as provided and within the time period set
forth in the first sentence of the second preceding paragraph
will be deemed to constitute Excess Proceeds.
When the aggregate amount of Excess Proceeds exceeds
$200.0 million, the Issuer shall make an offer to all
Holders of the Notes and, if required or permitted by the terms
of any Senior Indebtedness, to the holders of such Senior
Indebtedness (an Asset Sale Offer), to
purchase the maximum aggregate principal amount of the Notes and
such Senior Indebtedness that is a minimum of $2,000 or an
integral multiple of $1,000 in excess thereof that may be
purchased out of the Excess Proceeds at an offer price in cash
in an amount equal to 100% of the principal amount thereof, plus
accrued and unpaid interest and Additional Interest, if any, to
the date fixed for the closing of such offer, in accordance with
the
135
procedures set forth in the Indenture. The Issuer will commence
an Asset Sale Offer with respect to Excess Proceeds within ten
Business Days after the date that Excess Proceeds exceed
$200.0 million by mailing the notice required pursuant to
the terms of the Indenture, with a copy to the Trustee.
To the extent that the aggregate amount of Notes and such Junior
Lien Obligations or Obligations secured by a Lien permitted by
the Indenture (which Lien is not subordinate to the Lien of the
Notes with respect to the Collateral) tendered pursuant to a
Collateral Asset Sale Offer is less than the Collateral Excess
Proceeds, the Issuer may use any remaining Collateral Excess
Proceeds for general corporate purposes, subject to other
covenants contained in the Indenture. To the extent that the
aggregate amount of Notes and such Senior Indebtedness tendered
pursuant to an Asset Sale Offer is less than the Excess
Proceeds, the Issuer may use any remaining Excess Proceeds for
general corporate purposes, subject to other covenants contained
in the Indenture. If the aggregate principal amount of Notes or
Junior Lien Obligations or such other Obligations surrendered by
such holders thereof exceeds the amount of Collateral Excess
Proceeds, the Trustee shall select the Notes and such Junior
Lien Obligations or such other Obligations to be purchased on a
pro rata basis based on the accreted value or principal amount
of the Notes or such Junior Lien Obligations or such other
Obligations tendered. If the aggregate principal amount of Notes
or the Senior Indebtedness surrendered by such holders thereof
exceeds the amount of Excess Proceeds, the Trustee shall select
the Notes and such Senior Indebtedness to be purchased on a pro
rata basis based on the accreted value or principal amount of
the Notes or such Senior Indebtedness tendered. Upon completion
of any such Collateral Asset Sale Offer or Asset Sale Offer, the
amount of Collateral Excess Proceeds or Excess Proceeds, as the
case may be, shall be reset at zero. Additionally, the Issuer
may, at its option, make a Collateral Asset Sale Offer or an
Asset Sale Offer using proceeds from any Asset Sale at any time
after consummation of such Asset Sale; provided that such
Collateral Asset Sale Offer or Asset Sale Offer shall be in an
aggregate amount of not less than $50.0 million. Upon
consummation of such Collateral Asset Sale Offer or Asset Sale
Offer, any Net Proceeds not required to be used to purchase
Notes shall not be deemed Excess Proceeds.
Pending the final application of any Net Proceeds pursuant to
this covenant, the holder of such Net Proceeds may apply such
Net Proceeds temporarily to reduce Indebtedness outstanding
under a revolving credit facility or otherwise invest such Net
Proceeds in any manner not prohibited by the Indenture.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder to the extent such laws or regulations
are applicable in connection with the repurchase of the Notes
pursuant to a Collateral Asset Sale Offer or an Asset Sale
Offer. To the extent that the provisions of any securities laws
or regulations conflict with the provisions of the Indenture,
the Issuer will comply with the applicable securities laws and
regulations and shall not be deemed to have breached its
obligations described in the Indenture by virtue thereof.
Selection
and Notice
If the Issuer is redeeming less than all of the Notes issued by
it at any time, the Trustee will select the Notes to be redeemed
(a) if the Notes are listed on any national securities
exchange, in compliance with the requirements of the principal
national securities exchange on which the Notes are listed,
(b) on a pro rata basis to the extent practicable or
(c) by lot or such other similar method in accordance with
the procedures of DTC.
Notices of purchase or redemption shall be mailed by first-class
mail, postage prepaid, at least 30 but not more than
60 days before the purchase or Redemption Date to each
Holder of Notes at such Holders registered address or
otherwise in accordance with the procedures of DTC, except that
redemption notices may be mailed more than 60 days prior to
a Redemption Date if the notice is issued in connection
with a defeasance of the Notes or a satisfaction and discharge
of the Indenture. If any Note is to be purchased or redeemed in
part only, any notice of purchase or redemption that relates to
such Note shall state the portion of the principal amount
thereof that has been or is to be purchased or redeemed.
The Issuer will issue a new Note in a principal amount equal to
the unredeemed portion of the original Note in the name of the
Holder upon cancellation of the original Note. Notes called for
redemption become due on the date fixed for redemption. On and
after the Redemption Date, interest ceases to accrue on
Notes or portions thereof called for redemption.
136
Certain
Covenants
Set forth below are summaries of certain covenants contained in
the Indenture. If on any date following the Issue Date
(i) the Notes have Investment Grade Ratings from both
Rating Agencies, and (ii) no Default has occurred and is
continuing under the Indenture (the occurrence of the events
described in the foregoing clauses (i) and (ii) being
collectively referred to as a Covenant Suspension
Event), the Issuer and the Restricted Subsidiaries
will not be subject to the following covenants (collectively,
the Suspended Covenants):
(1) Repurchase at the Option of Holders;
(2) Limitation on Restricted Payments;
(3) Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
(4) clause (4) of the first paragraph of
Merger, Consolidation or Sale of All or
Substantially All Assets;
(5) Transactions with
Affiliates; and
(6) Dividend and Other Payment Restrictions
Affecting Restricted Subsidiaries.
In the event that the Issuer and the Restricted Subsidiaries are
not subject to the Suspended Covenants under the Indenture for
any period of time as a result of the foregoing, and on any
subsequent date (the Reversion Date) one or
both of the Rating Agencies (a) withdraw their Investment
Grade Rating or downgrade the rating assigned to the Notes below
an Investment Grade Rating
and/or
(b) the Issuer or any of its Affiliates enters into an
agreement to effect a transaction that would result in a Change
of Control and one or more of the Rating Agencies indicate that
if consummated, such transaction (alone or together with any
related recapitalization or refinancing transactions) would
cause such Rating Agency to withdraw its Investment Grade Rating
or downgrade the ratings assigned to the Notes below an
Investment Grade Rating, then the Issuer and the Restricted
Subsidiaries will thereafter again be subject to the Suspended
Covenants under the Indenture with respect to future events,
including, without limitation, a proposed transaction described
in clause (b) above.
The period of time between the Suspension Date and the Reversion
Date is referred to in this description as the
Suspension Period. Additionally, upon the
occurrence of a Covenant Suspension Event, the amount of Excess
Proceeds from Net Proceeds shall be reset at zero. In the event
of any such reinstatement, no action taken or omitted to be
taken by the Issuer or any of its Restricted Subsidiaries prior
to such reinstatement will give rise to a Default or Event of
Default under the Indentures with respect to Notes; provided
that (1) with respect to Restricted Payments made after
any such reinstatement, the amount of Restricted Payments made
will be calculated as though the covenant described under the
caption Limitation on Restricted
Payments had been in effect prior to, but not during the
Suspension Period, provided that any Subsidiaries
designated as Unrestricted Subsidiaries during the Suspension
Period shall automatically become Restricted Subsidiaries on the
Reversion Date (subject to the Issuers right to
subsequently designate them as Unrestricted Subsidiaries in
compliance with the covenants set out below), and (2) all
Indebtedness incurred, or Disqualified Stock or Preferred Stock
issued, during the Suspension Period will be classified to have
been incurred or issued pursuant to clause (3) of the
second paragraph of Limitation on Incurrence
of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock.
There can be no assurance that the Notes will ever achieve or
maintain Investment Grade Ratings.
137
Limitation
on Restricted Payments
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly:
(I) declare or pay any dividend or make any payment or
distribution on account of the Issuers, or any of its
Restricted Subsidiaries Equity Interests, including any
dividend or distribution payable in connection with any merger
or consolidation other than:
(a) dividends or distributions by the Issuer payable solely
in Equity Interests (other than Disqualified Stock) of the
Issuer; or
(b) dividends or distributions by a Restricted Subsidiary
so long as, in the case of any dividend or distribution payable
on or in respect of any class or series of securities issued by
a Restricted Subsidiary other than a Wholly-Owned Subsidiary,
the Issuer or a Restricted Subsidiary receives at least its pro
rata share of such dividend or distribution in accordance with
its Equity Interests in such class or series of securities;
(II) purchase, redeem, defease or otherwise acquire or
retire for value any Equity Interests of the Issuer or any
direct or indirect parent of the Issuer, including in connection
with any merger or consolidation;
(III) make any principal payment on, or redeem, repurchase,
defease or otherwise acquire or retire for value in each case,
prior to any scheduled repayment, sinking fund payment or
maturity, any Subordinated Indebtedness, other than:
(a) Indebtedness permitted under clauses (7) and
(8) of the covenant described under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock; or
(b) the purchase, repurchase or other acquisition of
Subordinated Indebtedness purchased in anticipation of
satisfying a sinking fund obligation, principal installment or
final maturity, in each case due within one year of the date of
purchase, repurchase or acquisition; or
(IV) make any Restricted Investment
(all such payments and other actions set forth in
clauses (I) through (IV) above (other than any
exception thereto) being collectively referred to as
Restricted Payments), unless, at the time of
such Restricted Payment:
(1) no Default shall have occurred and be continuing or
would occur as a consequence thereof;
(2) immediately after giving effect to such transaction on
a pro forma basis, the Issuer could incur $1.00 of additional
Indebtedness under the provisions of the first paragraph of the
covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock; and
(3) such Restricted Payment, together with the aggregate
amount of all other Restricted Payments made by the Issuer and
its Restricted Subsidiaries after November 17, 2006
(including Restricted Payments permitted by clauses (1), (2)
(with respect to the payment of dividends on Refunding Capital
Stock (as defined below) pursuant to clause (b) thereof
only), (6)(c), (9) and (14) of the next succeeding
paragraph, but excluding all other Restricted Payments permitted
by the next succeeding paragraph), is less than the sum of
(without duplication):
(a) 50% of the Consolidated Net Income of the Issuer for
the period (taken as one accounting period) beginning
October 1, 2006, to the end of the Issuers most
recently ended fiscal quarter for which internal financial
statements are available at the time of such Restricted Payment,
or, in the case such Consolidated Net Income for such period is
a deficit, minus 100% of such deficit; plus
(b) 100% of the aggregate net cash proceeds and the fair
market value, as determined in good faith by the Issuer, of
marketable securities or other property received by the Issuer
since
138
immediately after November 17, 2006 (other than net cash
proceeds to the extent such net cash proceeds have been used to
incur Indebtedness, Disqualified Stock or Preferred Stock
pursuant to clause (12)(a) of the second paragraph of
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock) from
the issue or sale of:
(i) (A) Equity Interests of the Issuer, including
Treasury Capital Stock (as defined below), but excluding cash
proceeds and the fair market value, as determined in good faith
by the Issuer, of marketable securities or other property
received from the sale of:
(x) Equity Interests to members of management, directors or
consultants of the Issuer, any direct or indirect parent company
of the Issuer and the Issuers Subsidiaries after
November 17, 2006 to the extent such amounts have been
applied to Restricted Payments made in accordance with
clause (4) of the next succeeding paragraph; and
(y) Designated Preferred Stock; and
(B) to the extent such net cash proceeds are actually
contributed to the Issuer, Equity Interests of the Issuers
direct or indirect parent companies (excluding contributions of
the proceeds from the sale of Designated Preferred Stock of such
companies or contributions to the extent such amounts have been
applied to Restricted Payments made in accordance with
clause (4) of the next succeeding paragraph); or
(ii) debt securities of the Issuer that have been converted
into or exchanged for such Equity Interests of the Issuer;
provided, however, that this clause (b) shall
not include the proceeds from (V) Refunding Capital Stock
(as defined below), (W) Equity Interests or convertible
debt securities of the Issuer sold to a Restricted Subsidiary,
as the case may be, (X) Disqualified Stock or debt
securities that have been converted into Disqualified Stock,
(Y) Excluded Contributions or (Z) the Delayed Equity
Amount; plus
(c) 100% of the aggregate amount of cash and the fair
market value, as determined in good faith by the Issuer, of
marketable securities or other property contributed to the
capital of the Issuer following November 17, 2006 (other
than net cash proceeds to the extent such net cash proceeds
(i) have been used to incur Indebtedness, Disqualified
Stock or Preferred Stock pursuant to clause (12)(a) of the
second paragraph of Limitation on Incurrence
of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock, (ii) are contributed by a Restricted
Subsidiary, (iii) constitute Excluded Contributions or
(iv) constitute the Delayed Equity Amount); plus
(d) 100% of the aggregate amount received in cash and the
fair market value, as determined in good faith by the Issuer, of
marketable securities or other property received by means of:
(i) the sale or other disposition (other than to the Issuer
or a Restricted Subsidiary) of Restricted Investments made by
the Issuer or its Restricted Subsidiaries and repurchases and
redemptions of such Restricted Investments from the Issuer or
its Restricted Subsidiaries and repayments of loans or advances,
and releases of guarantees, which constitute Restricted
Investments by the Issuer or its Restricted Subsidiaries, in
each case after November 17, 2006; or
(ii) the sale (other than to the Issuer or a Restricted
Subsidiary) of the stock of an Unrestricted Subsidiary or a
distribution from an Unrestricted Subsidiary (other than in each
case to the extent the Investment in such Unrestricted
Subsidiary was made by the Issuer or a Restricted Subsidiary
pursuant to clause (7) of the next succeeding paragraph or
to the extent such Investment constituted a Permitted
Investment) or a dividend from an Unrestricted Subsidiary after
November 17, 2006; plus
(e) in the case of the redesignation of an Unrestricted
Subsidiary as a Restricted Subsidiary after November 17,
2006, the fair market value of the Investment in such
Unrestricted Subsidiary, as
139
determined by the Issuer in good faith (or if such fair market
value exceeds $250.0 million, in writing by an Independent
Financial Advisor), at the time of the redesignation of such
Unrestricted Subsidiary as a Restricted Subsidiary other than to
the extent the Investment in such Unrestricted Subsidiary was
made by the Issuer or a Restricted Subsidiary pursuant to
clause (7) of the next succeeding paragraph or to the
extent such Investment constituted a Permitted Investment.
The foregoing provisions will not prohibit:
(1) the payment of any dividend within 60 days after
the date of declaration thereof, if at the date of declaration
such payment would have complied with the provisions of the
Indenture;
(2) (a) the redemption, repurchase, retirement or
other acquisition of any Equity Interests (Treasury
Capital Stock) or Subordinated Indebtedness of the
Issuer or any Equity Interests of any direct or indirect parent
company of the Issuer, in exchange for, or out of the proceeds
of the substantially concurrent sale (other than to a Restricted
Subsidiary) of, Equity Interests of the Issuer or any direct or
indirect parent company of the Issuer to the extent contributed
to the Issuer (in each case, other than any Disqualified Stock)
(Refunding Capital Stock) and (b) if
immediately prior to the retirement of Treasury Capital Stock,
the declaration and payment of dividends thereon was permitted
under clause (6) of this paragraph, the declaration and
payment of dividends on the Refunding Capital Stock (other than
Refunding Capital Stock the proceeds of which were used to
redeem, repurchase, retire or otherwise acquire any Equity
Interests of any direct or indirect parent company of the
Issuer) in an aggregate amount per year no greater than the
aggregate amount of dividends per annum that were declarable and
payable on such Treasury Capital Stock immediately prior to such
retirement;
(3) the redemption, repurchase or other acquisition or
retirement of Subordinated Indebtedness of the Issuer or a
Guarantor made in exchange for, or out of the proceeds of the
substantially concurrent sale of, new Indebtedness of the Issuer
or a Guarantor, as the case may be, which is incurred in
compliance with Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock so long as:
(a) the principal amount (or accreted value) of such new
Indebtedness does not exceed the principal amount of (or
accreted value, if applicable), plus any accrued and unpaid
interest on, the Subordinated Indebtedness being so redeemed,
repurchased, acquired or retired for value, plus the amount of
any reasonable premium (including reasonable tender premiums),
defeasance costs and any reasonable fees and expenses incurred
in connection with the issuance of such new Indebtedness;
(b) such new Indebtedness is subordinated to the Notes or
the applicable Guarantee at least to the same extent as such
Subordinated Indebtedness so purchased, exchanged, redeemed,
repurchased, acquired or retired for value;
(c) such new Indebtedness has a final scheduled maturity
date equal to or later than the final scheduled maturity date of
the Subordinated Indebtedness being so redeemed, repurchased,
acquired or retired; and
(d) such new Indebtedness has a Weighted Average Life to
Maturity equal to or greater than the remaining Weighted Average
Life to Maturity of the Subordinated Indebtedness being so
redeemed, repurchased, acquired or retired;
(4) a Restricted Payment to pay for the repurchase,
retirement or other acquisition or retirement for value of
Equity Interests (other than Disqualified Stock) of the Issuer
or any of its direct or indirect parent companies held by any
future, present or former employee, director or consultant of
the Issuer, any of its Subsidiaries or any of its direct or
indirect parent companies pursuant to any management equity plan
or stock option plan or any other management or employee benefit
plan or agreement, including any Equity Interests rolled over by
management of the Company or any of its direct or indirect
parent companies in connection with the Transaction;
provided, however, that the aggregate Restricted
Payments made under this clause (4) do not exceed in any
calendar year $75.0 million (which shall increase to
140
$150.0 million subsequent to the consummation of an
underwritten public Equity Offering by the Issuer or any direct
or indirect parent entity of the Issuer) (with unused amounts in
any calendar year being carried over to succeeding calendar
years subject to a maximum (without giving effect to the
following proviso) of $225.0 million in any calendar year
(which shall increase to $450.0 million subsequent to the
consummation of an underwritten public Equity Offering by the
Issuer or any direct or indirect parent corporation of the
Issuer)); provided further that such amount in any
calendar year may be increased by an amount not to exceed:
(a) the cash proceeds from the sale of Equity Interests
(other than Disqualified Stock) of the Issuer and, to the extent
contributed to the Issuer, Equity Interests of any of the
Issuers direct or indirect parent companies, in each case
to members of management, directors or consultants of the
Issuer, any of its Subsidiaries or any of its direct or indirect
parent companies that occurs after November 17, 2006, to
the extent the cash proceeds from the sale of such Equity
Interests have not otherwise been applied to the payment of
Restricted Payments by virtue of clause (3) of the
preceding paragraph; plus
(b) the cash proceeds of key man life insurance policies
received by the Issuer or its Restricted Subsidiaries after
November 17, 2006; less
(c) the amount of any Restricted Payments previously made
with the cash proceeds described in clauses (a) and
(b) of this clause (4);
and provided, further, that cancellation of
Indebtedness owing to the Issuer or any Restricted Subsidiary
from members of management of the Issuer, any of the
Issuers direct or indirect parent companies or any of the
Issuers Restricted Subsidiaries in connection with a
repurchase of Equity Interests of the Issuer or any of its
direct or indirect parent companies will not be deemed to
constitute a Restricted Payment for purposes of this covenant or
any other provision of the Indenture;
(5) the declaration and payment of dividends to holders of
any class or series of Disqualified Stock of the Issuer or any
of its Restricted Subsidiaries or any class or series of
Preferred Stock of any Restricted Subsidiary issued in
accordance with the covenant described under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock to the
extent such dividends are included in the definition of
Fixed Charges;
(6) (a) the declaration and payment of dividends to
holders of any class or series of Designated Preferred Stock
(other than Disqualified Stock) issued by the Issuer after
November 17, 2006;
(b) the declaration and payment of dividends to a direct or
indirect parent company of the Issuer, the proceeds of which
will be used to fund the payment of dividends to holders of any
class or series of Designated Preferred Stock (other than
Disqualified Stock) of such parent corporation issued after the
Issue Date; provided that the amount of dividends paid pursuant
to this clause (b) shall not exceed the aggregate amount of
cash actually contributed to the Issuer from the sale of such
Designated Preferred Stock; or
(c) the declaration and payment of dividends on Refunding
Capital Stock that is Preferred Stock in excess of the dividends
declarable and payable thereon pursuant to clause (2) of
this paragraph;
provided, however, in the case of each of
(a) and (c) of this clause (6), that for the most
recently ended four full fiscal quarters for which internal
financial statements are available immediately preceding the
date of issuance of such Designated Preferred Stock or the
declaration of such dividends on Refunding Capital Stock that is
Preferred Stock, after giving effect to such issuance or
declaration on a pro forma basis, the Issuer and its Restricted
Subsidiaries on a consolidated basis would have had a Fixed
Charge Coverage Ratio of at least 2.00 to 1.00;
(7) Investments in Unrestricted Subsidiaries having an
aggregate fair market value, taken together with all other
Investments made pursuant to this clause (7) that are at
the time outstanding, without giving effect to the sale of an
Unrestricted Subsidiary to the extent the proceeds of such sale
do not consist of cash or marketable securities, not to exceed
2.5% of Total Assets at the time of such Investment (with the
141
fair market value of each Investment being measured at the time
made and without giving effect to subsequent changes in value);
(8) repurchases of Equity Interests deemed to occur upon
exercise of stock options or warrants if such Equity Interests
represent a portion of the exercise price of such options or
warrants;
(9) the declaration and payment of dividends on the
Issuers common stock (or the payment of dividends to any
direct or indirect parent entity to fund a payment of dividends
on such entitys common stock), following consummation of
the first public offering of the Issuers common stock or
the common stock of any of its direct or indirect parent
companies after November 17, 2006, of up to 6% per annum of
the net cash proceeds received by or contributed to the Issuer
in or from any such public offering, other than public offerings
with respect to the Issuers common stock registered on
Form S-8
and other than any public sale constituting an Excluded
Contribution;
(10) Restricted Payments that are made with Excluded
Contributions;
(11) other Restricted Payments in an aggregate amount taken
together with all other Restricted Payments made pursuant to
this clause (11) not to exceed 3.0% of Total Assets at the
time made;
(12) distributions or payments of Receivables Fees;
(13) any Restricted Payment used to fund amounts owed to
Affiliates (including dividends to any direct or indirect parent
of the Issuer to permit payment by such parent of such amount),
in each case to the extent permitted by the covenant described
under Transactions with Affiliates;
(14) the repurchase, redemption or other acquisition or
retirement for value of any Subordinated Indebtedness in
accordance with the provisions similar to those described under
the captions Repurchase at the Option of
Holders Change of Control and Repurchase
at the Option of Holders Asset Sales; provided
that all Notes tendered by Holders in connection with a Change
of Control Offer, Collateral Asset Sale Offer or Asset Sale
Offer, as applicable, have been repurchased, redeemed or
acquired for value;
(15) the declaration and payment of dividends by the Issuer
to, or the making of loans to, any direct or indirect parent in
amounts required for any direct or indirect parent companies to
pay, in each case without duplication,
(a) franchise and excise taxes and other fees, taxes and
expenses required to maintain their corporate existence;
(b) foreign, federal, state and local income taxes, to the
extent such income taxes are attributable to the income of the
Issuer and its Restricted Subsidiaries and, to the extent of the
amount actually received from its Unrestricted Subsidiaries, in
amounts required to pay such taxes to the extent attributable to
the income of such Unrestricted Subsidiaries; provided that in
each case the amount of such payments in any fiscal year does
not exceed the amount that the Issuer and its Restricted
Subsidiaries would be required to pay in respect of foreign,
federal, state and local taxes for such fiscal year were the
Issuer, its Restricted Subsidiaries and its Unrestricted
Subsidiaries (to the extent described above) to pay such taxes
separately from any such parent entity;
(c) for as long as Hercules Holding II, LLC is a parent of
the Issuer, distributions equal to any taxable income of
Hercules Holding II, LLC resulting from the Hedging Arrangements
multiplied by 45%;
(d) customary salary, bonus and other benefits payable to
officers and employees of any direct or indirect parent company
of the Issuer to the extent such salaries, bonuses and other
benefits are attributable to the ownership or operation of the
Issuer and its Restricted Subsidiaries;
(e) general corporate operating and overhead costs and
expenses of any direct or indirect parent company of the Issuer
to the extent such costs and expenses are attributable to the
ownership or operation of the Issuer and its Restricted
Subsidiaries; and
142
(f) fees and expenses other than to Affiliates of the
Issuer related to any unsuccessful equity or debt offering of
such parent entity; and
(16) the distribution, by dividend or otherwise, of shares
of Capital Stock of, or Indebtedness owed to the Issuer or a
Restricted Subsidiary by, Unrestricted Subsidiaries (other than
Unrestricted Subsidiaries, the primary assets of which are cash
and/or Cash
Equivalents);
provided, however, that at the time of, and after
giving effect to, any Restricted Payment permitted under
clauses (11) and (16), no Default shall have occurred and
be continuing or would occur as a consequence thereof.
As of the Issue Date, all of the Issuers Subsidiaries are
Restricted Subsidiaries. The Issuer will not permit any
Unrestricted Subsidiary to become a Restricted Subsidiary except
pursuant to the last sentence of the definition of
Unrestricted Subsidiary. For purposes of designating
any Restricted Subsidiary as an Unrestricted Subsidiary, all
outstanding Investments by the Issuer and its Restricted
Subsidiaries (except to the extent repaid) in the Subsidiary so
designated will be deemed to be Restricted Payments in an amount
determined as set forth in the last sentence of the definition
of Investment. Such designation will be permitted
only if a Restricted Payment in such amount would be permitted
at such time, whether pursuant to the first paragraph of this
covenant or under clause (7), (10) or (11) of the
second paragraph of this covenant, or pursuant to the definition
of Permitted Investments, and if such Subsidiary
otherwise meets the definition of an Unrestricted Subsidiary.
Unrestricted Subsidiaries are not be subject to any of the
restrictive covenants set forth in the Indenture.
Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly, create, incur, issue,
assume, guarantee or otherwise become directly or indirectly
liable, contingently or otherwise (collectively,
incur and collectively, an
incurrence) with respect to any Indebtedness
(including Acquired Indebtedness), and the Issuer will not issue
any shares of Disqualified Stock and will not permit any
Restricted Subsidiary to issue any shares of Disqualified Stock
or Preferred Stock; provided, however, that the
Issuer may incur Indebtedness (including Acquired Indebtedness)
or issue shares of Disqualified Stock, and any of its Restricted
Subsidiaries may incur Indebtedness (including Acquired
Indebtedness), issue shares of Disqualified Stock and issue
shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
a consolidated basis for the Issuer and its Restricted
Subsidiaries most recently ended four fiscal quarters for
which internal financial statements are available immediately
preceding the date on which such additional Indebtedness is
incurred or such Disqualified Stock or Preferred Stock is issued
would have been at least 2.00 to 1.00, determined on a pro forma
basis (including a pro forma application of the net proceeds
therefrom), as if the additional Indebtedness had been incurred,
or the Disqualified Stock or Preferred Stock had been issued, as
the case may be, and the application of proceeds therefrom had
occurred at the beginning of such four-quarter period;
provided, further, that Restricted Subsidiaries that are
not Guarantors may not incur Indebtedness or Disqualified Stock
or Preferred Stock if, after giving pro forma effect to such
incurrence or issuance (including a pro forma application of the
net proceeds therefrom), more than an aggregate of
$2,000.0 million of Indebtedness or Disqualified Stock or
Preferred Stock of Restricted Subsidiaries that are not
Guarantors would be outstanding pursuant to this paragraph and
clauses (12), (14) and (19) below at such time.
The foregoing limitations will not apply to:
(1) the incurrence of Indebtedness under (x) Credit
Facilities (other than the ABL Facility) by the Issuer or any of
its Restricted Subsidiaries and the issuance and creation of
letters of credit and bankers acceptances thereunder (with
letters of credit and bankers acceptances being deemed to
have a principal amount equal to the face amount thereof), up to
an aggregate principal amount of $16,500.0 million
outstanding at any one time and (y) the ABL Facility by the
Issuer or any of its Restricted Subsidiaries and the issuance
and creation of letters of credit and bankers acceptances
thereunder (with letters of credit and bankers acceptances
being deemed to have a principal amount equal to the face amount
thereof), up to an aggregate principal amount equal to the ABL
Facility Cap;
143
(2) the incurrence by the Issuer and any Guarantor of
Indebtedness represented by the Notes (including any Guarantee)
(other than any Additional Notes and any Exchange Notes
(including Guarantees thereof));
(3) Indebtedness of the Issuer and its Restricted
Subsidiaries in existence on the Issue Date (other than
Indebtedness described in clauses (1) and (2)), including
the 2006 Notes and the Existing Notes;
(4) Indebtedness consisting of Capitalized Lease
Obligations and Purchase Money Obligations; so long as such
Indebtedness exists at the date of such purchase, lease or
improvement, or is created within 270 days thereafter;
(5) Indebtedness incurred by the Issuer or any of its
Restricted Subsidiaries constituting reimbursement obligations
with respect to letters of credit issued in the ordinary course
of business, including letters of credit in respect of
workers compensation, medical malpractice or employee
health claims, or other Indebtedness with respect to
reimbursement-type obligations regarding workers
compensation, medical malpractice or employee health claims;
provided, however, that upon the drawing of such letters of
credit or the incurrence of such Indebtedness, such obligations
are reimbursed within 30 days following such drawing or
incurrence;
(6) Indebtedness arising from agreements of the Issuer or
its Restricted Subsidiaries providing for indemnification,
adjustment of purchase price or similar obligations, in each
case, incurred or assumed in connection with the disposition of
any business, assets or a Subsidiary, other than guarantees of
Indebtedness incurred by any Person acquiring all or any portion
of such business, assets or a Subsidiary for the purpose of
financing such acquisition; provided, however, that such
Indebtedness is not reflected on the balance sheet of the
Issuer, or any of its Restricted Subsidiaries (contingent
obligations referred to in a footnote to financial statements
and not otherwise reflected on the balance sheet will not be
deemed to be reflected on such balance sheet for purposes of
this clause (6));
(7) Indebtedness of the Issuer to a Restricted Subsidiary;
provided that any such Indebtedness owing to a Restricted
Subsidiary that is not a Guarantor is expressly subordinated in
right of payment to the Notes; provided, further, that any
subsequent issuance or transfer of any Capital Stock or any
other event which results in any Restricted Subsidiary ceasing
to be a Restricted Subsidiary or any other subsequent transfer
of any such Indebtedness (except to the Issuer or another
Restricted Subsidiary) shall be deemed, in each case, to be an
incurrence of such Indebtedness;
(8) Indebtedness of a Restricted Subsidiary to the Issuer
or another Restricted Subsidiary; provided that if a Guarantor
incurs such Indebtedness to a Restricted Subsidiary that is not
a Guarantor, such Indebtedness is expressly subordinated in
right of payment to the Guarantee of the Notes of such
Guarantor; provided, further, that any subsequent transfer of
any such Indebtedness (except to the Issuer or another
Restricted Subsidiary) shall be deemed, in each case, to be an
incurrence of such Indebtedness not permitted by this clause (8);
(9) shares of Preferred Stock of a Restricted Subsidiary
issued to the Issuer or another Restricted Subsidiary; provided
that any subsequent issuance or transfer of any Capital Stock or
any other event which results in any such Restricted Subsidiary
ceasing to be a Restricted Subsidiary or any other subsequent
transfer of any such shares of Preferred Stock (except to the
Issuer or another of its Restricted Subsidiaries) shall be
deemed in each case to be an issuance of such shares of
Preferred Stock not permitted by this clause (9);
(10) Hedging Obligations (excluding Hedging Obligations
entered into for speculative purposes) for the purpose of
limiting interest rate risk with respect to any Indebtedness
permitted to be incurred pursuant to
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock,
exchange rate risk or commodity pricing risk;
(11) obligations in respect of performance, bid, appeal and
surety bonds and completion guarantees provided by the Issuer or
any of its Restricted Subsidiaries in the ordinary course of
business;
144
(12) (a) Indebtedness or Disqualified Stock of the
Issuer and Indebtedness, Disqualified Stock or Preferred Stock
of the Issuer or any Restricted Subsidiary equal to 200.0% of
the net cash proceeds received by the Issuer since immediately
after November 17, 2006 from the issue or sale of Equity
Interests of the Issuer or cash contributed to the capital of
the Issuer (in each case, other than Excluded Contributions or
proceeds of Disqualified Stock or sales of Equity Interests to
the Issuer or any of its Subsidiaries) as determined in
accordance with clauses (3)(b) and (3)(c) of the first paragraph
of Limitation on Restricted Payments to
the extent such net cash proceeds or cash have not been applied
pursuant to such clauses to make Restricted Payments or to make
other Investments, payments or exchanges pursuant to the second
paragraph of Limitation on Restricted
Payments or to make Permitted Investments (other than
Permitted Investments specified in clauses (1) and
(3) of the definition thereof) and (b) Indebtedness or
Disqualified Stock of Issuer and Indebtedness, Disqualified
Stock or Preferred Stock of the Issuer or any Restricted
Subsidiary not otherwise permitted hereunder in an aggregate
principal amount or liquidation preference, which when
aggregated with the principal amount and liquidation preference
of all other Indebtedness, Disqualified Stock and Preferred
Stock then outstanding and incurred pursuant to this clause
(12)(b), does not at any one time outstanding exceed
$1,500.0 million; provided, however, that on a pro forma
basis, together with any amounts incurred and outstanding by
Restricted Subsidiaries that are not Guarantors pursuant to the
second proviso to the first paragraph of this covenant and
clauses (14) and (19), no more than $2,000.0 million
of Indebtedness, Disqualified Stock or Preferred Stock at any
one time outstanding and incurred pursuant to this clause
(12)(b) shall be incurred by Restricted Subsidiaries that are
not Guarantors (it being understood that any Indebtedness,
Disqualified Stock or Preferred Stock incurred pursuant to this
clause (12)(b) shall cease to be deemed incurred or outstanding
for purposes of this clause (12)(b) but shall be deemed incurred
for the purposes of the first paragraph of this covenant from
and after the first date on which the Issuer or such Restricted
Subsidiary could have incurred such Indebtedness, Disqualified
Stock or Preferred Stock under the first paragraph of this
covenant without reliance on this clause (12)(b));
(13) the incurrence or issuance by the Issuer or any
Restricted Subsidiary of Indebtedness, Disqualified Stock or
Preferred Stock which serves to refund or refinance any
Indebtedness, Disqualified Stock or Preferred Stock of the
Issuer or any Restricted Subsidiary incurred as permitted under
the first paragraph of this covenant and clauses (2), (3),
(4) and (12)(a) above, this clause (13) and
clause (14) below or any Indebtedness, Disqualified Stock
or Preferred Stock of the Issuer or any Restricted Subsidiary
issued to so refund or refinance such Indebtedness, Disqualified
Stock or Preferred Stock of the Issuer or any Restricted
Subsidiary including additional Indebtedness, Disqualified Stock
or Preferred Stock incurred to pay premiums (including
reasonable tender premiums), defeasance costs and fees in
connection therewith (the Refinancing Indebtedness)
prior to its respective maturity; provided, however, that such
Refinancing Indebtedness:
(a) has a Weighted Average Life to Maturity at the time
such Refinancing Indebtedness is incurred which is not less than
the remaining Weighted Average Life to Maturity of the
Indebtedness, Disqualified Stock or Preferred Stock being
refunded or refinanced,
(b) to the extent such Refinancing Indebtedness refinances
(i) Indebtedness subordinated or pari passu to the
Notes or any Guarantee thereof, such Refinancing Indebtedness is
subordinated or pari passu to the Notes or the Guarantee
at least to the same extent as the Indebtedness being refinanced
or refunded or (ii) Disqualified Stock or Preferred Stock,
such Refinancing Indebtedness must be Disqualified Stock or
Preferred Stock, respectively, and
(c) shall not include Indebtedness, Disqualified Stock or
Preferred Stock of a Subsidiary of the Issuer that is not a
Guarantor that refinances Indebtedness, Disqualified Stock or
Preferred Stock of the Issuer or a Guarantor;
and, provided, further, that subclause (a) of
this clause (13) will not apply to any refunding or
refinancing of any Priority Lien Obligations and Obligations
secured by Permitted Liens;
(14) Indebtedness, Disqualified Stock or Preferred Stock of
(x) the Issuer or a Restricted Subsidiary incurred to
finance an acquisition or (y) Persons that are acquired by
the Issuer or any Restricted
145
Subsidiary or merged into the Issuer or a Restricted Subsidiary
in accordance with the terms of the Indenture; provided
that after giving effect to such acquisition or merger,
either
(a) the Issuer would be permitted to incur at least $1.00
of additional Indebtedness pursuant to the Fixed Charge Coverage
Ratio test set forth in the first sentence of this
covenant, or
(b) the Fixed Charge Coverage Ratio of the Issuer and the
Restricted Subsidiaries is greater than immediately prior to
such acquisition or merger;
provided, however, that on a pro forma basis,
together with amounts incurred and outstanding pursuant to the
second proviso to the first paragraph of this covenant and
clauses (12) and (19), no more than $2,000.0 million
of Indebtedness, Disqualified Stock or Preferred Stock at any
one time outstanding and incurred by Restricted Subsidiaries
that are not Guarantors pursuant to this clause (14) shall
be incurred and outstanding;
(15) Indebtedness arising from the honoring by a bank or
other financial institution of a check, draft or similar
instrument drawn against insufficient funds in the ordinary
course of business; provided that such Indebtedness is
extinguished within two Business Days of its incurrence;
(16) Indebtedness of the Issuer or any of its Restricted
Subsidiaries supported by a letter of credit issued pursuant to
any Credit Facilities, in a principal amount not in excess of
the stated amount of such letter of credit;
(17) (a) any guarantee by the Issuer or a Restricted
Subsidiary of Indebtedness or other obligations of any
Restricted Subsidiary, so long as the incurrence of such
Indebtedness incurred by such Restricted Subsidiary is permitted
under the terms of the Indenture, or (b) any guarantee by a
Restricted Subsidiary of Indebtedness of the Issuer; provided
that such guarantee is incurred in accordance with the
covenant described below under Limitation on
Guarantees of Indebtedness by Restricted Subsidiaries;
(18) Indebtedness of Foreign Subsidiaries of the Issuer in
an amount not to exceed at any one time outstanding and together
with any other Indebtedness incurred under this clause (18)
7.5% of the Total Assets of the Foreign Subsidiaries (it being
understood that any Indebtedness incurred pursuant to this
clause (18) shall cease to be deemed incurred or
outstanding for purposes of this clause (18) but shall be
deemed incurred for the purposes of the first paragraph of this
covenant from and after the first date on which the Issuer or
such Restricted Subsidiaries could have incurred such
Indebtedness under the first paragraph of this covenant without
reliance on this clause (18));
(19) Indebtedness, Disqualified Stock or Preferred Stock of
a Restricted Subsidiary incurred to finance or assumed in
connection with an acquisition in a principal amount not to
exceed $200.0 million in the aggregate at any one time
outstanding together with all other Indebtedness, Disqualified
Stock and/or
Preferred Stock issued under this clause (19) (it being
understood that any Indebtedness, Disqualified Stock or
Preferred Stock incurred pursuant to this clause (19) shall
cease to be deemed incurred or outstanding for purposes of this
clause (19) but shall be deemed incurred for the purposes
of the first paragraph of this covenant from and after the first
date on which such Restricted Subsidiary could have incurred
such Indebtedness, Disqualified Stock or Preferred Stock under
the first paragraph of this covenant without reliance on this
clause (19)); provided, however, that on a pro
forma basis, together with amounts incurred and outstanding by
Restricted Subsidiaries that are not Guarantors pursuant to the
second proviso to the first paragraph of this covenant and
clauses (12) and (14), no more than $2,000.0 million
of Indebtedness would be incurred and outstanding by Restricted
Subsidiaries that are not Guarantors;
(20) Indebtedness of the Issuer or any of its Restricted
Subsidiaries consisting of (i) the financing of insurance
premiums or
(ii) take-or-pay
obligations contained in supply arrangements, in each case,
incurred in the ordinary course of business;
(21) Indebtedness consisting of Indebtedness issued by the
Issuer or any of its Restricted Subsidiaries to current or
former officers, directors and employees thereof, their
respective estates, spouses or former spouses, in each case to
finance the purchase or redemption of Equity Interests of the
Issuer or
146
any direct or indirect parent company of the Issuer to the
extent described in clause (4) of the second paragraph
under the caption Limitation on Restricted
Payments;
(22) Physician Support Obligations incurred by the Issuer
or any Restricted Subsidiary; and
(23) Indebtedness of the Issuer or any of its Restricted
Subsidiaries undertaken in connection with cash management and
related activities with respect to any Subsidiary or joint
venture operating one or more healthcare facilities, including,
without limitation, hospitals, ambulatory surgery centers,
outpatient diagnostic centers or imaging centers, in each case,
in the ordinary course of business.
For purposes of determining compliance with this covenant:
(1) in the event that an item of Indebtedness, Disqualified
Stock or Preferred Stock (or any portion thereof) meets the
criteria of more than one of the categories of permitted
Indebtedness, Disqualified Stock or Preferred Stock described in
clauses (1) through (23) above or is entitled to be
incurred pursuant to the first paragraph of this covenant, the
Issuer, in its sole discretion, will classify or reclassify such
item of Indebtedness, Disqualified Stock or Preferred Stock (or
any portion thereof) and will only be required to include the
amount and type of such Indebtedness, Disqualified Stock or
Preferred Stock in one of the above clauses; provided
that all Indebtedness outstanding under the Credit
Facilities on November 17, 2006 will be treated as incurred
on November 17, 2006 under clause (1) of the preceding
paragraph; and
(2) at the time of incurrence, the Issuer will be entitled
to divide and classify an item of Indebtedness in more than one
of the types of Indebtedness described in the first and second
paragraphs above.
Accrual of interest, the accretion of accreted value and the
payment of interest in the form of additional Indebtedness,
Disqualified Stock or Preferred Stock will not be deemed to be
an incurrence of Indebtedness, Disqualified Stock or Preferred
Stock for purposes of this covenant.
For purposes of determining compliance with any
U.S. dollar-denominated restriction on the incurrence of
Indebtedness, the U.S. dollar-equivalent principal amount
of Indebtedness denominated in a foreign currency shall be
calculated based on the relevant currency exchange rate in
effect on the date such Indebtedness was incurred, in the case
of term debt, or first committed, in the case of revolving
credit debt; provided that if such Indebtedness is
incurred to refinance other Indebtedness denominated in a
foreign currency, and such refinancing would cause the
applicable U.S. dollar-denominated restriction to be
exceeded if calculated at the relevant currency exchange rate in
effect on the date of such refinancing, such
U.S. dollar-denominated restriction shall be deemed not to
have been exceeded so long as the principal amount of such
refinancing Indebtedness does not exceed the principal amount of
such Indebtedness being refinanced.
The principal amount of any Indebtedness incurred to refinance
other Indebtedness, if incurred in a different currency from the
Indebtedness being refinanced, shall be calculated based on the
currency exchange rate applicable to the currencies in which
such respective Indebtedness is denominated that is in effect on
the date of such refinancing.
The Indenture provides that the Issuer will not, and will not
permit any Guarantor to, directly or indirectly, incur any
Indebtedness (including Acquired Indebtedness) that is
subordinated or junior in right of payment to any Indebtedness
of the Issuer or such Guarantor, as the case may be, unless such
Indebtedness is expressly subordinated in right of payment to
the Notes or such Guarantors Guarantee to the extent and
in the same manner as such Indebtedness is subordinated to other
Indebtedness of the Issuer or such Guarantor, as the case may be.
The Indenture does not treat (1) unsecured Indebtedness as
subordinated or junior to Secured Indebtedness merely because it
is unsecured or (2) Senior Indebtedness as subordinated or
junior to any other Senior Indebtedness merely because it has a
junior priority with respect to the same collateral.
147
Limitation
on Prepayment or Modification of Existing Notes
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly purchase, redeem,
defease or otherwise acquire or retire for value any of the
Existing Notes prior to the final maturity date thereof (as in
effect on November 17, 2006); provided that the
Issuer may:
(1) purchase, redeem, defease or otherwise acquire or
retire for value any of the Existing Notes which have a final
maturity date (as in effect on November 17, 2006) on
or prior to December 31, 2011; and
(2) purchase, redeem, defease or otherwise acquire or
retire for value any other Existing Notes which have a final
maturity date (as in effect on November 17, 2006) on
or prior to November 15, 2016; provided that, in the
case of any such prepayment funded with the proceeds of the
issuance of Secured Indebtedness, at the time of incurrence and
after giving pro forma effect thereto and to the application of
the proceeds thereof, (x) the Consolidated Secured Debt
Ratio would be no greater than 5.25 to 1.0 and (y) the
Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, amend the Existing Notes Indenture, or any
supplemental indenture in respect thereof, in any way to advance
the final maturity date or shorten the Weighted Average Life to
Maturity of any series of the Existing Notes such that any
Existing Notes with a maturity date following the maturity of
the Notes would have a maturity date on or prior to the date one
year following the maturity date of the
91/4%
2006 Notes or which would prohibit the making of the Guarantees
or the creation of Liens in favor of the Notes and the
Guarantees on the Collateral.
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, designate any additional subsidiaries as
Restricted Subsidiaries (as defined in the Existing
Notes Indenture) for purposes of the Existing Notes Indenture.
Liens
The Issuer will not, and will not permit any Guarantor to,
directly or indirectly, create, incur, assume or suffer to exist
any Lien (except Permitted Liens) that secures obligations under
any Indebtedness or any related Guarantee, on any asset or
property of the Issuer or any Guarantor, or any income or
profits therefrom, or assign or convey any right to receive
income therefrom, unless:
(1) in the case of Liens securing Subordinated
Indebtedness, the Notes and related Guarantees are secured by a
Lien on such property, assets or proceeds that is senior in
priority to such Liens; or
(2) in all other cases, the Notes or the Guarantees are
equally and ratably secured or are secured by a Lien on such
property, assets or proceeds that is senior in priority to such
Liens;
except that the foregoing shall not apply to (a) Liens
securing the Notes and the related Guarantees, (b) Liens
securing Indebtedness permitted to be incurred under Credit
Facilities, including any letter of credit relating thereto,
that was permitted by the terms of the Indenture to be incurred
pursuant to clause (1) of the second paragraph under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock;
provided that, with respect to Liens securing Obligations
permitted under this subclause (b), the Notes and the related
Guarantees are secured by Liens on the assets subject to such
Liens (except any European Collateral) to the extent, with the
priority and subject to intercreditor arrangements, in each case
no less favorable to the holders of the Notes than those
described under Security above and (c) Liens
which are senior in priority to the Liens securing the Notes and
related Guarantees and are incurred to secure Obligations in
respect of any Indebtedness permitted to be incurred pursuant to
the covenant described above under Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock; provided that, with respect to
Liens securing Obligations permitted under this subclause (c),
(i) at the time of incurrence and after giving pro forma
effect thereto, the ratio of (1) the aggregate amount of
Indebtedness subject to a Lien incurred pursuant to
subclause (b) above, this subclause (c) and
clause (6) of the definition of Permitted Liens
(other than Liens securing Indebtedness incurred pursuant to
clauses (4) and (18) of the covenant
148
described above under Limitation on Incurrence
of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock) to (2) the Issuers EBITDA for the most
recently ended four full fiscal quarters for which internal
financial statements are available immediately preceding the
date on which such event for which such calculation is being
made shall occur, in each case with such pro forma adjustments
to Indebtedness and EBITDA as are appropriate and consistent
with the pro forma adjustment provisions set forth in the
definition of Fixed Charge Coverage Ratio would be no greater
than 4.25 to 1.0 and (ii) the Notes and the Guarantees are
secured by Liens with the priority and subject to intercreditor
arrangements no less favorable to the holders of the Notes than
those described under Security above.
Merger,
Consolidation or Sale of All or Substantially All
Assets
The Issuer may not consolidate or merge with or into or wind up
into (whether or not the Issuer is the surviving corporation),
or sell, assign, transfer, lease, convey or otherwise dispose of
all or substantially all of its properties or assets, in one or
more related transactions, to any Person unless:
(1) the Issuer is the surviving corporation or the Person
formed by or surviving any such consolidation or merger (if
other than the Issuer) or to which such sale, assignment,
transfer, lease, conveyance or other disposition will have been
made is a corporation organized or existing under the laws of
the jurisdiction of organization of the Issuer or the laws of
the United States, any state thereof, the District of Columbia,
or any territory thereof (such Person, as the case may be, being
herein called the Successor Company);
(2) the Successor Company, if other than the Issuer,
expressly assumes all the obligations of the Issuer under the
Notes and the Security Documents pursuant to supplemental
indentures or other documents or instruments in form reasonably
satisfactory to the Trustee;
(3) immediately after such transaction, no Default exists;
(4) immediately after giving pro forma effect to such
transaction and any related financing transactions, as if such
transactions had occurred at the beginning of the applicable
four-quarter period,
(a) the Successor Company would be permitted to incur at
least $1.00 of additional Indebtedness pursuant to the Fixed
Charge Coverage Ratio test set forth in the first sentence of
the covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock, or
(b) the Fixed Charge Coverage Ratio for the Successor
Company, the Issuer and its Restricted Subsidiaries would be
greater than such ratio for the Issuer and its Restricted
Subsidiaries immediately prior to such transaction;
(5) each Guarantor, unless it is the other party to the
transactions described above, in which case clause (b) of
the second succeeding paragraph shall apply, shall have by
supplemental indenture confirmed that its Guarantee shall apply
to such Persons obligations under the Indenture, the Notes
and the Registration Rights Agreement;
(6) the Collateral owned by the Successor Company will
(a) continue to constitute Collateral under the Indenture
and the Security Documents, (b) be subject to a Lien in
favor of the Junior Lien Collateral Agent for the benefit of the
Trustee and the Holders of the Notes and (c) not be subject
to any other Lien, other than Permitted Liens;
(7) to the extent any assets of the Person which is merged
or consolidated with or into the Successor Company are assets of
the type which would constitute Collateral under the Security
Documents, the Successor Company will take such action as may be
reasonably necessary to cause such property and assets to be
made subject to the Lien of the Security Documents in the manner
and to the extent required in the Indenture or any of the
Security Documents and shall take all reasonably necessary
action so that such Lien is perfected to the extent required by
the Security Documents; and
149
(8) the Issuer shall have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel, each
stating that such consolidation, merger or transfer and such
supplemental indentures, if any, comply with the Indenture and,
if a supplemental indenture or any supplement to any Security
Document is required in connection with such transaction, such
supplement shall comply with the applicable provisions of the
Indenture.
The Successor Company will succeed to, and be substituted for
the Issuer, as the case may be, under the Indenture, the
Guarantees and the Notes, as applicable. Notwithstanding the
foregoing clauses (3) and (4),
(1) any Restricted Subsidiary may consolidate with or merge
into or transfer all or part of its properties and assets to the
Issuer, and
(2) the Issuer may merge with an Affiliate of the Issuer,
as the case may be, solely for the purpose of reincorporating
the Issuer in a State of the United States or any state thereof,
the District of Columbia or any territory thereof so long as the
amount of Indebtedness of the Issuer and its Restricted
Subsidiaries is not increased thereby.
Subject to certain limitations described in the Indenture
governing release of a Guarantee upon the sale, disposition or
transfer of a Guarantor, no Guarantor will, and the Issuer will
not permit any Guarantor to, consolidate or merge with or into
or wind up into (whether or not the Issuer or Guarantor is the
surviving corporation), or sell, assign, transfer, lease, convey
or otherwise dispose of all or substantially all of its
properties or assets, in one or more related transactions, to
any Person unless:
(1) (a) such Guarantor is the surviving corporation or
the Person formed by or surviving any such consolidation or
merger (if other than such Guarantor) or to which such sale,
assignment, transfer, lease, conveyance or other disposition
will have been made is a corporation, partnership, limited
partnership, limited liability corporation or trust organized or
existing under the laws of the jurisdiction of organization of
such Guarantor, as the case may be, or the laws of the United
States, any state thereof, the District of Columbia, or any
territory thereof (such Guarantor or such Person, as the case
may be, being herein called the Successor Person);
(b) the Successor Person, if other than such Guarantor,
expressly assumes all the obligations of such Guarantor under
the Indenture and such Guarantors related Guarantee
pursuant to supplemental indentures or other documents or
instruments in form reasonably satisfactory to the Trustee;
(c) immediately after such transaction, no Default
exists; and
(d) the Issuer shall have delivered to the Trustee an
Officers Certificate, each stating that such
consolidation, merger or transfer and such supplemental
indentures, if any, comply with the Indenture; or
(2) the transaction is made in compliance with the covenant
described under Repurchase at the Option of
Holders Asset Sales.
Subject to certain limitations described in the Indenture, the
Successor Person will succeed to, and be substituted for, such
Guarantor under the Indenture and such Guarantors
Guarantee. Notwithstanding the foregoing, any Guarantor may
(i) merge into or transfer all or part of its properties
and assets to another Guarantor or the Issuer, (ii) merge
with an Affiliate of the Company solely for the purpose of
reincorporating the Guarantor in the United States, any state
thereof, the District of Columbia or any territory thereof or
(iii) convert into a corporation, partnership, limited
partnership, limited liability corporation or trust organized or
existing under the laws of the jurisdiction of organization of
such Guarantor.
Transactions
with Affiliates
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, make any payment to, or sell, lease, transfer
or otherwise dispose of any of its properties or assets to, or
purchase any property or assets from, or enter into or make or
amend any transaction, contract, agreement, understanding, loan,
advance or
150
guarantee with, or for the benefit of, any Affiliate of the
Issuer (each of the foregoing, an Affiliate
Transaction) involving aggregate payments or
consideration in excess of $40.0 million, unless:
(1) such Affiliate Transaction is on terms that are not
materially less favorable to the Issuer or its relevant
Restricted Subsidiary than those that would have been obtained
in a comparable transaction by the Issuer or such Restricted
Subsidiary with an unrelated Person on an arms-length
basis; and
(2) the Issuer delivers to the Trustee with respect to any
Affiliate Transaction or series of related Affiliate
Transactions involving aggregate payments or consideration in
excess of $80.0 million, a resolution adopted by the
majority of the board of directors of the Issuer approving such
Affiliate Transaction and set forth in an Officers
Certificate certifying that such Affiliate Transaction complies
with clause (1) above.
The foregoing provisions will not apply to the following:
(1) transactions between or among the Issuer or any of its
Restricted Subsidiaries;
(2) Restricted Payments permitted by the provisions of the
Indenture described above under the covenant
Limitation on Restricted Payments and
the definition of Permitted Investments;
(3) the payment of management, consulting, monitoring and
advisory fees and related expenses to the Investors and the
Frist Entities pursuant to the Sponsor Management Agreement
(plus any unpaid management, consulting, monitoring and advisory
fees and related expenses accrued in any prior year) and the
termination fees pursuant to the Sponsor Management Agreement,
in each case as in effect on the Issue Date, or any amendment
thereto (so long as any such amendment is not disadvantageous in
the good faith judgment of the board of directors of the Issuer
to the Holders when taken as a whole as compared to the Sponsor
Management Agreement in effect on the Issue Date);
(4) the payment of reasonable and customary fees paid to,
and indemnities provided for the benefit of, officers,
directors, employees or consultants of Issuer, any of its direct
or indirect parent companies or any of its Restricted
Subsidiaries;
(5) transactions in which the Issuer or any of its
Restricted Subsidiaries, as the case may be, delivers to the
Trustee a letter from an Independent Financial Advisor stating
that such transaction is fair to the Issuer or such Restricted
Subsidiary from a financial point of view or stating that the
terms are not materially less favorable to the Issuer or its
relevant Restricted Subsidiary than those that would have been
obtained in a comparable transaction by the Issuer or such
Restricted Subsidiary with an unrelated Person on an
arms-length basis;
(6) any agreement as in effect as of the Issue Date, or any
amendment thereto (so long as any such amendment is not
disadvantageous to the Holders when taken as a whole as compared
to the applicable agreement as in effect on the Issue Date);
(7) the existence of, or the performance by the Issuer or
any of its Restricted Subsidiaries of its obligations under the
terms of, any stockholders agreement (including any registration
rights agreement or purchase agreement related thereto) to which
it is a party as of the Issue Date and any similar agreements
which it may enter into thereafter; provided, however, that the
existence of, or the performance by the Issuer or any of its
Restricted Subsidiaries of obligations under any future
amendment to any such existing agreement or under any similar
agreement entered into after the Issue Date shall only be
permitted by this clause (7) to the extent that the terms
of any such amendment or new agreement are not otherwise
disadvantageous to the Holders when taken as a whole;
(8) [reserved];
(9) transactions with customers, clients, suppliers, or
purchasers or sellers of goods or services, in each case in the
ordinary course of business and otherwise in compliance with the
terms of the Indenture which are fair to the Issuer and its
Restricted Subsidiaries, in the reasonable determination of the
board of directors of the Issuer or the senior management
thereof, or are on terms at least as favorable as might
reasonably have been obtained at such time from an unaffiliated
party;
151
(10) the issuance of Equity Interests (other than
Disqualified Stock) of the Issuer to any Permitted Holder or to
any director, officer, employee or consultant;
(11) sales of accounts receivable, or participations
therein, in connection with the ABL Facility and any Receivables
Facility;
(12) payments by the Issuer or any of its Restricted
Subsidiaries to any of the Investors made for any financial
advisory, financing, underwriting or placement services or in
respect of other investment banking activities, including,
without limitation, in connection with acquisitions or
divestitures, which payments are approved by a majority of the
board of directors of the Issuer in good faith;
(13) payments or loans (or cancellation of loans) to
employees or consultants of the Issuer, any of its direct or
indirect parent companies or any of its Restricted Subsidiaries
and employment agreements, stock option plans and other similar
arrangements with such employees or consultants which, in each
case, are approved by the Issuer in good faith;
(14) investments by the Investors or the Frist Entities in
securities of the Issuer or any of its Restricted Subsidiaries
so long as (i) the investment is being offered generally to
other investors on the same or more favorable terms and
(ii) the investment constitutes less than 5% of the
proposed or outstanding issue amount of such class of securities;
(15) payments to or from, and transactions with, any joint
venture owning or operating one or more healthcare facilities,
including, without limitation, hospitals, ambulatory surgery
centers, outpatient diagnostic centers or imaging centers, in
each case in the ordinary course of business (including, without
limitation, any cash management activities related
thereto); and
(16) payments by the Issuer (and any direct or indirect
parent thereof) and its Subsidiaries pursuant to tax sharing
agreements among the Issuer (and any such parent) and its
Subsidiaries on customary terms to the extent attributable to
the ownership or operation of the Issuer and its Subsidiaries;
provided that in each case the amount of such payments in any
fiscal year does not exceed the amount that the Issuer, its
Restricted Subsidiaries and its Unrestricted Subsidiaries (to
the extent of amounts received from Unrestricted Subsidiaries)
would be required to pay in respect of foreign, federal, state
and local taxes for such fiscal year were the Issuer and its
Restricted Subsidiaries (to the extent described above) to pay
such taxes separately from any such parent entity.
Dividend
and Other Payment Restrictions Affecting Restricted
Subsidiaries
The Issuer will not, and will not permit any of its Restricted
Subsidiaries that are not Guarantors to, directly or indirectly,
create or otherwise cause or suffer to exist or become effective
any consensual encumbrance or consensual restriction on the
ability of any such Restricted Subsidiary to:
(1) (a) pay dividends or make any other distributions
to the Issuer or any of its Restricted Subsidiaries on its
Capital Stock or with respect to any other interest or
participation in, or measured by, its profits, or
(b) pay any Indebtedness owed to the Issuer or any of its
Restricted Subsidiaries;
(2) make loans or advances to the Issuer or any of its
Restricted Subsidiaries; or
(3) sell, lease or transfer any of its properties or assets
to the Issuer or any of its Restricted Subsidiaries, except (in
each case) for such encumbrances or restrictions existing under
or by reason of:
(a) contractual encumbrances or restrictions in effect on
the Issue Date, including pursuant to the Senior Credit
Facilities and the related documentation, the Existing Notes
Indenture and the related documentation and the 2006 Notes
Indenture and the related documentation;
(b) the Indenture and the Notes;
(c) purchase money obligations for property acquired in the
ordinary course of business that impose restrictions of the
nature discussed in clause (3) above on the property so
acquired;
152
(d) applicable law or any applicable rule, regulation or
order;
(e) any agreement or other instrument of a Person acquired
by the Issuer or any Restricted Subsidiary in existence at the
time of such acquisition (but not created in contemplation
thereof), which encumbrance or restriction is not applicable to
any Person, or the properties or assets of any Person, other
than the Person and its Subsidiaries, or the property or assets
of the Person and its Subsidiaries, so acquired;
(f) contracts for the sale of assets, including customary
restrictions with respect to a Subsidiary of the Issuer pursuant
to an agreement that has been entered into for the sale or
disposition of all or substantially all of the Capital Stock or
assets of such Subsidiary;
(g) Secured Indebtedness that limits the right of the
debtor to dispose of the assets securing such Indebtedness that
is otherwise permitted to be incurred pursuant to the covenants
described under Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock and Liens;
(h) restrictions on cash or other deposits or net worth
imposed by customers under contracts entered into in the
ordinary course of business;
(i) other Indebtedness, Disqualified Stock or Preferred
Stock of Foreign Subsidiaries permitted to be incurred
subsequent to the Issue Date pursuant to the provisions of the
covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock;
(j) customary provisions in joint venture agreements and
other agreements or arrangements relating solely to such joint
venture;
(k) customary provisions contained in leases or licenses of
intellectual property and other agreements, in each case entered
into in the ordinary course of business;
(l) any encumbrances or restrictions of the type referred
to in clauses (1), (2) and (3) above imposed by any
amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings of the
contracts, instruments or obligations referred to in
clauses (a) through (k) above; provided that such
amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings are, in
the good faith judgment of the Issuer, no more restrictive with
respect to such encumbrance and other restrictions taken as a
whole than those prior to such amendment, modification,
restatement, renewal, increase, supplement, refunding,
replacement or refinancing; and
(m) restrictions created in connection with any Receivables
Facility that, in the good faith determination of the Issuer,
are necessary or advisable to effect the transactions
contemplated under such Receivables Facility.
Limitation
on Guarantees of Indebtedness by Restricted
Subsidiaries
The Issuer will not permit any of its Wholly-Owned Subsidiaries
that are Restricted Subsidiaries (and non-Wholly-Owned
Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
other capital markets debt securities of the Issuer or any
Guarantor), other than a Guarantor, a Foreign Subsidiary or a
Receivables Subsidiary, to guarantee the payment of any
Indebtedness of the Issuer or any other Guarantor unless:
(1) such Restricted Subsidiary within 30 days executes
and delivers a supplemental indenture to the Indenture providing
for a Guarantee by such Restricted Subsidiary, except that with
respect to a guarantee of Indebtedness of the Issuer or any
Guarantor:
(a) if the Notes or such Guarantors Guarantee is
subordinated in right of payment to such Indebtedness, the
Guarantee under the supplemental indenture shall be subordinated
to such Restricted Subsidiarys guarantee with respect to
such Indebtedness substantially to the same extent as the Notes
are subordinated to such Indebtedness; and
153
(b) if such Indebtedness is by its express terms
subordinated in right of payment to the Notes or such
Guarantors Guarantee, any such guarantee by such
Restricted Subsidiary with respect to such Indebtedness shall be
subordinated in right of payment to such Guarantee substantially
to the same extent as such Indebtedness is subordinated to the
Notes; and
(2) such Restricted Subsidiary waives, and will not in any
manner whatsoever claim or take the benefit or advantage of, any
rights of reimbursement, indemnity or subrogation or any other
rights against the Issuer or any other Restricted Subsidiary as
a result of any payment by such Restricted Subsidiary under its
Guarantee;
provided that this covenant shall not be applicable to
(i) any guarantee of any Restricted Subsidiary that existed
at the time such Person became a Restricted Subsidiary and was
not incurred in connection with, or in contemplation of, such
Person becoming a Restricted Subsidiary and (ii) guarantees
of the ABL Facility by the ABL Financing Entities or of any
Receivables Facility by any Receivables Subsidiary.
Reports
and Other Information
Notwithstanding that the Issuer may not be subject to the
reporting requirements of Section 13 or 15(d) of the
Exchange Act or otherwise report on an annual and quarterly
basis on forms provided for such annual and quarterly reporting
pursuant to rules and regulations promulgated by the SEC, the
Indenture requires the Issuer to file with the SEC (and make
available to the Trustee and Holders of the Notes (without
exhibits), without cost to any Holder, within 15 days after
it files them with the SEC) from and after the Issue Date,
(1) within 90 days (or any other time period then in
effect under the rules and regulations of the Exchange Act with
respect to the filing of a
Form 10-K
by a non-accelerated filer) after the end of each fiscal year,
annual reports on
Form 10-K,
or any successor or comparable form, containing the information
required to be contained therein, or required in such successor
or comparable form;
(2) within 45 days after the end of each of the first
three fiscal quarters of each fiscal year, reports on
Form 10-Q
containing all quarterly information that would be required to
be contained in
Form 10-Q,
or any successor or comparable form;
(3) promptly from time to time after the occurrence of an
event required to be therein reported, such other reports on
Form 8-K,
or any successor or comparable form; and
(4) any other information, documents and other reports
which the Issuer would be required to file with the SEC if it
were subject to Section 13 or 15(d) of the Exchange Act;
in each case in a manner that complies in all material respects
with the requirements specified in such form; provided
that the Issuer shall not be so obligated to file such
reports with the SEC if the SEC does not permit such filing, in
which event the Issuer will make available such information to
prospective purchasers of Notes, in addition to providing such
information to the Trustee and the Holders of the Notes, in each
case within 15 days after the time the Issuer would be
required to file such information with the SEC if it were
subject to Section 13 or 15(d) of the Exchange Act. In
addition, to the extent not satisfied by the foregoing, the
Issuer has agreed that, for so long as any Notes are
outstanding, it will furnish to Holders and to securities
analysts and prospective investors, upon their request, the
information required to be delivered pursuant to
Rule 144A(d)(4) under the Securities Act.
In the event that any direct or indirect parent company of the
Issuer becomes a Guarantor of the Notes, the Indenture permits
the Issuer to satisfy its obligations in this covenant with
respect to financial information relating to the Issuer by
furnishing financial information relating to such parent;
provided that the same is accompanied by consolidating
information that explains in reasonable detail the differences
between the information relating to such parent, on the one
hand, and the information relating to the Issuer and its
Restricted Subsidiaries on a standalone basis, on the other hand.
Notwithstanding the foregoing, such requirements shall be deemed
satisfied prior to the commencement of the exchange offer or the
effectiveness of the shelf registration statement described in
the Registration Rights Agreement (1) by the filing with
the SEC of the exchange offer registration statement or shelf
154
registration statement (or any other similar registration
statement), and any amendments thereto, with such financial
information that satisfies
Regulation S-X,
subject to exceptions consistent with the presentation of
financial information in the Offering Memorandum, to the extent
filed within the times specified above, or (2) by posting
reports that would be required to be filed substantially in the
form required by the SEC on the Companys website (or that
of any of its parent companies) or providing such reports to the
Trustee within 15 days after the time the Issuer would be
required to file such information with the SEC if it were
subject to Section 13 or 15(d) of the Exchange Act, the
financial information (including a Managements
Discussion and Analysis of Financial Condition and Results of
Operations section) that would be required to be included
in such reports, subject to exceptions consistent with the
presentation of financial information in the Offering
Memorandum, to the extent filed within the times specified above.
Events of
Default and Remedies
The Indenture provides that each of the following is an
Event of Default:
(1) default in payment when due and payable, upon
redemption, acceleration or otherwise, of principal of, or
premium, if any, on the Notes;
(2) default for 30 days or more in the payment when
due of interest or Additional Interest on or with respect to the
Notes;
(3) failure by the Issuer or any Guarantor for 60 days
after receipt of written notice given by the Trustee or the
Holders of not less 30% in principal amount of the Notes to
comply with any of its obligations, covenants or agreements
(other than a default referred to in clauses (1) and
(2) above) contained in the Indenture or the Notes;
(4) default under any mortgage, indenture or instrument
under which there is issued or by which there is secured or
evidenced any Indebtedness for money borrowed by the Issuer or
any of its Restricted Subsidiaries or the payment of which is
guaranteed by the Issuer or any of its Restricted Subsidiaries,
other than Indebtedness owed to the Issuer or a Restricted
Subsidiary, whether such Indebtedness or guarantee now exists or
is created after the issuance of the Notes, if both:
(a) such default either results from the failure to pay any
principal of such Indebtedness at its stated final maturity
(after giving effect to any applicable grace periods) or relates
to an obligation other than the obligation to pay principal of
any such Indebtedness at its stated final maturity and results
in the holder or holders of such Indebtedness causing such
Indebtedness to become due prior to its stated maturity; and
(b) the principal amount of such Indebtedness, together
with the principal amount of any other such Indebtedness in
default for failure to pay principal at stated final maturity
(after giving effect to any applicable grace periods), or the
maturity of which has been so accelerated, aggregate
$200.0 million or more at any one time outstanding;
(5) failure by the Issuer or any Significant Subsidiary to
pay final judgments aggregating in excess of
$200.0 million, which final judgments remain unpaid,
undischarged and unstayed for a period of more than 60 days
after such judgment becomes final, and in the event such
judgment is covered by insurance, an enforcement proceeding has
been commenced by any creditor upon such judgment or decree
which is not promptly stayed;
(6) certain events of bankruptcy or insolvency with respect
to the Issuer or any Significant Subsidiary;
(7) the Guarantee of any Significant Subsidiary shall for
any reason cease to be in full force and effect or be declared
null and void or any responsible officer of any Guarantor that
is a Significant Subsidiary, as the case may be, denies that it
has any further liability under its Guarantee or gives notice to
such effect, other than by reason of the termination of the
Indenture or the release of any such Guarantee in accordance
with the Indenture; or
155
(8) with respect to any Collateral having a fair market
value in excess of $200 million, individually or in the
aggregate, (a) the security interest under the Security
Documents, at any time, ceases to be in full force and effect
for any reason other than in accordance with the terms of the
Indenture, the Security Documents and the Intercreditor
Agreements, (b) any security interest created thereunder or
under the Indenture is declared invalid or unenforceable by a
court of competent jurisdiction or (c) the Issuer or any
Guarantor asserts, in any pleading in any court of competent
jurisdiction, that any such security interest is invalid or
unenforceable.
If any Event of Default (other than of a type specified in
clause (6) above) occurs and is continuing under the
Indenture, the Trustee or the Holders of at least 30% in
principal amount of the then total outstanding Notes may declare
the principal, premium, if any, interest and any other monetary
obligations on all the then outstanding Notes to be due and
payable immediately.
Upon the effectiveness of such declaration, such principal and
interest will be due and payable immediately. Notwithstanding
the foregoing, in the case of an Event of Default arising under
clause (6) of the first paragraph of this section, all
outstanding Notes will become due and payable without further
action or notice. The Indenture provides that the Trustee may
withhold from the Holders notice of any continuing Default,
except a Default relating to the payment of principal, premium,
if any, or interest, if it determines that withholding notice is
in their interest. In addition, the Trustee shall have no
obligation to accelerate the Notes if in the best judgment of
the Trustee acceleration is not in the best interest of the
Holders of the Notes.
The Indenture provides that the Holders of a majority in
aggregate principal amount of the then outstanding Notes by
notice to the Trustee may on behalf of the Holders of all of the
Notes waive any existing Default and its consequences under the
Indenture except a continuing Default in the payment of interest
on, premium, if any, or the principal of any Note held by a
non-consenting Holder. In the event of any Event of Default
specified in clause (4) above, such Event of Default and
all consequences thereof (excluding any resulting payment
default, other than as a result of acceleration of the Notes)
shall be annulled, waived and rescinded, automatically and
without any action by the Trustee or the Holders, if within
20 days after such Event of Default arose:
(1) the Indebtedness or guarantee that is the basis for
such Event of Default has been discharged; or
(2) holders thereof have rescinded or waived the
acceleration, notice or action (as the case may be) giving rise
to such Event of Default; or
(3) the default that is the basis for such Event of Default
has been cured.
Subject to the provisions of the Indenture relating to the
duties of the Trustee thereunder, in case an Event of Default
occurs and is continuing, the Trustee is under no obligation to
exercise any of the rights or powers under the Indenture at the
request or direction of any of the Holders of the Notes unless
the Holders have offered to the Trustee reasonable indemnity or
security against any loss, liability or expense. Except to
enforce the right to receive payment of principal, premium, if
any, or interest when due, no Holder of a Note may pursue any
remedy with respect to the Indenture or the Notes unless:
(1) such Holder has previously given the Trustee notice
that an Event of Default is continuing;
(2) Holders of at least 30% in principal amount of the
total outstanding Notes have requested the Trustee to pursue the
remedy;
(3) Holders of the Notes have offered the Trustee
reasonable security or indemnity against any loss, liability or
expense;
(4) the Trustee has not complied with such request within
60 days after the receipt thereof and the offer of security
or indemnity; and
(5) Holders of a majority in principal amount of the total
outstanding Notes have not given the Trustee a direction
inconsistent with such request within such
60-day
period.
156
Subject to certain restrictions, under the Indenture the Holders
of a majority in principal amount of the total outstanding Notes
are given the right to direct the time, method and place of
conducting any proceeding for any remedy available to the
Trustee or of exercising any trust or power conferred on the
Trustee. The Trustee, however, may refuse to follow any
direction that conflicts with law or the Indenture or that the
Trustee determines is unduly prejudicial to the rights of any
other Holder of a Note or that would involve the Trustee in
personal liability.
The Indenture provides that the Issuer is required to deliver to
the Trustee annually a statement regarding compliance with the
Indenture, and the Issuer is required, within five Business
Days, upon becoming aware of any Default, to deliver to the
Trustee a statement specifying such Default.
No
Personal Liability of Directors, Officers, Employees and
Stockholders
No director, officer, employee, incorporator or stockholder of
the Issuer or any Guarantor or any of their parent companies
(other than the Issuer and the Guarantors) shall have any
liability for any obligations of the Issuer or the Guarantors
under the Notes, the Guarantees or the Indenture or for any
claim based on, in respect of, or by reason of such obligations
or their creation. Each Holder by accepting the Notes waives and
releases all such liability. The waiver and release are part of
the consideration for issuance of the Notes. Such waiver may not
be effective to waive liabilities under the federal securities
laws, and it is the view of the SEC that such a waiver is
against public policy.
Legal
Defeasance and Covenant Defeasance
The obligations of the Issuer and the Guarantors under the
Indenture will terminate (other than certain obligations) and
will be released upon payment in full of all of the Notes. The
Issuer may, at its option and at any time, elect to have all of
its obligations discharged with respect to the Notes and have
the Issuers and each Guarantors obligation
discharged with respect to its Guarantee (Legal
Defeasance) and cure all then existing Events of
Default except for:
(1) the rights of Holders of Notes to receive payments in
respect of the principal of, premium, if any, and interest on
the Notes when such payments are due solely out of the trust
created pursuant to the Indenture;
(2) the Issuers obligations with respect to Notes
concerning issuing temporary Notes, registration of such Notes,
mutilated, destroyed, lost or stolen Notes and the maintenance
of an office or agency for payment and money for security
payments held in trust;
(3) the rights, powers, trusts, duties and immunities of
the Trustee, and the Issuers obligations in connection
therewith; and
(4) the Legal Defeasance provisions of the Indenture.
In addition, the Issuer may, at its option and at any time,
elect to have its obligations and those of each Guarantor
released with respect to certain covenants that are described in
the Indenture (Covenant Defeasance) and
thereafter any omission to comply with such obligations shall
not constitute a Default with respect to the Notes. In the event
Covenant Defeasance occurs, certain events (not including
bankruptcy, receivership, rehabilitation and insolvency events
pertaining to the Issuer) described under Events of
Default and Remedies will no longer constitute an Event of
Default with respect to the Notes.
In order to exercise either Legal Defeasance or Covenant
Defeasance with respect to the Notes:
(1) the Issuer must irrevocably deposit with the Trustee,
in trust, for the benefit of the Holders of the Notes, cash in
U.S. dollars, Government Securities, or a combination
thereof, in such amounts as will be sufficient, in the opinion
of a nationally recognized firm of independent public
accountants, to pay the principal of, premium, if any, and
interest due on the Notes on the stated maturity date or on the
redemption date, as the case may be, of such principal, premium,
if any, or interest on such Notes, and the Issuer must specify
whether such Notes are being defeased to maturity or to a
particular redemption date;
157
(2) in the case of Legal Defeasance, the Issuer shall have
delivered to the Trustee an Opinion of Counsel reasonably
acceptable to the Trustee confirming that, subject to customary
assumptions and exclusions,
(a) the Issuer has received from, or there has been
published by, the United States Internal Revenue Service a
ruling, or
(b) since the issuance of the Notes, there has been a
change in the applicable U.S. federal income tax law,
in either case to the effect that, and based thereon such
Opinion of Counsel shall confirm that, subject to customary
assumptions and exclusions, the Holders of the Notes will not
recognize income, gain or loss for U.S. federal income tax
purposes, as applicable, as a result of such Legal Defeasance
and will be subject to U.S. federal income tax on the same
amounts, in the same manner and at the same times as would have
been the case if such Legal Defeasance had not occurred;
(3) in the case of Covenant Defeasance, the Issuer shall
have delivered to the Trustee an Opinion of Counsel reasonably
acceptable to the Trustee confirming that, subject to customary
assumptions and exclusions, the Holders of the Notes will not
recognize income, gain or loss for U.S. federal income tax
purposes as a result of such Covenant Defeasance and will be
subject to such tax on the same amounts, in the same manner and
at the same times as would have been the case if such Covenant
Defeasance had not occurred;
(4) no Default (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith) shall have
occurred and be continuing on the date of such deposit;
(5) such Legal Defeasance or Covenant Defeasance shall not
result in a breach or violation of, or constitute a default
under the Senior Credit Facilities or any other material
agreement or instrument (other than the Indenture) to which the
Issuer or any Guarantor is a party or by which the Issuer or any
Guarantor is bound (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith);
(6) the Issuer shall have delivered to the Trustee an
Opinion of Counsel to the effect that, as of the date of such
opinion and subject to customary assumptions and exclusions
following the deposit, the trust funds will not be subject to
the effect of Section 547 of Title 11 of the United
States Code;
(7) the Issuer shall have delivered to the Trustee an
Officers Certificate stating that the deposit was not made
by the Issuer with the intent of defeating, hindering, delaying
or defrauding any creditors of the Issuer or any Guarantor or
others; and
(8) the Issuer shall have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel (which
Opinion of Counsel may be subject to customary assumptions and
exclusions) each stating that all conditions precedent provided
for or relating to the Legal Defeasance or the Covenant
Defeasance, as the case may be, have been complied with.
Satisfaction
and Discharge
The Indenture will be discharged and will cease to be of further
effect as to all Notes, when either:
(1) all Notes theretofore authenticated and delivered,
except lost, stolen or destroyed Notes which have been replaced
or paid and Notes for whose payment money has theretofore been
deposited in trust, have been delivered to the Trustee for
cancellation; or
(2) (a) all Notes not theretofore delivered to the
Trustee for cancellation have become due and payable by reason
of the making of a notice of redemption or otherwise, will
become due and payable within one year or may be called for
redemption within one year under arrangements satisfactory to
the Trustee for the giving of notice of redemption by the
Trustee in the name, and at the expense, of the
158
Issuer, and the Issuer or any Guarantor has irrevocably
deposited or caused to be deposited with the Trustee as trust
funds in trust solely for the benefit of the Holders of the
Notes, cash in U.S. dollars, Government Securities, or a
combination thereof, in such amounts as will be sufficient
without consideration of any reinvestment of interest to pay and
discharge the entire indebtedness on the Notes not theretofore
delivered to the Trustee for cancellation for principal,
premium, if any, and accrued interest to the date of maturity or
redemption;
(b) no Default (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith) with
respect to the Indenture or the Notes shall have occurred and be
continuing on the date of such deposit or shall occur as a
result of such deposit, and such deposit will not result in a
breach or violation of, or constitute a default under, the
Senior Credit Facilities or any other material agreement or
instrument (other than the Indenture) to which the Issuer or any
Guarantor is a party or by which the Issuer or any Guarantor is
bound (other than that resulting from borrowing funds to be
applied to make such deposit and any similar and simultaneous
deposit relating to other Indebtedness and, in each case, the
granting of Liens in connection therewith);
(c) the Issuer has paid or caused to be paid all sums
payable by it under the Indenture; and
(d) the Issuer has delivered irrevocable instructions to
the Trustee to apply the deposited money toward the payment of
the Notes at maturity or the redemption date, as the case may be.
In addition, the Issuer must deliver an Officers
Certificate and an Opinion of Counsel to the Trustee stating
that all conditions precedent to satisfaction and discharge have
been satisfied.
Amendment,
Supplement and Waiver
Except as provided in the next two succeeding paragraphs, the
Indenture, any Guarantee, any Security Document and the Notes
may be amended or supplemented with the consent of the Holders
of at least a majority in principal amount of the Notes then
outstanding, including consents obtained in connection with a
purchase of, or tender offer or exchange offer for, Notes, and
any existing Default or compliance with any provision of the
Indenture, the Notes issued thereunder, any Guarantee or the
Security Documents may be waived with the consent of the Holders
of a majority in principal amount of the then outstanding Notes,
other than Notes beneficially owned by the Issuer or its
Affiliates (including consents obtained in connection with a
purchase of or tender offer or exchange offer for the Notes).
The Indenture provides that, without the consent of each
affected Holder of Notes, an amendment or waiver may not, with
respect to any Notes held by a non-consenting Holder:
(1) reduce the principal amount of such Notes whose Holders
must consent to an amendment, supplement or waiver;
(2) reduce the principal of or change the fixed final
maturity of any such Note or alter or waive the provisions with
respect to the redemption of such Notes (other than provisions
relating to the covenants described above under the caption
Repurchase at the Option of Holders);
(3) reduce the rate of or change the time for payment of
interest on any Note;
(4) waive a Default in the payment of principal of or
premium, if any, or interest on the Notes, except a rescission
of acceleration of the Notes by the Holders of at least a
majority in aggregate principal amount of the Notes and a waiver
of the payment default that resulted from such acceleration, or
in respect of a covenant or provision contained in the Indenture
or any Guarantee which cannot be amended or modified without the
consent of all Holders;
(5) make any Note payable in money other than that stated
therein;
(6) make any change in the provisions of the Indenture
relating to waivers of past Defaults or the rights of Holders to
receive payments of principal of or premium, if any, or interest
on the Notes;
159
(7) make any change in these amendment and waiver
provisions;
(8) impair the right of any Holder to receive payment of
principal of, or interest on such Holders Notes on or
after the due dates therefor or to institute suit for the
enforcement of any payment on or with respect to such
Holders Notes;
(9) make any change to or modify the ranking of the Notes
or the subordination of the Liens with respect to the Notes that
would adversely affect the Holders; or
(10) except as expressly permitted by the Indenture, modify
the Guarantees of any Significant Subsidiary in any manner
adverse to the Holders of the Notes.
In addition, without the consent of at least 75% in aggregate
principal amount of Notes then outstanding, an amendment,
supplement or waiver may not:
(1) modify any Security Document or the provisions of the
Indenture dealing with the Security Documents or application of
trust moneys, or otherwise release any Collateral, in any manner
materially adverse to the Holders other than in accordance with
the Indenture, the Security Documents and the Intercreditor
Agreements; or
(2) modify any Intercreditor Agreement in any manner
materially adverse to the Holders other than in accordance with
the Indenture, the Security Documents and the Intercreditor
Agreements.
Notwithstanding the foregoing, the Issuer, any Guarantor (with
respect to a Guarantee or the Indenture to which it is a party)
and the Trustee may amend or supplement the Indenture, any
Security Document and any Guarantee or Notes without the consent
of any Holder;
(1) to cure any ambiguity, omission, mistake, defect or
inconsistency;
(2) to provide for uncertificated Notes of such series in
addition to or in place of certificated Notes;
(3) to comply with the covenant relating to mergers,
consolidations and sales of assets;
(4) to provide for the assumption of the Issuers or
any Guarantors obligations to the Holders;
(5) to make any change that would provide any additional
rights or benefits to the Holders or that does not adversely
affect the legal rights under the Indenture of any such Holder;
(6) to add covenants for the benefit of the Holders or to
surrender any right or power conferred upon the Issuer or any
Guarantor;
(7) to comply with requirements of the SEC in order to
effect or maintain the qualification of the Indenture under the
Trust Indenture Act;
(8) to evidence and provide for the acceptance and
appointment under the Indenture of a successor Trustee
thereunder pursuant to the requirements thereof;
(9) to provide for the issuance of Exchange Notes or
private exchange notes, which are identical to Exchange Notes
except that they are not freely transferable;
(10) to add a Guarantor under the Indenture;
(11) to conform the text of the Indenture, Security
Documents, Guarantees or the Notes to any provision of this
Description of Notes to the extent that such
provision in this Description of Notes was intended
to be a verbatim recitation of a provision of the Indenture,
Security Documents, Guarantee or Notes;
(12) to make any amendment to the provisions of the
Indenture relating to the transfer and legending of Notes as
permitted by the Indenture, including, without limitation to
facilitate the issuance and administration of the Notes;
provided, however, that (i) compliance with
the Indenture as so amended would not result in Notes being
transferred in violation of the Securities Act or any applicable
securities
160
law and (ii) such amendment does not materially and
adversely affect the rights of Holders to transfer Notes;
(13) to mortgage, pledge, hypothecate or grant any other
Lien in favor of the Trustee for the benefit of the Holders of
the Notes, as additional security for the payment and
performance of all or any portion of the Obligations, in any
property or assets, including any which are required to be
mortgaged, pledged or hypothecated, or in which a Lien is
required to be granted to or for the benefit of the Trustee or
the Collateral Agent pursuant to the Indenture, any of the
Security Documents or otherwise; or
(14) to release Collateral from the Lien of the Indenture
and the Security Documents when permitted or required by the
Security Documents or the Indenture.
The consent of the Holders is not necessary under the Indenture
to approve the particular form of any proposed amendment. It is
sufficient if such consent approves the substance of the
proposed amendment.
Notices
Notices given by publication will be deemed given on the first
date on which publication is made and notices given by
first-class mail, postage prepaid, will be deemed given five
calendar days after mailing.
Concerning
the Trustee
The Indenture contains certain limitations on the rights of the
Trustee thereunder, should it become a creditor of the Issuer,
to obtain payment of claims in certain cases, or to realize on
certain property received in respect of any such claim as
security or otherwise. The Trustee is permitted to engage in
other transactions; however, if it acquires any conflicting
interest it must eliminate such conflict within 90 days,
apply to the SEC for permission to continue or resign.
The Indenture provides that the Holders of a majority in
principal amount of the outstanding Notes will have the right to
direct the time, method and place of conducting any proceeding
for exercising any remedy available to the Trustee, subject to
certain exceptions. The Indenture provides that in case an Event
of Default shall occur (which shall not be cured), the Trustee
will be required, in the exercise of its power, to use the
degree of care of a prudent person in the conduct of his own
affairs. Subject to such provisions, the Trustee is under no
obligation to exercise any of its rights or powers under the
Indenture at the request of any Holder of the Notes, unless such
Holder shall have offered to the Trustee security and indemnity
satisfactory to it against any loss, liability or expense.
Governing
Law
The Indenture, the Notes and any Guarantee are governed by and
construed in accordance with the laws of the State of New York.
Certain
Definitions
Set forth below are certain defined terms used in the Indenture.
For purposes of the Indenture, unless otherwise specifically
indicated, the term consolidated with respect
to any Person refers to such Person on a consolidated basis in
accordance with GAAP, but excluding from such consolidation any
Unrestricted Subsidiary as if such Unrestricted Subsidiary were
not an Affiliate of such Person.
2006 Notes means the $1,000,000,000 aggregate
principal amount of
91/8% Senior
Secured Notes due 2014, the $3,200,000,000 aggregate principal
amount of
91/4% Senior
Secured Notes due 2016 and the $1,500,000,000
95/8%/103/8% Senior
Secured Toggle Notes due 2016, each issued by the Issuer under
the 2006 Notes Indenture.
2006 Notes Indenture means that certain
Indenture, dated as of November 17, 2006, among the Issuer,
the guarantors named on Schedule I thereto and The Bank of
New York, as trustee.
161
ABL Facility means the Asset-Based Revolving
Credit Agreement entered into as of November 17, 2006 by
and among the Issuer, the lenders party thereto in their
capacities as lenders thereunder and Bank of America, N.A., as
Administrative Agent, including any guarantees, collateral
documents, instruments and agreements executed in connection
therewith, and any amendments, supplements, modifications,
extensions, renewals, restatements, refundings or refinancings
thereof and any indentures or credit facilities or commercial
paper facilities with banks or other institutional lenders or
investors that replace, refund or refinance any part of the
loans, notes, other credit facilities or commitments thereunder,
including any such replacement, refunding or refinancing
facility or indenture that increases the amount borrowable
thereunder or alters the maturity thereof (provided that
such increase in borrowings is permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock
above).
ABL Facility Cap means an amount equal to the
greater of (x) $2,000.0 million and (y) 75% of
the consolidated accounts receivable of the Issuer and its
subsidiaries determined in accordance with GAAP.
ABL Financing Entity means the Issuer and
certain of its subsidiaries from time to time named as borrowers
or guarantors under the ABL Facility.
ABL Obligations means Obligations under the
ABL Facility.
ABL Secured Parties means each of
(i) the ABL Collateral Agent on behalf of itself and the
lenders under the ABL Facility and lenders or their affiliates
counterparty to related Hedging Obligations and (ii) each
other holder of ABL Obligations.
Acquired Indebtedness means, with respect to
any specified Person,
(1) Indebtedness of any other Person existing at the time
such other Person is merged with or into or became a Restricted
Subsidiary of such specified Person, including Indebtedness
incurred in connection with, or in contemplation of, such other
Person merging with or into or becoming a Restricted Subsidiary
of such specified Person, and
(2) Indebtedness secured by a Lien encumbering any asset
acquired by such specified Person.
Additional Interest means all additional
interest then owing pursuant to the Registration Rights
Agreement.
Affiliate of any specified Person means any
other Person directly or indirectly controlling or controlled by
or under direct or indirect common control with such specified
Person. For purposes of this definition, control
(including, with correlative meanings, the terms
controlling, controlled by and
under common control with), as used with respect to
any Person, shall mean the possession, directly or indirectly,
of the power to direct or cause the direction of the management
or policies of such Person, whether through the ownership of
voting securities, by agreement or otherwise.
Applicable Premium means, with respect to any
Note on any Redemption Date, the greater of:
(1) 1.0% of the principal amount of such Note; and
(2) the excess, if any, of (a) the present value at
such Redemption Date of (i) the redemption price of
such Note at February 15, 2013 (such redemption price being
set forth in the tables appearing above under the caption
Optional Redemption), plus (ii) all required
interest payments due on such Note through February 15,
2013 (excluding accrued but unpaid interest to the
Redemption Date), computed using a discount rate equal to
the Treasury Rate as of such Redemption Date plus
50 basis points; over (b) the principal amount of such
Note.
Asset Sale means:
(1) the sale, conveyance, transfer or other disposition,
whether in a single transaction or a series of related
transactions, of property or assets (including by way of a Sale
and Lease-Back Transaction) of the Issuer or any of its
Restricted Subsidiaries (each referred to in this definition as
a disposition); or
162
(2) the issuance or sale of Equity Interests of any
Restricted Subsidiary, whether in a single transaction or a
series of related transactions (other than Preferred Stock of
Restricted Subsidiaries issued in compliance with the covenant
described under Certain Covenants Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock);
in each case, other than:
(a) any disposition of Cash Equivalents or Investment Grade
Securities or obsolete or worn out equipment in the ordinary
course of business or any disposition of inventory or goods (or
other assets) held for sale in the ordinary course of business;
(b) the disposition of all or substantially all of the
assets of the Issuer in a manner permitted pursuant to the
provisions described above under Certain
Covenants Merger, Consolidation or Sale of All or
Substantially All Assets or any disposition that
constitutes a Change of Control pursuant to the Indenture;
(c) the making of any Restricted Payment or Permitted
Investment that is permitted to be made, and is made, under the
covenant described above under Certain
Covenants Limitation on Restricted Payments;
(d) any disposition of assets or issuance or sale of Equity
Interests of any Restricted Subsidiary in any transaction or
series of related transactions with an aggregate fair market
value of less than $100.0 million;
(e) any disposition of property or assets or issuance of
securities by a Restricted Subsidiary of the Issuer to the
Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
to another Restricted Subsidiary of the Issuer;
(f) to the extent allowable under Section 1031 of the
Code or any comparable or successor provision, any exchange of
like property (excluding any boot thereon) for use in a Similar
Business;
(g) the lease, assignment or
sub-lease of
any real or personal property in the ordinary course of business;
(h) any issuance or sale of Equity Interests in, or
Indebtedness or other securities of, an Unrestricted Subsidiary;
(i) foreclosures on assets;
(j) sales of accounts receivable, or participations
therein, in connection with the ABL Facility or any Receivables
Facility;
(k) any financing transaction with respect to property
built or acquired by the Issuer or any Restricted Subsidiary
after November 17, 2006, including Sale and Lease-Back
Transactions and asset securitizations permitted by the
Indenture;
(l) dispositions in the ordinary course of business by any
Restricted Subsidiary (including, without limitation, HCI)
engaged in the insurance business in order to provide insurance
to the Issuer and its Subsidiaries;
(m) sales, transfers and other dispositions of Investments
in joint ventures to the extent required by, or made pursuant
to, customary buy/sell arrangements between the joint venture
parties set forth in joint venture arrangements and similar
binding arrangements;
(n) any issuance or sale of Equity Interests or
dispositions in connection with ordinary course syndications of
Subsidiaries or joint ventures owning or operating one or more
healthcare facilities, including, without limitation, hospitals,
ambulatory surgery centers, outpatient diagnostic centers or
imaging centers in any transaction or series of related
transactions with an aggregate fair market value of less than
$100.0 million; and
163
(o) any issuance or sale of Equity Interests of any
Restricted Subsidiary (including, without limitation,
HealthTrust Purchasing Group, L.P.) to any Person operating in a
Similar Business for which such Restricted Subsidiary provides
shared purchasing, billing, collection or similar services in
the ordinary course of business.
Asset Sale Offer has the meaning set forth in
the fourth paragraph under Repurchase at the Option of
Holders Asset Sales.
Bankruptcy Code means Title 11 of the
United States Code, as amended.
Bankruptcy Law means the Bankruptcy Code and
any similar federal, state or foreign law for the relief of
debtors.
Business Day means each day which is not a
Legal Holiday.
Capital Stock means:
(1) in the case of a corporation, corporate stock;
(2) in the case of an association or business entity, any
and all shares, interests, participations, rights or other
equivalents (however designated) of corporate stock;
(3) in the case of a partnership or limited liability
company, partnership or membership interests (whether general or
limited); and
(4) any other interest or participation that confers on a
Person the right to receive a share of the profits and losses
of, or distributions of assets of, the issuing Person.
Capitalized Lease Obligation means, at the
time any determination thereof is to be made, the amount of the
liability in respect of a capital lease that would at such time
be required to be capitalized and reflected as a liability on a
balance sheet (excluding the footnotes thereto) in accordance
with GAAP.
Capitalized Software Expenditures means, for
any period, the aggregate of all expenditures (whether paid in
cash or accrued as liabilities) by a Person and its Restricted
Subsidiaries during such period in respect of purchased software
or internally developed software and software enhancements that,
in conformity with GAAP, are or are required to be reflected as
capitalized costs on the consolidated balance sheet of a Person
and its Restricted Subsidiaries.
Cash Equivalents means:
(1) United States dollars;
(2) euros or any national currency of any participating
member state of the EMU or such local currencies held by the
Company and its Restricted Subsidiaries from time to time in the
ordinary course of business;
(3) securities issued or directly and fully and
unconditionally guaranteed or insured by the
U.S. government (or any agency or instrumentality thereof
the securities of which are unconditionally guaranteed as a full
faith and credit obligation of the U.S. government) with
maturities of 24 months or less from the date of
acquisition;
(4) certificates of deposit, time deposits and eurodollar
time deposits with maturities of one year or less from the date
of acquisition, bankers acceptances with maturities not
exceeding one year and overnight bank deposits, in each case
with any commercial bank having capital and surplus of not less
than $500.0 million in the case of U.S. banks and
$100.0 million (or the U.S. dollar equivalent as of
the date of determination) in the case of
non-U.S. banks;
(5) repurchase obligations for underlying securities of the
types described in clauses (3) and (4) entered into
with any financial institution meeting the qualifications
specified in clause (4) above;
(6) commercial paper rated at least
P-1 by
Moodys or at least
A-1 by
S&P and in each case maturing within 24 months after
the date of creation thereof;
164
(7) marketable short-term money market and similar
securities having a rating of at least
P-2 or
A-2 from
either Moodys or S&P, respectively (or, if at any
time neither Moodys nor S&P shall be rating such
obligations, an equivalent rating from another Rating Agency)
and in each case maturing within 24 months after the date
of creation thereof;
(8) investment funds investing 95% of their assets in
securities of the types described in clauses (1) through
(7) above;
(9) readily marketable direct obligations issued by any
state, commonwealth or territory of the United States or any
political subdivision or taxing authority thereof having an
Investment Grade Rating from either Moodys or S&P
with maturities of 24 months or less from the date of
acquisition;
(10) Indebtedness or Preferred Stock issued by Persons with
a rating of A or higher from S&P or A2 or higher from
Moodys with maturities of 24 months or less from the
date of acquisition; and
(11) Investments with average maturities of 24 months
or less from the date of acquisition in money market funds rated
AAA- (or the equivalent thereof) or better by S&P or Aaa3
(or the equivalent thereof) or better by Moodys.
Notwithstanding the foregoing, Cash Equivalents shall include
amounts denominated in currencies other than those set forth in
clauses (1) and (2) above; provided that such
amounts are converted into any currency listed in
clauses (1) and (2) as promptly as practicable and in
any event within ten Business Days following the receipt of such
amounts.
Change of Control means the occurrence of any
of the following:
(1) the sale, lease or transfer, in one or a series of
related transactions, of all or substantially all of the assets
of the Issuer and its Subsidiaries, taken as a whole, to any
Person other than a Permitted Holder; or
(2) the Issuer becomes aware (by way of a report or any
other filing pursuant to Section 13(d) of the Exchange Act,
proxy, vote, written notice or otherwise) of the acquisition by
any Person or group (within the meaning of Section 13(d)(3)
or Section 14(d)(2) of the Exchange Act, or any successor
provision), including any group acting for the purpose of
acquiring, holding or disposing of securities (within the
meaning of
Rule 13d-5(b)(1)
under the Exchange Act), other than the Permitted Holders, in a
single transaction or in a related series of transactions, by
way of merger, consolidation or other business combination or
purchase of beneficial ownership (within the meaning of
Rule 13d-3
under the Exchange Act, or any successor provision) of 50% or
more of the total voting power of the Voting Stock of the Issuer
or any of its direct or indirect parent companies holding
directly or indirectly 100% of the total voting power of the
Voting Stock of the Issuer.
Code means the Internal Revenue Code of 1986,
as amended, or any successor thereto.
Collateral means, collectively, the Shared
Receivables Collateral and Non-Receivables Collateral.
Collateral Asset Sale Offer has the meaning
set forth in the third paragraph under Repurchase at the
Option of Holders Asset Sales.
Collateral Excess Proceeds has the meaning
set forth in the third paragraph under Repurchase at the
Option of Holders Asset Sales.
Consolidated Depreciation and Amortization
Expense means with respect to any Person for any
period, the total amount of depreciation and amortization
expense, including the amortization of deferred financing fees,
debt issuance costs, commissions, fees and expenses and
Capitalized Software Expenditures, of such Person and its
Restricted Subsidiaries for such period on a consolidated basis
and otherwise determined in accordance with GAAP.
165
Consolidated Interest Expense means, with
respect to any Person for any period, without duplication, the
sum of:
(1) consolidated interest expense of such Person and its
Restricted Subsidiaries for such period, to the extent such
expense was deducted (and not added back) in computing
Consolidated Net Income (including (a) amortization of
original issue discount resulting from the issuance of
Indebtedness at less than par, (b) all commissions,
discounts and other fees and charges owed with respect to
letters of credit or bankers acceptances,
(c) non-cash interest payments (but excluding any non-cash
interest expense attributable to the movement in the mark to
market valuation of Hedging Obligations or other derivative
instruments pursuant to GAAP), (d) the interest component
of Capitalized Lease Obligations, and (e) net payments, if
any, pursuant to interest rate Hedging Obligations with respect
to Indebtedness, and excluding (u) accretion or accrual of
discounted liabilities not constituting Indebtedness,
(v) any expense resulting from the discounting of the
Existing Notes or other Indebtedness in connection with the
application of recapitalization accounting or, if applicable,
purchase accounting, (w) any Additional Interest and any
comparable additional interest with respect to other
securities, (x) amortization of deferred financing fees,
debt issuance costs, commissions, fees and expenses,
(y) any expensing of bridge, commitment and other financing
fees and (z) commissions, discounts, yield and other fees
and charges (including any interest expense) related to any
Receivables Facility); plus
(2) consolidated capitalized interest of such Person and
its Restricted Subsidiaries for such period, whether paid or
accrued; less
(3) interest income for such period.
For purposes of this definition, interest on a Capitalized Lease
Obligation shall be deemed to accrue at an interest rate
reasonably determined by such Person to be the rate of interest
implicit in such Capitalized Lease Obligation in accordance with
GAAP.
Consolidated Leverage Ratio, with respect to
any Person as of any date of determination, means the ratio of
(x) Consolidated Total Indebtedness of such Person as of
the end of the most recent fiscal quarter for which internal
financial statements are available immediately preceding the
date on which such event for which such calculation is being
made shall occur to (y) the aggregate amount of EBITDA of
such Person for the period of the most recently ended four full
consecutive fiscal quarters for which internal financial
statements are available immediately preceding the date on which
such event for which such calculation is being made shall occur,
in each case with such pro forma adjustments to Consolidated
Total Indebtedness and EBITDA as are appropriate and consistent
with the pro forma adjustment provisions set forth in the
definition of Fixed Charge Coverage Ratio.
Consolidated Net Income means, with respect
to any Person for any period, the aggregate of the Net Income of
such Person for such period, on a consolidated basis, and
otherwise determined in accordance with GAAP; provided,
however, that, without duplication,
(1) any after-tax effect of extraordinary, non-recurring or
unusual gains or losses (less all fees and expenses relating
thereto) or expenses, severance, relocation costs, consolidation
and closing costs, integration and facilities opening costs,
business optimization costs, transition costs, restructuring
costs, signing, retention or completion bonuses, and
curtailments or modifications to pension and post-retirement
employee benefit plans shall be excluded,
(2) the cumulative effect of a change in accounting
principles during such period shall be excluded,
(3) any after-tax effect of income (loss) from disposed,
abandoned or discontinued operations and any net after-tax gains
or losses on disposal of disposed, abandoned, transferred,
closed or discontinued operations shall be excluded,
(4) any after-tax effect of gains or losses (less all fees
and expenses relating thereto) attributable to asset
dispositions or abandonments other than in the ordinary course
of business, as determined in good faith by the Issuer, shall be
excluded,
166
(5) the Net Income for such period of any Person that is an
Unrestricted Subsidiary shall be excluded, and, solely for the
purpose of determining the amount available for Restricted
Payments under clause 3(a) of the first paragraph of
Certain Covenants Limitation on Restricted
Payments, the Net Income for such period of any Person
that is not a Subsidiary or that is accounted for by the equity
method of accounting shall be excluded; provided that
Consolidated Net Income of the Issuer shall be increased by the
amount of dividends or distributions or other payments that are
actually paid in cash (or to the extent converted into cash) to
the referent Person or a Restricted Subsidiary thereof in
respect of such period,
(6) solely for the purpose of determining the amount
available for Restricted Payments under clause (3)(a) of the
first paragraph of Certain Covenants
Limitation on Restricted Payments, the Net Income for such
period of any Restricted Subsidiary (other than any Guarantor)
shall be excluded to the extent that the declaration or payment
of dividends or similar distributions by that Restricted
Subsidiary of its Net Income is not at the date of determination
wholly permitted without any prior governmental approval (which
has not been obtained) or, directly or indirectly, by the
operation of the terms of its charter or any agreement,
instrument, judgment, decree, order, statute, rule, or
governmental regulation applicable to that Restricted Subsidiary
or its stockholders, unless such restriction with respect to the
payment of dividends or similar distributions has been legally
waived; provided that Consolidated Net Income of the Issuer will
be increased by the amount of dividends or other distributions
or other payments actually paid in cash (or to the extent
converted into cash) or Cash Equivalents to the Issuer or a
Restricted Subsidiary thereof in respect of such period, to the
extent not already included therein,
(7) effects of adjustments (including the effects of such
adjustments pushed down to the Issuer and its Restricted
Subsidiaries) in the property, equipment, inventory, software
and other intangible assets, deferred revenue and debt line
items in such Persons consolidated financial statements
pursuant to GAAP resulting from the application of
recapitalization accounting or, if applicable, purchase
accounting in relation to the Transactions or any consummated
acquisition or the amortization or write-off of any amounts
thereof, net of taxes, shall be excluded,
(8) any after-tax effect of income (loss) from the early
extinguishment of Indebtedness or Hedging Obligations or other
derivative instruments shall be excluded,
(9) any impairment charge or asset write-off, including,
without limitation, impairment charges or asset write-offs
related to intangible assets, long-lived assets or investments
in debt and equity securities, in each case, pursuant to GAAP
and the amortization of intangibles arising pursuant to GAAP
shall be excluded,
(10) any non-cash compensation expense recorded from grants
of stock appreciation or similar rights, stock options,
restricted stock or other rights, and any cash charges
associated with the rollover, acceleration or payout of Equity
Interests by management of the Company or any of its direct or
indirect parent companies in connection with the Transaction,
shall be excluded,
(11) any fees and expenses incurred during such period, or
any amortization thereof for such period, in connection with any
acquisition, Investment, Asset Sale, issuance or repayment of
Indebtedness, issuance of Equity Interests, refinancing
transaction or amendment or modification of any debt instrument
(in each case, including any such transaction consummated prior
to the Issue Date and any such transaction undertaken but not
completed) and any charges or non-recurring merger costs
incurred during such period as a result of any such transaction
shall be excluded,
(12) accruals and reserves that are established or adjusted
within twelve months after November 17, 2006 that are so
required to be established as a result of the Transaction in
accordance with GAAP, or changes as a result of adoption or
modification of accounting policies, shall be excluded, and
(13) to the extent covered by insurance and actually
reimbursed, or, so long as the Issuer has made a determination
that there exists reasonable evidence that such amount will in
fact be reimbursed by the insurer and only to the extent that
such amount is (a) not denied by the applicable carrier in
writing within 180 days and (b) in fact reimbursed
within 365 days of the date of such evidence (with a
deduction for any amount so added back to the extent not so
reimbursed within 365 days), expenses with respect to
liability or casualty events or business interruption shall be
excluded.
167
Notwithstanding the foregoing, for the purpose of the covenant
described under Certain Covenants Limitation
on Restricted Payments only (other than clause (3)(d)
thereof), there shall be excluded from Consolidated Net Income
any income arising from any sale or other disposition of
Restricted Investments made by the Issuer and its Restricted
Subsidiaries, any repurchases and redemptions of Restricted
Investments from the Issuer and its Restricted Subsidiaries, any
repayments of loans and advances which constitute Restricted
Investments by the Issuer or any of its Restricted Subsidiaries,
any sale of the stock of an Unrestricted Subsidiary or any
distribution or dividend from an Unrestricted Subsidiary, in
each case only to the extent such amounts increase the amount of
Restricted Payments permitted under such covenant pursuant to
clause (3)(d) thereof.
Consolidated Secured Debt Ratio as of any
date of determination, means the ratio of (1) Consolidated
Total Indebtedness of the Issuer and its Restricted Subsidiaries
that is secured by Liens as of the end of the most recent fiscal
period for which internal financial statements are available
immediately preceding the date on which such event for which
such calculation is being made shall occur to (2) the
Issuers EBITDA for the most recently ended four full
fiscal quarters for which internal financial statements are
available immediately preceding the date on which such event for
which such calculation is being made shall occur, in each case
with such pro forma adjustments to Consolidated Total
Indebtedness and EBITDA as are appropriate and consistent with
the pro forma adjustment provisions set forth in the definition
of Fixed Charge Coverage Ratio.
Consolidated Total Indebtedness means, as at
any date of determination, an amount equal to the sum of
(1) the aggregate amount of all outstanding Indebtedness of
the Issuer and its Restricted Subsidiaries on a consolidated
basis consisting of Indebtedness for borrowed money, Obligations
in respect of Capitalized Lease Obligations and debt obligations
evidenced by promissory notes and similar instruments (and
excluding, for the avoidance of doubt, all obligations relating
to Receivables Facilities) and (2) the aggregate amount of
all outstanding Disqualified Stock of the Issuer and all
Preferred Stock of its Restricted Subsidiaries on a consolidated
basis, with the amount of such Disqualified Stock and Preferred
Stock equal to the greater of their respective voluntary or
involuntary liquidation preferences and maximum fixed repurchase
prices, in each case determined on a consolidated basis in
accordance with GAAP. For purposes hereof, the maximum
fixed repurchase price of any Disqualified Stock or
Preferred Stock that does not have a fixed repurchase price
shall be calculated in accordance with the terms of such
Disqualified Stock or Preferred Stock as if such Disqualified
Stock or Preferred Stock were purchased on any date on which
Consolidated Total Indebtedness shall be required to be
determined pursuant to the Indenture, and if such price is based
upon, or measured by, the fair market value of such Disqualified
Stock or Preferred Stock, such fair market value shall be
determined reasonably and in good faith by the Issuer.
Contingent Obligations means, with respect to
any Person, any obligation of such Person guaranteeing any
leases, dividends or other obligations that do not constitute
Indebtedness (primary obligations) of any
other Person (the primary obligor) in any
manner, whether directly or indirectly, including, without
limitation, any obligation of such Person, whether or not
contingent,
(1) to purchase any such primary obligation or any property
constituting direct or indirect security therefor,
(2) to advance or supply funds
(a) for the purchase or payment of any such primary
obligation, or
(b) to maintain working capital or equity capital of the
primary obligor or otherwise to maintain the net worth or
solvency of the primary obligor, or
(3) to purchase property, securities or services primarily
for the purpose of assuring the owner of any such primary
obligation of the ability of the primary obligor to make payment
of such primary obligation against loss in respect thereof.
Credit Facilities means, with respect to the
Issuer or any of its Restricted Subsidiaries, one or more debt
facilities, including the Senior Credit Facilities, or other
financing arrangements (including, without
168
limitation, commercial paper facilities or indentures) providing
for revolving credit loans, term loans, letters of credit or
other long-term indebtedness, including any notes, mortgages,
guarantees, collateral documents, instruments and agreements
executed in connection therewith, and any amendments,
supplements, modifications, extensions, renewals, restatements
or refundings thereof and any indentures or credit facilities or
commercial paper facilities that replace, refund or refinance
any part of the loans, notes, other credit facilities or
commitments thereunder, including any such replacement,
refunding or refinancing facility or indenture that increases
the amount permitted to be borrowed thereunder or alters the
maturity thereof (provided that such increase in
borrowings is permitted under Certain Covenants
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock) or
adds Restricted Subsidiaries as additional borrowers or
guarantors thereunder and whether by the same or any other
agent, lender or group of lenders.
Default means any event that is, or with the
passage of time or the giving of notice or both would be, an
Event of Default.
Delayed Equity Amount means any equity
contribution of the Investors, the Frist Entities or certain
other management investors described in the Offering Memorandum
on or before March 31, 2007, the proceeds of which are used
to repay borrowings under the senior secured revolving credit
facility included in the General Credit Facility or the ABL
Facility in the manner described in the Offering Memorandum.
Designated Non-cash Consideration means the
fair market value of non-cash consideration received by the
Issuer or a Restricted Subsidiary in connection with an Asset
Sale that is so designated as Designated Non-cash Consideration
pursuant to an Officers Certificate, setting forth the
basis of such valuation, executed by the principal financial
officer of the Issuer, less the amount of cash or Cash
Equivalents received in connection with a subsequent sale of or
collection on such Designated Non-cash Consideration.
Designated Preferred Stock means Preferred
Stock of the Issuer or any parent corporation thereof (in each
case other than Disqualified Stock) that is issued for cash
(other than to a Restricted Subsidiary or an employee stock
ownership plan or trust established by the Issuer or any of its
Subsidiaries) and is so designated as Designated Preferred
Stock, pursuant to an Officers Certificate executed by the
principal financial officer of the Issuer or the applicable
parent corporation thereof, as the case may be, on the issuance
date thereof, the cash proceeds of which are excluded from the
calculation set forth in clause (3) of the first paragraph
under Certain Covenants Limitation on
Restricted Payments.
Discharge of First Lien Obligations shall
mean the satisfaction and discharge of all of the First Lien
Obligations in full in cash, pursuant to the First Lien
Documents and the General Intercreditor Agreement.
Disqualified Stock means, with respect to any
Person, any Capital Stock of such Person which, by its terms, or
by the terms of any security into which it is convertible or for
which it is putable or exchangeable, or upon the happening of
any event, matures or is mandatorily redeemable (other than
solely as a result of a change of control or asset sale)
pursuant to a sinking fund obligation or otherwise, or is
redeemable at the option of the holder thereof (other than
solely as a result of a change of control or asset sale), in
whole or in part, in each case prior to the date 91 days
after the earlier of the maturity date of the Notes or the date
the Notes are no longer outstanding; provided,
however, that if such Capital Stock is issued to any plan
for the benefit of employees of the Issuer or its Subsidiaries
or by any such plan to such employees, such Capital Stock shall
not constitute Disqualified Stock solely because it may be
required to be repurchased by the Issuer or its Subsidiaries in
order to satisfy applicable statutory or regulatory obligations.
EBITDA means, with respect to any Person for
any period, the Consolidated Net Income of such Person for such
period
(1) increased (without duplication) by:
(a) provision for taxes based on income or profits or
capital gains, including, without limitation, foreign, federal,
state, franchise and similar taxes (such as the Pennsylvania
capital tax) and foreign withholding taxes (including penalties
and interest related to such taxes or arising from tax
examinations) of such Person paid or accrued during such period
deducted (and not added back) in computing Consolidated Net
Income; plus
169
(b) Fixed Charges of such Person for such period (including
(x) net losses on Hedging Obligations or other derivative
instruments entered into for the purpose of hedging interest
rate risk and (y) costs of surety bonds in connection with
financing activities, in each case, to the extent included in
Fixed Charges), together with items excluded from the definition
of Consolidated Interest Expense pursuant to clauses
(1)(u), (v), (w), (x), (y) and (z) of the definition
thereof, and, in each such case, to the extent the same were
deducted (and not added back) in calculating such Consolidated
Net Income; plus
(c) Consolidated Depreciation and Amortization Expense of
such Person for such period to the extent the same was deducted
(and not added back) in computing Consolidated Net Income;
plus
(d) any expenses or charges (other than depreciation or
amortization expense) related to any Equity Offering, Permitted
Investment, acquisition, disposition, recapitalization or the
incurrence of Indebtedness permitted to be incurred by the
Indenture (including a refinancing thereof) (whether or not
successful), including (i) such fees, expenses or charges
related to the offering of the Notes and any Credit Facilities
and (ii) any amendment or other modification of the Notes,
and, in each case, deducted (and not added back) in computing
Consolidated Net Income; plus
(e) the amount of any restructuring charge or reserve
deducted (and not added back) in such period in computing
Consolidated Net Income, including any one-time costs incurred
in connection with acquisitions after November 17, 2006 and
costs related to the closure
and/or
consolidation of facilities; plus
(f) any other non-cash charges, including any write-offs or
write-downs, reducing Consolidated Net Income for such period
(provided that if any such non-cash charges represent an accrual
or reserve for potential cash items in any future period, the
cash payment in respect thereof in such future period shall be
subtracted from EBITDA to such extent, and excluding
amortization of a prepaid cash item that was paid in a prior
period); plus
(g) the amount of any minority interest expense consisting
of income attributable to minority equity interests of third
parties deducted (and not added back) in such period in
calculating Consolidated Net Income; plus
(h) the amount of management, monitoring, consulting and
advisory fees and related expenses paid in such period to the
Investors and the Frist Entities to the extent otherwise
permitted under Certain Covenants Transactions
with Affiliates; plus
(i) the amount of net cost savings projected by the Issuer
in good faith to be realized as a result of specified actions
taken or to be taken (calculated on a pro forma basis as though
such cost savings had been realized on the first day of such
period), net of the amount of actual benefits realized during
such period from such actions; provided that (w) such cost
savings are reasonably identifiable and factually supportable,
(x) such actions have been taken or are to be taken within
15 months after the date of determination to take such
action, (y) no cost savings shall be added pursuant to this
clause (i) to the extent duplicative of any expenses or
charges relating to such cost savings that are included in
clause (e) above with respect to such period and
(z) the aggregate amount of cost savings added pursuant to
this clause (i) shall not exceed $150.0 million for
any four consecutive quarter period (which adjustments may be
incremental to pro forma adjustments made pursuant to the second
paragraph of the definition of Fixed Charge Coverage
Ratio); plus
(j) the amount of loss on sales of receivables and related
assets to the Receivables Subsidiary in connection with a
Receivables Facility; plus
(k) any costs or expense incurred by the Issuer or a
Restricted Subsidiary pursuant to any management equity plan or
stock option plan or any other management or employee benefit
plan or agreement or any stock subscription or shareholder
agreement, to the extent that such cost or expenses are funded
with cash proceeds contributed to the capital of the Issuer or
net cash proceeds of an issuance of Equity Interests of the
Issuer (other than Disqualified Stock) solely to the extent that
such net cash
170
proceeds are excluded from the calculation set forth in
clause (3) of the first paragraph under Certain
Covenants Limitation on Restricted Payments;
(2) decreased by (without duplication) non-cash gains
increasing Consolidated Net Income of such Person for such
period, excluding any non-cash gains to the extent they
represent the reversal of an accrual or reserve for a potential
cash item that reduced EBITDA in any prior period; and
(3) increased or decreased by (without duplication):
(a) any net gain or loss resulting in such period from
Hedging Obligations and the application of Statement of
Financial Accounting Standards No. 133; plus or minus, as
applicable,
(b) any net gain or loss resulting in such period from
currency translation gains or losses related to currency
remeasurements of Indebtedness (including any net loss or gain
resulting from Hedging Obligations for currency exchange risk).
EMU means the economic and monetary union as
contemplated in the Treaty on European Union.
Equity Interests means Capital Stock and all
warrants, options or other rights to acquire Capital Stock, but
excluding any debt security that is convertible into, or
exchangeable for, Capital Stock.
Equity Offering means any public or private
sale of common stock or Preferred Stock of the Issuer or any of
its direct or indirect parent companies (excluding Disqualified
Stock), other than:
(1) public offerings with respect to the Issuers or
any direct or indirect parent companys common stock
registered on
Form S-8;
(2) issuances to any Subsidiary of the Issuer; and
(3) any such public or private sale that constitutes an
Excluded Contribution.
euro means the single currency of
participating member states of the EMU.
European Collateral has the meaning set forth
under Description of Other Indebtedness Senior
Secured Credit Facilities Guarantee and
Security.
Event of Default has the meaning set forth
under Events of Default and Remedies.
Excess Proceeds has the meaning set forth in
the fourth paragraph under Repurchase at the Option of
Holders Asset Sales.
Exchange Act means the Securities Exchange
Act of 1934, as amended, and the rules and regulations of the
SEC promulgated thereunder.
Exchange Notes means any notes issued in
exchange for the Notes pursuant to the Registration Rights
Agreement or similar agreement.
Excluded Contribution means net cash
proceeds, marketable securities or Qualified Proceeds received
by the Issuer after November 17, 2006 from
(1) contributions to its common equity capital, and
(2) the sale (other than to a Subsidiary of the Issuer or
to any management equity plan or stock option plan or any other
management or employee benefit plan or agreement of the Issuer)
of Capital Stock (other than Disqualified Stock and Designated
Preferred Stock) of the Issuer,
in each case designated as Excluded Contributions pursuant to an
Officers Certificate executed by the principal financial
officer of the Issuer on the date such capital contributions are
made or the date such Equity Interests are sold, as the case may
be, which are excluded from the calculation set forth in
clause (3) of the first paragraph under Certain
Covenants Limitation on Restricted Payments.
Existing Notes means the $121.2 million
aggregate principal amount of 8.700% medium-term notes due 2010,
$691.2 million aggregate principal amount of
8.750% notes due 2010, £150.0 million aggregate
171
principal amount of 8.750% notes due 2010,
$475.8 million aggregate principal amount of
7.875% notes due 2011, $500.0 million aggregate
principal amount of 6.950% notes due 2012,
$500.0 million aggregate principal amount of
6.300% notes due 2012, $500.0 million aggregate
principal amount of 6.250% notes due 2013,
$500.0 million aggregate principal amount of
6.750% notes due 2013, $500.0 million aggregate
principal amount of 5.750% notes due 2014,
$121.1 million aggregate principal amount of 9.000%
medium-term notes due 2014, $750.0 million aggregate
principal amount of 6.375% notes due 2015,
$150.0 million aggregate principal amount of
7.190% debentures due 2015, $1,000.0 million aggregate
principal amount of 6.500% notes due 2016,
$135.6 million aggregate principal amount of
7.500% debentures due 2023, $150.0 million aggregate
principal amount of 8.360% debentures due 2024,
$291.4 million aggregate principal amount of
7.690% notes due 2025, $125.0 million aggregate
principal amount of 7.580% medium-term notes due 2025,
$150.0 million aggregate principal amount of
7.050% debentures due 2027, $250.0 million aggregate
principal amount of 7.500% notes due 2033,
$100.0 million aggregate principal amount of
7.750% debentures due 2036 and $200.0 million
aggregate principal amount of 7.500% debentures due 2095,
each issued by the Issuer and outstanding on November 17,
2006.
Existing Notes Indenture means that certain
Indenture, dated as of December 16, 1993, between Columbia
Healthcare Corporation and The First National Bank of Chicago,
as Trustee, as amended by the First Supplemental Indenture,
dated as of May 25, 2000, between the Issuer and Bank One
Trust Company, N.A., as Trustee, the Second Supplemental
Indenture, dated as of July 1, 2001, between the Issuer and
Bank One Trust Company, N.A., as Trustee, and the Third
Supplemental Indenture, dated as of December 5, 2001,
between the Issuer and The Bank of New York, as Trustee.
First Lien Collateral means all of the assets
of the Issuer or any Guarantor, whether real, personal or mixed,
with respect to which a Lien has been granted as security for
any First Lien Obligations pursuant to a First Lien Document.
First Lien Collateral Agent shall mean Bank
of America, N.A., in its capacity as administrative agent and
collateral agent for the lenders and other secured parties under
the General Credit Facility and the other First Lien Documents,
together with its successors and permitted assigns under the
General Credit Facility exercising substantially the same rights
and powers; and in each case provided that if such First Lien
Collateral Agent is not Bank of America, N.A., such First Lien
Collateral Agent shall have become a party to the Intercreditor
Agreements and the other applicable First Lien Security
Documents.
First Lien Documents means the credit,
guarantee and security documents governing the First Lien
Obligations, including, without limitation, the General Credit
Facility and the First Lien Security Documents.
First Lien Obligations shall mean
(a) all General Credit Facility Obligations and
(b) all other Obligations of the Issuer and its
Subsidiaries under any refinancings of the General Credit
Facility Obligations (and any related Hedging Obligations). For
the avoidance of doubt, Obligations with respect to the ABL
Facility shall not constitute First Lien Obligations.
First Lien Secured Parties means, at any
relevant time, the holders of First Lien Obligations at such
time, including, without limitation, the lenders and agents
under the General Credit Facility and the First Lien Collateral
Agent.
First Lien Security Documents means the
Security Documents (as defined in the General Credit Facility)
and any other agreement, document or instrument pursuant to
which a Lien is granted or purported to be granted securing
First Lien Obligations or under which rights or remedies with
respect to such Liens are governed.
First Priority Liens means the first priority
Liens securing the First Lien Obligations.
Fixed Charge Coverage Ratio means, with
respect to any Person for any period, the ratio of EBITDA of
such Person for such period to the Fixed Charges of such Person
for such period. In the event that the Issuer or any Restricted
Subsidiary incurs, assumes, guarantees, redeems, retires or
extinguishes any Indebtedness (other than Indebtedness incurred
under any revolving credit facility unless such Indebtedness has
been permanently repaid and has not been replaced) or issues or
redeems Disqualified Stock or Preferred Stock
172
subsequent to the commencement of the period for which the Fixed
Charge Coverage Ratio is being calculated but prior to or
simultaneously with the event for which the calculation of the
Fixed Charge Coverage Ratio is made (the Fixed Charge
Coverage Ratio Calculation Date), then the Fixed
Charge Coverage Ratio shall be calculated giving pro forma
effect to such incurrence, assumption, guarantee, redemption,
retirement or extinguishment of Indebtedness, or such issuance
or redemption of Disqualified Stock or Preferred Stock, as if
the same had occurred at the beginning of the applicable
four-quarter period.
For purposes of making the computation referred to above,
Investments, acquisitions, dispositions, mergers, consolidations
and disposed operations (as determined in accordance with GAAP)
that have been made by the Issuer or any of its Restricted
Subsidiaries during the four-quarter reference period or
subsequent to such reference period and on or prior to or
simultaneously with the Fixed Charge Coverage Ratio Calculation
Date shall be calculated on a pro forma basis assuming that all
such Investments, acquisitions, dispositions, mergers,
consolidations and disposed operations (and the change in any
associated fixed charge obligations and the change in EBITDA
resulting therefrom) had occurred on the first day of the
four-quarter reference period. If, since the beginning of such
period, any Person that subsequently became a Restricted
Subsidiary or was merged with or into the Issuer or any of its
Restricted Subsidiaries since the beginning of such period shall
have made any Investment, acquisition, disposition, merger,
consolidation or disposed operation that would have required
adjustment pursuant to this definition, then the Fixed Charge
Coverage Ratio shall be calculated giving pro forma effect
thereto for such period as if such Investment, acquisition,
disposition, merger, consolidation or disposed operation had
occurred at the beginning of the applicable four-quarter period.
For purposes of this definition, whenever pro forma effect is to
be given to a transaction, the pro forma calculations shall be
made in good faith by a responsible financial or accounting
officer of the Issuer. If any Indebtedness bears a floating rate
of interest and is being given pro forma effect, the interest on
such Indebtedness shall be calculated as if the rate in effect
on the Fixed Charge Coverage Ratio Calculation Date had been the
applicable rate for the entire period (taking into account any
Hedging Obligations applicable to such Indebtedness). Interest
on a Capitalized Lease Obligation shall be deemed to accrue at
an interest rate reasonably determined by a responsible
financial or accounting officer of the Issuer to be the rate of
interest implicit in such Capitalized Lease Obligation in
accordance with GAAP. For purposes of making the computation
referred to above, interest on any Indebtedness under a
revolving credit facility computed on a pro forma basis shall be
computed based upon the average daily balance of such
Indebtedness during the applicable period except as set forth in
the first paragraph of this definition. Interest on Indebtedness
that may optionally be determined at an interest rate based upon
a factor of a prime or similar rate, a eurocurrency interbank
offered rate or other rate shall be deemed to have been based
upon the rate actually chosen, or, if none, then based upon such
optional rate chosen as the Issuer may designate.
Fixed Charges means, with respect to any
Person for any period, the sum of:
(1) Consolidated Interest Expense of such Person for such
period;
(2) all cash dividends or other distributions paid
(excluding items eliminated in consolidation) on any series of
Preferred Stock during such period; and
(3) all cash dividends or other distributions paid
(excluding items eliminated in consolidation) on any series of
Disqualified Stock during such period.
Foreign Subsidiary means, with respect to any
Person, any Restricted Subsidiary of such Person that is not
organized or existing under the laws of the United States, any
state thereof or the District of Columbia and any Restricted
Subsidiary of such Foreign Subsidiary.
Frist Entities means Dr. Thomas F.
Frist, Jr., any Person controlled by Dr. Frist and any
charitable organization selected by Dr. Frist that holds
Equity Interests of the Issuer on November 17, 2006.
GAAP means generally accepted accounting
principles in the United States which are in effect on
November 17, 2006.
173
General Credit Facility means the credit
agreement entered into as of November 17, 2006 by and among
the Issuer, the European subsidiary borrowers party thereto, the
lenders party thereto in their capacities as lenders thereunder
and Bank of America, N.A., as U.S. Administrative Agent and
as European Administrative Agent, including any guarantees,
collateral documents, instruments and agreements executed in
connection therewith, and any amendments, supplements,
modifications, extensions, renewals, restatements, refundings or
refinancings thereof and any indentures or credit facilities or
commercial paper facilities with banks or other institutional
lenders or investors that replace, refund or refinance any part
of the loans, notes, other credit facilities or commitments
thereunder, including any such replacement, refunding or
refinancing facility or indenture that increases the amount
borrowable thereunder or alters the maturity thereof
(provided that such increase in borrowings is permitted
under Certain Covenants Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock above).
General Credit Facility Obligations means
Obligations as defined in the General Credit
Facility.
General Intercreditor Agreement has the
meaning set forth under Security Liens with
Respect to the Collateral.
Government Securities means securities that
are:
(1) direct obligations of the United States of America for
the timely payment of which its full faith and credit is
pledged; or
(2) obligations of a Person controlled or supervised by and
acting as an agency or instrumentality of the United States of
America the timely payment of which is unconditionally
guaranteed as a full faith and credit obligation by the United
States of America,
which, in either case, are not callable or redeemable at the
option of the issuers thereof, and shall also include a
depository receipt issued by a bank (as defined in
Section 3(a)(2) of the Securities Act), as custodian with
respect to any such Government Securities or a specific payment
of principal of or interest on any such Government Securities
held by such custodian for the account of the holder of such
depository receipt; provided that (except as required by
law) such custodian is not authorized to make any deduction from
the amount payable to the holder of such depository receipt from
any amount received by the custodian in respect of the
Government Securities or the specific payment of principal of or
interest on the Government Securities evidenced by such
depository receipt.
guarantee means a guarantee (other than by
endorsement of negotiable instruments for collection in the
ordinary course of business), direct or indirect, in any manner
(including letters of credit and reimbursement agreements in
respect thereof), of all or any part of any Indebtedness or
other obligations.
Guarantee means the guarantee by any
Guarantor of the Issuers Obligations under the Indenture.
Guarantor means each Restricted Subsidiary
that Guarantees the Notes in accordance with the terms of the
Indenture.
HCI means Health Care Indemnity, Inc., an
insurance company formed under the laws of the State of Colorado
and a Wholly-Owned Subsidiary of the Issuer.
Hedging Arrangements means the fixed-pay
interest rate swap agreements, entered into by Hercules Holding
on or about September 13, 2006 and with respect to which
the Issuer will be the counterparty in connection with the
Recapitalization, relating to $8,000 million of the
outstanding principal amount under the First Lien Obligations
and the ABL Obligations.
Hedging Obligations means, with respect to
any Person, the obligations of such Person under any interest
rate swap agreement, interest rate cap agreement, interest rate
collar agreement, commodity swap agreement, commodity cap
agreement, commodity collar agreement, foreign exchange
contract, currency swap agreement or similar agreement providing
for the transfer or mitigation of interest rate or currency
risks either generally or under specific contingencies.
Holder means the Person in whose name a Note
is registered on the registrars books.
174
Indebtedness means, with respect to any
Person, without duplication:
(1) any indebtedness (including principal and premium) of
such Person, whether or not contingent:
(a) in respect of borrowed money;
(b) evidenced by bonds, notes, debentures or similar
instruments or letters of credit or bankers acceptances
(or, without duplication, reimbursement agreements in respect
thereof);
(c) representing the balance deferred and unpaid of the
purchase price of any property (including Capitalized Lease
Obligations), except (i) any such balance that constitutes
a trade payable or similar obligation to a trade creditor, in
each case accrued in the ordinary course of business and
(ii) any earn-out obligations until such obligation becomes
a liability on the balance sheet of such Person in accordance
with GAAP; or
(d) representing any Hedging Obligations;
if and to the extent that any of the foregoing Indebtedness
(other than letters of credit and Hedging Obligations) would
appear as a liability upon a balance sheet (excluding the
footnotes thereto) of such Person prepared in accordance with
GAAP;
(2) to the extent not otherwise included, any obligation by
such Person to be liable for, or to pay, as obligor, guarantor
or otherwise on, the obligations of the type referred to in
clause (1) of a third Person (whether or not such items
would appear upon the balance sheet of the such obligor or
guarantor), other than by endorsement of negotiable instruments
for collection in the ordinary course of business; and
(3) to the extent not otherwise included, the obligations
of the type referred to in clause (1) of a third Person
secured by a Lien on any asset owned by such first Person,
whether or not such Indebtedness is assumed by such first Person;
provided, however, that notwithstanding the
foregoing, Indebtedness shall be deemed not to include
(a) Contingent Obligations incurred in the ordinary course
of business or (b) obligations under or in respect of
Receivables Facilities.
Independent Financial Advisor means an
accounting, appraisal, investment banking firm or consultant to
Persons engaged in Similar Businesses of nationally recognized
standing that is, in the good faith judgment of the Issuer,
qualified to perform the task for which it has been engaged.
Initial Purchasers means Banc of America
Securities LLC, Citigroup Global Markets, Inc., J.P. Morgan
Securities Inc., Wachovia Capital Markets, LLC and the other
initial purchasers party to the purchase agreement related to
the Notes.
insolvency or liquidation proceeding means:
(1) any case commenced by or against the Issuer or any
Guarantor under any Bankruptcy Law for the relief of debtors,
any other proceeding for the reorganization, recapitalization or
adjustment or marshalling of the assets or liabilities of the
Issuer or any Guarantor, any receivership or assignment for the
benefit of creditors relating to the Issuer or any Guarantor or
any similar case or proceeding relative to the Issuer or any
Guarantor or its creditors, as such, in each case whether or not
voluntary;
(2) any liquidation, dissolution, marshalling of assets or
liabilities or other winding up of or relating to the Issuer or
any Guarantor, in each case whether or not voluntary and whether
or not involving bankruptcy or insolvency; or
(3) any other proceeding of any type or nature in which
substantially all claims of creditors of the Issuer or any
Guarantor are determined and any payment or distribution is or
may be made on account of such claims.
Intercreditor Agreements means, collectively,
the Shared Receivables Intercreditor Agreement and the General
Intercreditor Agreement.
175
Investment Grade Rating means a rating equal
to or higher than Baa3 (or the equivalent) by Moodys and
BBB- (or the equivalent) by S&P, or an equivalent rating by
any other Rating Agency.
Investment Grade Securities means:
(1) securities issued or directly and fully guaranteed or
insured by the United States government or any agency or
instrumentality thereof (other than Cash Equivalents);
(2) debt securities or debt instruments with an Investment
Grade Rating, but excluding any debt securities or instruments
constituting loans or advances among the Issuer and its
Subsidiaries;
(3) investments in any fund that invests exclusively in
investments of the type described in clauses (1) and
(2) which fund may also hold immaterial amounts of cash
pending investment or distribution; and
(4) corresponding instruments in countries other than the
United States customarily utilized for high quality investments.
Investments means, with respect to any
Person, all investments by such Person in other Persons
(including Affiliates) in the form of loans (including
guarantees), advances or capital contributions (excluding
accounts receivable, trade credit, advances to customers,
commissions, travel and similar advances to officers and
employees, in each case made in the ordinary course of
business), purchases or other acquisitions for consideration of
Indebtedness, Equity Interests or other securities issued by any
other Person and investments that are required by GAAP to be
classified on the balance sheet (excluding the footnotes) of the
Issuer in the same manner as the other investments included in
this definition to the extent such transactions involve the
transfer of cash or other property. For purposes of the
definition of Unrestricted Subsidiary and the
covenant described under Certain Covenants
Limitation on Restricted Payments:
(1) Investments shall include the
portion (proportionate to the Issuers equity interest in
such Subsidiary) of the fair market value of the net assets of a
Subsidiary of the Issuer at the time that such Subsidiary is
designated an Unrestricted Subsidiary; provided,
however, that upon a redesignation of such Subsidiary as
a Restricted Subsidiary, the Issuer shall be deemed to continue
to have a permanent Investment in an Unrestricted
Subsidiary in an amount (if positive) equal to:
(a) the Issuers Investment in such
Subsidiary at the time of such redesignation; less
(b) the portion (proportionate to the Issuer equity
interest in such Subsidiary) of the fair market value of the net
assets of such Subsidiary at the time of such
redesignation; and
(2) any property transferred to or from an Unrestricted
Subsidiary shall be valued at its fair market value at the time
of such transfer, in each case as determined in good faith by
the Issuer.
Investors means Bain Capital Partners, LLC,
Kohlberg Kravis Roberts & Co. L.P., Merrill Lynch
Global Partners, Inc. and each of their respective Affiliates
but not including, however, any portfolio companies of any of
the foregoing.
Issue Date means February 19, 2009.
Issuer has the meaning set forth in the first
paragraph under General; provided that when
used in the context of determining the fair market value of an
asset or liability under the Indenture, Issuer shall
be deemed to mean the board of directors of the Issuer when the
fair market value is equal to or in excess of
$500.0 million (unless otherwise expressly stated).
Junior Lien Collateral Agent shall mean
(i) so long as the Notes are outstanding, The Bank of New
York Mellon, in its capacity as trustee and collateral agent for
the holders of the 2006 Notes and other secured parties under
the 2006 Notes Indenture and the Security Documents (including
the Holders), and (ii) at any time thereafter, such agent
or trustee as is designated Junior Lien Collateral
Agent by Junior Lien Secured Parties holding a majority in
principal amount of the Junior Lien Obligations then outstanding
or pursuant to such other arrangements as agreed to among the
holders of the Junior Lien Obligations, it being understood that
as of the Issue Date, the trustee under the 2006 Notes Indenture
shall be the Junior Lien Collateral Agent.
176
Junior Lien Documents means the credit and
security documents governing the Junior Lien Obligations,
including, without limitation, the Indenture, the related
Security Documents and Intercreditor Agreements.
Junior Lien Obligations means the Notes and
Obligations with respect to other Indebtedness (including the
2006 Notes and any permitted refinancing thereof) permitted to
be incurred under the Indenture and the General Credit Facility
which is by its terms intended to be secured equally and ratably
with the Notes or on a basis junior to the Liens securing the
Notes; provided such Lien is permitted to be incurred
under the Indenture and the General Credit Facility;
provided, further, that the holders of such Indebtedness
or their Junior Lien Representative is a party to the Security
Documents in accordance with the terms thereof and has appointed
the Junior Lien Collateral Agent as collateral agent for such
holders of Junior Lien Obligations with respect to all or a
portion of the Collateral.
Junior Lien Representative means any duly
authorized representative of any holders of Junior Lien
Obligations, which representative is party to the Security
Documents.
Junior Lien Secured Parties means
(i) Holders (including the Holders of any Additional Notes
subsequently issued under and in compliance with the terms of
the Indenture), (ii) the Junior Lien Collateral Agent and
(iii) the holders from time to time of any other Junior
Lien Obligations and each Junior Lien Representative.
Junior Liens means the Liens securing the
Junior Lien Obligations.
Legal Holiday means a Saturday, a Sunday or a
day on which commercial banking institutions are not required to
be open in the State of New York.
Lien means, with respect to any asset, any
mortgage, lien (statutory or otherwise), pledge, hypothecation,
charge, security interest, preference, priority or encumbrance
of any kind in respect of such asset, whether or not filed,
recorded or otherwise perfected under applicable law, including
any conditional sale or other title retention agreement, any
lease in the nature thereof, any option or other agreement to
sell or give a security interest in and any filing of or
agreement to give any financing statement under the Uniform
Commercial Code (or equivalent statutes) of any jurisdiction;
provided that in no event shall an operating lease be
deemed to constitute a Lien.
Moodys means Moodys Investors
Service, Inc. and any successor to its rating agency business.
Net Income means, with respect to any Person,
the net income (loss) of such Person, determined in accordance
with GAAP and before any reduction in respect of Preferred Stock
dividends.
Net Proceeds means the aggregate cash
proceeds received by the Issuer or any of its Restricted
Subsidiaries in respect of any Asset Sale, including any cash
received upon the sale or other disposition of any Designated
Non-cash Consideration received in any Asset Sale, net of the
direct costs relating to such Asset Sale and the sale or
disposition of such Designated Non-cash Consideration, including
legal, accounting and investment banking fees, and brokerage and
sales commissions, any relocation expenses incurred as a result
thereof, taxes paid or payable as a result thereof (after taking
into account any available tax credits or deductions and any tax
sharing arrangements), amounts required to be applied to the
repayment of principal, premium, if any, and interest on Senior
Indebtedness required (other than required by clause (1) of
the second paragraph of Repurchase at the Option of
Holders Asset Sales) to be paid as a result of
such transaction and any deduction of appropriate amounts to be
provided by the Issuer or any of its Restricted Subsidiaries as
a reserve in accordance with GAAP against any liabilities
associated with the asset disposed of in such transaction and
retained by the Issuer or any of its Restricted Subsidiaries
after such sale or other disposition thereof, including pension
and other post-employment benefit liabilities and liabilities
related to environmental matters or against any indemnification
obligations associated with such transaction.
Non-Conforming Plan of Reorganization means
any Plan of Reorganization that grants the Junior Lien
Collateral Agent or any Junior Lien Secured Party any right or
benefit, directly or indirectly, which right or benefit is
prohibited at such time by the provisions of the General
Intercreditor Agreement.
177
Non-Receivables Collateral has the meaning
set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security, subject to
the provisions of the third and fourth sentences of the first
paragraph under Security
General.
Obligations means any principal, interest
(including any interest accruing subsequent to the filing of a
petition in bankruptcy, reorganization or similar proceeding at
the rate provided for in the documentation with respect thereto,
whether or not such interest is an allowed claim under
applicable state, federal or foreign law), premium, penalties,
fees, indemnifications, reimbursements (including reimbursement
obligations with respect to letters of credit and bankers
acceptances), damages and other liabilities, and guarantees of
payment of such principal, interest, penalties, fees,
indemnifications, reimbursements, damages and other liabilities,
payable under the documentation governing any Indebtedness.
Offering Memorandum means the offering
memorandum, dated February 11, 2009, relating to the
initial private offering of the Notes.
Officer means the Chairman of the Board, the
Chief Executive Officer, the President, any Executive Vice
President, Senior Vice President or Vice President, the
Treasurer or the Secretary of the Issuer or a Guarantor, as
applicable.
Officers Certificate means a
certificate signed on behalf of the Issuer by an Officer of the
Issuer or on behalf of a Guarantor by an Officer of such
Guarantor, who must be the principal executive officer, the
principal financial officer, the treasurer or the principal
accounting officer of the Issuer or Guarantor, as applicable,
that meets the requirements set forth in the Indenture.
Opinion of Counsel means a written opinion
from legal counsel who is acceptable to the Trustee. The counsel
may be an employee of or counsel to the Issuer or the Trustee.
Permitted Asset Swap means the concurrent
purchase and sale or exchange of Related Business Assets or a
combination of Related Business Assets and cash or Cash
Equivalents between the Issuer or any of its Restricted
Subsidiaries and another Person; provided, that any cash
or Cash Equivalents received must be applied in accordance with
the covenant described under Repurchase at the Option of
Holders Asset Sales.
Permitted Holders means each of the
Investors, the Frist Entities, members of management of the
Issuer (or its direct or indirect parent) and any assignees of
the equity commitments of the Investors on November 17,
2006 who are (or will be, pursuant to the agreements described
under Management Equity Investment by Senior
Management Participants and Equity
Investment by Other Management Participants) holders of
Equity Interests of the Issuer (or any of its direct or indirect
parent companies) and any group (within the meaning of
Section 13(d)(3) or Section 14(d)(2) of the Exchange
Act or any successor provision) of which any of the foregoing
are members; provided that, in the case of such group and
without giving effect to the existence of such group or any
other group, such Investors, Frist Entities, members of
management and assignees of the equity commitments of the
Investors, collectively, have beneficial ownership of more than
50% of the total voting power of the Voting Stock of the Issuer
or any of its direct or indirect parent companies.
Permitted Investments means:
(1) any Investment in the Issuer or any of its Restricted
Subsidiaries;
(2) any Investment in cash and Cash Equivalents or
Investment Grade Securities;
(3) any Investment by the Issuer or any of its Restricted
Subsidiaries in a Person that is engaged in a Similar Business
if as a result of such Investment:
(a) such Person becomes a Restricted Subsidiary; or
(b) such Person, in one transaction or a series of related
transactions, is merged or consolidated with or into, or
transfers or conveys substantially all of its assets to, or is
liquidated into, the Issuer or a Restricted Subsidiary, and, in
each case, any Investment held by such Person; provided
that such
178
Investment was not acquired by such Person in contemplation of
such acquisition, merger, consolidation or transfer;
(4) any Investment in securities or other assets not
constituting cash, Cash Equivalents or Investment Grade
Securities and received in connection with an Asset Sale made
pursuant to the provisions described under Repurchase at
the Option of Holders Asset Sales or any other
disposition of assets not constituting an Asset Sale;
(5) any Investment existing on the Issue Date;
(6) any Investment acquired by the Issuer or any of its
Restricted Subsidiaries:
(a) in exchange for any other Investment or accounts
receivable held by the Issuer or any such Restricted Subsidiary
in connection with or as a result of a bankruptcy, workout,
reorganization or recapitalization of the issuer of such other
Investment or accounts receivable; or
(b) as a result of a foreclosure by the Issuer or any of
its Restricted Subsidiaries with respect to any secured
Investment or other transfer of title with respect to any
secured Investment in default;
(7) Hedging Obligations permitted under clause (10) of
the second paragraph of the covenant described in Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
(8) any Investment in a Similar Business having an
aggregate fair market value, taken together with all other
Investments made pursuant to this clause (8) that are at
that time outstanding, not to exceed 5% of Total Assets at the
time of such Investment (with the fair market value of each
Investment being measured at the time made and without giving
effect to subsequent changes in value);
(9) Investments the payment for which consists of Equity
Interests (exclusive of Disqualified Stock) of the Issuer or any
of its direct or indirect parent companies; provided,
however, that such Equity Interests will not increase the
amount available for Restricted Payments under clause (3)
of the first paragraph under the covenant described in
Certain Covenants Limitations on Restricted
Payments;
(10) guarantees of Indebtedness permitted under the
covenant described in Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock;
(11) any transaction to the extent it constitutes an
Investment that is permitted and made in accordance with the
provisions of the second paragraph of the covenant described
under Certain Covenants Transactions with
Affiliates (except transactions described in clauses (2),
(5) and (9) of such paragraph);
(12) Investments consisting of purchases and acquisitions
of inventory, supplies, material or equipment;
(13) additional Investments having an aggregate fair market
value, taken together with all other Investments made pursuant
to this clause (13) that are at that time outstanding
(without giving effect to the sale of an Unrestricted Subsidiary
to the extent the proceeds of such sale do not consist of cash
or marketable securities), not to exceed 5% of Total Assets at
the time of such Investment (with the fair market value of each
Investment being measured at the time made and without giving
effect to subsequent changes in value);
(14) Investments relating to an ABL Financing Entity or a
Receivables Subsidiary that, in the good faith determination of
the Issuer, are necessary or advisable to effect the ABL
Facility or any Receivables Facility, as the case may be;
(15) advances to, or guarantees of Indebtedness of,
employees not in excess of $50.0 million outstanding at any
one time, in the aggregate;
(16) loans and advances to officers, directors and
employees for business-related travel expenses, moving expenses
and other similar expenses, in each case incurred in the
ordinary course of business or
179
consistent with past practices or to fund such Persons
purchase of Equity Interests of the Issuer or any direct or
indirect parent company thereof;
(17) Physician Support Obligations made by the Issuer or
any Restricted Subsidiary;
(18) any Investment in any joint venture existing on the
Issue Date that owns or operates one or more healthcare
facilities, including, without limitation, hospitals, ambulatory
surgery centers, outpatient diagnostic centers or imaging
centers to the extent contemplated by the organizational
documents of such joint venture as in existence on the Issue
Date;
(19) any Investment in the ordinary course of business or
as may be required by applicable law by any Restricted
Subsidiary (including, without limitation, HCI) engaged in the
insurance business in order to provide insurance to the Issuer
and its Subsidiaries;
(20) any Investment pursuant to any customary buy/sell
arrangement in favor of investors or joint venture parties in
connection with syndications of healthcare facilities,
including, without limitation, hospitals, ambulatory surgery
centers, outpatient diagnostic centers or imaging
centers; and
(21) any Investment in any Subsidiary or any joint venture
in connection with intercompany cash management arrangements or
related activities arising in the ordinary course of business.
Permitted Liens means, with respect to any
Person:
(1) pledges or deposits by such Person under workmens
compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids,
tenders, contracts (other than for the payment of Indebtedness)
or leases to which such Person is a party, or deposits to secure
public or statutory obligations of such Person or deposits of
cash or U.S. government bonds to secure surety or appeal
bonds to which such Person is a party, or deposits as security
for contested taxes or import duties or for the payment of rent,
in each case incurred in the ordinary course of business;
(2) Liens imposed by law, such as carriers,
warehousemens and mechanics Liens, in each case for
sums not yet overdue for a period of more than 30 days or
being contested in good faith by appropriate proceedings or
other Liens arising out of judgments or awards against such
Person with respect to which such Person shall then be
proceeding with an appeal or other proceedings for review if
adequate reserves with respect thereto are maintained on the
books of such Person in accordance with GAAP;
(3) Liens for taxes, assessments or other governmental
charges not yet overdue for a period of more than 30 days
or payable or subject to penalties for nonpayment or which are
being contested in good faith by appropriate proceedings
diligently conducted, if adequate reserves with respect thereto
are maintained on the books of such Person in accordance with
GAAP;
(4) Liens in favor of issuers of performance and surety
bonds or bid bonds or with respect to other regulatory
requirements or letters of credit issued pursuant to the request
of and for the account of such Person in the ordinary course of
its business;
(5) minor survey exceptions, minor encumbrances, easements
or reservations of, or rights of others for, licenses,
rights-of-way,
sewers, electric lines, telegraph and telephone lines and other
similar purposes, or zoning or other restrictions as to the use
of real properties or Liens incidental to the conduct of the
business of such Person or to the ownership of its properties
which were not incurred in connection with Indebtedness and
which do not in the aggregate materially adversely affect the
value of said properties or materially impair their use in the
operation of the business of such Person;
(6) Liens securing Indebtedness permitted to be incurred
pursuant to clause (4), (12), (13), (18) or (19) of
the second paragraph under Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock; provided that
(a) Liens securing Indebtedness, Disqualified Stock or
Preferred Stock permitted to be incurred pursuant to
clause (13) relate only to Refinancing Indebtedness that
serves to refund or refinance Indebtedness, Disqualified Stock
or Preferred Stock incurred under clause (4) or
(12) of the second paragraph under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock,
(b) Liens securing
180
Indebtedness permitted to be incurred pursuant to
clause (18) extend only to the assets of Foreign
Subsidiaries, (c) Liens securing Indebtedness permitted to
be incurred pursuant to clause (19) are solely on acquired
property or the assets of the acquired entity, as the case may
be and (d) Liens securing Indebtedness, Disqualified Stock
or Preferred Stock permitted to be incurred pursuant to
clause (4) of the second paragraph under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock
extend only to the assets so financed, purchased, constructed or
improved;
(7) Liens existing on the Issue Date (other than Liens in
favor of (i) the lenders under the Senior Credit Facilities
ranking senior to the Liens securing the Notes and (ii) the
holders of the 2006 Notes);
(8) Liens on property or shares of stock of a Person at the
time such Person becomes a Subsidiary; provided, however, such
Liens are not created or incurred in connection with, or in
contemplation of, such other Person becoming such a Subsidiary;
provided, further, however, that such Liens may not extend to
any other property owned by the Issuer or any of its Restricted
Subsidiaries;
(9) Liens on property at the time the Issuer or a
Restricted Subsidiary acquired the property, including any
acquisition by means of a merger or consolidation with or into
the Issuer or any of its Restricted Subsidiaries; provided,
however, that such Liens are not created or incurred in
connection with, or in contemplation of, such acquisition;
provided, further, however, that the Liens may not extend to any
other property owned by the Issuer or any of its Restricted
Subsidiaries;
(10) Liens securing Indebtedness or other obligations of a
Restricted Subsidiary owing to the Issuer or another Restricted
Subsidiary permitted to be incurred in accordance with the
covenant described under Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock;
(11) Liens securing Hedging Obligations so long as the
related Indebtedness is, and is permitted to be under the
Indenture, secured by a Lien on the same property securing such
Hedging Obligations;
(12) Liens on specific items of inventory or other goods
and proceeds of any Person securing such Persons
obligations in respect of bankers acceptances issued or
created for the account of such Person to facilitate the
purchase, shipment or storage of such inventory or other goods;
(13) leases, subleases, licenses or sublicenses granted to
others in the ordinary course of business which do not
materially interfere with the ordinary conduct of the business
of the Issuer or any of its Restricted Subsidiaries and do not
secure any Indebtedness;
(14) Liens arising from Uniform Commercial Code financing
statement filings regarding operating leases entered into by the
Issuer and its Restricted Subsidiaries in the ordinary course of
business;
(15) Liens in favor of the Issuer or any Guarantor;
(16) Liens on equipment of the Issuer or any of its
Restricted Subsidiaries granted in the ordinary course of
business;
(17) Liens on accounts receivable and related assets
incurred in connection with a Receivables Facility;
(18) Liens to secure any refinancing, refunding, extension,
renewal or replacement (or successive refinancing, refunding,
extensions, renewals or replacements) as a whole, or in part, of
any Indebtedness secured by any Lien referred to in the
foregoing clauses (6), (7), (8) and (9); provided, however,
that (a) such new Lien shall be limited to all or part of
the same property that secured the original Lien (plus
improvements on such property), and (b) the Indebtedness
secured by such Lien at such time is not increased to any amount
greater than the sum of (i) the outstanding principal
amount or, if greater, committed amount of the Indebtedness
described under clauses (6), (7), (8) and (9) at the
time the original Lien became a Permitted Lien under the
Indenture, and (ii) an amount necessary to pay any fees and
expenses, including premiums, related to such refinancing,
refunding, extension, renewal or replacement;
181
(19) deposits made in the ordinary course of business to
secure liability to insurance carriers;
(20) other Liens securing obligations incurred in the
ordinary course of business which obligations do not exceed
$100.0 million at any one time outstanding;
(21) Liens securing judgments for the payment of money not
constituting an Event of Default under clause (5) under the
caption Events of Default and Remedies so long as
such Liens are adequately bonded and any appropriate legal
proceedings that may have been duly initiated for the review of
such judgment have not been finally terminated or the period
within which such proceedings may be initiated has not expired;
(22) Liens in favor of customs and revenue authorities
arising as a matter of law to secure payment of customs duties
in connection with the importation of goods in the ordinary
course of business;
(23) Liens (i) of a collection bank arising under
Section 4-210
of the Uniform Commercial Code, or any comparable or successor
provision, on items in the course of collection,
(ii) attaching to commodity trading accounts or other
commodity brokerage accounts incurred in the ordinary course of
business, and (iii) in favor of banking institutions
arising as a matter of law encumbering deposits (including the
right of set-off) and which are within the general parameters
customary in the banking industry;
(24) Liens deemed to exist in connection with Investments
in repurchase agreements permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
provided that such Liens do not extend to any assets other than
those that are the subject of such repurchase agreements;
(25) Liens encumbering reasonable customary initial
deposits and margin deposits and similar Liens attaching to
commodity trading accounts or other brokerage accounts incurred
in the ordinary course of business and not for speculative
purposes;
(26) Liens that are contractual rights of set-off
(i) relating to the establishment of depository relations
with banks not given in connection with the issuance of
Indebtedness, (ii) relating to pooled deposit or sweep
accounts of the Issuer or any of its Restricted Subsidiaries to
permit satisfaction of overdraft or similar obligations incurred
in the ordinary course of business of the Issuer and its
Restricted Subsidiaries or (iii) relating to purchase
orders and other agreements entered into with customers of the
Issuer or any of its Restricted Subsidiaries in the ordinary
course of business; and
(27) Liens arising out of conditional sale, title
retention, consignment or similar arrangements for the sale or
purchase of goods entered into by the Issuer or any Restricted
Subsidiary in the ordinary course of business.
For purposes of this definition, the term
Indebtedness shall be deemed to include interest on
such Indebtedness.
Person means any individual, corporation,
limited liability company, partnership, joint venture,
association, joint stock company, trust, unincorporated
organization, government or any agency or political subdivision
thereof or any other entity.
Physician Support Obligation means (1) a
loan to or on behalf of, or a guarantee of Indebtedness or
income of, a physician or healthcare professional providing
service to patients in the service area of a healthcare facility
operated by the Issuer, any of its Restricted Subsidiaries or
any affiliated joint venture otherwise permitted by the
Indenture made or given by the Issuer or any Restricted
Subsidiary of the Issuer in the ordinary course of business and
pursuant to a written agreement having a period not to exceed
five years or (2) guarantees by the Issuer or any
Restricted Subsidiary of the Issuer of leases and loans to
acquire property (real or personal) for or on behalf of a
physician or healthcare professional providing service to
patients in the service area of a healthcare facility operated
by the Issuer, any of its Restricted Subsidiaries or any
affiliated joint venture otherwise permitted by the Indenture.
182
Plan of Reorganization means any plan of
reorganization, plan of liquidation, agreement for composition,
or other type of plan of arrangement proposed in or in
connection with any insolvency or liquidation proceeding.
Preferred Stock means any Equity Interest
with preferential rights of payment of dividends or upon
liquidation, dissolution or winding up.
Principal Property means each acute care
hospital providing general medical and surgical services
(excluding equipment, personal property and hospitals that
primarily provide specialty medical services, such as
psychiatric and obstetrical and gynecological services) owned
solely by the Issuer
and/or one
or more of its Subsidiaries (used in this definition as defined
in the Existing Notes Indenture) and located in the
United States of America.
Priority Lien Obligations means,
collectively, ABL Obligations and First Lien Obligations.
Priority Lien Secured Parties means,
collectively, the ABL Secured Parties and the First Lien Secured
Parties.
Purchase Money Obligations means any
Indebtedness incurred to finance or refinance the acquisition,
leasing, construction or improvement of property (real or
personal) or assets (other than Capital Stock), and whether
acquired through the direct acquisition of such property or
assets, or otherwise.
Qualified Proceeds means assets that are used
or useful in, or Capital Stock of any Person engaged in, a
Similar Business; provided that the fair market value of
any such assets or Capital Stock shall be determined by the
Issuer in good faith.
Rating Agencies means Moodys and
S&P or if Moodys or S&P or both shall not make a
rating on the Notes publicly available, a nationally recognized
statistical rating agency or agencies, as the case may be,
selected by the Issuer which shall be substituted for
Moodys or S&P or both, as the case may be.
Receivables Facility means any of one or more
receivables financing facilities as amended, supplemented,
modified, extended, renewed, restated or refunded from time to
time, the Obligations of which are non-recourse (except for
customary representations, warranties, covenants and indemnities
made in connection with such facilities) to the Issuer or any of
its Restricted Subsidiaries (other than a Receivables
Subsidiary) pursuant to which the Issuer or any of its
Restricted Subsidiaries purports to sell its accounts receivable
to either (a) a Person that is not a Restricted Subsidiary
or (b) a Receivables Subsidiary that in turn funds such
purchase by purporting to sell its accounts receivable to a
Person that is not a Restricted Subsidiary or by borrowing from
such a Person or from another Receivables Subsidiary that in
turn funds itself by borrowing from such a Person.
Receivables Fees means distributions or
payments made directly or by means of discounts with respect to
any accounts receivable or participation interest therein issued
or sold in connection with, and other fees paid to a Person that
is not a Restricted Subsidiary in connection with any
Receivables Facility.
Receivables Subsidiary means any Subsidiary
formed for the purpose of facilitating or entering into one or
more Receivables Facilities, and in each case engages only in
activities reasonably related or incidental thereto.
Redemption Date has the meaning set
forth under Optional Redemption.
Registration Rights Agreement means the
Registration Rights Agreement related to the Notes, dated as of
the Issue Date, among the Issuer, the Guarantors and the Initial
Purchasers.
Related Business Assets means assets (other
than cash or Cash Equivalents) used or useful in a Similar
Business; provided that any assets received by the Issuer
or a Restricted Subsidiary in exchange for assets transferred by
the Issuer or a Restricted Subsidiary will not be deemed to be
Related Business Assets if they consist of securities of a
Person, unless upon receipt of the securities of such Person,
such Person would become a Restricted Subsidiary.
Restricted Investment means an Investment
other than a Permitted Investment.
183
Restricted Subsidiary means, at any time, any
direct or indirect Subsidiary of the Issuer (including any
Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
provided, however, that upon an Unrestricted
Subsidiarys ceasing to be an Unrestricted Subsidiary, such
Subsidiary shall be included in the definition of
Restricted Subsidiary.
S&P means Standard &
Poors, a division of The McGraw-Hill Companies, Inc., and
any successor to its rating agency business.
Sale and Lease-Back Transaction means any
arrangement providing for the leasing by the Issuer or any of
its Restricted Subsidiaries of any real or tangible personal
property, which property has been or is to be sold or
transferred by the Issuer or such Restricted Subsidiary to a
third Person in contemplation of such leasing.
SEC means the U.S. Securities and
Exchange Commission.
Secured Indebtedness means any Indebtedness
of the Issuer or any of its Restricted Subsidiaries secured by a
Lien.
Securities Act means the Securities Act of
1933, as amended, and the rules and regulations of the SEC
promulgated thereunder.
Security Documents means, collectively, the
Intercreditor Agreements, the security agreements relating to
the Collateral and the mortgages and instruments filed and
recorded in appropriate jurisdictions to preserve and protect
the Liens on the Collateral (including, without limitation,
financing statements under the Uniform Commercial Code of the
relevant states) applicable to the Collateral, each as in effect
on the Issue Date and as amended, amended and restated,
modified, renewed or replaced from time to time.
Senior Credit Facilities means the ABL
Facility and the General Credit Facility.
Senior Indebtedness means:
(1) all Indebtedness of the Issuer or any Guarantor
outstanding under the Senior Credit Facilities or Notes and
related Guarantees (including interest accruing on or after the
filing of any petition in bankruptcy or similar proceeding or
for reorganization of the Issuer or any Guarantor (at the rate
provided for in the documentation with respect thereto,
regardless of whether or not a claim for post-filing interest is
allowed in such proceedings)), and any and all other fees,
expense reimbursement obligations, indemnification amounts,
penalties, and other amounts (whether existing on the Issue Date
or thereafter created or incurred) and all obligations of the
Issuer or any Guarantor to reimburse any bank or other Person in
respect of amounts paid under letters of credit, acceptances or
other similar instruments;
(2) all Hedging Obligations (and guarantees thereof) owing
to a Lender (as defined in the Senior Credit Facilities) or any
Affiliate of such Lender (or any Person that was a Lender or an
Affiliate of such Lender at the time the applicable agreement
giving rise to such Hedging Obligation was entered into);
provided that such Hedging Obligations are permitted to be
incurred under the terms of the Indenture;
(3) any other Indebtedness of the Issuer or any Guarantor
permitted to be incurred under the terms of the Indenture,
unless the instrument under which such Indebtedness is incurred
expressly provides that it is subordinated in right of payment
to the Notes or any related Guarantee; and
(4) all Obligations with respect to the items listed in the
preceding clauses (1), (2) and (3);
provided, however, that Senior Indebtedness shall
not include:
(a) any obligation of such Person to the Issuer or any of
its Subsidiaries;
(b) any liability for federal, state, local or other taxes
owed or owing by such Person;
(c) any accounts payable or other liability to trade
creditors arising in the ordinary course of business;
184
(d) any Indebtedness or other Obligation of such Person
which is subordinate or junior in any respect to any other
Indebtedness or other Obligation of such Person; or
(e) that portion of any Indebtedness which at the time of
incurrence is incurred in violation of the Indenture.
Separate Receivables Collateral has the
meaning set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
Shared Receivables Collateral has the meaning
set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
Shared Receivables Intercreditor Agreement
has the meaning set forth under Security Liens
with Respect to Shared Receivables Collateral.
Significant Subsidiary means any Restricted
Subsidiary that would be a significant subsidiary as
defined in Article 1,
Rule 1-02
of
Regulation S-X,
promulgated pursuant to the Securities Act, as such regulation
is in effect on the Issue Date.
Similar Business means any business conducted
or proposed to be conducted by the Issuer and its Restricted
Subsidiaries on the Issue Date or any business that is similar,
reasonably related, incidental or ancillary thereto.
Sponsor Management Agreement means the
management agreement between certain of the management companies
associated with the Investors, the Frist Entities and the Issuer.
Subordinated Indebtedness means, with respect
to the Notes,
(1) any Indebtedness of the Issuer which is by its terms
subordinated in right of payment to the Notes, and
(2) any Indebtedness of any Guarantor which is by its terms
subordinated in right of payment to the Guarantee of such entity
of the Notes.
Subsidiary means, with respect to any Person:
(1) any corporation, association, or other business entity
(other than a partnership, joint venture, limited liability
company or similar entity) of which more than 50% of the total
voting power of shares of Capital Stock entitled (without regard
to the occurrence of any contingency) to vote in the election of
directors, managers or trustees thereof is at the time of
determination owned or controlled, directly or indirectly, by
such Person or one or more of the other Subsidiaries of that
Person or a combination thereof or is consolidated under GAAP
with such Person at such time; and
(2) any partnership, joint venture, limited liability
company or similar entity of which
(x) more than 50% of the capital accounts, distribution
rights, total equity and voting interests or general or limited
partnership interests, as applicable, are owned or controlled,
directly or indirectly, by such Person or one or more of the
other Subsidiaries of that Person or a combination thereof
whether in the form of membership, general, special or limited
partnership or otherwise, and
(y) such Person or any Restricted Subsidiary of such Person
is a controlling general partner or otherwise controls such
entity.
Total Assets means the total assets of the
Issuer and its Restricted Subsidiaries on a consolidated basis,
as shown on the most recent consolidated balance sheet of the
Issuer or such other Person as may be expressly stated.
Transaction means the transactions
contemplated by the Transaction Agreement, the issuance of the
Notes and borrowings under the Senior Credit Facilities as in
effect on November 17, 2006.
185
Transaction Agreement means the Agreement and
Plan of Merger, dated as of July 24, 2006, between Hercules
Holding II, LLC, Hercules Acquisition Corporation and the
Issuer, as the same may be amended prior to the Issue Date.
Treasury Rate means, as of any
Redemption Date, the yield to maturity as of such
Redemption Date of United States Treasury securities with a
constant maturity (as compiled and published in the most recent
Federal Reserve Statistical Release H.15 (519) that has
become publicly available at least two Business Days prior to
the Redemption Date (or, if such Statistical Release is no
longer published, any publicly available source of similar
market data)) most nearly equal to the period from the
Redemption Date to February 15, 2013; provided,
however, that if the period from the Redemption Date
to February 15, 2013 is less than one year, the weekly
average yield on actually traded United States Treasury
securities adjusted to a constant maturity of one year will be
used.
Trust Indenture Act means the
Trust Indenture Act of 1939, as amended (15 U.S.C.
§§ 77aaa-777bbbb).
Unrestricted Subsidiary means:
(1) any Subsidiary of the Issuer which at the time of
determination is an Unrestricted Subsidiary (as designated by
the Issuer, as provided below); and
(2) any Subsidiary of an Unrestricted Subsidiary.
The Issuer may designate any Subsidiary of the Issuer (including
any existing Subsidiary and any newly acquired or newly formed
Subsidiary) to be an Unrestricted Subsidiary unless such
Subsidiary or any of its Subsidiaries owns any Equity Interests
or Indebtedness of, or owns or holds any Lien on, any property
of, the Issuer or any Subsidiary of the Issuer (other than
solely any Subsidiary of the Subsidiary to be so designated);
provided that
(1) any Unrestricted Subsidiary must be an entity of which
the Equity Interests entitled to cast at least a majority of the
votes that may be cast by all Equity Interests having ordinary
voting power for the election of directors or Persons performing
a similar function are owned, directly or indirectly, by the
Issuer;
(2) such designation complies with the covenants described
under Certain Covenants Limitation on
Restricted Payments; and
(3) each of:
(a) the Subsidiary to be so designated; and
(b) its Subsidiaries has not at the time of designation,
and does not thereafter, create, incur, issue, assume, guarantee
or otherwise become directly or indirectly liable with respect
to any Indebtedness pursuant to which the lender has recourse to
any of the assets of the Issuer or any Restricted Subsidiary.
The Issuer may designate any Unrestricted Subsidiary to be a
Restricted Subsidiary; provided that, immediately after
giving effect to such designation, no Default shall have
occurred and be continuing and either:
(1) the Issuer could incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio test
described in the first paragraph under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred
Stock; or
(2) the Fixed Charge Coverage Ratio for the Issuer and its
Restricted Subsidiaries would be greater than such ratio for the
Issuer and its Restricted Subsidiaries immediately prior to such
designation, in each case on a pro forma basis taking into
account such designation.
Any such designation by the Issuer shall be notified by the
Issuer to the Trustee by promptly filing with the Trustee a copy
of the resolution of the board of directors of the Issuer or any
committee thereof giving effect to such designation and an
Officers Certificate certifying that such designation
complied with the foregoing provisions.
186
Voting Stock of any Person as of any date
means the Capital Stock of such Person that is at the time
entitled to vote in the election of the board of directors of
such Person.
Weighted Average Life to Maturity means, when
applied to any Indebtedness, Disqualified Stock or Preferred
Stock, as the case may be, at any date, the quotient obtained by
dividing:
(1) the sum of the products of the number of years from the
date of determination to the date of each successive scheduled
principal payment of such Indebtedness or redemption or similar
payment with respect to such Disqualified Stock or Preferred
Stock multiplied by the amount of such payment; by
(2) the sum of all such payments.
Wholly-Owned Subsidiary of any Person means a
Subsidiary of such Person, 100% of the outstanding Equity
Interests of which (other than directors qualifying
shares) shall at the time be owned by such Person or by one or
more Wholly-Owned Subsidiaries of such Person.
Senior
Secured Notes Issued Under the 2009 First Lien
Indenture
HCA Inc. has issued senior secured notes as described below
under an indenture, dated as of April 22, 2009, among the
Issuer, the Guarantors, Deutsche Bank Trust Company
Americas, paying agent, registrar and transfer agent and Law
Debenture Trust Company of New York, as trustee. Terms used
in this Senior Secured Notes Issued Under the
2009 First Lien Indenture apply only to the Notes
described herein.
General
Certain terms used in this description are defined under the
subheading Certain Definitions. In this
description, the terms we, our,
us and the Company each
refer to HCA Inc. (the Issuer) and its
consolidated Subsidiaries.
The Issuer issued $1,500,000,000 aggregate principal amount of
81/2% senior
secured notes due 2019 (the Notes) under an
indenture to be dated as of the closing date of the offering of
the Notes (the Indenture) among the Issuer,
the Guarantors and Law Debenture Trust Company of New York,
as trustee (the Trustee), Deutsche Bank
Trust Company Americas, as Paying Agent, Registrar and
Transfer Agent and Bank of America, N.A., as collateral agent.
The Notes were issued in a private transaction that was not
subject to the registration requirements of the Securities Act.
Except as set forth herein, the terms of the Notes include those
stated in the Indenture and those made part of the Indenture by
reference to the Trust Indenture Act.
The following description is only a summary of the material
provisions of the Indenture, does not purport to be complete and
is qualified in its entirety by reference to the provisions of
those agreements, including the definitions therein of certain
terms used below. We urge you to read the Indenture because it,
and not this description, will define your rights as Holders of
the Notes.
Brief
Description of Notes
The Notes:
|
|
|
|
|
are general senior obligations of the Issuer;
|
|
|
|
are secured on a first-priority basis, equally and ratably with
all existing and future obligations of the Issuer and the
Guarantors under any existing and future First Lien Obligations,
by all of the assets of the Issuer and the Guarantors which
secure the General Credit Facility (other than the European
Collateral), subject to the Liens securing the Issuers and
the Guarantors ABL Obligations and other Permitted Liens;
|
|
|
|
are secured on a second-priority basis, equally and ratably with
all existing and future obligations of the Issuer and the
Guarantors under any existing and future First Lien Obligations,
by all of the assets of the Issuer and the Guarantors securing
the ABL Facility which also secure the General Credit Facility,
subject to the Liens securing the Issuers and the
Guarantors ABL Obligations and other Permitted Liens;
|
187
|
|
|
|
|
are effectively subordinated to the Issuers and the
Guarantors obligations under the ABL Facility, to the
extent of the value of the Shared Receivables Collateral;
|
|
|
|
are effectively subordinated to any obligations secured by
Permitted Liens, to the extent of the value of the assets of the
Issuer and the Guarantors subject to those Permitted Liens;
|
|
|
|
are structurally subordinated to any existing and future
indebtedness and liabilities of non-guarantor Subsidiaries,
including the ABL Financing Entities and the Issuers
Foreign Subsidiaries and any Unrestricted Subsidiaries and
including indebtedness under the Companys senior secured
European term loan facility included in the General Credit
Facility;
|
|
|
|
rank equally in right of payment with all existing and future
senior Indebtedness of the Issuer and the Guarantors but, to the
extent of the value of the Collateral, are effectively senior to
all of the Issuers and the Guarantors unsecured
senior Indebtedness (including the Existing Notes) and Junior
Lien Obligations (including the Existing Second Priority Notes);
|
|
|
|
are senior in right of payment to any future Subordinated
Indebtedness (as defined with respect to the Notes) of the
Issuer;
|
|
|
|
are initially unconditionally guaranteed on a joint and several
and senior basis by each Restricted Subsidiary that guarantees
the General Credit Facility (other than any Foreign
Subsidiary); and
|
|
|
|
are subject to registration with the SEC pursuant to the
Registration Rights Agreement.
|
Guarantees
The Guarantors, as primary obligors and not merely as sureties,
jointly and severally fully and unconditionally guaranteed, on a
senior basis, the performance and full and punctual payment when
due, whether at maturity, by acceleration or otherwise, of all
obligations of the Issuer under the Indenture and the Notes,
whether for payment of principal of, premium, if any, or
interest or Additional Interest in respect of the Notes,
expenses, indemnification or otherwise, on the terms set forth
in the Indenture by executing the Indenture.
The Restricted Subsidiaries which guarantee the General Credit
Facility guarantee the Notes. Each of the Guarantees of the
Notes is a general senior obligation of each Guarantor and is
secured by a first-priority lien on all of the assets of each
Guarantor which secure the General Credit Facility (other than
the European Collateral) and by a second-priority lien on all of
the assets of each Guarantor which secure the ABL Facility. The
Guarantees rank equally in right of payment with all existing
and future senior Indebtedness of the Guarantor but, to the
extent of the value of the Collateral, are effectively senior to
all of the Guarantors unsecured senior Indebtedness and
Junior Lien Obligations and, to the extent of the Shared
Receivables Collateral, are effectively subordinated to the
Guarantors Obligations under the ABL Facility and any
future ABL Obligations. The Guarantees are senior in right of
payment to all existing and future Subordinated Indebtedness of
each Guarantor. The Notes are structurally subordinated to
Indebtedness and other liabilities of Subsidiaries of the Issuer
that do not Guarantee the Notes.
Not all of the Issuers Subsidiaries Guarantee the Notes.
In the event of a bankruptcy, liquidation or reorganization of
any of these non-guarantor Subsidiaries, the non-guarantor
Subsidiaries will pay the holders of their debt and their trade
creditors before they will be able to distribute any of their
assets to the Issuer. None of our Subsidiaries which are
Restricted Subsidiaries for purposes of the Existing
Notes Indenture, Foreign Subsidiaries, ABL Financing Entities,
non-Wholly Owned Subsidiaries or any Receivables Subsidiaries
will guarantee the Notes.
On an as adjusted basis after giving effect to our offering of
$1.500 billion aggregate principal amount of first lien
notes in April 2009 and the use of proceeds therefrom, our
non-guarantor subsidiaries would have accounted for
approximately $11.867 billion, or 41.8%, of our total
revenues for the year ended December 31, 2008,
approximately $3.038 billion, or 40.9%, of our total
revenues for the three months ended March 31, 2009,
approximately $9.876 billion, or 40.7%, of our total
assets, and approximately $7.517 billion, or 22.5%, of our
total liabilities, in each case, as of December 31, 2008,
and approximately $9.817 billion, or 40.4%, of
188
our total assets, and approximately $7.224 billion, or
21.9%, of our total liabilities, in each case, as of
March 31, 2009.
The obligations of each Guarantor under its Guarantee are
limited as necessary to prevent the Guarantee from constituting
a fraudulent conveyance under applicable law.
Any entity that makes a payment under its Guarantee is entitled
upon payment in full of all guaranteed obligations under the
Indenture to a contribution from each other Guarantor in an
amount equal to such other Guarantors pro rata portion of
such payment based on the respective net assets of all the
Guarantors at the time of such payment determined in accordance
with GAAP.
If a Guarantee were rendered voidable, it could be subordinated
by a court to all other indebtedness (including guarantees and
other contingent liabilities) of the Guarantor, and, depending
on the amount of such indebtedness, a Guarantors liability
on its Guarantee could be reduced to zero. See Risk
Factors Risks Related to the Notes
Federal and state fraudulent transfer laws may permit a court to
void the notes, and with respect to the senior secured notes,
the guarantees, and, if that occurs, you may not receive any
payment on the notes.
Each Guarantee by a Guarantor provides by its terms that it will
be automatically and unconditionally released and discharged
upon:
1. (a) any sale, exchange or transfer (by merger or
otherwise) of the Capital Stock of such Guarantor (including any
sale, exchange or transfer), after which the applicable
Guarantor is no longer a Restricted Subsidiary or all or
substantially all the assets of such Guarantor, which sale,
exchange or transfer is made in compliance with the applicable
provisions of the Indenture;
the release or discharge of the guarantee by such Guarantor of
the Senior Credit Facilities or such other guarantee that
resulted in the creation of such Guarantee, except a discharge
or release by or as a result of payment under such guarantee;
the designation of any Restricted Subsidiary that is a Guarantor
as an Unrestricted Subsidiary in compliance with the applicable
provisions of the Indenture; or
the exercise by the Issuer of its legal defeasance option or
covenant defeasance option as described under Legal
Defeasance and Covenant Defeasance or the discharge of the
Issuers obligations under the Indenture in accordance with
the terms of the Indenture; and
2. such Guarantor delivering to the Trustee an
Officers Certificate and an Opinion of Counsel, each
stating that all conditions precedent provided for in the
Indenture relating to such transaction have been complied with.
Holding
Company Structure
The Issuer is a holding company for its Subsidiaries, with no
material operations of its own and only limited assets.
Accordingly, the Issuer is dependent upon the distribution of
the earnings of its Subsidiaries, whether in the form of
dividends, advances or payments on account of intercompany
obligations, to service its debt obligations.
Security
General
The Notes and the Guarantees are secured by perfected
first-priority security interests in the Non-Receivables
Collateral and by perfected second-priority security interests
in the Shared Receivables Collateral (second in priority to the
first-priority Liens on the Shared Receivables Collateral
securing the ABL Obligations), in each case, subject to
Permitted Liens. Notwithstanding the foregoing, neither the
Notes nor the Guarantees are secured by the European Collateral
or the Separate Receivables Collateral. The ABL Secured Parties
have rights and remedies with respect to the Shared Receivables
Collateral that, if exercised, could adversely affect the value
of the Shared Receivables Collateral or the ability of the
respective agents
189
under the Intercreditor Agreements to realize or foreclose on
the Shared Receivables Collateral on behalf of the First Lien
Secured Parties. First Lien Secured Parties other than the
Holders of the Notes have rights and remedies with respect to
the Collateral that, if exercised, could also adversely affect
the value of the Collateral on behalf of the Holders of the
Notes, particularly the rights described below under
First Lien Intercreditor Agreement. For
a description of the Shared Receivables Collateral and the
Non-Receivables Collateral, see Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
The Issuer and the Guarantors are and will be able to incur
additional Indebtedness in the future which could share in the
Collateral, including additional First Lien Obligations,
additional ABL Obligations, additional Junior Lien Obligations
and Obligations secured by Permitted Liens. The amount of such
additional Obligations is and will be limited by the covenant
described under Certain Covenants Liens
and the covenant described under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock.
Under certain circumstances, the amount of any such additional
Obligations could be significant.
After-Acquired
Collateral
From and after the Issue Date and subject to certain limitations
and exceptions, (a) if the Issuer or any Guarantor creates
any additional security interest upon any property or asset that
would constitute Collateral to secure any First Lien Obligations
(other than European Collateral and Separate Receivables
Collateral), it must concurrently grant a first-priority
perfected security interest (subject to Permitted Liens) upon
such property as security for the Notes and (b) if the
Issuer or any Guarantor creates any additional security interest
upon any property or asset that would constitute Shared
Receivables Collateral to secure any ABL Obligations, it must
concurrently grant a second-priority perfected security interest
(subject to Permitted Liens) upon such property as security for
the Notes.
Liens
with Respect to the Collateral
The Issuer, the Guarantors and the First Lien Collateral Agent
entered into Security Documents in connection with the General
Credit Facility with respect to the Collateral defining the
terms of the security interests that secure the General Credit
Facility with respect to such Collateral and that also define
the terms of the security interests that secure the Notes and
the Guarantees with respect to such Collateral. These security
interests secure the payment and performance when due of all of
the Obligations of the Issuers and the Guarantors under the
Notes, the Indenture, the Guarantees and the Security Documents,
as provided in the Security Documents.
First
Lien Intercreditor Agreement
The Trustee and the First Lien Collateral Agent entered into a
First Lien Intercreditor Agreement (as the same may be amended
from time to time, the First Lien Intercreditor
Agreement) with the Authorized Representative of the
General Credit Facility Obligations with respect to the
Collateral, which may be amended from time to time without the
consent of the Holders to add other parties holding First Lien
Obligations permitted to be incurred under the Indenture,
General Credit Facility and the First Lien Intercreditor
Agreement. The First Lien Collateral Agent is initially the
collateral agent under the General Credit Facility.
Under the First Lien Intercreditor Agreement, as described
below, the Applicable Authorized Representative has
the right to direct foreclosures and take other actions with
respect to the Common Collateral, and the Authorized
Representatives of other Series of First Lien Obligations have
no right to take actions with respect to the Common Collateral.
The Applicable Authorized Representative is initially the
administrative agent under the General Credit Facility, and the
Trustee for the Holders, as Authorized Representative in respect
of the Notes, has no rights to take any action under the First
Lien Intercreditor Agreement.
The administrative agent under the General Credit Facility will
remain the Applicable Authorized Representative until the
earlier of (1) the Discharge of General Credit Facility
Obligations and (2) the Non-Controlling Authorized
Representative Enforcement Date (such date, the
Applicable Authorized Agent
190
Date). After the Applicable Authorized Agent Date,
the Applicable Authorized Representative will be the Authorized
Representative of the Series of Additional First Lien
Obligations that constitutes the largest outstanding principal
amount of any then outstanding Series of First Lien Obligations,
other than the General Credit Facility Obligations, with respect
to the Common Collateral (the Major Non-Controlling
Authorized Representative).
The Non-Controlling Authorized Representative
Enforcement Date is the date that is 90 days
(throughout which
90-day
period the applicable Authorized Representative was the Major
Non-Controlling Authorized Representative) after the occurrence
of both (a) an event of default, as defined in the
Indenture or other applicable indenture for that Series of First
Lien Obligations, and (b) the First Lien Collateral
Agents and each other Authorized Representatives
receipt of written notice from that Authorized Representative
certifying that (i) such Authorized Representative is the
Major Non-Controlling Authorized Representative and that an
event of default, as defined in the Indenture or other
applicable indenture for that Series of First Lien Obligations,
has occurred and is continuing and (ii) the First Lien
Obligations of that Series are currently due and payable in full
(whether as a result of acceleration thereof or otherwise) in
accordance with the Indenture or other applicable indenture for
that Series of First Lien Obligations; provided that the
Non-Controlling Authorized Representative Enforcement Date shall
be stayed and shall not occur and shall be deemed not to have
occurred with respect to any Shared Collateral (1) at any
time the administrative agent under the General Credit Facility
or the First Lien Collateral Agent has commenced and is
diligently pursuing any enforcement action with respect to such
Common Collateral or (2) at any time the Issuer or the
Guarantor that has granted a security interest in such Common
Collateral is then a debtor under or with respect to (or
otherwise subject to) any insolvency or liquidation proceeding.
The Applicable Authorized Representative shall have the sole
right to instruct the First Lien Collateral Agent to act or
refrain from acting with respect to the Common Collateral,
(b) the First Lien Collateral Agent shall not follow any
instructions with respect to such Common Collateral from any
representative of any Non-Controlling Secured Party or other
First Lien Secured Party (other than the Applicable Authorized
Representative), and (c) no Authorized Representative of
any Non-Controlling Secured Party or other First Lien Secured
Party (other than the Applicable Authorized Representative) will
instruct the First Lien Collateral Agent to commence any
judicial or non-judicial foreclosure proceedings with respect
to, seek to have a trustee, receiver, liquidator or similar
official appointed for or over, attempt any action to take
possession of, exercise any right, remedy or power with respect
to, or otherwise take any action to enforce its interests in or
realize upon, or take any other action available to it in
respect of, the Common Collateral.
Notwithstanding the equal priority of the Liens, the First Lien
Collateral Agent, acting on the instructions of the Applicable
Authorized Representative, may deal with the Common Collateral
as if such Applicable Authorized Representative had a senior
Lien on such Collateral. No representative of any
Non-Controlling Secured Party may contest, protest or object to
any foreclosure proceeding or action brought by the First Lien
Collateral Agent, Applicable Authorized Representative or
Controlling Secured Party. The Trustee and each other Authorized
Representative will agree that it will not accept any Lien on
any Collateral for the benefit of the Holders (other than funds
deposited for the discharge or defeasance of the Notes) other
than pursuant to the First Lien Security Documents. Each of the
First Lien Secured Parties also will agree that it will not
contest or support any other person in contesting, in any
proceeding (including any insolvency or liquidation proceeding),
the perfection, priority, validity or enforceability of a Lien
held by or on behalf of any of the First Lien Secured Parties in
all or any part of the Collateral, or the provisions of the
First Lien Intercreditor Agreement.
If a First Lien Event of Default has occurred and is continuing
and the First Lien Collateral Agent is taking action to enforce
rights in respect of any Common Collateral, or any distribution
is made with respect to any Common Collateral in any bankruptcy
case of the Issuer or any Guarantor, the proceeds of any sale,
collection or other liquidation of any such Collateral by the
First Lien Collateral Agent or any other First Lien Secured
Party (or received pursuant to any other intercreditor
agreement), as applicable, and proceeds of any such distribution
(subject, in the case of any such distribution, to the paragraph
immediately following) to which the First Lien Obligations are
entitled under any other intercreditor agreement shall be
applied among
191
the First Lien Obligations to the payment in full of the First
Lien Obligations on a ratable basis, after payment of all
amounts owing to the First Lien Collateral Agent.
Notwithstanding the foregoing, with respect to any Common
Collateral for which a third party (other than a First Lien
Secured Party) has a lien or security interest that is junior in
priority to the security interest of any Series of First Lien
Obligations but senior (as determined by appropriate legal
proceedings in the case of any dispute) to the security interest
of any other Series of First Lien Obligations (such third party,
an Intervening Creditor), the value of any
Common Collateral or proceeds which are allocated to such
Intervening Creditor shall be deducted on a ratable basis solely
from the Common Collateral or proceeds to be distributed in
respect of the Series of First Lien Obligations with respect to
which such Impairment exists.
None of the First Lien Secured Parties may institute any suit or
assert in any suit, bankruptcy, insolvency or other proceeding
any claim against the First Lien Collateral Agent or any other
First Lien Secured Party seeking damages from or other relief by
way of specific performance, instructions or otherwise with
respect to any Common Collateral. In addition, none of the First
Lien Secured Parties may seek to have any Common Collateral or
any part thereof marshaled upon any foreclosure or other
disposition of such Collateral. If any First Lien Secured Party
obtains possession of any Common Collateral or realizes any
proceeds or payment in respect thereof, at any time prior to the
discharge of each of the First Lien Obligations, then it must
hold such Common Collateral, proceeds or payment in trust for
the other First Lien Secured Parties and promptly transfer such
Common Collateral, proceeds or payment to the First Lien
Collateral Agent to be distributed in accordance with the First
Lien Intercreditor Agreement.
If the Issuer or any Guarantor becomes subject to any bankruptcy
case, the First Lien Intercreditor Agreement provides that
(1) if the Issuer or any Guarantor shall, as
debtor(s)-in-possession, move for approval of financing (the
DIP Financing) to be provided by one or more
lenders (the DIP Lenders) under
Section 364 of the Bankruptcy Code or the use of cash
collateral under Section 363 of the Bankruptcy Code, each
First Lien Secured Party will agree not to object to any such
financing or to the Liens on the Common Collateral securing the
same (the DIP Financing Liens) or to any use
of cash collateral that constitutes Common Collateral, unless
any Controlling Secured Party, or an Authorized Representative
of any Controlling Secured Party, shall then oppose or object to
such DIP Financing or such DIP Financing Liens or use of cash
collateral (and (i) to the extent that such DIP Financing
Liens are senior to the Liens on any such Common Collateral for
the benefit of the Controlling Secured Parties, each
Non-Controlling Secured Party will subordinate its Liens with
respect to such Common Collateral on the same terms as the Liens
of the Controlling Secured Parties (other than any Liens of any
First Lien Secured Parties constituting DIP Financing Liens) are
subordinated thereto, and (ii) to the extent that such DIP
Financing Liens rank pari passu with the Liens on any
such Common Collateral granted to secure the First Lien
Obligations of the Controlling Secured Parties, each
Non-Controlling Secured Party will confirm the priorities with
respect to such Common Collateral as set forth in the First Lien
Intercreditor Agreement), in each case so long as;
(A) the First Lien Secured Parties of each Series retain
the benefit of their Liens on all such Common Collateral pledged
to the DIP Lenders, including proceeds thereof arising after the
commencement of such proceeding, with the same priority
vis-a-vis
all the other First Lien Secured Parties (other than any Liens
of the First Lien Secured Parties constituting DIP Financing
Liens) as existed prior to the commencement of the bankruptcy
case,
(B) the First Lien Secured Parties of each Series are
granted Liens on any additional collateral pledged to any First
Lien Secured Parties as adequate protection or otherwise in
connection with such DIP Financing or use of cash collateral,
with the same priority
vis-a-vis
the First Lien Secured Parties as set forth in the First Lien
Intercreditor Agreement,
(C) if any amount of such DIP Financing or cash collateral
is applied to repay any of the First Lien Obligations, such
amount is applied pursuant to the First Lien Intercreditor
Agreement, and
(D) if any First Lien Secured Parties are granted adequate
protection, including in the form of periodic payments, in
connection with such DIP Financing or use of cash collateral,
the proceeds of such adequate protection is applied pursuant to
the First Lien Intercreditor Agreement;
192
provided that the First Lien Secured Parties of each
Series shall have a right to object to the grant of a Lien to
secure the DIP Financing over any Collateral subject to Liens in
favor of the First Lien Secured Parties of such Series or its
representative that shall not constitute Common Collateral; and
provided, further, that the First Lien Secured
Parties receiving adequate protection shall not object to any
other First Lien Secured Party receiving adequate protection
comparable to any adequate protection granted to such First Lien
Secured Parties in connection with a DIP Financing or use of
cash collateral.
The First Lien Secured Parties acknowledge that the First Lien
Obligations of any Series may, subject to the limitations set
forth in the other First Lien Documents, be increased, extended,
renewed, replaced, restated, supplemented, restructured, repaid,
refunded, refinanced or otherwise amended or modified from time
to time, all without affecting the priorities set forth in the
First Lien Intercreditor Agreement defining the relative rights
of the First Lien Secured Parties of any Series.
Additional
General Intercreditor Agreement
The First Lien Collateral Agent is a party to an Additional
General Intercreditor Agreement dated as of the Issue Date, (as
the same may be amended from time to time, the
Additional General Intercreditor Agreement),
by and among the First Lien Collateral Agent, the Junior Lien
Collateral Agent and the trustees under the Existing Second
Priority Notes Indentures, by which the Notes are given the same
ranking and rights with respect to the Collateral as provided to
the General Credit Facility under the General Intercreditor
Agreement, dated as of November 17, 2006, by and among the
First Lien Collateral Agent and the Junior Lien Collateral
Agent. Pursuant to the terms of the Additional General
Intercreditor Agreement and subject to the First-Lien
Intercreditor Agreement, prior to the Discharge of New First
Lien Obligations, the First Lien Collateral Agent, acting on
behalf of the New First Lien Secured Parties, will determine the
time and method by which the security interests in the
Collateral will be enforced and will have the sole and exclusive
right to manage, perform and enforce the terms of the Security
Documents relating to the Collateral and to exercise and enforce
all privileges, rights and remedies thereunder according to its
direction, including to take or retake control or possession of
such Collateral and to hold, prepare for sale, marshall,
process, sell, lease, dispose of or liquidate such Collateral,
including, without limitation, following the occurrence of a
Default or Event of Default under the Indenture. The Junior Lien
Collateral Agent will not be permitted to enforce the security
interests even if any event of default under an Existing Second
Priority Notes Indenture has occurred and the Existing Second
Priority Notes issued thereunder have been accelerated except
(a) in any insolvency or liquidation proceeding, solely as
necessary to file a proof of claim or statement of interest with
respect to the Junior Lien Obligations or (b) as necessary
to take any action in order to prove, preserve, perfect or
protect (but not enforce) its security interest and rights in,
and the perfection and priority of its Lien on, the Collateral.
The Junior Lien Collateral Agent, for itself and on behalf of
each Junior Lien Secured Party, has agreed pursuant to the
Additional General Intercreditor Agreement that (a) it will
not (and thereby waives any right to) take any action to
challenge, contest or support any other Person in contesting or
challenging, directly or indirectly, in any proceeding
(including any insolvency or liquidation proceeding), the
validity, perfection, priority or enforceability of a Lien
securing any New First Lien Obligations held (or purported to be
held) by or on behalf of the First Lien Collateral Agent or any
of the New First Lien Secured Parties or any agent or trustee
therefor in any Collateral or other collateral securing both the
New First Lien Obligations and any Junior Lien Obligations and
(b) it will not oppose or otherwise contest (or support any
other Person contesting) any request for judicial relief made in
any court by the First Lien Collateral Agent or any New First
Lien Secured Parties relating to the lawful enforcement of any
First Priority Lien on Collateral or other collateral securing
both the New First Lien Obligations and any Junior Lien
Obligations.
In addition, the Security Documents provide that, subject to the
First Lien Intercreditor Agreement, prior to the Discharge of
New First Lien Obligations, the First Lien Collateral Agent may
take actions with respect to the Collateral (including the
release of Collateral and the manner of realization (subject to
the provisions described under Release of
Collateral)) without the consent of the Junior Lien
Collateral Agent or other Junior Lien Secured Parties.
193
The Collateral or proceeds thereof received in connection with
the sale or other disposition of, or collection on, such
Non-Receivables Collateral upon the exercise of remedies will be
applied to the First Lien Obligations to be distributed in
accordance with the First Lien Intercreditor Agreement prior to
application to any Junior Lien Obligations in such order as
specified in the relevant First Lien Documents until the
Discharge of New First Lien Obligations has occurred.
In addition, so long as the Discharge of New First Lien
Obligations has not occurred, neither the Junior Lien Collateral
Agent nor any Junior Lien Representative shall acquire or hold
any Lien on any assets of the Issuer or any Subsidiary (and
neither the Issuer nor any Subsidiary shall grant such Lien)
securing any Junior Lien Obligations that are not also subject
to the First Priority Lien in respect of the New First Lien
Obligations under the First Lien Documents.
The Junior Lien Collateral Agent and each other Junior Lien
Secured Party have agreed that any Lien purported to be granted
on any collateral as security for New First Lien Obligations
shall be deemed to be and shall be deemed to remain senior in
all respects and prior to all Liens on such collateral securing
any Junior Lien Obligations for all purposes regardless of
whether the Lien purported to be granted is found to be
improperly granted, improperly perfected, preferential, a
fraudulent conveyance or legally or otherwise deficient in any
manner.
If any New First Lien Secured Party is required in any
insolvency or liquidation proceeding or otherwise to turn over
or otherwise pay to the estate of the Issuer or any other
Guarantor (or any trustee, receiver or similar person therefor),
because the payment of such amount was declared to be fraudulent
or preferential in any respect or for any other reason, any
amount (a Recovery), whether received as
proceeds of security, enforcement of any right of setoff or
otherwise, then as among the parties hereto, the New First Lien
Obligations shall be deemed to be reinstated to the extent of
such Recovery and to be outstanding as if such payment had not
occurred and such New First Lien Secured Party shall be entitled
to a reinstatement of New First Lien Obligations with respect to
all such recovered amounts and shall have all rights hereunder.
If the Additional General Intercreditor Agreement shall have
been terminated prior to such Recovery, the Additional General
Intercreditor Agreement shall be reinstated in full force and
effect, and such prior termination shall not diminish, release,
discharge, impair or otherwise affect the obligations of the
parties thereto.
The Additional General Intercreditor Agreement provides that so
long as the Discharge of New First Lien Obligations has not
occurred, whether or not any insolvency or liquidation
proceeding has been commenced by or against the Issuer or any
Guarantor, (i) neither the Junior Lien Collateral Agent,
any Junior Lien Representative nor any Junior Lien Secured Party
will (x) exercise or seek to exercise any rights or
remedies (including setoff or the right to credit bid debt
(except under limited circumstances)) with respect to any
collateral securing both the New First Lien Obligations and any
Junior Lien Obligations in respect of any applicable Junior Lien
Obligations, or institute any action or proceeding with respect
to such rights or remedies (including any action of
foreclosure), (y) contest, protest or otherwise object to
any foreclosure or enforcement proceeding or action brought with
respect to the Collateral or any other collateral by the First
Lien Collateral Agent or any New First Lien Secured Party in
respect of the New First Lien Obligations, the exercise of any
right by the First Lien Collateral Agent or any New First Lien
Secured Party (or any agent or
sub-agent on
their behalf) in respect of the New First Lien Obligations under
any control agreement, lockbox agreement, landlord waiver or
bailees letter or similar agreement or arrangement to
which the Junior Lien Collateral Agent, any Junior Lien
Representative or any Junior Lien Secured Party either is a
party or may have rights as a third-party beneficiary, or any
other exercise by any such party of any rights and remedies as a
secured party relating to such collateral or any other
collateral under the First Lien Documents or otherwise in
respect of New First Lien Obligations, or (z) object to any
waiver or forbearance by the First Lien Secured Parties from or
in respect of bringing or pursuing any foreclosure proceeding or
action or any other exercise of any rights or remedies relating
to such collateral or any other collateral in respect of New
First Lien Obligations and (ii) except as otherwise
provided in the Additional General Intercreditor Agreement, the
First Lien Collateral Agent and the New First Lien Secured
Parties shall have the sole and exclusive right to enforce
rights, exercise remedies (including setoff and the right to
credit bid their debt), marshal, process and make determinations
regarding the release, disposition or restrictions, or waiver or
forbearance of rights or remedies
194
with respect to such collateral without any consultation with or
the consent of the Junior Lien Collateral Agent, any Junior Lien
Representative or any Junior Lien Secured Party.
In addition, the Junior Lien Collateral Agent, each Junior Lien
Representative and each other Junior Lien Secured Party have
agreed, among other things, that if the Issuer or any Guarantor
is subject to any insolvency or liquidation proceeding if the
First Lien Collateral Agent, subject to the First Lien
Intercreditor Agreement, desires to permit the use of cash
collateral or to permit the Issuer or any Guarantor to obtain
financing under Section 363 or Section 364 of the
Bankruptcy Code or any similar provision in any Bankruptcy Law
(DIP Financing), including if such DIP
Financing is secured by Liens senior in priority to the Liens
securing the Junior Lien Obligations, then the Junior Lien
Collateral Agent and each Junior Lien Representative, on behalf
of itself and each applicable Junior Lien Secured Party, agrees
not to object to such use of cash collateral or DIP Financing
and will not request adequate protection or any other relief in
connection therewith (except to the extent permitted by the
Additional General Intercreditor Agreement) and, to the extent
the Liens securing the new First Lien Obligations are
subordinated or pari passu with such DIP Financing, will
subordinate its Liens in the Collateral and any other collateral
to such DIP Financing (and all Obligations relating thereto) on
the same basis as they are subordinated to the New First Lien
Obligations.
Subject to the terms of the Security Documents, the Issuer and
the Guarantors have the right to remain in possession and retain
exclusive control of the Collateral securing the Notes and the
Notes Obligations (other than securities, instruments and
chattel paper constituting part of the Collateral and deposited
with the First Lien Collateral Agent in accordance with the
provisions of the First Lien Security Documents and any Shared
Receivables Collateral subject to a control agreement under the
circumstances described in the First Lien Security Documents),
to freely operate the Collateral and to collect, invest and
dispose of any income therefrom.
Release
of Collateral
Under the First Lien Intercreditor Agreement, if at any time the
Applicable Authorized Representative forecloses upon or
otherwise exercises remedies against any Common Collateral, then
(whether or not any insolvency or liquidation proceeding is
pending at the time) the Liens in favor of the First Lien
Collateral Agent for the benefit of the Trustee and the Holders
of the Notes and each other Series of First Lien Secured Parties
upon such Common Collateral will automatically be released and
discharged. However, any proceeds of any Common Collateral
realized therefrom will be applied as described under
First Lien Intercreditor Agreement.
Under the Additional Receivables Intercreditor Agreement, if at
any time the Issuer or any Guarantor or any ABL Secured Party
delivers notice that any Shared Receivables Collateral is sold,
transferred or otherwise disposed of by the owner of that
Collateral in a transaction permitted under the ABL Facility,
the General Credit Facility and the Indenture or the ABL Secured
Parties are releasing or have released their Liens on such
Shared Receivables Collateral in connection with a disposition
in connection with an exercise of remedies with respect to such
Collateral, then the Liens on such Shared Receivables Collateral
securing New First Lien Obligations or Junior Lien Obligations
will automatically be released and discharged as and when, but
only to the extent, such Liens on such Shared Receivables
Collateral securing ABL Obligations are released and discharged,
provided that in the case of a disposition in connection with an
exercise of remedies, any proceeds thereof not applied to repay
ABL Obligations shall be subject to the Liens securing the First
Lien Obligations and the Junior Lien Obligations and shall be
applied pursuant to the Additional Receivables Intercreditor
Agreement and the First Lien Intercreditor Agreement.
The Issuer and the Guarantors are entitled to the release of
property and other assets constituting Collateral from the Liens
securing the Notes and the Notes Obligations under any one or
more of the following circumstances:
(1) to enable us to consummate the sale, transfer or other
disposition of such property or assets to the extent not
prohibited under the covenant described under
Repurchase at the Option of
Holders Asset Sales;
195
(2) the release of Excess Proceeds or Collateral Excess
Proceeds that remain unexpended after the conclusion of an Asset
Sale Offer or a Collateral Asset Sale Offer conducted in
accordance with the Indenture;
(3) in the case of a Guarantor that is released from its
Guarantee with respect to the Notes pursuant to the terms of the
Indenture, the release of the property and assets of such
Guarantor;
(4) with the consent of the holders of at least 75% of the
aggregate principal amount of the Notes then outstanding and
affected thereby and a majority of all Junior Lien Obligations
(including the Existing Second Priority Notes) then outstanding
and affected thereby (including, without limitation, consents
obtained in connection with a tender offer or exchange offer
for, or purchase of, Junior Lien Obligations); or
(5) as described under Amendment,
Supplement and Waiver below.
To the extent necessary and for so long as required for such
Subsidiary not to be subject to any requirement pursuant to
Rule 3-16
of
Regulation S-X
under the Securities Act to file separate financial statements
with the SEC (or any other governmental agency), the Capital
Stock of any Subsidiary of the Company (excluding Healthtrust,
Inc. The Hospital Company, a Delaware corporation
and its successors and assigns) shall not be included in the
Collateral with respect to the respective Notes so affected (as
described under Certain Limitations on the
Collateral) and shall not be subject to the Liens securing
such Notes and the Notes Obligations.
The Liens on the Collateral securing the Notes and the
Guarantees also will be released upon (i) payment in full
of the principal of, together with accrued and unpaid interest
(including Additional Interest, if any) on, the Notes and all
other Obligations under the Indenture, the Guarantees and the
Security Documents that are due and payable at or prior to the
time such principal, together with accrued and unpaid interest
(including Additional Interest, if any), are paid or (ii) a
legal defeasance or covenant defeasance under the Indenture as
described below under Legal Defeasance and Covenant
Defeasance or a discharge of the Indenture as described
under Satisfaction and Discharge.
Any certificate or opinion required by Section 314(d) of
the Trust Indenture Act may be made by an Officer of the
Company, except in cases where Section 314(d) requires that
such certificate or opinion be made by an independent engineer,
appraiser or other expert.
Notwithstanding anything to the contrary herein, the Issuer and
its Subsidiaries will not be required to comply with all or any
portion of Section 314(d) of the Trust Indenture Act
if they determine, in good faith based on advice of counsel,
that under the terms of that section
and/or any
interpretation or guidance as to the meaning thereof of the SEC
and its staff, including no action letters or
exemptive orders, all or any portion of Section 314(d) of
the Trust Indenture Act is inapplicable to the released
Collateral.
Without limiting the generality of the foregoing, certain no
action letters issued by the SEC have permitted an indenture
qualified under the Trust Indenture Act to contain
provisions permitting the release of collateral from Liens under
such indenture in the ordinary course of the issuers
business without requiring the issuer to provide certificates
and other documents under Section 314(d) of the
Trust Indenture Act. The Issuer and the Guarantors may,
subject to the provisions of the Indenture, among other things,
without any release or consent by the First Lien Collateral
Agent, conduct ordinary course activities with respect to the
Collateral, including, without limitation:
|
|
|
|
|
selling or otherwise disposing of, in any transaction or series
of related transactions, any property subject to the Lien of the
Security Documents that has become worn out, defective, obsolete
or not used or useful in the business;
|
|
|
|
abandoning, terminating, canceling, releasing or making
alterations in or substitutions of any leases or contracts
subject to the Lien of the Indenture or any of the Security
Documents;
|
|
|
|
surrendering or modifying any franchise, license or permit
subject to the Lien of the Security Documents that it may own or
under which it may be operating;
|
196
|
|
|
|
|
altering, repairing, replacing, changing the location or
position of and adding to its structures, machinery, systems,
equipment, fixtures and appurtenances;
|
|
|
|
granting a license of any intellectual property;
|
|
|
|
selling, transferring or otherwise disposing of inventory in the
ordinary course of business;
|
|
|
|
collecting accounts receivable in the ordinary course of
business as permitted by the covenant described under
Repurchase at the Option of Holders Asset
Sales;
|
|
|
|
making cash payments (including for the repayment of
Indebtedness or interest) from cash that is at any time part of
the Collateral in the ordinary course of business that are not
otherwise prohibited by the Indenture and the Security
Documents; and
|
|
|
|
abandoning any intellectual property that is no longer used or
useful in the Issuers business.
|
The Issuer must deliver an Officers Certificate to the
First Lien Collateral Agent within 30 calendar days following
the end of each six-month period beginning on May 15 and
November 15 of each year, to the effect that all such releases
and withdrawals during the preceding six-month period in the
ordinary course of the Issuers or the Guarantors
business, as described in the preceding paragraph, were not
prohibited by the Indenture.
Additional
Receivables Intercreditor Agreement
In addition, the First Lien Collateral Agent is a party to an
Additional Receivables Intercreditor Agreement, dated as of the
Issue Date, (as the same may be amended from time to time, the
Additional Receivables Intercreditor
Agreement), by and between the First Lien Collateral
Agent and the collateral agent under the ABL Facility (the
ABL Collateral Agent), by which the Notes are
given the same ranking and rights with respect to the Shared
Receivables Collateral as provided to the General Credit
Facility under the Receivables Intercreditor Agreement dated as
of November 17, 2006 by and among the Junior Lien
Collateral Agent, the First Lien Collateral Agent and the ABL
Collateral Agent. The Additional Receivables Intercreditor
Agreement contains provisions with respect to the Shared
Receivables Collateral and the relative rights, privileges and
obligations relating thereto as between (a) the First Lien
Collateral Agent and the New First Lien Secured Parties and
(b) the ABL Collateral Agent and the ABL Secured Parties.
The Additional Receivables Intercreditor Agreement provides for
first-priority Liens in the Shared Receivables Collateral in
favor of the ABL Secured Parties and junior priority Liens in
the Shared Receivables Collateral in favor of the New First Lien
Secured Parties, subject to Permitted Liens. The relative
rights, privileges and obligations with respect to the Shared
Receivables Collateral of the ABL Secured Parties, on the one
hand, and the New First Lien Secured Parties, on the other, are
substantially similar to the relative rights, privileges and
obligations with respect to the Non-Receivables Collateral of
the New First Lien Secured Parties, on the one hand, and the
Junior Lien Secured Parties, on the other, respectively, except
that the Liens of the New First Lien Secured Parties in the
Shared Receivables Collateral are second-priority Liens and the
Liens of the ABL Secured Parties in the Shared Receivables
Collateral are first-priority liens and except to the extent
customary or necessary with respect to collateral of the type
that constitutes Shared Receivables Collateral.
The relative rights, privileges and obligations with respect to
the Shared Receivables Collateral (a) as between the First
Lien Collateral Agent and the First Lien Secured Parties, on the
one hand, and the Junior Lien Collateral Agent and the Junior
Lien Secured Parties, on the other, are governed by the
Additional General Intercreditor Agreement described above and
(b) as among the First Lien Secured Parties, are governed
by the First Lien Intercreditor Agreement described above.
Certain
Limitations on the Collateral
The Collateral securing the Notes does not include any of the
following assets:
(1) the property or assets owned by any Subsidiary of the
Issuer that is not a Guarantor, including each ABL Financing
Entity;
197
(2) any rights or interests of the Issuer or any Guarantor
in, to or under any agreement, contract, license, instrument,
document or other general intangible (referred to solely for
purposes of this clause (2) as a
Contract), any intellectual property or any
security or other investment property (i) to the extent the
security interest in such Collateral is prohibited by any
applicable contract, agreement or other instrument without the
consent of any other party thereto (other than a party to the
General Credit Facility or the Indenture or, in the case of
investment property, a Wholly-Owned Subsidiary), (ii) to
the extent the security interest in such Contract would give any
other party (other than a party to the General Credit Facility
or the Indenture or, in the case of investment property, a
Wholly-Owned Subsidiary) to such Collateral the right to
terminate its obligations thereunder or (iii) to the extent
all necessary consents to such grant of a security interest have
not been obtained from the other parties thereto (other than to
the extent that any such prohibition referred to in clauses (i),
(ii) and (iii) would be rendered ineffective pursuant
to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
successor provision or provisions) of any relevant jurisdiction
or any other applicable law); provided that this
limitation shall not affect, limit, restrict or impair the grant
by the Issuer or such Guarantor of a security interest in any
account receivable or any money or other amounts due or to
become due under any Contract;
(3) any equipment of the Issuer or any Guarantor that is
subject to, or secured by, a Capitalized Lease Obligation or
Purchase Money Obligations and any equipment that constitutes an
asset of an entity acquired in a transaction permitted by the
Indenture to the extent that such equipment subject to a Lien
permitted by the Indenture and the terms of the Indebtedness
secured by such Lien prohibit assignment of, or granting of a
security interest in, the Issuers or such Guarantors
rights and interests therein (other than to the extent that any
such prohibition would be rendered ineffective pursuant to
Sections 9-406,
9-407, 9-408
or 9-409 of the Uniform Commercial Code (or any successor
provision or provisions) of any relevant jurisdiction or any
other applicable law); provided that immediately upon the
repayment of all Indebtedness secured by such Lien, the Issuer
or the Guarantor, as the case may be, shall be deemed to have
granted a security interest in all the rights and interests with
respect to such equipment;
(4) any Voting Stock that is issued by any Foreign
Subsidiary, if and to the extent that the inclusion of such
Voting Stock in the Collateral would cause the Collateral
pledged by the Issuer or the applicable Guarantor, as the case
may be, to include in the aggregate more than 65% of the total
combined voting power of all classes of Voting Stock of such
Foreign Subsidiary;
(5) any Capital Stock that is issued by a Subsidiary that
is not owned directly by the Issuer or a Guarantor;
(6) any Capital Stock and other securities of a Subsidiary
(excluding Healthtrust, Inc. The Hospital Company, a
Delaware corporation and its successors and assigns) to the
extent that the pledge of such Capital Stock and other
securities results in the Companys being required to file
separate financial statements of such Subsidiary with the SEC,
but only to the extent necessary to not be subject to such
requirement and only for so long as such requirement is in
existence and only with respect to the relevant Notes affected;
provided that neither the Issuer nor any Subsidiary shall
take any action in the form of a reorganization, merger or other
restructuring a principal purpose of which is to provide for the
release of the Lien on any Capital Stock pursuant to this clause
(6). In addition, in the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
the SEC to require (or is replaced with another rule or
regulation, or any other law, rule or regulation is adopted,
which would require) the filing with the SEC (or any other
governmental agency) of separate financial statements of any
Subsidiary of the Company (excluding Healthtrust,
Inc. The Hospital Company, a Delaware corporation
and its successors and assigns) due to the fact that such
Subsidiarys Capital Stock secures the Notes affected
thereby, then the Capital Stock of such Subsidiary will
automatically be deemed not to be part of the Collateral
securing the relevant Notes affected thereby but only to the
extent necessary to not be subject to such requirement and only
for so long as required to not be subject to such requirement.
In such event, the Security Documents may be amended or
modified, without the consent of any holder of such Notes, to
the extent necessary to release the security interests in favor
of the First Lien Collateral Agent on the shares of Capital
Stock that are so deemed to no longer constitute part of the
Collateral for
198
the relevant Notes. In the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
the SEC to permit (or is replaced with another rule or
regulation, or any other law, rule or regulation is adopted,
which would permit) such Subsidiarys Capital Stock to
secure the Notes in excess of the amount then pledged without
the filing with the SEC (or any other governmental agency) of
separate financial statements of such Subsidiary, then the
Capital Stock of such Subsidiary will automatically be deemed to
be a part of the Collateral for the relevant Notes;
(7) certain non-Principal Properties that do not constitute
Non-Receivables Collateral;
(8) any deposit accounts, other bank or securities accounts
or cash of the Issuer or any Guarantor;
(9) any leaseholds and motor vehicles of the Issuer or any
Guarantor;
(10) any Capital Stock or securities convertible into or
exchangeable for Capital Stock (i) if, in the reasonable
judgment of the Issuer, the cost or other consequences of
pledging such Collateral shall be excessive in view of the
benefits to be obtained by the First Lien Secured Parties
therefrom or (ii) the pledge of such Collateral would
result in adverse tax consequences to the Issuer or any of its
Subsidiaries as reasonably determined by the Issuer and
identified in writing to the First Lien Collateral Agent;
(11) any collateral to the extent the grant of the security
interest therein would violate any requirement of law; and
(12) proceeds and products from any and all of the
foregoing excluded collateral described in clauses (1)
through (11), unless such proceeds or products would otherwise
constitute Collateral securing the Notes.
Sufficiency
of Collateral
The fair market value of the Collateral is subject to
fluctuations based on factors that include, among others, the
condition of the health care industry, the ability to sell the
Collateral in an orderly sale, general economic conditions, the
availability of buyers and similar factors. The amount to be
received upon a sale of the Collateral would also be dependent
on numerous factors, including, but not limited to, the actual
fair market value of the Collateral at such time and the timing
and the manner of the sale. By their nature, portions of the
Collateral may be illiquid and may have no readily ascertainable
market value. Accordingly, there can be no assurance that the
Collateral can be sold in a short period of time or in an
orderly manner. In addition, in the event of a bankruptcy, the
ability of the holders to realize upon any of the Collateral may
be subject to certain bankruptcy law limitations as described
below.
Certain
Bankruptcy Limitations
The right of the Trustee to repossess and dispose of the
Collateral upon the occurrence of an Event of Default would be
significantly impaired by any Bankruptcy Law in the event that a
bankruptcy case were to be commenced by or against the Company
or any Guarantor prior to the Trustees having repossessed
and disposed of the Collateral. Upon the commencement of a case
for relief under the Bankruptcy Code, a secured creditor such as
the Trustee is prohibited from repossessing its security from a
debtor in a bankruptcy case, or from disposing of security
without bankruptcy court approval.
In view of the broad equitable powers of a U.S. bankruptcy
court, it is impossible to predict how long payments under the
Notes could be delayed following commencement of a bankruptcy
case, whether or when the Trustee could repossess or dispose of
the Collateral, the value of the Collateral at any time during a
bankruptcy case or whether or to what extent Holders of the
Notes would be compensated for any delay in payment or loss of
value of the Collateral. The Bankruptcy Code permits only the
payment
and/or
accrual of post-petition interest, costs and attorneys
fees to a secured creditor during a debtors bankruptcy
case to the extent the value of such creditors interest in
the Collateral is determined by the bankruptcy court to exceed
the aggregate outstanding principal amount of the obligations
secured by the Collateral.
Furthermore, in the event a domestic or foreign bankruptcy court
determines that the value of the Collateral is not sufficient to
repay all amounts due on the Notes, the Holders of the Notes
would hold secured
199
claims only to the extent of the value of the Collateral to
which the Holders of the Notes are entitled, and unsecured
claims with respect to such shortfall.
Paying
Agent and Registrar for the Notes
The Issuer must maintain one or more paying agents for the Notes
in the Borough of Manhattan, City of New York. The initial
paying agent for the Notes is Deutsche Bank Trust Company
Americas.
The Issuer must also maintain a registrar with offices in the
Borough of Manhattan, City of New York. The initial registrar is
Deutsche Bank Trust Company Americas. The registrar
maintains a register reflecting ownership of the Notes
outstanding from time to time and will make payments on and
facilitate transfer of Notes on behalf of the Issuer.
The Issuer may change the paying agents or the registrars
without prior notice to the Holders. The Issuer or any of its
Subsidiaries may act as a paying agent or registrar.
Transfer
and Exchange
A Holder may transfer or exchange Notes in accordance with the
Indenture. The registrar and the Trustee may require a Holder to
furnish appropriate endorsements and transfer documents in
connection with a transfer of Notes. Holders will be required to
pay all taxes due on transfer. The Issuer will not be required
to transfer or exchange any Note selected for redemption. Also,
the Issuer will not be required to transfer or exchange any Note
for a period of 15 days before a selection of Notes to be
redeemed.
Principal,
Maturity and Interest
The Issuer issued $1,500,000,000 in aggregate principal amount
of Notes in this offering. The Notes will mature on
April 15, 2019. Subject to compliance with the covenant
described below under the caption Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock,
the Issuer may issue additional Notes, from time to time after
this offering under the Indenture (any such Notes,
Additional Notes). Except as described under
Amendment, Supplement and Waiver, the Notes of the
Issuer and any Additional Notes subsequently issued under the
Indenture will be treated as a single class for all purposes
under the Indenture, including waivers, amendments, redemptions
and offers to purchase. Unless the context requires otherwise,
references to Notes for all purposes of the
Indenture and this Description of Notes include any
Additional Notes that are actually issued.
Interest on the Notes will accrue at the rate of
81/2%
per annum and is payable semi-annually in arrears on April 15
and October 15 commencing October 15, 2009, to the Holders
of record on the immediately preceding April 1 and
October 1. Interest on the Notes will accrue from the most
recent date to which interest has been paid or, if no interest
has been paid, from and including the Issue Date. Interest on
the Notes is computed on the basis of a
360-day year
comprised of twelve
30-day
months.
Additional
Interest
Additional Interest may accrue on the Notes in certain
circumstances pursuant to the Registration Rights Agreement. All
references in the Indenture, in any context, to any interest or
other amount payable on or with respect to the Notes shall be
deemed to include any Additional Interest pursuant to the
Registration Rights Agreement. Principal of, premium, if any,
and interest on the Notes is payable at the office or agency of
the Issuer maintained for such purpose within the City and State
of New York or, at the option of the Issuer, payment of interest
may be made by check mailed to the Holders of the Notes at their
respective addresses set forth in the register of Holders;
provided that all payments of principal, premium, if any,
and interest with respect to the Notes represented by one or
more global notes registered in the name of or held by DTC or
its nominee will be made by wire transfer of immediately
available funds to the accounts specified by the Holder or
Holders thereof. Until otherwise designated by the Issuer, the
Issuers office or agency in New York will be the office of
the Registrar and Paying Agent maintained for such purpose.
200
Mandatory
Redemption; Offers to Purchase; Open Market Purchases
The Issuer will not be required to make any mandatory redemption
or sinking fund payments with respect to the Notes. However,
under certain circumstances, the Issuer may be required to offer
to purchase Notes as described under the caption
Repurchase at the Option of Holders. The Issuer may
at any time and from time to time purchase Notes in the open
market or otherwise.
Optional
Redemption
Except as set forth below, the Issuer is not entitled to redeem
Notes at its option prior to April 15, 2014.
At any time prior to April 15, 2014, the Issuer may redeem
all or a part of the Notes, upon not less than 30 nor more than
60 days prior notice mailed by first-class mail to
the registered address of each Holder or otherwise in accordance
with the procedures of DTC, at a redemption price equal to 100%
of the principal amount of the Notes redeemed plus the
Applicable Premium as of, and accrued and unpaid interest and
Additional Interest, if any, to the date of redemption (the
Redemption Date), subject to the rights
of Holders of the Notes on the relevant record date to receive
interest due on the relevant interest payment date.
On and after April 15, 2014 the Issuer may redeem the
Notes, in whole or in part, upon not less than 30 nor more than
60 days prior notice mailed by first-class mail to
the registered address of each Holder or otherwise in accordance
with the procedures of DTC, at the redemption prices (expressed
as percentages of principal amount of the Notes to be redeemed)
set forth below, plus accrued and unpaid interest thereon and
Additional Interest, if any, to the applicable
Redemption Date, subject to the right of Holders of record
on the relevant record date to receive interest due on the
relevant interest payment date, if redeemed during the
twelve-month period beginning on April 15 of each of the years
indicated below:
|
|
|
|
|
Year
|
|
Percentage
|
|
|
2014
|
|
|
104.250
|
%
|
2015
|
|
|
102.833
|
%
|
2016
|
|
|
101.417
|
%
|
2017 and thereafter
|
|
|
100.000
|
%
|
In addition, until April 15, 2012, the Issuer may, at its
option, on one or more occasions redeem up to 35% of the
aggregate principal amount of Notes at a redemption price equal
to 108.500% of the aggregate principal amount thereof, plus
accrued and unpaid interest thereon and Additional Interest, if
any, to the applicable Redemption Date, subject to the
right of Holders of record on the relevant record date to
receive interest due on the relevant interest payment date, with
the net cash proceeds of one or more Equity Offerings;
provided that at least 50% of the sum of the original
aggregate principal amount of Notes issued under the Indenture
and the original principal amount of any Additional Notes that
are Notes issued under the Indenture after the Issue Date
remains outstanding immediately after the occurrence of each
such redemption; provided further that each such
redemption occurs within 90 days of the date of closing of
each such Equity Offering.
Any notice of any redemption may be given prior to the
redemption thereof, and any such redemption or notice may, at
the Issuers discretion, be subject to one or more
conditions precedent, including, but not limited to, completion
of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding Notes,
the Registrar and Paying Agent shall select the Notes to be
redeemed in the manner described under Repurchase at the
Option of Holders Selection and Notice.
Repurchase
at the Option of Holders
Change
of Control
The Notes provide that if a Change of Control occurs, unless the
Issuer has previously or concurrently mailed a redemption notice
with respect to all the outstanding Notes as described under
Optional Redemption, the Issuer will make an offer
to purchase all of the Notes pursuant to the offer described
below
201
(the Change of Control Offer) at a price in
cash (the Change of Control Payment) equal to
101% of the aggregate principal amount thereof plus accrued and
unpaid interest and Additional Interest, if any, to the date of
purchase, subject to the right of Holders of the Notes of record
on the relevant record date to receive interest due on the
relevant interest payment date. Within 30 days following
any Change of Control, the Issuer will send notice of such
Change of Control Offer by first-class mail, with a copy to the
Trustee and the Registrar, to each Holder of Notes to the
address of such Holder appearing in the security register with a
copy to the Trustee and the Registrar or otherwise in accordance
with the procedures of DTC, with the following information:
(1) that a Change of Control Offer is being made pursuant
to the covenant entitled Change of Control and that
all Notes properly tendered pursuant to such Change of Control
Offer will be accepted for payment by the Issuer;
(2) the purchase price and the purchase date, which will be
no earlier than 30 days nor later than 60 days from
the date such notice is mailed (the Change of Control
Payment Date);
(3) that any Note not properly tendered will remain
outstanding and continue to accrue interest;
(4) that unless the Issuer defaults in the payment of the
Change of Control Payment, all Notes accepted for payment
pursuant to the Change of Control Offer will cease to accrue
interest on the Change of Control Payment Date;
(5) that Holders electing to have any Notes purchased
pursuant to a Change of Control Offer will be required to
surrender such Notes, with the form entitled Option of
Holder to Elect Purchase on the reverse of such Notes
completed, to the paying agent specified in the notice at the
address specified in the notice prior to the close of business
on the third Business Day preceding the Change of Control
Payment Date;
(6) that Holders will be entitled to withdraw their
tendered Notes and their election to require the Issuer to
purchase such Notes; provided that the paying agent
receives, not later than the close of business on the
30th day following the date of the Change of Control
notice, a telegram, facsimile transmission or letter setting
forth the name of the Holder of the Notes, the principal amount
of Notes tendered for purchase, and a statement that such Holder
is withdrawing its tendered Notes and its election to have such
Notes purchased;
(7) that if the Issuer is redeeming less than all of the
Notes, the Holders of the remaining Notes will be issued new
Notes and such new Notes will be equal in principal amount to
the unpurchased portion of the Notes surrendered. The
unpurchased portion of the Notes must be equal to $2,000 or an
integral multiple of $1,000 in excess thereof; and
(8) the other instructions, as determined by us, consistent
with the covenant described hereunder, that a Holder must follow.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder to the extent such laws or regulations
are applicable in connection with the repurchase of Notes
pursuant to a Change of Control Offer. To the extent that the
provisions of any securities laws or regulations conflict with
the provisions of the Indenture, the Issuer will comply with the
applicable securities laws and regulations and shall not be
deemed to have breached its obligations described in the
Indenture by virtue thereof.
On the Change of Control Payment Date, the Issuer will, to the
extent permitted by law,
(1) accept for payment all Notes issued by it or portions
thereof properly tendered pursuant to the Change of Control
Offer;
(2) deposit with the paying agent an amount equal to the
aggregate Change of Control Payment in respect of all Notes or
portions thereof so tendered; and
202
(3) deliver, or cause to be delivered, to the Trustee for
cancellation the Notes so accepted together with an
Officers Certificate to the Trustee stating that such
Notes or portions thereof have been tendered to and purchased by
the Issuer.
The Senior Credit Facilities provide, and future credit
agreements or other agreements relating to Senior Indebtedness
to which the Issuer becomes a party may provide, that certain
change of control events with respect to the Issuer would
constitute a default thereunder (including a Change of Control
under the Indenture). If we experience a change of control that
triggers a default under our Senior Credit Facilities, we could
seek a waiver of such default or seek to refinance our Senior
Credit Facilities. In the event we do not obtain such a waiver
or refinance the Senior Credit Facilities, such default could
result in amounts outstanding under our Senior Credit Facilities
being declared due and payable and could cause a Receivables
Facility to be wound down.
Our ability to pay cash to the Holders of the Notes following
the occurrence of a Change of Control may be limited by our
then-existing financial resources. Therefore, sufficient funds
may not be available when necessary to make any required
repurchases.
The Change of Control purchase feature of the Notes may in
certain circumstances make more difficult or discourage a sale
or takeover of us and, thus, the removal of incumbent
management. The Change of Control purchase feature is a result
of negotiations between the Initial Purchasers and us. After the
Issue Date, we have no present intention to engage in a
transaction involving a Change of Control, although it is
possible that we could decide to do so in the future. Subject to
the limitations discussed below, we could, in the future, enter
into certain transactions, including acquisitions, refinancings
or other recapitalizations, that would not constitute a Change
of Control under the Indenture, but that could increase the
amount of indebtedness outstanding at such time or otherwise
affect our capital structure or credit ratings. Restrictions on
our ability to incur additional Indebtedness are contained in
the covenants described under Certain Covenants
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock and
Certain Covenants Liens. Such
restrictions in the Indenture can be waived only with the
consent of the Holders of a majority in principal amount of the
Notes then outstanding. Except for the limitations contained in
such covenants, however, the Indenture will not contain any
covenants or provisions that may afford Holders of the Notes
protection in the event of a highly leveraged transaction.
The Issuer is not required to make a Change of Control Offer
following a Change of Control if a third party makes the Change
of Control Offer in the manner, at the times and otherwise in
compliance with the requirements set forth in the Indenture
applicable to a Change of Control Offer made by us and purchases
all Notes validly tendered and not withdrawn under such Change
of Control Offer. Notwithstanding anything to the contrary
herein, a Change of Control Offer may be made in advance of a
Change of Control, conditional upon such Change of Control, if a
definitive agreement is in place for the Change of Control at
the time of making of the Change of Control Offer.
The definition of Change of Control includes a
disposition of all or substantially all of the assets of the
Issuer to any Person. Although there is a limited body of case
law interpreting the phrase substantially all, there
is no precise established definition of the phrase under
applicable law. Accordingly, in certain circumstances there may
be a degree of uncertainty as to whether a particular
transaction would involve a disposition of all or
substantially all of the assets of the Issuer. As a
result, it may be unclear as to whether a Change of Control has
occurred and whether a Holder of Notes may require the Issuer to
make an offer to repurchase the Notes as described above.
The provisions under the Indenture relating to the Issuers
obligation to make an offer to repurchase the Notes as a result
of a Change of Control may be waived or modified with the
written consent of the Holders of a majority in principal amount
of the Notes.
203
Asset
Sales
The Indenture provides that the Issuer will not, and will not
permit any of its Restricted Subsidiaries to consummate,
directly or indirectly, an Asset Sale, unless:
(1) the Issuer or such Restricted Subsidiary, as the case
may be, receives consideration at the time of such Asset Sale at
least equal to the fair market value (as determined in good
faith by the Issuer) of the assets sold or otherwise disposed
of; and
(2) except in the case of a Permitted Asset Swap, at least
75% of the consideration therefor received by the Issuer or such
Restricted Subsidiary, as the case may be, is in the form of
cash or Cash Equivalents; provided that the amount of:
(a) any liabilities (as shown on the Issuers or such
Restricted Subsidiarys most recent balance sheet or in the
footnotes thereto) of the Issuer or such Restricted Subsidiary,
other than liabilities that are by their terms subordinated to
the Notes, that are assumed by the transferee of any such assets
and for which the Issuer and all of its Restricted Subsidiaries
have been validly released by all creditors in writing,
(b) any securities received by the Issuer or such
Restricted Subsidiary from such transferee that are converted by
the Issuer or such Restricted Subsidiary into cash (to the
extent of the cash received) within 180 days following the
closing of such Asset Sale, and
(c) any Designated Non-cash Consideration received by the
Issuer or such Restricted Subsidiary in such Asset Sale having
an aggregate fair market value, taken together with all other
Designated Non-cash Consideration received pursuant to this
clause (c) that is at that time outstanding, not to exceed
5% of Total Assets at the time of the receipt of such Designated
Non-cash Consideration, with the fair market value of each item
of Designated Non-cash Consideration being measured at the time
received and without giving effect to subsequent changes in
value,
shall be deemed to be cash for purposes of this provision and
for no other purpose.
Within 450 days after the receipt of any Net Proceeds of
any Asset Sale, the Issuer or such Restricted Subsidiary, at its
option, may apply the Net Proceeds from such Asset Sale,
(1) to permanently reduce:
(a) Obligations constituting First Lien Obligations (and,
if the Indebtedness repaid is revolving credit Indebtedness, to
correspondingly reduce commitments with respect thereto)
(provided that (x) to the extent that the terms of
First Lien Obligations other than Obligations under the Notes
require that such First Lien Obligations are repaid with the Net
Proceeds of Asset Sales prior to repayment of other
Indebtedness, the Issuer and its Restricted Subsidiaries shall
be entitled to repay such other First Lien Obligations prior to
repaying the Obligations under the Notes and (y) subject to
the foregoing clause (x), if the Issuer or any Guarantor shall
so reduce First Lien Obligations, the Issuer will equally and
ratably reduce Obligations under the Notes through open-market
purchases (provided that such purchases are at or above
100% of the principal amount thereof) or by making an offer (in
accordance with the procedures set forth below for an Asset Sale
Offer) to all holders to purchase at a purchase price equal to
100% of the principal amount thereof, plus accrued and unpaid
interest and additional interest, if any, on the pro rata
principal amount of Notes);
(b) Obligations under the Existing Notes which have a final
maturity date (as in effect on the Issue Date) on or prior to
the maturity date of the Notes; provided that, at the
time of, and after giving effect to, such repurchase, redemption
or defeasance, the aggregate amount of Net Proceeds used to
repurchase, redeem or defease Existing Notes pursuant to this
subclause (b) following the Issue Date shall not exceed 5%
of the consolidated total assets of the Issuer and is
subsidiaries at such time; or
(c) Indebtedness of a Restricted Subsidiary that is not a
Guarantor, other than Indebtedness owed to the Issuer or another
Restricted Subsidiary (or any affiliate thereof);
204
(2) to make (a) an Investment in any one or more
businesses, provided that such Investment in any business
is in the form of the acquisition of Capital Stock and results
in the Issuer or another of its Restricted Subsidiaries, as the
case may be, owning an amount of the Capital Stock of such
business such that it constitutes a Restricted Subsidiary,
(b) capital expenditures or (c) acquisitions of other
assets, in each of (a), (b) and (c), used or useful in a
Similar Business; or
(3) to make an investment in (a) any one or more
businesses, provided that such Investment in any business
is in the form of the acquisition of Capital Stock and results
in the Issuer or another of its Restricted Subsidiaries, as the
case may be, owning an amount of the Capital Stock of such
business such that it constitutes a Restricted Subsidiary,
(b) properties or (c) acquisitions of other assets
that, in each of (a), (b) and (c), replace the businesses,
properties
and/or
assets that are the subject of such Asset Sale;
provided that, in the case of clauses (2) and
(3) above, a binding commitment shall be treated as a
permitted application of the Net Proceeds from the date of such
commitment so long as the Issuer, or such other Restricted
Subsidiary enters into such commitment with the good faith
expectation that such Net Proceeds will be applied to satisfy
such commitment within 180 days of such commitment (an
Acceptable Commitment) and, in the event any
Acceptable Commitment is later cancelled or terminated for any
reason before the Net Proceeds are applied in connection
therewith, the Issuer or such Restricted Subsidiary enters into
another Acceptable Commitment (a Second
Commitment) within 180 days of such cancellation
or termination; provided, further, that if any
Second Commitment is later cancelled or terminated for any
reason before such Net Proceeds are applied, then such Net
Proceeds shall constitute Excess Proceeds.
Any Net Proceeds from Asset Sales of Collateral that are not
invested or applied as set forth in the first sentence of the
preceding paragraph will be deemed to constitute
Collateral Excess Proceeds. When the
aggregate amount of Collateral Excess Proceeds exceeds
$200.0 million, the Issuer shall make an offer to all
Holders of the Notes and, if required by the terms of any First
Lien Obligations or Obligations secured by a Lien permitted
under the Indenture (which Lien is not subordinate to the Lien
of the Notes with respect to the Collateral), to the holders of
such First Lien Obligations or such other Obligations (a
Collateral Asset Sale Offer), to purchase the
maximum aggregate principal amount of the Notes and such First
Lien Obligations or such other Obligations that is a minimum of
$2,000 or an integral multiple of $1,000 in excess thereof that
may be purchased out of the Collateral Excess Proceeds at an
offer price in cash in an amount equal to 100% of the principal
amount thereof, plus accrued and unpaid interest and Additional
Interest, if any, to the date fixed for the closing of such
offer, in accordance with the procedures set forth in the
Indenture. The Issuer will commence a Collateral Asset Sale
Offer with respect to Collateral Excess Proceeds within ten
Business Days after the date that Collateral Excess Proceeds
exceed $200.0 million by mailing the notice required
pursuant to the terms of the Indenture, with a copy to the
Trustee.
Any Net Proceeds from Asset Sales of non-Collateral that are not
invested or applied as provided and within the time period set
forth in the first sentence of the second preceding paragraph
will be deemed to constitute Excess Proceeds.
When the aggregate amount of Excess Proceeds exceeds
$200.0 million, the Issuer shall make an offer to all
Holders of the Notes and, if required or permitted by the terms
of any Senior Indebtedness, to the holders of such Senior
Indebtedness (an Asset Sale Offer), to
purchase the maximum aggregate principal amount of the Notes and
such Senior Indebtedness that is a minimum of $2,000 or an
integral multiple of $1,000 in excess thereof that may be
purchased out of the Excess Proceeds at an offer price in cash
in an amount equal to 100% of the principal amount thereof, plus
accrued and unpaid interest and Additional Interest, if any, to
the date fixed for the closing of such offer, in accordance with
the procedures set forth in the Indenture. The Issuer will
commence an Asset Sale Offer with respect to Excess Proceeds
within ten Business Days after the date that Excess Proceeds
exceed $200.0 million by mailing the notice required
pursuant to the terms of the Indenture, with a copy to the
Trustee.
To the extent that the aggregate amount of Notes and such other
First Lien Obligations or Obligations secured by a Lien
permitted by the Indenture (which Lien is not subordinate to the
Lien of the Notes with respect to the Collateral) tendered
pursuant to a Collateral Asset Sale Offer is less than the
Collateral Excess Proceeds, the Issuer may use any remaining
Collateral Excess Proceeds for general corporate purposes,
subject to other covenants contained in the Indenture. To the
extent that the aggregate amount of Notes and such
205
Senior Indebtedness tendered pursuant to an Asset Sale Offer is
less than the Excess Proceeds, the Issuer may use any remaining
Excess Proceeds for general corporate purposes, subject to other
covenants contained in the Indenture. If the aggregate principal
amount of Notes or other First Lien Obligations or such other
Obligations surrendered by such holders thereof exceeds the
amount of Collateral Excess Proceeds, the Trustee shall select
the Notes and such other First Lien Obligations or such other
Obligations to be purchased on a pro rata basis based on the
accreted value or principal amount of the Notes or such other
First Lien Obligations or such other Obligations tendered. If
the aggregate principal amount of Notes or the Senior
Indebtedness surrendered by such holders thereof exceeds the
amount of Excess Proceeds, the Trustee shall select the Notes
and such Senior Indebtedness to be purchased on a pro rata basis
based on the accreted value or principal amount of the Notes or
such Senior Indebtedness tendered. Upon completion of any such
Collateral Asset Sale Offer or Asset Sale Offer, the amount of
Collateral Excess Proceeds or Excess Proceeds, as the case may
be, shall be reset at zero. Additionally, the Issuer may, at its
option, make a Collateral Asset Sale Offer or an Asset Sale
Offer using proceeds from any Asset Sale at any time after
consummation of such Asset Sale; provided that such
Collateral Asset Sale Offer or Asset Sale Offer shall be in an
aggregate amount of not less than $50.0 million. Upon
consummation of such Collateral Asset Sale Offer or Asset Sale
Offer, any Net Proceeds not required to be used to purchase
Notes shall not be deemed Excess Proceeds.
Pending the final application of any Net Proceeds pursuant to
this covenant, the holder of such Net Proceeds may apply such
Net Proceeds temporarily to reduce Indebtedness outstanding
under a revolving credit facility or otherwise invest such Net
Proceeds in any manner not prohibited by the Indenture.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder to the extent such laws or regulations
are applicable in connection with the repurchase of the Notes
pursuant to a Collateral Asset Sale Offer or an Asset Sale
Offer. To the extent that the provisions of any securities laws
or regulations conflict with the provisions of the Indenture,
the Issuer will comply with the applicable securities laws and
regulations and shall not be deemed to have breached its
obligations described in the Indenture by virtue thereof.
Selection
and Notice
If the Issuer is redeeming less than all of the Notes issued by
it at any time, the Registrar and Paying Agent will select the
Notes to be redeemed (a) if the Notes are listed on any
national securities exchange, in compliance with the
requirements of the principal national securities exchange on
which the Notes are listed, (b) on a pro rata basis to the
extent practicable or (c) by lot or such other similar
method in accordance with the procedures of DTC.
Notices of purchase or redemption shall be mailed by first-class
mail, postage prepaid, at least 30 but not more than
60 days before the purchase or Redemption Date to each
Holder of Notes at such Holders registered address or
otherwise in accordance with the procedures of DTC, except that
redemption notices may be mailed more than 60 days prior to
a Redemption Date if the notice is issued in connection
with a defeasance of the Notes or a satisfaction and discharge
of the Indenture. If any Note is to be purchased or redeemed in
part only, any notice of purchase or redemption that relates to
such Note shall state the portion of the principal amount
thereof that has been or is to be purchased or redeemed.
The Issuer will issue a new Note in a principal amount equal to
the unredeemed portion of the original Note in the name of the
Holder upon cancellation of the original Note. Notes called for
redemption become due on the date fixed for redemption. On and
after the Redemption Date, interest ceases to accrue on
Notes or portions thereof called for redemption.
Certain
Covenants
Set forth below are summaries of certain covenants contained in
the Indenture. If on any date following the Issue Date
(i) the Notes have Investment Grade Ratings from both
Rating Agencies, and (ii) no Default has occurred and is
continuing under the Indenture (the occurrence of the events
described in the foregoing clauses (i) and (ii) being
collectively referred to as a Covenant Suspension
Event), the Issuer and the
206
Restricted Subsidiaries will not be subject to the following
covenants (collectively, the Suspended
Covenants):
(1) Repurchase at the Option of Holders;
(2) Limitation on Restricted
Payments;
(3) Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock;
(4) clause (4) of the first paragraph of
Merger, Consolidation or Sale of All or
Substantially All Assets;
(5) Transactions with
Affiliates; and
(6) Dividend and Other Payment Restrictions
Affecting Restricted Subsidiaries.
In the event that the Issuer and the Restricted Subsidiaries are
not subject to the Suspended Covenants under the Indenture for
any period of time as a result of the foregoing, and on any
subsequent date (the Reversion Date) one or
both of the Rating Agencies (a) withdraw their Investment
Grade Rating or downgrade the rating assigned to the Notes below
an Investment Grade Rating
and/or
(b) the Issuer or any of its Affiliates enters into an
agreement to effect a transaction that would result in a Change
of Control and one or more of the Rating Agencies indicate that
if consummated, such transaction (alone or together with any
related recapitalization or refinancing transactions) would
cause such Rating Agency to withdraw its Investment Grade Rating
or downgrade the ratings assigned to the Notes below an
Investment Grade Rating, then the Issuer and the Restricted
Subsidiaries will thereafter again be subject to the Suspended
Covenants under the Indenture with respect to future events,
including, without limitation, a proposed transaction described
in clause (b) above.
The period of time between the Suspension Date and the Reversion
Date is referred to in this description as the
Suspension Period. Additionally, upon the
occurrence of a Covenant Suspension Event, the amount of Excess
Proceeds from Net Proceeds shall be reset at zero. In the event
of any such reinstatement, no action taken or omitted to be
taken by the Issuer or any of its Restricted Subsidiaries prior
to such reinstatement will give rise to a Default or Event of
Default under the Indentures with respect to Notes; provided
that (1) with respect to Restricted Payments made after
any such reinstatement, the amount of Restricted Payments made
will be calculated as though the covenant described under the
caption Limitation on Restricted
Payments had been in effect prior to, but not during the
Suspension Period, provided that any Subsidiaries
designated as Unrestricted Subsidiaries during the Suspension
Period shall automatically become Restricted Subsidiaries on the
Reversion Date (subject to the Issuers right to
subsequently designate them as Unrestricted Subsidiaries in
compliance with the covenants set out below), and (2) all
Indebtedness incurred, or Disqualified Stock or Preferred Stock
issued, during the Suspension Period will be classified to have
been incurred or issued pursuant to clause (3) of the
second paragraph of Limitation on Incurrence
of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock.
There can be no assurance that the Notes will ever achieve or
maintain Investment Grade Ratings.
Limitation
on Restricted Payments
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly:
(I) declare or pay any dividend or make any payment or
distribution on account of the Issuers, or any of its
Restricted Subsidiaries Equity Interests, including any
dividend or distribution payable in connection with any merger
or consolidation other than:
(a) dividends or distributions by the Issuer payable solely
in Equity Interests (other than Disqualified Stock) of the
Issuer; or
(b) dividends or distributions by a Restricted Subsidiary
so long as, in the case of any dividend or distribution payable
on or in respect of any class or series of securities issued by
a Restricted
207
Subsidiary other than a Wholly-Owned Subsidiary, the Issuer or a
Restricted Subsidiary receives at least its pro rata share of
such dividend or distribution in accordance with its Equity
Interests in such class or series of securities;
(II) purchase, redeem, defease or otherwise acquire or
retire for value any Equity Interests of the Issuer or any
direct or indirect parent of the Issuer, including in connection
with any merger or consolidation;
(III) make any principal payment on, or redeem, repurchase,
defease or otherwise acquire or retire for value in each case,
prior to any scheduled repayment, sinking fund payment or
maturity, any Subordinated Indebtedness, other than:
(a) Indebtedness permitted under clauses (7) and
(8) of the covenant described under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock; or
(b) the purchase, repurchase or other acquisition of
Subordinated Indebtedness purchased in anticipation of
satisfying a sinking fund obligation, principal installment or
final maturity, in each case due within one year of the date of
purchase, repurchase or acquisition; or
(IV) make any Restricted Investment
(all such payments and other actions set forth in
clauses (I) through (IV) above (other than any
exception thereto) being collectively referred to as
Restricted Payments), unless, at the time of
such Restricted Payment:
(1) no Default shall have occurred and be continuing or
would occur as a consequence thereof;
(2) immediately after giving effect to such transaction on
a pro forma basis, the Issuer could incur $1.00 of additional
Indebtedness under the provisions of the first paragraph of the
covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock; and
(3) such Restricted Payment, together with the aggregate
amount of all other Restricted Payments made by the Issuer and
its Restricted Subsidiaries after November 17, 2006
(including Restricted Payments permitted by clauses (1), (2)
(with respect to the payment of dividends on Refunding Capital
Stock (as defined below) pursuant to clause (b) thereof
only), (6)(c), (9) and (14) of the next succeeding
paragraph, but excluding all other Restricted Payments permitted
by the next succeeding paragraph), is less than the sum of
(without duplication):
(a) 50% of the Consolidated Net Income of the Issuer for
the period (taken as one accounting period) beginning
October 1, 2006, to the end of the Issuers most
recently ended fiscal quarter for which internal financial
statements are available at the time of such Restricted Payment,
or, in the case such Consolidated Net Income for such period is
a deficit, minus 100% of such deficit; plus
(b) 100% of the aggregate net cash proceeds and the fair
market value, as determined in good faith by the Issuer, of
marketable securities or other property received by the Issuer
since immediately after November 17, 2006 (other than net
cash proceeds to the extent such net cash proceeds have been
used to incur Indebtedness, Disqualified Stock or Preferred
Stock pursuant to clause (12)(a) of the second paragraph of
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock) from
the issue or sale of:
(i) (A) Equity Interests of the Issuer, including
Treasury Capital Stock (as defined below), but excluding cash
proceeds and the fair market value, as determined in good faith
by the Issuer, of marketable securities or other property
received from the sale of:
(x) Equity Interests to members of management, directors or
consultants of the Issuer, any direct or indirect parent company
of the Issuer and the Issuers Subsidiaries after
208
November 17, 2006 to the extent such amounts have been
applied to Restricted Payments made in accordance with
clause (4) of the next succeeding paragraph; and
(y) Designated Preferred Stock; and
(B) to the extent such net cash proceeds are actually
contributed to the Issuer, Equity Interests of the Issuers
direct or indirect parent companies (excluding contributions of
the proceeds from the sale of Designated Preferred Stock of such
companies or contributions to the extent such amounts have been
applied to Restricted Payments made in accordance with
clause (4) of the next succeeding paragraph); or
(ii) debt securities of the Issuer that have been converted
into or exchanged for such Equity Interests of the Issuer;
provided, however, that this clause (b) shall
not include the proceeds from (V) Refunding Capital Stock
(as defined below), (W) Equity Interests or convertible
debt securities of the Issuer sold to a Restricted Subsidiary,
as the case may be, (X) Disqualified Stock or debt
securities that have been converted into Disqualified Stock,
(Y) Excluded Contributions or (Z) the Delayed Equity
Amount; plus
(c) 100% of the aggregate amount of cash and the fair
market value, as determined in good faith by the Issuer, of
marketable securities or other property contributed to the
capital of the Issuer following November 17, 2006 (other
than net cash proceeds to the extent such net cash proceeds
(i) have been used to incur Indebtedness, Disqualified
Stock or Preferred Stock pursuant to clause (12)(a) of the
second paragraph of Limitation on Incurrence
of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock, (ii) are contributed by a Restricted
Subsidiary, (iii) constitute Excluded Contributions or
(iv) constitute the Delayed Equity Amount); plus
(d) 100% of the aggregate amount received in cash and the
fair market value, as determined in good faith by the Issuer, of
marketable securities or other property received by means of:
(i) the sale or other disposition (other than to the Issuer
or a Restricted Subsidiary) of Restricted Investments made by
the Issuer or its Restricted Subsidiaries and repurchases and
redemptions of such Restricted Investments from the Issuer or
its Restricted Subsidiaries and repayments of loans or advances,
and releases of guarantees, which constitute Restricted
Investments by the Issuer or its Restricted Subsidiaries, in
each case after November 17, 2006; or
(ii) the sale (other than to the Issuer or a Restricted
Subsidiary) of the stock of an Unrestricted Subsidiary or a
distribution from an Unrestricted Subsidiary (other than in each
case to the extent the Investment in such Unrestricted
Subsidiary was made by the Issuer or a Restricted Subsidiary
pursuant to clause (7) of the next succeeding paragraph or
to the extent such Investment constituted a Permitted
Investment) or a dividend from an Unrestricted Subsidiary after
November 17, 2006; plus
(e) in the case of the redesignation of an Unrestricted
Subsidiary as a Restricted Subsidiary after November 17,
2006, the fair market value of the Investment in such
Unrestricted Subsidiary, as determined by the Issuer in good
faith (or if such fair market value exceeds $250.0 million,
in writing by an Independent Financial Advisor), at the time of
the redesignation of such Unrestricted Subsidiary as a
Restricted Subsidiary other than to the extent the Investment in
such Unrestricted Subsidiary was made by the Issuer or a
Restricted Subsidiary pursuant to clause (7) of the next
succeeding paragraph or to the extent such Investment
constituted a Permitted Investment.
The foregoing provisions will not prohibit:
(1) the payment of any dividend within 60 days after
the date of declaration thereof, if at the date of declaration
such payment would have complied with the provisions of the
Indenture;
209
(2) (a) the redemption, repurchase, retirement or
other acquisition of any Equity Interests (Treasury
Capital Stock) or Subordinated Indebtedness of the
Issuer or any Equity Interests of any direct or indirect parent
company of the Issuer, in exchange for, or out of the proceeds
of the substantially concurrent sale (other than to a Restricted
Subsidiary) of, Equity Interests of the Issuer or any direct or
indirect parent company of the Issuer to the extent contributed
to the Issuer (in each case, other than any Disqualified Stock)
(Refunding Capital Stock) and (b) if
immediately prior to the retirement of Treasury Capital Stock,
the declaration and payment of dividends thereon was permitted
under clause (6) of this paragraph, the declaration and
payment of dividends on the Refunding Capital Stock (other than
Refunding Capital Stock the proceeds of which were used to
redeem, repurchase, retire or otherwise acquire any Equity
Interests of any direct or indirect parent company of the
Issuer) in an aggregate amount per year no greater than the
aggregate amount of dividends per annum that were declarable and
payable on such Treasury Capital Stock immediately prior to such
retirement;
(3) the redemption, repurchase or other acquisition or
retirement of Subordinated Indebtedness of the Issuer or a
Guarantor made in exchange for, or out of the proceeds of the
substantially concurrent sale of, new Indebtedness of the Issuer
or a Guarantor, as the case may be, which is incurred in
compliance with Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock so long as:
(a) the principal amount (or accreted value) of such new
Indebtedness does not exceed the principal amount of (or
accreted value, if applicable), plus any accrued and unpaid
interest on, the Subordinated Indebtedness being so redeemed,
repurchased, acquired or retired for value, plus the amount of
any reasonable premium (including reasonable tender premiums),
defeasance costs and any reasonable fees and expenses incurred
in connection with the issuance of such new Indebtedness;
(b) such new Indebtedness is subordinated to the Notes or
the applicable Guarantee at least to the same extent as such
Subordinated Indebtedness so purchased, exchanged, redeemed,
repurchased, acquired or retired for value;
(c) such new Indebtedness has a final scheduled maturity
date equal to or later than the final scheduled maturity date of
the Subordinated Indebtedness being so redeemed, repurchased,
acquired or retired; and
(d) such new Indebtedness has a Weighted Average Life to
Maturity equal to or greater than the remaining Weighted Average
Life to Maturity of the Subordinated Indebtedness being so
redeemed, repurchased, acquired or retired;
(4) a Restricted Payment to pay for the repurchase,
retirement or other acquisition or retirement for value of
Equity Interests (other than Disqualified Stock) of the Issuer
or any of its direct or indirect parent companies held by any
future, present or former employee, director or consultant of
the Issuer, any of its Subsidiaries or any of its direct or
indirect parent companies pursuant to any management equity plan
or stock option plan or any other management or employee benefit
plan or agreement, including any Equity Interests rolled over by
management of the Company or any of its direct or indirect
parent companies in connection with the Transaction;
provided, however, that the aggregate Restricted
Payments made under this clause (4) do not exceed in any
calendar year $75.0 million (which shall increase to
$150.0 million subsequent to the consummation of an
underwritten public Equity Offering by the Issuer or any direct
or indirect parent entity of the Issuer) (with unused amounts in
any calendar year being carried over to succeeding calendar
years subject to a maximum (without giving effect to the
following proviso) of $225.0 million in any calendar year
(which shall increase to $450.0 million subsequent to the
consummation of an underwritten public Equity Offering by the
Issuer or any direct or indirect parent corporation of the
Issuer)); provided further that such amount in any
calendar year may be increased by an amount not to exceed:
(a) the cash proceeds from the sale of Equity Interests
(other than Disqualified Stock) of the Issuer and, to the extent
contributed to the Issuer, Equity Interests of any of the
Issuers direct or
210
indirect parent companies, in each case to members of
management, directors or consultants of the Issuer, any of its
Subsidiaries or any of its direct or indirect parent companies
that occurs after November 17, 2006, to the extent the cash
proceeds from the sale of such Equity Interests have not
otherwise been applied to the payment of Restricted Payments by
virtue of clause (3) of the preceding paragraph; plus
(b) the cash proceeds of key man life insurance policies
received by the Issuer or its Restricted Subsidiaries after
November 17, 2006; less
(c) the amount of any Restricted Payments previously made
with the cash proceeds described in clauses (a) and
(b) of this clause (4);
and provided, further, that cancellation of
Indebtedness owing to the Issuer or any Restricted Subsidiary
from members of management of the Issuer, any of the
Issuers direct or indirect parent companies or any of the
Issuers Restricted Subsidiaries in connection with a
repurchase of Equity Interests of the Issuer or any of its
direct or indirect parent companies will not be deemed to
constitute a Restricted Payment for purposes of this covenant or
any other provision of the Indenture;
(5) the declaration and payment of dividends to holders of
any class or series of Disqualified Stock of the Issuer or any
of its Restricted Subsidiaries or any class or series of
Preferred Stock of any Restricted Subsidiary issued in
accordance with the covenant described under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock to the
extent such dividends are included in the definition of
Fixed Charges;
(6) (a) the declaration and payment of dividends to
holders of any class or series of Designated Preferred Stock
(other than Disqualified Stock) issued by the Issuer after
November 17, 2006;
(b) the declaration and payment of dividends to a direct or
indirect parent company of the Issuer, the proceeds of which
will be used to fund the payment of dividends to holders of any
class or series of Designated Preferred Stock (other than
Disqualified Stock) of such parent corporation issued after the
Issue Date; provided that the amount of dividends paid
pursuant to this clause (b) shall not exceed the aggregate
amount of cash actually contributed to the Issuer from the sale
of such Designated Preferred Stock; or
(c) the declaration and payment of dividends on Refunding
Capital Stock that is Preferred Stock in excess of the dividends
declarable and payable thereon pursuant to clause (2) of
this paragraph;
provided, however, in the case of each of
(a) and (c) of this clause (6), that for the most
recently ended four full fiscal quarters for which internal
financial statements are available immediately preceding the
date of issuance of such Designated Preferred Stock or the
declaration of such dividends on Refunding Capital Stock that is
Preferred Stock, after giving effect to such issuance or
declaration on a pro forma basis, the Issuer and its Restricted
Subsidiaries on a consolidated basis would have had a Fixed
Charge Coverage Ratio of at least 2.00 to 1.00;
(7) Investments in Unrestricted Subsidiaries having an
aggregate fair market value, taken together with all other
Investments made pursuant to this clause (7) that are at
the time outstanding, without giving effect to the sale of an
Unrestricted Subsidiary to the extent the proceeds of such sale
do not consist of cash or marketable securities, not to exceed
2.5% of Total Assets at the time of such Investment (with the
fair market value of each Investment being measured at the time
made and without giving effect to subsequent changes in value);
(8) repurchases of Equity Interests deemed to occur upon
exercise of stock options or warrants if such Equity Interests
represent a portion of the exercise price of such options or
warrants;
(9) the declaration and payment of dividends on the
Issuers common stock (or the payment of dividends to any
direct or indirect parent entity to fund a payment of dividends
on such entitys common stock), following consummation of
the first public offering of the Issuers common stock or
the common
211
stock of any of its direct or indirect parent companies after
November 17, 2006, of up to 6% per annum of the net cash
proceeds received by or contributed to the Issuer in or from any
such public offering, other than public offerings with respect
to the Issuers common stock registered on
Form S-8
and other than any public sale constituting an Excluded
Contribution;
(10) Restricted Payments that are made with Excluded
Contributions;
(11) other Restricted Payments in an aggregate amount taken
together with all other Restricted Payments made pursuant to
this clause (11) not to exceed 3.0% of Total Assets at the
time made;
(12) distributions or payments of Receivables Fees;
(13) any Restricted Payment used to fund amounts owed to
Affiliates (including dividends to any direct or indirect parent
of the Issuer to permit payment by such parent of such amount),
in each case to the extent permitted by the covenant described
under Transactions with Affiliates;
(14) the repurchase, redemption or other acquisition or
retirement for value of any Subordinated Indebtedness in
accordance with the provisions similar to those described under
the captions Repurchase at the Option of
Holders Change of Control and Repurchase
at the Option of Holders Asset Sales;
provided that all Notes tendered by Holders in connection
with a Change of Control Offer, Collateral Asset Sale Offer or
Asset Sale Offer, as applicable, have been repurchased, redeemed
or acquired for value;
(15) the declaration and payment of dividends by the Issuer
to, or the making of loans to, any direct or indirect parent in
amounts required for any direct or indirect parent companies to
pay, in each case without duplication,
(a) franchise and excise taxes and other fees, taxes and
expenses required to maintain their corporate existence;
(b) foreign, federal, state and local income taxes, to the
extent such income taxes are attributable to the income of the
Issuer and its Restricted Subsidiaries and, to the extent of the
amount actually received from its Unrestricted Subsidiaries, in
amounts required to pay such taxes to the extent attributable to
the income of such Unrestricted Subsidiaries; provided
that in each case the amount of such payments in any fiscal
year does not exceed the amount that the Issuer and its
Restricted Subsidiaries would be required to pay in respect of
foreign, federal, state and local taxes for such fiscal year
were the Issuer, its Restricted Subsidiaries and its
Unrestricted Subsidiaries (to the extent described above) to pay
such taxes separately from any such parent entity;
(c) for as long as Hercules Holding II, LLC is a parent of
the Issuer, distributions equal to any taxable income of
Hercules Holding II, LLC resulting from the Hedging Arrangements
multiplied by 45%;
(d) customary salary, bonus and other benefits payable to
officers and employees of any direct or indirect parent company
of the Issuer to the extent such salaries, bonuses and other
benefits are attributable to the ownership or operation of the
Issuer and its Restricted Subsidiaries;
(e) general corporate operating and overhead costs and
expenses of any direct or indirect parent company of the Issuer
to the extent such costs and expenses are attributable to the
ownership or operation of the Issuer and its Restricted
Subsidiaries; and
(f) fees and expenses other than to Affiliates of the
Issuer related to any unsuccessful equity or debt offering of
such parent entity; and
(16) the distribution, by dividend or otherwise, of shares
of Capital Stock of, or Indebtedness owed to the Issuer or a
Restricted Subsidiary by, Unrestricted Subsidiaries (other than
Unrestricted Subsidiaries, the primary assets of which are cash
and/or Cash
Equivalents);
212
provided, however, that at the time of, and after
giving effect to, any Restricted Payment permitted under
clauses (11) and (16), no Default shall have occurred and
be continuing or would occur as a consequence thereof.
As of the Issue Date, all of the Issuers Subsidiaries are
Restricted Subsidiaries. The Issuer will not permit any
Unrestricted Subsidiary to become a Restricted Subsidiary except
pursuant to the last sentence of the definition of
Unrestricted Subsidiary. For purposes of designating
any Restricted Subsidiary as an Unrestricted Subsidiary, all
outstanding Investments by the Issuer and its Restricted
Subsidiaries (except to the extent repaid) in the Subsidiary so
designated will be deemed to be Restricted Payments in an amount
determined as set forth in the last sentence of the definition
of Investment. Such designation will be permitted
only if a Restricted Payment in such amount would be permitted
at such time, whether pursuant to the first paragraph of this
covenant or under clause (7), (10) or (11) of the
second paragraph of this covenant, or pursuant to the definition
of Permitted Investments, and if such Subsidiary
otherwise meets the definition of an Unrestricted Subsidiary.
Unrestricted Subsidiaries are not subject to any of the
restrictive covenants set forth in the Indenture.
Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly, create, incur, issue,
assume, guarantee or otherwise become directly or indirectly
liable, contingently or otherwise (collectively,
incur and collectively, an
incurrence) with respect to any Indebtedness
(including Acquired Indebtedness), and the Issuer will not issue
any shares of Disqualified Stock and will not permit any
Restricted Subsidiary to issue any shares of Disqualified Stock
or Preferred Stock; provided, however, that the
Issuer may incur Indebtedness (including Acquired Indebtedness)
or issue shares of Disqualified Stock, and any of its Restricted
Subsidiaries may incur Indebtedness (including Acquired
Indebtedness), issue shares of Disqualified Stock and issue
shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
a consolidated basis for the Issuer and its Restricted
Subsidiaries most recently ended four fiscal quarters for
which internal financial statements are available immediately
preceding the date on which such additional Indebtedness is
incurred or such Disqualified Stock or Preferred Stock is issued
would have been at least 2.00 to 1.00, determined on a pro forma
basis (including a pro forma application of the net proceeds
therefrom), as if the additional Indebtedness had been incurred,
or the Disqualified Stock or Preferred Stock had been issued, as
the case may be, and the application of proceeds therefrom had
occurred at the beginning of such four-quarter period;
provided, further, that Restricted Subsidiaries that are
not Guarantors may not incur Indebtedness or Disqualified Stock
or Preferred Stock if, after giving pro forma effect to such
incurrence or issuance (including a pro forma application of the
net proceeds therefrom), more than an aggregate of
$2,000.0 million of Indebtedness or Disqualified Stock or
Preferred Stock of Restricted Subsidiaries that are not
Guarantors would be outstanding pursuant to this paragraph and
clauses (12), (14) and (19) below at such time.
The foregoing limitations will not apply to:
(1) the incurrence of Indebtedness under (x) Credit
Facilities (other than the ABL Facility) by the Issuer or any of
its Restricted Subsidiaries and the issuance and creation of
letters of credit and bankers acceptances thereunder (with
letters of credit and bankers acceptances being deemed to
have a principal amount equal to the face amount thereof), up to
an aggregate principal amount of $16,500.0 million
(including any Indebtedness incurred and represented by the
Notes (including the Guarantees) or any Additional First Lien
Obligations by the Issuer or any Guarantor, the proceeds of
which Notes or Additional First Lien Obligations are used to
repay such Credit Facilities) outstanding at any one time and
(y) the ABL Facility by the Issuer or any of its Restricted
Subsidiaries and the issuance and creation of letters of credit
and bankers acceptances thereunder (with letters of credit
and bankers acceptances being deemed to have a principal
amount equal to the face amount thereof), up to an aggregate
principal amount equal to the ABL Facility Cap;
(2) reserved;
213
(3) Indebtedness of the Issuer and its Restricted
Subsidiaries in existence on the Issue Date (other than
Indebtedness described in clause (1)), including the Existing
Second Priority Notes and the Existing Notes;
(4) Indebtedness consisting of Capitalized Lease
Obligations and Purchase Money Obligations; so long as such
Indebtedness exists at the date of such purchase, lease or
improvement, or is created within 270 days thereafter;
(5) Indebtedness incurred by the Issuer or any of its
Restricted Subsidiaries constituting reimbursement obligations
with respect to letters of credit issued in the ordinary course
of business, including letters of credit in respect of
workers compensation, medical malpractice or employee
health claims, or other Indebtedness with respect to
reimbursement-type obligations regarding workers
compensation, medical malpractice or employee health claims;
provided, however, that upon the drawing of such
letters of credit or the incurrence of such Indebtedness, such
obligations are reimbursed within 30 days following such
drawing or incurrence;
(6) Indebtedness arising from agreements of the Issuer or
its Restricted Subsidiaries providing for indemnification,
adjustment of purchase price or similar obligations, in each
case, incurred or assumed in connection with the disposition of
any business, assets or a Subsidiary, other than guarantees of
Indebtedness incurred by any Person acquiring all or any portion
of such business, assets or a Subsidiary for the purpose of
financing such acquisition; provided, however,
that such Indebtedness is not reflected on the balance sheet of
the Issuer, or any of its Restricted Subsidiaries (contingent
obligations referred to in a footnote to financial statements
and not otherwise reflected on the balance sheet will not be
deemed to be reflected on such balance sheet for purposes of
this clause (6));
(7) Indebtedness of the Issuer to a Restricted Subsidiary;
provided that any such Indebtedness owing to a Restricted
Subsidiary that is not a Guarantor is expressly subordinated in
right of payment to the Notes; provided, further,
that any subsequent issuance or transfer of any Capital Stock or
any other event which results in any Restricted Subsidiary
ceasing to be a Restricted Subsidiary or any other subsequent
transfer of any such Indebtedness (except to the Issuer or
another Restricted Subsidiary) shall be deemed, in each case, to
be an incurrence of such Indebtedness;
(8) Indebtedness of a Restricted Subsidiary to the Issuer
or another Restricted Subsidiary; provided that if a
Guarantor incurs such Indebtedness to a Restricted Subsidiary
that is not a Guarantor, such Indebtedness is expressly
subordinated in right of payment to the Guarantee of the Notes
of such Guarantor; provided, further, that any
subsequent transfer of any such Indebtedness (except to the
Issuer or another Restricted Subsidiary) shall be deemed, in
each case, to be an incurrence of such Indebtedness not
permitted by this clause (8);
(9) shares of Preferred Stock of a Restricted Subsidiary
issued to the Issuer or another Restricted Subsidiary;
provided that any subsequent issuance or transfer of any
Capital Stock or any other event which results in any such
Restricted Subsidiary ceasing to be a Restricted Subsidiary or
any other subsequent transfer of any such shares of Preferred
Stock (except to the Issuer or another of its Restricted
Subsidiaries) shall be deemed in each case to be an issuance of
such shares of Preferred Stock not permitted by this clause (9);
(10) Hedging Obligations (excluding Hedging Obligations
entered into for speculative purposes) for the purpose of
limiting interest rate risk with respect to any Indebtedness
permitted to be incurred pursuant to
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock,
exchange rate risk or commodity pricing risk;
(11) obligations in respect of performance, bid, appeal and
surety bonds and completion guarantees provided by the Issuer or
any of its Restricted Subsidiaries in the ordinary course of
business;
(12) (a) Indebtedness or Disqualified Stock of the
Issuer and Indebtedness, Disqualified Stock or Preferred Stock
of the Issuer or any Restricted Subsidiary equal to 200.0% of
the net cash proceeds received by the Issuer since immediately
after November 17, 2006 from the issue or sale of Equity
214
Interests of the Issuer or cash contributed to the capital of
the Issuer (in each case, other than Excluded Contributions or
proceeds of Disqualified Stock or sales of Equity Interests to
the Issuer or any of its Subsidiaries) as determined in
accordance with clauses (3)(b) and (3)(c) of the first paragraph
of Limitation on Restricted Payments to
the extent such net cash proceeds or cash have not been applied
pursuant to such clauses to make Restricted Payments or to make
other Investments, payments or exchanges pursuant to the second
paragraph of Limitation on Restricted
Payments or to make Permitted Investments (other than
Permitted Investments specified in clauses (1) and
(3) of the definition thereof) and (b) Indebtedness or
Disqualified Stock of Issuer and Indebtedness, Disqualified
Stock or Preferred Stock of the Issuer or any Restricted
Subsidiary not otherwise permitted hereunder in an aggregate
principal amount or liquidation preference, which when
aggregated with the principal amount and liquidation preference
of all other Indebtedness, Disqualified Stock and Preferred
Stock then outstanding and incurred pursuant to this clause
(12)(b), does not at any one time outstanding exceed
$1,500.0 million; provided, however, that on
a pro forma basis, together with any amounts incurred and
outstanding by Restricted Subsidiaries that are not Guarantors
pursuant to the second proviso to the first paragraph of this
covenant and clauses (14) and (19), no more than
$2,000.0 million of Indebtedness, Disqualified Stock or
Preferred Stock at any one time outstanding and incurred
pursuant to this clause (12)(b) shall be incurred by Restricted
Subsidiaries that are not Guarantors (it being understood that
any Indebtedness, Disqualified Stock or Preferred Stock incurred
pursuant to this clause (12)(b) shall cease to be deemed
incurred or outstanding for purposes of this clause (12)(b) but
shall be deemed incurred for the purposes of the first paragraph
of this covenant from and after the first date on which the
Issuer or such Restricted Subsidiary could have incurred such
Indebtedness, Disqualified Stock or Preferred Stock under the
first paragraph of this covenant without reliance on this clause
(12)(b));
(13) the incurrence or issuance by the Issuer or any
Restricted Subsidiary of Indebtedness, Disqualified Stock or
Preferred Stock which serves to refund or refinance any
Indebtedness, Disqualified Stock or Preferred Stock of the
Issuer or any Restricted Subsidiary incurred as permitted under
the first paragraph of this covenant and clauses (3),
(4) and (12)(a) above, this clause (13) and
clause (14) below or any Indebtedness, Disqualified Stock
or Preferred Stock of the Issuer or any Restricted Subsidiary
issued to so refund or refinance such Indebtedness, Disqualified
Stock or Preferred Stock of the Issuer or any Restricted
Subsidiary including additional Indebtedness, Disqualified Stock
or Preferred Stock incurred to pay premiums (including
reasonable tender premiums), defeasance costs and fees in
connection therewith (the Refinancing
Indebtedness) prior to its respective maturity;
provided, however, that such Refinancing
Indebtedness:
(a) has a Weighted Average Life to Maturity at the time
such Refinancing Indebtedness is incurred which is not less than
the remaining Weighted Average Life to Maturity of the
Indebtedness, Disqualified Stock or Preferred Stock being
refunded or refinanced,
(b) to the extent such Refinancing Indebtedness refinances
(i) Indebtedness subordinated or pari passu to the
Notes or any Guarantee thereof, such Refinancing Indebtedness is
subordinated or pari passu to the Notes or the Guarantee
at least to the same extent as the Indebtedness being refinanced
or refunded or (ii) Disqualified Stock or Preferred Stock,
such Refinancing Indebtedness must be Disqualified Stock or
Preferred Stock, respectively, and
(c) shall not include Indebtedness, Disqualified Stock or
Preferred Stock of a Subsidiary of the Issuer that is not a
Guarantor that refinances Indebtedness, Disqualified Stock or
Preferred Stock of the Issuer or a Guarantor;
and, provided, further, that subclause (a) of
this clause (13) will not apply to any refunding or
refinancing of any ABL Obligations and Obligations secured by
Permitted Liens;
(14) Indebtedness, Disqualified Stock or Preferred Stock of
(x) the Issuer or a Restricted Subsidiary incurred to
finance an acquisition or (y) Persons that are acquired by
the Issuer or any Restricted Subsidiary or merged into the
Issuer or a Restricted Subsidiary in accordance with the terms
of the Indenture; provided that after giving effect to
such acquisition or merger, either
215
(a) the Issuer would be permitted to incur at least $1.00
of additional Indebtedness pursuant to the Fixed Charge Coverage
Ratio test set forth in the first sentence of this
covenant, or
(b) the Fixed Charge Coverage Ratio of the Issuer and the
Restricted Subsidiaries is greater than immediately prior to
such acquisition or merger;
provided, however, that on a pro forma basis,
together with amounts incurred and outstanding pursuant to the
second proviso to the first paragraph of this covenant and
clauses (12) and (19), no more than $2,000.0 million
of Indebtedness, Disqualified Stock or Preferred Stock at any
one time outstanding and incurred by Restricted Subsidiaries
that are not Guarantors pursuant to this clause (14) shall
be incurred and outstanding;
(15) Indebtedness arising from the honoring by a bank or
other financial institution of a check, draft or similar
instrument drawn against insufficient funds in the ordinary
course of business; provided that such Indebtedness is
extinguished within two Business Days of its incurrence;
(16) Indebtedness of the Issuer or any of its Restricted
Subsidiaries supported by a letter of credit issued pursuant to
any Credit Facilities, in a principal amount not in excess of
the stated amount of such letter of credit;
(17) (a) any guarantee by the Issuer or a Restricted
Subsidiary of Indebtedness or other obligations of any
Restricted Subsidiary, so long as the incurrence of such
Indebtedness incurred by such Restricted Subsidiary is permitted
under the terms of the Indenture, or (b) any guarantee by a
Restricted Subsidiary of Indebtedness of the Issuer; provided
that such guarantee is incurred in accordance with the
covenant described below under Limitation on
Guarantees of Indebtedness by Restricted Subsidiaries;
(18) Indebtedness of Foreign Subsidiaries of the Issuer in
an amount not to exceed at any one time outstanding and together
with any other Indebtedness incurred under this clause (18)
7.5% of the Total Assets of the Foreign Subsidiaries (it being
understood that any Indebtedness incurred pursuant to this
clause (18) shall cease to be deemed incurred or
outstanding for purposes of this clause (18) but shall be
deemed incurred for the purposes of the first paragraph of this
covenant from and after the first date on which the Issuer or
such Restricted Subsidiaries could have incurred such
Indebtedness under the first paragraph of this covenant without
reliance on this clause (18));
(19) Indebtedness, Disqualified Stock or Preferred Stock of
a Restricted Subsidiary incurred to finance or assumed in
connection with an acquisition in a principal amount not to
exceed $200.0 million in the aggregate at any one time
outstanding together with all other Indebtedness, Disqualified
Stock and/or
Preferred Stock issued under this clause (19) (it being
understood that any Indebtedness, Disqualified Stock or
Preferred Stock incurred pursuant to this clause (19) shall
cease to be deemed incurred or outstanding for purposes of this
clause (19) but shall be deemed incurred for the purposes
of the first paragraph of this covenant from and after the first
date on which such Restricted Subsidiary could have incurred
such Indebtedness, Disqualified Stock or Preferred Stock under
the first paragraph of this covenant without reliance on this
clause (19)); provided, however, that on a pro
forma basis, together with amounts incurred and outstanding by
Restricted Subsidiaries that are not Guarantors pursuant to the
second proviso to the first paragraph of this covenant and
clauses (12) and (14), no more than $2,000.0 million
of Indebtedness would be incurred and outstanding by Restricted
Subsidiaries that are not Guarantors;
(20) Indebtedness of the Issuer or any of its Restricted
Subsidiaries consisting of (i) the financing of insurance
premiums or
(ii) take-or-pay
obligations contained in supply arrangements, in each case,
incurred in the ordinary course of business;
(21) Indebtedness consisting of Indebtedness issued by the
Issuer or any of its Restricted Subsidiaries to current or
former officers, directors and employees thereof, their
respective estates, spouses or former spouses, in each case to
finance the purchase or redemption of Equity Interests of the
Issuer or any direct or indirect parent company of the Issuer to
the extent described in clause (4) of the second paragraph
under the caption Limitation on Restricted
Payments;
216
(22) Physician Support Obligations incurred by the Issuer
or any Restricted Subsidiary; and
(23) Indebtedness of the Issuer or any of its Restricted
Subsidiaries undertaken in connection with cash management and
related activities with respect to any Subsidiary or joint
venture operating one or more health care facilities, including,
without limitation, hospitals, ambulatory surgery centers,
outpatient diagnostic centers or imaging centers, in each case,
in the ordinary course of business.
For purposes of determining compliance with this covenant:
(1) in the event that an item of Indebtedness, Disqualified
Stock or Preferred Stock (or any portion thereof) meets the
criteria of more than one of the categories of permitted
Indebtedness, Disqualified Stock or Preferred Stock described in
clauses (1) through (23) above or is entitled to be
incurred pursuant to the first paragraph of this covenant, the
Issuer, in its sole discretion, will classify or reclassify such
item of Indebtedness, Disqualified Stock or Preferred Stock (or
any portion thereof) and will only be required to include the
amount and type of such Indebtedness, Disqualified Stock or
Preferred Stock in one of the above clauses; provided
that all Indebtedness outstanding under the Credit
Facilities on November 17, 2006 will be treated as incurred
on November 17, 2006 under clause (1) of the preceding
paragraph; and
(2) at the time of incurrence, the Issuer will be entitled
to divide and classify an item of Indebtedness in more than one
of the types of Indebtedness described in the first and second
paragraphs above.
Accrual of interest, the accretion of accreted value and the
payment of interest in the form of additional Indebtedness,
Disqualified Stock or Preferred Stock will not be deemed to be
an incurrence of Indebtedness, Disqualified Stock or Preferred
Stock for purposes of this covenant.
For purposes of determining compliance with any
U.S. dollar-denominated restriction on the incurrence of
Indebtedness, the U.S. dollar-equivalent principal amount
of Indebtedness denominated in a foreign currency shall be
calculated based on the relevant currency exchange rate in
effect on the date such Indebtedness was incurred, in the case
of term debt, or first committed, in the case of revolving
credit debt; provided that if such Indebtedness is
incurred to refinance other Indebtedness denominated in a
foreign currency, and such refinancing would cause the
applicable U.S. dollar-denominated restriction to be
exceeded if calculated at the relevant currency exchange rate in
effect on the date of such refinancing, such
U.S. dollar-denominated restriction shall be deemed not to
have been exceeded so long as the principal amount of such
refinancing Indebtedness does not exceed the principal amount of
such Indebtedness being refinanced.
The principal amount of any Indebtedness incurred to refinance
other Indebtedness, if incurred in a different currency from the
Indebtedness being refinanced, shall be calculated based on the
currency exchange rate applicable to the currencies in which
such respective Indebtedness is denominated that is in effect on
the date of such refinancing.
The Indenture provides that the Issuer will not, and will not
permit any Guarantor to, directly or indirectly, incur any
Indebtedness (including Acquired Indebtedness) that is
subordinated or junior in right of payment to any Indebtedness
of the Issuer or such Guarantor, as the case may be, unless such
Indebtedness is expressly subordinated in right of payment to
the Notes or such Guarantors Guarantee to the extent and
in the same manner as such Indebtedness is subordinated to other
Indebtedness of the Issuer or such Guarantor, as the case may be.
The Indenture does not treat (1) unsecured Indebtedness as
subordinated or junior to Secured Indebtedness merely because it
is unsecured or (2) Senior Indebtedness as subordinated or
junior to any other Senior Indebtedness merely because it has a
junior priority with respect to the same collateral.
217
Limitation
on Prepayment or Modification of Existing Notes
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, directly or indirectly purchase, redeem,
defease or otherwise acquire or retire for value any of the
Existing Notes prior to the final maturity date thereof (as in
effect on the Issue Date); provided that the Issuer may:
(1) purchase, redeem, defease or otherwise acquire or
retire for value any of the Existing Notes which have a final
maturity date (as in effect on the Issue Date) on or prior to
December 31, 2011; and
(2) purchase, redeem, defease or otherwise acquire or
retire for value any other Existing Notes which have a final
maturity date (as in effect on the Issue Date) on or prior to
the maturity date of the Notes; provided that, in the
case of any such prepayment funded with the proceeds of the
issuance of Secured Indebtedness, at the time of incurrence and
after giving pro forma effect thereto and to the application of
the proceeds thereof, (x) the Consolidated Secured Debt
Ratio would be no greater than 5.25 to 1.0 and (y) the
Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, amend the Existing Notes Indenture, or any
supplemental indenture in respect thereof, in any way to advance
the final maturity date or shorten the Weighted Average Life to
Maturity of any series of the Existing Notes such that any
Existing Notes with a maturity date following the maturity of
the Notes would have a maturity date on or prior to the date one
year following the maturity date of the Notes or which would
prohibit the making of the Guarantees or the creation of Liens
in favor of the Notes and the Guarantees on the Collateral.
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, designate any additional subsidiaries as
Restricted Subsidiaries (as defined in the Existing
Notes Indenture) for purposes of the Existing Notes Indenture.
Liens
The Issuer will not, and will not permit any Guarantor to,
directly or indirectly, create, incur, assume or suffer to exist
any Lien (except Permitted Liens) that secures obligations under
any Indebtedness or any related Guarantee, on any asset or
property of the Issuer or any Guarantor, or any income or
profits therefrom, or assign or convey any right to receive
income therefrom, other than Liens securing Indebtedness that
are junior in priority to the Liens on such property, assets or
proceeds securing the Notes and related Guarantees.
The foregoing shall not apply to (a) Liens securing the
Notes and the related Guarantees, (b) Liens securing
Indebtedness permitted to be incurred under Credit Facilities,
including any letter of credit relating thereto, that was
permitted by the terms of the Indenture to be incurred pursuant
to clause (1) of the second paragraph under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock;
provided that, with respect to Liens securing Obligations
permitted under this subclause (b), the Notes and the related
Guarantees are secured by Liens on the assets subject to such
Liens (except any European Collateral) to the extent, with the
priority and subject to intercreditor arrangements, in each case
no less favorable to the Holders of the Notes than those
described under Security above and (c) Liens
which are pari passu in priority to the Liens securing
the Notes and related Guarantees and are incurred to secure
Obligations in respect of any Indebtedness permitted to be
incurred pursuant to the covenant described above under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock;
provided that, with respect to Liens securing Obligations
permitted under this subclause (c), at the time of incurrence
and after giving pro forma effect thereto, the ratio of
(1) the aggregate amount of Indebtedness secured by
property, assets or proceeds that secure the Notes and related
Guarantees that are subject to a Lien that is pari passu
or senior in priority to the Liens securing the Notes and
the related Guarantees incurred pursuant to subclause (b)
above, this subclause (c) and clause (6) of the
definition of Permitted Liens (other than Liens
securing Indebtedness incurred pursuant to clauses (4) and
(18) of the covenant described above under
Limitation on Incurrence of Indebtedness and
Issuance of Disqualified Stock and Preferred Stock) to
(2) the Issuers EBITDA for the most recently ended
four full fiscal quarters for which internal financial
statements are available immediately preceding the date on which
such event for which such calculation is being made shall occur,
in each case with such pro forma adjustments to Indebtedness and
EBITDA as are
218
appropriate and consistent with the pro forma adjustment
provisions set forth in the definition of Fixed Charge Coverage
Ratio would be no greater than 4.25 to 1.0; provided
that, with respect to Liens securing Obligations permitted
under this subclause (c), the Notes and the related Guarantees
are secured by Liens on the assets subject to such Liens (except
any European Collateral) to the extent, with the priority and
subject to intercreditor arrangements, in each case no less
favorable to the Holders of the Notes than those described under
Security above.
Merger,
Consolidation or Sale of All or Substantially All
Assets
The Issuer may not consolidate or merge with or into or wind up
into (whether or not the Issuer is the surviving corporation),
or sell, assign, transfer, lease, convey or otherwise dispose of
all or substantially all of its properties or assets, in one or
more related transactions, to any Person unless:
(1) the Issuer is the surviving corporation or the Person
formed by or surviving any such consolidation or merger (if
other than the Issuer) or to which such sale, assignment,
transfer, lease, conveyance or other disposition will have been
made is a corporation organized or existing under the laws of
the jurisdiction of organization of the Issuer or the laws of
the United States, any state thereof, the District of Columbia,
or any territory thereof (such Person, as the case may be, being
herein called the Successor Company);
(2) the Successor Company, if other than the Issuer,
expressly assumes all the obligations of the Issuer under the
Notes and the Security Documents pursuant to supplemental
indentures or other documents or instruments in form reasonably
satisfactory to the Trustee;
(3) immediately after such transaction, no Default exists;
(4) immediately after giving pro forma effect to such
transaction and any related financing transactions, as if such
transactions had occurred at the beginning of the applicable
four-quarter period,
(a) the Successor Company would be permitted to incur at
least $1.00 of additional Indebtedness pursuant to the Fixed
Charge Coverage Ratio test set forth in the first sentence of
the covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock, or
(b) the Fixed Charge Coverage Ratio for the Successor
Company, the Issuer and its Restricted Subsidiaries would be
greater than such ratio for the Issuer and its Restricted
Subsidiaries immediately prior to such transaction;
(5) each Guarantor, unless it is the other party to the
transactions described above, in which case clause (b) of
the second succeeding paragraph shall apply, shall have by
supplemental indenture confirmed that its Guarantee shall apply
to such Persons obligations under the Indenture, the Notes
and the Registration Rights Agreement;
(6) the Collateral owned by the Successor Company will
(a) continue to constitute Collateral under the Indenture
and the Security Documents, (b) be subject to a Lien in
favor of the Junior Lien Collateral Agent for the benefit of the
Trustee and the Holders of the Notes and (c) not be subject
to any other Lien, other than Permitted Liens;
(7) to the extent any assets of the Person which is merged
or consolidated with or into the Successor Company are assets of
the type which would constitute Collateral under the Security
Documents, the Successor Company will take such action as may be
reasonably necessary to cause such property and assets to be
made subject to the Lien of the Security Documents in the manner
and to the extent required in the Indenture or any of the
Security Documents and shall take all reasonably necessary
action so that such Lien is perfected to the extent required by
the Security Documents; and
(8) the Issuer shall have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel, each
stating that such consolidation, merger or transfer and such
supplemental indentures, if any, comply with the Indenture and,
if a supplemental indenture or any supplement to any Security
Document is
219
required in connection with such transaction, such supplement
shall comply with the applicable provisions of the Indenture.
The Successor Company will succeed to, and be substituted for
the Issuer, as the case may be, under the Indenture, the
Guarantees and the Notes, as applicable. Notwithstanding the
foregoing clauses (3) and (4),
(1) any Restricted Subsidiary may consolidate with or merge
into or transfer all or part of its properties and assets to the
Issuer, and
(2) the Issuer may merge with an Affiliate of the Issuer,
as the case may be, solely for the purpose of reincorporating
the Issuer in a State of the United States or any state thereof,
the District of Columbia or any territory thereof so long as the
amount of Indebtedness of the Issuer and its Restricted
Subsidiaries is not increased thereby.
Subject to certain limitations described in the Indenture
governing release of a Guarantee upon the sale, disposition or
transfer of a Guarantor, no Guarantor will, and the Issuer will
not permit any Guarantor to, consolidate or merge with or into
or wind up into (whether or not the Issuer or Guarantor is the
surviving corporation), or sell, assign, transfer, lease, convey
or otherwise dispose of all or substantially all of its
properties or assets, in one or more related transactions, to
any Person unless:
(1) (a) such Guarantor is the surviving corporation or
the Person formed by or surviving any such consolidation or
merger (if other than such Guarantor) or to which such sale,
assignment, transfer, lease, conveyance or other disposition
will have been made is a corporation, partnership, limited
partnership, limited liability corporation or trust organized or
existing under the laws of the jurisdiction of organization of
such Guarantor, as the case may be, or the laws of the United
States, any state thereof, the District of Columbia, or any
territory thereof (such Guarantor or such Person, as the case
may be, being herein called the Successor
Person);
(b) the Successor Person, if other than such Guarantor,
expressly assumes all the obligations of such Guarantor under
the Indenture and such Guarantors related Guarantee
pursuant to supplemental indentures or other documents or
instruments in form reasonably satisfactory to the Trustee;
(c) immediately after such transaction, no Default
exists; and
(d) the Issuer shall have delivered to the Trustee an
Officers Certificate, each stating that such
consolidation, merger or transfer and such supplemental
indentures, if any, comply with the Indenture; or
(2) the transaction is made in compliance with the covenant
described under Repurchase at the Option of
Holders Asset Sales.
Subject to certain limitations described in the Indenture, the
Successor Person will succeed to, and be substituted for, such
Guarantor under the Indenture and such Guarantors
Guarantee. Notwithstanding the foregoing, any Guarantor may
(i) merge into or transfer all or part of its properties
and assets to another Guarantor or the Issuer, (ii) merge
with an Affiliate of the Company solely for the purpose of
reincorporating the Guarantor in the United States, any state
thereof, the District of Columbia or any territory thereof or
(iii) convert into a corporation, partnership, limited
partnership, limited liability corporation or trust organized or
existing under the laws of the jurisdiction of organization of
such Guarantor.
Transactions
with Affiliates
The Issuer will not, and will not permit any of its Restricted
Subsidiaries to, make any payment to, or sell, lease, transfer
or otherwise dispose of any of its properties or assets to, or
purchase any property or assets from, or enter into or make or
amend any transaction, contract, agreement, understanding, loan,
advance or guarantee with, or for the benefit of, any Affiliate
of the Issuer (each of the foregoing, an Affiliate
Transaction) involving aggregate payments or
consideration in excess of $40.0 million, unless:
(1) such Affiliate Transaction is on terms that are not
materially less favorable to the Issuer or its relevant
Restricted Subsidiary than those that would have been obtained
in a comparable transaction by the Issuer or such Restricted
Subsidiary with an unrelated Person on an arms-length
basis; and
220
(2) the Issuer delivers to the Trustee with respect to any
Affiliate Transaction or series of related Affiliate
Transactions involving aggregate payments or consideration in
excess of $80.0 million, a resolution adopted by the
majority of the board of directors of the Issuer approving such
Affiliate Transaction and set forth in an Officers
Certificate certifying that such Affiliate Transaction complies
with clause (1) above.
The foregoing provisions will not apply to the following:
(1) transactions between or among the Issuer or any of its
Restricted Subsidiaries;
(2) Restricted Payments permitted by the provisions of the
Indenture described above under the covenant
Limitation on Restricted Payments and
the definition of Permitted Investments;
(3) the payment of management, consulting, monitoring and
advisory fees and related expenses to the Investors and the
Frist Entities pursuant to the Sponsor Management Agreement
(plus any unpaid management, consulting, monitoring and advisory
fees and related expenses accrued in any prior year) and the
termination fees pursuant to the Sponsor Management Agreement,
in each case as in effect on the Issue Date, or any amendment
thereto (so long as any such amendment is not disadvantageous in
the good faith judgment of the board of directors of the Issuer
to the Holders when taken as a whole as compared to the Sponsor
Management Agreement in effect on the Issue Date);
(4) the payment of reasonable and customary fees paid to,
and indemnities provided for the benefit of, officers,
directors, employees or consultants of Issuer, any of its direct
or indirect parent companies or any of its Restricted
Subsidiaries;
(5) transactions in which the Issuer or any of its
Restricted Subsidiaries, as the case may be, delivers to the
Trustee a letter from an Independent Financial Advisor stating
that such transaction is fair to the Issuer or such Restricted
Subsidiary from a financial point of view or stating that the
terms are not materially less favorable to the Issuer or its
relevant Restricted Subsidiary than those that would have been
obtained in a comparable transaction by the Issuer or such
Restricted Subsidiary with an unrelated Person on an
arms-length basis;
(6) any agreement as in effect as of the Issue Date, or any
amendment thereto (so long as any such amendment is not
disadvantageous to the Holders when taken as a whole as compared
to the applicable agreement as in effect on the Issue Date);
(7) the existence of, or the performance by the Issuer or
any of its Restricted Subsidiaries of its obligations under the
terms of, any stockholders agreement (including any registration
rights agreement or purchase agreement related thereto) to which
it is a party as of the Issue Date and any similar agreements
which it may enter into thereafter; provided, however, that the
existence of, or the performance by the Issuer or any of its
Restricted Subsidiaries of obligations under any future
amendment to any such existing agreement or under any similar
agreement entered into after the Issue Date shall only be
permitted by this clause (7) to the extent that the terms
of any such amendment or new agreement are not otherwise
disadvantageous to the Holders when taken as a whole;
(8) reserved;
(9) transactions with customers, clients, suppliers, or
purchasers or sellers of goods or services, in each case in the
ordinary course of business and otherwise in compliance with the
terms of the Indenture which are fair to the Issuer and its
Restricted Subsidiaries, in the reasonable determination of the
board of directors of the Issuer or the senior management
thereof, or are on terms at least as favorable as might
reasonably have been obtained at such time from an unaffiliated
party;
(10) the issuance of Equity Interests (other than
Disqualified Stock) of the Issuer to any Permitted Holder or to
any director, officer, employee or consultant;
(11) sales of accounts receivable, or participations
therein, in connection with the ABL Facility and any Receivables
Facility;
221
(12) payments by the Issuer or any of its Restricted
Subsidiaries to any of the Investors made for any financial
advisory, financing, underwriting or placement services or in
respect of other investment banking activities, including,
without limitation, in connection with acquisitions or
divestitures, which payments are approved by a majority of the
board of directors of the Issuer in good faith;
(13) payments or loans (or cancellation of loans) to
employees or consultants of the Issuer, any of its direct or
indirect parent companies or any of its Restricted Subsidiaries
and employment agreements, stock option plans and other similar
arrangements with such employees or consultants which, in each
case, are approved by the Issuer in good faith;
(14) investments by the Investors or the Frist Entities in
securities of the Issuer or any of its Restricted Subsidiaries
so long as (i) the investment is being offered generally to
other investors on the same or more favorable terms and
(ii) the investment constitutes less than 5% of the
proposed or outstanding issue amount of such class of securities;
(15) payments to or from, and transactions with, any joint
venture owning or operating one or more health care facilities,
including, without limitation, hospitals, ambulatory surgery
centers, outpatient diagnostic centers or imaging centers, in
each case in the ordinary course of business (including, without
limitation, any cash management activities related
thereto); and
(16) payments by the Issuer (and any direct or indirect
parent thereof) and its Subsidiaries pursuant to tax sharing
agreements among the Issuer (and any such parent) and its
Subsidiaries on customary terms to the extent attributable to
the ownership or operation of the Issuer and its Subsidiaries;
provided that in each case the amount of such payments in any
fiscal year does not exceed the amount that the Issuer, its
Restricted Subsidiaries and its Unrestricted Subsidiaries (to
the extent of amounts received from Unrestricted Subsidiaries)
would be required to pay in respect of foreign, federal, state
and local taxes for such fiscal year were the Issuer and its
Restricted Subsidiaries (to the extent described above) to pay
such taxes separately from any such parent entity.
Dividend
and Other Payment Restrictions Affecting Restricted
Subsidiaries
The Issuer will not, and will not permit any of its Restricted
Subsidiaries that are not Guarantors to, directly or indirectly,
create or otherwise cause or suffer to exist or become effective
any consensual encumbrance or consensual restriction on the
ability of any such Restricted Subsidiary to:
(1) (a) pay dividends or make any other distributions
to the Issuer or any of its Restricted Subsidiaries on its
Capital Stock or with respect to any other interest or
participation in, or measured by, its profits, or
(b) pay any Indebtedness owed to the Issuer or any of its
Restricted Subsidiaries;
(2) make loans or advances to the Issuer or any of its
Restricted Subsidiaries; or
(3) sell, lease or transfer any of its properties or assets
to the Issuer or any of its Restricted Subsidiaries,
except (in each case) for such encumbrances or restrictions
existing under or by reason of:
(a) contractual encumbrances or restrictions in effect on
the Issue Date, including pursuant to the Senior Credit
Facilities and the related documentation, the Existing Notes
Indenture and the related documentation and the Existing Second
Priority Notes Indentures and the related documentation;
(b) the Indenture and the Notes;
(c) purchase money obligations for property acquired in the
ordinary course of business that impose restrictions of the
nature discussed in clause (3) above on the property so
acquired;
(d) applicable law or any applicable rule, regulation or
order;
222
(e) any agreement or other instrument of a Person acquired
by the Issuer or any Restricted Subsidiary in existence at the
time of such acquisition (but not created in contemplation
thereof), which encumbrance or restriction is not applicable to
any Person, or the properties or assets of any Person, other
than the Person and its Subsidiaries, or the property or assets
of the Person and its Subsidiaries, so acquired;
(f) contracts for the sale of assets, including customary
restrictions with respect to a Subsidiary of the Issuer pursuant
to an agreement that has been entered into for the sale or
disposition of all or substantially all of the Capital Stock or
assets of such Subsidiary;
(g) Secured Indebtedness that limits the right of the
debtor to dispose of the assets securing such Indebtedness that
is otherwise permitted to be incurred pursuant to the covenants
described under Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock and Liens;
(h) restrictions on cash or other deposits or net worth
imposed by customers under contracts entered into in the
ordinary course of business;
(i) other Indebtedness, Disqualified Stock or Preferred
Stock of Foreign Subsidiaries permitted to be incurred
subsequent to the Issue Date pursuant to the provisions of the
covenant described under Limitation on
Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock;
(j) customary provisions in joint venture agreements and
other agreements or arrangements relating solely to such joint
venture;
(k) customary provisions contained in leases or licenses of
intellectual property and other agreements, in each case entered
into in the ordinary course of business;
(l) any encumbrances or restrictions of the type referred
to in clauses (1), (2) and (3) above imposed by any
amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacements or refinancings of the
contracts, instruments or obligations referred to in
clauses (a) through (k) above; provided that
such amendments, modifications, restatements, renewals,
increases, supplements, refundings, replacements or refinancings
are, in the good faith judgment of the Issuer, no more
restrictive with respect to such encumbrance and other
restrictions taken as a whole than those prior to such
amendment, modification, restatement, renewal, increase,
supplement, refunding, replacement or refinancing; and
(m) restrictions created in connection with any Receivables
Facility that, in the good faith determination of the Issuer,
are necessary or advisable to effect the transactions
contemplated under such Receivables Facility.
Limitation
on Guarantees of Indebtedness by Restricted
Subsidiaries
The Issuer will not permit any of its Wholly-Owned Subsidiaries
that are Restricted Subsidiaries (and non-Wholly-Owned
Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
other capital markets debt securities of the Issuer or any
Guarantor), other than a Guarantor, a Foreign Subsidiary or a
Receivables Subsidiary, to guarantee the payment of any
Indebtedness of the Issuer or any other Guarantor unless:
(1) such Restricted Subsidiary within 30 days executes
and delivers a supplemental indenture to the Indenture providing
for a Guarantee by such Restricted Subsidiary, except that with
respect to a guarantee of Indebtedness of the Issuer or any
Guarantor:
(a) if the Notes or such Guarantors Guarantee is
subordinated in right of payment to such Indebtedness, the
Guarantee under the supplemental indenture shall be subordinated
to such Restricted Subsidiarys guarantee with respect to
such Indebtedness substantially to the same extent as the Notes
are subordinated to such Indebtedness; and
(b) if such Indebtedness is by its express terms
subordinated in right of payment to the Notes or such
Guarantors Guarantee, any such guarantee by such
Restricted Subsidiary with respect to
223
such Indebtedness shall be subordinated in right of payment to
such Guarantee substantially to the same extent as such
Indebtedness is subordinated to the Notes; and
(2) such Restricted Subsidiary waives, and will not in any
manner whatsoever claim or take the benefit or advantage of, any
rights of reimbursement, indemnity or subrogation or any other
rights against the Issuer or any other Restricted Subsidiary as
a result of any payment by such Restricted Subsidiary under its
Guarantee;
provided that this covenant shall not be applicable to
(i) any guarantee of any Restricted Subsidiary that existed
at the time such Person became a Restricted Subsidiary and was
not incurred in connection with, or in contemplation of, such
Person becoming a Restricted Subsidiary and (ii) guarantees
of the ABL Facility by the ABL Financing Entities or of any
Receivables Facility by any Receivables Subsidiary.
Reports
and Other Information
Notwithstanding that the Issuer may not be subject to the
reporting requirements of Section 13 or 15(d) of the
Exchange Act or otherwise report on an annual and quarterly
basis on forms provided for such annual and quarterly reporting
pursuant to rules and regulations promulgated by the SEC, the
Indenture requires the Issuer to file with the SEC (and make
available to the Trustee and Holders of the Notes (without
exhibits), without cost to any Holder, within 15 days after
it files them with the SEC) from and after the Issue Date,
(1) within 90 days (or any other time period then in
effect under the rules and regulations of the Exchange Act with
respect to the filing of a
Form 10-K
by a non-accelerated filer) after the end of each fiscal year,
annual reports on
Form 10-K,
or any successor or comparable form, containing the information
required to be contained therein, or required in such successor
or comparable form;
(2) within 45 days after the end of each of the first
three fiscal quarters of each fiscal year, reports on
Form 10-Q
containing all quarterly information that would be required to
be contained in
Form 10-Q,
or any successor or comparable form;
(3) promptly from time to time after the occurrence of an
event required to be therein reported, such other reports on
Form 8-K,
or any successor or comparable form; and
(4) any other information, documents and other reports
which the Issuer would be required to file with the SEC if it
were subject to Section 13 or 15(d) of the Exchange Act;
in each case in a manner that complies in all material respects
with the requirements specified in such form; provided
that the Issuer shall not be so obligated to file such
reports with the SEC if the SEC does not permit such filing, in
which event the Issuer will make available such information to
prospective purchasers of Notes, in addition to providing such
information to the Trustee and the Holders of the Notes, in each
case within 15 days after the time the Issuer would be
required to file such information with the SEC if it were
subject to Section 13 or 15(d) of the Exchange Act. In
addition, to the extent not satisfied by the foregoing, the
Issuer has agreed that, for so long as any Notes are
outstanding, it will furnish to Holders and to securities
analysts and prospective investors, upon their request, the
information required to be delivered pursuant to
Rule 144A(d)(4) under the Securities Act.
In the event that any direct or indirect parent company of the
Issuer becomes a Guarantor of the Notes, the Indenture permits
the Issuer to satisfy its obligations in this covenant with
respect to financial information relating to the Issuer by
furnishing financial information relating to such parent;
provided that the same is accompanied by consolidating
information that explains in reasonable detail the differences
between the information relating to such parent, on the one
hand, and the information relating to the Issuer and its
Restricted Subsidiaries on a standalone basis, on the other hand.
Notwithstanding the foregoing, such requirements shall be deemed
satisfied prior to the commencement of the exchange offer or the
effectiveness of the shelf registration statement described in
the Registration Rights Agreement (1) by the filing with
the SEC of the exchange offer registration statement or shelf
registration statement (or any other similar registration
statement), and any amendments thereto, with such financial
information that satisfies
Regulation S-X,
subject to exceptions consistent with the presentation of
224
financial information in the Offering Memorandum, to the extent
filed within the times specified above, or (2) by posting
reports that would be required to be filed substantially in the
form required by the SEC on the Companys website (or that
of any of its parent companies) or providing such reports to the
Trustee within 15 days after the time the Issuer would be
required to file such information with the SEC if it were
subject to Section 13 or 15(d) of the Exchange Act, the
financial information (including a Managements
Discussion and Analysis of Financial Condition and Results of
Operations section) that would be required to be included
in such reports, subject to exceptions consistent with the
presentation of financial information in the Offering
Memorandum, to the extent filed within the times specified above.
Events
of Default and Remedies
The Indenture provides that each of the following is an
Event of Default:
(1) default in payment when due and payable, upon
redemption, acceleration or otherwise, of principal of, or
premium, if any, on the Notes;
(2) default for 30 days or more in the payment when
due of interest or Additional Interest on or with respect to the
Notes;
(3) failure by the Issuer or any Guarantor for 60 days
after receipt of written notice given by the Trustee or the
Holders of not less than 30% in principal amount of the Notes to
comply with any of its obligations, covenants or agreements
(other than a default referred to in clauses (1) and
(2) above) contained in the Indenture or the Notes;
(4) default under any mortgage, indenture or instrument
under which there is issued or by which there is secured or
evidenced any Indebtedness for money borrowed by the Issuer or
any of its Restricted Subsidiaries or the payment of which is
guaranteed by the Issuer or any of its Restricted Subsidiaries,
other than Indebtedness owed to the Issuer or a Restricted
Subsidiary, whether such Indebtedness or guarantee now exists or
is created after the issuance of the Notes, if both:
(a) such default either results from the failure to pay any
principal of such Indebtedness at its stated final maturity
(after giving effect to any applicable grace periods) or relates
to an obligation other than the obligation to pay principal of
any such Indebtedness at its stated final maturity and results
in the holder or holders of such Indebtedness causing such
Indebtedness to become due prior to its stated maturity; and
(b) the principal amount of such Indebtedness, together
with the principal amount of any other such Indebtedness in
default for failure to pay principal at stated final maturity
(after giving effect to any applicable grace periods), or the
maturity of which has been so accelerated, aggregate
$200.0 million or more at any one time outstanding;
(5) failure by the Issuer or any Significant Subsidiary to
pay final judgments aggregating in excess of
$200.0 million, which final judgments remain unpaid,
undischarged and unstayed for a period of more than 60 days
after such judgment becomes final, and in the event such
judgment is covered by insurance, an enforcement proceeding has
been commenced by any creditor upon such judgment or decree
which is not promptly stayed;
(6) certain events of bankruptcy or insolvency with respect
to the Issuer or any Significant Subsidiary;
(7) the Guarantee of any Significant Subsidiary shall for
any reason cease to be in full force and effect or be declared
null and void or any responsible officer of any Guarantor that
is a Significant Subsidiary, as the case may be, denies that it
has any further liability under its Guarantee or gives notice to
such effect, other than by reason of the termination of the
Indenture or the release of any such Guarantee in accordance
with the Indenture; or
(8) with respect to any Collateral having a fair market
value in excess of $200 million, individually or in the
aggregate, (a) the security interest under the Security
Documents, at any time, ceases to be in
225
full force and effect for any reason other than in accordance
with the terms of the Indenture, the Security Documents and the
Intercreditor Agreements, (b) any security interest created
thereunder or under the Indenture is declared invalid or
unenforceable by a court of competent jurisdiction or
(c) the Issuer or any Guarantor asserts, in any pleading in
any court of competent jurisdiction, that any such security
interest is invalid or unenforceable.
If any Event of Default (other than of a type specified in
clause (6) above) occurs and is continuing under the
Indenture, the Trustee or the Holders of at least 30% in
principal amount of the then total outstanding Notes may declare
the principal, premium, if any, interest and any other monetary
obligations on all the then outstanding Notes to be due and
payable immediately.
Upon the effectiveness of such declaration, such principal and
interest will be due and payable immediately. Notwithstanding
the foregoing, in the case of an Event of Default arising under
clause (6) of the first paragraph of this section, all
outstanding Notes will become due and payable without further
action or notice. The Indenture provides that the Trustee may
withhold from the Holders notice of any continuing Default,
except a Default relating to the payment of principal, premium,
if any, or interest, if it determines that withholding notice is
in their interest. In addition, the Trustee shall have no
obligation to accelerate the Notes if in the best judgment of
the Trustee acceleration is not in the best interest of the
Holders of the Notes.
The Indenture provides that the Holders of a majority in
aggregate principal amount of the then outstanding Notes by
notice to the Trustee may on behalf of the Holders of all of the
Notes waive any existing Default and its consequences under the
Indenture except a continuing Default in the payment of interest
on, premium, if any, or the principal of any Note held by a
non-consenting Holder. In the event of any Event of Default
specified in clause (4) above, such Event of Default and
all consequences thereof (excluding any resulting payment
default, other than as a result of acceleration of the Notes)
shall be annulled, waived and rescinded, automatically and
without any action by the Trustee or the Holders, if within
20 days after such Event of Default arose:
(1) the Indebtedness or guarantee that is the basis for
such Event of Default has been discharged; or
(2) holders thereof have rescinded or waived the
acceleration, notice or action (as the case may be) giving rise
to such Event of Default; or
(3) the default that is the basis for such Event of Default
has been cured.
Subject to the provisions of the Indenture relating to the
duties of the Trustee thereunder, in case an Event of Default
occurs and is continuing, the Trustee is under no obligation to
exercise any of the rights or powers under the Indenture at the
request or direction of any of the Holders of the Notes unless
the Holders have offered to the Trustee indemnity or security
reasonably satisfactory to it against any loss, liability or
expense. Except to enforce the right to receive payment of
principal, premium, if any, or interest when due, no Holder of a
Note may pursue any remedy with respect to the Indenture or the
Notes unless:
(1) such Holder has previously given the Trustee notice
that an Event of Default is continuing;
(2) Holders of at least 30% in principal amount of the
total outstanding Notes have requested the Trustee to pursue the
remedy;
(3) Holders of the Notes have offered the Trustee
reasonable security or indemnity against any loss, liability or
expense;
(4) the Trustee has not complied with such request within
60 days after the receipt thereof and the offer of security
or indemnity; and
(5) Holders of a majority in principal amount of the total
outstanding Notes have not given the Trustee a direction
inconsistent with such request within such
60-day
period.
Subject to certain restrictions, under the Indenture the Holders
of a majority in principal amount of the total outstanding Notes
are given the right to direct the time, method and place of
conducting any proceeding for any remedy available to the
Trustee or of exercising any trust or power conferred on the
Trustee. The
226
Trustee, however, may refuse to follow any direction that
conflicts with law or the Indenture or that the Trustee
determines is unduly prejudicial to the rights of any other
Holder of a Note or that would involve the Trustee in personal
liability.
The Indenture provides that the Issuer is required to deliver to
the Trustee annually a statement regarding compliance with the
Indenture, and the Issuer is required, within five Business
Days, upon becoming aware of any Default, to deliver to the
Trustee a statement specifying such Default.
No
Personal Liability of Directors, Officers, Employees and
Stockholders
No director, officer, employee, incorporator or stockholder of
the Issuer or any Guarantor or any of their parent companies
(other than the Issuer and the Guarantors) shall have any
liability for any obligations of the Issuer or the Guarantors
under the Notes, the Guarantees or the Indenture or for any
claim based on, in respect of, or by reason of such obligations
or their creation. Each Holder by accepting the Notes waives and
releases all such liability. The waiver and release are part of
the consideration for issuance of the Notes. Such waiver may not
be effective to waive liabilities under the federal securities
laws, and it is the view of the SEC that such a waiver is
against public policy.
Legal
Defeasance and Covenant Defeasance
The obligations of the Issuer and the Guarantors under the
Indenture will terminate (other than certain obligations) and
will be released upon payment in full of all of the Notes. The
Issuer may, at its option and at any time, elect to have all of
its obligations discharged with respect to the Notes and have
the Issuers and each Guarantors obligation
discharged with respect to its Guarantee (Legal
Defeasance) and cure all then existing Events of
Default except for:
(1) the rights of Holders of the Notes to receive payments
in respect of the principal of, premium, if any, and interest on
the Notes when such payments are due solely out of the trust
created pursuant to the Indenture;
(2) the Issuers obligations with respect to Notes
concerning issuing temporary Notes, registration of such Notes,
mutilated, destroyed, lost or stolen Notes and the maintenance
of an office or agency for payment and money for security
payments held in trust;
(3) the rights, powers, trusts, duties and immunities of
the Trustee, and the Issuers obligations in connection
therewith; and
(4) the Legal Defeasance provisions of the Indenture.
In addition, the Issuer may, at its option and at any time,
elect to have its obligations and those of each Guarantor
released with respect to certain covenants that are described in
the Indenture (Covenant Defeasance) and
thereafter any omission to comply with such obligations shall
not constitute a Default with respect to the Notes. In the event
Covenant Defeasance occurs, certain events (not including
bankruptcy, receivership, rehabilitation and insolvency events
pertaining to the Issuer) described under Events of
Default and Remedies will no longer constitute an Event of
Default with respect to the Notes.
In order to exercise either Legal Defeasance or Covenant
Defeasance with respect to the Notes:
(1) the Issuer must irrevocably deposit with the Trustee,
in trust, for the benefit of the Holders of the Notes, cash in
U.S. dollars, Government Securities, or a combination
thereof, in such amounts as will be sufficient, in the opinion
of a nationally recognized firm of independent public
accountants, to pay the principal of, premium, if any, and
interest due on the Notes on the stated maturity date or on the
redemption date, as the case may be, of such principal, premium,
if any, or interest on such Notes, and the Issuer must specify
whether such Notes are being defeased to maturity or to a
particular redemption date;
227
(2) in the case of Legal Defeasance, the Issuer shall have
delivered to the Trustee an Opinion of Counsel reasonably
acceptable to the Trustee confirming that, subject to customary
assumptions and exclusions,
(a) the Issuer has received from, or there has been
published by, the United States Internal Revenue Service a
ruling, or
(b) since the issuance of the Notes, there has been a
change in the applicable U.S. federal income tax law,
in either case to the effect that, and based thereon such
Opinion of Counsel shall confirm that, subject to customary
assumptions and exclusions, the Holders of the Notes will not
recognize income, gain or loss for U.S. federal income tax
purposes, as applicable, as a result of such Legal Defeasance
and will be subject to U.S. federal income tax on the same
amounts, in the same manner and at the same times as would have
been the case if such Legal Defeasance had not occurred;
(3) in the case of Covenant Defeasance, the Issuer shall
have delivered to the Trustee an Opinion of Counsel reasonably
acceptable to the Trustee confirming that, subject to customary
assumptions and exclusions, the Holders of the Notes will not
recognize income, gain or loss for U.S. federal income tax
purposes as a result of such Covenant Defeasance and will be
subject to such tax on the same amounts, in the same manner and
at the same times as would have been the case if such Covenant
Defeasance had not occurred;
(4) no Default (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith) shall have
occurred and be continuing on the date of such deposit;
(5) such Legal Defeasance or Covenant Defeasance shall not
result in a breach or violation of, or constitute a default
under the Senior Credit Facilities or any other material
agreement or instrument (other than the Indenture) to which the
Issuer or any Guarantor is a party or by which the Issuer or any
Guarantor is bound (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith);
(6) the Issuer shall have delivered to the Trustee an
Opinion of Counsel to the effect that, as of the date of such
opinion and subject to customary assumptions and exclusions
following the deposit, the trust funds will not be subject to
the effect of Section 547 of Title 11 of the United
States Code;
(7) the Issuer shall have delivered to the Trustee an
Officers Certificate stating that the deposit was not made
by the Issuer with the intent of defeating, hindering, delaying
or defrauding any creditors of the Issuer or any Guarantor or
others; and
(8) the Issuer shall have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel (which
Opinion of Counsel may be subject to customary assumptions and
exclusions) each stating that all conditions precedent provided
for or relating to the Legal Defeasance or the Covenant
Defeasance, as the case may be, have been complied with.
Satisfaction
and Discharge
The Indenture will be discharged and will cease to be of further
effect as to all Notes, when either:
(1) all Notes theretofore authenticated and delivered,
except lost, stolen or destroyed Notes which have been replaced
or paid and Notes for whose payment money has theretofore been
deposited in trust, have been delivered to the Trustee for
cancellation; or
(2) (a) all Notes not theretofore delivered to the
Trustee for cancellation have become due and payable by reason
of the making of a notice of redemption or otherwise, will
become due and payable within one year or may be called for
redemption within one year under arrangements satisfactory to
the Trustee for the giving of notice of redemption by the
Trustee in the name, and at the expense, of the
228
Issuer, and the Issuer or any Guarantor has irrevocably
deposited or caused to be deposited with the Trustee as trust
funds in trust solely for the benefit of the Holders of the
Notes, cash in U.S. dollars, Government Securities, or a
combination thereof, in such amounts as will be sufficient
without consideration of any reinvestment of interest to pay and
discharge the entire indebtedness on the Notes not theretofore
delivered to the Trustee for cancellation for principal,
premium, if any, and accrued interest to the date of maturity or
redemption;
(b) no Default (other than that resulting from borrowing
funds to be applied to make such deposit and any similar and
simultaneous deposit relating to other Indebtedness and, in each
case, the granting of Liens in connection therewith) with
respect to the Indenture or the Notes shall have occurred and be
continuing on the date of such deposit or shall occur as a
result of such deposit, and such deposit will not result in a
breach or violation of, or constitute a default under, the
Senior Credit Facilities or any other material agreement or
instrument (other than the Indenture) to which the Issuer or any
Guarantor is a party or by which the Issuer or any Guarantor is
bound (other than that resulting from borrowing funds to be
applied to make such deposit and any similar and simultaneous
deposit relating to other Indebtedness and, in each case, the
granting of Liens in connection therewith);
(c) the Issuer has paid or caused to be paid all sums
payable by it under the Indenture; and
(d) the Issuer has delivered irrevocable instructions to
the Trustee to apply the deposited money toward the payment of
the Notes at maturity or the redemption date, as the case may be.
In addition, the Issuer must deliver an Officers
Certificate and an Opinion of Counsel to the Trustee stating
that all conditions precedent to satisfaction and discharge have
been satisfied.
Amendment,
Supplement and Waiver
Except as provided in the next two succeeding paragraphs, the
Indenture, any Guarantee, any Security Document and the Notes
may be amended or supplemented with the consent of the Holders
of at least a majority in principal amount of the Notes then
outstanding, including consents obtained in connection with a
purchase of, or tender offer or exchange offer for, Notes, and
any existing Default or compliance with any provision of the
Indenture, the Notes issued thereunder, any Guarantee or the
Security Documents may be waived with the consent of the Holders
of a majority in principal amount of the then outstanding Notes,
other than Notes beneficially owned by the Issuer or its
Affiliates (including consents obtained in connection with a
purchase of or tender offer or exchange offer for the Notes).
The Indenture provides that, without the consent of each
affected Holder of Notes, an amendment or waiver may not, with
respect to any Notes held by a non-consenting Holder:
(1) reduce the principal amount of such Notes whose Holders
must consent to an amendment, supplement or waiver;
(2) reduce the principal of or change the fixed final
maturity of any such Note or alter or waive the provisions with
respect to the redemption of such Notes (other than provisions
relating to the covenants described above under the caption
Repurchase at the Option of Holders);
(3) reduce the rate of or change the time for payment of
interest on any Note;
(4) waive a Default in the payment of principal of or
premium, if any, or interest on the Notes, except a rescission
of acceleration of the Notes by the Holders of at least a
majority in aggregate principal amount of the Notes and a waiver
of the payment default that resulted from such acceleration, or
in respect of a covenant or provision contained in the Indenture
or any Guarantee which cannot be amended or modified without the
consent of all Holders;
(5) make any Note payable in money other than that stated
therein;
(6) make any change in the provisions of the Indenture
relating to waivers of past Defaults or the rights of Holders to
receive payments of principal of or premium, if any, or interest
on the Notes;
229
(7) make any change in these amendment and waiver
provisions;
(8) impair the right of any Holder to receive payment of
principal of, or interest on such Holders Notes on or
after the due dates therefor or to institute suit for the
enforcement of any payment on or with respect to such
Holders Notes;
(9) make any change to or modify the ranking of the Notes
or the subordination of the Liens with respect to the Notes that
would adversely affect the Holders; or
(10) except as expressly permitted by the Indenture, modify
the Guarantees of any Significant Subsidiary in any manner
adverse to the Holders of the Notes.
In addition, without the consent of at least 75% in aggregate
principal amount of Notes then outstanding, an amendment,
supplement or waiver may not:
(1) modify any Security Document or the provisions of the
Indenture dealing with the Security Documents or application of
trust moneys, or otherwise release any Collateral, in any manner
materially adverse to the Holders other than in accordance with
the Indenture, the Security Documents and the Intercreditor
Agreements; or
(2) modify any Intercreditor Agreement in any manner
materially adverse to the Holders other than in accordance with
the Indenture, the Security Documents and the Intercreditor
Agreements.
Notwithstanding the foregoing, the Issuer, any Guarantor (with
respect to a Guarantee or the Indenture to which it is a party)
and the Trustee may amend or supplement the Indenture, any
Security Document and any Guarantee or Notes without the consent
of any Holder;
(1) to cure any ambiguity, omission, mistake, defect or
inconsistency;
(2) to provide for uncertificated Notes of such series in
addition to or in place of certificated Notes;
(3) to comply with the covenant relating to mergers,
consolidations and sales of assets;
(4) to provide for the assumption of the Issuers or
any Guarantors obligations to the Holders;
(5) to make any change that would provide any additional
rights or benefits to the Holders or that does not adversely
affect the legal rights under the Indenture of any such Holder;
(6) to add covenants for the benefit of the Holders or to
surrender any right or power conferred upon the Issuer or any
Guarantor;
(7) to comply with requirements of the SEC in order to
effect or maintain the qualification of the Indenture under the
Trust Indenture Act;
(8) to evidence and provide for the acceptance and
appointment under the Indenture of a successor Trustee
thereunder pursuant to the requirements thereof;
(9) to provide for the issuance of Exchange Notes or
private exchange notes, which are identical to Exchange Notes
except that they are not freely transferable;
(10) to add a Guarantor under the Indenture;
(11) to conform the text of the Indenture, Security
Documents, Guarantees or the Notes to any provision of this
Description of Notes to the extent that such
provision in this Description of Notes was intended
to be a verbatim recitation of a provision of the Indenture,
Security Documents, Guarantee or Notes;
(12) to make any amendment to the provisions of the
Indenture relating to the transfer and legending of Notes as
permitted by the Indenture, including, without limitation to
facilitate the issuance and administration of the Notes;
provided, however, that (i) compliance with
the Indenture as so amended would not result in Notes being
transferred in violation of the Securities Act or any applicable
securities
230
law and (ii) such amendment does not materially and
adversely affect the rights of Holders to transfer Notes;
(13) to mortgage, pledge, hypothecate or grant any other
Lien in favor of the Trustee for the benefit of the Holders of
the Notes, as additional security for the payment and
performance of all or any portion of the Obligations, in any
property or assets, including any which are required to be
mortgaged, pledged or hypothecated, or in which a Lien is
required to be granted to or for the benefit of the Trustee or
the Collateral Agent pursuant to the Indenture, any of the
Security Documents or otherwise;
(14) to release Collateral from the Lien of the Indenture
and the Security Documents when permitted or required by the
Security Documents or the Indenture; or
(15) to add Additional First Lien Secured Parties or
additional ABL Secured Parties, to any Security Documents.
The consent of the Holders is not necessary under the Indenture
to approve the particular form of any proposed amendment. It is
sufficient if such consent approves the substance of the
proposed amendment.
Notices
Notices given by publication will be deemed given on the first
date on which publication is made and notices given by
first-class mail, postage prepaid, will be deemed given five
calendar days after mailing.
Concerning
the Trustee
The Indenture contains certain limitations on the rights of the
Trustee thereunder, should it become a creditor of the Issuer,
to obtain payment of claims in certain cases, or to realize on
certain property received in respect of any such claim as
security or otherwise. The Trustee is permitted to engage in
other transactions; however, if it acquires any conflicting
interest it must eliminate such conflict within 90 days,
apply to the SEC for permission to continue or resign.
The Indenture provides that the Holders of a majority in
principal amount of the outstanding Notes will have the right to
direct the time, method and place of conducting any proceeding
for exercising any remedy available to the Trustee, subject to
certain exceptions. The Indenture provides that in case an Event
of Default shall occur (which shall not be cured), the Trustee
will be required, in the exercise of its power, to use the
degree of care of a prudent person in the conduct of his own
affairs. Subject to such provisions, the Trustee is under no
obligation to exercise any of its rights or powers under the
Indenture at the request of any Holder of the Notes, unless such
Holder shall have offered to the Trustee security and indemnity
satisfactory to it against any loss, liability or expense.
Governing
Law
The Indenture, the Notes and any Guarantee are governed by and
construed in accordance with the laws of the State of New York.
Certain
Definitions
Set forth below are certain defined terms used in the Indenture.
For purposes of the Indenture, unless otherwise specifically
indicated, the term consolidated with respect
to any Person refers to such Person on a consolidated basis in
accordance with GAAP, but excluding from such consolidation any
Unrestricted Subsidiary as if such Unrestricted Subsidiary were
not an Affiliate of such Person.
2006 Second Priority Notes means the
$1,000,000,000 aggregate principal amount of
91/8% Senior
Secured Notes due 2014, the $3,200,000,000 aggregate principal
amount of
91/4% Senior
Secured Notes due 2016 and the $1,500,000,000
95/8%/103/8% Senior
Secured Toggle Notes due 2016, each issued by the Issuer under
the 2006 Second Priority Notes Indenture.
231
2006 Second Priority Notes Indenture means
that certain Indenture, dated as of November 17, 2006,
among the Issuer, the guarantors named on Schedule I
thereto and The Bank of New York, as trustee.
2009 Second Priority Notes means the
$310,000,000 aggregate principal amount of
97/8% Senior
Secured Notes due 2017, issued by the Issuer under the 2009
Second Priority Notes Indenture.
2009 Second Priority Notes Indenture means
that certain Indenture, dated as of February 19, 2009,
among the Issuer, the guarantors named on Schedule I
thereto, The Bank of New York Mellon Trust Company, N.A.,
as trustee, and The Bank of New York Mellon, as collateral agent.
ABL Facility means the Amended and Restated
Asset-Based Revolving Credit Agreement, dated as of
June 20, 2007, by and among the Issuer, the lenders party
thereto in their capacities as lenders thereunder and Bank of
America, N.A., as Administrative Agent, as amended as of
March 2, 2009, including any guarantees, collateral
documents, instruments and agreements executed in connection
therewith, and any amendments, supplements, modifications,
extensions, renewals, restatements, refundings or refinancings
thereof and any indentures or credit facilities or commercial
paper facilities with banks or other institutional lenders or
investors that replace, refund or refinance any part of the
loans, notes, other credit facilities or commitments thereunder,
including any such replacement, refunding or refinancing
facility or indenture that increases the amount borrowable
thereunder or alters the maturity thereof (provided that
such increase in borrowings is permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock
above).
ABL Facility Cap means an amount equal to the
greater of (x) $2,000.0 million and (y) 75% of
the consolidated accounts receivable of the Issuer and its
subsidiaries determined in accordance with GAAP.
ABL Financing Entity means the Issuer and
certain of its subsidiaries from time to time named as borrowers
or guarantors under the ABL Facility.
ABL Obligations means Obligations under the
ABL Facility.
ABL Secured Parties means each of
(i) the ABL Collateral Agent on behalf of itself and the
lenders under the ABL Facility and lenders or their affiliates
counterparty to related Hedging Obligations and (ii) each
other holder of ABL Obligations.
Acquired Indebtedness means, with respect to
any specified Person,
(1) Indebtedness of any other Person existing at the time
such other Person is merged with or into or became a Restricted
Subsidiary of such specified Person, including Indebtedness
incurred in connection with, or in contemplation of, such other
Person merging with or into or becoming a Restricted Subsidiary
of such specified Person, and
(2) Indebtedness secured by a Lien encumbering any asset
acquired by such specified Person.
Additional First Lien Obligations shall have
the meaning given such term by the U.S. Security Agreement
and shall include the Notes Obligations.
Additional First Lien Secured Party means the
holders of any Additional First Lien Obligations, including the
Holders, and any Authorized Representative with respect thereto,
including the Trustee.
Additional General Intercreditor Agreement
has the meaning set forth under Security
Additional General Intercreditor Agreement.
Additional Interest means all additional
interest then owing pursuant to the Registration Rights
Agreement.
Additional Receivables Intercreditor Agreement
has the meaning set forth under Security
Additional Receivables Intercreditor Agreement.
Affiliate of any specified Person means any
other Person directly or indirectly controlling or controlled by
or under direct or indirect common control with such specified
Person. For purposes of this definition, control
(including, with correlative meanings, the terms
controlling, controlled by and
under common
232
control with), as used with respect to any Person, shall
mean the possession, directly or indirectly, of the power to
direct or cause the direction of the management or policies of
such Person, whether through the ownership of voting securities,
by agreement or otherwise.
Applicable Authorized Representative means,
with respect to any Common Collateral, (i) until the
earlier of (x) the Discharge of General Credit Facility
Obligations and (y) the Non-Controlling Authorized
Representative Enforcement Date, the administrative agent under
the General Credit Facility and (ii) from and after the
earlier of (x) the Discharge of General Credit Facility
Obligations and (y) the Non-Controlling Authorized
Representative Enforcement Date, the Major Non-Controlling
Authorized Representative.
Applicable Premium means, with respect to any
Note on any Redemption Date, the greater of:
(1) 1.0% of the principal amount of such Note; and
(2) the excess, if any, of (a) the present value at
such Redemption Date of (i) the redemption price of
such Note at April 15, 2014 (such redemption price being
set forth in the tables appearing above under the caption
Optional Redemption), plus (ii) all required
interest payments due on such Note through April 15, 2014
(excluding accrued but unpaid interest to the
Redemption Date), computed using a discount rate equal to
the Treasury Rate as of such Redemption Date plus
50 basis points; over (b) the principal amount of such
Note.
Asset Sale means:
(1) the sale, conveyance, transfer or other disposition,
whether in a single transaction or a series of related
transactions, of property or assets (including by way of a Sale
and Lease-Back Transaction) of the Issuer or any of its
Restricted Subsidiaries (each referred to in this definition as
a disposition); or
(2) the issuance or sale of Equity Interests of any
Restricted Subsidiary, whether in a single transaction or a
series of related transactions (other than Preferred Stock of
Restricted Subsidiaries issued in compliance with the covenant
described under Certain Covenants Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock);
in each case, other than:
(a) any disposition of Cash Equivalents or Investment Grade
Securities or obsolete or worn out equipment in the ordinary
course of business or any disposition of inventory or goods (or
other assets) held for sale in the ordinary course of business;
(b) the disposition of all or substantially all of the
assets of the Issuer in a manner permitted pursuant to the
provisions described above under Certain
Covenants Merger, Consolidation or Sale of All or
Substantially All Assets or any disposition that
constitutes a Change of Control pursuant to the Indenture;
(c) the making of any Restricted Payment or Permitted
Investment that is permitted to be made, and is made, under the
covenant described above under Certain
Covenants Limitation on Restricted Payments;
(d) any disposition of assets or issuance or sale of Equity
Interests of any Restricted Subsidiary in any transaction or
series of related transactions with an aggregate fair market
value of less than $100.0 million;
(e) any disposition of property or assets or issuance of
securities by a Restricted Subsidiary of the Issuer to the
Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
to another Restricted Subsidiary of the Issuer;
(f) to the extent allowable under Section 1031 of the
Code or any comparable or successor provision, any exchange of
like property (excluding any boot thereon) for use in a Similar
Business;
(g) the lease, assignment or
sub-lease of
any real or personal property in the ordinary course of business;
233
(h) any issuance or sale of Equity Interests in, or
Indebtedness or other securities of, an Unrestricted Subsidiary;
(i) foreclosures on assets;
(j) sales of accounts receivable, or participations
therein, in connection with the ABL Facility or any Receivables
Facility;
(k) any financing transaction with respect to property
built or acquired by the Issuer or any Restricted Subsidiary
after November 17, 2006, including Sale and Lease-Back
Transactions and asset securitizations permitted by the
Indenture;
(l) dispositions in the ordinary course of business by any
Restricted Subsidiary (including, without limitation, HCI)
engaged in the insurance business in order to provide insurance
to the Issuer and its Subsidiaries;
(m) sales, transfers and other dispositions of Investments
in joint ventures to the extent required by, or made pursuant
to, customary buy/sell arrangements between the joint venture
parties set forth in joint venture arrangements and similar
binding arrangements;
(n) any issuance or sale of Equity Interests or
dispositions in connection with ordinary course syndications of
Subsidiaries or joint ventures owning or operating one or more
health care facilities, including, without limitation,
hospitals, ambulatory surgery centers, outpatient diagnostic
centers or imaging centers in any transaction or series of
related transactions with an aggregate fair market value of less
than $100.0 million; and
(o) any issuance or sale of Equity Interests of any
Restricted Subsidiary (including, without limitation,
HealthTrust Purchasing Group, L.P.) to any Person operating in a
Similar Business for which such Restricted Subsidiary provides
shared purchasing, billing, collection or similar services in
the ordinary course of business.
Asset Sale Offer has the meaning set forth in
the fourth paragraph under Repurchase at the Option of
Holders Asset Sales.
Authorized Representative means (i) in
the case of any General Credit Facility Obligations or the
General Credit Facility Secured Parties, the administrative
agent under the General Credit Facility, (ii) in the case
of the Notes Obligations or the Holders, the Trustee and
(iii) in the case of any Series of Additional First Lien
Obligations or Additional First Lien Secured Parties that become
subject to the First Lien Intercreditor Agreement, the
Authorized Representative named for such Series in the
applicable joinder agreement.
Bankruptcy Code means Title 11 of the
United States Code, as amended.
Bankruptcy Law means the Bankruptcy Code and
any similar federal, state or foreign law for the relief of
debtors.
Business Day means each day which is not a
Legal Holiday.
Capital Stock means:
(1) in the case of a corporation, corporate stock;
(2) in the case of an association or business entity, any
and all shares, interests, participations, rights or other
equivalents (however designated) of corporate stock;
(3) in the case of a partnership or limited liability
company, partnership or membership interests (whether general or
limited); and
(4) any other interest or participation that confers on a
Person the right to receive a share of the profits and losses
of, or distributions of assets of, the issuing Person.
234
Capitalized Lease Obligation means, at the
time any determination thereof is to be made, the amount of the
liability in respect of a capital lease that would at such time
be required to be capitalized and reflected as a liability on a
balance sheet (excluding the footnotes thereto) in accordance
with GAAP.
Capitalized Software Expenditures means, for
any period, the aggregate of all expenditures (whether paid in
cash or accrued as liabilities) by a Person and its Restricted
Subsidiaries during such period in respect of purchased software
or internally developed software and software enhancements that,
in conformity with GAAP, are or are required to be reflected as
capitalized costs on the consolidated balance sheet of a Person
and its Restricted Subsidiaries.
Cash Equivalents means:
(1) United States dollars;
(2) euros or any national currency of any participating
member state of the EMU or such local currencies held by the
Company and its Restricted Subsidiaries from time to time in the
ordinary course of business;
(3) securities issued or directly and fully and
unconditionally guaranteed or insured by the
U.S. government (or any agency or instrumentality thereof
the securities of which are unconditionally guaranteed as a full
faith and credit obligation of the U.S. government) with
maturities of 24 months or less from the date of
acquisition;
(4) certificates of deposit, time deposits and eurodollar
time deposits with maturities of one year or less from the date
of acquisition, bankers acceptances with maturities not
exceeding one year and overnight bank deposits, in each case
with any commercial bank having capital and surplus of not less
than $500.0 million in the case of U.S. banks and
$100.0 million (or the U.S. dollar equivalent as of
the date of determination) in the case of
non-U.S. banks;
(5) repurchase obligations for underlying securities of the
types described in clauses (3) and (4) entered into
with any financial institution meeting the qualifications
specified in clause (4) above;
(6) commercial paper rated at least
P-1 by
Moodys or at least
A-1 by
S&P and in each case maturing within 24 months after
the date of creation thereof;
(7) marketable short-term money market and similar
securities having a rating of at least
P-2 or
A-2 from
either Moodys or S&P, respectively (or, if at any
time neither Moodys nor S&P shall be rating such
obligations, an equivalent rating from another Rating Agency)
and in each case maturing within 24 months after the date
of creation thereof;
(8) investment funds investing 95% of their assets in
securities of the types described in clauses (1) through
(7) above;
(9) readily marketable direct obligations issued by any
state, commonwealth or territory of the United States or any
political subdivision or taxing authority thereof having an
Investment Grade Rating from either Moodys or S&P
with maturities of 24 months or less from the date of
acquisition;
(10) Indebtedness or Preferred Stock issued by Persons with
a rating of A or higher from S&P or A2 or higher from
Moodys with maturities of 24 months or less from the
date of acquisition; and
(11) Investments with average maturities of 24 months
or less from the date of acquisition in money market funds rated
AAA- (or the equivalent thereof) or better by S&P or Aaa3
(or the equivalent thereof) or better by Moodys.
Notwithstanding the foregoing, Cash Equivalents shall include
amounts denominated in currencies other than those set forth in
clauses (1) and (2) above; provided that such
amounts are converted into any currency listed in
clauses (1) and (2) as promptly as practicable and in
any event within ten Business Days following the receipt of such
amounts.
235
Change of Control means the occurrence of any
of the following:
(1) the sale, lease or transfer, in one or a series of
related transactions, of all or substantially all of the assets
of the Issuer and its Subsidiaries, taken as a whole, to any
Person other than a Permitted Holder; or
(2) the Issuer becomes aware (by way of a report or any
other filing pursuant to Section 13(d) of the Exchange Act,
proxy, vote, written notice or otherwise) of the acquisition by
any Person or group (within the meaning of Section 13(d)(3)
or Section 14(d)(2) of the Exchange Act, or any successor
provision), including any group acting for the purpose of
acquiring, holding or disposing of securities (within the
meaning of
Rule 13d-5(b)(1)
under the Exchange Act), other than the Permitted Holders, in a
single transaction or in a related series of transactions, by
way of merger, consolidation or other business combination or
purchase of beneficial ownership (within the meaning of
Rule 13d-3
under the Exchange Act, or any successor provision) of 50% or
more of the total voting power of the Voting Stock of the Issuer
or any of its direct or indirect parent companies holding
directly or indirectly 100% of the total voting power of the
Voting Stock of the Issuer.
Code means the Internal Revenue Code of 1986,
as amended, or any successor thereto.
Collateral means, collectively, the Shared
Receivables Collateral and Non-Receivables Collateral.
Collateral Asset Sale Offer has the meaning
set forth in the third paragraph under Repurchase at the
Option of Holders Asset Sales.
Collateral Excess Proceeds has the meaning
set forth in the third paragraph under Repurchase at the
Option of Holders Asset Sales.
Common Collateral means, at any time,
Collateral in which the holders of two or more Series of First
Lien Obligations (or their respective Authorized
Representatives) hold a valid and perfected security interest at
such time. If more than two Series of First Lien Obligations are
outstanding at any time and the holders of less than all Series
of First Lien Obligations hold a valid and perfected security
interest in any Collateral at such time then such Collateral
shall constitute Common Collateral for those Series of First
Lien Obligations that hold a valid security interest in such
Collateral at such time and shall not constitute Common
Collateral for any Series which does not have a valid and
perfected security interest in such Collateral at such time.
Consolidated Depreciation and Amortization
Expense means with respect to any Person for any
period, the total amount of depreciation and amortization
expense, including the amortization of deferred financing fees,
debt issuance costs, commissions, fees and expenses and
Capitalized Software Expenditures, of such Person and its
Restricted Subsidiaries for such period on a consolidated basis
and otherwise determined in accordance with GAAP.
Consolidated Interest Expense means, with
respect to any Person for any period, without duplication, the
sum of:
(1) consolidated interest expense of such Person and its
Restricted Subsidiaries for such period, to the extent such
expense was deducted (and not added back) in computing
Consolidated Net Income (including (a) amortization of
original issue discount resulting from the issuance of
Indebtedness at less than par, (b) all commissions,
discounts and other fees and charges owed with respect to
letters of credit or bankers acceptances,
(c) non-cash interest payments (but excluding any non-cash
interest expense attributable to the movement in the mark to
market valuation of Hedging Obligations or other derivative
instruments pursuant to GAAP), (d) the interest component
of Capitalized Lease Obligations, and (e) net payments, if
any, pursuant to interest rate Hedging Obligations with respect
to Indebtedness, and excluding (u) accretion or accrual of
discounted liabilities not constituting Indebtedness,
(v) any expense resulting from the discounting of the
Existing Notes or other Indebtedness in connection with the
application of recapitalization accounting or, if applicable,
purchase accounting, (w) any Additional Interest and any
comparable additional interest with respect to other
securities, (x) amortization of deferred financing fees,
debt issuance costs, commissions, fees and expenses,
(y) any expensing of bridge,
236
commitment and other financing fees and (z) commissions,
discounts, yield and other fees and charges (including any
interest expense) related to any Receivables Facility); plus
(2) consolidated capitalized interest of such Person and
its Restricted Subsidiaries for such period, whether paid or
accrued; less
(3) interest income for such period.
For purposes of this definition, interest on a Capitalized Lease
Obligation shall be deemed to accrue at an interest rate
reasonably determined by such Person to be the rate of interest
implicit in such Capitalized Lease Obligation in accordance with
GAAP.
Consolidated Leverage Ratio, with respect to
any Person as of any date of determination, means the ratio of
(x) Consolidated Total Indebtedness of such Person as of
the end of the most recent fiscal quarter for which internal
financial statements are available immediately preceding the
date on which such event for which such calculation is being
made shall occur to (y) the aggregate amount of EBITDA of
such Person for the period of the most recently ended four full
consecutive fiscal quarters for which internal financial
statements are available immediately preceding the date on which
such event for which such calculation is being made shall occur,
in each case with such pro forma adjustments to Consolidated
Total Indebtedness and EBITDA as are appropriate and consistent
with the pro forma adjustment provisions set forth in the
definition of Fixed Charge Coverage Ratio.
Consolidated Net Income means, with respect
to any Person for any period, the aggregate of the Net Income of
such Person for such period, on a consolidated basis, and
otherwise determined in accordance with GAAP; provided,
however, that, without duplication,
(1) any after-tax effect of extraordinary, non-recurring or
unusual gains or losses (less all fees and expenses relating
thereto) or expenses, severance, relocation costs, consolidation
and closing costs, integration and facilities opening costs,
business optimization costs, transition costs, restructuring
costs, signing, retention or completion bonuses, and
curtailments or modifications to pension and post-retirement
employee benefit plans shall be excluded,
(2) the cumulative effect of a change in accounting
principles during such period shall be excluded,
(3) any after-tax effect of income (loss) from disposed,
abandoned or discontinued operations and any net after-tax gains
or losses on disposal of disposed, abandoned, transferred,
closed or discontinued operations shall be excluded,
(4) any after-tax effect of gains or losses (less all fees
and expenses relating thereto) attributable to asset
dispositions or abandonments other than in the ordinary course
of business, as determined in good faith by the Issuer, shall be
excluded,
(5) the Net Income for such period of any Person that is an
Unrestricted Subsidiary shall be excluded, and, solely for the
purpose of determining the amount available for Restricted
Payments under clause 3(a) of the first paragraph of
Certain Covenants Limitation on Restricted
Payments, the Net Income for such period of any Person
that is not a Subsidiary or that is accounted for by the equity
method of accounting shall be excluded; provided that
Consolidated Net Income of the Issuer shall be increased by the
amount of dividends or distributions or other payments that are
actually paid in cash (or to the extent converted into cash) to
the referent Person or a Restricted Subsidiary thereof in
respect of such period,
(6) solely for the purpose of determining the amount
available for Restricted Payments under clause (3)(a) of the
first paragraph of Certain Covenants
Limitation on Restricted Payments, the Net Income for such
period of any Restricted Subsidiary (other than any Guarantor)
shall be excluded to the extent that the declaration or payment
of dividends or similar distributions by that Restricted
Subsidiary of its Net Income is not at the date of determination
wholly permitted without any prior governmental approval (which
has not been obtained) or, directly or indirectly, by the
operation of the terms of its charter or any agreement,
instrument, judgment, decree, order, statute, rule, or
governmental regulation applicable to that Restricted Subsidiary
or its stockholders, unless such restriction with respect to the
payment of dividends or similar
237
distributions has been legally waived; provided that
Consolidated Net Income of the Issuer will be increased by the
amount of dividends or other distributions or other payments
actually paid in cash (or to the extent converted into cash) or
Cash Equivalents to the Issuer or a Restricted Subsidiary
thereof in respect of such period, to the extent not already
included therein,
(7) effects of adjustments (including the effects of such
adjustments pushed down to the Issuer and its Restricted
Subsidiaries) in the property, equipment, inventory, software
and other intangible assets, deferred revenues and debt line
items in such Persons consolidated financial statements
pursuant to GAAP resulting from the application of
recapitalization accounting or, if applicable, purchase
accounting in relation to the Transactions or any consummated
acquisition or the amortization or write-off of any amounts
thereof, net of taxes, shall be excluded,
(8) any after-tax effect of income (loss) from the early
extinguishment of Indebtedness or Hedging Obligations or other
derivative instruments shall be excluded,
(9) any impairment charge or asset write-off, including,
without limitation, impairment charges or asset write-offs
related to intangible assets, long-lived assets or investments
in debt and equity securities, in each case, pursuant to GAAP
and the amortization of intangibles arising pursuant to GAAP
shall be excluded,
(10) any non-cash compensation expense recorded from grants
of stock appreciation or similar rights, stock options,
restricted stock or other rights, and any cash charges
associated with the rollover, acceleration or payout of Equity
Interests by management of the Company or any of its direct or
indirect parent companies in connection with the Transaction,
shall be excluded,
(11) any fees and expenses incurred during such period, or
any amortization thereof for such period, in connection with any
acquisition, Investment, Asset Sale, issuance or repayment of
Indebtedness, issuance of Equity Interests, refinancing
transaction or amendment or modification of any debt instrument
(in each case, including any such transaction consummated prior
to the Issue Date and any such transaction undertaken but not
completed) and any charges or non-recurring merger costs
incurred during such period as a result of any such transaction
shall be excluded,
(12) accruals and reserves that are established or adjusted
within twelve months after November 17, 2006 that are so
required to be established as a result of the Transaction in
accordance with GAAP, or changes as a result of adoption or
modification of accounting policies, shall be excluded, and
(13) to the extent covered by insurance and actually
reimbursed, or, so long as the Issuer has made a determination
that there exists reasonable evidence that such amount will in
fact be reimbursed by the insurer and only to the extent that
such amount is (a) not denied by the applicable carrier in
writing within 180 days and (b) in fact reimbursed
within 365 days of the date of such evidence (with a
deduction for any amount so added back to the extent not so
reimbursed within 365 days), expenses with respect to
liability or casualty events or business interruption shall be
excluded.
Notwithstanding the foregoing, for the purpose of the covenant
described under Certain Covenants Limitation
on Restricted Payments only (other than clause (3)(d)
thereof), there shall be excluded from Consolidated Net Income
any income arising from any sale or other disposition of
Restricted Investments made by the Issuer and its Restricted
Subsidiaries, any repurchases and redemptions of Restricted
Investments from the Issuer and its Restricted Subsidiaries, any
repayments of loans and advances which constitute Restricted
Investments by the Issuer or any of its Restricted Subsidiaries,
any sale of the stock of an Unrestricted Subsidiary or any
distribution or dividend from an Unrestricted Subsidiary, in
each case only to the extent such amounts increase the amount of
Restricted Payments permitted under such covenant pursuant to
clause (3)(d) thereof.
Consolidated Net Tangible Assets means the
total amount of assets (less applicable reserves and other
properly deductible items) after deducting therefrom
(a) all current liabilities as disclosed on the
consolidated balance sheet of the Issuer (excluding any thereof
which are by their terms extendible or renewable at the option
of the obligor thereon to a time more than 12 months after
the time as of which the amount thereof is being computed and
further excluding any deferred income taxes that are included in
current liabilities) and
238
(b) all goodwill, trade names, trademarks, patents,
unamortized debt discount and expense and other like intangible
assets, all as set forth on the most recent consolidated balance
sheet of the Issuer and computed in accordance with generally
accepted accounting principles.
Consolidated Secured Debt Ratio as of any
date of determination, means the ratio of (1) Consolidated
Total Indebtedness of the Issuer and its Restricted Subsidiaries
that is secured by Liens as of the end of the most recent fiscal
period for which internal financial statements are available
immediately preceding the date on which such event for which
such calculation is being made shall occur to (2) the
Issuers EBITDA for the most recently ended four full
fiscal quarters for which internal financial statements are
available immediately preceding the date on which such event for
which such calculation is being made shall occur, in each case
with such pro forma adjustments to Consolidated Total
Indebtedness and EBITDA as are appropriate and consistent with
the pro forma adjustment provisions set forth in the definition
of Fixed Charge Coverage Ratio.
Consolidated Total Indebtedness means, as at
any date of determination, an amount equal to the sum of
(1) the aggregate amount of all outstanding Indebtedness of
the Issuer and its Restricted Subsidiaries on a consolidated
basis consisting of Indebtedness for borrowed money, Obligations
in respect of Capitalized Lease Obligations and debt obligations
evidenced by promissory notes and similar instruments (and
excluding, for the avoidance of doubt, all obligations relating
to Receivables Facilities) and (2) the aggregate amount of
all outstanding Disqualified Stock of the Issuer and all
Preferred Stock of its Restricted Subsidiaries on a consolidated
basis, with the amount of such Disqualified Stock and Preferred
Stock equal to the greater of their respective voluntary or
involuntary liquidation preferences and maximum fixed repurchase
prices, in each case determined on a consolidated basis in
accordance with GAAP. For purposes hereof, the maximum
fixed repurchase price of any Disqualified Stock or
Preferred Stock that does not have a fixed repurchase price
shall be calculated in accordance with the terms of such
Disqualified Stock or Preferred Stock as if such Disqualified
Stock or Preferred Stock were purchased on any date on which
Consolidated Total Indebtedness shall be required to be
determined pursuant to the Indenture, and if such price is based
upon, or measured by, the fair market value of such Disqualified
Stock or Preferred Stock, such fair market value shall be
determined reasonably and in good faith by the Issuer.
Contingent Obligations means, with respect to
any Person, any obligation of such Person guaranteeing any
leases, dividends or other obligations that do not constitute
Indebtedness (primary obligations) of any
other Person (the primary obligor) in any
manner, whether directly or indirectly, including, without
limitation, any obligation of such Person, whether or not
contingent,
(1) to purchase any such primary obligation or any property
constituting direct or indirect security therefor,
(2) to advance or supply funds
(a) for the purchase or payment of any such primary
obligation, or
(b) to maintain working capital or equity capital of the
primary obligor or otherwise to maintain the net worth or
solvency of the primary obligor, or
(3) to purchase property, securities or services primarily
for the purpose of assuring the owner of any such primary
obligation of the ability of the primary obligor to make payment
of such primary obligation against loss in respect thereof.
Controlling Secured Parties means, with
respect to any Common Collateral, the Series of First Lien
Secured Parties whose Authorized Representative is the
Applicable Authorized Representative for such Common Collateral.
Credit Facilities means, with respect to the
Issuer or any of its Restricted Subsidiaries, one or more debt
facilities, including the Senior Credit Facilities, or other
financing arrangements (including, without limitation,
commercial paper facilities or indentures) providing for
revolving credit loans, term loans, letters of credit or other
long-term indebtedness, including any notes, mortgages,
guarantees, collateral documents, instruments and agreements
executed in connection therewith, and any amendments,
supplements,
239
modifications, extensions, renewals, restatements or refundings
thereof and any indentures or credit facilities or commercial
paper facilities that replace, refund or refinance any part of
the loans, notes, other credit facilities or commitments
thereunder, including any such replacement, refunding or
refinancing facility or indenture that increases the amount
permitted to be borrowed thereunder or alters the maturity
thereof (provided that such increase in borrowings is
permitted under Certain Covenants Limitation
on Incurrence of Indebtedness and Issuance of Disqualified Stock
and Preferred Stock) or adds Restricted Subsidiaries as
additional borrowers or guarantors thereunder and whether by the
same or any other agent, lender or group of lenders.
Default means any event that is, or with the
passage of time or the giving of notice or both would be, an
Event of Default.
Delayed Equity Amount means any equity
contribution of the Investors, the Frist Entities or certain
other management investors described in the Offering Memorandum
on or before March 31, 2007, the proceeds of which are used
to repay borrowings under the senior secured revolving credit
facility included in the General Credit Facility or the ABL
Facility in the manner described in the Offering Memorandum.
Designated Non-cash Consideration means the
fair market value of non-cash consideration received by the
Issuer or a Restricted Subsidiary in connection with an Asset
Sale that is so designated as Designated Non-cash Consideration
pursuant to an Officers Certificate, setting forth the
basis of such valuation, executed by the principal financial
officer of the Issuer, less the amount of cash or Cash
Equivalents received in connection with a subsequent sale of or
collection on such Designated Non-cash Consideration.
Designated Preferred Stock means Preferred
Stock of the Issuer or any parent corporation thereof (in each
case other than Disqualified Stock) that is issued for cash
(other than to a Restricted Subsidiary or an employee stock
ownership plan or trust established by the Issuer or any of its
Subsidiaries) and is so designated as Designated Preferred
Stock, pursuant to an Officers Certificate executed by the
principal financial officer of the Issuer or the applicable
parent corporation thereof, as the case may be, on the issuance
date thereof, the cash proceeds of which are excluded from the
calculation set forth in clause (3) of the first paragraph
under Certain Covenants Limitation on
Restricted Payments.
Discharge of New First Lien Obligations
means, except to the extent any such New First Lien
Obligations are reinstated pursuant to the Additional General
Intercreditor Agreement, the discharge or legal defeasance or
covenant defeasance of the Indenture in accordance with its
terms; provided that the Discharge of New First Lien
Obligations shall not be deemed to have occurred if such
payments are made with proceeds of other New First Lien
Obligations that constitute and exchange or replacement for or a
refinancing, in whole or in part, of such New First Lien
Obligations. In the event the New First Lien Obligations are
modified and such Obligations are paid over time or otherwise
modified pursuant to Section 1129 of the Bankruptcy Code,
the New First Lien Obligations shall be deemed to be discharged
when the final payment is made, in cash, in respect of such
indebtedness and any obligations pursuant to such new
indebtedness shall have been satisfied.
Discharge of General Credit Facility Obligations
means, with respect to any Common Collateral, the date on
which the General Credit Facility Obligations are no longer
secured by such Common Collateral; provided that the
Discharge of General Credit Facility Obligations shall not be
deemed to have occurred in connection with a refinancing of such
General Credit Facility Obligations with additional First Lien
Obligations secured by such Common Collateral under an agreement
relating to Additional First Lien Obligations which has been
designated in writing by the administrative agent under the
General Credit Facility so refinanced to the First Lien
Collateral Agent and each other Authorized Representative as the
General Credit Facility for purposes of the First Lien
Intercreditor Agreement.
Disqualified Stock means, with respect to any
Person, any Capital Stock of such Person which, by its terms, or
by the terms of any security into which it is convertible or for
which it is putable or exchangeable, or upon the happening of
any event, matures or is mandatorily redeemable (other than
solely as a result of a change of control or asset sale)
pursuant to a sinking fund obligation or otherwise, or is
redeemable at the option of the holder thereof (other than
solely as a result of a change of control or asset sale), in
whole or in part, in each case prior to the date 91 days
after the earlier of the maturity date of the Notes or the date
the
240
Notes are no longer outstanding; provided,
however, that if such Capital Stock is issued to any plan
for the benefit of employees of the Issuer or its Subsidiaries
or by any such plan to such employees, such Capital Stock shall
not constitute Disqualified Stock solely because it may be
required to be repurchased by the Issuer or its Subsidiaries in
order to satisfy applicable statutory or regulatory obligations.
EBITDA means, with respect to any Person for
any period, the Consolidated Net Income of such Person for such
period
(1) increased (without duplication) by:
(a) provision for taxes based on income or profits or
capital gains, including, without limitation, foreign, federal,
state, franchise and similar taxes (such as the Pennsylvania
capital tax) and foreign withholding taxes (including penalties
and interest related to such taxes or arising from tax
examinations) of such Person paid or accrued during such period
deducted (and not added back) in computing Consolidated Net
Income; plus
(b) Fixed Charges of such Person for such period (including
(x) net losses on Hedging Obligations or other derivative
instruments entered into for the purpose of hedging interest
rate risk and (y) costs of surety bonds in connection with
financing activities, in each case, to the extent included in
Fixed Charges), together with items excluded from the definition
of Consolidated Interest Expense pursuant to clauses
(1)(u), (v), (w), (x), (y) and (z) of the definition
thereof, and, in each such case, to the extent the same were
deducted (and not added back) in calculating such Consolidated
Net Income; plus
(c) Consolidated Depreciation and Amortization Expense of
such Person for such period to the extent the same was deducted
(and not added back) in computing Consolidated Net Income;
plus
(d) any expenses or charges (other than depreciation or
amortization expense) related to any Equity Offering, Permitted
Investment, acquisition, disposition, recapitalization or the
incurrence of Indebtedness permitted to be incurred by the
Indenture (including a refinancing thereof) (whether or not
successful), including (i) such fees, expenses or charges
related to the offering of the Notes and any Credit Facilities
and (ii) any amendment or other modification of the Notes,
and, in each case, deducted (and not added back) in computing
Consolidated Net Income; plus
(e) the amount of any restructuring charge or reserve
deducted (and not added back) in such period in computing
Consolidated Net Income, including any one-time costs incurred
in connection with acquisitions after November 17, 2006 and
costs related to the closure
and/or
consolidation of facilities; plus
(f) any other non-cash charges, including any write-offs or
write-downs, reducing Consolidated Net Income for such period
(provided that if any such non-cash charges represent an
accrual or reserve for potential cash items in any future
period, the cash payment in respect thereof in such future
period shall be subtracted from EBITDA to such extent, and
excluding amortization of a prepaid cash item that was paid in a
prior period); plus
(g) the amount of any minority interest expense consisting
of income attributable to minority equity interests of third
parties deducted (and not added back) in such period in
calculating Consolidated Net Income; plus
(h) the amount of management, monitoring, consulting and
advisory fees and related expenses paid in such period to the
Investors and the Frist Entities to the extent otherwise
permitted under Certain Covenants Transactions
with Affiliates; plus
(i) the amount of net cost savings projected by the Issuer
in good faith to be realized as a result of specified actions
taken or to be taken (calculated on a pro forma basis as though
such cost savings had been realized on the first day of such
period), net of the amount of actual benefits realized during
such period from such actions; provided that
(w) such cost savings are reasonably identifiable and
factually supportable, (x) such actions have been taken or
are to be taken within 15 months after the date of
determination to take such action, (y) no cost savings
shall be added pursuant to this clause (i) to the
241
extent duplicative of any expenses or charges relating to such
cost savings that are included in clause (e) above with
respect to such period and (z) the aggregate amount of cost
savings added pursuant to this clause (i) shall not exceed
$150.0 million for any four consecutive quarter period
(which adjustments may be incremental to pro forma adjustments
made pursuant to the second paragraph of the definition of
Fixed Charge Coverage Ratio); plus
(j) the amount of loss on sales of receivables and related
assets to the Receivables Subsidiary in connection with a
Receivables Facility; plus
(k) any costs or expense incurred by the Issuer or a
Restricted Subsidiary pursuant to any management equity plan or
stock option plan or any other management or employee benefit
plan or agreement or any stock subscription or shareholder
agreement, to the extent that such cost or expenses are funded
with cash proceeds contributed to the capital of the Issuer or
net cash proceeds of an issuance of Equity Interests of the
Issuer (other than Disqualified Stock) solely to the extent that
such net cash proceeds are excluded from the calculation set
forth in clause (3) of the first paragraph under
Certain Covenants Limitation on Restricted
Payments;
(2) decreased by (without duplication) non-cash gains
increasing Consolidated Net Income of such Person for such
period, excluding any non-cash gains to the extent they
represent the reversal of an accrual or reserve for a potential
cash item that reduced EBITDA in any prior period; and
(3) increased or decreased by (without duplication):
(a) any net gain or loss resulting in such period from
Hedging Obligations and the application of Statement of
Financial Accounting Standards No. 133; plus or
minus, as applicable,
(b) any net gain or loss resulting in such period from
currency translation gains or losses related to currency
remeasurements of Indebtedness (including any net loss or gain
resulting from Hedging Obligations for currency exchange risk).
EMU means the economic and monetary union as
contemplated in the Treaty on European Union.
Equity Interests means Capital Stock and all
warrants, options or other rights to acquire Capital Stock, but
excluding any debt security that is convertible into, or
exchangeable for, Capital Stock.
Equity Offering means any public or private
sale of common stock or Preferred Stock of the Issuer or any of
its direct or indirect parent companies (excluding Disqualified
Stock), other than:
(1) public offerings with respect to the Issuers or
any direct or indirect parent companys common stock
registered on
Form S-8;
(2) issuances to any Subsidiary of the Issuer; and
(3) any such public or private sale that constitutes an
Excluded Contribution.
euro means the single currency of
participating member states of the EMU.
European Collateral has the meaning set forth
under Description of Other Indebtedness Senior
Secured Credit Facilities Guarantee and
Security.
Event of Default has the meaning set forth
under Events of Default and Remedies.
Excess Proceeds has the meaning set forth in
the fourth paragraph under Repurchase at the Option of
Holders Asset Sales.
Exchange Act means the Securities Exchange
Act of 1934, as amended, and the rules and regulations of the
SEC promulgated thereunder.
Exchange Notes means any notes issued in
exchange for the Notes pursuant to the Registration Rights
Agreement or similar agreement.
242
Excluded Contribution means net cash
proceeds, marketable securities or Qualified Proceeds received
by the Issuer after November 17, 2006 from
(1) contributions to its common equity capital, and
(2) the sale (other than to a Subsidiary of the Issuer or
to any management equity plan or stock option plan or any other
management or employee benefit plan or agreement of the Issuer)
of Capital Stock (other than Disqualified Stock and Designated
Preferred Stock) of the Issuer,
in each case designated as Excluded Contributions pursuant to an
Officers Certificate executed by the principal financial
officer of the Issuer on the date such capital contributions are
made or the date such Equity Interests are sold, as the case may
be, which are excluded from the calculation set forth in
clause (3) of the first paragraph under Certain
Covenants Limitation on Restricted Payments.
Existing Notes means the $121.2 million
aggregate principal amount of 8.700% medium-term notes due 2010,
$691.2 million aggregate principal amount of
8.750% notes due 2010, £150.0 million aggregate
principal amount of 8.750% notes due 2010,
$475.8 million aggregate principal amount of
7.875% notes due 2011, $500.0 million aggregate
principal amount of 6.950% notes due 2012,
$500.0 million aggregate principal amount of
6.300% notes due 2012, $500.0 million aggregate
principal amount of 6.250% notes due 2013,
$500.0 million aggregate principal amount of
6.750% notes due 2013, $500.0 million aggregate
principal amount of 5.750% notes due 2014,
$121.1 million aggregate principal amount of 9.000%
medium-term notes due 2014, $750.0 million aggregate
principal amount of 6.375% notes due 2015,
$150.0 million aggregate principal amount of
7.190% debentures due 2015, $1,000.0 million aggregate
principal amount of 6.500% notes due 2016,
$135.6 million aggregate principal amount of
7.500% debentures due 2023, $150.0 million aggregate
principal amount of 8.360% debentures due 2024,
$291.4 million aggregate principal amount of
7.690% notes due 2025, $125.0 million aggregate
principal amount of 7.580% medium-term notes due 2025,
$150.0 million aggregate principal amount of
7.050% debentures due 2027, $250.0 million aggregate
principal amount of 7.500% notes due 2033,
$100.0 million aggregate principal amount of
7.750% debentures due 2036 and $200.0 million
aggregate principal amount of 7.500% debentures due 2095,
each issued by the Issuer and outstanding on November 17,
2006.
Existing Notes Indenture means that certain
Indenture, dated as of December 16, 1993, between Columbia
Healthcare Corporation and The First National Bank of Chicago,
as Trustee, as amended by the First Supplemental Indenture,
dated as of May 25, 2000, between the Issuer and Bank One
Trust Company, N.A., as Trustee, the Second Supplemental
Indenture, dated as of July 1, 2001, between the Issuer and
Bank One Trust Company, N.A., as Trustee, and the Third
Supplemental Indenture, dated as of December 5, 2001,
between the Issuer and The Bank of New York, as Trustee.
Existing Second Priority Notes means the 2006
Second Priority Notes and the 2009 Second Priority Notes and any
refinancings thereof permitted pursuant to the terms of the
Indenture.
Existing Second Priority Notes Indentures
means the 2006 Second Priority Notes Indenture and the 2009
Second Priority Notes Indenture.
First Lien Collateral Agent shall mean Bank
of America, N.A., in its capacity as administrative agent and
collateral agent for the lenders and other secured parties under
the General Credit Facility and the other First Lien Documents
and in its capacity as collateral agent for the New First Lien
Secured Parties, together with its successors and permitted
assigns under the General Credit Facility, the Indenture and the
First Lien Documents exercising substantially the same rights
and powers; and in each case provided that if such First
Lien Collateral Agent is not Bank of America, N.A., such First
Lien Collateral Agent shall have become a party to the
Additional General Intercreditor Agreement, the General
Intercreditor Agreement, dated as of November 17, 2006,
among the First Lien Collateral Agent and the Junior Lien
Collateral Agent, and the other applicable First Lien Security
Documents.
First Lien Documents means the credit,
guarantee and security documents governing the New First Lien
Obligations, including, without limitation, the Indenture and
the First Lien Security Documents.
243
First Lien Event of Default means an
Event of Default under and as defined in the General
Credit Facility, the Indenture or any other First Lien Documents
governing First Lien Obligations.
First Lien Obligations means, collectively,
(a) all General Credit Facility Obligations, (b) the
Notes Obligations and (c) any Series of Additional First
Lien Obligations. For the avoidance of doubt, Obligations with
respect to the ABL Facility will not constitute First Lien
Obligations.
First Lien Secured Parties means (a) the
Secured Parties, as defined in the General Credit
Facility, (b) the New First Lien Secured Parties and
(c) any Additional First Lien Secured Parties.
First Lien Security Documents means the
Security Documents (as defined in the Indenture) and any other
agreement, document or instrument pursuant to which a Lien is
granted or purported to be granted securing New First Lien
Obligations or under which rights or remedies with respect to
such Liens are governed, in each case to the extent relating to
the collateral securing both the New First Lien Obligations and
any Junior Lien Obligations.
First Priority Liens means the first priority
Liens securing the New First Lien Obligations.
Fixed Charge Coverage Ratio means, with
respect to any Person for any period, the ratio of EBITDA of
such Person for such period to the Fixed Charges of such Person
for such period. In the event that the Issuer or any Restricted
Subsidiary incurs, assumes, guarantees, redeems, retires or
extinguishes any Indebtedness (other than Indebtedness incurred
under any revolving credit facility unless such Indebtedness has
been permanently repaid and has not been replaced) or issues or
redeems Disqualified Stock or Preferred Stock subsequent to the
commencement of the period for which the Fixed Charge Coverage
Ratio is being calculated but prior to or simultaneously with
the event for which the calculation of the Fixed Charge Coverage
Ratio is made (the Fixed Charge Coverage Ratio
Calculation Date), then the Fixed Charge Coverage
Ratio shall be calculated giving pro forma effect to such
incurrence, assumption, guarantee, redemption, retirement or
extinguishment of Indebtedness, or such issuance or redemption
of Disqualified Stock or Preferred Stock, as if the same had
occurred at the beginning of the applicable four-quarter period.
For purposes of making the computation referred to above,
Investments, acquisitions, dispositions, mergers, consolidations
and disposed operations (as determined in accordance with GAAP)
that have been made by the Issuer or any of its Restricted
Subsidiaries during the four-quarter reference period or
subsequent to such reference period and on or prior to or
simultaneously with the Fixed Charge Coverage Ratio Calculation
Date shall be calculated on a pro forma basis assuming that all
such Investments, acquisitions, dispositions, mergers,
consolidations and disposed operations (and the change in any
associated fixed charge obligations and the change in EBITDA
resulting therefrom) had occurred on the first day of the
four-quarter reference period. If, since the beginning of such
period, any Person that subsequently became a Restricted
Subsidiary or was merged with or into the Issuer or any of its
Restricted Subsidiaries since the beginning of such period shall
have made any Investment, acquisition, disposition, merger,
consolidation or disposed operation that would have required
adjustment pursuant to this definition, then the Fixed Charge
Coverage Ratio shall be calculated giving pro forma effect
thereto for such period as if such Investment, acquisition,
disposition, merger, consolidation or disposed operation had
occurred at the beginning of the applicable four-quarter period.
For purposes of this definition, whenever pro forma effect is to
be given to a transaction, the pro forma calculations shall be
made in good faith by a responsible financial or accounting
officer of the Issuer. If any Indebtedness bears a floating rate
of interest and is being given pro forma effect, the interest on
such Indebtedness shall be calculated as if the rate in effect
on the Fixed Charge Coverage Ratio Calculation Date had been the
applicable rate for the entire period (taking into account any
Hedging Obligations applicable to such Indebtedness). Interest
on a Capitalized Lease Obligation shall be deemed to accrue at
an interest rate reasonably determined by a responsible
financial or accounting officer of the Issuer to be the rate of
interest implicit in such Capitalized Lease Obligation in
accordance with GAAP. For purposes of making the computation
referred to above, interest on any Indebtedness under a
revolving credit facility computed on a pro forma basis shall be
computed based upon the average daily balance of such
Indebtedness during the applicable period except as set forth in
the first paragraph of this definition. Interest on Indebtedness
that may
244
optionally be determined at an interest rate based upon a factor
of a prime or similar rate, a eurocurrency interbank offered
rate or other rate shall be deemed to have been based upon the
rate actually chosen, or, if none, then based upon such optional
rate chosen as the Issuer may designate.
Fixed Charges means, with respect to any
Person for any period, the sum of:
(1) Consolidated Interest Expense of such Person for such
period;
(2) all cash dividends or other distributions paid
(excluding items eliminated in consolidation) on any series of
Preferred Stock during such period; and
(3) all cash dividends or other distributions paid
(excluding items eliminated in consolidation) on any series of
Disqualified Stock during such period.
Foreign Subsidiary means, with respect to any
Person, any Restricted Subsidiary of such Person that is not
organized or existing under the laws of the United States, any
state thereof or the District of Columbia and any Restricted
Subsidiary of such Foreign Subsidiary.
Frist Entities means Dr. Thomas F.
Frist, Jr., any Person controlled by Dr. Frist and any
charitable organization selected by Dr. Frist that holds
Equity Interests of the Issuer on November 17, 2006.
GAAP means generally accepted accounting
principles in the United States which are in effect on
November 17, 2006.
General Credit Facility means the credit
agreement entered into as of November 17, 2006 by and among
the Issuer, the European subsidiary borrowers party thereto, the
lenders party thereto in their capacities as lenders thereunder
and Bank of America, N.A., as U.S. Administrative Agent and
as European Administrative Agent, as amended as of
February 16, 2007 and as further amended as of
March 2, 2009, including any guarantees, collateral
documents, instruments and agreements executed in connection
therewith, and any amendments, supplements, modifications,
extensions, renewals, restatements, refundings or refinancings
thereof and any indentures or credit facilities or commercial
paper facilities with banks or other institutional lenders or
investors that replace, refund or refinance any part of the
loans, notes, other credit facilities or commitments thereunder,
including any such replacement, refunding or refinancing
facility or indenture that increases the amount borrowable
thereunder or alters the maturity thereof (provided that
such increase in borrowings is permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock
above).
General Credit Facility Obligations means
Obligations as defined in the General Credit
Facility.
Government Securities means securities that
are:
(1) direct obligations of the United States of America for
the timely payment of which its full faith and credit is
pledged; or
(2) obligations of a Person controlled or supervised by and
acting as an agency or instrumentality of the United States of
America the timely payment of which is unconditionally
guaranteed as a full faith and credit obligation by the United
States of America,
which, in either case, are not callable or redeemable at the
option of the issuers thereof, and shall also include a
depository receipt issued by a bank (as defined in
Section 3(a)(2) of the Securities Act), as custodian with
respect to any such Government Securities or a specific payment
of principal of or interest on any such Government Securities
held by such custodian for the account of the holder of such
depository receipt; provided that (except as required by
law) such custodian is not authorized to make any deduction from
the amount payable to the holder of such depository receipt from
any amount received by the custodian in respect of the
Government Securities or the specific payment of principal of or
interest on the Government Securities evidenced by such
depository receipt.
Guarantee means a guarantee (other than by
endorsement of negotiable instruments for collection in the
ordinary course of business), direct or indirect, in any manner
(including letters of credit and reimbursement agreements in
respect thereof), of all or any part of any Indebtedness or
other obligations.
245
Guarantee means the guarantee by any
Guarantor of the Issuers Obligations under the Indenture.
Guarantor means each Restricted Subsidiary
that Guarantees the Notes in accordance with the terms of the
Indenture.
HCI means Health Care Indemnity, Inc., an
insurance company formed under the laws of the State of Colorado
and a Wholly-Owned Subsidiary of the Issuer.
Hedging Arrangements means the fixed-pay
interest rate swap agreements, entered into by Hercules Holding
on or about September 13, 2006 and with respect to which
the Issuer will be the counterparty in connection with the
Recapitalization, relating to $8,000 million of the
outstanding principal amount under the First Lien Obligations
and the ABL Obligations.
Hedging Obligations means, with respect to
any Person, the obligations of such Person under any interest
rate swap agreement, interest rate cap agreement, interest rate
collar agreement, commodity swap agreement, commodity cap
agreement, commodity collar agreement, foreign exchange
contract, currency swap agreement or similar agreement providing
for the transfer or mitigation of interest rate or currency
risks either generally or under specific contingencies.
Holder means the Person in whose name a Note
is registered on the registrars books.
Impairment means, with respect to any Series
of First Lien Obligations, (i) any determination by a court
of competent jurisdiction that (x) any of the First Lien
Obligations of such Series are unenforceable under applicable
law or are subordinated to any other obligations (other than
another Series of First Lien Obligations), (y) any of the
First Lien Obligations of such Series do not have an enforceable
security interest in any of the Collateral securing any other
Series of First Lien Obligations
and/or
(z) any intervening security interest exists securing any
other obligations (other than another Series of First Lien
Obligations) on a basis ranking prior to the security interest
of such Series of First Lien Obligations but junior to the
security interest of any other Series of First Lien Obligations
or (ii) the existence of any Collateral for any other
Series of First Lien Obligations that is not Common Collateral.
Indebtedness means, with respect to any
Person, without duplication:
(1) any indebtedness (including principal and premium) of
such Person, whether or not contingent:
(a) in respect of borrowed money;
(b) evidenced by bonds, notes, debentures or similar
instruments or letters of credit or bankers acceptances
(or, without duplication, reimbursement agreements in respect
thereof);
(c) representing the balance deferred and unpaid of the
purchase price of any property (including Capitalized Lease
Obligations), except (i) any such balance that constitutes
a trade payable or similar obligation to a trade creditor, in
each case accrued in the ordinary course of business and
(ii) any earn-out obligations until such obligation becomes
a liability on the balance sheet of such Person in accordance
with GAAP; or
(d) representing any Hedging Obligations;
if and to the extent that any of the foregoing Indebtedness
(other than letters of credit and Hedging Obligations) would
appear as a liability upon a balance sheet (excluding the
footnotes thereto) of such Person prepared in accordance with
GAAP;
(2) to the extent not otherwise included, any obligation by
such Person to be liable for, or to pay, as obligor, guarantor
or otherwise on, the obligations of the type referred to in
clause (1) of a third Person (whether or not such items
would appear upon the balance sheet of the such obligor or
guarantor), other than by endorsement of negotiable instruments
for collection in the ordinary course of business; and
(3) to the extent not otherwise included, the obligations
of the type referred to in clause (1) of a third Person
secured by a Lien on any asset owned by such first Person,
whether or not such Indebtedness is assumed by such first Person;
246
provided, however, that notwithstanding the
foregoing, Indebtedness shall be deemed not to include
(a) Contingent Obligations incurred in the ordinary course
of business or (b) obligations under or in respect of
Receivables Facilities.
Independent Financial Advisor means an
accounting, appraisal, investment banking firm or consultant to
Persons engaged in Similar Businesses of nationally recognized
standing that is, in the good faith judgment of the Issuer,
qualified to perform the task for which it has been engaged.
Initial Purchasers means Citigroup Global
Markets Inc., Banc of America Securities LLC, J.P. Morgan
Securities Inc., Deutsche Bank Securities Inc., Goldman,
Sachs & Co. and the other initial purchasers party to
the purchase agreement related to the Notes.
insolvency or liquidation proceeding means:
(1) any case commenced by or against the Issuer or any
Guarantor under any Bankruptcy Law for the relief of debtors,
any other proceeding for the reorganization, recapitalization or
adjustment or marshalling of the assets or liabilities of the
Issuer or any Guarantor, any receivership or assignment for the
benefit of creditors relating to the Issuer or any Guarantor or
any similar case or proceeding relative to the Issuer or any
Guarantor or its creditors, as such, in each case whether or not
voluntary;
(2) any liquidation, dissolution, marshalling of assets or
liabilities or other winding up of or relating to the Issuer or
any Guarantor, in each case whether or not voluntary and whether
or not involving bankruptcy or insolvency; or
(3) any other proceeding of any type or nature in which
substantially all claims of creditors of the Issuer or any
Guarantor are determined and any payment or distribution is or
may be made on account of such claims.
Intercreditor Agreements means, collectively,
the First Lien Intercreditor Agreement, the Additional
Receivables Intercreditor Agreement and the Additional General
Intercreditor Agreement.
Investment Grade Rating means a rating equal
to or higher than Baa3 (or the equivalent) by Moodys and
BBB- (or the equivalent) by S&P, or an equivalent rating by
any other Rating Agency.
Investment Grade Securities means:
(1) securities issued or directly and fully guaranteed or
insured by the United States government or any agency or
instrumentality thereof (other than Cash Equivalents);
(2) debt securities or debt instruments with an Investment
Grade Rating, but excluding any debt securities or instruments
constituting loans or advances among the Issuer and its
Subsidiaries;
(3) investments in any fund that invests exclusively in
investments of the type described in clauses (1) and
(2) which fund may also hold immaterial amounts of cash
pending investment or distribution; and
(4) corresponding instruments in countries other than the
United States customarily utilized for high quality investments.
Investments means, with respect to any
Person, all investments by such Person in other Persons
(including Affiliates) in the form of loans (including
guarantees), advances or capital contributions (excluding
accounts receivable, trade credit, advances to customers,
commissions, travel and similar advances to officers and
employees, in each case made in the ordinary course of
business), purchases or other acquisitions for consideration of
Indebtedness, Equity Interests or other securities issued by any
other Person and investments that are required by GAAP to be
classified on the balance sheet (excluding the footnotes) of the
Issuer in the same manner as the other investments included in
this definition to the extent such transactions involve the
247
transfer of cash or other property. For purposes of the
definition of Unrestricted Subsidiary and the
covenant described under Certain Covenants
Limitation on Restricted Payments:
(1) Investments shall include the
portion (proportionate to the Issuers equity interest in
such Subsidiary) of the fair market value of the net assets of a
Subsidiary of the Issuer at the time that such Subsidiary is
designated an Unrestricted Subsidiary; provided,
however, that upon a redesignation of such Subsidiary as
a Restricted Subsidiary, the Issuer shall be deemed to continue
to have a permanent Investment in an Unrestricted
Subsidiary in an amount (if positive) equal to:
(a) the Issuers Investment in such
Subsidiary at the time of such redesignation; less
(b) the portion (proportionate to the Issuer equity
interest in such Subsidiary) of the fair market value of the net
assets of such Subsidiary at the time of such
redesignation; and
(2) any property transferred to or from an Unrestricted
Subsidiary shall be valued at its fair market value at the time
of such transfer, in each case as determined in good faith by
the Issuer.
Investors means Bain Capital Partners, LLC,
Kohlberg Kravis Roberts & Co. L.P., Merrill Lynch
Global Private Equity, Inc. (formerly known as Merrill Lynch
Global Partners, Inc.) and each of their respective Affiliates
but not including, however, any portfolio companies of any of
the foregoing.
Issue Date means April 22, 2009.
Issuer has the meaning set forth in the first
paragraph under General; provided that when
used in the context of determining the fair market value of an
asset or liability under the Indenture, Issuer shall
be deemed to mean the board of directors of the Issuer when the
fair market value is equal to or in excess of
$500.0 million (unless otherwise expressly stated).
Junior Lien Collateral Agent shall mean
(i) so long as the 2006 Second Priority Notes are
outstanding, the trustee under the 2006 Second Priority Notes
Indenture, in its capacity as trustee and collateral agent for
the holders of 2006 Second Priority Notes and other secured
parties under the 2006 Second Priority Notes Indenture and the
related security documents (including the holders of the 2009
Second Priority Notes), and (ii) at any time thereafter,
such agent or trustee as is designated Junior Lien
Collateral Agent by Junior Lien Secured Parties holding a
majority in principal amount of the Junior Lien Obligations then
outstanding or pursuant to such other arrangements as agreed to
among the holders of the Junior Lien Obligations, it being
understood that as of the Issue Date, the trustee under the 2006
Second Priority Notes Indenture shall be the Junior Lien
Collateral Agent.
Junior Lien Documents means the credit and
security documents governing the Junior Lien Obligations,
including, without limitation, the Existing Second Priority
Notes Indentures, the related security documents and
intercreditor agreements.
Junior Lien Obligations means the Existing
Second Priority Notes and Obligations with respect to other
Indebtedness permitted to be incurred under the Existing Second
Priority Notes Indentures and the General Credit Facility which
is by its terms intended to be secured equally and ratably with
the Existing Second Priority Notes or on a basis junior to the
Liens securing the Existing Second Priority Notes; provided
such Lien is permitted to be incurred under the Existing
Second Priority Notes Indentures and the General Credit
Facility; provided, further, that the holders of such
Indebtedness or their Junior Lien Representative is a party to
the applicable security documents in accordance with the terms
thereof and has appointed the Junior Lien Collateral Agent as
collateral agent for such holders of Junior Lien Obligations
with respect to all or a portion of the Collateral.
Junior Lien Representative means any duly
authorized representative of any holders of Junior Lien
Obligations, which representative is party to the applicable
security documents.
Junior Lien Secured Parties means
(i) holders of Existing Second Priority Notes (including
the holders of any Additional Notes (as defined in the Existing
Second Priority Notes Indentures) subsequently issued under and
in compliance with the terms of the Existing Second Priority
Notes Indentures), (ii) the Junior Lien
248
Collateral Agent and (iii) the holders from time to time of
any other Junior Lien Obligations and each Junior Lien
Representative.
Legal Holiday means a Saturday, a Sunday or a
day on which commercial banking institutions are not required to
be open in the State of New York.
Lien means, with respect to any asset, any
mortgage, lien (statutory or otherwise), pledge, hypothecation,
charge, security interest, preference, priority or encumbrance
of any kind in respect of such asset, whether or not filed,
recorded or otherwise perfected under applicable law, including
any conditional sale or other title retention agreement, any
lease in the nature thereof, any option or other agreement to
sell or give a security interest in and any filing of or
agreement to give any financing statement under the Uniform
Commercial Code (or equivalent statutes) of any jurisdiction;
provided that in no event shall an operating lease be
deemed to constitute a Lien.
Major Non-Controlling Authorized Representative
has the meaning set forth under Security
First Lien Intercreditor.
Moodys means Moodys Investors
Service, Inc. and any successor to its rating agency business.
Net Income means, with respect to any Person,
the net income (loss) of such Person, determined in accordance
with GAAP and before any reduction in respect of Preferred Stock
dividends.
Net Proceeds means the aggregate cash
proceeds received by the Issuer or any of its Restricted
Subsidiaries in respect of any Asset Sale, including any cash
received upon the sale or other disposition of any Designated
Non-cash Consideration received in any Asset Sale, net of the
direct costs relating to such Asset Sale and the sale or
disposition of such Designated Non-cash Consideration, including
legal, accounting and investment banking fees, and brokerage and
sales commissions, any relocation expenses incurred as a result
thereof, taxes paid or payable as a result thereof (after taking
into account any available tax credits or deductions and any tax
sharing arrangements), amounts required to be applied to the
repayment of principal, premium, if any, and interest on Senior
Indebtedness required (other than required by clause (1) of
the second paragraph of Repurchase at the Option of
Holders Asset Sales) to be paid as a result of
such transaction and any deduction of appropriate amounts to be
provided by the Issuer or any of its Restricted Subsidiaries as
a reserve in accordance with GAAP against any liabilities
associated with the asset disposed of in such transaction and
retained by the Issuer or any of its Restricted Subsidiaries
after such sale or other disposition thereof, including pension
and other post-employment benefit liabilities and liabilities
related to environmental matters or against any indemnification
obligations associated with such transaction.
New First Lien Obligations means all advances
to, and debts, liabilities, obligations, covenants and duties
of, the Issuer or any Guarantor arising under the Indenture and
any other First Lien Documents, whether or not direct or
indirect (including those acquired by assumption), absolute or
contingent, due or to become due, now existing or hereafter
arising and including interest and fees that accrue after the
commencement by or against the Issuer, any Guarantor or any
Affiliate thereof of any proceeding in bankruptcy or insolvency
law naming such Person as the debtor in such proceeding,
regardless of whether such interest and fees are allowed claims
in such proceeding.
New First Lien Secured Parties means, at any
relevant time, the holders of New First Lien Obligations at such
time, including without limitation the Trustee, the Registrar,
Paying Agent and Transfer Agent, and the Holders (including the
Holders of any Additional Notes subsequently issued under and in
compliance with the terms of the Indenture).
Non-Conforming Plan of Reorganization means
any Plan of Reorganization that grants the Junior Lien
Collateral Agent or any Junior Lien Secured Party any right or
benefit, directly or indirectly, which right or benefit is
prohibited at such time by the provisions of the Additional
General Intercreditor Agreement.
Non-Controlling Authorized Representative Enforcement
Date has the meaning set forth under
Security First Lien Intercreditor.
249
Non-Controlling Secured Parties means, with
respect to any Common Collateral, the First Lien Secured Parties
which are not Controlling Secured Parties with respect to such
Common Collateral.
Non-Receivables Collateral has the meaning
set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security, subject to
the provisions of the second sentence of the first paragraph
under Security General.
Notes Documents means the credit and security
documents governing the Notes Obligations, including, without
limitation, the Indenture, the related Security Documents and
Intercreditor Agreements.
Notes Obligations means Obligations in
respect of the Notes, the Indenture or the Security Documents,
including, for the avoidance of doubt, obligations in respect of
exchange notes and guarantees thereof.
Obligations means any principal, interest
(including any interest accruing subsequent to the filing of a
petition in bankruptcy, reorganization or similar proceeding at
the rate provided for in the documentation with respect thereto,
whether or not such interest is an allowed claim under
applicable state, federal or foreign law), premium, penalties,
fees, indemnifications, reimbursements (including reimbursement
obligations with respect to letters of credit and bankers
acceptances), damages and other liabilities, and guarantees of
payment of such principal, interest, penalties, fees,
indemnifications, reimbursements, damages and other liabilities,
payable under the documentation governing any Indebtedness.
Offering Memorandum means the offering
memorandum, dated April 15, 2009, relating to the initial
private offering of the Notes.
Officer means the Chairman of the Board, the
Chief Executive Officer, the President, any Executive Vice
President, Senior Vice President or Vice President, the
Treasurer or the Secretary of the Issuer or a Guarantor, as
applicable.
Officers Certificate means a
certificate signed on behalf of the Issuer by an Officer of the
Issuer or on behalf of a Guarantor by an Officer of such
Guarantor, who must be the principal executive officer, the
principal financial officer, the treasurer or the principal
accounting officer of the Issuer or Guarantor, as applicable,
that meets the requirements set forth in the Indenture.
Opinion of Counsel means a written opinion
from legal counsel who is acceptable to the Trustee. The counsel
may be an employee of or counsel to the Issuer or the Trustee.
Permitted Asset Swap means the concurrent
purchase and sale or exchange of Related Business Assets or a
combination of Related Business Assets and cash or Cash
Equivalents between the Issuer or any of its Restricted
Subsidiaries and another Person; provided, that any cash
or Cash Equivalents received must be applied in accordance with
the covenant described under Repurchase at the Option of
Holders Asset Sales.
Permitted Holders means each of the
Investors, the Frist Entities, members of management of the
Issuer (or its direct or indirect parent) and any assignees of
the equity commitments of the Investors on November 17,
2006 who are (or will be, pursuant to the agreements described
under Management Equity Investment by Senior
Management Participants and Equity
Investment by Other Management Participants) holders of
Equity Interests of the Issuer (or any of its direct or indirect
parent companies) and any group (within the meaning of
Section 13(d)(3) or Section 14(d)(2) of the Exchange
Act or any successor provision) of which any of the foregoing
are members; provided that, in the case of such group and
without giving effect to the existence of such group or any
other group, such Investors, Frist Entities, members of
management and assignees of the equity commitments of the
Investors, collectively, have beneficial ownership of more than
50% of the total voting power of the Voting Stock of the Issuer
or any of its direct or indirect parent companies.
Permitted Investments means:
(1) any Investment in the Issuer or any of its Restricted
Subsidiaries;
(2) any Investment in cash and Cash Equivalents or
Investment Grade Securities;
250
(3) any Investment by the Issuer or any of its Restricted
Subsidiaries in a Person that is engaged in a Similar Business
if as a result of such Investment:
(a) such Person becomes a Restricted Subsidiary; or
(b) such Person, in one transaction or a series of related
transactions, is merged or consolidated with or into, or
transfers or conveys substantially all of its assets to, or is
liquidated into, the Issuer or a Restricted Subsidiary,
and, in each case, any Investment held by such Person;
provided that such Investment was not acquired by such
Person in contemplation of such acquisition, merger,
consolidation or transfer;
(4) any Investment in securities or other assets not
constituting cash, Cash Equivalents or Investment Grade
Securities and received in connection with an Asset Sale made
pursuant to the provisions described under Repurchase at
the Option of Holders Asset Sales or any other
disposition of assets not constituting an Asset Sale;
(5) any Investment existing on the Issue Date;
(6) any Investment acquired by the Issuer or any of its
Restricted Subsidiaries:
(a) in exchange for any other Investment or accounts
receivable held by the Issuer or any such Restricted Subsidiary
in connection with or as a result of a bankruptcy, workout,
reorganization or recapitalization of the issuer of such other
Investment or accounts receivable; or
(b) as a result of a foreclosure by the Issuer or any of
its Restricted Subsidiaries with respect to any secured
Investment or other transfer of title with respect to any
secured Investment in default;
(7) Hedging Obligations permitted under clause (10) of
the second paragraph of the covenant described in Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
(8) any Investment in a Similar Business having an
aggregate fair market value, taken together with all other
Investments made pursuant to this clause (8) that are at
that time outstanding, not to exceed 5% of Total Assets at the
time of such Investment (with the fair market value of each
Investment being measured at the time made and without giving
effect to subsequent changes in value);
(9) Investments the payment for which consists of Equity
Interests (exclusive of Disqualified Stock) of the Issuer or any
of its direct or indirect parent companies; provided, however,
that such Equity Interests will not increase the amount
available for Restricted Payments under clause (3) of the
first paragraph under the covenant described in Certain
Covenants Limitations on Restricted Payments;
(10) guarantees of Indebtedness permitted under the
covenant described in Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock;
(11) any transaction to the extent it constitutes an
Investment that is permitted and made in accordance with the
provisions of the second paragraph of the covenant described
under Certain Covenants Transactions with
Affiliates (except transactions described in clauses (2),
(5) and (9) of such paragraph);
(12) Investments consisting of purchases and acquisitions
of inventory, supplies, material or equipment;
(13) additional Investments having an aggregate fair market
value, taken together with all other Investments made pursuant
to this clause (13) that are at that time outstanding
(without giving effect to the sale of an Unrestricted Subsidiary
to the extent the proceeds of such sale do not consist of cash
or marketable securities), not to exceed 5% of Total Assets at
the time of such Investment (with the fair market value of each
Investment being measured at the time made and without giving
effect to subsequent changes in value);
251
(14) Investments relating to an ABL Financing Entity or a
Receivables Subsidiary that, in the good faith determination of
the Issuer, are necessary or advisable to effect the ABL
Facility or any Receivables Facility, as the case may be;
(15) advances to, or guarantees of Indebtedness of,
employees not in excess of $50.0 million outstanding at any
one time, in the aggregate;
(16) loans and advances to officers, directors and
employees for business-related travel expenses, moving expenses
and other similar expenses, in each case incurred in the
ordinary course of business or consistent with past practices or
to fund such Persons purchase of Equity Interests of the
Issuer or any direct or indirect parent company thereof;
(17) Physician Support Obligations made by the Issuer or
any Restricted Subsidiary;
(18) any Investment in any joint venture existing on the
Issue Date that owns or operates one or more health care
facilities, including, without limitation, hospitals, ambulatory
surgery centers, outpatient diagnostic centers or imaging
centers to the extent contemplated by the organizational
documents of such joint venture as in existence on the Issue
Date;
(19) any Investment in the ordinary course of business or
as may be required by applicable law by any Restricted
Subsidiary (including, without limitation, HCI) engaged in the
insurance business in order to provide insurance to the Issuer
and its Subsidiaries;
(20) any Investment pursuant to any customary buy/sell
arrangement in favor of investors or joint venture parties in
connection with syndications of health care facilities,
including, without limitation, hospitals, ambulatory surgery
centers, outpatient diagnostic centers or imaging
centers; and
(21) any Investment in any Subsidiary or any joint venture
in connection with intercompany cash management arrangements or
related activities arising in the ordinary course of business.
Permitted Liens means, with respect to any
Person:
(1) pledges or deposits by such Person under workmens
compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids,
tenders, contracts (other than for the payment of Indebtedness)
or leases to which such Person is a party, or deposits to secure
public or statutory obligations of such Person or deposits of
cash or U.S. government bonds to secure surety or appeal
bonds to which such Person is a party, or deposits as security
for contested taxes or import duties or for the payment of rent,
in each case incurred in the ordinary course of business;
(2) Liens imposed by law, such as carriers,
warehousemens and mechanics Liens, in each case for
sums not yet overdue for a period of more than 30 days or
being contested in good faith by appropriate proceedings or
other Liens arising out of judgments or awards against such
Person with respect to which such Person shall then be
proceeding with an appeal or other proceedings for review if
adequate reserves with respect thereto are maintained on the
books of such Person in accordance with GAAP;
(3) Liens for taxes, assessments or other governmental
charges not yet overdue for a period of more than 30 days
or payable or subject to penalties for nonpayment or which are
being contested in good faith by appropriate proceedings
diligently conducted, if adequate reserves with respect thereto
are maintained on the books of such Person in accordance with
GAAP;
(4) Liens in favor of issuers of performance and surety
bonds or bid bonds or with respect to other regulatory
requirements or letters of credit issued pursuant to the request
of and for the account of such Person in the ordinary course of
its business;
(5) minor survey exceptions, minor encumbrances, easements
or reservations of, or rights of others for, licenses,
rights-of-way,
sewers, electric lines, telegraph and telephone lines and other
similar purposes, or zoning or other restrictions as to the use
of real properties or Liens incidental to the conduct of the
business of such Person or to the ownership of its properties
which were not incurred in connection
252
with Indebtedness and which do not in the aggregate materially
adversely affect the value of said properties or materially
impair their use in the operation of the business of such Person;
(6) Liens securing Indebtedness permitted to be incurred
pursuant to clause (4), (12), (13), (18) or (19) of
the second paragraph under Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock; provided that
(a) Liens securing Indebtedness, Disqualified Stock or
Preferred Stock permitted to be incurred pursuant to
clause (13) relate only to Refinancing Indebtedness that
serves to refund or refinance Indebtedness, Disqualified Stock
or Preferred Stock incurred under clause (4) or
(12) of the second paragraph under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock,
(b) Liens securing Indebtedness permitted to be incurred
pursuant to clause (18) extend only to the assets of
Foreign Subsidiaries, (c) Liens securing Indebtedness
permitted to be incurred pursuant to clause (19) are solely
on acquired property or the assets of the acquired entity, as
the case may be and (d) Liens securing Indebtedness,
Disqualified Stock or Preferred Stock permitted to be incurred
pursuant to clause (4) of the second paragraph under
Certain Covenants Limitation on Incurrence of
Indebtedness and Issuance of Disqualified Stock and Preferred
Stock extend only to the assets so financed, purchased,
constructed or improved;
(7) Liens existing on the Issue Date (other than Liens in
favor of (i) the lenders under the Senior Credit Facilities
and (ii) the holders of the Existing Second Priority Notes);
(8) Liens on property or shares of stock of a Person at the
time such Person becomes a Subsidiary; provided, however, such
Liens are not created or incurred in connection with, or in
contemplation of, such other Person becoming such a Subsidiary;
provided, further, however, that such Liens may not extend to
any other property owned by the Issuer or any of its Restricted
Subsidiaries;
(9) Liens on property at the time the Issuer or a
Restricted Subsidiary acquired the property, including any
acquisition by means of a merger or consolidation with or into
the Issuer or any of its Restricted Subsidiaries;
provided, however, that such Liens are not created
or incurred in connection with, or in contemplation of, such
acquisition; provided, further, however,
that the Liens may not extend to any other property owned by the
Issuer or any of its Restricted Subsidiaries;
(10) Liens securing Indebtedness or other obligations of a
Restricted Subsidiary owing to the Issuer or another Restricted
Subsidiary permitted to be incurred in accordance with the
covenant described under Certain Covenants
Limitation on Incurrence of Indebtedness and Issuance of
Disqualified Stock and Preferred Stock;
(11) Liens securing Hedging Obligations so long as the
related Indebtedness is, and is permitted to be under the
Indenture, secured by a Lien on the same property securing such
Hedging Obligations;
(12) Liens on specific items of inventory or other goods
and proceeds of any Person securing such Persons
obligations in respect of bankers acceptances issued or
created for the account of such Person to facilitate the
purchase, shipment or storage of such inventory or other goods;
(13) leases, subleases, licenses or sublicenses granted to
others in the ordinary course of business which do not
materially interfere with the ordinary conduct of the business
of the Issuer or any of its Restricted Subsidiaries and do not
secure any Indebtedness;
(14) Liens arising from Uniform Commercial Code financing
statement filings regarding operating leases entered into by the
Issuer and its Restricted Subsidiaries in the ordinary course of
business;
(15) Liens in favor of the Issuer or any Guarantor;
(16) Liens on equipment of the Issuer or any of its
Restricted Subsidiaries granted in the ordinary course of
business;
(17) Liens on accounts receivable and related assets
incurred in connection with a Receivables Facility;
253
(18) Liens to secure any refinancing, refunding, extension,
renewal or replacement (or successive refinancing, refunding,
extensions, renewals or replacements) as a whole, or in part, of
any Indebtedness secured by any Lien referred to in the
foregoing clauses (6), (7), (8) and (9); provided,
however, that (a) such new Lien shall be limited to
all or part of the same property that secured the original Lien
(plus improvements on such property), and (b) the
Indebtedness secured by such Lien at such time is not increased
to any amount greater than the sum of (i) the outstanding
principal amount or, if greater, committed amount of the
Indebtedness described under clauses (6), (7), (8) and
(9) at the time the original Lien became a Permitted Lien
under the Indenture, and (ii) an amount necessary to pay
any fees and expenses, including premiums, related to such
refinancing, refunding, extension, renewal or replacement;
(19) deposits made in the ordinary course of business to
secure liability to insurance carriers;
(20) other Liens securing obligations incurred in the
ordinary course of business which obligations do not exceed
$100.0 million at any one time outstanding;
(21) Liens securing judgments for the payment of money not
constituting an Event of Default under clause (5) under the
caption Events of Default and Remedies so long as
such Liens are adequately bonded and any appropriate legal
proceedings that may have been duly initiated for the review of
such judgment have not been finally terminated or the period
within which such proceedings may be initiated has not expired;
(22) Liens in favor of customs and revenue authorities
arising as a matter of law to secure payment of customs duties
in connection with the importation of goods in the ordinary
course of business;
(23) Liens (i) of a collection bank arising under
Section 4-210
of the Uniform Commercial Code, or any comparable or successor
provision, on items in the course of collection,
(ii) attaching to commodity trading accounts or other
commodity brokerage accounts incurred in the ordinary course of
business, and (iii) in favor of banking institutions
arising as a matter of law encumbering deposits (including the
right of set-off) and which are within the general parameters
customary in the banking industry;
(24) Liens deemed to exist in connection with Investments
in repurchase agreements permitted under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred Stock;
provided that such Liens do not extend to any assets other than
those that are the subject of such repurchase agreements;
(25) Liens encumbering reasonable customary initial
deposits and margin deposits and similar Liens attaching to
commodity trading accounts or other brokerage accounts incurred
in the ordinary course of business and not for speculative
purposes;
(26) Liens that are contractual rights of set-off
(i) relating to the establishment of depository relations
with banks not given in connection with the issuance of
Indebtedness, (ii) relating to pooled deposit or sweep
accounts of the Issuer or any of its Restricted Subsidiaries to
permit satisfaction of overdraft or similar obligations incurred
in the ordinary course of business of the Issuer and its
Restricted Subsidiaries or (iii) relating to purchase
orders and other agreements entered into with customers of the
Issuer or any of its Restricted Subsidiaries in the ordinary
course of business;
(27) Liens arising out of conditional sale, title
retention, consignment or similar arrangements for the sale or
purchase of goods entered into by the Issuer or any Restricted
Subsidiary in the ordinary course of business; and
(28) Liens that rank junior to the Liens securing the Notes
securing the Junior Lien Obligations.
For purposes of this definition, the term
Indebtedness shall be deemed to include interest on
such Indebtedness.
Person means any individual, corporation,
limited liability company, partnership, joint venture,
association, joint stock company, trust, unincorporated
organization, government or any agency or political subdivision
thereof or any other entity.
254
Physician Support Obligation means (1) a
loan to or on behalf of, or a guarantee of Indebtedness or
income of, a physician or health care professional providing
service to patients in the service area of a health care
facility operated by the Issuer, any of its Restricted
Subsidiaries or any affiliated joint venture otherwise permitted
by the Indenture made or given by the Issuer or any Restricted
Subsidiary of the Issuer in the ordinary course of business and
pursuant to a written agreement having a period not to exceed
five years or (2) guarantees by the Issuer or any
Restricted Subsidiary of the Issuer of leases and loans to
acquire property (real or personal) for or on behalf of a
physician or health care professional providing service to
patients in the service area of a health care facility operated
by the Issuer, any of its Restricted Subsidiaries or any
affiliated joint venture otherwise permitted by the Indenture.
Plan of Reorganization means any plan of
reorganization, plan of liquidation, agreement for composition,
or other type of plan of arrangement proposed in or in
connection with any insolvency or liquidation proceeding.
Preferred Stock means any Equity Interest
with preferential rights of payment of dividends or upon
liquidation, dissolution or winding up.
Principal Property means each acute care
hospital providing general medical and surgical services
(excluding equipment, personal property and hospitals that
primarily provide specialty medical services, such as
psychiatric and obstetrical and gynecological services) owned
solely by the Issuer
and/or one
or more of its Subsidiaries (used in this definition as defined
in the Existing Notes Indenture) and located in the
United States of America.
Purchase Money Obligations means any
Indebtedness incurred to finance or refinance the acquisition,
leasing, construction or improvement of property (real or
personal) or assets (other than Capital Stock), and whether
acquired through the direct acquisition of such property or
assets, or otherwise.
Qualified Proceeds means assets that are used
or useful in, or Capital Stock of any Person engaged in, a
Similar Business; provided that the fair market value of
any such assets or Capital Stock shall be determined by the
Issuer in good faith.
Rating Agencies means Moodys and
S&P or if Moodys or S&P or both shall not make a
rating on the Notes publicly available, a nationally recognized
statistical rating agency or agencies, as the case may be,
selected by the Issuer which shall be substituted for
Moodys or S&P or both, as the case may be.
Receivables Facility means any of one or more
receivables financing facilities as amended, supplemented,
modified, extended, renewed, restated or refunded from time to
time, the Obligations of which are non-recourse (except for
customary representations, warranties, covenants and indemnities
made in connection with such facilities) to the Issuer or any of
its Restricted Subsidiaries (other than a Receivables
Subsidiary) pursuant to which the Issuer or any of its
Restricted Subsidiaries purports to sell its accounts receivable
to either (a) a Person that is not a Restricted Subsidiary
or (b) a Receivables Subsidiary that in turn funds such
purchase by purporting to sell its accounts receivable to a
Person that is not a Restricted Subsidiary or by borrowing from
such a Person or from another Receivables Subsidiary that in
turn funds itself by borrowing from such a Person.
Receivables Fees means distributions or
payments made directly or by means of discounts with respect to
any accounts receivable or participation interest therein issued
or sold in connection with, and other fees paid to a Person that
is not a Restricted Subsidiary in connection with any
Receivables Facility.
Receivables Subsidiary means any Subsidiary
formed for the purpose of facilitating or entering into one or
more Receivables Facilities, and in each case engages only in
activities reasonably related or incidental thereto.
Redemption Date has the meaning set
forth under Optional Redemption.
Registration Rights Agreement means the
Registration Rights Agreement related to the Notes, dated as of
the Issue Date, among the Issuer, the Guarantors and the Initial
Purchasers.
255
Related Business Assets means assets (other
than cash or Cash Equivalents) used or useful in a Similar
Business; provided that any assets received by the Issuer
or a Restricted Subsidiary in exchange for assets transferred by
the Issuer or a Restricted Subsidiary will not be deemed to be
Related Business Assets if they consist of securities of a
Person, unless upon receipt of the securities of such Person,
such Person would become a Restricted Subsidiary.
Restricted Investment means an Investment
other than a Permitted Investment.
Restricted Subsidiary means, at any time, any
direct or indirect Subsidiary of the Issuer (including any
Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
provided, however, that upon an Unrestricted
Subsidiarys ceasing to be an Unrestricted Subsidiary, such
Subsidiary shall be included in the definition of
Restricted Subsidiary.
S&P means Standard &
Poors, a division of The McGraw-Hill Companies, Inc., and
any successor to its rating agency business.
Sale and Lease-Back Transaction means any
arrangement providing for the leasing by the Issuer or any of
its Restricted Subsidiaries of any real or tangible personal
property, which property has been or is to be sold or
transferred by the Issuer or such Restricted Subsidiary to a
third Person in contemplation of such leasing.
SEC means the U.S. Securities and
Exchange Commission.
Secured Indebtedness means any Indebtedness
of the Issuer or any of its Restricted Subsidiaries secured by a
Lien.
Securities Act means the Securities Act of
1933, as amended, and the rules and regulations of the SEC
promulgated thereunder.
Security Agreement means the amended and
restated Security Agreement, dated as of March 2, 2009, by
and among the Issuer, the subsidiary grantors named therein and
the First Lien Collateral Agent, as the same may be further
amended, restated or modified from time to time, to which the
Trustee, as Authorized Representative for the Holders were
joined on the Issue Date.
Security Documents means, collectively, the
Intercreditor Agreements, the Security Agreement, other security
agreements relating to the Collateral and the mortgages and
instruments filed and recorded in appropriate jurisdictions to
preserve and protect the Liens on the Collateral (including,
without limitation, financing statements under the Uniform
Commercial Code of the relevant states) applicable to the
Collateral, each as in effect on the Issue Date and as amended,
amended and restated, modified, renewed or replaced from time to
time.
Senior Credit Facilities means the ABL
Facility and the General Credit Facility.
Senior Indebtedness means:
(1) all Indebtedness of the Issuer or any Guarantor
outstanding under the Senior Credit Facilities or Notes and
related Guarantees (including interest accruing on or after the
filing of any petition in bankruptcy or similar proceeding or
for reorganization of the Issuer or any Guarantor (at the rate
provided for in the documentation with respect thereto,
regardless of whether or not a claim for post-filing interest is
allowed in such proceedings)), and any and all other fees,
expense reimbursement obligations, indemnification amounts,
penalties, and other amounts (whether existing on the Issue Date
or thereafter created or incurred) and all obligations of the
Issuer or any Guarantor to reimburse any bank or other Person in
respect of amounts paid under letters of credit, acceptances or
other similar instruments;
(2) all Hedging Obligations (and guarantees thereof) owing
to a Lender (as defined in the Senior Credit Facilities) or any
Affiliate of such Lender (or any Person that was a Lender or an
Affiliate of such Lender at the time the applicable agreement
giving rise to such Hedging Obligation was entered into);
provided that such Hedging Obligations are permitted to
be incurred under the terms of the Indenture;
256
(3) any other Indebtedness of the Issuer or any Guarantor
permitted to be incurred under the terms of the Indenture,
unless the instrument under which such Indebtedness is incurred
expressly provides that it is subordinated in right of payment
to the Notes or any related Guarantee; and
(4) all Obligations with respect to the items listed in the
preceding clauses (1), (2) and (3);
provided, however, that Senior Indebtedness shall
not include:
(a) any obligation of such Person to the Issuer or any of
its Subsidiaries;
(b) any liability for federal, state, local or other taxes
owed or owing by such Person;
(c) any accounts payable or other liability to trade
creditors arising in the ordinary course of business;
(d) any Indebtedness or other Obligation of such Person
which is subordinate or junior in any respect to any other
Indebtedness or other Obligation of such Person; or
(e) that portion of any Indebtedness which at the time of
incurrence is incurred in violation of the Indenture.
Separate Receivables Collateral has the
meaning set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
Series means (a) with respect to the
First Lien Secured Parties, each of (i) the General Credit
Facility Secured Parties (in their capacities as such),
(ii) the Holders and the Trustee, each in their capacity as
such) and (iii) the Additional First Lien Secured Parties
that become subject to the First Lien Intercreditor Agreement
after the date hereof that are represented by a common
Authorized Representative (in its capacity as such for such
Additional First Lien Secured Parties) and (b) with respect
to any First Lien Obligations, each of (i) the General
Credit Facility Obligations, (ii) the Notes Obligations and
(iii) the Additional First Lien Obligations incurred
pursuant to any applicable agreement, which pursuant to any
joinder agreement, are to be represented under the First Lien
Intercreditor Agreement by a common Authorized Representative
(in its capacity as such for such Additional First Lien
Obligations).
Shared Receivables Collateral has the meaning
set forth under Description of Other
Indebtedness Senior Secured Credit
Facilities Guarantee and Security.
Significant Subsidiary means any Restricted
Subsidiary that would be a significant subsidiary as
defined in Article 1,
Rule 1-02
of
Regulation S-X,
promulgated pursuant to the Securities Act, as such regulation
is in effect on the Issue Date.
Similar Business means any business conducted
or proposed to be conducted by the Issuer and its Restricted
Subsidiaries on the Issue Date or any business that is similar,
reasonably related, incidental or ancillary thereto.
Sponsor Management Agreement means the
management agreement between certain of the management companies
associated with the Investors, the Frist Entities and the Issuer.
Subordinated Indebtedness means, with respect
to the Notes,
(1) any Indebtedness of the Issuer which is by its terms
subordinated in right of payment to the Notes, and
(2) any Indebtedness of any Guarantor which is by its terms
subordinated in right of payment to the Guarantee of such entity
of the Notes.
Subsidiary means, with respect to any Person:
(1) any corporation, association, or other business entity
(other than a partnership, joint venture, limited liability
company or similar entity) of which more than 50% of the total
voting power of shares of Capital Stock entitled (without regard
to the occurrence of any contingency) to vote in the election of
directors, managers or trustees thereof is at the time of
determination owned or controlled, directly or
257
indirectly, by such Person or one or more of the other
Subsidiaries of that Person or a combination thereof or is
consolidated under GAAP with such Person at such time; and
(2) any partnership, joint venture, limited liability
company or similar entity of which
(x) more than 50% of the capital accounts, distribution
rights, total equity and voting interests or general or limited
partnership interests, as applicable, are owned or controlled,
directly or indirectly, by such Person or one or more of the
other Subsidiaries of that Person or a combination thereof
whether in the form of membership, general, special or limited
partnership or otherwise, and
(y) such Person or any Restricted Subsidiary of such Person
is a controlling general partner or otherwise controls such
entity.
Total Assets means the total assets of the
Issuer and its Restricted Subsidiaries on a consolidated basis,
as shown on the most recent consolidated balance sheet of the
Issuer or such other Person as may be expressly stated.
Transaction means the transactions
contemplated by the Transaction Agreement, the issuance of the
Notes and borrowings under the Senior Credit Facilities as in
effect on November 17, 2006.
Transaction Agreement means the Agreement and
Plan of Merger, dated as of July 24, 2006, between Hercules
Holding II, LLC, Hercules Acquisition Corporation and the
Issuer, as the same may be amended prior to the Issue Date.
Treasury Rate means, as of any
Redemption Date, the yield to maturity as of such
Redemption Date of United States Treasury securities with a
constant maturity (as compiled and published in the most recent
Federal Reserve Statistical Release H.15 (519) that has
become publicly available at least two Business Days prior to
the Redemption Date (or, if such Statistical Release is no
longer published, any publicly available source of similar
market data)) most nearly equal to the period from the
Redemption Date to April 15, 2014; provided,
however, that if the period from the Redemption Date
to April 15, 2014 is less than one year, the weekly average
yield on actually traded United States Treasury securities
adjusted to a constant maturity of one year will be used.
Trust Indenture Act means the
Trust Indenture Act of 1939, as amended (15 U.S.C.
§§ 77aaa-777bbbb).
Unrestricted Subsidiary means:
(1) any Subsidiary of the Issuer which at the time of
determination is an Unrestricted Subsidiary (as designated by
the Issuer, as provided below); and
(2) any Subsidiary of an Unrestricted Subsidiary.
The Issuer may designate any Subsidiary of the Issuer (including
any existing Subsidiary and any newly acquired or newly formed
Subsidiary) to be an Unrestricted Subsidiary unless such
Subsidiary or any of its Subsidiaries owns any Equity Interests
or Indebtedness of, or owns or holds any Lien on, any property
of, the Issuer or any Subsidiary of the Issuer (other than
solely any Subsidiary of the Subsidiary to be so designated);
provided that
(1) any Unrestricted Subsidiary must be an entity of which
the Equity Interests entitled to cast at least a majority of the
votes that may be cast by all Equity Interests having ordinary
voting power for the election of directors or Persons performing
a similar function are owned, directly or indirectly, by the
Issuer;
(2) such designation complies with the covenants described
under Certain Covenants Limitation on
Restricted Payments; and
(3) each of:
(a) the Subsidiary to be so designated; and
(b) its Subsidiaries
258
has not at the time of designation, and does not thereafter,
create, incur, issue, assume, guarantee or otherwise become
directly or indirectly liable with respect to any Indebtedness
pursuant to which the lender has recourse to any of the assets
of the Issuer or any Restricted Subsidiary.
The Issuer may designate any Unrestricted Subsidiary to be a
Restricted Subsidiary; provided that, immediately after
giving effect to such designation, no Default shall have
occurred and be continuing and either:
(1) the Issuer could incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio test
described in the first paragraph under Certain
Covenants Limitation on Incurrence of Indebtedness
and Issuance of Disqualified Stock and Preferred
Stock; or
(2) the Fixed Charge Coverage Ratio for the Issuer and its
Restricted Subsidiaries would be greater than such ratio for the
Issuer and its Restricted Subsidiaries immediately prior to such
designation, in each case on a pro forma basis taking into
account such designation.
Any such designation by the Issuer shall be notified by the
Issuer to the Trustee by promptly filing with the Trustee a copy
of the resolution of the board of directors of the Issuer or any
committee thereof giving effect to such designation and an
Officers Certificate certifying that such designation
complied with the foregoing provisions.
Voting Stock of any Person as of any date
means the Capital Stock of such Person that is at the time
entitled to vote in the election of the board of directors of
such Person.
Weighted Average Life to Maturity means, when
applied to any Indebtedness, Disqualified Stock or Preferred
Stock, as the case may be, at any date, the quotient obtained by
dividing:
(1) the sum of the products of the number of years from the
date of determination to the date of each successive scheduled
principal payment of such Indebtedness or redemption or similar
payment with respect to such Disqualified Stock or Preferred
Stock multiplied by the amount of such payment; by
(2) the sum of all such payments.
Wholly-Owned Subsidiary of any Person means a
Subsidiary of such Person, 100% of the outstanding Equity
Interests of which (other than directors qualifying
shares) shall at the time be owned by such Person or by one or
more Wholly-Owned Subsidiaries of such Person.
259
BOOK-ENTRY
ISSUANCE
We have issued each series of notes as global securities (the
global securities). We have deposited each global
security with, or on behalf of, The Depository
Trust Company (DTC), as depositary, or its
nominee and registered it in the name of a nominee of DTC.
Except under the limited circumstances described below, global
securities are not exchangeable for certificated securities.
Only institutions that have accounts with DTC or its nominee
(participants) or persons that may hold interests
through participants may own beneficial interests in a global
security. DTC will maintain records evidencing ownership by
participants in the global securities and transfers of those
ownership interests. Participants maintain records evidencing
ownership of beneficial interests in the global securities by
persons that hold through those participants and transfers of
those ownership interests within those participants. DTC has no
knowledge of the actual beneficial owners of the securities. You
will not receive written confirmation from DTC of your purchase,
but we do expect that you will receive written confirmations
providing details of the transaction, as well as periodic
statements of your holdings from the participant through which
you entered the transaction. The laws of some jurisdictions
require that certain purchasers of securities take physical
delivery of those securities in certificated form. Those laws
may impair your ability to transfer beneficial interests in a
global security.
DTC has advised us that upon the issuance of a global security
and the deposit of that global security with DTC, DTC will
immediately credit, on its book-entry registration and transfer
system, the respective principal amounts or number of shares
represented by that global security to the accounts of its
participants.
We will make payments on securities represented by a global
security to DTC or its nominee, as the case may be, as the
registered owner and holder of the global security representing
those securities. DTC has advised us that upon receipt of any
payment on a global security, DTC will immediately credit
accounts of participants with payments in amounts proportionate
to their respective beneficial interests in that security, as
shown in the records of DTC. Standing instructions and customary
practices will govern payments by participants to owners of
beneficial interests in a global security held through those
participants, as is now the case with securities held for the
accounts of customers in bearer form or registered in
street name. Those payments will be the sole
responsibility of those participants, subject to any statutory
or regulatory requirements in effect from time to time.
Neither we, the trustees, the agents nor any agent of ours or
theirs will have any responsibility or liability for any aspect
of the records of DTC, any nominee or any participant relating
to, or payments made on account of, beneficial interests in a
global security, for maintaining, supervising or reviewing any
of the records of DTC, any nominee or any participant relating
to those beneficial interests or for any other matter relating
to the actions and practices of DTC, any nominee or any
participant.
A global security is exchangeable for certificated securities
registered in the name of a person other than DTC or its nominee
only if:
|
|
|
|
|
DTC (1) notifies us that it is unwilling or unable to
continue as Depositary for that global security or (2) has
ceased to be a clearing agency registered under the Securities
Exchange Act of 1934 and, in either case, we fail to appoint a
successor depository;
|
|
|
|
we, in our discretion at any time, determine not to require all
of the notes of a particular series to be represented by a
global security and so notify the applicable trustee; or
|
|
|
|
with respect to global securities representing any series of our
senior secured notes, there has occurred and is continuing an
event of default with respect to such senior secured notes.
|
In addition, beneficial interests in a global security may be
exchanged for certificated securities upon prior written notice
given to the applicable trustee by or on behalf of DTC in
accordance with the applicable indenture. In all cases,
certificated securities delivered in exchange for any global
security or beneficial interests in global securities will be
registered in the names, and issued in any approved
denominations, requested by or on behalf of the depositary (in
accordance with its customary procedures).
260
The registrar will register the certificated securities in the
name or names instructed by DTC. We expect that those
instructions may be based upon directions received by DTC from
its participants with respect to ownership of beneficial
interests in the global security. In the case of global debt
securities, we will make payment of any principal and interest
on the certificated securities and will register transfers and
exchanges of those certificated securities at the corporate
trust office of the respective transfer agent and registrar in
the Borough of Manhattan, The City of New York. However, we may
elect to pay interest by check mailed to the address of the
person entitled to that interest payment as of the record date,
as shown on the register for the securities.
Except as provided above, as an owner of a beneficial interest
in a global security, you will not be entitled to receive
physical delivery of securities in certificated form and will
not be considered a holder of securities for any purpose under
the indentures. No global security will be exchangeable except
for another global security of like denomination and tenor to be
registered in the name of DTC or its nominee. Accordingly, you
must rely on the procedures of DTC and the participant through
which you own your interest to exercise any rights of a holder
under the global security or the applicable indenture.
We understand that, under existing industry practices, in the
event that we request any action of holders, or an owner of a
beneficial interest in a global security desires to take any
action that a holder is entitled to take under the securities or
the indentures, DTC would authorize the participants holding the
relevant beneficial interests to take that action, and those
participants would authorize beneficial owners owning through
those participants to take that action or would otherwise act
upon the instructions of beneficial owners owning through them.
DTC has advised us that DTC is a limited purpose trust company
organized under the New York Banking Law, a banking
organization within the meaning of the New York Banking
Law, a member of the U.S. Federal Reserve System, a
clearing corporation within the meaning of the New
York Uniform Commercial Code and a clearing agency
registered under the Securities Exchange Act of 1934. DTC holds
securities that its participants deposit with DTC. DTC also
facilitates the clearance and settlement of securities
transactions among its participants in deposited securities,
such as transfers and pledges, through electronic computerized
book-entry changes in accounts of the participants, thereby
eliminating the need for physical movement of securities
certificates. DTCs participants include securities brokers
and dealers, banks, trust companies, clearing corporations and
certain other organizations. DTC is owned by a number of its
participants and by the New York Stock Exchange, Inc., the
American Stock Exchange, Inc. and the National Association of
Securities Dealers, Inc. Access to DTCs system is also
available to others, such as banks, brokers, dealers and trust
companies that clear through or maintain a custodial
relationship with a participant, either directly or indirectly.
The rules applicable to DTC and its participants are on file
with the SEC.
Investors may elect to hold interests in securities outside the
United States through Clearstream Banking, société
anonyme (Clearstream) or Euroclear Bank S.A./N.V.,
as operator of the Euroclear System (Euroclear), if
they are participants in those systems, or indirectly through
organizations that are participants in those systems.
Clearstream and Euroclear will hold interests on behalf of their
participants through customers securities accounts in
Clearstreams and Euroclears names on the books of
their respective depositaries. Those depositaries in turn hold
those interests in customers securities accounts in the
depositaries names on the books of DTC.
Clearstream has advised us that it is incorporated under the
laws of Luxembourg as a bank. Clearstream holds securities for
its customers and facilitates the clearance and settlement of
securities transactions between its customers through electronic
book-entry changes in their accounts. Clearstream provides to
its customers, among other things, services for safekeeping,
administration, clearance and settlement of internationally
traded securities and securities lending and borrowing.
Clearstream interfaces with domestic securities markets in over
30 countries through established depository and custodial
relationships. As a bank, Clearstream is subject to regulation
by the Luxembourg Commission for the Supervision of the
Financial Sector, also known as the Commission de
Surveillance du Secteur Financier and the Luxembourg Central
Bank. Clearstream customers are financial institutions around
the world, including underwriters, securities brokers and
dealers, banks, trust companies, clearing corporations and other
organizations. Its customers in the United States are limited to
securities brokers and dealers and banks. Indirect access to
Clearstream is also available to other institutions such as
banks, brokers, dealers and trust companies that clear through
or maintain a custodial relationship with the customer.
261
Distributions with respect to global securities held
beneficially through Clearstream will be credited to cash
accounts of Clearstream customers in accordance with its rules
and procedures, to the extent received by the
U.S. depositary for Clearstream.
Euroclear has advised us that it was created in 1968 to hold
securities for its participants and to clear and settle
transactions between Euroclear participants through simultaneous
electronic book-entry delivery against payment, thereby
eliminating the need for physical movement of certificates and
any risk from lack of simultaneous transfers of securities and
cash. Euroclear provides various other services, including
securities lending and borrowing, and interfaces with domestic
markets in several countries. Euroclear is operated by Euroclear
Bank S.A./N.V. Euroclear Clearance Systems S.C. establishes
policy for Euroclear on behalf of Euroclear participants.
Euroclear participants include banks (including central banks),
securities brokers and dealers and other professional financial
intermediaries. Indirect access to Euroclear is also available
to other firms that clear through or maintain a custodial
relationship with a Euroclear participant, either directly or
indirectly.
Distributions with respect to interests in global securities
held beneficially through Euroclear will be credited to the cash
accounts of Euroclear participants in accordance with
Euroclears terms and conditions and operating procedures
and applicable Belgian law, to the extent received by the
U.S. depositary for Euroclear.
Global
Clearance and Settlement Procedures
Unless otherwise specified with respect to a particular series
of global securities, initial settlement for global securities
will be made in immediately available funds. Transfers between
DTC participants will be effected under DTCs procedures
and will be settled in
same-day
funds.
If the interests in the global securities may be held through
Clearstream or Euroclear, Clearstream customers
and/or
Euroclear participants will conduct secondary market trading
with other Clearstream customers
and/or
Euroclear participants in the ordinary way in accordance with
the applicable rules and operating procedures of Clearstream and
Euroclear. Thereafter, secondary market trades will settle in
immediately available funds.
Cross-market transfers between persons holding directly or
indirectly through DTC participants on the one hand, and
directly or indirectly through Clearstream customers or
Euroclear participants, on the other, will be effected in DTC in
accordance with DTCs rules on behalf of the relevant
European international clearing system by the
U.S. depositary for that system; however, those
cross-market transactions will require delivery by the
counterparty in the relevant European international clearing
system of instructions to that system in accordance with its
rules and procedures and within its established deadlines
(European time). The relevant European international clearing
system will, if the transaction meets its settlement
requirements, deliver instructions to the U.S. depositary
for that system to take action to effect final settlement on its
behalf by delivering or receiving interests in global securities
in DTC, and making or receiving payment in accordance with
normal procedures for
same-day
funds settlement applicable to DTC. Clearstream customers and
Euroclear participants may not deliver instructions directly to
DTC.
Because of time-zone differences, credits of interests in global
securities received by Clearstream or Euroclear as a result of a
transaction with a DTC participant will be made during
subsequent securities settlement processing and will be credited
the business day following the DTC settlement date. Those
credits or any transactions in global securities settled during
that processing will be reported to the relevant Euroclear
participants or Clearstream customers on that business day. Cash
received by Clearstream or Euroclear as a result of sales of
interests in global securities by or through a Clearstream
customer or a Euroclear participant to a DTC participant will be
received with value on the DTC settlement date but will be
available in the relevant Clearstream or Euroclear cash account
only as of the business day following settlement in DTC.
Although DTC, Clearstream and Euroclear have agreed to the
procedures described above in order to facilitate transfers of
interests in global securities among participants of DTC,
Clearstream and Euroclear, they are under no obligation to
perform those procedures and those procedures may be
discontinued at any time.
262
CERTAIN
U.S. FEDERAL TAX CONSEQUENCES
The following is a summary of certain U.S. federal income
and, in the case of
non-U.S. holders
(as defined below), estate tax consequences of the purchase,
ownership and disposition of the notes as of the date of this
prospectus. Unless otherwise stated, this summary deals only
with notes held as capital assets. For purposes of this
discussion, toggle notes means the
95/8%/103/8% senior
secured toggle notes due 2016, cash-pay OID notes
means the
97/8%
second lien senior secured notes due 2017 and the
81/2%
first lien senior secured notes due 2019, and cash-pay
notes means notes other than the toggle notes and cash-pay
OID notes.
As used herein, a U.S. holder means a
beneficial owner of the notes that is for U.S. federal
income tax purposes any of the following:
|
|
|
|
|
an individual citizen or resident of the United States;
|
|
|
|
a corporation (or any other entity treated as a corporation for
U.S. federal income tax purposes) created or organized in
or under the laws of the United States, any state thereof or the
District of Columbia;
|
|
|
|
an estate the income of which is subject to U.S. federal
income taxation regardless of its source; or
|
|
|
|
a trust if it (1) is subject to the primary supervision of
a court within the United States and one or more United States
persons have the authority to control all substantial decisions
of the trust or (2) has a valid election in effect under
applicable United States Treasury regulations to be treated as a
United States person.
|
The term
non-U.S. holder
means a beneficial owner of the notes (other than a partnership
or any other entity treated as a partnership for
U.S. federal income tax purposes) that is not a
U.S. holder.
This summary does not represent a detailed description of the
U.S. federal income tax consequences applicable to you if
you are a person subject to special tax treatment under the
U.S. federal income tax laws, including, without limitation:
|
|
|
|
|
a dealer in securities or currencies;
|
|
|
|
a financial institution;
|
|
|
|
a regulated investment company;
|
|
|
|
a real estate investment trust;
|
|
|
|
a tax-exempt organization;
|
|
|
|
an insurance company;
|
|
|
|
a person holding the notes as part of a hedging, integrated,
conversion or constructive sale transaction or a straddle;
|
|
|
|
a trader in securities that has elected the
mark-to-market
method of accounting for your securities;
|
|
|
|
a person liable for alternative minimum tax;
|
|
|
|
a partnership or other pass-through entity for U.S. federal
income tax purposes (or an investor in such entities);
|
|
|
|
a U.S. holder whose functional currency is not
the U.S. dollar;
|
|
|
|
a controlled foreign corporation;
|
|
|
|
a passive foreign investment company; or
|
|
|
|
a United States expatriate.
|
This summary is based on the Internal Revenue Code of 1986, as
amended (the Code), United States Treasury
regulations, administrative rulings and judicial decisions as of
the date hereof. Those authorities may
263
be changed, possibly on a retroactive basis, so as to result in
U.S. federal income and estate tax consequences different
from those summarized below. We have not and will not seek any
rulings from the Internal Revenue Service (IRS)
regarding the matters discussed below. There can be no assurance
that the IRS will not take positions concerning the tax
consequences of the purchase, ownership or disposition of the
notes that are different from those discussed below.
If a partnership (including any entity classified as a
partnership for U.S. federal income tax purposes) holds
notes, the tax treatment of a partner will generally depend upon
the status of the partner and the activities of the partnership.
If you are a partnership or a partner in a partnership holding
notes, you should consult your own tax advisors.
This summary does not represent a detailed description of the
U.S. federal income and estate tax consequences to you in
light of your particular circumstances and does not address the
effects of any state, local or
non-U.S. tax
laws. It is not intended to be, and should not be construed to
be, legal or tax advice to any particular purchaser of notes.
You should consult your own tax advisors concerning the
particular U.S. federal income and estate tax consequences
to you of the ownership of the notes, as well as the
consequences to you arising under the laws of any other taxing
jurisdiction.
Certain
Tax Consequences to U.S. Holders
The following is a summary of certain U.S. federal income
tax consequences that will apply to U.S. holders of the
notes.
Cash-Pay
Notes
Stated Interest on Cash-Pay Notes. Stated
interest on a cash-pay note will generally be taxable to you as
ordinary income at the time it is received or accrued, depending
on your method of accounting for U.S. federal income tax
purposes.
Market Discount. If you purchase a cash-pay
note for an amount that is less than its principal amount, the
amount of the difference will be treated as market
discount for U.S. federal income tax purposes, unless
that difference is less than a specified de minimis amount.
Under the market discount rules, you will be required to treat
any principal payment on, or any gain on the sale, exchange,
retirement or other disposition of, a cash-pay note as ordinary
income to the extent of the market discount that you have not
previously included in income and are treated as having accrued
on the note at the time of the payment or disposition.
In addition, you may be required to defer, until the maturity of
the cash-pay note or its earlier disposition in a taxable
transaction, the deduction of all or a portion of the interest
expense on any indebtedness attributable to the note. You may
elect, on a
note-by-note
basis, to deduct the deferred interest expense in a tax year
prior to the year of disposition. You should consult your own
tax advisors before making this election.
Any market discount will be considered to accrue ratably during
the period from the date of acquisition to the maturity date of
the cash-pay note, unless you elect to accrue on a constant
interest method. You may elect to include market discount in
income currently as it accrues, on either a ratable or constant
interest method, in which case the rule described above
regarding deferral of interest deductions will not apply.
Amortizable Bond Premium. If you purchase a
cash-pay note for an amount in excess of its principal amount,
you will be considered to have purchased the cash-pay note at a
premium. You generally may elect to amortize the
premium over the remaining term of the cash-pay note on a
constant yield method as an offset to interest when includible
in income under your regular accounting method. If you do not
elect to amortize bond premium, that premium will decrease the
gain or increase the loss you would otherwise recognize on
disposition of the cash-pay note.
Sale, Exchange, Retirement, or Other Taxable Disposition of
Cash-Pay Notes. Upon the sale, exchange,
retirement, redemption or other disposition of a cash-pay note,
you generally will recognize gain or loss equal to the
difference between the amount realized upon the sale, exchange,
retirement, redemption or other
264
disposition (less an amount equal to any accrued and unpaid
stated interest, which will be taxable as interest income as
discussed above) and the adjusted tax basis of the cash-pay
note. Your adjusted tax basis in a cash-pay note will, in
general, be your cost for that cash-pay note, increased by any
market discount previously included in income, and reduced by
any amortized premium. Except as described above with respect to
market discount, any gain or loss will be capital gain or loss.
Capital gains of non-corporate U.S. holders derived in
respect of capital assets held for more than one year are
generally eligible for reduced rates of taxation. The
deductibility of capital losses is subject to limitations.
Cash-Pay
OID Notes
Stated Interest on Cash-Pay OID Notes. Stated
interest on a cash-pay OID note will generally be taxable to you
as ordinary income at the time it is received or accrued,
depending on your method of accounting for U.S. federal
income tax purposes.
Original Issue Discount. The cash-pay OID
notes are treated as having been issued with original issue
discount (OID) in an amount equal to the difference
between their stated redemption price at maturity
(the sum of all payments to be made on the cash-pay OID notes
other than qualified stated interest) and their
issue price.
The issue price of a cash-pay OID note is the first
price at which a substantial amount of that particular offering
of the cash-pay OID notes was sold (excluding sales to bond
houses, brokers or similar persons or organizations acting in
the capacity of underwiter, placement agent or wholesaler). The
term qualified stated interest means stated interest
that is unconditionally payable in cash or in property (other
than debt instruments of the issuer) at least annually at a
single fixed rate or, subject to certain conditions, based on
one or more interest indices. The stated interest payments on
the cash-pay OID notes are qualified stated interest, and are
treated as described above under Stated
Interest on Cash-Pay OID Notes.
You generally must include OID in income in advance of the
receipt of cash attributable to that income using the
constant yield method described in the following
paragraphs.
The amount of OID that you must include in income each year is
the sum of the daily portions of OID with respect to
the cash-pay OID note for each day during the taxable year or
portion of the taxable year in which you held that cash-pay OID
note (accrued OID). The daily portion is determined
by allocating to each day in any accrual period a
pro rata portion of the OID allocable to that accrual period.
The accrual period for a cash-pay OID note may be of
any length and may vary in length over the term of the cash-pay
OID note, provided that each accrual period is no longer than
one year and each scheduled payment of principal or interest
occurs on the first day or the final day of an accrual period.
The amount of OID allocable to any accrual period other than the
final accrual period is an amount equal to the excess, if any,
of:
|
|
|
|
|
the product of the cash-pay OID notes adjusted issue
price at the beginning of such accrual period and its
yield to maturity (determined on the basis of compounding at the
close of each accrual period and properly adjusted for the
length of the accrual period), over
|
|
|
|
the aggregate of all qualified stated interest allocable to the
accrual period.
|
OID allocable to a final accrual period is the difference
between the amount payable at maturity (other than a payment of
qualified stated interest) and the adjusted issue price at the
beginning of the final accrual period. The yield to maturity of
the cash-pay OID note is the discount rate that causes the
present value of all payments on the note as of its original
issue date to equal the issue price of such note.
The adjusted issue price of a cash-pay OID note at
the beginning of any accrual period is equal to its issue price
increased by the accrued OID for each prior accrual period,
determined without regard to the amortization of any acquisition
or bond premium, as described below.
You may elect to treat all interest on a cash-pay OID note as
OID and calculate the amount includible in gross income under
the constant yield method described above. The election is to be
made for the taxable year in which you acquired the cash-pay OID
note and may not be revoked without the consent of the IRS. You
should consult with your own tax advisors about this election.
265
Market Discount. If you purchase a cash-pay
OID note for an amount that is less than its adjusted issue
price, the amount of the difference will be treated as
market discount for U.S. federal income tax
purposes, unless that difference is less than a specified de
minimis amount. Under the market discount rules, you will be
required to treat any principal payment on, or any gain on the
sale, exchange, retirement or other disposition of, a cash-pay
OID note as ordinary income to the extent of the market discount
that you have not previously included in income and are treated
as having accrued on the note at the time of the payment or
disposition.
In addition, you may be required to defer, until the maturity of
the cash-pay OID note or its earlier disposition in a taxable
transaction, the deduction of all or a portion of the interest
expense on any indebtedness attributable to the note. You may
elect, on a
note-by-note
basis, to deduct the deferred interest expense in a tax year
prior to the year of disposition. You should consult your own
tax advisors before making this election.
Any market discount will be considered to accrue ratably during
the period from the date of acquisition to the maturity date of
the cash-pay OID note, unless you elect to accrue on a constant
interest method. You may elect to include market discount in
income currently as it accrues, on either a ratable or constant
interest method, in which case the rule described above
regarding deferral of interest deductions will not apply.
Acquisition Premium, Amortizable Bond
Premium. If you purchase a cash-pay OID note for
an amount that is greater than its adjusted issue price but
equal to or less than its principal amount, you will be
considered to have purchased that cash-pay OID note at an
acquisition premium. Under the acquisition premium
rules, the amount of OID that you must include in gross income
with respect to the cash-pay OID note for any taxable year will
be reduced by the portion of the acquisition premium properly
allocable to that year.
If you purchase a cash-pay OID note for an amount in excess of
its principal amount, you will be considered to have purchased
the cash-pay OID note at a premium and you will not
be required to include any OID in income. You generally may
elect to amortize the premium over the remaining term of the
cash-pay OID note on a constant yield method as an offset to
interest when includible in income under your regular accounting
method. If you do not elect to amortize bond premium, that
premium will decrease the gain or increase the loss you would
otherwise recognize on disposition of the cash-pay OID note.
Sale, Exchange, Retirement, or Other Taxable Disposition of
Cash-Pay OID Notes. Upon the sale, exchange,
retirement, redemption or other disposition of a cash-pay OID
note, you generally will recognize gain or loss equal to the
difference between the amount realized upon the sale, exchange,
retirement, redemption or other disposition (less an amount
equal to any accrued and unpaid qualified stated interest, which
will be taxable as interest income as discussed above) and the
adjusted tax basis of the cash-pay OID note. Your adjusted tax
basis in a cash-pay OID note will, in general, be your cost for
that cash-pay OID note, increased by any OID or market discount
previously included in income, and reduced by any amortized
premium. Except as described above with respect to market
discount, any gain or loss will be capital gain or loss. Capital
gains of non-corporate U.S. holders derived in respect of
capital assets held for more than one year are generally
eligible for reduced rates of taxation. The deductibility of
capital losses is subject to limitations.
Toggle
Notes
Original Issue Discount. The toggle notes are
treated as having been issued with OID for U.S. federal
income tax purposes, as described below. The issuance of PIK
Notes generally is not treated as a payment of interest.
Instead, the toggle note and any PIK Notes issued in respect of
PIK Interest thereon are treated as a single debt instrument
under the OID rules.
The toggle notes are treated as having been issued with OID in
an amount equal to the difference between their stated
redemption price at maturity (the sum of all payments to
be made on the toggle notes other than qualified stated
interest) and their issue price.
The issue price of a toggle note is the first price
at which a substantial amount of the toggle notes was sold
(excluding sales to bond houses, brokers or similar persons or
organizations acting in the capacity of
266
underwiter, placement agent or wholesaler). The term
qualified stated interest means stated interest that
is unconditionally payable in cash or in property (other than
debt instruments of the issuer) at least annually at a single
fixed rate or, subject to certain conditions, based on one or
more interest indices. Because we have the option in any
interest payment period after the initial interest payment and
prior to November 15, 2011 to make interest payments in PIK
Interest instead of paying cash, the stated interest payments on
the toggle notes are not qualified stated interest.
You generally must include OID in income in advance of the
receipt of cash attributable to that income using the
constant yield method described in the following
paragraphs.
The amount of OID that you must include in income each year is
the sum of the daily portions of OID with respect to
the toggle note for each day during the taxable year or portion
of the taxable year in which you held that toggle note
(accrued OID). The daily portion is determined by
allocating to each day in any accrual period a pro
rata portion of the OID allocable to that accrual period. The
accrual period for a toggle note may be of any
length and may vary in length over the term of the toggle note,
provided that each accrual period is no longer than one year and
each scheduled payment of principal or interest occurs on the
first day or the final day of an accrual period. The amount of
OID allocable to any accrual period other than the final accrual
period is an amount equal to the product of the toggle
notes adjusted issue price at the beginning of
such accrual period and its yield to maturity (determined on the
basis of compounding at the close of each accrual period and
properly adjusted for the length of the accrual period). OID
allocable to a final accrual period is the difference between
the amount payable at maturity and the adjusted issue price at
the beginning of the final accrual period. The yield to maturity
of the toggle note is the discount rate that causes the present
value of all payments on the note as of its original issue date
to equal the issue price of such note. For purposes of
determining the yield to maturity, the assumption is that we
will pay interest in cash and not exercise the option to pay PIK
Interest, except in respect of any period in which we actually
elect to pay PIK Interest.
The adjusted issue price of a toggle note at the
beginning of any accrual period is equal to its issue price
increased by the accrued OID for each prior accrual period,
determined without regard to the amortization of any acquisition
or bond premium, as described below, and reduced by any payments
previously made on such toggle note.
If we in fact pay interest in cash on the toggle notes, you will
not be required to adjust your OID inclusions. Each payment made
in cash under a toggle note will be treated first as a payment
of any accrued OID that has not been allocated to prior payments
and second as a payment of principal. You generally will not be
required to include separately in income cash payments received
on the toggle notes to the extent such payments constitute
payments of previously accrued OID or payments of principal.
With respect to any interest payment period for which we
exercise our option to pay interest in the form of PIK Interest,
your OID calculation for future periods will be adjusted by
treating the toggle note as if it had been retired and then
reissued for an amount equal to its adjusted issue price on the
date preceding the first date of such interest payment period,
and recalculating the yield to maturity of the reissued note by
treating the amount of PIK Interest (and of any prior PIK
Interest) as a payment that will be made on the maturity date of
such note.
The rules regarding OID are complex and the rules described
above may not apply in all cases. Accordingly, you should
consult your own tax advisors regarding their application.
Market Discount. If you purchase a toggle note
for an amount that is less than its adjusted issue price, the
amount of the difference will be treated as market
discount for U.S. federal income tax purposes, unless
that difference is less than a specified de minimis amount.
Under the market discount rules, you will be required to treat
any principal payment on, or any gain on the sale, exchange,
retirement or other disposition of, a toggle note as ordinary
income to the extent of the market discount that you have not
previously included in income and are treated as having accrued
on the note at the time of the payment or disposition.
In addition, you may be required to defer, until the maturity of
the toggle note or its earlier disposition in a taxable
transaction, the deduction of all or a portion of the interest
expense on any indebtedness attributable
267
to the note. You may elect, on a
note-by-note
basis, to deduct the deferred interest expense in a tax year
prior to the year of disposition. You should consult your own
tax advisors before making this election.
Any market discount will be considered to accrue ratably during
the period from the date of acquisition to the maturity date of
the toggle note, unless you elect to accrue on a constant
interest method. You may elect to include market discount in
income currently as it accrues, on either a ratable or constant
interest method, in which case the rule described above
regarding deferral of interest deductions will not apply.
Acquisition Premium, Amortizable Bond
Premium. If you purchase a toggle note for an
amount that is greater than its adjusted issue price but equal
to or less than the sum of all amounts payable on the toggle
note after the purchase date, you will be considered to have
purchased that toggle note at an acquisition
premium. Under the acquisition premium rules, the amount
of OID that you must include in gross income with respect to the
toggle note for any taxable year will be reduced by the portion
of the acquisition premium properly allocable to that year.
If you purchase a toggle note for an amount in excess of the sum
of all amounts payable on the toggle note after the purchase
date, you will be considered to have purchased the toggle note
at a premium and you will not be required to include
any OID in income. You generally may elect to amortize the
premium over the remaining term of the toggle note on a constant
yield method as an offset to interest when includible in income
under your regular accounting method. If you do not elect to
amortize bond premium, that premium will decrease the gain or
increase the loss you would otherwise recognize on disposition
of the toggle note.
Sale, Exchange, Retirement, or Other Taxable Disposition of
Toggle Notes. Subject to the discussion below
regarding the Mandatory Principal Redemption, upon the sale,
exchange, retirement, redemption or other disposition of a
toggle note (or a PIK Note), you generally will recognize gain
or loss equal to the difference between the amount realized upon
the sale, exchange, retirement, redemption or other disposition
and the adjusted tax basis of the toggle note (or the PIK Note).
Your adjusted tax basis in a toggle note will, in general, be
your cost for the toggle note, increased by OID or market
discount previously included in income, and reduced by any
amortized premium and any cash payments on the toggle note.
Although not free from doubt, your adjusted tax basis in the
toggle note should be allocated between the original toggle note
and any PIK Notes received in respect of PIK Interest thereon in
proportion to their relative principal amounts. Your holding
period in any PIK Note received in respect of PIK Interest would
likely be identical to your holding period for the original
toggle note with respect to which the PIK Note was received.
Except as described above with respect to market discount, any
gain or loss will be capital gain or loss. Capital gains of
non-corporate U.S. holders derived in respect of capital
assets held for more than one year are generally eligible for
reduced rates of taxation. The deductibility of capital losses
is subject to limitations.
Payments received by a U.S. holder upon the Mandatory
Principal Redemption of a portion of a toggle note will be
treated as tax-free payments of a portion of the then accrued
OID with respect to such toggle note in its entirety (including
the portion of the toggle note not redeemed).
Certain
Tax Consequences to
Non-U.S.
Holders
The following is a summary of certain U.S. federal income
and estate tax consequences that will apply to
non-U.S. holders
of the notes.
U.S.
Federal Withholding Tax
The 30% U.S. federal withholding tax will not apply to any
payment of interest (which for purposes of this discussion
includes OID) on the notes under the portfolio interest
rule, provided that:
|
|
|
|
|
interest paid on the notes (including OID) is not effectively
connected with your conduct of a trade or business in the United
States;
|
|
|
|
you do not actually (or constructively) own 10% or more of the
total combined voting power of all classes of our voting stock
within the meaning of the Code and applicable United States
Treasury regulations;
|
268
|
|
|
|
|
you are not a controlled foreign corporation that is related to
us actually or constructively through stock ownership;
|
|
|
|
you are not a bank whose receipt of interest (including OID) on
the notes is described in Section 881(c)(3)(A) of the
Code; and
|
|
|
|
either (a) you provide your name and address on an IRS
Form W-8BEN
(or other applicable form), and certify, under penalties of
perjury, that you are not a United States person as defined
under the Code or (b) you hold your notes through certain
foreign intermediaries and satisfy the certification
requirements of applicable United States Treasury regulations.
Special certification rules apply to
non-U.S. holders
that are pass-through entities rather than corporations or
individuals.
|
If you cannot satisfy the requirements described above, payments
of interest (including OID) made to you will be subject to the
30% U.S. federal withholding tax, unless you provide us
with a properly executed:
|
|
|
|
|
IRS
Form W-8BEN
(or other applicable form) certifying an exemption from or
reduction in withholding under the benefit of an applicable
income tax treaty; or
|
|
|
|
IRS
Form W-8ECI
(or other applicable form) certifying that interest (including
OID) paid on the notes is not subject to withholding tax because
it is effectively connected with your conduct of a trade or
business in the United States (as discussed below under
U.S. Federal Income Tax).
|
The 30% U.S. federal withholding tax generally will not
apply to any payment of principal or gain that you realize on
the sale, exchange, retirement, redemption or other disposition
of a note; provided, however, that payments received by a
non-U.S. holder
upon the Mandatory Principal Redemption of a portion of a toggle
note will be treated as payments of a portion of the then
accrued OID with respect to such toggle note in its entirety
(including the portion of the toggle note not redeemed) and
therefore possibly subject to the 30% U.S. federal
withholding tax.
U.S.
Federal Income Tax
If you are engaged in a trade or business in the United States
and interest (including OID) on the notes is effectively
connected with the conduct of that trade or business (and, if
required by an applicable income tax treaty, is attributable to
a United States permanent establishment), then you will be
subject to U.S. federal income tax on that interest
(including OID) on a net income in generally the same manner as
if you were a United States person as defined under the Code. In
addition, if you are a foreign corporation, you may be subject
to a branch profits tax equal to 30% (or lower applicable income
tax treaty rate) of such interest (including OID), subject to
adjustments. If interest received with respect to the notes is
effectively connected income (whether or not a treaty applies),
the 30% withholding tax described above will not apply, provided
the certification requirements discussed above in
U.S. Federal Withholding Tax are
satisfied.
Subject to the discussion of backup withholding below, any gain
realized on the disposition of a note generally will not be
subject to U.S. federal income tax unless:
|
|
|
|
|
the gain is effectively connected with your conduct of a trade
or business in the United States (and, if required by an
applicable income tax treaty, is attributable to a United States
permanent establishment); or
|
|
|
|
you are an individual who is present in the United States for
183 days or more in the taxable year of that disposition,
and certain other conditions are met.
|
U.S.
Federal Estate Tax
Your estate will not be subject to U.S. federal estate tax
on notes beneficially owned by you at the time of your death,
provided that any payment to you on the notes would be eligible
for exemption from the 30% U.S. federal withholding tax
under the portfolio interest rule described above
under U.S. Federal Withholding Tax
without regard to the statement requirement described in the
fifth bullet point of that section.
269
Information
Reporting and Backup Withholding
U.S.
Holders
In general, information reporting requirements will apply to
certain payments of principal and interest (including OID) paid
on the notes and to the proceeds of sale or other disposition
(including retirement or a redemption) of a note paid to you
(unless you are an exempt recipient such as a corporation).
Backup withholding (currently at a rate of 28%) may apply to
such payments if you fail to provide a correct taxpayer
identification number or a certification that you are not
subject to backup withholding or if you fail to report in full
dividend and interest income.
Backup withholding is not an additional tax and any amounts
withheld under the backup withholding rules may be allowed as a
refund or a credit against your U.S. federal income tax
liability provided the required information is timely furnished
to the IRS.
Non-U.S.
Holders
In general, we must report to the IRS and to you the amount of
interest (including OID) paid to you and the amount of tax, if
any, withheld with respect to those payments. Copies of the
information returns reporting such interest payments and any
withholding may also be made available to the tax authorities in
the country in which you reside under the provisions of an
applicable income tax treaty.
In general, you will not be subject to backup withholding with
respect to payments of interest (including OID) on the notes
that we make to you provided that we do not have actual
knowledge or reason to know that you are a United States person
as defined under the Code and we have received from you the
required certification that you are a
non-U.S. holder
described above in the fifth bullet point under
Certain Tax Consequences to
Non-U.S. Holders
U.S. Federal Withholding Tax.
Information reporting and, depending on the circumstances,
backup withholding will apply to the proceeds of a sale or other
disposition (including a retirement or redemption) of notes
within the United States or conducted through certain United
States-related financial intermediaries, unless you certify to
the payor under penalties of perjury that you are a
non-U.S. holder
(and the payor does not have actual knowledge or reason to know
that you are a United States person as defined under the Code),
or you otherwise establish an exemption.
Backup withholding is not an additional tax and any amounts
withheld under the backup withholding rules may be allowed as a
refund or a credit against your U.S. federal income tax
liability provided the required information is timely furnished
to the IRS.
270
PLAN OF
DISTRIBUTION
This prospectus is to be used by Banc of America Securities LLC,
Merrill Lynch, Pierce, Fenner & Smith Incorporated and
their affiliates in connection with offers and sales of the
notes in market-making transactions effected from time to time.
Such affiliates may act as principal or agent in such
transactions, including as agent for the counterparty when
acting as principal or as agent for both counterparties, and may
receive compensation in the form of discounts and commissions,
including from both counterparties, when they act as agents for
both. Such sales will be made at prevailing market prices at the
time of sale, at prices related thereto or at negotiated prices.
We will not receive any of the proceeds from such sales.
Merrill Lynch Global Private Equity (previously the private
equity arm of Merrill Lynch & Co., Inc., which is a
wholly-owned subsidiary of Bank of America Corporation), owned
24.8% of our common stock, and other affiliates of Bank of
America Corporation owned an additional 1.0% of our common
stock, as of April 30, 2009. The agreement among the
investors in HCA Inc., including Merrill Lynch Global Private
Equity, gives such investors the right to elect members to serve
on our Board of Directors. In addition, Banc of America
Securities LLC or its affiliates, is the administrative agent
under our senior secured credit facilities and, as such, is
entitled to receive and has received fees related thereto. Banc
of America Securities LLC and its affiliates have also in the
past engaged, and may in the future engage, in transactions with
and perform services for, including commercial banking,
financial advisory and investment banking services, us and our
affiliates in the ordinary course of business for which they
have received customary fees and expenses. This section and the
applicable descriptions of certain agreements set forth herein
(including those descriptions incorporated herein by reference
to Item 13. Certain Relationships and Related
Transactions of our 2008
10-K)
constitute notice to potential purchasers of the notes pursuant
to Rule 312(f)(2) of the New York Stock Exchange to the extent
that affiliates of Banc of America Securities LLC may be deemed
to control us for purposes of such rule.
We have been advised by Banc of America Securities LLC that,
subject to applicable laws and regulations, they currently
intend to make a market in the notes. However, they are not
obligated to do so, and any such market-making may be
interrupted or discontinued at any time without notice.
We and Banc of America Securities LLC, among other parties, have
entered into a registration rights agreement with respect to the
use by Banc of America Securities LLC and its affiliates of this
prospectus. Pursuant to such agreement, we agreed to indemnify
Banc of America Securities LLC and Merrill Lynch, Pierce,
Fenner & Smith Incorporated and their affiliates, in
their capacity as a market maker, against certain liabilities,
including liabilities under the Securities Act.
271
EXPERTS
The consolidated financial statements of HCA Inc. appearing in
HCA Inc.s Current Report
(Form 8-K)
dated May 27, 2009 for the year ended December 31,
2008, and the effectiveness of HCA Inc.s internal control
over financial reporting as of December 31, 2008 included
in its Annual Report
(Form 10-K)
have been audited by Ernst & Young LLP, an independent
registered public accounting firm, as set forth in their reports
thereon, included therein, and incorporated herein by reference.
Such consolidated financial statements and HCA Inc.
managements assessment of the effectiveness of internal
control over financial reporting as of December 31, 2008
are incorporated herein by reference in reliance upon such
reports given on the authority of such firm as experts in
accounting and auditing.
LEGAL
OPINIONS
Robert A. Waterman, Esq., our Senior Vice President and
General Counsel, and Simpson Thacher & Bartlett LLP,
New York, New York, have each provided an opinion regarding the
validity of HCA Inc.s debt securities and the related
guarantees referenced herein. An investment vehicle comprised of
several partners of Simpson Thacher & Bartlett LLP,
members of their families, related persons and others own
interests representing less than 1% of the capital commitments
of the KKR Millennium Fund, L.P. and KKR 2006 Fund L.P,
which indirectly own capital stock of HCA Inc. In addition,
Robert A. Waterman, Esq. beneficially owns, directly and
indirectly, less than 1% of the capital stock of HCA Inc.
272
HCA
Inc.
Debt
Securities
Prospectus
,
2009
PART II
INFORMATION
NOT REQUIRED IN PROSPECTUS
|
|
Item 13.
|
Other
Expenses of Issuance and Distribution
|
The registration rights agreement relating to the securities of
the Registrant being registered hereby provides that HCA Inc.
will bear all expenses in connection with the performance of its
obligation relating to the market-making activities of Banc of
America Securities LLC, Merrill Lynch, Pierce,
Fenner & Smith Incorporated or their affiliates. These
expenses include the following:
|
|
|
|
|
Attorneys fees and expenses
|
|
|
75,000
|
*
|
Accountants fees and expenses
|
|
|
25,000
|
*
|
Printing expenses
|
|
|
100,000
|
*
|
|
|
|
|
|
Total
|
|
$
|
200,000
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 14.
|
Indemnification
of Directors and Officers.
|
Set forth below are summaries of the statutes, charter
provisions, by-laws, contracts or other arrangements under which
the directors and officers of the Company and the additional
registrant guarantors may be indemnified against liability which
they may incur in their capacity as such. In the summaries that
follow, defined terms used in each respective subsection apply
only to that subsection.
California
Registrants
(a) Columbia ASC Management, L.P. and Riverside
Healthcare System, L.P. are registered under the laws of
California.
The partnership agreements of Columbia ASC Management, L.P. and
Riverside Healthcare System, L.P. provide that the limited
partner shall indemnify and hold harmless the general partner;
its partners, managers, employees, agents and representatives;
and the officers, directors, employees, agents and
representatives of its partners to the fullest extent permitted
by the California Limited Partnership Act and the California
Revised Partnership Act. Neither of these acts, however,
addresses indemnification.
Section 15904.06 (Operative January 1, 2008) of
the 2008 California Revised Limited Partnership Act addresses
the rights of a general partner with respect to its management
and conduct of partnership activities. The 2008 California
Revised Limited Partnership Act provides that a limited
partnership shall reimburse a general partner for payments made,
and indemnify a general partner for liabilities incurred by, the
general partner in the ordinary course of the activities of the
partnership or for the preservation of its activities or
property.
(b) Columbia Riverside, Inc., Encino Hospital
Corporation, Inc., Los Robles Regional Medical Center and MCA
Investment Company are incorporated under the laws of
California.
Section 317 of the California General Corporation Law sets
forth the provisions pertaining to the indemnification of
corporate agents. For purposes of this law, an agent
is any person who is or was a director, officer, employee or
other agent of a corporation, or is or was serving at the
request of the corporation in such capacity with respect to any
other corporation, partnership, join venture, trust or other
enterprise. Indemnification for expenses, including amounts paid
on settling or otherwise disposing of a threatened or pending
action or defending against the same, can be made in certain
circumstances by action of the company through:
|
|
|
|
|
a majority vote of a quorum of the corporations Board of
Directors consisting of directors who are not party to the
proceedings;
|
II-1
|
|
|
|
|
approval of the shareholders, with the shares owned by the
person to be indemnified not being entitled to vote
thereon; or
|
|
|
|
such court in which the proceeding is or was pending upon
application by designated parties.
|
Under certain circumstances, an agent can be indemnified, even
when found liable. Indemnification is mandatory where the
agents defense is successful on the merits. The law allows
a corporation to make advances of expenses for certain actions
upon the receipt of an undertaking that the agent will reimburse
the corporation if the agent is found liable. The
indemnification provided by Section 317 for acts while
serving as a director or officer of the corporation, but not
involving breach of duty to the corporation and its
shareholders, shall not be deemed exclusive of any other rights
to which those seeking indemnification may be entitled under any
bylaw to the extent authorized by the corporations
articles of the corporation.
The bylaws of each of the California Registrants in this
section (b) provide, in relevant part, that each of the
Registrants will indemnify its respective officers and
directors, under the circumstances and to the extent provided
for therein, for expenses, damages, judgments, fines and
settlements such officers and directors may be required to pay
in any action, suit or proceeding which they are or may be made
a party by reason of their position as a director, officer or
other agent of such Registrant, and otherwise to the full extent
permitted under California law and our bylaws for any taken on
behalf of the corporation that does not involve gross negligence
or willful misconduct.
(c) Surgicare of Riverside, LLC is registered under the
laws of California.
Under Section 17155 of the California Limited Liability
Company Act, except for a breach of duty, the articles of
organization or written operating agreement of a limited
liability company may provide for indemnification of any person,
including, without limitation, any manager, member, officer,
employee or agent of the limited liability company, against
judgments, settlements, penalties, fines or expenses of any kind
incurred as a result of acting in that capacity. A limited
liability company shall have the power to purchase and maintain
insurance on behalf of any manager, member, officer, employee or
agent of the limited liability company against any liability
asserted against or incurred by the person in that capacity or
arising out of the persons status as a manager, member,
officer, employee or agent of the limited liability company.
The limited liability company agreement of Surgicare of
Riverside, LLC states that the company shall indemnify its
officers and managers against all reasonable expense incurred by
them in defending claims or suits, irrespective of the time of
the occurrence of the claims or causes of action in such suits,
made or brought against them as officers or managers of the
company, and against all liability in such suits, except in such
cases as involve gross negligence or willful misconduct in the
performance of their duties. Such indemnification extends to the
payment of judgments against such officers and managers and to
reimbursement of amounts paid in settlement of such claims or
actions and may apply to judgments in favor of the company or
amounts paid in settlement to the company. Such indemnification
also extends to the payment of counsel fees and expenses of such
officers and managers in suits against them where successfully
defended by them or where unsuccessfully defended, if there is
no finding or judgment that the claim or action arose from the
gross negligence or willful misconduct of such officers or
directors. Such right of indemnification is not exclusive of any
right to which such officer or director may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and directors.
Colorado
Registrants
(a) Colorado Health Systems, Inc., Columbine Psychiatric
Center, Inc. and New Rose Holding Company, Inc. are incorporated
under the laws of Colorado.
Sections 7-109-102
through 7-109-110 of the Colorado Business Corporation Act (the
Act) grant the registrants broad powers to
indemnify any person in connection with legal proceedings
brought against him by reason of his present or past status as
an officer or director of the registrant, provided with respect
to conduct in an official capacity with the registrant, the
person acted in good faith and in a manner he reasonably
believed to be in the best interests of the registrant, with
respect to all other conduct, the person believed the conduct to
be at least not opposed to the best interests of the registrant,
and with respect to any
II-2
criminal action or proceeding, the person had no reasonable
cause to believe his conduct was unlawful. Indemnification is
limited to reasonable expenses incurred in connection with the
proceeding. No indemnification may be made (i) in
connection with a proceeding by or in the right of the
registrant in which the person was adjudged liable to the
registrant; or (ii) in connection with any other
proceedings charging that the person derived an improper
personal benefit, whether or not involving action in an official
capacity, in which proceeding the person was judged liable on
the basis that he derived an improper personal benefit, unless
and only to the extent the court in which such action was
brought or another court of competent jurisdiction determines
upon application that, despite such adjudication, but in view of
all relevant circumstances, the person is fairly and reasonably
entitled to indemnity for reasonable expenses as the court deems
proper. In addition, to the extent that any such person is
successful in the defense of any such legal proceeding, the
registrant is required by the Act to indemnify him against
reasonable expenses.
The bylaws of these Colorado registrants state that the
corporation shall indemnify its officers and directors against
all reasonable expense incurred by them in defending claims or
suits, irrespective of the time of the occurrence of the claims
or causes of action in such suits, made or brought against them
as officers or directors of the corporation, and against all
liability in such suits, except in such cases as involve gross
negligence or willful misconduct in the performance of their
duties. Such indemnification extends to the payment of judgments
against such officers and directors and to reimbursement of
amounts paid in settlement of such claims or actions and may
apply to judgments in favor of the corporation or amounts paid
in settlement to the corporation. Such indemnification also
extends to the payment of counsel fees and expenses of such
officers and directors in suits against them where successfully
defended by them or where unsuccessfully defended, if there is
no finding or judgment that the claim or action arose from the
gross negligence or willful misconduct of such officers or
directors. Such right of indemnification is not exclusive of any
right to which such officer or director may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and directors.
Delaware
Registrants
(a) HCA Inc., American Medicorp Development Co.,
GPCH-GP, Inc., HCA IT&S Field Operations, Inc.,
HCA IT&S Inventory Management, Inc., Management
Services Holdings, Inc., Midwest Holdings, Inc., Hospital
Development Properties, Inc., Riverside Hospital, Inc., Terre
Haute Hospital GP, Inc. and Terre Haute Hospital Holdings, Inc.
are incorporated under the laws of Delaware.
Section 145 of the Delaware General Corporation Law (the
DGCL) grants each corporation organized thereunder
the power to indemnify any person who is or was a director,
officer, employee or agent of a corporation or enterprise,
against expenses, including attorneys fees, judgments,
fines and amounts paid in settlement actually and reasonably
incurred by him in connection with any threatened, pending or
completed action, suit or proceeding, whether civil, criminal,
administrative or investigative, other than an action by or in
the right of the corporation, by reason of being or having been
in any such capacity, if he acted in good faith in a manner
reasonably believed to be in, or not opposed to, the best
interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe his
conduct was unlawful.
Section 102(b)(7) of the DGCL enables a corporation in its
certificate of incorporation or an amendment thereto to
eliminate or limit the personal liability of a director to the
corporation or its stockholders of monetary damages for
violations of the directors fiduciary duty of care, except
(i) for any breach of the directors duty of loyalty
to the corporation or its stockholders, (ii) for acts or
omissions not in good faith or that involve intentional
misconduct or a knowing violation of law, (iii) pursuant to
Section 174 of the DGCL (providing for liability of
directors for unlawful payment of dividends or unlawful stock
purchases or redemptions) or (iv) for any transaction from
which a director derived an improper personal benefit.
HCA Inc.s bylaws indemnify the directors and officers to
the full extent of the DGCL and also allow the Board of
Directors to indemnify all other employees. The bylaws of the
remainder of the Delaware corporate registrants indemnify their
officers and directors against all reasonable expense incurred
by them in defending claims or suits, irrespective of the time
of the occurrence of the claims or causes of action in such
suits, made or brought against them as officers or directors of
the corporation, and against all liability in such suits, except
II-3
in such cases as involve gross negligence or willful misconduct
in the performance of their duties. Such indemnification extends
to the payment of judgments against such officers and directors
and to reimbursement of amounts paid in settlement of such
claims or actions and may apply to judgments in favor of the
corporation or amounts paid in settlement to the corporation.
Such indemnification also extends to the payment of counsel fees
and expenses of such officers and directors in suits against
them where successfully defended by them or where unsuccessfully
defended, if there is no finding or judgment that the claim or
action arose from the gross negligence or willful misconduct of
such officers or directors. Such right of indemnification is not
exclusive of any right to which such officer or director may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and directors.
(b) Nashville Shared Services General Partnership is a
general partnership under the laws of Delaware and Integrated
Regional Laboratories, LLP is registered under the laws of
Delaware.
Section 15-110
of the Delaware Revised Uniform Partnership Act provides that
subject to such standards and restrictions, if any, as are set
forth in its partnership agreement, a partnership may, and shall
have the power to, indemnify and hold harmless any partner or
other person from and against any and all claims and demands
whatsoever.
The Nashville Shared Services General Partnership partnership
agreement states that indemnification is controlled by the
Delaware Revised Uniform Partnership Act. The partnership
agreement of Integrated Regional Laboratories, LLP indemnifies
its officers and directors against all reasonable expense
incurred by them in defending claims or suits, irrespective of
the time of the occurrence of the claims or causes of action in
such suits, made or brought against them as officers or
directors of the company, and against all liability in such
suits, except in such cases as involve gross negligence or
willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the company or amounts paid in settlement to the
company. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and directors in
suits against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or directors. Such right of
indemnification is not exclusive of any right to which such
officer or director may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
directors.
(c) Centerpoint Medical Center of Independence, LLC, CMS
GP, LLC, Dallas/Ft. Worth Physician, LLC, Edmond Regional
Medical Center, LLC, EP Health, LLC, Fairview Park GP, LLC,
General Healthserv, LLC, Goppert-Trinity Family Care, LLC, Grand
Strand Regional Medical Center, LLC, Healthtrust MOB, LLC, HSS
Holdco, LLC, HSS Systems VA, LLC, HSS Systems, LLC, Lakeland
Medical Center, LLC, Lakeview Medical Center, LLC, Lewis-Gale
Medical Center, LLC, Medical Centers of Oklahoma, LLC, Medical
Office Buildings of Kansas, LLC, Midwest Division
ACH, LLC, Midwest Division LRHC, LLC, Midwest
Division LSH, LLC, Midwest Division MCI,
LLC, Midwest Division MMC, LLC, Midwest
Division OPRMC, LLC, Midwest Division
PFC, LLC, Midwest Division RMC, LLC, Midwest
Division RPC, LLC, Notami Hospitals, LLC, Outpatient
Cardiovascular Center of Central Florida, LLC, Reston Hospital
Center, LLC, Samaritan, LLC, San Jose Medical Center, LLC,
San Jose, LLC, SJMC, LLC, Trident Medical Center, LLC, Utah
Medco, LLC and Wesley Medical Center, LLC are registered under
the laws of Delaware.
Section 18-108
of the Delaware Limited Liability Company Act empowers a
Delaware limited liability company to indemnify and hold
harmless any member or manager of the limited liability company
from and against any and all claims and demands whatsoever.
The operating agreement of Healthtrust MOB, LLC indemnifies the
directors and officers to the full extent of the law. The
operating agreements of the remainder of the Delaware limited
liability company registrants indemnify their officers and
directors against all reasonable expense incurred by them in
defending claims or suits, irrespective of the time of the
occurrence of the claims or causes of action in such suits, made
or brought against them as officers or directors of the company,
and against all liability in such suits, except in such cases as
involve gross negligence or willful misconduct in the
performance of their duties. Such
II-4
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the company or amounts paid in settlement to the
company. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and directors in
suits against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or directors. Such right of
indemnification is not exclusive of any right to which such
officer or director may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
directors.
(d) CHCA Bayshore, L.P., CHCA Conroe, L.P., CHCA
Mainland, L.P., CHCA West Houston, L.P., CHCA Womans
Hospital, L.P., Columbia Valley Healthcare System, L.P.,
Columbia Rio Grande Healthcare, L.P., HCA Management Services,
L.P., Good Samaritan Hospital, L.P., JFK Medical Center Limited
Partnership, Palms West Hospital Limited Partnership, Plantation
General Hospital, L.P., San Jose Healthcare System, LP,
Terre Haute Regional Hospital, L.P. and San Jose Hospital,
L.P. are registered under the laws of Delaware.
Section 17-108
of the Delaware Revised Uniform Limited Partnership Act (DRULPA)
permits a limited partnership to indemnify and hold harmless any
partner or other person from and against any and all claims and
demands whatsoever.
The Columbia Valley Healthcare System, L.P. partnership
agreement allows the partnership to indemnify the general
partners for everything but willful misconduct or gross
negligence. The other Delaware limited partnership registrants
allow for indemnification to the fullest extent under the DRULPA.
Florida
Registrants
(a) Bay Hospital, Inc., Central Florida Regional
Hospital, Inc., Columbia Jacksonville Healthcare System, Inc.,
Edward White Hospital, Inc., HCA Health Services of Florida,
Inc., HD&S Corp. Successor, Inc., Largo Medical Center,
Inc., Lawnwood Medical Center, Inc., Marion Community Hospital,
Inc., Memorial Healthcare Group, Inc., New Port Richey Hospital,
Inc., North Florida Immediate Care Center, Inc., North Florida
Regional Medical Center, Inc., Okaloosa Hospital, Inc.,
Okeechobee Hospital, Inc., Sarasota Doctors Hospital, Inc., Sun
City Hospital, Inc., Surgicare of Brandon, Inc., Surgicare of
Florida, Inc., Surgicare of Manatee, Inc., Surgicare of New Port
Richey, Inc., Tallahassee Medical Center, Inc. and West Florida
Regional Medical Center, Inc. are incorporated under the laws of
Florida.
Section 607.0831 of the Florida Business Corporation Act
provides, among other things, that a director is not personally
liable for monetary damages to a company or any other person for
any statement, vote, decision, or failure to act, by the
director, regarding corporate management or policy, unless the
director breached or failed to perform his or her duties as a
director and such breach or failure constitutes (a) a
violation of criminal law, unless the director had reasonable
cause to believe his or her conduct was lawful or had no
reasonable cause to believe his or her conduct was unlawful;
(b) a transaction from which the director derived an
improper personal benefit; (c) a circumstance under which
the liability provisions of Section 607.0834 of the Florida
Business Corporation Act (relating to the liability of the
directors for improper distributions) are applicable;
(d) willful misconduct or a conscious disregard for the
best interest of the company in the case of a proceeding by or
in the right of the company to procure a judgment in its favor
or by or in the right of a stockholders; or
(e) recklessness or an act or omission in bad faith or with
malicious purpose of with wanton and willful disregard of human
rights, safety or property, in a proceeding by or in the right
of someone other than such company or a stockholder.
Section 607.0850 of the Florida Business Corporation Act
authorizes, among other things, a company to indemnify any
person who was or is a party to any proceeding (other than an
action by or in the right of the company) by reason of the fact
that he is or was a director, officer, employee or agent of the
company (or is or was serving at the request of the company in
such a position for any entity) against liability incurred in
connection with such proceedings, if he or she acted in good
faith and in a manner reasonably believed to be
II-5
in the best interests of the company and, with respect to
criminal proceedings, had no reasonable cause to believe his or
her conduct was unlawful.
The Florida Business Corporation Act requires that a director,
officer or employee be indemnified for actual and reasonable
expenses (including attorneys fees) to the extent that he
or she has been successful on the merits or otherwise in the
defense of any proceeding. Florida law also allows expenses of
defending a proceeding to be advanced by a company before the
final disposition of the proceedings, provided that the officer,
director or employee undertakes to repay such advance if it is
ultimately determined that indemnification is not permitted.
The Florida Business Corporation Act states that the
indemnification and advancement of expenses provided pursuant to
Section 607.0850 is not exclusive and that indemnification
may be provided by a company pursuant to other means, including
agreements or bylaw provisions. Florida law prohibits
indemnification or advancement of expenses, however, if a
judgment or other final adjudication establishes that the
actions of a director, officer or employee constitute (i) a
violation of criminal law, unless he or she had reasonable cause
to believe his or her conduct was lawful or had no reasonable
cause to believe his or her conduct was unlawful; (ii) a
transaction from which such person derived an improper personal
benefit; (iii) willful misconduct or conscious disregard
for the best interests of the company in the case of a
derivative action or a proceeding by or in the right of a
stockholder, or (iv) in the case of a director, a
circumstance under which the liability provisions of
Section 607.0834 of the Florida Business Corporation Act
(relating to the liability of directors for improper
distributions) are applicable.
The bylaws of all the Florida corporate registrants indemnify
their officers and directors against all reasonable expense
incurred by them in defending claims or suits, irrespective of
the time of the occurrence of the claims or causes of action in
such suits, made or brought against them as officers or
directors of the corporation, and against all liability in such
suits, except in such cases as involve gross negligence or
willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the corporation or amounts paid in settlement to the
corporation. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and directors in
suits against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or directors. Such right of
indemnification is not exclusive of any right to which such
officer or director may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
directors.
(b) Integrated Regional Lab, LLC and Surgicare of Palms
West, LLC are registered under the laws of Florida.
Section 608.4229 of the Florida Limited Liability Company
Act indemnifies members, managers, managing members, officers,
employees, and agents subject to such standards and
restrictions, if any, as are set forth in its articles of
organization or operating agreement. A limited liability company
may, and has the power to, but is not be required to, indemnify
and hold harmless any member or manager or other person from and
against any and all claims and demands whatsoever.
Notwithstanding the foregoing, indemnification or advancement of
expenses should not be made to or on behalf of any member,
manager, managing member, officer, employee, or agent if a
judgment or other final adjudication establishes that the
actions, or omissions to act, of such member, manager, managing
member, officer, employee, or agent were material to the cause
of action so adjudicated and constitute any of the following:
(i) a violation of criminal law, unless the member,
manager, managing member, officer, employee, or agent had no
reasonable cause to believe such conduct was unlawful;
(ii) a transaction from which the member, manager, managing
member, officer, employee, or agent derived an improper personal
benefit; (iii) in the case of a manager or managing member,
a circumstance under which the liability provisions of s.
608.426 are applicable; or (iv) willful misconduct or a
conscious
II-6
disregard for the best interests of the limited liability
company in a proceeding by or in the right of the limited
liability company to procure a judgment in its favor or in a
proceeding by or in the right of a member.
The operating agreements of both of the Florida limited
liability company registrants indemnify their officers and
managers against all reasonable expense incurred by them in
defending claims or suits, irrespective of the time of the
occurrence of the claims or causes of action in such suits, made
or brought against them as officers or managers of the company,
and against all liability in such suits, except in such cases as
involve gross negligence or willful misconduct in the
performance of their duties. Such indemnification extends to the
payment of judgments against such officers and managers and to
reimbursement of amounts paid in settlement of such claims or
actions and may apply to judgments in favor of the company or
amounts paid in settlement to the company. Such indemnification
also extends to the payment of counsel fees and expenses of such
officers and managers in suits against them where successfully
defended by them or where unsuccessfully defended, if there is
no finding or judgment that the claim or action arose from the
gross negligence or willful misconduct of such officers or
managers. Such right of indemnification is not exclusive of any
right to which such officer or manager may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and managers.
Georgia
Registrants
(a) Columbia Polk General Hospital, Inc., Columbus
Cardiology, Inc., Marietta Surgical Center, Inc., Palmyra Park
Hospital, Inc. and Redmond Physician Practice Company are
incorporated under the laws of Georgia.
Section 14-2-202(b)(4)
of the Georgia Business Corporation Code provides that a
corporations articles of incorporation may include a
provision that eliminates or limits the liability of directors
for monetary damages to a corporation or its shareholders for
any action taken, or failure to take any action, as a director.
The section does not, however, authorize a corporation to
eliminate or limit the liability of a director for
appropriating, in violation of his or her duties, any business
opportunity of the corporation, for acts or omissions which
involve intentional misconduct or a knowing violation of law,
for any transaction from which the director received an improper
personal benefit, or authorizing a dividend, stock repurchase or
redemption, distribution of assets or other distribution in
violation of
Section 14-2-640
of the Georgia Business Corporation Code if it is established
that the director did not perform his or her duties in
compliance with
Section 14-2-832
of the Georgia Business Corporation Code, which sets forth
general standards for directors.
Section 14-2-202(b)(4)
also does not eliminate or limit the right of a corporation or
any shareholder to seek an injunction, a rescission or any other
equitable (non-monetary) relief for any action taken or not
taken by a director. In addition,
Section 14-2-202(b)(4)
applies only to claims against a director arising out of his or
her role as a director and does not relieve a director from
liability arising from his or her role as an officer or in any
other capacity.
Sections 14-2-852
and 14-2-857
of the Georgia Business Corporation Code provide that any
director or officer who is wholly successful in the defense of
any proceeding to which he or she was a party because her or she
was an officer or a director of the corporation are entitled to
indemnification against reasonable expenses as of right. On the
other hand, if the charges made in any action are sustained, the
determination of whether the required standard of conduct has
been met will be made, in accordance with the provisions of
Georgia Business Corporation Code
Section 14-2-855,
by either the board of directors or a committee thereof, acting
by disinterested members, by special legal counsel or by the
shareholders, but shares owned by or voted under the control of
directors seeking indemnification may not be voted.
The bylaws of each of the Georgia corporate registrants
indemnify their officers and directors against all reasonable
expense incurred by them in defending claims or suits,
irrespective of the time of the occurrence of the claims or
causes of action in such suits, made or brought against them as
officers or directors of the corporation, and against all
liability in such suits, except in such cases as involve gross
negligence or willful misconduct in the performance of their
duties. Such indemnification extends to the payment of judgments
against such officers and directors and to reimbursement of
amounts paid in settlement of such claims or actions and may
apply to judgments in favor of the corporation or amounts paid
in settlement to the corporation. Such indemnification also
extends to the payment of counsel fees and expenses of such
officers
II-7
and directors in suits against them where successfully defended
by them or where unsuccessfully defended, if there is no finding
or judgment that the claim or action arose from the gross
negligence or willful misconduct of such officers or directors.
Such right of indemnification is not exclusive of any right to
which such officer or director may be entitled as a matter of
law and shall extend and apply to the estates of deceased
officers and directors.
(b) Dublin Community Hospital, LLC, Northlake Medical
Center, LLC and Redmond Park Hospital, LLC are registered under
the laws of Georgia.
Georgia law provides that a limited liability company may
indemnify a member, manager or other person against liability
incurred in connection with the limited liability company
subject to any standards or restrictions set forth in the
articles of organization or operating agreement. Unless the
member or manager is aware of information which would cause any
reliance to be unwarranted, he or she is entitled to rely upon
information prepared or presented by other members, managers,
committees and employees of the limited liability company and
legal counsel, public accountants or other professionals or
experts.
However, Georgia law does not permit indemnification if the
member or manager has engaged in any intentional misconduct or a
knowing violation of law or was involved in any transaction in
which the member or manager received a personal benefit as a
result of his or her breach of any provision in the operating
agreement.
The operating agreements of each of the Georgia limited
liability companies indemnify their officers and managers
against all reasonable expense incurred by them in defending
claims or suits, irrespective of the time of the occurrence of
the claims or causes of action in such suits, made or brought
against them as officers or managers of the limited liability
company, and against all liability in such suits, except in such
cases as involve gross negligence or willful misconduct in the
performance of their duties. Such indemnification extends to the
payment of judgments against such officers and managers and to
reimbursement of amounts paid in settlement of such claims or
actions and may apply to judgments in favor of the company or
amounts paid in settlement to the company. Such indemnification
also extends to the payment of counsel fees and expenses of such
officers and directors in suits against them where successfully
defended by them or where unsuccessfully defended, if there is
no finding or judgment that the claim or action arose from the
gross negligence or willful misconduct of such officers or
managers. Such right of indemnification is not exclusive of any
right to which such officer or manager may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and managers.
(c) Fairview Park, Limited Partnership is registered
under the laws of Georgia.
Section 14-9-108
of the Georgia Revised Uniform Limited Partnership Act provides
that:
(a) Subject to any limitations expressly set forth in the
partnership agreement, a limited partnership may, and shall have
the power to, indemnify and hold harmless any partner or other
person from and against any and all claims and demands
whatsoever, provided that the partnership shall not indemnify
any person:
(1) For intentional misconduct or a knowing violation of
law; or
(2) For any transaction for which the person received a
personal benefit in violation or breach of any provision of the
partnership agreement.
(b) To the extent that, at law or in equity, a partner has
duties including but not limited to fiduciary duties and
liabilities relating thereto to a limited partnership or another
partner:
(1) The partners duties and liabilities may be
expanded, restricted, or eliminated by provisions in the
partnership agreement; provided, however, that no such provision
shall eliminate or limit the liability of a partner for
intentional misconduct or a knowing violation of law or for any
transaction for which the partner received a personal benefit in
violation or breach of any provision of the partnership
agreement; and
II-8
(2) The partner shall have no liability to the limited
partnership or to any other partner for his or her good faith
reliance on the provisions of the partnership agreement,
including, without limitation, provisions thereof that relate to
the scope of duties including but not limited to fiduciary
duties of partners.
Fairview Park Limited Partnerships Partnership Agreement
allows the limited partnership to indemnify its general partner,
directors and officers to the full extent of the Georgia Revised
Uniform Limited Partnership Act.
Idaho
Registrants
(a) Eastern Idaho Health Services, Inc. and West Valley
Medical Center, Inc. are incorporated under the laws of
Idaho.
Under Title 30,
Section 30-1-851
of the Idaho Code, the registrants directors and officers
may be indemnified against certain liabilities which they may
incur in their capacities as such. The material terms of the
indemnification provisions are indemnification:
|
|
|
|
|
with respect to civil, criminal, administrative or investigative
proceedings brought because the defendant is or was serving as
an officer, director, employee or agent of the company;
|
|
|
|
for judgments, fines and amounts paid in settlement reasonably
incurred;
|
|
|
|
if the defendant acted in good faith and reasonably believed in
the case of conduct in his official capacity that his conduct
was in the best interests of the company, and in all other cases
that his conduct was at least not opposed to the best interests
of the company; and
|
|
|
|
if, with respect to a criminal proceeding, he had no reasonable
cause to believe his conduct was unlawful.
|
Attorneys fees are included in such indemnification to the
extent the indemnified party is successful on the merits in
defense of the proceeding. If the foregoing criteria are met,
indemnification also applies to a suit threatened or pending by
the company against the officer, director, employee or agent
with respect to attorneys fees unless there is negligence
on the part of the indemnified party. Indemnification is made
only upon a determination by the company that it is proper under
the circumstances because the applicable standard is met.
Generally, expenses for defense may be paid in advance of final
disposition of the proceeding if the indemnified party provides
a written affirmation of his good faith belief that he has met
the relevant standard of conduct under the Idaho Code and
further provides a written undertaking to repay such amounts if
it is determined that the applicable standard has not been met.
The bylaws of both of the Idaho corporate registrants indemnify
their officers and directors against all reasonable expense
incurred by them in defending claims or suits, irrespective of
the time of the occurrence of the claims or causes of action in
such suits, made or brought against them as officers or
directors of the corporation, and against all liability in such
suits, except in such cases as involve gross negligence or
willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the corporation or amounts paid in settlement to the
corporation. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and directors in
suits against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or directors. Such right of
indemnification is not exclusive of any right to which such
officer or director may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
directors.
II-9
Illinois
Registrant
(a) Columbia LaGrange Hospital, Inc. is incorporated
under the laws of Illinois.
Section 8.75 of the Illinois Business Corporation Act of
1983, as amended (the IBCA), provides for a
limitation of director liability. Under Section 8.75 of the
IBCA, directors and officers may be indemnified by the
registrant against all expenses incurred in connection with
actions (including, under certain circumstances, derivative
actions) brought against such director or officer by reason of
his or her status as our representative, or by reason of the
fact that such director or officer serves or served as a
representative of another entity at our request, so long as the
director or officer acted in good faith and in a manner he or
she reasonably believed to be in, or not opposed to, our best
interests.
The bylaws of Columbia La Grange Hospital, Inc indemnify
its officers and directors against all reasonable expense
incurred by them in defending claims or suits, irrespective of
the time of the occurrence of the claims or causes of action in
such suits, made or brought against them as officers or
directors of the corporation, and against all liability in such
suits, except in such cases as involve gross negligence or
willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the corporation or amounts paid in settlement to the
corporation. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and directors in
suits against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or directors. Such right of
indemnification is not exclusive of any right to which such
officer or director may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
directors.
Indiana
Registrant
(a) Terre Haute MOB, L.P. is registered under the laws
of Indiana.
Title 23, Article 16, Chapter 2 of the Indiana
Code provides that a domestic or foreign limited partnership may
indemnify a person made a party to an action because the person
is or was a partner or officer of the partnership against
liability incurred in the action if:
(1) the persons conduct was in good faith; and
(2) the person reasonably believed:
(A) in the case of conduct in the persons capacity as
a partner, that the persons conduct was in the best
interests of the partnership; and
(B) in all other cases that the persons conduct was
at least not opposed to the best interests of the limited
partnership or foreign limited partnership; and
(3) in the case of any criminal action, the person either:
(A) had reasonable cause to believe the persons
conduct was lawful; or
(B) had no reasonable cause to believe the persons
conduct was unlawful.
The indemnification provided for above does not exclude any
other rights to indemnification that a partner or officer of the
limited partnership may have under the partnership agreement or
with the written consent of all partners.
The general partners of Terre Haute MOB, L.P. are indemnified by
the partnership pursuant to the partnership agreement for all
actions relating to their performance or nonperformance on
behalf of the partnership.
II-10
Kentucky
Registrants
(a) Frankfort Hospital, Inc. and Greenview Hospital,
Inc. are incorporated under the laws of Kentucky.
Sections 271B.8-500
to 271B.8-580 of the Kentucky Business Corporation Act; provides
that, subject to restrictions contained in the statute, a
corporation may indemnify any person made or threatened to be
made a party to any threatened, pending or completed action,
suit or proceeding by reason of the fact that he is or was a
director or officer of the corporation. A person who has been
successful on the merits or otherwise in any suit or matter
covered by the indemnification statute shall be indemnified
against expenses (including attorneys fees) reasonably
incurred by him in connection therewith. Indemnification is
authorized upon a determination that the person to be
indemnified has met the applicable standard of conduct required.
Expenses incurred in defense may be paid in advance upon receipt
by the corporation of a written affirmation by the director of
his good faith belief that he has met the applicable standard of
conduct required, a written undertaking by or on behalf of the
director to repay such advance if it is ultimately determined
that he did not meet the standard of conduct, and a
determination that the facts then known to those making the
determination would not preclude indemnification under the
statute. The indemnification provided by statute shall not be
deemed exclusive of any other rights to which those seeking
indemnification may be entitled under any
by-law,
agreement, vote of shareholders or disinterested directors, or
otherwise, which shall inure to the benefit of the heirs,
executors and administrators of such a person. Insurance may be
purchased on behalf of any person entitled to indemnification by
the corporation against any liability incurred in an official
capacity regardless of whether the person could be indemnified
under the statute.
The bylaws of Frankfort Hospital, Inc. and Greenview Hospital,
Inc. indemnify their officers and directors against all
reasonable expense incurred by them in defending claims or
suits, irrespective of the time of the occurrence of the claims
or causes of action in such suits, made or brought against them
as officers or directors of the corporation, and against all
liability in such suits, except in such cases as involve gross
negligence or willful misconduct in the performance of their
duties. Such indemnification extends to the payment of judgments
against such officers and directors and to reimbursement of
amounts paid in settlement of such claims or actions and may
apply to judgments in favor of the corporation or amounts paid
in settlement to the corporation. Such indemnification also
extends to the payment of counsel fees and expenses of such
officers and directors in suits against them where successfully
defended by them or where unsuccessfully defended, if there is
no finding or judgment that the claim or action arose from the
gross negligence or willful misconduct of such officers or
directors. Such right of indemnification is not exclusive of any
right to which such officer or director may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and directors.
Louisiana
Registrants
(a) Dauterive Hospital Corporation, Hamilton Medical
Center, Inc., HCA Health Services of Louisiana, Inc., Notami
Hospitals of Louisiana, Inc. and Womens and
Childrens Hospital, Inc. are incorporated under the laws
of Louisiana.
Section 83 of the Louisiana Business Corporation Law
provides that a corporation may indemnify any person who was or
is a party or is threatened to be made a party to any action,
suit or proceeding, whether civil, criminal, administrative, or
investigative (other than an action by or in the right of the
corporation), by reason of the fact that he is or was a director
or officer of the corporation. The indemnity may include
expenses, including attorneys fees, judgments, fines, and
amounts paid in settlement actually and reasonably incurred by
him in connection with such action, suit, or proceeding if he
acted in good faith and in a manner he reasonably believed to be
in, or not opposed to, the best interests of the corporation,
and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful.
Section 83 further provides that a Louisiana corporation
may indemnify officers and directors in an action by or in the
right of the corporation under the same conditions except that
no indemnification is permitted without judicial approval if the
director or officer shall have been adjudged to be liable for
willful or intentional misconduct in the performance of his duty
to the corporation. Where an officer or director is successful
on the merits or
II-11
otherwise in any defense of any action referred to above or any
claim therein, the corporation must indemnify him against such
expenses that such officer or director actually incurred.
Section 83 permits a corporation to pay expenses incurred
by the officer or director in defending an action, suit or
proceeding in advance of the final disposition thereof if
approved by the board of directors.
The bylaws of each of the Louisiana corporations indemnify their
officers and directors against all reasonable expense incurred
by them in defending claims or suits, irrespective of the time
of the occurrence of the claims or causes of action in such
suits, made or brought against them as officers or directors of
the corporation, and against all liability in such suits, except
in such cases as involve gross negligence or willful misconduct
in the performance of their duties. Such indemnification extends
to the payment of judgments against such officers and directors
and to reimbursement of amounts paid in settlement of such
claims or actions and may apply to judgments in favor of the
corporation or amounts paid in settlement to the corporation.
Such indemnification also extends to the payment of counsel fees
and expenses of such officers and directors in suits against
them where successfully defended by them or where unsuccessfully
defended, if there is no finding or judgment that the claim or
action arose from the gross negligence or willful misconduct of
such officers or directors. Such right of indemnification is not
exclusive of any right to which such officer or director may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and directors.
Mississippi
Registrant
(a) Brookwood Medical Center of Gulfport, Inc. is
incorporated under the laws of Mississippi.
Article 8, Subarticle E of the Mississippi Business
Corporation Act (MBCA) permits Mississippi
corporations to indemnify officers and directors. MBCA
Section 79-4-2.02(b)(5)
permits the corporation to include an obligatory indemnification
for directors in its Articles of Incorporation for all acts
other than: (i) distributions made in excess of standards
established by Mississippi law or in the corporations
articles of incorporation, for which
Section 79-4-8.33
imposes personal liability on directors to the corporation; and
(ii) circumstances where, in his performance as a director,
a director has received a financial benefit to which he is not
entitled, he intentionally inflicts harm on the corporation or
its stockholders or he intentionally violates any criminal law.
The law further permits us to advance all expenses for defense
of a director in any lawsuit brought against a director in his
capacity as a director. The MBCA specifically provides in
Section 79-4-8.53
that such advances are allowed by Mississippi law. Such advances
may be made under the MBCA only after a determination that the
director met all relevant standards of conduct.
Section 79-4-8.56
of the MBCA permits a Mississippi corporation to indemnify any
officer to the same extent as to a director. Indemnification of
officers and directors against reasonable expenses is mandatory
under
Section 79-4-8.52
of the MBCA to the extent the officer or director is successful
on the merits or otherwise in the defense of any action or suit
against him giving rise to a claim of indemnification.
The bylaws of Brookwood Medical Center of Gulfport, Inc
indemnify its officers and directors against all reasonable
expense incurred by them in defending claims or suits,
irrespective of the time of the occurrence of the claims or
causes of action in such suits, made or brought against them as
officers or directors of the corporation, and against all
liability in such suits, except in such cases as involve gross
negligence or willful misconduct in the performance of their
duties. Such indemnification extends to the payment of judgments
against such officers and directors and to reimbursement of
amounts paid in settlement of such claims or actions and may
apply to judgments in favor of the corporation or amounts paid
in settlement to the corporation. Such indemnification also
extends to the payment of counsel fees and expenses of such
officers and directors in suits against them where successfully
defended by them or where unsuccessfully defended, if there is
no finding or judgment that the claim or action arose from the
gross negligence or willful misconduct of such officers or
directors. Such right of indemnification is not exclusive of any
right to which such officer or director may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and directors.
II-12
Missouri
Registrants
(a) Health Midwest Office Facilities Corporation and
Health Midwest Ventures Group, Inc. are incorporated under the
laws of Missouri.
Section 351.355(1) of the Revised Statutes of Missouri
provides that a corporation may indemnify a director or officer
of the corporation in any action, suit or proceeding other than
an action by or in the right of the corporation, against
expenses (including attorneys fees), judgments, fines and
settlement amounts actually and reasonably incurred by him in
connection with such action, suit or proceeding if he acted in
good faith and in a manner he reasonably believed to be in or
not opposed to the best interests of the corporation and, with
respect to any criminal action, had no reasonable cause to
believe his conduct was unlawful. Section 351.355(2)
provides that the corporation may indemnify any such person in
any action or suit by or in the right of the corporation against
expenses (including attorneys fees) and settlement amounts
actually and reasonably incurred by him in connection with the
defense or settlement of the action or suit if he acted in good
faith and in a manner he reasonably believed to be in or not
opposed to the best interests of the corporation, except that he
may not be indemnified in respect of any matter in which he has
been adjudged liable for negligence or misconduct in the
performance of his duty to the corporation, unless authorized by
the court. Section 351.355(3) provides that a corporation
shall indemnify any such person against expenses (including
attorneys fees) actually and reasonably incurred by him in
connection with the action, suit or proceeding if he has been
successful in defense of such action, suit or proceeding and if
such action, suit or proceeding is one for which the corporation
may indemnify him under Section 351.355(1) or (2).
Section 351.355(7) provides that a corporation shall have
the power to give any further indemnity to any such person, in
addition to the indemnity otherwise authorized under
Section 351.355, provided such further indemnity is either
(i) authorized, directed or provided for in the articles of
incorporation of the corporation or any duly adopted amendment
thereof or (ii) is authorized, directed or provided for in
any bylaw or agreement of the corporation which has been adopted
by a vote of the shareholders of the corporation, provided that
no such indemnity shall indemnify any person from or on account
of such persons conduct which was finally adjudged to have
been knowingly fraudulent, deliberately dishonest or willful
misconduct.
The bylaws of both Health Midwest Office Facilities Corporation
and Health Midwest Ventures Group, Inc indemnify their officers
and directors against all reasonable expense incurred by them in
defending claims or suits, irrespective of the time of the
occurrence of the claims or causes of action in such suits, made
or brought against them as officers or directors of the
corporation, and against all liability in such suits, except in
such cases as involve gross negligence or willful misconduct in
the performance of their duties. Such indemnification extends to
the payment of judgments against such officers and directors and
to reimbursement of amounts paid in settlement of such claims or
actions and may apply to judgments in favor of the corporation
or amounts paid in settlement to the corporation. Such
indemnification also extends to the payment of counsel fees and
expenses of such officers and directors in suits against them
where successfully defended by them or where unsuccessfully
defended, if there is no finding or judgment that the claim or
action arose from the gross negligence or willful misconduct of
such officers or directors. Such right of indemnification is not
exclusive of any right to which such officer or director may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and directors.
(b) Midwest Division RBH, LLC is registered
under the laws of Missouri.
The operating agreement of Midwest Division RBH, LLC
indemnifies its officers and managers against all reasonable
expense incurred by them in defending claims or suits,
irrespective of the time of the occurrence of the claims or
causes of action in such suits, made or brought against them as
officers or directors of the company, and against all liability
in such suits, except in such cases as involve gross negligence
or willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the company or amounts paid in settlement to the
company. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and managers in suits
against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such
II-13
officers or managers. Such right of indemnification is not
exclusive of any right to which such officer or manager may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and managers.
The Missouri Limited Liability Company Act is silent with
respect to the limits of a limited liability companys
ability to provide for the indemnification of its officers and
managers in its operating agreement. However,
Section 347.081(2) states that it is the policy of the
Missouri Limited Liability Company Act to give the maximum
effect to the principle of freedom of contract and to the
enforceability of operating agreements.
Nevada
Registrants
(a) Las Vegas Surgicare, Inc., Sunrise Mountainview
Hospital, Inc., VH Holdco, Inc., VH Holdings, Inc. and Western
Plains Capital, Inc. are incorporated under the laws of
Nevada.
Chapter 78 of the Nevada Revised Statutes (NRS)
allows directors and officers to be indemnified against
liabilities they may incur while serving in such capacities.
Under the applicable statutory provisions, the registrant may
indemnify its directors or officers who were or are a party or
are threatened to be made a party to any threatened, pending, or
completed action, suit, or proceeding, whether civil, criminal,
administrative, or investigative, by reason of the fact that
they are or were directors or officers of the corporation, or
are or were serving at the request of the corporation as
directors or officers of another corporation, partnership, joint
venture, trust, or other enterprise, against expenses, including
attorneys fees, judgments, fines, and amounts paid in
settlement, actually and reasonably incurred by them in
connection with the action, suit, or proceeding, unless it is
ultimately determined by a court of competent jurisdiction that
they breached their fiduciary duties by intentional misconduct,
fraud, or a knowing violation of law or did not act in good
faith and in a manner which they reasonably believed to be in or
not opposed to the best interests of the registrant, and, with
respect to any criminal action or proceeding, had no reasonable
cause to believe their conduct was unlawful. In addition, the
applicable statutory provisions mandate that the registrant
indemnify its directors and officers who have been successful on
the merits or otherwise in defense of any action, suit, or
proceeding against expenses, including attorneys fees,
actually and reasonably incurred by him in connection with the
defense. The registrant will advance expenses incurred by
directors or officers in defending any such action, suit, or
proceeding upon receipt of written confirmation from such
officers or directors that they have met certain standards of
conduct and an undertaking by or on behalf of such officers or
directors to repay such advances if it is ultimately determined
that they are not entitled to indemnification by the registrant.
The bylaws of all the Nevada corporate registrants indemnify
their officers and directors against all reasonable expense
incurred by them in defending claims or suits, irrespective of
the time of the occurrence of the claims or causes of action in
such suits, made or brought against them as officers or
directors of the corporation, and against all liability in such
suits, except in such cases as involve gross negligence or
willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the corporation or amounts paid in settlement to the
corporation. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and directors in
suits against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or directors. Such right of
indemnification is not exclusive of any right to which such
officer or director may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
directors.
(b) Southern Hills Medical Center, LLC is registered
under the laws of Nevada.
Section 86.411 of the NRS permits a limited liability
company to indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or
completed action, suit or proceeding (except an action by or in
the right of the limited liability company), by reason of being
or having been a manager or member of the limited liability
company. As with corporations, indemnification may include
attorneys fees, judgments, fines and amounts paid in
settlement actually and reasonably incurred by the person to be
indemnified. Section 86.421 of the NRS permits a limited
liability company to indemnify any
II-14
person who was or is a party or is threatened to be made a party
to any threatened, pending or completed action or suit by or in
the right of the limited liability company to procure a judgment
in its favor by reason of being or having been a manager or
member of the limited liability company except that
indemnification may not be made for any claim, issue or matter
as to which such a person has been finally adjudged by a court
of competent jurisdiction to be liable to the limited liability
company or for amounts paid in settlement to the limited
liability company, unless and only to the extent that the court
in which the action or suit was brought or other court of
competent jurisdiction determines upon application that, in view
of all the circumstances, the person is fairly and reasonably
entitled to indemnity for such expenses as the court deems
proper. In either case, however, to be entitled to
indemnification, the person to be indemnified must have acted in
good faith and in a manner which he or she reasonably believed
to be in or not opposed to the best interests of the limited
liability company and, with respect to any criminal action or
proceeding, had no reasonable cause to believe his or her
conduct was unlawful.
Section 86.431 of the NRS also provides that to the extent
a manager or member of a limited liability company has been
successful on the merits or otherwise in defense of any such
action, he or she must be indemnified by the limited liability
company against expenses, including attorneys fees
actually and reasonably incurred in connection with the defense.
Section 86.441 of the NRS permits a limited liability
company, in its articles of organization, operating agreement or
other agreement, to provide for the payment of expenses incurred
by members or managers in defending any civil or criminal
action, suit or proceeding as they are incurred and in advance
of the final disposition of the action, suit or proceeding, upon
receipt of an undertaking to repay the amount if it is
ultimately determined by a court of competent jurisdiction that
the person is not entitled to indemnification.
Section 86.461 of the NRS permits a limited liability
company to purchase and maintain insurance or make other
financial arrangements on behalf of the limited liability
companys managers or members for any liability and
expenses incurred by them in their capacities as managers or
members or arising out of their status as such, whether or not
the limited liability company has the authority to indemnify
him, her or them against such liability and expenses.
The operating agreement of Southern Hills Medical Center, LLC
indemnifies its officers and managers against all reasonable
expense incurred by them in defending claims or suits,
irrespective of the time of the occurrence of the claims or
causes of action in such suits, made or brought against them as
officers or managers of the company, and against all liability
in such suits, except in such cases as involve gross negligence
or willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and managers and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the company or amounts paid in settlement to the
company. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and managers in suits
against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or managers. Such right of
indemnification is not exclusive of any right to which such
officer or manager may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
managers.
Oklahoma
Registrant
(a) HCA Health Services of Oklahoma, Inc. is
incorporated under the laws of Oklahoma.
Section 1031 of the Oklahoma General Corporation Act
provides that an Oklahoma corporation may indemnify any persons,
including officers and directors, who are, or are threatened to
be made, parties to any threatened, pending or completed legal
action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in
the right of such corporation), by reason of the fact that such
person was an officer or director of such corporation, or is or
was serving at the request of such corporation as a director,
officer, employee or agent of another corporation or enterprise.
The indemnity may include expenses (including attorneys
fees), judgments, fines and amounts paid in settlement actually
and reasonably incurred by such person in connection with such
action, suit or proceeding, provided such officer or director
II-15
acted in good faith and in a manner he reasonably believed to be
in or not opposed to the corporations best interests and,
for criminal proceedings, had no reasonable cause to believe
that his conduct was illegal. An Oklahoma corporation may
indemnify officers and directors in an action by or in the right
of the corporation under the same conditions, except that no
indemnification is permitted without judicial approval if the
officer or director is adjudged to be liable to the corporation.
Where an officer or director is successful on the merits or
otherwise in the defense of any action referred to above, the
corporation must indemnify him against the expenses which such
officer or director actually and reasonably incurred.
The bylaws of HCA Health Services of Oklahoma indemnify its
officers and directors against all reasonable expense incurred
by them in defending claims or suits, irrespective of the time
of the occurrence of the claims or causes of action in such
suits, made or brought against them as officers or directors of
the corporation, and against all liability in such suits, except
in such cases as involve gross negligence or willful misconduct
in the performance of their duties. Such indemnification extends
to the payment of judgments against such officers and directors
and to reimbursement of amounts paid in settlement of such
claims or actions and may apply to judgments in favor of the
corporation or amounts paid in settlement to the corporation.
Such indemnification also extends to the payment of counsel fees
and expenses of such officers and directors in suits against
them where successfully defended by them or where unsuccessfully
defended, if there is no finding or judgment that the claim or
action arose from the gross negligence or willful misconduct of
such officers or directors. Such right of indemnification is not
exclusive of any right to which such officer or director may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and directors.
South
Carolina Registrant
(a) Walterboro Community Hospital, Inc. is incorporated
under the laws of South Carolina.
Under Section 33 of the South Carolina Code of Laws, a
corporation may indemnify an individual made a party to a
proceeding because he is or was a director or officer against
liability incurred in the proceeding if: (1) he conducted
himself in good faith; and (2) he reasonably believed:
(i) in the case of conduct in his official capacity with
the corporation, that his conduct was in its best interest; and
(ii) in all other cases, that his conduct was at least not
opposed to its best interest; and (3) in the case of any
criminal proceeding, he had no reasonable cause to believe his
conduct was unlawful.
The bylaws of Walterboro Community Hospital, Inc indemnify its
officers and directors against all reasonable expense incurred
by them in defending claims or suits, irrespective of the time
of the occurrence of the claims or causes of action in such
suits, made or brought against them as officers or directors of
the corporation, and against all liability in such suits, except
in such cases as involve gross negligence or willful misconduct
in the performance of their duties. Such indemnification extends
to the payment of judgments against such officers and directors
and to reimbursement of amounts paid in settlement of such
claims or actions and may apply to judgments in favor of the
corporation or amounts paid in settlement to the corporation.
Such indemnification also extends to the payment of counsel fees
and expenses of such officers and directors in suits against
them where successfully defended by them or where unsuccessfully
defended, if there is no finding or judgment that the claim or
action arose from the gross negligence or willful misconduct of
such officers or directors. Such right of indemnification is not
exclusive of any right to which such officer or director may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and directors.
Tennessee
Registrants
(a) Central Tennessee Hospital Corporation, HCA Central
Group, Inc., HCA Health Services of Tennessee, Inc., HCA Realty,
Inc., Hendersonville Hospital Corporation, Hospital Corporation
of Tennessee, HTI Memorial Hospital Corporation, Spring Hill
Hospital, Inc. and TCMC
Madison-Portland,
Inc. are incorporated under the laws of Tennessee.
The Tennessee Business Corporation Act (TBCA) sets
forth in
Sections 48-18-502
through
48-18-508
the circumstances governing the indemnification of directors and
officers of a corporation against liability
II-16
incurred in the course of their official capacities.
Section 48-18-502
of the TBCA provides that a corporation may indemnify any
director against liability incurred in connection with a
proceeding if (i) the director acted in good faith,
(ii) the director reasonably believed, in the case of
conduct in his or her official capacity with the corporation,
that such conduct was in the corporations best interest,
or, in all other cases, that his or her conduct was not opposed
to the best interests of the corporation and (iii) in
connection with any criminal proceeding, the director had no
reasonable cause to believe that his or her conduct was
unlawful. In actions brought by or in the right of the
corporation, however, the TBCA provides that no indemnification
may be made if the director or officer is adjudged to be liable
to the corporation. Similarly, the TBCA prohibits
indemnification in connection with any proceeding charging
improper personal benefit to a director, if such director is
adjudged liable on the basis that a personal benefit was
improperly received. In cases where the director is wholly
successful, on the merits or otherwise, in the defense of any
proceeding instigated because of his or her status as a director
of a corporation,
Section 48-18-503
of the TBCA mandates that the corporation indemnify the director
against reasonable expenses incurred in the proceeding.
Notwithstanding the foregoing,
Section 48-18-505
of the TBCA provides that a court of competent jurisdiction,
upon application, may order that a director or officer be
indemnified for reasonable expense if, in consideration of all
relevant circumstances, the court determines that such
individual is fairly and reasonably entitled to indemnification,
whether or not the standard of conduct set forth above was met.
Officers who are not directors are entitled, through the
provisions of
Section 48-18-507
of the TBCA, to the same indemnification afforded to directors
under
Sections 48-18-503
and
48-18-505.
The bylaws of each of the Tennessee corporations indemnify its
officers and directors against all reasonable expense incurred
by them in defending claims or suits, irrespective of the time
of the occurrence of the claims or causes of action in such
suits, made or brought against them as officers or directors of
the corporation, and against all liability in such suits, except
in such cases as involve gross negligence or willful misconduct
in the performance of their duties. Such indemnification extends
to the payment of judgments against such officers and directors
and to reimbursement of amounts paid in settlement of such
claims or actions and may apply to judgments in favor of the
corporation or amounts paid in settlement to the corporation.
Such indemnification also extends to the payment of counsel fees
and expenses of such officers and directors in suits against
them where successfully defended by them or where unsuccessfully
defended, if there is no finding or judgment that the claim or
action arose from the gross negligence or willful misconduct of
such officers or directors. Such right of indemnification is not
exclusive of any right to which such officer or director may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and directors.
Texas
Registrants
(a) Columbia Medical Center of Las Colinas, Inc., Conroe
Hospital Corporation, El Paso Surgicenter, Inc.,
KPH-Consolidation, Inc., National Patient Account Services,
Inc., Pasadena Bayshore Hospital, Inc., Rio Grande Regional
Hospital, Inc., Spring Branch Medical Center, Inc., Surgicare of
Houston Womens, Inc., W & C Hospital, Inc.,
WHMC, Inc. and Womans Hospital of Texas, Incorporated are
incorporated under the laws of Texas.
Under
Article 2.02-1
of the Texas Business Corporation Act (TBCA), a
company may indemnify any person who was, is or is threatened to
be made a named defendant or respondent in a proceeding because
the person is or was a director or officer against judgment,
penalties (including excise and similar taxes), fines,
settlements, and reasonable expenses (including court costs and
attorneys fees) actually incurred by the person in
connection with the proceeding if it is determined that the
person seeking indemnification acted in good faith, reasonably
believed that his or her conduct was in or at least not opposed
to our best interests and, in the case of a criminal proceeding,
has no reasonable cause to believe his or her conduct was
unlawful.
A company is required by
Article 2.02-1
of the TBCA to indemnify a director or officer against
reasonable expenses (including court costs and attorneys
fees) incurred by the director or officer in connection with a
proceeding in which the director or officer is a named defendant
or respondent because the director or officer is or was in that
position if the director or officer has been wholly successful,
on the merits or otherwise, in the defense of the proceeding.
The TBCA prohibits a company from indemnifying a director or
II-17
officer in respect of a proceeding in which the person is found
liable to the company or on the basis that a personal benefit
was improperly received by him or her, other than for reasonable
expenses (including court costs and attorneys fees)
actually incurred by him or her in connection with the
proceeding; provided, that the TBCA further prohibits a company
from indemnifying a director or officer in respect of any such
proceeding in which the person is found liable for willful or
intentional misconduct in the performance of his or her duties.
Under
Article 2.02-1(J)
of the TBCA, a court of competent jurisdiction may order a
company to indemnify a director or officer if the court
determines that the director or officer is fairly and reasonably
entitled to indemnification in view of all the relevant
circumstances; however, if the director or officer is found
liable to the company or is found liable on the basis that a
personal benefit was improperly received by him or her, the
indemnification will be limited to reasonable expenses
(including court costs and attorneys fees) actually
incurred by him or her in connection with the proceeding.
The bylaws of each of the Texas corporations indemnity its
officers and directors against all reasonable expense incurred
by them in defending claims or suits, irrespective of the time
of the occurrence of the claims or causes of action in such
suits, made or brought against them as officers or directors of
the corporation, and against all liability in such suits, except
in such cases as involve gross negligence or willful misconduct
in the performance of their duties. Such indemnification extends
to the payment of judgments against such officers and directors
and to reimbursement of amounts paid in settlement of such
claims or actions and may apply to judgments in favor of the
corporation or amounts paid in settlement to the corporation.
Such indemnification also extends to the payment of counsel fees
and expenses of such officers and directors in suits against
them where successfully defended by them or where unsuccessfully
defended, if there is no finding or judgment that the claim or
action arose from the gross negligence or willful misconduct of
such officers or directors. Such right of indemnification is not
exclusive of any right to which such officer or director may be
entitled as a matter of law and shall extend and apply to the
estates of deceased officers and directors.
(b) Columbia Medical Center of Arlington Subsidiary,
L.P., Columbia Medical Center of Denton Subsidiary, L.P.,
Columbia Medical Center of Lewisville Subsidiary, L.P., Columbia
Medical Center of McKinney Subsidiary, L.P., Columbia Medical
Center of Plano Subsidiary, L.P., Columbia North Hills Hospital
Subsidiary, L.P., Columbia Plaza Medical Center of
Fort Worth Subsidiary, L.P. and Green Oaks Hospital
Subsidiary, L.P. are registered under the laws of Texas.
Article 11 of the Texas Revised Limited Partnership Act
(TRLPA) provides for the indemnification of a
general partner or limited partner by the limited partnership
under certain circumstances against expenses and liabilities
incurred in legal proceedings involving such persons because of
their being or having been a general partner or limited partner.
Under the TRLPA, a limited partnership may purchase insurance on
behalf of a general partner or limited partner against any
liability incurred regardless of whether the person could be
indemnified under the TLRPA.
The partnership agreement of each Texas limited partnership
indemnifies the general partners to the fullest extent permitted
under the TRLPA.
Utah
Registrants
(a) Brigham City Community Hospital, Inc., Columbia
Ogden Medical Center, Inc., Hospital Corporation of Utah,
Mountain View Hospital, Inc., Northern Utah Healthcare
Corporation, St. Marks Lone Peak Hospital, Inc. and
Timpanogos Regional Medical Services, Inc. are incorporated
under the laws of Utah.
Section 16-10a-902
of the Utah Revised Business Corporation Act (the Revised
Act) provides that a corporation may indemnify any
individual who was, is, or is threatened to be made a named
defendant or respondent (a Party) in any threatened,
pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative and whether formal or
informal (a Proceeding), because he or she is or was
a director of the corporation against any obligation incurred
with respect to a Proceeding, including any judgment,
settlement, penalty, fine or reasonable expenses (including
attorneys fees), incurred in the
II-18
Proceeding if his or her conduct was in good faith, he or she
reasonably believed that his or her conduct was in, or not
opposed to, the best interests of the corporation, and, in the
case of any criminal Proceeding, had no reasonable cause to
believe such conduct was unlawful; provided, however, that
(i) pursuant to Subsection 902(5), indemnification under
Section 902 in connection with a Proceeding by or in the
right of the corporation is limited to payment of reasonable
expenses (including attorneys fees) incurred in connection
with the Proceeding and (ii) pursuant to 902(4), the
corporation may not indemnify an Indemnifiable Director in
connection with a Proceeding by or in the right of the
corporation in which the Indemnifiable Director was adjudged
liable to the corporation, or in connection with any other
Proceeding charging that the Indemnifiable Director derived an
improper personal benefit, whether or not involving action in
his or her official capacity, in which Proceeding he or she was
adjudged liable on the basis that he or she derived an improper
personal benefit.
Section 16-10a-907
of the Revised Act permits corporations to indemnify officers
and advance expenses to the same extent as a director and in
some cases to a greater extent than a director.
The bylaws of each of the Utah corporate registrants indemnify
its officers and directors against all reasonable expense
incurred by them in defending claims or suits, irrespective of
the time of the occurrence of the claims or causes of action in
such suits, made or brought against them as officers or
directors of the corporation, and against all liability in such
suits, except in such cases as involve gross negligence or
willful misconduct in the performance of their duties. Such
indemnification extends to the payment of judgments against such
officers and directors and to reimbursement of amounts paid in
settlement of such claims or actions and may apply to judgments
in favor of the corporation or amounts paid in settlement to the
corporation. Such indemnification also extends to the payment of
counsel fees and expenses of such officers and directors in
suits against them where successfully defended by them or where
unsuccessfully defended, if there is no finding or judgment that
the claim or action arose from the gross negligence or willful
misconduct of such officers or directors. Such right of
indemnification is not exclusive of any right to which such
officer or director may be entitled as a matter of law and shall
extend and apply to the estates of deceased officers and
directors.
Virginia
Registrants
(a) Capital Division, Inc., Chippenham &
Johnston-Willis Hospitals, Inc., Columbia/Alleghany Regional
Hospital, Incorporated, Columbia/HCA John Randolph, Inc., HCA
Health Services of Virginia, Inc., Lewis-Gale Hospital,
Incorporated, Montgomery Regional Hospital, Inc., Pulaski
Community Hospital, Inc., Spotsylvania Medical Center, Inc and
Virginia Psychiatric Company, Inc. are incorporated under the
laws of Virginia.
Under
Sections 13.1-697
and 13.1-702 of the Virginia Stock Corporation Act, a Virginia
corporation generally is authorized to indemnify its directors
and officers in civil and criminal actions if they acted in good
faith and believed their conduct to be in the best interests of
the corporation and, in the case of criminal actions, had no
reasonable cause to believe that the conduct was unlawful. In
addition, the Virginia Stock Corporation Act eliminates the
liability for monetary damages of a director or officer in a
shareholder or derivative proceeding. This elimination of
liability will not apply in the event of willful misconduct or a
knowing violation of criminal law or any federal or state
securities law.
Sections 13.1-692.1
and 13.1-696 through 704 of the Virginia Stock Corporation Act
are incorporated into this paragraph by reference.
The bylaws of each of the Virginia corporate registrants
indemnify its officers and directors against all reasonable
expense incurred by them in defending claims or suits,
irrespective of the time of the occurrence of the claims or
causes of action in such suits, made or brought against them as
officers or directors of the corporation, and against all
liability in such suits, except in such cases as involve gross
negligence or willful misconduct in the performance of their
duties. Such indemnification extends to the payment of judgments
against such officers and directors and to reimbursement of
amounts paid in settlement of such claims or actions and may
apply to judgments in favor of the corporation or amounts paid
in settlement to the corporation. Such indemnification also
extends to the payment of counsel fees and expenses of such
officers and directors in suits against them where successfully
defended by them or where unsuccessfully defended, if
II-19
there is no finding or judgment that the claim or action arose
from the gross negligence or willful misconduct of such officers
or directors. Such right of indemnification is not exclusive of
any right to which such officer or director may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and directors.
(b) Central Shared Services, LLC, Galen Property, LLC,
Lewis-Gale Physicians, LLC, Northern Virginia Community
Hospital, LLC and Retreat Hospital, LLC are registered under the
laws of Virginia.
Section 13.1-1009(16)
of the Virginia Limited Liability Company Act permits a limited
liability company to indemnify and hold harmless any member or
manager or other person from and against any and all claims and
demands whatsoever, and to pay for or reimburse any member or
manager or other person for reasonable expenses incurred by such
a person who is a party to a proceeding in advance of final
disposition of the proceeding.
The operating agreements of each of the Virginia limited
liability companies indemnifies its officers and managers
against all reasonable expense incurred by them in defending
claims or suits, irrespective of the time of the occurrence of
the claims or causes of action in such suits, made or brought
against them as officers or managers of the company, and against
all liability in such suits, except in such cases as involve
gross negligence or willful misconduct in the performance of
their duties. Such indemnification extends to the payment of
judgments against such officers and managers and to
reimbursement of amounts paid in settlement of such claims or
actions and may apply to judgments in favor of the company or
amounts paid in settlement to the company. Such indemnification
also extends to the payment of counsel fees and expenses of such
officers and managers in suits against them where successfully
defended by them or where unsuccessfully defended, if there is
no finding or judgment that the claim or action arose from the
gross negligence or willful misconduct of such officers or
managers. Such right of indemnification is not exclusive of any
right to which such officer or manager may be entitled as a
matter of law and shall extend and apply to the estates of
deceased officers and managers.
(c) HSS Virginia, L.P. is registered under the laws of
Virginia
HSS Virginia, L.P. is governed by the Virginia Revised Uniform
Limited Partnership Act. However, neither the partnership
agreement nor the Virginia Revised Uniform Partnership Act
specify the extent to which a limited partnership may indemnify
its general partners.
West
Virginia Registrant
(a) Columbia Parkersburg Healthcare System, LLC is
registered under the laws of West Virginia.
Section 31B-4-403
of the West Virginia Uniform Limited Liability Company Act
discusses members and managers rights to payments
and reimbursement. A limited liability company shall reimburse a
member or manager for payments made and indemnify a member or
manager for liabilities incurred by the member or manager in the
ordinary course of the business of the company or for the
preservation of its business or property. A limited liability
company shall reimburse a member for an advance to the company
beyond the amount of contribution the member agreed to make. A
payment or advance made by a member which gives rise to an
obligation of a limited liability company under the West
Virginia statute constitutes a loan to the company upon which
interest accrues from the date of the payment or advance. A
member is not entitled to remuneration for services performed
for a limited liability company, except for reasonable
compensation for services rendered in winding up the business of
the company.
The organizational documents of Columbia Parkersburg Healthcare
System, LLC indemnify its managers and officers to the fullest
extent of the West Virginia Uniform Limited Liability Company
Act.
II-20
Certain
Other Arrangements
HCA Inc. maintains a directors and officers
liability insurance policy that covers the directors and
officers of each of the registrants in amounts that HCA Inc.
believes are customary in its industry, including for
liabilities in connection with the registration, offering and
sale of the notes.
In addition, pursuant to the Management Agreement entered into
with the Sponsors and their affiliates and the Frists, the
Company has agreed to customary exculpation and indemnification
provisions for the benefit of the Sponsors, the Frists, their
affiliates, directors, officers and certain other persons. See
the section of our fiscal 2008
Form 10-K
captioned Certain Relationships and Related Transactions,
and Director Independence Sponsor Management
Agreement.
|
|
Item 15.
|
Recent
Sales of Unregistered Securities
|
On November 17, 2006, we issued $4.200 billion of
senior secured notes (comprised of $1.000 billion of
91/8% notes
due 2014 and $3.200 billion of
91/4% notes
due 2016) and $1.500 billion of
95/8%/103/8% senior
secured toggle notes due 2016 the proceeds of which were used to
finance the acquisition by certain investors if HCA Inc.
On February 19, 2009, we issued $310 million aggregate
principal amount of senior secured notes due 2017 at a price of
96.673% of their face value resulting in approximately
$300 million of gross proceeds, which were used to repay
outstanding indebtedness under our cash flow credit facility.
On April 22, 2009, we issued $1.500 billion aggregate
principal amount of senior secured notes due 2019 at a price of
96.755% of their face value resulting in approximately
$1.451 billion of gross proceeds, which were used to repay
outstanding indebtedness under our cash flow credit facility.
Each of the above transactions was offered to qualified
institutional buyers pursuant to Rule 144A under the
Securities Act or to
non-U.S. investors
outside the United States in compliance with Regulation S
of the Securities Act.
|
|
Item 16.
|
Exhibits
and Financial Statement Schedules.
|
(a) Exhibits
|
|
|
|
|
|
2
|
.1
|
|
Agreement and Plan of Merger, dated July 24, 2006, by and
among HCA Inc., Hercules Holding II, LLC and Hercules
Acquisition Corporation (filed as Exhibit 2.1 to the
Companys Current Report on
Form 8-K
filed July 25, 2006, and incorporated herein by reference).
|
|
3
|
.1
|
|
Amended and Restated Certificate of Incorporation of the Company
(filed as Exhibit 3.1 to the Companys Annual Report
on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).
|
|
3
|
.2
|
|
Amended and Restated Bylaws of the Company (filed as
Exhibit 3.2 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).
|
|
3
|
.3
|
|
American Medicorp Development Co. Articles of Incorporation*
|
|
3
|
.4
|
|
American Medicorp Development Co. By-Laws*
|
|
3
|
.5
|
|
Bay Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.5 to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.6
|
|
Bay Hospital, Inc. By-Laws. (filed as Exhibit 3.6 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.7
|
|
Brigham City Community Hospital, Inc. Articles of Incorporation.
(filed as Exhibit 3.7 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.8
|
|
Brigham City Community Hospital, Inc. By-Laws. (filed as
Exhibit 3.8 to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-21
|
|
|
|
|
|
3
|
.9
|
|
Brookwood Medical Center of Gulfport, Inc. Certificate of
Incorporation (filed as Exhibit 3.9 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.10
|
|
Brookwood Medical Center of Gulfport, Inc. By-Laws (filed as
Exhibit 3.10 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.11
|
|
Capital Division, Inc. Articles of Incorporation (filed as
Exhibit 3.11 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.12
|
|
Capital Division, Inc. By-Laws (filed as Exhibit 3.12 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.13
|
|
Centerpoint Medical Center of Independence, LLC Certificate of
Formation (filed as Exhibit 3.13 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.14
|
|
Centerpoint Medical Center of Independence, LLC Limited
Liability Company Agreement (filed as Exhibit 3.14 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.15
|
|
Central Florida Regional Hospital, Inc. Articles of
Incorporation (filed as Exhibit 3.15 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.16
|
|
Central Florida Regional Hospital, Inc. By-Laws (filed as
Exhibit 3.16 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.17
|
|
Central Shared Services, LLC Articles of Organization (filed as
Exhibit 3.17 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.18
|
|
Central Shared Services, LLC Limited Liability Company Agreement
(filed as Exhibit 3.18 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.19
|
|
Central Tennessee Hospital Corporation Charter (filed as
Exhibit 3.19 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.20
|
|
Central Tennessee Hospital Corporation By-Laws (filed as
Exhibit 3.20 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.21
|
|
CHCA Bayshore, L.P. Certificate of Limited Partnership (filed as
Exhibit 3.21 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.22
|
|
CHCA Bayshore, L.P. Agreement of Limited Partnership (filed as
Exhibit 3.22 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.23
|
|
CHCA Conroe, L.P. Certificate of Limited Partnership (filed as
Exhibit 3.23 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.24
|
|
CHCA Conroe, L.P. Agreement of Limited Partnership (filed as
Exhibit 3.24 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.25
|
|
CHCA Mainland, L.P. Certificate of Limited Partnership (filed as
Exhibit 3.27 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.26
|
|
CHCA Mainland, L.P. Agreement of Limited Partnership (filed as
Exhibit 3.28 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.27
|
|
CHCA West Houston, L.P. Certificate of Limited Partnership
(filed as Exhibit 3.29 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.28
|
|
CHCA West Houston, L.P. Agreement of Limited Partnership (filed
as Exhibit 3.30 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.29
|
|
CHCA Womans Hospital, L.P. Certificate of Limited
Partnership (filed as Exhibit 3.31 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-22
|
|
|
|
|
|
3
|
.30
|
|
CHCA Womans Hospital, L.P. Agreement of Limited
Partnership (filed as Exhibit 3.32 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.31
|
|
Chippenham & Johnston-Willis Hospitals, Inc. Articles
of Incorporation (filed as Exhibit 3.33 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.32
|
|
Chippenham & Johnston-Willis Hospitals, Inc. By-Laws
(filed as Exhibit 3.34 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.33
|
|
CMS GP, LLC Certificate of Formation (filed as Exhibit 3.35
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.34
|
|
CMS GP, LLC Limited Liability Company Agreement (filed as
Exhibit 3.36 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.35
|
|
Colorado Health Systems, Inc. Articles of Incorporation (filed
as Exhibit 3.37 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.36
|
|
Colorado Health Systems, Inc. By-Laws (filed as
Exhibit 3.38 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.37
|
|
Columbia ASC Management, L.P. Certificate of Limited Partnership
(filed as Exhibit 3.39 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.38
|
|
Columbia ASC Management, L.P. Agreement of Partnership (filed as
Exhibit 3.40 to the Companys Registration Statement
on
Form S-4
(File No. 333-145054), and incorporated herein by reference).
|
|
3
|
.39
|
|
Columbia Jacksonville Healthcare System, Inc. Articles of
Incorporation (filed as Exhibit 3.41 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.40
|
|
Columbia Jacksonville Healthcare System, Inc. By-Laws (filed as
Exhibit 3.42 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.41
|
|
Columbia LaGrange Hospital, Inc. Articles of Incorporation
(filed as Exhibit 3.43 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.42
|
|
Columbia LaGrange Hospital, Inc. By-Laws (filed as
Exhibit 3.44 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.43
|
|
Columbia Medical Center of Arlington Subsidiary, L.P.
Certificate of Limited Partnership (filed as Exhibit 3.45
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.44
|
|
Columbia Medical Center of Arlington Subsidiary, L.P. Agreement
of Limited Partnership (filed as Exhibit 3.46 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.45
|
|
Columbia Medical Center of Denton Subsidiary, L.P. Certificate
of Limited Partnership (filed as Exhibit 3.47 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.46
|
|
Columbia Medical Center of Denton Subsidiary, L.P. Agreement of
Limited Partnership (filed as Exhibit 3.48 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.47
|
|
Columbia Medical Center of Las Colinas, Inc. Articles of
Incorporation (filed as Exhibit 3.49 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.48
|
|
Columbia Medical Center of Las Colinas, Inc. By-Laws (filed as
Exhibit 3.50 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.49
|
|
Columbia Medical Center of Lewisville Subsidiary, L.P.
Certificate of Limited Partnership (filed as Exhibit 3.51
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-23
|
|
|
|
|
|
3
|
.50
|
|
Columbia Medical Center of Lewisville Subsidiary, L.P. Agreement
of Limited Partnership (filed as Exhibit 3.52 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.51
|
|
Columbia Medical Center of McKinney Subsidiary, L.P. Certificate
of Limited Partnership (filed as Exhibit 3.53 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.52
|
|
Columbia Medical Center of McKinney Subsidiary, L.P. Agreement
of Limited Partnership (filed as Exhibit 3.54 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.53
|
|
Columbia Medical Center of Plano Subsidiary, L.P. Certificate of
Limited Partnership (filed as Exhibit 3.55 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.54
|
|
Columbia Medical Center of Plano Subsidiary, L.P. Agreement of
Limited Partnership (filed as Exhibit 3.56 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.55
|
|
Columbia North Hills Hospital Subsidiary, L.P. Certificate of
Limited Partnership (filed as Exhibit 3.57 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.56
|
|
Columbia North Hills Hospital Subsidiary, L.P. Agreement of
Limited Partnership (filed as Exhibit 3.58 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.57
|
|
Columbia Ogden Medical Center, Inc. Articles of Incorporation
(filed as Exhibit 3.59 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.58
|
|
Columbia Ogden Medical Center, Inc. By-Laws (filed as
Exhibit 3.60 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.59
|
|
Columbia Parkersburg Healthcare System, LLC Articles of
Incorporation (filed as Exhibit 3.61 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.60
|
|
Columbia Parkersburg Healthcare System, LLC, Articles of
Conversion.*
|
|
3
|
.61
|
|
Columbia Parkersburg Healthcare System, LLC Operating Agreement
(filed as Exhibit 3.62 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.62
|
|
Columbia Plaza Medical Center of Fort Worth Subsidiary,
L.P. Certificate of Limited Partnership (filed as
Exhibit 3.63 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.63
|
|
Columbia Plaza Medical Center of Fort Worth Subsidiary,
L.P. Agreement of Limited Partnership (filed as
Exhibit 3.64 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.64
|
|
Columbia Polk General Hospital, Inc. Articles of Incorporation
(filed as Exhibit 3.65 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.65
|
|
Columbia Polk General Hospital, Inc. By-Laws (filed as
Exhibit 3.66 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.66
|
|
Columbia Rio Grande Healthcare, L.P. Certificate of Limited
Partnership (filed as Exhibit 3.67 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.67
|
|
Columbia Rio Grande Healthcare, L.P. Amended and Restated
Limited Partnership Agreement (filed as Exhibit 3.68 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.68
|
|
Columbia Riverside, Inc. Articles of Incorporation (filed as
Exhibit 3.69 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-24
|
|
|
|
|
|
3
|
.69
|
|
Columbia Riverside, Inc. By-Laws (filed as Exhibit 3.70 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.70
|
|
Columbia Valley Healthcare System, L.P. Certificate of Limited
Partnership (filed as Exhibit 3.71 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.71
|
|
Columbia Valley Healthcare System, L.P. Amended and Restated
Limited Partnership Agreement (filed as Exhibit 3.72 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.72
|
|
Columbia/Alleghany Regional Hospital, Incorporated Articles of
Incorporation (filed as Exhibit 3.73 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.73
|
|
Columbia/Alleghany Regional Hospital, Incorporated By-Laws
(filed as Exhibit 3.74 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.74
|
|
Columbia/HCA John Randolph, Inc. Articles of Incorporation
(filed as Exhibit 3.75 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.75
|
|
Columbia/HCA John Randolph, Inc. By-Laws (filed as
Exhibit 3.76 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.76
|
|
Columbine Psychiatric Center, Inc. Articles of Incorporation
(filed as Exhibit 3.77 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.77
|
|
Columbine Psychiatric Center, Inc. By-Laws (filed as
Exhibit 3.78 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.78
|
|
Columbus Cardiology, Inc. Certificate of Incorporation (filed as
Exhibit 3.79 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.79
|
|
Columbus Cardiology, Inc. By-Laws (filed as Exhibit 3.80 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.80
|
|
Conroe Hospital Corporation Articles of Incorporation (filed as
Exhibit 3.81 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.81
|
|
Conroe Hospital Corporation By-Laws (filed as Exhibit 3.82
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.82
|
|
Dallas/Ft. Worth Physician, LLC Certificate of Formation
(filed as Exhibit 3.83 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.83
|
|
Dallas/Ft. Worth Physician, LLC Limited Liability Company
Agreement (filed as Exhibit 3.84 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.84
|
|
Dauterive Hospital Corporation Articles of Incorporation (filed
as Exhibit 3.85 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.85
|
|
Dauterive Hospital Corporation By-Laws (filed as
Exhibit 3.86 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.86
|
|
Dublin Community Hospital, LLC Limited Liability Company
Agreement (filed as Exhibit 3.87 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.87
|
|
Dublin Community Hospital, LLC Articles of Organization (filed
as Exhibit 3.88 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.88
|
|
Eastern Idaho Health Services, Inc. Articles of Incorporation
(filed as Exhibit 3.89 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.89
|
|
Eastern Idaho Health Services, Inc. By-Laws (filed as
Exhibit 3.90 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-25
|
|
|
|
|
|
3
|
.90
|
|
Edmond Regional Medical Center, LLC Certificate of Formation
(filed as Exhibit 3.91 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.91
|
|
Edmond Regional Medical Center, LLC Limited Liability Company
Agreement (filed as Exhibit 3.92 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.92
|
|
Edward White Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.95 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.93
|
|
Edward White Hospital, Inc. By-Laws (filed as Exhibit 3.96
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.94
|
|
El Paso Surgicenter, Inc. Articles of Incorporation (filed
as Exhibit 3.93 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.95
|
|
El Paso Surgicenter, Inc. By-Laws (filed as
Exhibit 3.94 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.96
|
|
Encino Hospital Corporation, Inc. Articles of Incorporation
(filed as Exhibit 3.97 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.97
|
|
Encino Hospital Corporation, Inc. By-Laws (filed as
Exhibit 3.98 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.98
|
|
EP Health, LLC Limited Liability Company Agreement (filed as
Exhibit 3.99 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.99
|
|
EP Health, LLC Limited Liability Company Agreement (filed as
Exhibit 3.100 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.100
|
|
Fairview Park GP, LLC Certificate of Formation (filed as
Exhibit 3.101 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.101
|
|
Fairview Park GP, LLC Limited Liability Company Agreement (filed
as Exhibit 3.102 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.102
|
|
Fairview Park, Limited Partnership Certificate of Limited
Partnership (filed as Exhibit 3.103 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.103
|
|
Fairview Park, Limited Partnership Agreement of Limited
Partnership (filed as Exhibit 3.104 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.104
|
|
Frankfort Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.105 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.105
|
|
Frankfort Hospital, Inc. By-Laws (filed as Exhibit 3.106 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.106
|
|
Galen Property, LLC Articles of Organization (filed as
Exhibit 3.107 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.107
|
|
Galen Property, LLC Operating Agreement (filed as
Exhibit 3.108 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.108
|
|
General Healthserv, LLC Certificate of Formation (filed as
Exhibit 3.109 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.109
|
|
General Healthserv, LLC Limited Liability Company Agreement
(filed as Exhibit 3.110 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.110
|
|
Good Samaritan Hospital, L.P. Certificate of Limited Partnership
(filed as Exhibit 3.111 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.111
|
|
Good Samaritan Hospital, L.P. Agreement of Limited Partnership
(filed as Exhibit 3.112 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-26
|
|
|
|
|
|
3
|
.112
|
|
Goppert-Trinity Family Care, LLC Certificate of Formation (filed
as Exhibit 3.113 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.113
|
|
Goppert-Trinity Family Care, LLC Limited Liability Company
Agreement (filed as Exhibit 3.114 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.114
|
|
GPCH-GP, Inc. Certificate of Incorporation (filed as
Exhibit 3.115 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.115
|
|
GPCH-GP, Inc. By-Laws (filed as Exhibit 3.116 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.116
|
|
Grand Strand Regional Medical Center, LLC Certificate of
Formation (filed as Exhibit 3.117 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.117
|
|
Grand Strand Regional Medical Center, LLC Limited Liability
Company Agreement (filed as Exhibit 3.118 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.118
|
|
Green Oaks Hospital Subsidiary, L.P. Certificate of Limited
Partnership (filed as Exhibit 3.119 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.119
|
|
Green Oaks Hospital Subsidiary, L.P. Agreement of Limited
Partnership (filed as Exhibit 3.120 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.120
|
|
Greenview Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.121 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.121
|
|
Greenview Hospital, Inc. By-Laws (filed as Exhibit 3.122 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.122
|
|
Hamilton Medical Center, Inc. Articles of Incorporation (filed
as Exhibit 3.123 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.123
|
|
Hamilton Medical Center, Inc. By-Laws (filed as
Exhibit 3.124 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.124
|
|
HCA IT&S Field Operations, Inc. Articles of
Incorporation*
|
|
3
|
.125
|
|
HCA IT&S Field Operations, Inc. By-Laws*
|
|
3
|
.126
|
|
HCA IT&S Inventory Management, Inc. Articles
of Incorporation*
|
|
3
|
.127
|
|
HCA IT&S Inventory Management, Inc. By-Laws*
|
|
3
|
.128
|
|
HCA Central Group, Inc. Certificate of Incorporation (filed as
Exhibit 3.125 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.129
|
|
HCA Central Group, Inc. By-Laws (filed as Exhibit 3.126 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.130
|
|
HCA Health Services of Florida, Inc. Articles of Incorporation
(filed as Exhibit 3.127 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.131
|
|
HCA Health Services of Florida, Inc. By-Laws (filed as
Exhibit 3.128 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.132
|
|
HCA Health Services of Louisiana, Inc. Articles of Incorporation
(filed as Exhibit 3.129 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.133
|
|
HCA Health Services of Louisiana, Inc. By-Laws (filed as
Exhibit 3.130 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.134
|
|
HCA Health Services of Oklahoma, Inc. Articles of Incorporation
(filed as Exhibit 3.131 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-27
|
|
|
|
|
|
3
|
.135
|
|
HCA Health Services of Oklahoma, Inc. By-Laws (filed as
Exhibit 3.132 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.136
|
|
HCA Health Services of Tennessee, Inc. Charter (filed as
Exhibit 3.133 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.137
|
|
HCA Health Services of Tennessee, Inc. By-Laws (filed as
Exhibit 3.134 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.138
|
|
HCA Health Services of Virginia, Inc. Certificate of
Incorporation (filed as Exhibit 3.135 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.139
|
|
HCA Health Services of Virginia, Inc. By-Laws (filed as
Exhibit 3.136 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.140
|
|
HCA Management Services, L.P. Certificate of Limited Partnership
(filed as Exhibit 3.137 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.141
|
|
HCA Management Services, L.P. Agreement of Limited Partnership
(filed as Exhibit 3.138 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.142
|
|
HCA Realty, Inc. Charter*
|
|
3
|
.143
|
|
HCA Realty, Inc. By-Laws*
|
|
3
|
.144
|
|
HD&S Corp. Successor, Inc. Articles of Incorporation (filed
as Exhibit 3.139 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.145
|
|
HD&S Corp. Successor, Inc. By-Laws (filed as
Exhibit 3.140 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.146
|
|
Health Midwest Office Facilities Corporation Articles of
Incorporation (filed as Exhibit 3.141 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.147
|
|
Health Midwest Office Facilities Corporation By-Laws (filed as
Exhibit 3.142 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.148
|
|
Health Midwest Ventures Group, Inc. Articles of Incorporation
(filed as Exhibit 3.143 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.149
|
|
Health Midwest Ventures Group, Inc. By-Laws (filed as
Exhibit 3.144 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.150
|
|
Healthtrust MOB, LLC Certificate of Formation (filed as
Exhibit 3.145 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.151
|
|
Healthtrust MOB, LLC Limited Liability Company Agreement (filed
as Exhibit 3.146 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.152
|
|
Hendersonville Hospital Corporation Charter (filed as
Exhibit 3.147 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.153
|
|
Hendersonville Hospital Corporation By-Laws (filed as
Exhibit 3.148 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.154
|
|
Hospital Corporation of Tennessee Charter (filed as
Exhibit 3.151 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.155
|
|
Hospital Corporation of Tennessee By-Laws (filed as
Exhibit 3.152 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.156
|
|
Hospital Corporation of Utah Articles of Incorporation (filed as
Exhibit 3.153 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.157
|
|
Hospital Corporation of Utah By-Laws (filed as
Exhibit 3.154 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-28
|
|
|
|
|
|
3
|
.158
|
|
Hospital Development Properties, Inc. Certificate of
Incorporation (filed as Exhibit 3.155 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.159
|
|
Hospital Development Properties, Inc. By-Laws (filed as
Exhibit 3.156 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.160
|
|
HSS Holdco, LLC Certificate of Formation (filed as
Exhibit 3.157 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.161
|
|
HSS Holdco, LLC Limited Liability Company Agreement (filed as
Exhibit 3.158 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.162
|
|
HSS Systems VA, LLC Certificate of Formation (filed as
Exhibit 3.159 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.163
|
|
HSS Systems VA, LLC Limited Liability Company Agreement (filed
as Exhibit 3.160 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.164
|
|
HSS Systems, LLC Certificate of Formation (filed as
Exhibit 3.161 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.165
|
|
HSS Systems, LLC Limited Liability Company Agreement (filed as
Exhibit 3.162 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.166
|
|
HSS Virginia, L.P. Certificate of Limited Partnership (filed as
Exhibit 3.163 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.167
|
|
HSS Virginia, L.P. Agreement of Limited Partnership (filed as
Exhibit 3.164 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.168
|
|
HTI Memorial Hospital Corporation Articles of Incorporation
(filed as Exhibit 3.165 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.169
|
|
HTI Memorial Hospital Corporation By-Laws (filed as
Exhibit 3.166 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.170
|
|
Integrated Regional Lab, LLC Articles of Organization (filed as
Exhibit 3.167 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.171
|
|
Integrated Regional Lab, LLC Operating Agreement (filed as
Exhibit 3.168 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.172
|
|
Integrated Regional Laboratories, LLP Statement of Qualification
of Limited Liability Partnership (filed as Exhibit 3.169 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.173
|
|
Integrated Regional Laboratories, LLP Partnership Agreement
(filed as Exhibit 3.170 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.174
|
|
JFK Medical Center Limited Partnership Articles of Limited
Partnership (filed as Exhibit 3.171 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.175
|
|
JFK Medical Center Limited Partnership Agreement of Limited
Partnership (filed as Exhibit 3.172 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.176
|
|
KPH-Consolidation, Inc. Articles of Incorporation (filed as
Exhibit 3.173 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.177
|
|
KPH-Consolidation, Inc. By-Laws (filed as Exhibit 3.174 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.178
|
|
Lakeland Medical Center, LLC Certificate of Formation (filed as
Exhibit 3.175 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-29
|
|
|
|
|
|
3
|
.179
|
|
Lakeland Medical Center, LLC Limited Liability Company Agreement
(filed as Exhibit 3.176 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.180
|
|
Lakeview Medical Center, LLC Certificate of Formation (filed as
Exhibit 3.177 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.181
|
|
Lakeview Medical Center, LLC Limited Liability Company Agreement
(filed as Exhibit 3.178 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.182
|
|
Largo Medical Center, Inc. Articles of Incorporation (filed as
Exhibit 3.179 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.183
|
|
Largo Medical Center, Inc. By-Laws (filed as Exhibit 3.180
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.184
|
|
Las Vegas Surgicare, Inc. Articles of Incorporation (filed as
Exhibit 3.181 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.185
|
|
Las Vegas Surgicare, Inc. By-Laws (filed as Exhibit 3.182
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.186
|
|
Lawnwood Medical Center, Inc. Articles of Incorporation (filed
as Exhibit 3.183 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.187
|
|
Lawnwood Medical Center, Inc. By-Laws (filed as
Exhibit 3.184 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.188
|
|
Lewis-Gale Hospital, Incorporated Articles of Incorporation
(filed as Exhibit 3.185 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.189
|
|
Lewis-Gale Hospital, Incorporated By-Laws (filed as
Exhibit 3.186 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.190
|
|
Lewis-Gale Medical Center, LLC Certificate of Formation (filed
as Exhibit 3.187 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.191
|
|
Lewis-Gale Medical Center, LLC Limited Liability Company
Agreement (filed as Exhibit 3.188 to the Companys
Registration Statement on
Form S-4
(File No. 333-145054), and incorporated herein by
reference).
|
|
3
|
.192
|
|
Lewis-Gale Physicians, LLC Articles of Organization (filed as
Exhibit 3.189 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.193
|
|
Lewis-Gale Physicians, LLC Operating Agreement (filed as
Exhibit 3.190 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.194
|
|
Los Robles Regional Medical Center Articles of Incorporation
(filed as Exhibit 3.191 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.195
|
|
Los Robles Regional Medical Center By-Laws (filed as
Exhibit 3.192 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.196
|
|
Management Services Holdings, Inc. Certificate of Incorporation
(filed as Exhibit 3.193 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.197
|
|
Management Services Holdings, Inc. By-Laws (filed as
Exhibit 3.194 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.198
|
|
Marietta Surgical Center, Inc. Articles of Incorporation (filed
as Exhibit 3.195 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.199
|
|
Marietta Surgical Center, Inc. By-Laws (filed as
Exhibit 3.196 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.200
|
|
Marion Community Hospital, Inc. Articles of Incorporation (filed
as Exhibit 3.197 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-30
|
|
|
|
|
|
3
|
.201
|
|
Marion Community Hospital, Inc. By-Laws (filed as
Exhibit 3.198 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.202
|
|
MCA Investment Company Articles of Incorporation (filed as
Exhibit 3.199 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.203
|
|
MCA Investment Company By-Laws (filed as Exhibit 3.200 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.204
|
|
Medical Centers of Oklahoma, LLC Certificate of Formation (filed
as Exhibit 3.201 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.205
|
|
Medical Centers of Oklahoma, LLC Limited Liability Company
Agreement (filed as Exhibit 3.202 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.206
|
|
Medical Office Buildings of Kansas, LLC Certificate of Formation
(filed as Exhibit 3.203 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.207
|
|
Medical Office Buildings of Kansas, LLC Operating Agreement
(filed as Exhibit 3.204 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.208
|
|
Memorial Healthcare Group, Inc. Articles of Incorporation (filed
as Exhibit 3.205 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.209
|
|
Memorial Healthcare Group, Inc. By-Laws (filed as
Exhibit 3.206 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.210
|
|
Midwest Division ACH, LLC Certificate of Formation
(filed as Exhibit 3.207 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.211
|
|
Midwest Division ACH, LLC Limited Liability Company
Agreement (filed as Exhibit 3.208 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.212
|
|
Midwest Division LRHC, LLC Certificate of Formation
(filed as Exhibit 3.209 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.213
|
|
Midwest Division LRHC, LLC Limited Liability Company
Agreement (filed as Exhibit 3.210 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.214
|
|
Midwest Division LSH, LLC Certificate of Formation
(filed as Exhibit 3.211 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.215
|
|
Midwest Division LSH, LLC Limited Liability Company
Agreement (filed as Exhibit 3.212 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.216
|
|
Midwest Division MCI, LLC Certificate of Formation
(filed as Exhibit 3.213 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.217
|
|
Midwest Division MCI, LLC Limited Liability Company
Agreement (filed as Exhibit 3.214 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.218
|
|
Midwest Division MMC, LLC Certificate of Formation
(filed as Exhibit 3.215 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.219
|
|
Midwest Division MMC, LLC Limited Liability Company
Agreement (filed as Exhibit 3.216 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.220
|
|
Midwest Division OPRMC, LLC Certificate of Formation
(filed as Exhibit 3.217 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-31
|
|
|
|
|
|
3
|
.221
|
|
Midwest Division OPRMC, LLC Limited Liability
Company Agreement (filed as Exhibit 3.218 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.222
|
|
Midwest Division PFC, LLC Certificate of Formation
(filed as Exhibit 3.219 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.223
|
|
Midwest Division PFC, LLC Limited Liability Company
Agreement (filed as Exhibit 3.220 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.224
|
|
Midwest Division RBH, LLC Articles of Organization
(filed as Exhibit 3.221 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.225
|
|
Midwest Division RBH, LLC Limited Liability Company
Agreement (filed as Exhibit 3.222 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.226
|
|
Midwest Division RMC, LLC Certificate of Formation
(filed as Exhibit 3.223 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.227
|
|
Midwest Division RMC, LLC Limited Liability Company
Agreement (filed as Exhibit 3.224 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.228
|
|
Midwest Division RPC, LLC Certificate of Formation
(filed as Exhibit 3.225 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.229
|
|
Midwest Division RPC, LLC Limited Liability Company
Agreement (filed as Exhibit 3.226 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.230
|
|
Midwest Holdings, Inc. Certificate of Incorporation (filed as
Exhibit 3.227 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.231
|
|
Midwest Holdings, Inc. By-Laws (filed as Exhibit 3.228 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.232
|
|
Montgomery Regional Hospital, Inc. Articles of Incorporation
(filed as Exhibit 3.229 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.233
|
|
Montgomery Regional Hospital, Inc. By-Laws (filed as
Exhibit 3.230 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.234
|
|
Mountain View Hospital, Inc. Certificate of Incorporation (filed
as Exhibit 3.231 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.235
|
|
Mountain View Hospital, Inc. By-Laws (filed as
Exhibit 3.232 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.236
|
|
Nashville Shared Services General Partnership General
Partnership Agreement (filed as Exhibit 3.233 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.237
|
|
National Patient Account Services, Inc. Articles of
Incorporation (filed as Exhibit 3.235 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.238
|
|
National Patient Account Services, Inc. By-Laws (filed as
Exhibit 3.236 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.239
|
|
New Port Richey Hospital, Inc. Articles of Incorporation (filed
as Exhibit 3.237 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.240
|
|
New Port Richey Hospital, Inc. By-Laws (filed as
Exhibit 3.238 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.241
|
|
New Rose Holding Company, Inc. Articles of Incorporation (filed
as Exhibit 3.239 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-32
|
|
|
|
|
|
3
|
.242
|
|
New Rose Holding Company, Inc. By-Laws (filed as
Exhibit 3.240 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.243
|
|
North Florida Immediate Care Center, Inc. Articles of
Incorporation (filed as Exhibit 3.241 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.244
|
|
North Florida Immediate Care Center, Inc. By-Laws (filed as
Exhibit 3.242 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.245
|
|
North Florida Regional Medical Center, Inc. Articles of
Incorporation (filed as Exhibit 3.243 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.246
|
|
North Florida Regional Medical Center, Inc. By-Laws (filed as
Exhibit 3.244 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.247
|
|
Northern Utah Healthcare Corporation Articles of Incorporation
(filed as Exhibit 3.245 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.248
|
|
Northern Utah Healthcare Corporation By-Laws (filed as
Exhibit 3.246 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.249
|
|
Northern Virginia Community Hospital, LLC Articles of
Organization (filed as Exhibit 3.247 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.250
|
|
Northern Virginia Community Hospital, LLC Limited Liability
Company Agreement (filed as Exhibit 3.248 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.251
|
|
Northlake Medical Center, LLC Certificate of Formation (filed as
Exhibit 3.249 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.252
|
|
Northlake Medical Center, LLC Limited Liability Company
Agreement (filed as Exhibit 3.250 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.253
|
|
Notami Hospitals of Louisiana, Inc. Articles of Incorporation
(filed as Exhibit 3.251 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.254
|
|
Notami Hospitals of Louisiana, Inc. By-Laws (filed as
Exhibit 3.252 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.255
|
|
Notami Hospitals, LLC Certificate of Formation (filed as
Exhibit 3.253 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.256
|
|
Notami Hospitals, LLC Limited Liability Company Agreement (filed
as Exhibit 3.254 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.257
|
|
Okaloosa Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.255 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.258
|
|
Okaloosa Hospital, Inc. By-Laws (filed as Exhibit 3.256 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.259
|
|
Okeechobee Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.257 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.260
|
|
Okeechobee Hospital, Inc. By-Laws (filed as Exhibit 3.258
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.261
|
|
Outpatient Cardiovascular Center of Central Florida, LLC
Certificate of Formation (filed as Exhibit 3.259 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.262
|
|
Outpatient Cardiovascular Center of Central Florida, LLC
Operating Agreement (filed as Exhibit 3.260 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-33
|
|
|
|
|
|
3
|
.263
|
|
Palms West Hospital Limited Partnership Agreement of Limited
Partnership (filed as Exhibit 3.261 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.264
|
|
Palms West Hospital Limited Partnership Certificate of Limited
Partnership (filed as Exhibit 3.262 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.265
|
|
Palmyra Park Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.263 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.266
|
|
Palmyra Park Hospital, Inc. By-Laws (filed as Exhibit 3.264
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.267
|
|
Pasadena Bayshore Hospital, Inc. Articles of Incorporation*
|
|
3
|
.268
|
|
Pasadena Bayshore Hospital Inc. By-Laws*
|
|
3
|
.269
|
|
Plantation General Hospital, L.P. Agreement of Limited
Partnership (filed as Exhibit 3.265 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.270
|
|
Plantation General Hospital, L.P. Agreement of Limited
Partnership (filed as Exhibit 3.266 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.271
|
|
Pulaski Community Hospital, Inc. Articles of Incorporation
(filed as Exhibit 3.267 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.272
|
|
Pulaski Community Hospital, Inc. By-Laws (filed as
Exhibit 3.268 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.273
|
|
Redmond Park Hospital, LLC Articles of Organization (filed as
Exhibit 3.269 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.274
|
|
Redmond Park Hospital, LLC Limited Liability Company Agreement
(filed as Exhibit 3.270 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.275
|
|
Redmond Physician Practice Company Articles of Incorporation
(filed as Exhibit 3.271 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.276
|
|
Redmond Physician Practice Company By-Laws (filed as
Exhibit 3.272 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.277
|
|
Reston Hospital Center, LLC Certificate of Formation (filed as
Exhibit 3.273 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.278
|
|
Reston Hospital Center, LLC Limited Liability Company Agreement
(filed as Exhibit 3.274 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.279
|
|
Retreat Hospital, LLC Articles of Incorporation*
|
|
3
|
.280
|
|
Retreat Hospital, LLC Limited Liability Company Agreement*
|
|
3
|
.281
|
|
Rio Grande Regional Hospital, Inc. Articles of Incorporation
(filed as Exhibit 3.277 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.282
|
|
Rio Grande Regional Hospital, Inc. By-Laws (filed as
Exhibit 3.278 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.283
|
|
Riverside Healthcare System, L.P. Certificate of Limited
Partnership (filed as Exhibit 3.279 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.284
|
|
Riverside Healthcare System, L.P. Limited Partnership Agreement
(filed as Exhibit 3.280 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-34
|
|
|
|
|
|
3
|
.285
|
|
Riverside Hospital, Inc. Certificate of Incorporation (filed as
Exhibit 3.281 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.286
|
|
Riverside Hospital, Inc. By-Laws (filed as Exhibit 3.282 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.287
|
|
Samaritan, LLC Certificate of Formation (filed as
Exhibit 3.283 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.288
|
|
Samaritan, LLC Limited Liability Company Agreement (filed as
Exhibit 3.284 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.289
|
|
San Jose Healthcare System, LP Certificate of Limited
Partnership (filed as Exhibit 3.285 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.290
|
|
San Jose Healthcare System, LP Limited Partnership
Agreement (filed as Exhibit 3.286 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.291
|
|
San Jose Hospital, L.P. Agreement of Limited Partnership
(filed as Exhibit 3.287 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.292
|
|
San Jose Hospital, L.P. Certificate of Limited Partnership
(filed as Exhibit 3.288 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.293
|
|
San Jose Medical Center, LLC Certificate of Formation
(filed as Exhibit 3.289 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.294
|
|
San Jose Medical Center, LLC Limited Liability Company
Agreement (filed as Exhibit 3.290 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.295
|
|
San Jose, LLC Certificate of Formation (filed as
Exhibit 3.291 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.296
|
|
San Jose, LLC Limited Liability Company Agreement (filed as
Exhibit 3.292 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.297
|
|
Sarasota Doctors Hospital, Inc. Articles of Incorporation (filed
as Exhibit 3.293 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.298
|
|
Sarasota Doctors Hospital, Inc. By-Laws (filed as
Exhibit 3.294 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.299
|
|
SJMC, LLC Certificate of Formation (filed as Exhibit 3.295
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.300
|
|
SJMC, LLC Limited Liability Company Agreement (filed as
Exhibit 3.296 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.301
|
|
Southern Hills Medical Center, LLC Certificate of Formation
(filed as Exhibit 3.297 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.302
|
|
Southern Hills Medical Center, LLC Limited Liability Company
Agreement (filed as Exhibit 3.298 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.303
|
|
Spotsylvania Medical Center, Inc. Articles of Incorporation
(filed as Exhibit 3.299 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.304
|
|
Spotsylvania Medical Center, Inc By-Laws (filed as
Exhibit 3.300 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.305
|
|
Spring Branch Medical Center, Inc. Articles of Incorporation
(filed as Exhibit 3.301 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.306
|
|
Spring Branch Medical Center, Inc. By-Laws (filed as
Exhibit 3.302 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-35
|
|
|
|
|
|
3
|
.307
|
|
Spring Hill Hospital, Inc. Charter (filed as Exhibit 3.303
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.308
|
|
Spring Hill Hospital, Inc. By-Laws (filed as Exhibit 3.304
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.309
|
|
St. Marks Lone Peak Hospital, Inc. Articles of
Incorporation (filed as Exhibit 3.305 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.310
|
|
St. Marks Lone Peak Hospital, Inc. By-Laws (filed as
Exhibit 3.306 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.311
|
|
Sun City Hospital, Inc. Articles of Incorporation (filed as
Exhibit 3.307 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.312
|
|
Sun City Hospital, Inc. By-Laws (filed as Exhibit 3.308 to
the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.313
|
|
Sunrise Mountainview Hospital, Inc. Articles of Incorporation
(filed as Exhibit 3.311 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.314
|
|
Sunrise Mountainview Hospital, Inc. By-Laws (filed as
Exhibit 3.312 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.315
|
|
Surgicare of Brandon, Inc. Articles of Incorporation (filed as
Exhibit 3.313 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.316
|
|
Surgicare of Brandon, Inc. By-Laws (filed as Exhibit 3.314
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.317
|
|
Surgicare of Florida, Inc. Articles of Incorporation (filed as
Exhibit 3.315 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.318
|
|
Surgicare of Florida, Inc. By-Laws (filed as Exhibit 3.316
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.319
|
|
Surgicare of Houston Womens, Inc. Articles of
Incorporation (filed as Exhibit 3.317 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.320
|
|
Surgicare of Houston Womens, Inc. By-Laws (filed as
Exhibit 3.318 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.321
|
|
Surgicare of Manatee, Inc. Articles of Incorporation (filed as
Exhibit 3.319 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.322
|
|
Surgicare of Manatee, Inc. By-Laws (filed as Exhibit 3.320
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.323
|
|
Surgicare of New Port Richey, Inc. Articles of Incorporation
(filed as Exhibit 3.321 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.324
|
|
Surgicare of New Port Richey, Inc. By-Laws (filed as
Exhibit 3.322 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.325
|
|
Surgicare of Palms West, LLC Articles of Organization (filed as
Exhibit 3.323 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.326
|
|
Surgicare of Palms West, LLC Articles of Organization Agreement
(filed as Exhibit 3.324 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.327
|
|
Surgicare of Riverside, LLC Articles of Organization (filed as
Exhibit 3.325 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.328
|
|
Surgicare of Riverside, LLC Limited Liability Company Agreement
(filed as Exhibit 3.326 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-36
|
|
|
|
|
|
3
|
.329
|
|
Tallahassee Medical Center, Inc. Articles of Incorporation
(filed as Exhibit 3.327 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.330
|
|
Tallahassee Medical Center, Inc. By-Laws (filed as
Exhibit 3.328 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.331
|
|
TCMC Madison-Portland, Inc. Articles of Incorporation (filed as
Exhibit 3.329 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.332
|
|
TCMC Madison-Portland, Inc. By-Laws (filed as Exhibit 3.330
to the Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.333
|
|
Terre Haute Hospital GP, Inc. Certificate of Incorporation
(filed as Exhibit 3.331 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.334
|
|
Terre Haute Hospital GP, Inc. By-Laws (filed as
Exhibit 3.332 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.335
|
|
Terre Haute Hospital Holdings, Inc. Certificate of Incorporation
(filed as Exhibit 3.333 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.336
|
|
Terre Haute Hospital Holdings, Inc. By-Laws (filed as
Exhibit 3.334 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.337
|
|
Terre Haute MOB, L.P. Certificate of Limited Partnership (filed
as Exhibit 3.335 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.338
|
|
Terre Haute MOB, L.P. Limited Partnership Agreement (filed as
Exhibit 3.336 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.339
|
|
Terre Haute Regional Hospital, L.P. Certificate of Limited
Partnership (filed as Exhibit 3.337 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.340
|
|
Terre Haute Regional Hospital, L.P. Limited Partnership
Agreement (filed as Exhibit 3.338 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.341
|
|
Timpanogos Regional Medical Services, Inc. Certificate of
Incorporation (filed as Exhibit 3.339 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.342
|
|
Timpanogos Regional Medical Services, Inc. By-Laws (filed as
Exhibit 3.340 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.343
|
|
Trident Medical Center, LLC Certificate of Formation (filed as
Exhibit 3.341 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.344
|
|
Trident Medical Center, LLC Limited Liability Company Agreement
(filed as Exhibit 3.342 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.345
|
|
Utah Medco, LLC Certificate of Formation (filed as
Exhibit 3.343 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.346
|
|
Utah Medco, LLC Limited Liability Company Agreement (filed as
Exhibit 3.344 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.347
|
|
VH Holdco, Inc. Articles of Incorporation (filed as
Exhibit 3.345 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.348
|
|
VH Holdco, Inc. By-Laws (filed as Exhibit 3.346 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.349
|
|
VH Holdings, Inc. Articles of Incorporation (filed as
Exhibit 3.347 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.350
|
|
VH Holdings, Inc. By-Laws (filed as Exhibit 3.348 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-37
|
|
|
|
|
|
3
|
.351
|
|
Virginia Psychiatric Company, Inc. Articles of Incorporation
(filed as Exhibit 3.349 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.352
|
|
Virginia Psychiatric Company, Inc. By-Laws (filed as
Exhibit 3.350 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.353
|
|
W & C Hospital, Inc. Articles of Incorporation (filed
as Exhibit 3.351 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.354
|
|
W & C Hospital, Inc. By-Laws (filed as
Exhibit 3.352 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.355
|
|
Walterboro Community Hospital, Inc. Articles of Incorporation
(filed as Exhibit 3.353 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.356
|
|
Walterboro Community Hospital, Inc. By-Laws (filed as
Exhibit 3.354 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.357
|
|
Wesley Medical Center, LLC Certificate of Formation (filed as
Exhibit 3.355 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.358
|
|
Wesley Medical Center, LLC Limited Liability Company Agreement
(filed as Exhibit 3.356 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.359
|
|
West Florida Regional Medical Center, Inc. Articles of
Incorporation (filed as Exhibit 3.357 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.360
|
|
West Florida Regional Medical Center, Inc. By-Laws (filed as
Exhibit 3.358 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.361
|
|
West Valley Medical Center, Inc. Articles of Incorporation
(filed as Exhibit 3.359 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.362
|
|
West Valley Medical Center, Inc. By-Laws (filed as
Exhibit 3.360 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.363
|
|
Western Plains Capital, Inc. Articles of Incorporation (filed as
Exhibit 3.361 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.364
|
|
Western Plains Capital, Inc. By-Laws (filed as
Exhibit 3.362 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.365
|
|
WHMC, Inc. Articles of Incorporation (filed as
Exhibit 3.363 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.366
|
|
WHMC, Inc. By-Laws (filed as Exhibit 3.364 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.367
|
|
Womans Hospital of Texas, Incorporated Certificate of
Incorporation (filed as Exhibit 3.365 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.368
|
|
Womans Hospital of Texas, Incorporated By-Laws (filed as
Exhibit 3.366 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.369
|
|
Womens and Childrens Hospital, Inc. Articles of
Incorporation (filed as Exhibit 3.367 to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
3
|
.370
|
|
Womens and Childrens Hospital, Inc. By-Laws (filed
as Exhibit 3.368 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.1
|
|
Specimen Certificate for shares of Common Stock, par value $0.01
per share, of the Company (filed as Exhibit 3 to the
Companys
Form 8-A/A,
Amendment No. 2, dated March 11, 2004, and
incorporated herein by reference).
|
|
4
|
.2
|
|
Indenture, dated November 17, 2006, among HCA Inc., the
guarantors party thereto and The Bank of New York, as trustee
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
II-38
|
|
|
|
|
|
4
|
.3
|
|
Security Agreement, dated as of November 17, 2006, among
HCA Inc., the subsidiary grantors party thereto and The Bank of
New York, as collateral agent (filed as Exhibit 4.2 to the
Companys Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.4
|
|
Pledge Agreement, dated as of November 17, 2006, among HCA
Inc., the subsidiary pledgors party thereto and The Bank of New
York, as collateral agent (filed as Exhibit 4.3 to the
Companys Current Report of
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.5(a)
|
|
Form of
91/8% Senior
Secured Notes due 2014 (included in Exhibit 4.2).
|
|
4
|
.5(b)
|
|
Form of
91/4% Senior
Secured Notes due 2016 (included in Exhibit 4.2).
|
|
4
|
.5(c)
|
|
Form of
95/8%/103/8% Senior
Secured Toggle Notes due 1016 (included in Exhibit 4.2).
|
|
4
|
.6
|
|
Indenture, dated February 19, 2009, among HCA Inc, the
guarantors party thereto, The Bank of New York Mellon, as
collateral agent and The Bank of New York Mellon
Trust Company, N.A., as trustee. (filed as Exhibit 4.1
to the Companys Current Report on
Form 8-K
filed February 25, 2009, and incorporated herein by
reference).
|
|
4
|
.7
|
|
Form of
97/8% Senior
Secured Notes due 2017 (included in Exhibit 4.6).
|
|
4
|
.8(a)
|
|
$13,550,000,000 1,000,000,000 Credit
Agreement, dated as of November 17, 2006, among HCA Inc.,
HCA UK Capital Limited, the lending institutions from time to
time parties thereto, Banc of America Securities LLC,
J.P. Morgan Securities Inc., Citigroup Global Markets Inc.
and Merrill Lynch, Pierce, Fenner & Smith
Incorporated, as joint lead arrangers and joint bookrunners,
Bank of America, N.A., as administrative agent, JPMorgan Chase
Bank, N.A. and Citicorp North America, Inc., as co-syndication
agents and Merrill Lynch Capital Corporation, as documentation
agent (filed as Exhibit 4.8 to the Companys Current
Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.8(b)
|
|
Amendment No. 1 to the Credit Agreement, dated as of
February 16, 2007, among HCA Inc., HCA UK Capital Limited,
the lending institutions from time to time parties thereto, Bank
of America, N.A., as administrative agent, JPMorgan Chase Bank,
N.A., and Citicorp North America, Inc., as Co-Syndication
Agents, Banc of America Securities, LLC, J.P. Morgan
Securities Inc., Citigroup Global Markets Inc. and Merrill
Lynch, Pierce, Fenner & Smith Incorporated, as joint
lead arrangers and bookrunners, Deutsche Bank Securities and
Wachovia Capital Markets LLC, as joint bookrunners and Merrill
Lynch Capital Corporation, as documentation agent (filed as
Exhibit 4.7(b) to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
4
|
.8(c)
|
|
Amendment No. 2 to the Credit Agreement, dated as of
March 2, 2009, among HCA Inc., HCA UK Capital Limited,
the lending institutions from time to time parties thereto, Bank
of America, N.A., as administrative agent, JPMorgan Chase Bank,
N.A., and Citicorp North America, Inc., as Co-Syndication
Agents, Banc of America Securities, LLC, J.P. Morgan
Securities Inc., Citigroup Global Markets Inc. and Merrill
Lynch, Pierce, Fenner & Smith Incorporated, as joint
lead arrangers and bookrunners, Deutsche Bank Securities and
Wachovia Capital Markets LLC, as joint bookrunners and Merrill
Lynch Capital Corporation, as documentation agent (filed as
exhibit 4.8(c) to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
4
|
.9
|
|
U.S. Guarantee, dated November 17, 2006, among HCA Inc.,
the subsidiary guarantors party thereto and Bank of America,
N.A., as administrative agent (filed as Exhibit 4.9 to the
Companys Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.10
|
|
Indenture, dated as of April 22, 2009, among HCA Inc., the
guarantors party thereto, Deutsche Bank Trust Company
Americas, as paying agent, registrar and transfer agent, and Law
Debenture Trust Company of New York, as trustee (filed as
Exhibit 4.1 to the Companys Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
|
|
4
|
.11
|
|
Security Agreement, dated as of November 17, 2006, and
amended and restated as of March 2, 2009, among the
Company, the Subsidiary Grantors named therein and Bank of
America, N.A., as Collateral Agent (filed as exhibit 4.10
to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
II-39
|
|
|
|
|
|
4
|
.12
|
|
Pledge Agreement, dated as of November 17, 2006, and
amended and restated as of March 2, 2009, among the
Company, the Subsidiary Pledgors named therein and Bank of
America, N.A., as Collateral Agent (filed as exhibit 4.11
to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
4
|
.13
|
|
Form of
81/2% Senior
Secured Notes due 2019 (included in Exhibit 4.10).
|
|
4
|
.14(a)
|
|
$2,000,000,000 Amended and Restated Credit Agreement, dated as
of June 20, 2007, among HCA Inc., the subsidiary borrowers
parties thereto, the lending institutions from time to time
parties thereto, Banc of America Securities LLC,
J.P. Morgan Securities Inc., Citigroup Global Markets Inc.
and Merrill Lynch, Pierce, Fenner & Smith
Incorporated, as joint lead arrangers and joint bookrunners,
Bank of America, N.A., as administrative agent, JPMorgan Chase
Bank, N.A. and Citicorp North America, Inc., as co-syndication
agents, and Merrill Lynch Capital Corporation, as documentation
agent (filed as Exhibit 4.1 to the Companys Current
Report on
Form 8-K
filed June 26, 2007, and incorporated herein by reference).
|
|
4
|
.14(b)
|
|
Amendment No. 1 to the $2,000,000,000 Amended and Restated
Credit Agreement, dated as of March 2, 2009, among HCA
Inc., the subsidiary borrowers parties thereto, the lending
institutions from time to time parties thereto, Banc of America
Securities LLC, J.P. Morgan Securities Inc., Citigroup
Global Markets Inc. and Merrill Lynch, Pierce,
Fenner & Smith Incorporated, as joint lead arrangers
and joint bookrunners, Bank of America, N.A., as administrative
agent, JPMorgan Chase Bank, N.A. and Citicorp North America,
Inc., as co-syndication agents, and Merrill Lynch Capital
Corporation, as documentation agent (filed as
exhibit 4.12(b) to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
4
|
.15
|
|
Security Agreement, dated as of November 17, 2006, among
HCA Inc., the subsidiary borrowers party thereto and Bank of
America, N.A., as collateral agent (filed as Exhibit 4.13
to the Companys Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.16(a)
|
|
General Intercreditor Agreement, dated as of November 17,
2006, between Bank of America, N.A., as First Lien Collateral
Agent, and The Bank of New York, as Junior Lien Collateral Agent
(filed as Exhibit 4.13(a) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.16(b)
|
|
Additional General Intercreditor Agreement, dated as of
April 22, 2009, by and among Bank of America, N.A., in its
capacity as First Lien Collateral Agent, The Bank of New York
Mellon, in its capacity as Junior Lien Collateral Agent and in
its capacity as 2006 Second Lien Trustee and The Bank of New
York Mellon Trust Company, N.A., in its capacity as 2009
Second Lien Trustee (filed as Exhibit 4.6 to the
Companys Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
|
|
4
|
.16(c)
|
|
Receivables Intercreditor Agreement, dated as of
November 17, 2006, among Bank of America, N.A., as ABL
Collateral Agent, Bank of America, N.A., as CF Collateral Agent
and The Bank of New York, as Bonds Collateral Agent (filed as
Exhibit 4.13(b) to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.16(d)
|
|
Additional Receivables Intercreditor Agreement, dated as of
April 22, 2009, by and between Bank of America, N.A. as ABL
Collateral Agent, and Bank of America, N.A. as New First Lien
Collateral Agent (filed as Exhibit 4.7 to the
Companys Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
|
|
4
|
.16(e)
|
|
First Lien Intercreditor Agreement, dated as of April 22,
2009, among Bank of America, N.A. as Collateral Agent, Bank of
America, N.A. as Authorized Representative under the Credit
Agreement and Law Debenture Trust Company of New York as
the Initial Additional Authorized Representative (filed as
Exhibit 4.5 to the Companys Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
|
|
4
|
.17
|
|
Registration Rights Agreement, dated as of November 17,
2006, among HCA Inc., Hercules Holding II, LLC and certain other
parties thereto (filed as Exhibit 4.4 to the Companys
Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
II-40
|
|
|
|
|
|
4
|
.18
|
|
Registration Rights Agreement, dated as of March 16, 1989,
by and among HCA-Hospital Corporation of America and the persons
listed on the signature pages thereto (filed as
Exhibit 4.14 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.19
|
|
Assignment and Assumption Agreement, dated as of
February 10, 1994, between HCA-Hospital Corporation of
America and the Company relating to the Registration Rights
Agreement, as amended (filed as Exhibit 4.15 to the
Companys Registration Statement on
Form S-4
(File No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.20(a)
|
|
Indenture, dated as of December 16, 1993 between the
Company and The First National Bank of Chicago, as Trustee
(filed as Exhibit 4.16(a) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.20(b)
|
|
First Supplemental Indenture, dated as of May 25, 2000
between the Company and Bank One Trust Company, N.A., as
Trustee (filed as Exhibit 4.16(b) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.20(c)
|
|
Second Supplemental Indenture, dated as of July 1, 2001
between the Company and Bank One Trust Company, N.A., as
Trustee (filed as Exhibit 4.16(c) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.20(d)
|
|
Third Supplemental Indenture, dated as of December 5, 2001
between the Company and The Bank of New York, as Trustee (filed
as Exhibit 4.16(d) to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.20(e)
|
|
Fourth Supplemental Indenture, dated as of November 14,
2006, between the Company and The Bank of New York, as Trustee
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
filed November 16, 2006, and incorporated herein by
reference).
|
|
4
|
.21
|
|
Form of 7.5% Debentures due 2023 (filed as
Exhibit 4.17 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.22
|
|
Form of 8.36% Debenture due 2024 (filed as
Exhibit 4.18 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.23
|
|
Form of Fixed Rate Global Medium-Term Note (filed as
Exhibit 4.19 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.24
|
|
Form of Floating Rate Global Medium-Term Note (filed as
Exhibit 4.20 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.25
|
|
Form of 7.69% Note due 2025 (filed as Exhibit 4.10 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2004, and
incorporated herein by reference).
|
|
4
|
.26
|
|
Form of 7.19% Debenture due 2015 (filed as
Exhibit 4.22 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.27
|
|
Form of 7.50% Debenture due 2095 (filed as
Exhibit 4.23 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.24
|
|
Form of 7.05% Debenture due 2027 (filed as
Exhibit 4.24 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.28
|
|
Form of Fixed Rate Global Medium-Term Note (filed as
Exhibit 4.25 to the Companys Registration Statement
on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.29(a)
|
|
8.750% Note in the principal amount of $400,000,000 due
2010 (filed as Exhibit 4.26(a) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.29(b)
|
|
8.750% Note in the principal amount of $350,000,000 due
2010 (filed as Exhibit 4.26(b) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.30
|
|
8.75% Note due 2010 in the principal amount of
£150,000,000 (filed as Exhibit 4.27 to the
Companys Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
II-41
|
|
|
|
|
|
4
|
.31(a)
|
|
77/8% Note
in the principal amount of $100,000,000 due 2011 (filed as
Exhibit 4.28(a) to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.31(b)
|
|
77/8% Note
in the principal amount of $400,000,000 due 2011 (filed as
Exhibit 4.28(b) to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.32(a)
|
|
6.95% Note due 2012 in the principal amount of $400,000,000
(filed as Exhibit 4.29(a) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.32(b)
|
|
6.95% Note due 2012 in the principal amount of $100,000,000
(filed as Exhibit 4.29(b) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.33(a)
|
|
6.30% Note due 2012 in the principal amount of $400,000,000
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
dated September 18, 2002, and incorporated herein by
reference).
|
|
4
|
.33(b)
|
|
6.30% Note due 2012 in the principal amount of $100,000,000
(filed as Exhibit 4.2 to the Companys Current Report
on
Form 8-K
dated September 18, 2002, and incorporated herein by
reference).
|
|
4
|
.34(a)
|
|
6.25% Note due 2013 in the principal amount of $400,000,000
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
dated February 5, 2003, and incorporated herein by
reference).
|
|
4
|
.34(b)
|
|
6.25% Note due 2013 in the principal amount of $100,000,000
(filed as Exhibit 4.2 to the Companys Current Report
on
Form 8-K
dated February 5, 2003, and incorporated herein by
reference).
|
|
4
|
.35(a)
|
|
63/4% Note
due 2013 in the principal amount of $400,000,000 (filed as
Exhibit 4.1 to the Companys Current Report on
Form 8-K
dated July 23, 2003, and incorporated herein by reference).
|
|
4
|
.35(b)
|
|
63/4% Note
due 2013 in the principal amount of $100,000,000 (filed as
Exhibit 4.2 to the Companys Current Report on
Form 8-K
dated July 23, 2003, and incorporated herein by reference).
|
|
4
|
.36
|
|
7.50% Note due 2033 in the principal amount of $250,000,000
(filed as Exhibit 4.2 to the Companys Current Report
on
Form 8-K
dated November 6, 2003, and incorporated herein by
reference).
|
|
4
|
.37
|
|
5.75% Note due 2014 in the principal amount of $500,000,000
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
dated March 8, 2004, and incorporated herein by reference).
|
|
4
|
.38
|
|
5.500% Note due 2009 in the principal amount of
$500,000,000 (filed as Exhibit 4.1 to the Companys
Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
reference).
|
|
4
|
.39(a)
|
|
6.375% Note due 2015 in the principal amount of
$500,000,000 (filed as Exhibit 4.2 to the Companys
Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
reference).
|
|
4
|
.39(b)
|
|
6.375% Note due 2015 in the principal amount of
$250,000,000 (filed as Exhibit 4.3 to the Companys
Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
reference).
|
|
4
|
.40(a)
|
|
6.500% Note due 2016 in the principal amount of
$500,000,000 (filed as Exhibit 4.1 to the Companys
Current Report on
Form 8-K
filed on February 8, 2006, and incorporated herein by
reference).
|
|
4
|
.41(b)
|
|
6.500% Note due 2016 in the principal amount of
$500,000,000 (filed as Exhibit 4.2 to the Companys
Current Report on
Form 8-K
filed on February 8, 2006, and incorporated herein by
reference).
|
|
5
|
.1
|
|
Opinion of Simpson Thacher & Bartlett LLP.*
|
II-42
|
|
|
|
|
|
5
|
.2
|
|
Opinion of Robert A. Waterman.*
|
|
10
|
.1(a)
|
|
Amended and Restated Columbia/HCA Healthcare Corporation 1992
Stock and Incentive Plan (filed as Exhibit 10.7(b) to the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 1998, and
incorporated herein by reference).
|
|
10
|
.1(b)
|
|
First Amendment to Amended and Restated Columbia/HCA Healthcare
Corporation 1992 Stock and Incentive Plan (filed as
Exhibit 10.2 to the Companys Quarterly Report on
Form 10-Q
for the quarter ended September 30, 1999, and incorporated
herein by reference).
|
|
10
|
.2
|
|
HCA-Hospital Corporation of America Nonqualified Initial Option
Plan (filed as Exhibit 4.6 to the Companys
Registration Statement on
Form S-3
(File
No. 33-52379),
and incorporated herein by reference).
|
|
10
|
.3
|
|
Form of Indemnity Agreement with certain officers and directors
(filed as Exhibit 10.3 to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054)
and incorporated herein by reference).
|
|
10
|
.4
|
|
Form of Galen Health Care, Inc. 1993 Adjustment Plan (filed as
Exhibit 4.15 to the Companys Registration Statement
on
Form S-8
(File
No. 33-50147)
and incorporated herein by reference).
|
|
10
|
.5
|
|
Form of HCA-Hospital Corporation of America 1992 Stock
Compensation Plan (filed as Exhibit 4.2 to the
Companys Registration Statement on
Form S-8
(File
No. 33-52253),
and incorporated herein by reference).
|
|
10
|
.6
|
|
Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan
(filed as Exhibit A to the Companys Proxy Statement
for the Annual Meeting of Stockholders on May 25, 2000, and
incorporated herein by reference).
|
|
10
|
.7
|
|
Form of Non-Qualified Stock Option Award Agreement (Officers)
(filed as Exhibit 99.2 to the Companys Current Report
on
Form 8-K
dated February 2, 2005, and incorporated herein by
reference).
|
|
10
|
.8
|
|
HCA 2005 Equity Incentive Plan (filed as Exhibit B to the
Companys Proxy Statement for the Annual Meeting of
Shareholders on May 26, 2005, and incorporated herein by
reference).
|
|
10
|
.9
|
|
Form of 2005 Non-Qualified Stock Option Agreement (Officers)
(filed as Exhibit 99.2 to the Companys Current Report
on
Form 8-K
dated October 6, 2005, and incorporated herein by
reference).
|
|
10
|
.10
|
|
Form of 2006 Non-Qualified Stock Option Award Agreement
(Officers) (filed as Exhibit 10.2 to the Companys
Current Report on
Form 8-K
dated February 1, 2006, and incorporated herein by
reference).
|
|
10
|
.11
|
|
2006 Stock Incentive Plan for Key Employees of HCA Inc. and its
Affiliates (filed as Exhibit 10.11 to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.12
|
|
Management Stockholders Agreement dated November 17,
2006 (filed as Exhibit 10.12 to the Companys Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.13
|
|
Sale Participation Agreement dated November 17, 2006 (filed
as Exhibit 10.13 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.14
|
|
Form of Option Rollover Agreement (filed as Exhibit 10.14
to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.15
|
|
Form of Option Agreement (2007) (filed as Exhibit 10.15 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.16
|
|
Form of Option Agreement (2008) (filed as Exhibit 10.16 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).
|
|
10
|
.17
|
|
Form of Option Agreement (2009) (filed as Exhibit 10.17 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
10
|
.18
|
|
Exchange and Purchase Agreement (filed as Exhibit 10.16 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
II-43
|
|
|
|
|
|
10
|
.19
|
|
Civil and Administrative Settlement Agreement, dated
December 14, 2000 between the Company, the United States
Department of Justice and others (filed as Exhibit 99.2 to
the Companys Current Report on
Form 8-K
dated December 20, 2000, and incorporated herein by
reference).
|
|
10
|
.20
|
|
Plea Agreement, dated December 14, 2000 between the
Company, Columbia Homecare Group, Inc., Columbia Management
Companies, Inc. and the United States Department of Justice
(filed as Exhibit 99.3 to the Companys Current Report
on
Form 8-K
dated December 20, 2000, and incorporated herein by
reference).
|
|
10
|
.21
|
|
Corporate Integrity Agreement, dated December 14, 2000
between the Company and the Office of Inspector General of the
United States Department of Health and Human Services (filed as
Exhibit 99.4 to the Companys Current Report on
Form 8-K
dated December 20, 2000, and incorporated herein by
reference).
|
|
10
|
.22
|
|
Management Agreement, dated November 17, 2006, among HCA
Inc., Bain Capital Partners, LLC, Kohlberg Kravis
Roberts & Co. L.P., Dr. Thomas F. Frist Jr.,
Patricia F. Elcan, William R. Frist and Thomas F.
Frist, III, and Merrill Lynch Global Partners, Inc. (filed
as Exhibit 10.20 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.23
|
|
Retirement Agreement between the Company and Thomas F. Frist,
Jr., M.D. dated as of January 1, 2002 (filed as
Exhibit 10.30 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2001, and
incorporated herein by reference).
|
|
10
|
.24
|
|
Amended and Restated HCA Supplemental Executive Retirement Plan,
effective January 1, 2007, except as provided therein.)
(filed as Exhibit 10.24 to the Companys Annual Report
on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
10
|
.25
|
|
Amended and Restated HCA Restoration Plan, effective
January 1, 2008.) (filed as Exhibit 10.25 to the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
10
|
.26
|
|
HCA Inc. 2006 Senior Officer Performance Excellence Program
(filed as Exhibit 10.3 to the Companys Current Report
on 8-K filed
February 1, 2006, and incorporated herein by reference).
|
|
10
|
.27
|
|
HCA Inc. 2007 Senior Officer Performance Excellence Program
(filed as Exhibit 10.26 to the Companys Annual Report
on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.28(a)
|
|
HCA Inc.
2008-2009
Senior Officer Performance Excellence Program (filed as
Exhibit 10.27 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).
|
|
10
|
.28(b)
|
|
HCA Inc. Amendment No. 1 to the
2008-2009
Senior Officer Performance Excellence Program (filed as
Exhibit 10.28(b) to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
10
|
.29(a)
|
|
Employment Agreement dated November 16, 2006 (Jack O.
Bovender, Jr.) (filed as Exhibit 10.27(a) to the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.29(b)
|
|
Employment Agreement dated November 16, 2006 (Richard M.
Bracken) (filed as Exhibit 10.27(b) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.29(c)
|
|
Employment Agreement dated November 16, 2006 (R. Milton
Johnson) (filed as Exhibit 10.27(c) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.29(d)
|
|
Employment Agreement dated November 16, 2006 (Samuel N.
Hazen) (filed as Exhibit 10.27(d) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.29(e)
|
|
Employment Agreement dated November 16, 2006 (Beverly B.
Wallace) (filed as Exhibit 10.28(e) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).
|
II-44
|
|
|
|
|
|
10
|
.29(f)
|
|
Amended and Restated Employment Agreement dated October 27,
2008 (Jack O. Bovender, Jr.) (filed as Exhibit 10.29(f) to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
10
|
.29(g)
|
|
Amendment to Employment Agreement effective January 1, 2009
(Richard M. Bracken) (filed as Exhibit 10.29(g) to the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
incorporated herein by reference).
|
|
10
|
.30
|
|
Administrative Settlement Agreement dated June 25, 2003 by
and between the United States Department of Health and Human
Services, acting through the Centers for Medicare and Medicaid
Services, and the Company (filed as Exhibit 10.1 to the
Companys Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2003, and incorporated
herein by reference).
|
|
10
|
.31
|
|
Civil Settlement Agreement by and among the United States of
America, acting through the United States Department of Justice
and on behalf of the Office of Inspector General of the
Department of Health and Human Services, the TRICARE Management
Activity (filed as Exhibit 10.2 to the Companys
Quarterly Report of
Form 10-Q
for the quarter ended June 30, 2003, and incorporated
herein by reference).
|
|
10
|
.32
|
|
Form of Amended and Restated Limited Liability Company Agreement
of Hercules Holding II, LLC dated as of November 17, 2006,
among Hercules Holding II, LLC and certain other parties thereto
(filed as Exhibit 10.3 to the Companys Registration
Statement on
Form 8-A
(File
No. 000-18406)
and incorporated herein by reference).
|
|
12
|
.1
|
|
Statement Regarding Computation of Ratio of Earnings to Fixed
Charges.*
|
|
21
|
.1
|
|
List of Subsidiaries.*
|
|
23
|
.1
|
|
Consent of Simpson Thacher & Bartlett LLP (included as
part of its opinion filed as Exhibit 5.1 hereto).*
|
|
23
|
.2
|
|
Consent of Robert A. Waterman (included as part of opinion filed
as Exhibit 5.2).*
|
|
23
|
.3
|
|
Consent of Ernst & Young LLP.*
|
|
24
|
.1
|
|
Powers of Attorney (included in signature pages of this
Registration Statement).
|
|
25
|
.1
|
|
Form T-1
Statement of Eligibility under the Trust Indenture Act of
1939 of The Bank of New York Mellon as trustee under the
Indenture, dated as of December 16, 1993, between HCA Inc.
and The Bank of New York Mellon (as successor trustee to The
First National Bank of Chicago), as Trustee.*
|
|
25
|
.2
|
|
Form T-1
Statement of Eligibility under the Trust Indenture Act of
1939 of The Bank of New York Mellon as trustee under the
Indenture, dated as of November 17, 2006, among HCA Inc.,
the guarantors party thereto and The Bank of New York Mellon, as
Trustee.*
|
|
25
|
.3
|
|
Form T-1
Statement of Eligibility under the Trust Indenture Act of
1939 of The Bank of New York Mellon Trust Company, N.A. as
trustee under the Indenture, dated as of February 19, 2009,
among HCA Inc., the guarantors party thereto, The Bank of New
York Mellon, as collateral agent and The Bank of New York Mellon
Trust Company, N.A., as Trustee.*
|
|
25
|
.4
|
|
Form T-1
Statement of Eligibility under the Trust Indenture Act of
1939 of Law Debenture Trust Company of New York, as trustee
under the Indenture, dated as of April 22, 2009, among HCA
Inc., the guarantors party thereto, Deutsche Bank
Trust Company Americas as paying agent, registrar and
transfer agent and Law Debenture Trust Company of New York,
as Trustee.*
|
(b) Financial Statement Schedules
All schedules are omitted because the required information is
either not present, not present in material amounts or presented
within the consolidated financial statements included with our
annual report on
Form 10-K
for the fiscal year ended December 31, 2008 and
incorporated herein by reference.
II-45
(a) Each of the undersigned registrants hereby undertakes:
(1) to file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(i) to include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933;
(ii) to reflect in the prospectus any facts or events
arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20% change in the maximum aggregate
offering price set forth in the Calculation of
Registration Fee table in the effective registration
statement; and
(iii) to include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement;
(2) that, for the purpose of determining any liability
under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof;
(3) to remove from registration by means of a
post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering;
(4) that, for the purpose of determining liability under
the Securities Act of 1933 to any purchaser, each prospectus
filed pursuant to Rule 424(b) as part of a registration
statement relating to an offering, other than registration
statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part
of and included in the registration statement as of the date it
is first used after effectiveness. Provided, however, that no
statement made in a registration statement or prospectus that is
part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of
contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or
prospectus that was part of the registration statement or made
in any such document immediately prior to such date of first
use; and
(5) that, for the purpose of determining liability of the
registrants under the Securities Act of 1933 to any purchaser in
the initial distribution of the securities:
The undersigned registrants undertake that in a primary offering
of securities of the undersigned registrants pursuant to this
registration statement, regardless of the underwriting method
used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the
following communications, the undersigned registrants will be
sellers to the purchaser and will be considered to offer or sell
such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the
undersigned registrants relating to the offering required to be
filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned registrants or used
or referred to by the undersigned registrants
II-46
(iii) The portion of any other free writing prospectus
relating to the offering containing material information about
the undersigned registrants or their securities provided by or
on behalf of the undersigned registrants; and
(iv) Any other communication that is an offer in the
offering made by the undersigned registrants to the purchaser.
(b) Insofar as indemnification for liabilities arising
under the Securities Act of 1933 may be permitted to
directors, officers and controlling persons of the registrants
pursuant to the foregoing provisions, or otherwise, the
registrants have been advised that in the opinion of the
Securities and Exchange Commission such indemnification is
against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment
by the registrants of expenses incurred or paid by a director,
officer or controlling person of the registrants in the
successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in
connection with the securities being registered, the registrants
will, unless in the opinion of their counsel the matter has been
settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such
indemnification by them is against public policy as expressed in
the Securities Act and will be governed by the final
adjudication of such issue.
II-47
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
HCA INC.
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Executive Vice President and
|
Chief Financial Officer
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes Jack O.
Bovender, Jr., Richard M. Bracken and R. Milton
Johnson, or any of them, as his or her attorney in fact and
agent, with full power of substitution and resubstitution, to
execute, in his name and on his behalf, in any and all
capacities, a Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Jack
O. Bovender, Jr.
Jack
O. Bovender, Jr.
|
|
Chairman of the Board
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Richard
M. Bracken
Richard
M. Bracken
|
|
President, Chief Executive Officer
and Director
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Christopher
J. Birosak
Christopher
J. Birosak
|
|
Director
|
|
May 27, 2009
|
II-48
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ John
P. Connaughton
John
P. Connaughton
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ James
D. Forbes
James
D. Forbes
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Kenneth
W. Freeman
Kenneth
W. Freeman
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Thomas
F. Frist, III
Thomas
F. Frist, III
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ William
R. Frist
William
R. Frist
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Christopher
R. Gordon
Christopher
R. Gordon
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Michael
W. Michelson
Michael
W. Michelson
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ James
C. Momtazee
James
C. Momtazee
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Stephen
G. Pagliuca
Stephen
G. Pagliuca
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Nathan
C. Thorne
Nathan
C. Thorne
|
|
Director
|
|
May 27, 2009
|
II-49
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule I of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any of
them, as his or her attorney in fact and agent, with full power
of substitution and resubstitution, to execute, in his name and
on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
President and Director
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director
|
|
May 27, 2009
|
II-50
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule II of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
President and Director
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ William
B. Rutherford
William
B. Rutherford
|
|
Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary
|
|
May 27, 2009
|
II-51
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule III of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any
of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
President and Manager
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager
|
|
May 27, 2009
|
II-52
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule IV of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
President and Manager
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ William
B. Rutherford
William
B. Rutherford
|
|
Manager
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary
|
|
May 27, 2009
|
II-53
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule V of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Beverly
B. Wallace
Beverly
B. Wallace
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager
|
|
May 27, 2009
|
II-54
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in city the of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule VI of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Charles
J. Hall
Charles
J. Hall
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director
|
|
May 27, 2009
|
II-55
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule VII of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any of
them, as his or her attorney in fact and agent, with full power
of substitution and resubstitution, to execute, in his name and
on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Charles
J. Hall
Charles
J. Hall
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager
|
|
May 27, 2009
|
II-56
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule VIII of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Gregary
W. Beasley
Gregary
W. Beasley
|
|
President and Director
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President and Assistant Secretary
|
|
May 27, 2009
|
II-57
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule IX of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any
of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Gregary
W. Beasley
Gregary
W. Beasley
|
|
President and Manager
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Manager
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President and Assistant Secretary
|
|
May 27, 2009
|
II-58
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule X of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any
of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Noel
B. Williams
Noel
B. Williams
|
|
President and Chief Information Officer
(Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director
|
|
May 27, 2009
|
II-59
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule XI of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any
of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Paul
Rutledge
Paul
Rutledge
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director
|
|
May 27, 2009
|
II-60
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule XII of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any
of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Paul
Rutledge
Paul
Rutledge
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager
|
|
May 27, 2009
|
II-61
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule XIII of Subsidiary Registrants)
|
|
|
|
By:
|
/s/
R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any
of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director
|
|
May 27, 2009
|
II-62
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule XIV of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or any
of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager
|
|
May 27, 2009
|
II-63
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
REGISTRANTS (as listed on the attached
Schedule XV of Subsidiary Registrants)
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the general partner
Columbia North Texas Subsidiary GP, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
of the general partner Columbia North Texas Subsidiary GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner Columbia
North Texas Subsidiary GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Manager (Principal Accounting Officer)
of the general partner Columbia North Texas Subsidiary GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner Columbia North Texas Subsidiary GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager of the general partner Columbia
North Texas Subsidiary GP, LLC
|
|
May 27, 2009
|
II-64
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
CHCA Bayshore, L.P.
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
Pasadena Bayshore Hospital, Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
of the general partner, Pasadena
Bayshore Hospital, Inc
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Pasadena
Bayshore Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director (Principal Accounting
Officer) of the general partner, Pasadena
Bayshore Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, Pasadena Bayshore Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner, Pasadena
Bayshore Hospital, Inc.
|
|
May 27, 2009
|
II-65
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
CHCA Conroe, L.P.
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
Conroe Hospital Corporation
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer) of the general partner
Conroe Hospital Corporation
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner Conroe
Hospital Corporation
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Senior Vice President and Director (Principal Accounting
Officer) of the general partner Conroe Hospital Corporation
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner Conroe Hospital Corporation
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner Conroe
Hospital Corporation
|
|
May 27, 2009
|
II-66
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
CHCA Mainland, L.P.
|
|
|
|
By:
|
/s/ R.
Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
Danforth Hospital, Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
of the general partner, Danforth Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Danforth
Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
of the general partner, Danforth Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, Danforth Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner Danforth
Hospital, Inc.
|
|
May 27, 2009
|
II-67
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
CHCA West Houston, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of general partner, WHMC,
Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel N. Hazen
|
|
President (Principal Executive Officer)
of the general partner, WHMC, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
of the general partner, WHMC, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
of the general partner, WHMC, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, WHMC, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner, WHMC,
Inc.
|
|
May 27, 2009
|
II-68
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
CHCA Womans Hospital, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President of general partner, Womans
Hospital of Texas, Incorporated
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel N. Hazen
|
|
President (Principal Executive Officer)
of the general partner, Womans Hospital of Texas,
Incorporated
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner,
Womans Hospital of Texas, Incorporated
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director (Principal Accounting
Officer) of the general partner, Womans Hospital of Texas,
Incorporated
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, Womans Hospital of Texas, Incorporated
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner, Womans
Hospital of Texas, Incorporated
|
|
May 27, 2009
|
II-69
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
CMS GP, LLC
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
President and Manager
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
President and Manager
(Principal Executive Officer and Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Manager
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager
|
|
May 27, 2009
|
II-70
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Columbia ASC Management, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manger of the general partner,
Medical Care America, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Gregary
W. Beasley
Gregary W. Beasley
|
|
President and Manager
(Principal Executive Officer) of the general partner, Medical
Care America, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Medical
Care America, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner, Medical
Care America, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Manager of the general partner,
Medical Care America, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President and Assistant Secretary of the general partner,
Medical Care America, LLC
|
|
May 27, 2009
|
II-71
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Columbia Rio Grande Healthcare, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
Rio Grande Regional Hospital, Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel N. Hazen
|
|
President (Principal Executive Officer) of the general partner,
Rio Grande Regional Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Rio Grande
Regional Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer) of the general partner, Rio
Grande Regional Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, Rio Grande Regional Hospital, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner, Rio Grande
Regional Hospital, Inc.
|
|
May 27, 2009
|
II-72
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Columbia Valley Healthcare System, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
Brownsville-Valley Regional Medical Center, Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel N. Hazen
|
|
President (Principal Executive Officer) of the general partner,
Brownsville-Valley Regional Medical Center, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer (Principal Financial Officer) of
the general partner, Brownsville-Valley Regional Medical
Center, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer) of the general partner,
Brownsville-Valley Regional Medical Center, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, Brownsville-Valley Regional Medical Center, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner,
Brownsville-Valley Regional Medical Center, Inc.
|
|
May 27, 2009
|
II-73
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Fairview Park, Limited Partnership
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of general partner,
Fairview Park GP, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Charles
J. Hall
Charles J. Hall
|
|
President (Principal Executive Officer) of the general partner,
Fairview Park GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer (Principal Financial Officer) of
the general partner, Fairview Park GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner, Fairview
Park GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner, Fairview Park GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager of the general partner, Fairview Park
GP, LLC
|
|
May 27, 2009
|
II-74
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Good Samaritan Hospital, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of general partner,
Samaritan, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel N. Hazen
|
|
President (Principal Executive Officer) of the general partner,
Samaritan, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer (Principal Financial Officer) of
the general partner, Samaritan, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager (Principal Accounting Officer)
of the general partner, Samaritan, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner, Samaritan, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager of the general partner, Samaritan, LLC
|
|
May 27, 2009
|
II-75
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
HCA Management Services, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
President and Manager of general partner, CMS GP, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
President and Manager (Principal Executive Officer and Principal
Accounting Officer) of the general partner, CMS GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer (Principal Financial Officer) of
the general partner, CMS GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Manager of the general partner, CMS
GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner, CMS GP, LLC
|
|
May 27, 2009
|
II-76
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in the city of Nashville, State of Tennessee, on
May 27, 2009.
Healthtrust MOB, LLC
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of managing member,
Healthtrust, Inc. The Hospital Company
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A. Bruce Moore, Jr.
|
|
President and Director (Principal Executive Officer) of the
managing member, Healthtrust, Inc. The Hospital
Company
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Senior Vice President and Treasurer (Principal Financial
Officer) of the managing member, Healthtrust, Inc.
The Hospital Company
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director (Principal Accounting
Officer) of the managing member, Healthtrust, Inc.
The Hospital Company
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Dora
A. Blackwood
Dora
A. Blackwood
|
|
Vice President, Secretary and Director of the managing member,
Healthtrust, Inc. The Hospital Company
|
|
May 27, 2009
|
II-77
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the managing
member, Healthtrust, Inc. The Hospital Company
|
|
May 27, 2009
|
|
|
|
|
|
/s/ William
B. Rutherford
William
B. Rutherford
|
|
Vice President and Director of the managing member, Healthtrust,
Inc. The Hospital Company
|
|
May 27, 2009
|
|
|
|
|
|
/s/ Donald
W. Stinnett
Donald
W. Stinnett
|
|
Vice President and Director of the managing member, Healthtrust,
Inc. The Hospital Company
|
|
May 27, 2009
|
II-78
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
HSS Virginia, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manger of the general partner, HSS
Holdco, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A. Bruce Moore, Jr.
|
|
President and Manager (Principal Executive Officer) of the
general partner, HSS Holdco, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, HSS
Holdco, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner, HSS
Holdco, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner, HSS Holdco, LLC
|
|
May 27, 2009
|
II-79
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Integrated Regional Laboratories, LLP
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the managing partner,
Integrated Regional Lab, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Charles
J. Hall
Charles J. Hall
|
|
President (Principal Executive Officer) of the managing
partner, Integrated Regional Lab, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the managing partner,
Integrated Regional Lab, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manage (Principal Accounting
Officer) of the managing partner, Integrated Regional Lab, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the managing
partner, Integrated Regional Lab, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager of the managing partner, Integrated
Regional Lab, LLC
|
|
May 27, 2009
|
II-80
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
JFK Medical Center Limited Partnership
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the general partner,
Columbia Palm Beach GP, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Charles
J. Hall
Charles J. Hall
|
|
President (Principal Executive Officer) of the general partner,
Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Columbia
Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager (Principal Accounting
Officer) of the general partner, Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Manager of the general partner,
Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner, Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
II-81
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
MCA Investment Company
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Gregary
W. Beasley
Gregary
W. Beasley
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director (Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director
|
|
May 27, 2009
|
II-82
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Nashville Shared Services General Partnership
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the managing partner,
HSS Systems, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Beverly
B. Wallace
Beverly
B. Wallace
|
|
President (Principal Executive Officer)
of the managing partner, HSS Systems, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the managing partner, HSS
Systems, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager (Principal Accounting Officer)
of the managing partner, HSS Systems, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary
and Manager of the managing partner,
HSS Systems, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager of the managing partner, HSS Systems,
LLC
|
|
May 27, 2009
|
II-83
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
National Patient Account Services, Inc.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Beverly
B. Wallace
Beverly
B. Wallace
|
|
President (Principal Executive Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary
and Director
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director
|
|
May 27, 2009
|
II-84
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Palms West Hospital Limited Partnership
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the general partner,
Columbia Palm Beach GP, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Charles
J. Hall
Charles
J. Hall
|
|
President (Principal Executive Officer)
of the general partner, Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Columbia
Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
of the general partner, Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Senior Vice President and Manager
of the general partner, Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner, Columbia Palm Beach GP, LLC
|
|
May 27, 2009
|
II-85
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Plantation General Hospital, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
HD&S Corp. Successor, Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Charles
J. Hall
Charles
J. Hall
|
|
President (Principal Executive Officer)
of the general partner, HD&S Corp. Successor, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, HD&S
Corp. Successor, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director (Principal Accounting
Officer) of the general partner, HD&S Corp. Successor,
Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, HD&S Corp. Successor, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner, HD&S
Corp. Successor, Inc.
|
|
May 27, 2009
|
II-86
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Riverside Healthcare System, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
Columbia Riverside, Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
of the general partner, Columbia Riverside, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer (Principal Financial Officer) of
the general partner, Columbia Riverside, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director (Principal Accounting
Officer) of the general partner, Columbia Riverside, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, Columbia Riverside, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner, Columbia
Riverside, Inc.
|
|
May 27, 2009
|
II-87
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
San Jose Healthcare System, LP
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the general partner,
San Jose, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities a Market-Maker
Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
of the general partner, San Jose, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner,
San Jose, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner,
San Jose, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary
and Manager of the general partner, San Jose, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Manager of the general partner,
San Jose, LLC
|
|
May 27, 2009
|
II-88
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
San Jose Hospital, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the general partner,
San Jose Medical Center, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Samuel
N. Hazen
Samuel
N. Hazen
|
|
President (Principal Executive Officer)
of the general partner, San Jose Medical Center, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner,
San Jose Medical Center, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager
(Principal Accounting Officer)
of the general partner, San Jose Medical Center, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the general
partner, San Jose Medical Center, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr
A.
Bruce Moore, Jr.
|
|
Vice President and Manager of the general partner, San Jose
Medical Center, LLC
|
|
May 27, 2009
|
II-89
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Terre Haute MOB, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Manager of the managing general
partner, HSS Holdco, LLC
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
President and Manager (Principal Executive Officer) of the
managing general partner, HSS Holdco, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the managing general partner,
HSS Holdco, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Manager (Principal Accounting Officer)
of the managing general partner, HSS Holdco, LLC
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Manager of the managing
general partner, HSS Holdco, LLC
|
|
May 27, 2009
|
II-90
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the city of Nashville, State of Tennessee, on
May 27, 2009.
Terre Haute Regional Hospital, L.P.
|
|
|
|
By:
|
/s/ R. Milton Johnson
|
Name: R. Milton Johnson
|
|
|
|
Title:
|
Senior Vice President and Director of the general partner,
Terre Haute Hospital GP, Inc.
|
SIGNATURES
AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
Franck II, David G. Anderson and R. Milton Johnson, or
any of them, as his or her attorney in fact and agent, with full
power of substitution and resubstitution, to execute, in his
name and on his behalf, in any and all capacities, a
Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
related to the notes described herein, and to file the same,
with all the exhibits thereto, and all other documents in
connection therewith, with the Securities and Exchange
Commission, necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, and any rules,
regulations and requirements of the Securities and Exchange
Commission, in respect thereof, in connection with the
registration of the notes described herein which are the subject
of such Market-Maker Registration Statement, as the case may be,
which amendments may make such changes in such Market Maker
Registration Statement, as the case may be, as such attorney may
deem appropriate, and with full power and authority to perform
and do any and all acts and things, whatsoever which any such
attorney or substitute may deem necessary or advisable to be
performed or done in connection with any or all of the
above-described matters, as fully as each of the undersigned
could do if personally present and acting, hereby ratifying and
approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Paul
Rutledge
Paul
Rutledge
|
|
President (Principal Executive Officer)
of the general partner, Terre Haute Hospital GP, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ David
G. Anderson
David
G. Anderson
|
|
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Terre
Haute Hospital GP, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ R. Milton Johnson
R. Milton Johnson
|
|
Senior Vice President and Director
(Principal Accounting Officer)
of the general partner, Terre Haute Hospital GP, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ John
M. Franck II
John
M. Franck II
|
|
Vice President, Assistant Secretary and Director of the general
partner, Terre Haute Hospital GP, Inc.
|
|
May 27, 2009
|
|
|
|
|
|
/s/ A.
Bruce Moore, Jr.
A.
Bruce Moore, Jr.
|
|
Vice President and Director of the general partner, Terre Haute
Hospital GP, Inc.
|
|
May 27, 2009
|
II-91
SCHEDULE I
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
AMERICAN MEDICORP DEVELOPMENT CO.
|
|
|
|
|
COLORADO HEALTH SYSTEMS, INC.
|
|
|
|
|
COLUMBIA JACKSONVILLE HEALTHCARE SYSTEM, INC.
|
|
|
|
|
COLUMBUS CARDIOLOGY, INC.
|
|
|
|
|
HCA REALTY, INC.
|
|
|
|
|
HOSPITAL DEVELOPMENT PROPERTIES, INC.
|
|
|
|
|
MANAGEMENT SERVICES HOLDINGS, INC.
|
|
|
|
|
TERRE HAUTE HOSPITAL HOLDINGS, INC.
|
|
|
|
|
VH HOLDCO, INC.
|
|
|
|
|
VH HOLDINGS, INC.
|
|
|
|
|
WESTERN PLAINS CAPITAL, INC.
|
|
|
|
|
II-92
SCHEDULE II
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
NORTH FLORIDA IMMEDIATE CARE CENTER, INC.
|
|
|
|
|
REDMOND PHYSICIAN PRACTICE COMPANY
|
|
|
|
|
II-93
SCHEDULE III
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
DUBLIN COMMUNITY HOSPITAL, LLC
|
|
|
|
|
EP HEALTH, LLC
|
|
|
|
|
GENERAL HEALTHSERV, LLC
|
|
|
|
|
HSS HOLDCO, LLC
|
|
|
|
|
MEDICAL CENTERS OF OKLAHOMA, LLC
|
|
|
|
|
NOTAMI HOSPITALS, LLC
|
|
|
|
|
SJMC, LLC
|
|
|
|
|
UTAH MEDCO, LLC
|
|
|
|
|
II-94
SCHEDULE IV
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
DALLAS/FT. WORTH PHYSICIAN, LLC
|
|
|
|
|
GOPPERT-TRINITY FAMILY CARE, LLC
|
|
|
|
|
LEWIS-GALE PHYSICIANS, LLC
|
|
|
|
|
OUTPATIENT CARDIOVASCULAR CENTER OF CENTRAL FLORIDA, LLC
|
|
|
|
|
II-95
SCHEDULE V
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
CENTRAL SHARED SERVICES, LLC
|
|
|
|
|
HSS SYSTEMS VA, LLC
|
|
|
|
|
HSS SYSTEMS, LLC
|
|
|
|
|
II-96
SCHEDULE VI
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
BAY HOSPITAL, INC.
|
|
|
|
|
CENTRAL FLORIDA REGIONAL HOSPITAL, INC.
|
|
|
|
|
COLUMBIA LAGRANGE HOSPITAL, INC.
|
|
|
|
|
EDWARD WHITE HOSPITAL, INC.
|
|
|
|
|
HCA HEALTH SERVICES OF FLORIDA, INC.
|
|
|
|
|
HD&S CORP. SUCCESSOR, INC.
|
|
|
|
|
LARGO MEDICAL CENTER, INC.
|
|
|
|
|
LAWNWOOD MEDICAL CENTER, INC.
|
|
|
|
|
MARION COMMUNITY HOSPITAL, INC.
|
|
|
|
|
MEMORIAL HEALTHCARE GROUP, INC.
|
|
|
|
|
NEW PORT RICHEY HOSPITAL, INC.
|
|
|
|
|
NORTH FLORIDA REGIONAL MEDICAL CENTER, INC.
|
|
|
|
|
OKALOOSA HOSPITAL, INC.
|
|
|
|
|
OKEECHOBEE HOSPITAL, INC.
|
|
|
|
|
PALMYRA PARK HOSPITAL, INC.
|
|
|
|
|
SARASOTA DOCTORS HOSPITAL, INC.
|
|
|
|
|
SUN CITY HOSPITAL, INC.
|
|
|
|
|
TALLAHASSEE MEDICAL CENTER, INC.
|
|
|
|
|
WALTERBORO COMMUNITY HOSPITAL, INC.
|
|
|
|
|
WEST FLORIDA REGIONAL MEDICAL CENTER, INC.
|
|
|
|
|
II-97
SCHEDULE VII
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
FAIRVIEW PARK GP, LLC
|
|
|
|
|
GRAND STRAND REGIONAL MEDICAL CENTER, LLC
|
|
|
|
|
INTEGRATED REGIONAL LAB, LLC
|
|
|
|
|
TRIDENT MEDICAL CENTER, LLC
|
|
|
|
|
II-98
SCHEDULE VIII
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
EL PASO SURGICENTER, INC.
|
|
|
|
|
LAS VEGAS SURGICARE, INC.
|
|
|
|
|
MARIETTA SURGICAL CENTER, INC.
|
|
|
|
|
SURGICARE OF BRANDON, INC.
|
|
|
|
|
SURGICARE OF FLORIDA, INC.
|
|
|
|
|
SURGICARE OF HOUSTON WOMENS, INC.
|
|
|
|
|
SURGICARE OF MANATEE, INC.
|
|
|
|
|
SURGICARE OF NEW PORT RICHEY, INC.
|
|
|
|
|
II-99
SCHEDULE IX
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
SURGICARE OF PALMS WEST, LLC
|
|
|
|
|
SURGICARE OF RIVERSIDE, LLC
|
|
|
|
|
II-100
SCHEDULE X
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
HCA IT&S FIELD OPERATIONS, INC.
|
|
|
|
|
HCA IT&S INVENTORY MANAGEMENT, INC
|
|
|
|
|
II-101
SCHEDULE XI
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
BROOKWOOD MEDICAL CENTER OF GULFPORT, INC.
|
|
|
|
|
CAPITAL DIVISION, INC.
|
|
|
|
|
CENTRAL TENNESSEE HOSPITAL CORPORATION
|
|
|
|
|
CHIPPENHAM & JOHNSTON-WILLIS HOSPITALS, INC.
|
|
|
|
|
COLUMBIA POLK GENERAL HOSPITAL, INC.
|
|
|
|
|
COLUMBIA/ALLEGHANY REGIONAL HOSPITAL, INCORPORATED
|
|
|
|
|
COLUMBIA/HCA JOHN RANDOLPH, INC.
|
|
|
|
|
DAUTERIVE HOSPITAL CORPORATION
|
|
|
|
|
FRANKFORT HOSPITAL, INC.
|
|
|
|
|
GPCH-GP, INC.
|
|
|
|
|
GREENVIEW HOSPITAL, INC.
|
|
|
|
|
HAMILTON MEDICAL CENTER, INC.
|
|
|
|
|
HCA CENTRAL GROUP, INC.
|
|
|
|
|
HCA HEALTH SERVICES OF LOUISIANA, INC.
|
|
|
|
|
HCA HEALTH SERVICES OF TENNESSEE, INC.
|
|
|
|
|
HCA HEALTH SERVICES OF VIRGINIA, INC.
|
|
|
|
|
HEALTH MIDWEST OFFICE FACILITIES CORPORATION
|
|
|
|
|
HEALTH MIDWEST VENTURES GROUP, INC.
|
|
|
|
|
HENDERSONVILLE HOSPITAL CORPORATION
|
|
|
|
|
HOSPITAL CORPORATION OF TENNESSEE
|
|
|
|
|
HTI MEMORIAL HOSPITAL CORPORATION
|
|
|
|
|
LEWIS-GALE HOSPITAL, INCORPORATED
|
|
|
|
|
MIDWEST HOLDINGS, INC.
|
|
|
|
|
MONTGOMERY REGIONAL HOSPITAL, INC.
|
|
|
|
|
NOTAMI HOSPITALS OF LOUISIANA, INC.
|
|
|
|
|
PULASKI COMMUNITY HOSPITAL, INC.
|
|
|
|
|
SPOTSYLVANIA MEDICAL CENTER, INC.
|
|
|
|
|
SPRING HILL HOSPITAL, INC.
|
|
|
|
|
TCMC MADISON-PORTLAND, INC.
|
|
|
|
|
TERRE HAUTE HOSPITAL GP, INC.
|
|
|
|
|
VIRGINIA PSYCHIATRIC COMPANY, INC.
|
|
|
|
|
WOMENS AND CHILDRENS HOSPITAL, INC.
|
|
|
|
|
II-102
SCHEDULE XII
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
CENTERPOINT MEDICAL CENTER OF INDEPENDENCE, LLC
|
|
|
|
|
COLUMBIA PARKERSBURG HEALTHCARE SYSTEM, LLC
|
|
|
|
|
GALEN PROPERTY, LLC
|
|
|
|
|
LAKELAND MEDICAL CENTER, LLC
|
|
|
|
|
LAKEVIEW MEDICAL CENTER, LLC
|
|
|
|
|
LEWIS-GALE MEDICAL CENTER, LLC
|
|
|
|
|
MEDICAL OFFICE BUILDINGS OF KANSAS, LLC
|
|
|
|
|
MIDWEST DIVISION ACH, LLC
|
|
|
|
|
MIDWEST DIVISION LRHC, LLC
|
|
|
|
|
MIDWEST DIVISION LSH, LLC
|
|
|
|
|
MIDWEST DIVISION MCI, LLC
|
|
|
|
|
MIDWEST DIVISION MMC, LLC
|
|
|
|
|
MIDWEST DIVISION OPRMC, LLC
|
|
|
|
|
MIDWEST DIVISION PFC, LLC
|
|
|
|
|
MIDWEST DIVISION RBH, LLC
|
|
|
|
|
MIDWEST DIVISION RMC, LLC
|
|
|
|
|
MIDWEST DIVISION RPC, LLC
|
|
|
|
|
NORTHERN VIRGINIA COMMUNITY HOSPITAL, LLC
|
|
|
|
|
NORTHLAKE MEDICAL CENTER, LLC
|
|
|
|
|
REDMOND PARK HOSPITAL, LLC
|
|
|
|
|
RESTON HOSPITAL CENTER, LLC
|
|
|
|
|
RETREAT HOSPITAL, LLC
|
|
|
|
|
SOUTHERN HILLS MEDICAL CENTER, LLC
|
|
|
|
|
II-103
SCHEDULE XIII
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
BRIGHAM CITY COMMUNITY HOSPITAL, INC.
|
|
|
|
|
COLUMBIA MEDICAL CENTER OF LAS COLINAS, INC.
|
|
|
|
|
COLUMBIA OGDEN MEDICAL CENTER, INC.
|
|
|
|
|
COLUMBIA RIVERSIDE, INC.
|
|
|
|
|
COLUMBINE PSYCHIATRIC CENTER, INC.
|
|
|
|
|
CONROE HOSPITAL CORPORATION
|
|
|
|
|
EASTERN IDAHO HEALTH SERVICES, INC.
|
|
|
|
|
ENCINO HOSPITAL CORPORATION, INC.
|
|
|
|
|
HCA HEALTH SERVICES OF OKLAHOMA, INC.
|
|
|
|
|
HOSPITAL CORPORATION OF UTAH
|
|
|
|
|
KPH-CONSOLIDATION, INC
|
|
|
|
|
LOS ROBLES REGIONAL MEDICAL CENTER
|
|
|
|
|
MOUNTAIN VIEW HOSPITAL, INC.
|
|
|
|
|
NEW ROSE HOLDING COMPANY, INC.
|
|
|
|
|
NORTHERN UTAH HEALTHCARE CORPORATION
|
|
|
|
|
PASADENA BAYSHORE HOSPITAL, INC.
|
|
|
|
|
RIO GRANDE REGIONAL HOSPITAL, INC.
|
|
|
|
|
RIVERSIDE HOSPITAL, INC.
|
|
|
|
|
SPRING BRANCH MEDICAL CENTER, INC.
|
|
|
|
|
ST. MARKS LONE PEAK HOSPITAL, INC.
|
|
|
|
|
SUNRISE MOUNTAINVIEW HOSPITAL, INC.
|
|
|
|
|
TIMPANOGOS REGIONAL MEDICAL SERVICES, INC.
|
|
|
|
|
W & C HOSPITAL, INC.
|
|
|
|
|
WEST VALLEY MEDICAL CENTER, INC.
|
|
|
|
|
WHMC, INC.
|
|
|
|
|
WOMANS HOSPITAL OF TEXAS, INCORPORATED
|
|
|
|
|
II-104
SCHEDULE XIV
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
EDMOND REGIONAL MEDICAL CENTER, LLC
|
|
|
|
|
SAMARITAN, LLC
|
|
|
|
|
SAN JOSE MEDICAL CENTER, LLC
|
|
|
|
|
SAN JOSE, LLC
|
|
|
|
|
WESLEY MEDICAL CENTER, LLC
|
|
|
|
|
II-105
SCHEDULE XV
OF SUBSIDIARY REGISTRANTS
|
|
|
|
|
COLUMBIA MEDICAL CENTER OF ARLINGTON SUBSIDIARY, L.P.
|
|
|
|
|
COLUMBIA MEDICAL CENTER OF DENTON SUBSIDIARY, L.P.
|
|
|
|
|
COLUMBIA MEDICAL CENTER OF LEWISVILLE SUBSIDIARY, L.P.
|
|
|
|
|
COLUMBIA MEDICAL CENTER OF MCKINNEY SUBSIDIARY, L.P.
|
|
|
|
|
COLUMBIA MEDICAL CENTER OF PLANO SUBSIDIARY, L.P.
|
|
|
|
|
COLUMBIA NORTH HILLS HOSPITAL SUBSIDIARY, L.P.
|
|
|
|
|
COLUMBIA PLAZA MEDICAL CENTER OF FORT WORTH SUBSIDIARY, L.P.
|
|
|
|
|
GREEN OAKS HOSPITAL SUBSIDIARY, L.P.
|
|
|
|
|
II-106